"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,GB,B,GB 2451534 B,024-067-247-470-627,2009-06-17,2009,GB 0804530 A,2008-03-12,GB 0804530 A,2008-03-12,Windscreen clearing apparatus,,DOHERTY PATRICK,DOHERTY PATRICK,,https://lens.org/024-067-247-470-627,Granted Patent,no,2,0,4,4,0,B60S1/54;;B60S1/548;;B60S1/54;;B60S1/548,B60S1/54,,0,0,,,,INACTIVE
2,AU,A,AU 1994/078966 A,085-054-389-986-135,1996-05-16,1996,AU 1994/078966 A,1994-06-21,AU 1994/078966 A,1994-06-21,Lampholder,,SEAPART LTD,DOHERTY PATRICK,,https://lens.org/085-054-389-986-135,Patent Application,no,0,0,2,2,0,,H01R13/453;;H01R33/46,,0,0,,,,EXPIRED
3,US,A1,US 2023/0186706 A1,023-021-028-167-652,2023-06-15,2023,US 202318108782 A,2023-02-13,US 202318108782 A;;US 202117465576 A;;US 202016925066 A;;US 202263310411 P;;US 202263349228 P;;US 202263408629 P;;US 202063028040 P,2020-05-21,HEALTH BASED DIGITAL FUNCTIONALITY AND ACCESS CONTROL,"The present disclosure includes embodiments for restricting or varying digital access or digital functionality based on health data. In one example, a method to vary functionality for an application is disclosed. The method includes receiving health data corresponding to a health status of a user, determining that the health status does not satisfy a health standard for an organization, and disabling at least one function for an application communicating with one or more devices of the organization based on the health status.",SATURDAY CAPITAL LLC,DOHERTY PATRICK,,https://lens.org/023-021-028-167-652,Patent Application,yes,0,0,1,3,0,H04L67/12;;G01K13/20;;G01K1/024;;G07C9/20;;G07C9/257;;G01K7/02;;H04L67/12;;G07C9/253,G07C9/25;;G01K7/02;;H04L67/12,,0,0,,,,PENDING
4,US,A,US 1628036 A,192-056-814-258-787,1927-05-10,1927,US 8809926 A,1926-02-13,US 8809926 A,1926-02-13,Vehicle headlight-dimming device,,PATRICK DOHERTY,PATRICK DOHERTY,,https://lens.org/192-056-814-258-787,Granted Patent,no,0,3,1,1,0,B60Q1/1438;;B60Q1/1438,B60Q1/14,,0,0,,,,EXPIRED
5,US,A,US 814945 A,049-857-838-481-073,1906-03-13,1906,US 1905/0268063 A,1905-07-03,US 1905/0268063 A,1905-07-03,SELF-REGISTERING FAUCET.,,DOHERTY PATRICK,DOHERTY PATRICK,,https://lens.org/049-857-838-481-073,Granted Patent,no,0,0,1,1,0,B67D7/22;;B67D7/22,,,0,0,,,,EXPIRED
6,GB,A,GB 2484385 A,114-058-813-796-241,2012-04-11,2012,GB 201116996 A,2011-10-03,GB 201016588 A,2010-10-04,Tyre bale and concrete block,"There is described a method of making constructional units from tires. The method uses a number of tyres which are severed into a tread portion and sidewall portions. The sidewall portions are formed into an annular stack having a central aperture into which the tread portions are placed to form a substantially solid cylindrical block of tyre parts. The block is then encased in concrete to form a constructional unit. Also described is a constructional unit made using the method, and a constructional unit comprising at least one block of tyre material encased in concrete, the block (or each block) comprising an annular stack of severed side wall portions filled with severed tread portions. The tyre block may be placed in a bag before encasing in concrete and haggles of the bag may provide lifting loops for the cast block. Waste tyre rubber can be recycled in this way and the concrete prevents leaching.",DOHERTY PATRICK,DOHERTY PATRICK,,https://lens.org/114-058-813-796-241,Patent Application,no,5,0,3,3,0,E04C1/40;;E04C1/41;;E04C1/40,E04C1/41;;E04C1/40,,0,0,,,,DISCONTINUED
7,WO,A1,WO 2009/112807 A1,103-866-733-807-613,2009-09-17,2009,GB 2009000598 W,2009-03-03,GB 0804530 A,2008-03-12,WINDSCREEN CLEARING APPARATUS,"Windscreen clearing apparatus comprising a reservoir for storing a gas, and a delivery device operatively connected to the reservoir. The delivery device is arranged, in use, to deliver a sequenced plurality of pulsed jets (5, 6, 7) of gas from the reservoir to a surface (8, 9, 10) of the windscreen, such that the sequencing of the plurality of jets pushes water across the windscreen. There is also described a vehicle comprising the windscreen clearing apparatus.",DOHERTY PATRICK,DOHERTY PATRICK,,https://lens.org/103-866-733-807-613,Patent Application,yes,5,1,4,4,0,B60S1/54;;B60S1/548;;B60S1/54;;B60S1/548,B60S1/54,,0,0,,,,PENDING
8,GB,A,GB 2451534 A,172-260-776-068-861,2009-02-04,2009,GB 0804530 A,2008-03-12,GB 0804530 A,2008-03-12,Windscreen clearing apparatus,"Windscreen clearing apparatus comprises a reservoir for storing a gas such as air, and a delivery device operatively connected to the reservoir, the delivery device arranged, in use, to deliver a sequenced plurality of pulsed jets of gas from the reservoir to a surface of the windscreen 2, 3, such that the sequencing of the plurality of push water across the windscreen 2, 3. The delivery device preferably includes a plurality of nozzles arranged in groups 5, 6, 7 and a processor maybe present to control the gas flow across the windshield 2, 3 as a result of vehicle speed, temperature, pressure, external precipitation and rain on the windscreen 2, 3.",DOHERTY PATRICK,DOHERTY PATRICK,,https://lens.org/172-260-776-068-861,Patent Application,no,2,0,4,4,0,B60S1/54;;B60S1/548;;B60S1/54;;B60S1/548,B60S1/54,,0,0,,,,INACTIVE
9,US,A1,US 2020/0391628 A1,119-013-133-984-743,2020-12-17,2020,US 202016835590 A,2020-03-31,US 202016835590 A;;US 201962921372 P,2019-06-13,Retractable Middle Car Seat Cushion,A front driver and passenger bucket car seat is provided. The middle seat cushion of both the front driver and passenger bucket seats can be detachable to retrieve or store objects from the car floor. The middle seat cushion of a front car seat can be flipped up for easy cleaning of the floor of the car under the front seats.,DOHERTY CHARLES PATRICK,DOHERTY CHARLES PATRICK,,https://lens.org/119-013-133-984-743,Patent Application,yes,0,1,1,1,0,B60N2/36;;B60N2/70;;B60N2/3047;;B60N3/002;;B60R7/043,B60N2/36;;B60N3/00,,0,0,,,,DISCONTINUED
10,WO,A1,WO 1986/001787 A1,121-656-716-461-339,1986-03-27,1986,GB 8500435 W,1985-09-20,GB 8424049 A;;GB 8426219 A;;GB 8429363 A;;GB 8500422 A;;GB 8512860 A;;GB 8517758 A;;GB 8518648 A,1984-09-22,PRESSURISED CONTAINER BUTTON ASSEMBLY,"A button assembly for controlling the discharge of fluid from a pressurised container having a displaceable valve actuating member which when moved relative to the container in at least one predetermined direction opens a valve in a discharge passage communicating with the interior of the container and its surroundings. The button assembly is permanently secured to the container, and a manually movable actuator (10) forming part of the assembly is movable relative to the container from a first position to a second position so as to displace the valve actuating member (13) and thereby connect the discharge passage to the surroundings. The actuator is automatically returned to the first position when the button assembly is released. The actuator defines surfaces (20) which interengage with surfaces (19) of the remainder of the button assembly such that movement of the actuator from the first to the second position requires relative movement between the portions of the button assembly defining the said surfaces in at least two mutually inclined directions. Actuation can require sequential twisting and pressing movements, or push and press movements, or lift and push movements for example.",DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/121-656-716-461-339,Patent Application,yes,7,8,3,9,0,B65D83/20;;B65D83/205;;B65D83/206;;B65D2215/02;;B65D2215/04,B65D83/16,F1R R3A3D2        R3A3D2,0,0,,,,PENDING
11,GB,B,GB 2289806 B,132-507-189-025-85X,1998-01-14,1998,GB 9509085 A,1995-05-04,GB 9408868 A;;GB 9409834 A,1994-05-04,Lampholder,,DOHERTY PATRICK JAMES,DOHERTY PATRICK JAMES,,https://lens.org/132-507-189-025-85X,Granted Patent,no,8,0,3,5,0,H01R13/4532;;H01R33/46;;H01R33/955,H01R13/453;;H01R33/46;;H01R33/955,H2E ECAC          ECAC;;H2E EDBA          EDBA274;;H2E E274          EDBA274;;U1S S1931,0,0,,,,EXPIRED
12,WO,A1,WO 1986/003277 A1,007-256-927-640-200,1986-06-05,1986,GB 8500543 W,1985-11-26,GB 8429860 A;;GB 8431853 A;;GB 8508177 A,1984-11-27,CEILING ROSES,"A ceiling rose comprising a base assembly (1) to be secured on a flat surface, a cover assembly (11) which is mountable on the base assembly, and first terminals (2-5) supported by the base assembly for connection to a supply cable. The cover assembly comprises second terminals (13) connected to a lighting assembly (18), the arrangement of the terminals being such that each of the second terminals is electrically connected to a corresponding one of the first terminals when the cover assembly is mounted on the base assembly.",KUDOS LIGHTING LTD,DOHERTY PATRICK JOHN,,https://lens.org/007-256-927-640-200,Patent Application,yes,5,15,6,10,0,F21V21/03;;H02G3/20,F21V21/03;;H02G3/20,H2E ECBF          ECBF;;H2E ECBX          ECBX;;U1S S1931,0,0,,,,PENDING
13,GB,A,GB 2296830 A,042-510-239-594-677,1996-07-10,1996,GB 9526031 A,1995-12-20,GB 9426298 A,1994-12-28,shuttered lampholder,"A safety lampholder comprises a housing (400) with slots (401) to receive bayonet pins (500) of an inserted bulb. Resilient bulb engaging contacts (520) supply electricity to the inserted bulb. The contacts (520) have ramp formations (522) at their respective free ends. A rotatable apertured shutter means (480) in also located within the housing (400) for selectively obstructing access to the contacts (520). The shutter (480) requires axial and rotational insertion of a bulb to actuate its displacement, between a first inoperative position in which it obstructs the contacts and the contacts are offset from the shutter apertures (492), and a second operative position in which the free ends of the contacts extend through the apertures (492) in the shutter means to bear against an inserted bulb. Both axial and rotational removal of a bulb actuates displacement of the shutter means (480) to drive the contacts (520) inwardly of the housing (400) and against the bias of the contacts (520) to the first inoperative position by interengagement of the shutter means (450) with ramp formations (522) on the contacts. Oppositely sloped cams (402, 484) engaged by a bulb bayonet pin cause the shutter to be actuated during axial movement of the bulb. <IMAGE>",DOHERTY PATRICK JAMES,DOHERTY PATRICK JAMES,,https://lens.org/042-510-239-594-677,Patent Application,no,1,1,5,5,0,H01R13/4532;;H01R13/4538;;H01R33/46,H01R13/453;;H01R33/46,H2E EDBA          EDBA271;;H2E E271          EDBA271,0,0,,,,EXPIRED
14,GB,B,GB 2273829 B,103-345-064-063-851,1996-08-21,1996,GB 9323541 A,1993-11-15,GB 9323541 A;;GB 9223784 A;;GB 9321263 A,1992-11-13,Lampholder,,DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/103-345-064-063-851,Granted Patent,no,1,0,3,5,0,H01R33/962;;H01R33/46;;H01R33/96;;H01R33/9656,H01R33/46;;H01R33/96;;H01R33/965,H2E ECAAT         ECAAT;;H2E ECCA          ECCA,0,0,,,,EXPIRED
15,WO,A1,WO 1984/000854 A1,117-079-550-117-826,1984-03-01,1984,GB 8300192 W,1983-08-04,GB 8222857 A;;GB 8223467 A;;GB 8226970 A;;GB 8235840 A;;GB 8304347 A;;GB 8306273 A;;GB 8307733 A;;GB 8312225 A,1982-08-09,LAMPHOLDER,"A safety lampholder in which in the absence of a bulb contacts that are accessible within the lampholder socket are electrically isolated from fixed terminals to which a supply cable is connected. The contacts are supported on a carrier and can only be moved into engagement with the fixed terminals by applying a force to a pin or pins extending into the socket. The pin may be sharp so that it cannot be pushed by an unprotected finger, or may lie along the wall of the socket so that its tip does not provide sufficient grip to an inserted finger. The pin and carrier may be relatively movable, movement of the pin relative to the carrier causing the carrier to rotate to a position in which it may move axially towards the fixed terminals.",DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/117-079-550-117-826,Patent Application,yes,6,0,7,12,0,H01R33/96;;H01R33/962,H01R33/46;;H01R33/96,H2E ECAA          ECAA;;H2E E114          ECAA;;U1S S1922,0,0,,,,PENDING
16,AU,A,AU 1996/050712 A,180-152-927-816-364,1997-10-23,1997,AU 1996/050712 A,1996-04-16,AU 1996/050712 A,1996-04-16,Lampholder,,SEAPART LTD,DOHERTY PATRICK JAMES,,https://lens.org/180-152-927-816-364,Patent Application,no,0,0,2,2,0,,F21V19/00;;H01R13/447,,0,0,,,,EXPIRED
17,GB,A,GB 2267607 A,180-724-497-937-609,1993-12-08,1993,GB 9309108 A,1993-05-04,GB 9309108 A;;GB 9209523 A;;GB 9211747 A;;GB 9214889 A;;GB 9218840 A,1992-05-01,Shuttered lampholder,"A shuttered lampholder comprises a body (10) having slots (11) to receive bayonet pins of a bulb. Electrical contacts (60) are located in the body (10), preferably within an axially movable contact carrier (30). A rotatable shutter (20) having apertures (26) is mounted in the body (10) for selectively obstructing access to the contacts (60). Rotation of the shutter (20) is actuable, directly or indirectly, by rotation of the inserted bulb. The shutter (20) or other part of the lampholder has surface formations (24), suitably of ramp form, to directly or indirectly actuate axial displacement of contacts (60) when the shutter is rotated, for example by moving the contact carrier (30). The lampholder may assume a first inoperative position in which the contacts are located behind the shutter (20) and second operative position in which they extend through apertures (26) in the shutter (20) so as to be available to supply electricity to an inserted bulb. <IMAGE>",DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/180-724-497-937-609,Patent Application,no,1,14,3,7,0,H01R13/4532;;H01R13/71;;H01R33/96,H01R13/453;;H01R13/71;;H01R33/96,H2E ECAAF         ECAAF;;H2E ECABF         ECAAF;;H2E EDBA          EDBA271;;H2E E271          EDBA271;;U1S S1928,0,0,,,,EXPIRED
18,AU,A,AU 1987/069351 A,196-043-287-549-381,1987-08-25,1987,AU 1987/069351 A,1987-02-02,GB 8602991 A;;GB 8604365 A;;GB 8629850 A,1986-02-06,LAMPHOLDER,,KUDOS LIGHTING LTD,DOHERTY PATRICK JOHN,,https://lens.org/196-043-287-549-381,Patent Application,no,0,0,7,15,0,H01R33/9656;;H01R33/96,H01R33/96;;H01R33/965,,0,0,,,,EXPIRED
19,AU,A,AU 1995/030496 A,196-714-512-724-962,1997-03-13,1997,AU 1995/030496 A,1995-09-06,AU 1995/030496 A,1995-09-06,Lampholder,,DOHERTY PATRICK JAMES,DOHERTY PATRICK JAMES,,https://lens.org/196-714-512-724-962,Patent Application,no,0,0,2,2,0,,F21V15/00;;F21V25/00;;H01R13/44;;H01R13/447;;H01R13/453,,0,0,,,,EXPIRED
20,CA,A,CA 19565 A,003-802-965-261-973,1884-06-14,1884,CA 19565D A,,CA 19565T A,,SKATE,,DOHERTY PATRICK J,DOHERTY PATRICK J,,https://lens.org/003-802-965-261-973,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
21,US,A,US 998604 A,116-789-236-552-619,1911-07-25,1911,US 1908/0462275 A,1908-11-12,US 1908/0462275 A,1908-11-12,SHOE.,,UNITED SHOE MACHINERY AB,DOHERTY PATRICK H,,https://lens.org/116-789-236-552-619,Granted Patent,no,0,0,1,1,0,A43B9/06;;A43B9/06,,,0,0,,,,EXPIRED
22,GB,A,GB 2279825 A,161-503-719-412-763,1995-01-11,1995,GB 9413759 A,1994-07-07,GB 9413759 A;;GB 9314120 A;;GB 9316164 A,1993-07-08,Lampholder,"A safety lampholder for a bayonet bulb comprises a housing 10 defining slots 11 to receive the bayonet pins of a bulb. Contacts 57 are provided within the housing 10. Axially moveable and rotatable shutter means 20 are also provided for selectively obstructing access to the contacts 57 and are moveable between a first inoperative position, in which the contacts 57 are shielded by the shutter means 20, and a second operative position in which the contacts 57 extend through apertures in the shutter means 20 for bearing against pad electrodes 101 of a bulb. Axial displacement of the shutter means is inhibited by shutter stops 26 abutting ribs 59 on a terminal block 50. On axial insertion of a bulb into the lampholder, the bulb shoulder 100 pushes shutter driving means 40 inwardly of the housing to rotate the shutter means by cooperating cams 24, 42 or gears and to align shutter apertures with the contacts. This displaces the shutter stops 26 relative to the ribs 59, to allow displacement of the shutter means 20 axially inwardly of the housing to the second operative position. The bulb is subsequently rotated to secure its bayonet pins in slots 11. The shutter means can comprise shutter halves driven to rotate relative to one another to release the stops and align the apertures. <IMAGE>",SEAPART LIMITED,DOHERTY PATRICK JAMES,,https://lens.org/161-503-719-412-763,Patent Application,no,2,13,3,6,0,H01R13/4532;;H01R33/46,H01R13/453;;H01R33/46,H2E EDBA          EDBA274;;H2E E274          EDBA274;;U1S S1931,0,0,,,,EXPIRED
23,DE,D1,DE 3371840 D1,018-641-008-204-467,1987-07-02,1987,DE 3371840 T,1983-08-04,GB 8222857 A;;GB 8223467 A;;GB 8226970 A;;GB 8235840 A;;GB 8304347 A;;GB 8306273 A;;GB 8307733 A;;GB 8312225 A,1982-08-09,LAMPHOLDER,,KUDOS LIGHTING LTD,DOHERTY PATRICK JOHN,,https://lens.org/018-641-008-204-467,Granted Patent,no,0,0,7,12,0,H01R33/96;;H01R33/962,H01R33/46;;H01R33/96,,0,0,,,,EXPIRED
24,EP,A1,EP 0101257 A1,024-743-358-212-621,1984-02-22,1984,EP 83304504 A,1983-08-04,GB 8222857 A;;GB 8223467 A;;GB 8226970 A;;GB 8235840 A;;GB 8304347 A;;GB 8306273 A;;GB 8307733 A;;GB 8312225 A,1982-08-09,Lampholder.,"A safety lampholder in which in the absence of a bulb contacts that are accessible within the lampholder socket are electrically isolated from fixed terminals to which a supply cable is connected. The contacts are supported on a carrier and can only be moved into engagement with the fixed terminals by applying a force to a pin or pins extending into the socket. The pin may be sharp so that it cannot be pushed by an unprotected finger, or may lie along the wall of the socket so that its tip does not provide sufficient grip to an inserted finger. The pin and carrier may be relatively movable, movement of the pin relative to the carrier causing the carrier to rotate to a position in which it may move axially towards the fixed terminals.",DOHERTY PATRICK J,DOHERTY PATRICK JOHN,KUDOS LIGHTING LIMITED (1986-05-21),https://lens.org/024-743-358-212-621,Patent Application,yes,6,4,7,12,0,H01R33/96;;H01R33/962,H01R33/46;;H01R33/96,,0,0,,,,EXPIRED
25,US,A,US 4768966 A,034-360-440-901-228,1988-09-06,1988,US 4217187 A,1987-06-11,GB 8413467 A;;GB 8502384 A;;GB 8502858 A,1984-05-25,Lampholder,"A lampholder for a screw-in lightbulb has a body supporting two cable terminals for connection to an electrical supply, and a contact carrier mounted on the body and defining a bulb receiving socket, the contact carrier being movable between first and second positions relative to the body in a direction parallel to the insertion direction of a bulb and supporting terminals which connect an inserted bulb to the cable terminals when the carrier is in the first position but are spaced from the cable terminals when the carrier is in the second position. A spring pushes the carrier to the second position. When a bulb is screwed part-way into the carrier socket it bears against a fixed abutment so that the carrier is moved from the second to the first positions as the bulb is screwed fully into the socket. Each cable terminal overlaps with a respective carrier terminal in the axial direction and an insulating support is provided which is fixed in position relative to one terminal of each cable/contact terminal pair. The insulating support is such that as the carrier moves from the first to the second positions the terminal which moves is moved onto the partition and out of contact with the other terminal.",DOHERTY PATRICK J,DOHERTY PATRICK J,KUDOS LIGHTING LIMITED (1986-02-05),https://lens.org/034-360-440-901-228,Granted Patent,yes,4,21,4,7,0,H01R13/44;;H01R33/962;;H01R33/962;;H01R13/44,H01R13/44;;H01R33/96,439/137;;439/140;;439/360;;439/667,0,0,,,,EXPIRED
26,IN,B,IN 169313 B,168-741-242-426-41X,1991-09-28,1991,IN 78MA1987 A,1987-02-05,GB 8602991 A,1986-02-06,A SAFETY LAMPHOLDER FOR RECEIVING A BAYONET BULB,,KUDOS LIGHTING LTD,PATRICK JOHN DOHERTY,,https://lens.org/168-741-242-426-41X,Granted Patent,no,0,0,2,15,0,,H01R33/96;;H01R33/97;;H01R33/975,,0,0,,,,EXPIRED
27,AU,B2,AU 659627 B2,092-258-137-874-071,1995-05-25,1995,AU 1992/011166 A,1992-02-21,GB 9103782 A;;GB 9103928 A;;GB 9109551 A,1991-02-22,Lampholder,,DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/092-258-137-874-071,Granted Patent,no,3,1,5,8,0,H01R33/96,H01R33/96,,0,0,,,,EXPIRED
28,EP,A1,EP 0181907 A1,098-743-912-199-095,1986-05-28,1986,EP 85902593 A,1985-05-24,GB 8413467 A;;GB 8502384 A;;GB 8502858 A,1984-05-25,LAMPHOLDER.,"Une douille pour une ampoule à visser comporte un corps (1) soutenant deux bornes de câble (12, B) en vue d'une connexion à une alimentation électrique, ainsi qu'un support de contact (5) monté sur le corps (1) et déterminant un porte-lampe recevant l'ampoule, le support de contact (5) étant déplaçable entre une première et une seconde positions par rapport au corps (1) dans une direction parallèle à la direction d'insertion d'une ampoule et comportant des bornes (9, 10) connectant une ampoule insérée aux bornes de câble (12, B) lorsque le support (5) se trouve dans la première position, mais espacées des bornes du câble (12, 13) lorsque le support (5) se trouve dans la seconde position. Un ressort (7) pousse le support (5) dans la seconde position. Lorsqu'une ampoule est vissée partiellement dans le porte-lampe du support (5), elle porte contre une butée fixe, si bien que le support (5) passe de la seconde à la première position lorsque l'ampoule est vissée entièrement dans le porte-lampe. Chaque borne de câble (12, 13) est recouverte d'une borne de support respective (9, 10) dans la direction axiale et une séparation (18) est prévue et fixée en position par rapport à une borne de chaque paire de bornes de câble/de contact. Les dimensions de la séparation (18) sont telles qu'elle s'étend entre les bornes de la paire lorsque le support (5) se trouve dans la seconde position mais n'empêche pas le contact entre les bornes de la paire lorsque le support (5) se trouve dans la première position; les formations d'interengagement de la séparation (18) et de la borne (9, 10) qui se déplace par rapport à elle sont telles que, au fur et à mesure que le support (5) passe de la première à la seconde position, la borne (9, 10) qui se déplace est soulevée sur la séparation et dégagée du contact avec l'autre borne (12, 13).",KUDOS LIGHTING LTD,DOHERTY PATRICK JOHN,,https://lens.org/098-743-912-199-095,Patent Application,yes,0,1,4,7,0,H01R13/44;;H01R33/962;;H01R33/962;;H01R13/44,H01R13/44;;H01R33/96,,0,0,,,,DISCONTINUED
29,EP,A1,EP 0203134 A1,146-576-128-723-950,1986-12-03,1986,EP 85905865 A,1985-11-26,GB 8429860 A;;GB 8431853 A;;GB 8508177 A,1984-11-27,CEILING ROSES.,"Rosace de plafond comportant un ensemble de base (1) se fixant sur une surface plate, un cache (11) se montant sur l'ensemble de base, et des premières bornes (2-5) portées par l'ensemble de base pour raccordement à un câble d'alimentation. L'ensemble de base comprend des secondes bornes (13) raccordées à un ensemble d'éclairage (18), les bornes étant disposées de sorte que chacune des secondes bornes est reliée électriquement à celle des premières bornes qui lui correspond lorsque le cache est monté sur l'ensemble de base.",KUDOS LIGHTING LTD,DOHERTY PATRICK JOHN,,https://lens.org/146-576-128-723-950,Patent Application,yes,0,0,6,10,0,F21V21/03;;H02G3/20,F21V21/03;;H02G3/20,,1,0,,,See references of WO 8603277A1,DISCONTINUED
30,EP,B1,EP 2898164 B1,048-227-125-414-230,2019-04-10,2019,EP 13777305 A,2013-09-11,GB 201216222 A;;GB 201303042 A;;GB 2013052375 W,2012-09-12,A DOOR GUARD ASSEMBLY,,DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/048-227-125-414-230,Granted Patent,yes,8,0,5,7,0,E05C17/04;;E05C17/166;;E05C17/30;;E05C17/365;;E05B15/04;;E05B17/0041;;Y10T292/31;;Y10T292/31;;E05B15/04;;E05B17/0041;;E05C17/365;;E05C17/30;;E05C17/166;;E05C17/04;;E05C17/48,E05C17/04;;E05C17/30;;E05C17/36,,0,0,,,,ACTIVE
31,GB,B,GB 2221804 B,182-471-891-786-247,1992-09-16,1992,GB 8910519 A,1989-05-08,GB 8810852 A,1988-05-07,SAFETY LAMPHOLDER,,KUDOS LIGHTING LTD;;DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/182-471-891-786-247,Granted Patent,no,3,0,4,4,0,H01R13/4532;;H01R33/46,H01R13/453;;H01R33/46,H2E EDBA          EDBA274;;H2E E274          EDBA274;;U1S S1928,0,0,,,,EXPIRED
32,EP,A1,EP 3894647 A1,043-991-174-887-976,2021-10-20,2021,EP 19839114 A,2019-12-11,GB 201820391 A;;GB 201905701 A;;GB 201908409 A;;GB 201915746 A;;GB 2019053509 W,2018-12-13,DOOR LOCK,,DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/043-991-174-887-976,Patent Application,yes,0,0,7,10,0,E05C19/182;;E05C19/182;;E05C19/182;;E05C19/188,E05C19/18,,0,0,,,,DISCONTINUED
33,GB,B,GB 2296830 B,088-258-325-899-773,1999-01-06,1999,GB 9526031 A,1995-12-20,GB 9426298 A,1994-12-28,Lampholder,,DOHERTY PATRICK JAMES,DOHERTY PATRICK JAMES,,https://lens.org/088-258-325-899-773,Granted Patent,no,1,0,5,5,0,H01R13/4532;;H01R13/4538;;H01R33/46,H01R13/453;;H01R33/46,H2E EDBA          EDBA271;;H2E E271          EDBA271,0,0,,,,EXPIRED
34,AU,A,AU 1994/064841 A,148-156-439-263-631,1995-06-15,1995,AU 1994/064841 A,1994-06-21,AU 1994/064841 A;;AU PM278393 A,1993-12-06,Safety lampholder,,CLIPSAL AUSTRALIA PTY LTD,DOHERTY PATRICK JOHN,,https://lens.org/148-156-439-263-631,Patent Application,no,0,0,2,3,0,,F21V25/00;;F21V25/02;;H01R13/44;;H01R33/46,,0,0,,,,EXPIRED
35,WO,A1,WO 1985/005740 A1,069-303-108-589-446,1985-12-19,1985,GB 8500225 W,1985-05-24,GB 8413467 A;;GB 8502384 A;;GB 8502858 A,1984-05-25,LAMPHOLDER,"A lampholder for a screw-in lightbulb has a body (1) supporting two cable terminals (12, B) for connection to an electrical supply, and a contact carrier (5) mounted on the body (1) and defining a bulb receiving socket, the contact carrier (5) being movable between first and second positions relative to the body (1) in a direction parallel to the insertion direction of a bulb and supporting terminals (9, 10) which connect an inserted bulb to the cable terminals (12, B) when the carrier (5) is in the first position but are spaced from the cable terminals (12, 13) when the carrier (5) is in the second position. A spring (7) pushes the carrier (5) to the second position. When a bulb is screwed part-way into the carrier socket (5) it bears against a fixed abutment so that the carrier (5) is moved from the second to the first positions as the bulb is screwed fully into the socket. Each cable terminal (12, 13) overlaps with a respective carrier terminal (9, 10) in the axial direction and a partition (18) is provided which is fixed in position relative to one terminal of each cable/contact terminal pair. The dimensions of the partition (18) are such that it extends between the terminals of the pair when the carrier (5) is in the second position but does not obstruct contact between the terminals of the pair when the carrier (5) is in the first position, and the interengaging formations of the partition (18) and the terminal (9, 10) which moves relative to it are such that as the carrier (5) moves from the first at the second positions the terminal (9, 10) which moves is lifted onto the partition and out of contact with the other terminal (12, 13).",KUDOS LIGHTING LTD,DOHERTY PATRICK JOHN,,https://lens.org/069-303-108-589-446,Patent Application,yes,4,3,4,7,0,H01R13/44;;H01R33/962;;H01R33/962;;H01R13/44,H01R13/44;;H01R33/96,H2E ECAA          ECAA;;H2E ECAAX         ECAAX301;;H2E E301          ECAAX301,1,0,,,"Machine Design, Volume 42, Nr. 13, 28 May 1970, Cleveland (US) ""Shockless Lamp Socket"", page 44",PENDING
36,GB,B,GB 2279825 B,085-727-957-183-642,1996-12-18,1996,GB 9413759 A,1994-07-07,GB 9413759 A;;GB 9314120 A;;GB 9316164 A,1993-07-08,LAmpholder,,SEAPART LIMITED,DOHERTY PATRICK JAMES,,https://lens.org/085-727-957-183-642,Granted Patent,no,2,0,3,6,0,H01R13/4532;;H01R33/46,H01R13/453;;H01R33/46,H2E EDBA          EDBA274;;H2E E274          EDBA274;;U1S S1931,0,0,,,,EXPIRED
37,GB,B,GB 2267607 B,123-877-963-082-274,1996-01-24,1996,GB 9309108 A,1993-05-04,GB 9309108 A;;GB 9209523 A;;GB 9211747 A;;GB 9214889 A;;GB 9218840 A,1992-05-01,Safety lampholder,,DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/123-877-963-082-274,Granted Patent,no,1,0,3,7,0,H01R13/4532;;H01R13/71;;H01R33/96,H01R13/453;;H01R13/71;;H01R33/96,H2E EDBA          EDBA271;;H2E E271          EDBA271;;U1S S1928,0,0,,,,EXPIRED
38,CA,A,CA 129918 A,116-387-258-707-325,1910-12-20,1910,CA 129918D A,1907-11-20,CA 129918T A,1907-11-20,GRIPPER,,UNITED SHOE MACHINERY AB;;DOHERTY PATRICK HENRY,DOHERTY PATRICK HENRY,,https://lens.org/116-387-258-707-325,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
39,US,B2,US 10865593 B2,150-305-875-548-80X,2020-12-15,2020,US 201314427289 A,2013-09-11,GB 201216222 A;;GB 201303042 A;;GB 2013052375 W,2012-09-12,Door guard assembly,"A door guard assembly is provided comprising: a first part that is attachable to a door; a second part that is attachable to a door frame; an elongate member; a slidable plate that comprises a receiving means; wherein the first part and/or the second part and/or the elongate member further comprise(s) a dampening means; and, wherein the elongate member is attached to the first part or the second part and in use can be engaged with the receiving means of the plate located on the other first or second part respectively when the plate is slid into an operating position such that the receiving means engages the outer surface of the elongate member as the door is opened and the receiving means and elongate member thus limit the opening of the door, and the dampening means absorbs an impact force that may be applied to the door whose opening has been limited in this way.",DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/150-305-875-548-80X,Granted Patent,yes,40,2,5,7,0,E05C17/04;;E05C17/166;;E05C17/30;;E05C17/365;;E05B15/04;;E05B17/0041;;Y10T292/31;;Y10T292/31;;E05B15/04;;E05B17/0041;;E05C17/365;;E05C17/30;;E05C17/166;;E05C17/04;;E05C17/48,E05C17/48;;E05B15/04;;E05B17/00;;E05C17/04;;E05C17/16;;E05C17/30;;E05C17/36,,1,0,,,International Search Report and Written Opinion for PCT/GB2013/052375.,ACTIVE
40,AU,B2,AU 700240 B2,187-066-229-098-688,1998-12-24,1998,AU 1995/030496 A,1995-09-06,AU 1995/030496 A,1995-09-06,Lampholder,,DOHERTY PATRICK JAMES,DOHERTY PATRICK JAMES,,https://lens.org/187-066-229-098-688,Granted Patent,no,3,0,2,2,0,,F21V15/00;;F21V25/00;;H01R13/44;;H01R13/447;;H01R13/453,,0,0,,,,EXPIRED
41,EP,A1,EP 0195061 A1,040-111-929-631-569,1986-09-24,1986,EP 85904838 A,1985-09-20,GB 8424049 A;;GB 8426219 A;;GB 8429363 A;;GB 8500422 A;;GB 8512860 A;;GB 8517758 A;;GB 8518648 A,1984-09-22,PRESSURISED CONTAINER BUTTON ASSEMBLY.,"Un agencement de bouton pour commander la décharge d'un fluide d'un récipient pressurisé comprend un élément mobile d'actionnement d'une soupape qui, lorsqu'on le déplace par rapport au récipient dans au moins une position prédéterminée, ouvre une soupape dans un passage de décharge en communication avec l'intérieur du récipient et avec l'environnement. L'agencement de bouton est fixé de façon permanente au récipient, et un dispositif mobile de commande manuelle (10) faisant partie de l'agencement peut être déplacé par rapport au récipient depuis une première position jusqu'à une deuxième position de façon à déplacer l'élément d'actionnement (13) de soupape et connecter ainsi le passage de décharge avec l'environnement. Le dispositif de commande revient automatiquement à la première position lorsque l'on relâche l'agencement de bouton. Le dispositif de commande définit des surfaces (20) qui enclenchent des surfaces (19) du reste de l'agencement de bouton, de telle sorte que le déplacement du dispositif de commande de la première à la deuxième position nécessite un déplacement relatif entre les parties de l'agencement de bouton qui définissent lesdites surfaces dans au moins deux directions inclinées l'une par rapport à l'autre. La commande peut nécessiter des mouvements consécutifs de torsion et de pression, ou de poussée et de pression, ou d'élévation et de poussée, par exemple.",DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/040-111-929-631-569,Patent Application,yes,0,0,3,9,0,B65D83/20;;B65D83/205;;B65D83/206;;B65D2215/02;;B65D2215/04,B65D83/16,,1,0,,,See references of WO 8601787A1,DISCONTINUED
42,ZA,B,ZA 974085 B,070-657-715-603-434,1997-12-09,1997,ZA 974085 A,1997-05-12,ZA 974085 A;;ZA 966771 A,1996-08-08,Board having thermal insulating properties.,,ALUCUSHION PROPRIETARY LTD,DOHERTY BRYAN PATRICK,,https://lens.org/070-657-715-603-434,Granted Patent,no,0,0,1,1,0,,B32B/;;E04B/;;F16L/,,0,0,,,,EXPIRED
43,EP,B1,EP 0101257 B1,071-688-444-206-266,1987-05-27,1987,EP 83304504 A,1983-08-04,GB 8222857 A;;GB 8223467 A;;GB 8226970 A;;GB 8235840 A;;GB 8304347 A;;GB 8306273 A;;GB 8307733 A;;GB 8312225 A,1982-08-09,LAMPHOLDER,,KUDOS LIGHTING LIMITED,"DOHERTY, PATRICK JOHN",KUDOS LIGHTING LIMITED (1986-05-21),https://lens.org/071-688-444-206-266,Granted Patent,yes,0,0,7,12,0,H01R33/96;;H01R33/962,H01R33/46;;H01R33/96,,0,0,,,,EXPIRED
44,CA,A,CA 134413 A,120-374-463-061-860,1911-07-18,1911,CA 134413D A,1909-05-26,CA 134413T A,1909-05-26,SHOE,,UNITED SHOE MACHINERY AB;;DOHERTY PATRICK HENRY,DOHERTY PATRICK HENRY,,https://lens.org/120-374-463-061-860,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
45,AU,A,AU 1985/044050 A,145-028-445-274-657,1985-12-31,1985,AU 1985/044050 A,1985-05-24,GB 8413467 A;;GB 8502384 A;;GB 8502858 A,1984-05-25,LAMPHOLDER,,KUDOS LIGHTING LTD,JOHN DOHERTY PATRICK,,https://lens.org/145-028-445-274-657,Patent Application,no,0,0,4,7,0,H01R13/44;;H01R33/962;;H01R33/962;;H01R13/44,H01R13/44;;H01R33/96,,0,0,,,,DISCONTINUED
46,AU,A,AU 1986/052003 A,182-169-250-535-90X,1986-06-18,1986,AU 1986/052003 A,1985-11-26,GB 8429860 A;;GB 8431853 A;;GB 8508177 A,1984-11-27,CEILING ROSES,,KUDOS LIGHTING LTD,JOHN DOHERTY PATRICK,,https://lens.org/182-169-250-535-90X,Patent Application,no,0,2,6,10,0,F21V21/03;;H02G3/20,F21V21/03;;H02G3/20,,0,0,,,,DISCONTINUED
47,AU,A,AU 1983/018254 A,184-588-188-885-309,1984-03-07,1984,AU 1983/018254 A,1983-08-04,GB 8222857 A;;GB 8223467 A;;GB 8226970 A;;GB 8235840 A;;GB 8304347 A;;GB 8306273 A;;GB 8307733 A;;GB 8312225 A,1982-08-09,LAMPHOLDER,,KUDOS LIGHTING LTD,JOHN DOHERTY PATRICK,,https://lens.org/184-588-188-885-309,Patent Application,no,0,0,7,12,0,H01R33/96;;H01R33/962,H01R33/46;;H01R33/96,,0,0,,,,EXPIRED
48,AU,B2,AU 575536 B2,191-542-242-694-803,1988-08-04,1988,AU 1983/018254 A,1983-08-04,GB 8222857 A;;GB 8223467 A;;GB 8226970 A;;GB 8235840 A;;GB 8304347 A;;GB 8306273 A;;GB 8307733 A;;GB 8312225 A,1982-08-09,LAMPHOLDER,,KUDOS LIGHTING LTD,DOHERTY PATRICK JOHN,,https://lens.org/191-542-242-694-803,Granted Patent,no,2,0,7,12,0,H01R33/96;;H01R33/962,H01R33/46;;H01R33/96,,0,0,,,,EXPIRED
49,US,A1,US 2017/0074013 A1,070-331-573-479-297,2017-03-16,2017,US 201615262209 A,2016-09-12,GB 201516028 A,2015-09-10,DOOR CHAIN DEVICE,A door chain assembly comprising a chain and an anchor plate. The anchor plate comprises a back plate and a chain-receiving plate and the chain-receiving plate extends from the back plate. The chain-receiving plate is provided with an aperture and/or a chain-holding slot. The chain comprises a plurality of links with adjacent links being rotationally offset with respect to one another.,DOHERTY PATRICK J,DOHERTY PATRICK J,,https://lens.org/070-331-573-479-297,Patent Application,yes,0,1,3,3,0,E05C17/365;;E05C17/365;;E05C17/365,E05C17/36,,0,0,,,,DISCONTINUED
50,EP,A1,EP 2898164 A1,100-956-642-492-134,2015-07-29,2015,EP 13777305 A,2013-09-11,GB 201216222 A;;GB 201303042 A;;GB 2013052375 W,2012-09-12,A DOOR GUARD ASSEMBLY,,DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/100-956-642-492-134,Patent Application,yes,0,0,5,7,0,E05C17/04;;E05C17/166;;E05C17/30;;E05C17/365;;E05B15/04;;E05B17/0041;;Y10T292/31;;Y10T292/31;;E05B15/04;;E05B17/0041;;E05C17/365;;E05C17/30;;E05C17/166;;E05C17/04;;E05C17/48,E05C17/04;;E05C17/30;;E05C17/36,,0,0,,,,ACTIVE
51,AU,B2,AU 736867 B2,125-385-498-838-065,2001-08-02,2001,AU 1996/050712 A,1996-04-16,AU 1996/050712 A,1996-04-16,Lampholder,,SEAPART LTD,DOHERTY PATRICK JAMES,,https://lens.org/125-385-498-838-065,Granted Patent,no,1,0,2,2,0,,F21V19/00;;H01R13/447,,0,0,,,,EXPIRED
52,US,A,US 912091 A,130-833-402-557-961,1909-02-09,1909,US 1908/0443357 A,1908-07-13,US 1908/0443357 A,1908-07-13,SELF-CLOSING FAUCET.,,DOHERTY PATRICK W,DOHERTY PATRICK W,,https://lens.org/130-833-402-557-961,Granted Patent,no,0,0,1,1,0,F16K31/52408;;F16K31/52408,,,0,0,,,,EXPIRED
53,US,A,US 3010774 A,144-617-871-746-732,1961-11-28,1961,US 79232159 A,1959-02-10,GB 3010774X A,1958-02-13,Workroom furniture,,JOHN DOHERTY PATRICK,JOHN DOHERTY PATRICK,,https://lens.org/144-617-871-746-732,Granted Patent,no,5,6,1,1,0,A61G15/14;;A61G15/14,A61G15/14,,0,0,,,,EXPIRED
54,GB,A,GB 2275833 A,176-408-152-234-167,1994-09-07,1994,GB 9404027 A,1994-03-02,GB 9304182 A,1993-03-02,Wall box,"A wall box, generally made of sheet metal, has a base (10) and four upstanding side walls (11). The box has an open front which is closable by a removable cover fastened to the box, for example by screws. A shield (530) shields any electrical conductors in the box from contact with, and potential damage by, the fastening means. The shield (530) may be formed from a piece of sheet metal deflected to form front, top and side panels 531, 522, 532, 533 respectively. Side panels 532 and 533 are also deflected to provide wings 532' and 533' respectively. Lugs 526 may be stamped out of side wall 11 to engage the wings 532' and 533', and a lug 553 is stamped from base 10 to engage front panel 531 of the shield 530. A shield may be separate from a screw-retainer of the box (figs. 1 to 3, figs. 4 to 6 not shown). Other embodiments disclose different shapes of shields and different organisations of shield, box and screw-retainer. <IMAGE>",DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/176-408-152-234-167,Patent Application,no,9,3,3,3,0,H02G3/18;;H02G3/081,H02G3/08;;H02G3/18,H1N NTM           NTM;;H1N N61X          NTM;;H2E EDCW          EDCW,0,0,,,,DISCONTINUED
55,US,A1,US 2022/0025685 A1,182-206-323-926-021,2022-01-27,2022,US 201917312047 A,2019-12-11,GB 201820391 A;;GB 201905701 A;;GB 201908409 A;;GB 201915746 A;;GB 2019053509 W,2018-12-13,DOOR LOCK,"A portable door locking device having a locking bar with a first section and a second section. The second section is pivotally connected to the first section, with the second section being provided with at least one section of enlarged thickness. A resiliently yieldable section is provided and the locking bar is at least partially received within the resiliently yieldable section.",DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/182-206-323-926-021,Patent Application,yes,5,0,7,10,0,E05C19/182;;E05C19/182;;E05C19/182;;E05C19/188,E05C19/18,,0,0,,,,DISCONTINUED
56,GB,B,GB 2253098 B,188-949-848-996-482,1995-05-03,1995,GB 9203670 A,1992-02-19,GB 9109551 A;;GB 9103928 A;;GB 9103782 A,1991-02-22,Lampholder,,DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/188-949-848-996-482,Granted Patent,no,4,0,5,8,0,H01R33/96,H01R33/96,H2E ECAC          ECAC,0,0,,,,EXPIRED
57,AU,A,AU 1992/011166 A,000-911-420-539-65X,1992-08-27,1992,AU 1992/011166 A,1992-02-21,GB 9103782 A;;GB 9103928 A;;GB 9109551 A,1991-02-22,LAMPHOLDER,,DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/000-911-420-539-65X,Patent Application,no,0,0,5,8,0,H01R33/96,H01R33/96,,0,0,,,,EXPIRED
58,AU,A,AU 1994/066175 A,044-864-036-872-965,1995-01-19,1995,AU 1994/066175 A,1994-07-06,GB 9314120 A,1993-07-08,Lampholder,,SEAPART LIMITED,DOHERTY PATRICK JAMES,,https://lens.org/044-864-036-872-965,Patent Application,no,0,0,2,6,0,,F21V25/00;;F21V25/02,,0,0,,,,PENDING
59,US,A1,US 2015/0240540 A1,064-617-302-432-32X,2015-08-27,2015,US 201314427289 A,2013-09-11,GB 201216222 A;;GB 201303042 A;;GB 2013052375 W,2012-09-12,Door Guard Assembly,"A door guard assembly is provided comprising: a first part that is attachable to a door; a second part that is attachable to a door frame; an elongate member; a slidable plate that comprises a receiving means; wherein the first part and/or the second part and/or the elongate member further comprise(s) a dampening means; and, wherein the elongate member is attached to the first part or the second part and in use can be engaged with the receiving means of the plate located on the other first or second part respectively when the plate is slid into an operating position such that the receiving means engages the outer surface of the elongate member as the door is opened and the receiving means and elongate member thus limit the opening of the door, and the dampening means absorbs an impact force that may be applied to the door whose opening has been limited in this way.",DOHERTY PATRICK J,JOHN DOHERTY PATRICK,,https://lens.org/064-617-302-432-32X,Patent Application,yes,27,4,5,7,0,E05C17/04;;E05C17/166;;E05C17/30;;E05C17/365;;E05B15/04;;E05B17/0041;;Y10T292/31;;Y10T292/31;;E05B15/04;;E05B17/0041;;E05C17/365;;E05C17/30;;E05C17/166;;E05C17/04;;E05C17/48,E05C17/48,,0,0,,,,ACTIVE
60,ZA,B,ZA 201501267 B,124-084-436-508-145,2016-01-27,2016,ZA 201501267 A,2015-02-25,ZA 201401404 A,2014-02-25,A CONSTRUCTION METHOD FOR AN INSULATED ROOF,,DOHERTY BRYN PATRICK,DOHERTY BRYN PATRICK,,https://lens.org/124-084-436-508-145,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,ACTIVE
61,GB,A,GB 2253098 A,191-423-789-256-514,1992-08-26,1992,GB 9203670 A,1992-02-19,GB 9109551 A;;GB 9103928 A;;GB 9103782 A,1991-02-22,Lampholder with safety switching,"A bayonet lampholder comprises a hollow body (1) which provides a bayonet socket and houses a rotatable member (2) which supports bulb contact terminals. The rotatable member is housed with the body such that insertion of a bayonet bulb rotates the body. The lampholder may be provided with a transverse switch bar (4) which in one position, the operative position, effects electrical contact between the bulb contact terminals and power supply terminals also housed within the body, and in a second position, the inoperative position, such electrical contact is broken. The switch bar and rotatable member define inter-engaging formations (Figs. 3, 5) whereby rotation of the rotatable member from a second (Fig. 5) to the first (Fig. 3) position resulting from the removal of a bulb from the lampholder causes a switch bar to be moved to the ""off"" position. The switch bar and the rotatable member define further locking formations which prevent the switch bar from being moved from the inoperative to the operative position until a bulb is again inserted into the socket and the rotatable member is rotated from the first to a second position. In another form (not shown), which may or may not have a switch bar, the rotatable member is arranged such that there can be no electrical contact between the bulb contacts and the power supply terminals when the rotatable member is in its first position. The contact terminals extend through the rotatable member and are axially movable between first and second Positions. Coil springs are provided to balance the bulb contact terminals into the first position. Insertion of a bayonet bulb into the lampholder socket depresses the bulb contacts from the first to the second position. The contact terminals provide locking means, whereby when they are in their first position the rotatable member cannot be rotated from its first to its second position. Thus electrical contact cannot be effected between the bulb contact terminals and the power supply terminals unless a bulb is inserted into the lampholder. <IMAGE>",DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/191-423-789-256-514,Patent Application,no,3,8,5,8,0,H01R33/96,H01R33/96,H2E ECAA          ECAA;;H2E ECAAT         ECAAT;;H2E ECAC          ECAC,0,0,,,,EXPIRED
62,WO,A1,WO 2020/120961 A1,028-046-970-216-524,2020-06-18,2020,GB 2019053509 W,2019-12-11,GB 201820391 A;;GB 201905701 A;;GB 201908409 A;;GB 201915746 A,2018-12-13,DOOR LOCK,"A portable door locking device having a locking bar with a first section and a second section. The second section is pivotally connected to the first section,withthe second section being provided with at least one section of enlarged thickness. A resiliently yieldable section is provided and the locking bar is at least partially received within the resiliently yieldable section.",DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/028-046-970-216-524,Patent Application,yes,8,0,7,10,0,E05C19/182;;E05C19/182;;E05C19/182;;E05C19/188,E05C19/18,,0,0,,,,PENDING
63,GB,B,GB 2258643 B,049-824-278-665-809,1995-03-29,1995,GB 9116286 A,1991-07-27,GB 9116286 A,1991-07-27,Electrically motor driven can opener,,DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/049-824-278-665-809,Granted Patent,no,6,0,4,4,0,B67B7/38,B67B7/46;;B67B7/72;;B67B7/74;;B67B7/82,B8D DFF           DFF;;B8D D41FY         DFF;;B8D D41F1         DFF;;B8D D41F2         DFF;;B8D D41K          DFF,0,0,,,,EXPIRED
64,GB,A,GB 2273829 A,052-449-339-660-953,1994-06-29,1994,GB 9323541 A,1993-11-15,GB 9323541 A;;GB 9223784 A;;GB 9321263 A,1992-11-13,Lampholder,"A lampholder comprises a hollow housing (10) which defines ""J"" type slots (11) along which the bayonet pins of a bulb slide during insertion and removal of the bulb. A rotatable member (50) has straight slots (52) which are arranged such that insertion of a bulb causes the rotatable member (50) to rotate between first and second positions. A contact carrier (40) in the housing (10) engages bulb engaging contacts (30) and bridging contacts (36) which are capable of effecting an electrical connection between power supply terminals (71) and the bulb engaging contacts (36). The contact carrier (40) is capable of obstructing rotation of the rotatable member (50) and is arranged so that, when in its second position, it is transversely or pivotally moveable upon rotation of the rotatable member (50) by the bulb to effect transverse displacement of the bridging contacts (36) to either engage or disengage the power supply terminals (71). In this way, rotation of the bulb makes and breaks the electrical connection between the power supply is terminals (71) and bulb engaging contacts (30). <IMAGE>",DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/052-449-339-660-953,Patent Application,no,1,2,3,5,0,H01R33/962;;H01R33/46;;H01R33/96;;H01R33/9656,H01R33/46;;H01R33/96;;H01R33/965,H2E ECAAT         ECAAT;;H2E ECCA          ECCA,0,0,,,,EXPIRED
65,WO,A1,WO 1987/004867 A1,135-011-483-801-477,1987-08-13,1987,GB 8700073 W,1987-02-02,GB 8602991 A;;GB 8604365 A;;GB 8629850 A,1986-02-06,LAMPHOLDER,"A safety lampholder for receiving a bayonet bulb, the lampholder comprising a body defining slots each of which has two mutually inclined limbs along which the bayonet pins of a bulb slide during insertion and removal of the bulb, a contact carrier mounted within the body and movable relative to the body between first and second positions, power supply terminals supported by the body and defining surfaces facing the carrier, direct access to the terminal surfaces being obstructed by the contact carrier, and contacts supported by and extending on both sides of the carrier. The contacts move with the carrier so as to be spaced from the terminal surfaces when the carrier is in the first position and so as to bear against the terminal surfaces when the carrier is in the second position. The carrier comprises a sleeve extending to the body slots and defining slots for engagement with the pins of an inserted bulb. The body slots and sleeve slots are arranged such that as a bulb is inserted its pins slide along one limb of the body slots and enter the sleeve slots and then slide along the other limb of the body slots whilst bearing against the edges of the sleeve slots so as to rotate the carrier with the bulb to the second position. As a bulb is removed its pins slide along the said other limb of the body slots whilst bearing against the edges of the sleeve slots so as to rotate the carrier with the bulb from the second position and then slide along the said one limb of the body slots and out of the sleeve slots to leave the carrier in the first position.",KUDOS LIGHTING LTD,DOHERTY PATRICK JOHN,,https://lens.org/135-011-483-801-477,Patent Application,yes,4,7,7,15,0,H01R33/9656;;H01R33/96,H01R33/96;;H01R33/965,H2E ECAA          ECAA;;H2E ECAAT         ECAAT,0,0,,,,PENDING
66,GB,A,GB 2221804 A,177-283-943-847-808,1990-02-14,1990,GB 8910519 A,1989-05-08,GB 8810852 A,1988-05-07,Lampholder with locking shutter,A lampholder for receiving a bayonet bulb includes a body (1) which defines slots (11) along which bayonet pins of an inserted bulb slide. Resilient contacts (4) are supported by the body and electrically connected to a power supply. A shutter (5) is mounted in the body and rotatable by engagement with an inserted bulb. When the bulb is fully inserted the contacts (4) extend through apertures (15) in the shutter and bear against the terminals of the inserted bulb. A locking member (8) is supported by the body and biased to prevent movement of the shutter (5). The looking member (8) is engaged by an inserted bulb so as to be moved to an unlocked position in which the shutter is free to rotate. <IMAGE>,KUDOS LIGHTING LTD,DOHERTY PATRICK JOHN,,https://lens.org/177-283-943-847-808,Patent Application,no,3,5,4,4,0,H01R13/4532;;H01R33/46,H01R13/453;;H01R33/46,H2E EDBA          EDBA274;;H2E E274          EDBA274;;U1S S1928,0,0,,,,EXPIRED
67,GB,A,GB 2207819 A,170-552-247-924-732,1989-02-08,1989,GB 8817744 A,1987-02-02,GB 8602991 A;;GB 8604365 A;;GB 8629850 A;;GB 8700073 W,1986-02-06,LAMPHOLDER,"A safety lampholder for receiving a bayonet bulb, the lampholder comprising a body defining slots each of which has two mutually inclined limbs along which the bayonet pins of a bulb slide during insertion and removal of the bulb, a contact carrier mounted within the body and movable relative to the body between first and second positions, power supply terminals supported by the body and defining surfaces facing the carrier, direct access to the terminal surfaces being obstructed by the contact carrier, and contacts supported by and extending on both sides of the carrier. The contacts move with the carrier so as to be spaced from the terminal surfaces when the carrier is in the first position and so as to bear against the terminal surfaces when the carrier is in the second position. The carrier comprises a sleeve extending to the body slots and defining slots for engagement with the pins of an inserted bulb. The body slots and sleeve slots are arranged such that as a bulb is inserted its pins slide along one limb of the body slots and enter the sleeve slots and then slide along the other limb of the body slots whilst bearing against the edges of the sleeve slots so as to rotate the carrier with the bulb to the second position. As a bulb is removed its pins slide along the said other limb of the body slots whilst bearing against the edges of the sleeve slots so as to rotate the carrier with the bulb from the second position and then slide along the said one limb of the body slots and out of the sleeve slots to leave the carrier in the first position.",KUDOS LIGHTING LTD,DOHERTY PATRICK JOHN,,https://lens.org/170-552-247-924-732,Patent Application,no,4,0,7,15,0,H01R33/9656;;H01R33/96,H01R33/96;;H01R33/965,H2E ECAA          ECAA;;H2E ECAAC         ECAAC;;U1S S1928,0,0,,,,EXPIRED
68,GB,A,GB 2179209 A,063-438-592-640-054,1987-02-25,1987,GB 8617435 A,1985-11-26,GB 8429860 A;;GB 8431853 A;;GB 8508177 A,1984-11-27,CEILING ROSES,"A ceiling rose comprising a base assembly (1) to be secured on a flat surface, a cover assembly (11) which is mountable on the base assembly, and first terminals (2-5) supported by the base assembly for connection to a supply cable. The cover assembly comprises second terminals (13) connected to a lighting assembly (18), the arrangement of the terminals being such that each of the second terminals is electrically connected to a corresponding one of the first terminals when the cover assembly is mounted on the base assembly.",KUDOS LIGHTING LTD,DOHERTY PATRICK JOHN,,https://lens.org/063-438-592-640-054,Patent Application,no,5,2,6,10,0,F21V21/03;;H02G3/20,F21V21/03;;H02G3/20,H2E ECBF          ECBF;;H2E ECBX          ECBX;;U1S S1931,0,0,,,,EXPIRED
69,SG,A1,SG 46163 A1,082-291-486-843-785,1998-02-20,1998,SG 1995002124 A,1995-12-13,GB 9426298 A,1994-12-28,Lampholder,,SEAPART LIMITED,DOHERTY PATRICK JAMES,,https://lens.org/082-291-486-843-785,Patent Application,no,0,0,5,5,0,H01R13/4532;;H01R13/4538;;H01R33/46,H01R13/453;;H01R33/46,,0,0,,,,PENDING
70,GB,A,GB 2289806 A,177-536-697-471-19X,1995-11-29,1995,GB 9509085 A,1995-05-04,GB 9408868 A;;GB 9409834 A,1994-05-04,Lampholder,"A safety lampholder for a bayonet bulb comprises a housing (10) which defines slots (11) to receive bayonet pins of an inserted bulb. The slots (11) each include an inclined portion (12). Contacts (80) are provided within the housing (110) for electrical connection to a power source to supply electricity to the bulb. A rotatable apertured shutter (30) is located in the housing (10) for selectively obstructing access to the contacts (82) and actuable by an inserted bulb between a first inoperative position in which the contacts (80) are behind the rotatable shutter (30) and a second operative position in which they extend through apertures (40) in the shutter (30) for bearing against a bulb. The shutter (30) supports surfaces (33) which are inclined in an opposing direction to the inclined portions (12) of the housing slots (11). The surfaces (33) extend adjacent the slots (11) so as to be engaged by an inserted bulb. Formations (76, 44) are provided within the housing (10) and arranged such that for the shutter (30) to be moved from the first to the second position it must first be rotated within the housing and then moved axially relative to the housing. The shutter surfaces (33) are positioned such that the bayonet pins of an inserted bulb slide along the said surfaces (33) to actuate rotation of the shutter (30). <IMAGE>",DOHERTY PATRICK JAMES,DOHERTY PATRICK JAMES,,https://lens.org/177-536-697-471-19X,Patent Application,no,8,0,3,5,0,H01R13/4532;;H01R33/46;;H01R33/955,H01R13/453;;H01R33/46;;H01R33/955,H2E ECAC          ECAC;;H2E EDBA          EDBA274;;H2E E274          EDBA274;;U1S S1931,0,0,,,,EXPIRED
71,GB,B,GB 2207819 B,025-535-761-333-933,1990-03-21,1990,GB 8817744 A,1987-02-02,GB 8602991 A;;GB 8604365 A;;GB 8629850 A;;GB 8700073 W,1986-02-06,LAMPHOLDER,,KUDOS LIGHTING LTD,DOHERTY PATRICK JOHN,,https://lens.org/025-535-761-333-933,Granted Patent,no,4,0,7,15,0,H01R33/9656;;H01R33/96,H01R33/96;;H01R33/965,H2E ECAA          ECAA;;U1S S1928,0,0,,,,EXPIRED
72,WO,A1,WO 1986/005037 A1,030-397-125-952-934,1986-08-28,1986,GB 8600088 W,1986-02-21,GB 8504553 A;;GB 8507593 A;;GB 8602991 A,1985-02-21,LAMPHOLDER,"A bayonet lampholder comprising a housing (1) supporting fixed terminals (3) to which in use electrical cables are connected, the housing defining a socket for receiving an inserted bulb and slots (9) for receiving the bayonet pins of an inserted bulb, and a carrier (2) mounted within the housing and supporting contacts (5) arranged to electrically contact a bulb inserted into the lampholder. The carrier (2) is movable between a first position in which the contacts (5) are isolated from the terminals (3) and a second position in which the contacts (5) electrically contact respective terminals (3), and the carrier (2) is spring-biased from the second position to the first position. The carrier supports surfaces (8) which extend adjacent the slots so as to be engaged by the bayonets (10) of an inserted bulb, and the carrier (2) and housing (1) define interacting formations (6, 7) such that for the carrier (2) to be moved from the first position to the second position it must initially execute a turning movement within the housing (1) and then an axial movement relative to the housing (1). The said carrier surfaces (8) are positioned such that the bayonets (10) of an inserted bulb slide along the said surfaces as the bayonets (10) are pushed into the slots (8), the slots (8) being inclined to the said surfaces such that the sliding contact between the bayonet and the surfaces causes the carrier to execute the required turning movement.",KUDOS LIGHTING LTD,DOHERTY PATRICK JOHN,,https://lens.org/030-397-125-952-934,Patent Application,yes,3,7,1,15,0,H01R33/96,H01R33/96,H2E ECAA          ECAA;;H2E ECAAT         ECAAT;;U1S S1922,0,0,,,,PENDING
73,GB,A,GB 2192385 A,037-734-728-022-153,1988-01-13,1988,GB 8700654 A,1987-01-13,GB 8600724 A;;GB 8601330 A,1986-01-14,Child-resistant closure,"A cap 2 and bottle neck 1 define formations 7, 8 which interengage when the cap is threaded or snapped onto the neck. One or both of the cap and neck are resiliently deformable to disengage the formations, for example, the neck may be compressed or extended by virtue of bellows portion 6, or the cap may be deformed to an elliptical shape. The cap can then be unthreaded or pulled off. The cap may incorporate a tamper-indicating band. <IMAGE>",DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/037-734-728-022-153,Patent Application,no,11,5,2,4,0,B65D50/046,B65D50/04,B8T THSB          THSB;;B8T T13A          THSB;;B8T T14D          THSB;;U1S S1400,0,0,,,,DISCONTINUED
74,WO,A1,WO 2014/041347 A1,129-015-634-211-492,2014-03-20,2014,GB 2013052375 W,2013-09-11,GB 201216222 A;;GB 201303042 A,2012-09-12,A DOOR GUARD ASSEMBLY,"A door guard assembly is provided comprising: a first part that is attachable to a door; a second part that is attachable to a door frame; an elongate member; a slidable plate that comprises a receiving means; wherein the first part and/or the second part and/or the elongate member further comprise(s) a dampening means; and, wherein the elongate member is attached to the first part or the second part and in use can be engaged with the receiving means of the plate located on the other first or second part respectively when the plate is slid into an operating position such that the receiving means engages the outer surface of the elongate member as the door is opened and the receiving means and elongate member thus limit the opening of the door, and the dampening means absorbs an impact force that may be applied to the door whose opening has been limited in this way.",DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/129-015-634-211-492,Patent Application,yes,8,5,5,7,0,E05C17/04;;E05C17/166;;E05C17/30;;E05C17/365;;E05B15/04;;E05B17/0041;;Y10T292/31;;Y10T292/31;;E05B15/04;;E05B17/0041;;E05C17/365;;E05C17/30;;E05C17/166;;E05C17/04;;E05C17/48,E05C17/04;;E05C17/30;;E05C17/36,,0,0,,,,PENDING
75,CA,A1,CA 3228227 A1,150-963-785-434-491,2023-02-16,2023,CA 3228227 A,2022-08-04,US 202163231857 P;;US 2022/0074548 W,2021-08-11,HYGIENIC DISPOSAL CATHETER PRODUCT,"An intermittent urinary catheter product includes a generally rectangular package (100) having opposed front (104) and rear (106) panels sealed together to define an interior cavity (103). At least one of an inner surface (105) of the front panel (104) and an inner surface (107) of the rear panel (106) includes a reclosable member (116) associated therewith. The front and rear panels are tearable adjacent to the reclosable member and in a direction parallel to the reclosable member so that the tear forms an opening (120) in communication with the interior cavity. A hydrophilic urinary catheter (123) and hydration fluid (140) may be stored in the package. After a user uses the catheter, the user may replace the catheter in the cavity and close the reclosable member, resealing the package.",HOLLISTER INC,DOHERTY JOHN PATRICK,,https://lens.org/150-963-785-434-491,Patent Application,no,0,0,2,2,0,A61M25/002;;B65D33/2533,,,0,0,,,,PENDING
76,AU,A,AU 1985/049553 A,189-782-583-322-670,1986-04-08,1986,AU 1985/049553 A,1985-09-20,GB 8424049 A;;GB 8426219 A;;GB 8429363 A;;GB 8500422 A;;GB 8512860 A;;GB 8517758 A;;GB 8518648 A,1984-09-22,PRESSURISED CONTAINER BUTTON ASSEMBLY,,DOHERTY P J,JOHN DOHERTY PATRICK,,https://lens.org/189-782-583-322-670,Patent Application,no,0,0,3,9,0,B65D83/20;;B65D83/205;;B65D83/206;;B65D2215/02;;B65D2215/04,B65D83/16,,0,0,,,,DISCONTINUED
77,CN,A,CN 113272512 A,010-618-203-367-337,2021-08-17,2021,CN 201980081782 A,2019-12-11,GB 201820391 A;;GB 201905701 A;;GB 201908409 A;;GB 201915746 A;;GB 2019053509 W,2018-12-13,DOOR LOCK,"A portable door locking device has a locking bar with a first section and a second section. The second section is pivotally connected to the first section,with the second section being provided with at least one section of enlarged thickness. A resiliently yieldable section is provided and the locking bar is at least partially received within the resiliently yieldable section.",DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/010-618-203-367-337,Patent Application,no,5,0,7,10,0,E05C19/182;;E05C19/182;;E05C19/182;;E05C19/188,E05C19/18,,0,0,,,,DISCONTINUED
78,AU,B2,AU 590053 B2,053-524-096-486-471,1989-10-26,1989,AU 1987/069351 A,1987-02-02,GB 8602991 A;;GB 8604365 A;;GB 8629850 A,1986-02-06,SAFETY LAMPHOLDER,,KUDOS LIGHTING LTD,DOHERTY PATRICK JOHN,,https://lens.org/053-524-096-486-471,Granted Patent,no,3,1,7,15,0,H01R33/9656;;H01R33/96,H01R33/96;;H01R33/965,,0,0,,,,EXPIRED
79,US,A,US 950317 A,060-236-092-608-782,1910-02-22,1910,US 1908/0450161 A,1908-08-25,US 1908/0450161 A,1908-08-25,SPEED-CHANGER.,,DOHERTY PATRICK H,DOHERTY PATRICK H,,https://lens.org/060-236-092-608-782,Granted Patent,no,0,2,1,1,0,F16H29/08;;F16H29/08;;Y10T74/1513;;Y10T74/1513;;Y10T74/1516;;Y10T74/1516;;Y10T74/1535;;Y10T74/1535;;Y10T74/1565;;Y10T74/1565;;Y10T74/1587;;Y10T74/1587;;Y10T74/18504;;Y10T74/18504,,,0,0,,,,EXPIRED
80,AU,A,AU 1986/055113 A,079-151-674-234-087,1986-09-10,1986,AU 1986/055113 A,1986-02-21,GB 8504553 A,1985-02-21,LAMPHOLDER,,KUDOS LIGHTING LTD,JOHN DOHERTY PATRICK,,https://lens.org/079-151-674-234-087,Patent Application,no,0,1,2,15,0,,H01R33/96,,0,0,,,,DISCONTINUED
81,AU,A,AU 1995/021638 A,077-013-750-753-279,1996-01-04,1996,AU 1995/021638 A,1995-06-07,AU PM635794 A;;AU 1995/021638 A,1994-06-21,Lampholder,,DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/077-013-750-753-279,Patent Application,no,0,0,1,2,0,,H01R33/46;;H01R33/96,,0,0,,,,PENDING
82,AU,B2,AU 671021 B2,131-999-525-855-180,1996-08-08,1996,AU 1994/064841 A,1994-06-21,AU 1994/064841 A;;AU PM278393 A,1993-12-06,Safety lampholder,,DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/131-999-525-855-180,Granted Patent,no,3,0,2,3,0,,F21V25/00;;F21V25/02;;H01R13/44;;H01R33/46,,0,0,,,,EXPIRED
83,AT,T1,AT E27514 T1,041-807-416-370-617,1987-06-15,1987,AT 83304504 T,1983-08-04,EP 83304504 A;;GB 8222857 A;;GB 8223467 A;;GB 8226970 A;;GB 8235840 A;;GB 8304347 A;;GB 8306273 A;;GB 8307733 A;;GB 8312225 A,1982-08-09,LAMPENFASSUNG.,,KUDOS LIGHTING LTD,DOHERTY PATRICK JOHN,,https://lens.org/041-807-416-370-617,Granted Patent,no,0,0,1,12,0,,H01R33/96,,0,0,,,,DISCONTINUED
84,GB,A,GB 2258643 A,049-106-309-869-26X,1993-02-17,1993,GB 9116286 A,1991-07-27,GB 9116286 A,1991-07-27,ELECTRICALLY MOTOR DRIVEN CAN OPENER,"An electrically driven can opener is adapted for mounting substantially flush with a surface and can be permanently connected to a mains electricity supply, thereby avoiding the need for a flex and electric plug. One such can opener 10 comprises a support/fixing plate 11 having an electricity driven cutter assembly 14, 15 projecting outwardly therefrom, means (not illustrated) for driving the cutter assembly 14, 15 are mounted behind the plate 11 in a recess behind surface 40 and connected to the mains electricity supply via a fuse link. In this way the plate 11 and cutter assembly 14, 15 may be arranged substantially flush with surface 40 when mounted. A cover 12 may be included to shield and protect the cutter assembly 14, 15 when the can opener 10 is not in use. <IMAGE>",DOHERTY PATRICK J,DOHERTY PATRICK JOHN,,https://lens.org/049-106-309-869-26X,Patent Application,no,6,0,4,4,0,B67B7/38,B67B7/46;;B67B7/72;;B67B7/74;;B67B7/82,B8D DFF           DFF;;B8D D41FY         DFF;;B8D D41F1         DFF;;B8D D41F2         DFF;;B8D D41K          DFF,0,0,,,,EXPIRED
85,US,A,US 1002828 A,065-677-875-389-796,1911-09-12,1911,US 1907/0403006 A,1907-11-20,US 1907/0403006 A,1907-11-20,GRIPPERS.,,UNITED SHOE MACHINERY AB,DOHERTY PATRICK H,,https://lens.org/065-677-875-389-796,Granted Patent,no,0,1,1,1,0,A43D23/027;;A43D23/027,,,0,0,,,,EXPIRED
86,GB,B,GB 2179209 B,095-398-447-809-105,1989-02-15,1989,GB 8617435 A,1985-11-26,GB 8429860 A;;GB 8431853 A;;GB 8508177 A,1984-11-27,CEILING ROSES,,KUDOS LIGHTING LTD,DOHERTY PATRICK JOHN,,https://lens.org/095-398-447-809-105,Granted Patent,no,0,0,6,10,0,F21V21/03;;H02G3/20,F21V21/03;;H02G3/20,H2ECBX;;U1S1931;;U1SH2E,0,0,,,,EXPIRED
87,BR,A,BR PI0414323 A,057-677-920-749-165,2006-11-07,2006,BR PI0414323 A,2004-09-10,US 50186403 P;;US 55989804 P;;US 60318704 P;;US 2004/0029888 W,2003-09-10,compostos que modulam crescimento neuronal e seus usos,"""COMPOSTOS QUE MODULAM CRESCIMENTO NEURONAL E SEUS USOS"". A presente invenção refere-se a peptídeos cíclicos e miméticos de peptídeo que são providos que se ligam a elou modulam atividades associadas com receptores de Trk, incluindo processos associados com o crescimento e reparo do sistema nervoso central (por exemplo, crescimento e sobrevivência neuronal, crescimento axonal, desenvolvimento de neurito e plasticidade sináptica). Peptídeos Cíclicos e miméticos de peptídeos também são providos que bloqueiam ou reduzem o efeito de outros fatores que inibem crescimento e/ou reparo do sistema nervoso central. Composições farmacêuticas e outras formulações compreendendo estes compostos são providas. Em adição, a invenção provê processos para uso de peptídeos cíclicos e miméticos de peptídeos para modulação de atividades mediadas por Trk, incluindo processos tais como crescimento, sobrevivência e recuperação neuronal, crescimento axonal, desenvolvimento de neurito, e plasticidade sináptica. Ainda, a invenção provê processos para promoção de crescimento de neurónio de sistema nervoso central (SNC) através de administração de um agente de ligação de receptor de p75.",WYETH CORP;;KING S COLLEGE LONDON,DOHERTY PATRICK;;WILLIAMS GARETH,,https://lens.org/057-677-920-749-165,Patent Application,no,0,0,15,16,0,A61K38/10;;A61K38/12;;A61K38/10;;A61K38/12;;A61P9/10;;A61P25/00;;A61P25/16;;A61P25/28;;A61P43/00;;C07K7/06;;C07K7/06;;C07K7/08;;C07K7/08,A61K/;;A61K38/00;;A61K38/12;;C07K7/64,,0,0,,,,DISCONTINUED
88,US,A1,US 2009/0131327 A1,113-284-325-112-022,2009-05-21,2009,US 91303206 A,2006-04-28,US 91303206 A;;US 67590205 P;;US 2006/0016217 W,2005-04-29,NOGO RECEPTOR FUNCTIONAL MOTIFS AND PEPTIDE MIMETICS RELATED THERETO AND METHODS OF USING THE SAME,"The present invention provides novel isolated and purified polynucleotides and polypeptides related to functional motifs of the Nogo receptor 1 (NgR1) and use of peptides mimicking these functional motifs as antagonists to NgR1 ligands, e.g., myelin-associated glycoprotein, oligodendrocyte myelin glycoprotein, Nogo-A, Nogo-66, an antibody to Nogo receptor, an antibody to GT1b, an antibody to p75 neurotrophin receptor, and an antibody to Lingo-1, etc. The invention also provides antibodies to the mimetic peptide antagonists. The present invention is further directed to novel therapeutics and therapeutic targets and to methods of screening and assessing test compounds for treatments requiring axonal regeneration, i.e., reversal of the effects of NgR1 ligand binding to the NgR1 (i.e., producing inhibition of axonal growth). The present invention also is directed to novel methods for treating disorders arising from inhibition of axonal growth mediated by the binding of NgR1 ligands to the NgR1.",DOHERTY PATRICK;;WILLIAMS GARETH,DOHERTY PATRICK;;WILLIAMS GARETH,WYETH (2008-03-25);;KING'S COLLEGE LONDON (2008-03-25),https://lens.org/113-284-325-112-022,Patent Application,yes,14,3,6,6,37,A61K38/00;;C07K14/705;;G01N33/6872;;G01N33/6896;;G01N2500/00;;G01N2800/28;;A61P25/00;;A61P25/16;;A61P25/28;;A61P43/00;;A61P9/10;;G01N33/6872;;A61K38/00;;C07K14/705;;G01N2800/28;;G01N2500/00;;G01N33/6896,A61K38/08;;A61K38/07;;C07K7/00;;C07K16/18;;C12N5/06;;G01N33/566,514/16;;530/330;;530/328;;530/329;;530/317;;436/501;;435/375;;514/18;;514/17;;530/387.9,0,0,,,,DISCONTINUED
89,WO,A2,WO 2006/119013 A2,185-447-241-995-185,2006-11-09,2006,US 2006/0016217 W,2006-04-28,US 67590205 P,2005-04-29,NOGO RECEPTOR FUNCTIONAL MOTIFS AND PEPTIDE MIMETICS RELATED THERETO AND METHODS OF USING THE SAME,"The present invention provides novel isolated and purified polynucleotides and polypeptides related to functional motifs of the Nogo receptor 1 (NgRl) and use of peptides mimicking these functional motifs as antagonists to NgRl ligands, e.g., myelin-associated glycoprotein, oligodendrocyte myelin glycoprotein, Nogo-A, Nogo-66, an antibody to Nogo receptor, an antibody to GTIb, an antibody to p75 neurotrophin receptor, and an antibody to Lingo-1, etc. The invention also provides antibodies to the mimetic peptide antagonists. The present invention is further directed to novel therapeutics and therapeutic targets and to methods of screening and assessing test compounds for treatments requiring axonal regeneration, i.e., reversal of the effects of NgRl ligand binding to the NgRl (i.e., producing inhibition of axonal growth). The present invention also is directed to novel methods for treating disorders arising from inhibition of axonal growth mediated by the binding of NgRl ligands to the NgRl .",WYETH CORP;;KING S COLLEGE LONDON;;DOHERTY PATRICK;;WILLIAMS GARETH,DOHERTY PATRICK;;WILLIAMS GARETH,,https://lens.org/185-447-241-995-185,Patent Application,yes,0,5,6,6,37,A61K38/00;;C07K14/705;;G01N33/6872;;G01N33/6896;;G01N2500/00;;G01N2800/28;;A61P25/00;;A61P25/16;;A61P25/28;;A61P43/00;;A61P9/10;;G01N33/6872;;A61K38/00;;C07K14/705;;G01N2800/28;;G01N2500/00;;G01N33/6896,A61K38/17;;C07K14/435;;G01N33/68,,0,0,,,,PENDING
90,AU,B2,AU 2004/272107 B2,032-016-604-862-988,2011-04-07,2011,AU 2004/272107 A,2004-09-10,US 50186403 P;;US 60318704 P;;US 55989804 P;;US 2004/0029888 W,2003-09-10,Compounds that modulate neuronal growth and their uses,,KING S COLLEGE LONDON;;WYETH CORP,WILLIAMS GARETH;;DOHERTY PATRICK,,https://lens.org/032-016-604-862-988,Granted Patent,no,2,0,15,16,0,A61K38/10;;A61K38/12;;A61K38/10;;A61K38/12;;A61P9/10;;A61P25/00;;A61P25/16;;A61P25/28;;A61P43/00;;C07K7/06;;C07K7/06;;C07K7/08;;C07K7/08,A61K38/00;;A61K/;;A61K38/12;;C07K7/64,,3,3,072-641-164-156-549;;006-757-312-943-554;;020-258-471-940-706,10.1021/bc0155566;;12009947;;10.2174/1381612023393215;;12369863;;10.1016/s0021-9258(18)50070-3;;1331077,"SU, Zi-Fen et al., BIOCONJUGATE CHEMISTRY, 2002, vol. 13, no. 3, pages 561-70 (X);;SARAGOVI, H.U. et al., Current Pharmac. Design. 2002, Vol. 8, pages 2201-16 (X);;CARDARELLI et al., J.Biol. Chem. 1992, Vol. 32, pages 23159-64 (X)",INACTIVE
91,WO,A2,WO 2005/025514 A2,111-202-371-223-028,2005-03-24,2005,US 2004/0029888 W,2004-09-10,US 50186403 P;;US 55989804 P;;US 60318704 P,2003-09-10,COMPOUNDS THAT MODULATE NEURONAL GROWTH AND THEIR USES,"Cyclic peptides and peptidomimetics are provided that bind to and/or modulate activities associated with Trk receptors, including processes associated with the growth and repair of the central nervous system (e.g., neuronal growth and survival, axonal growth, neurite outgrowth and synaptic plasticity). Cyclic peptides and peptidomimetics are also provided that block or reduce the effect of other factors that inhibit growth and/or repair of the central nervous system. Pharmaceutical compositions and other formulations comprising these compounds are provided. In addition, the invention provides methods for using the cyclic peptides and peptidomimetics to modulate Trk mediated activities, including processes such as neuronal growth, survival and recover, axonal growth, neurite outgrowth, and synaptic plasticity. Further, the invention provides methods for promoting central nervous system (CNS) neuron growth by administering a p75 receptor binding agent.",WYETH CORP;;DOHERTY PATRICK;;WILLIAMS GARETH,DOHERTY PATRICK;;WILLIAMS GARETH,,https://lens.org/111-202-371-223-028,Patent Application,yes,4,2,15,16,0,A61K38/10;;A61K38/12;;A61K38/10;;A61K38/12;;A61P9/10;;A61P25/00;;A61P25/16;;A61P25/28;;A61P43/00;;C07K7/06;;C07K7/06;;C07K7/08;;C07K7/08,A61K/;;A61K38/00;;A61K38/12;;C07K7/64,,6,4,026-518-229-693-803;;072-641-164-156-549;;088-822-106-739-66X;;125-470-665-664-362,8620518;;10.1021/bc0155566;;12009947;;1993122;;10.1016/0896-6273(91)90360-c;;7917292;;10.1016/0896-6273(94)90027-2,"""CANCER RESEARCH"", vol. 56, 1 January 1996, AMERICAN ASSOCIATION FOR CANCER RESEARCH, article ""BONE SIALOPROTEIN PEPTIDES ARE POTENT INHIBITORS OF BREAST CANCER CELL ADHESION TO BONE"", pages: 1948 - 1955;;SU ZI-FEN ET AL.: ""In vitro and in vivo evaluation of a technetium-99m-labeled cyclic RGD peptide as a specific marker of alphavbeta3 integrin for tumor imaging"", BIOCONJUGATE CHEMISTRY, vol. 13, no. 3, May 2002 (2002-05-01), pages 561 - 570;;BROOKS ET AL., J. COMPUT. CHEIN., vol. 4, 1983, pages L87 - 217;;DOHERTY ET AL., NEURON, vol. 6, 1991, pages 247 - 258;;WILLIAMS ET AL., NEURON, vol. 13, 1994, pages 583 - 594;;See also references of EP 1663276A4",PENDING
92,JP,A,JP 2011057685 A,110-168-579-253-688,2011-03-24,2011,JP 2010235591 A,2010-10-20,US 50186403 P;;US 55989804 P;;US 60318704 P,2003-09-10,COMPOUND THAT MODULATE NEURONAL GROWTH AND THE USE,"<P>PROBLEM TO BE SOLVED: To provide compositions and methods for modulating the growth and repair of the central nerve. <P>SOLUTION: Cyclic peptides and peptidomimetics that bind to Trk receptors and modulate activities associated with Trk receptors, are provided. Cyclic peptides and peptidomimetics that block or reduce the effect of other factors inhibiting growth and/or repair of the central nervous system, methods for administering pharmaceutical compositions and other formulations comprising these compounds, and methods for modulating Trk mediated activities, including neuronal growth, survival and recover, axonal growth, neurite outgrowth, and synaptic plasticity, by using these cyclic peptides and peptidomimetics, are also provided. <P>COPYRIGHT: (C)2011,JPO&INPIT",KING S COLLEGE LONDON;;WYETH LLC,DOHERTY PATRICK;;WILLIAMS GARETH,,https://lens.org/110-168-579-253-688,Patent Application,no,0,0,15,16,43,A61K38/10;;A61K38/12;;A61K38/10;;A61K38/12;;A61P9/10;;A61P25/00;;A61P25/16;;A61P25/28;;A61P43/00;;C07K7/06;;C07K7/06;;C07K7/08;;C07K7/08,C07K7/54;;A61K/;;A61K38/00;;A61K38/12;;A61P9/10;;A61P25/00;;A61P25/16;;A61P25/28;;A61P43/00;;C07K7/64;;C07K14/00,,4,0,,,"JPN6010021871; Ｊ．Ｂｉｏｌ．Ｃｈｅｍ．，２００２，２７７（６），ｐ．４３６１-７;;JPN5006013280; ＳＡＲＡＧＯＶＩ: ＣＵＲＲＥＮＴ ＰＨＡＲＭＡＣＥＵＴＩＣＡＬ ＤＥＳＩＧＮ Ｖ８, 2002, Ｐ２２０１-２２１６;;JPN6010021874; Ｂｉｏｃｏｎｊｕｇ．Ｃｈｅｍ．，２００２，１３（３），ｐ．５６１-７０;;JPN6010021873; Ｃａｎｃｅｒ Ｒｅｓ．，１９９６，５６（８），ｐ．１９４８-５５",PENDING
93,EP,A2,EP 1879917 A2,165-068-433-817-943,2008-01-23,2008,EP 06751752 A,2006-04-28,US 2006/0016217 W;;US 67590205 P,2005-04-29,NOGO RECEPTOR FUNCTIONAL MOTIFS AND PEPTIDE MIMETICS RELATED THERETO AND METHODS OF USING THE SAME,,WYETH CORP;;KING S COLLEGE LONDON,DOHERTY PATRICK;;WILLIAMS GARETH,KINGS COLLEGE LONDON (2010-04-21);;WYETH LLC (2010-04-21),https://lens.org/165-068-433-817-943,Patent Application,yes,0,0,6,6,0,A61K38/00;;C07K14/705;;G01N33/6872;;G01N33/6896;;G01N2500/00;;G01N2800/28;;A61P25/00;;A61P25/16;;A61P25/28;;A61P43/00;;A61P9/10;;G01N33/6872;;A61K38/00;;C07K14/705;;G01N2800/28;;G01N2500/00;;G01N33/6896,C07K14/435;;A61K38/17;;G01N33/68,,0,0,,,,DISCONTINUED
94,US,A1,US 2005/0164920 A1,180-464-315-660-04X,2005-07-28,2005,US 93840904 A,2004-09-09,US 93840904 A;;US 50186403 P;;US 55989804 P;;US 60318704 P,2003-09-10,Compounds that modulate neuronal growth and their uses,"Cyclic peptides and peptidomimetics are provided that bind to and/or modulate activities associated with Trk receptors, including processes associated with the growth and repair of the central nervous system (e.g., neuronal growth and survival, axonal growth, neurite outgrowth and synaptic plasticity). Cyclic peptides and peptidomimetics are also provided that block or reduce the effect of other factors that inhibit growth and/or repair of the central nervous system. Pharmaceutical compositions and other formulations comprising these compounds are provided. In addition, the invention provides methods for using the cyclic peptides and peptidomimetics to modulate Trk mediated activities, including processes such as neuronal growth, survival and recover, axonal growth, neurite outgrowth, and synaptic plasticity. Further, the invention provides methods for promoting central nervous system (CNS) neuron growth by administering a p75 receptor binding agent.",WYETH CORP,DOHERTY PATRICK;;WILLIAMS GARETH,WYETH (2005-10-19);;KING'S COLLEGE LONDON (2005-10-19),https://lens.org/180-464-315-660-04X,Patent Application,yes,1,7,15,16,43,A61K38/10;;A61K38/12;;A61K38/10;;A61K38/12;;A61P9/10;;A61P25/00;;A61P25/16;;A61P25/28;;A61P43/00;;C07K7/06;;C07K7/06;;C07K7/08;;C07K7/08,A61K/;;A61K38/00;;A61K38/12;;C07K7/64,514/9;;530/317,0,0,,,,INACTIVE
95,EP,A3,EP 2438925 A3,181-443-376-321-483,2012-08-29,2012,EP 11170573 A,2004-09-10,EP 04788721 A;;US 50186403 P;;US 55989804 P;;US 60318704 P,2003-09-10,Compounds that modulate neuronal growth and their uses,"Cyclic peptides and peptidomimetics are provided that bind to and/or modulate activities associated with Trk receptors, including processes associated with the growth and repair of the central nervous system (e.g., neuronal growth and survival, axonal growth, neurite outgrowth and synaptic plasticity). Cyclic peptides and peptidomimetics are also provided that block or reduce the effect of other factors that inhibit growth and/or repair of the central nervous system. Pharmaceutical compositions and other formulations comprising these compounds are provided. In addition, the invention provides methods for using the cyclic peptides and peptidomimetics to modulate Trk mediated activities, including processes such as neuronal growth, survival and recover, axonal growth, neurite outgrowth, and synaptic plasticity. Further, the invention provides methods for promoting central nervous system (CNS) neuron growth by administering a p75 receptor binding agent.
",WYETH LLC;;KING S COLLEGE LONDON,DOHERTY PATRICK;;WILLIAMS GARETH,,https://lens.org/181-443-376-321-483,Search Report,yes,2,0,15,16,0,A61K38/10;;A61K38/12;;A61K38/10;;A61K38/12;;A61P9/10;;A61P25/00;;A61P25/16;;A61P25/28;;A61P43/00;;C07K7/06;;C07K7/06;;C07K7/08;;C07K7/08,A61K38/08;;A61K/;;A61K38/00;;A61K38/10;;A61K38/12;;C07K7/06;;C07K7/08;;C07K7/64,,3,3,026-518-229-693-803;;072-641-164-156-549;;040-983-230-797-942,8620518;;10.1021/bc0155566;;12009947;;10.1074/jbc.m411121200;;15572360,"PLUIJM VAN DER G ET AL: ""BONE SIALOPROTEIN PEPTIDES ARE POTENT INHIBITORS OF BREAST CANCER CELL ADHESION TO BONE"", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD.; US, vol. 56, no. 8, 1 January 1996 (1996-01-01), pages 1948 - 1955, XP008070268;;SU ZI-FEN ET AL: ""In vitro and in vivo evaluation of a technetium-99m-labeled cyclic RGD peptide as a specific marker of alphavbeta3 integrin for tumor imaging"", BIOCONJUGATE CHEMISTRY, vol. 13, no. 3, May 2002 (2002-05-01), pages 561 - 570, XP002506272, ISSN: 1043-1802;;WILLIAMS GARETH ET AL: ""Overcoming the inhibitors of myelin with a novel neurotrophin strategy"", 18 February 2005, JOURNAL OF BIOLOGICAL CHEMISTRY, VOL. 280, NR. 7, PAGE(S) 5862-5869, ISSN: 0021-9258, XP002678357",DISCONTINUED
96,WO,A3,WO 2006/119013 A3,194-104-541-521-848,2007-03-15,2007,US 2006/0016217 W,2006-04-28,US 67590205 P,2005-04-29,NOGO RECEPTOR FUNCTIONAL MOTIFS AND PEPTIDE MIMETICS RELATED THERETO AND METHODS OF USING THE SAME,"The present invention provides novel isolated and purified polynucleotides and polypeptides related to functional motifs of the Nogo receptor 1 (NgRl) and use of peptides mimicking these functional motifs as antagonists to NgRl ligands, e.g., myelin-associated glycoprotein, oligodendrocyte myelin glycoprotein, Nogo-A, Nogo-66, an antibody to Nogo receptor, an antibody to GTIb, an antibody to p75 neurotrophin receptor, and an antibody to Lingo-1, etc. The invention also provides antibodies to the mimetic peptide antagonists. The present invention is further directed to novel therapeutics and therapeutic targets and to methods of screening and assessing test compounds for treatments requiring axonal regeneration, i.e., reversal of the effects of NgRl ligand binding to the NgRl (i.e., producing inhibition of axonal growth). The present invention also is directed to novel methods for treating disorders arising from inhibition of axonal growth mediated by the binding of NgRl ligands to the NgRl .",WYETH CORP;;KING S COLLEGE LONDON;;DOHERTY PATRICK;;WILLIAMS GARETH,DOHERTY PATRICK;;WILLIAMS GARETH,,https://lens.org/194-104-541-521-848,Search Report,yes,5,0,6,6,0,A61K38/00;;C07K14/705;;G01N33/6872;;G01N33/6896;;G01N2500/00;;G01N2800/28;;A61P25/00;;A61P25/16;;A61P25/28;;A61P43/00;;A61P9/10;;G01N33/6872;;A61K38/00;;C07K14/705;;G01N2800/28;;G01N2500/00;;G01N33/6896,C07K14/435;;A61K38/17;;G01N33/68,,4,3,178-273-877-509-110;;092-101-047-476-592;;065-649-181-988-518,7849421;;12839991;;10.1093/emboj/cdg325;;pmc165649;;10.2210/pdb1p8t/pdb;;12718853;;10.1016/s0896-6273(03)00232-0,"DATABASE REGISTRY [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 19 November 1999 (1999-11-19), XP002397079, retrieved from STN Database accession no. RN 250614-34-7;;RAMNARAYAN K ET AL: ""CHARACTERIZATION OF A LINEAR PENTAPEPTIDE CONTAINING TWO CONSECUTIVE BETA-TURNS"", PEPTIDE RESEARCH, NATICK, MA, US, vol. 7, no. 5, September 1994 (1994-09-01), pages 270 - 278, XP000700109, ISSN: 1040-5704;;BARTON WILLIAM A ET AL: ""Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins."", EMBO (EUROPEAN MOLECULAR BIOLOGY ORGANIZATION) JOURNAL, vol. 22, no. 13, 1 July 2003 (2003-07-01), pages 3291 - 3302, XP002397105, ISSN: 0261-4189;;HE XIAOLIN L ET AL: ""Structure of the nogo receptor ectodomain: A recognition module implicated in myelin inhibition."", NEURON, vol. 38, no. 2, 24 April 2003 (2003-04-24), pages 177 - 185, XP002397106, ISSN: 0896-6273",PENDING
97,CA,A1,CA 2535279 A1,006-172-829-123-90X,2005-03-24,2005,CA 2535279 A,2004-09-10,US 50186403 P;;US 55989804 P;;US 60318704 P;;US 2004/0029888 W,2003-09-10,COMPOUNDS THAT MODULATE NEURONAL GROWTH AND THEIR USES,"Cyclic peptides and peptidomimetics are provided that bind to and/or modulat e activities associated with Trk receptors, including processes associated wit h the growth and repair of the central nervous system (e.g., neuronal growth a nd survival, axonal growth, neurite outgrowth and synaptic plasticity). Cyclic peptides and peptidomimetics are also provided that block or reduce the effe ct of other factors that inhibit growth and/or repair of the central nervous system. Pharmaceutical compositions and other formulations comprising these compounds are provided. In addition, the invention provides methods for usin g the cyclic peptides and peptidomimetics to modulate Trk mediated activities, including processes such as neuronal growth, survival and recover, axonal growth, neurite outgrowth, and synaptic plasticity. Further, the invention provides methods for promoting central nervous system (CNS) neuron growth by administering a p75 receptor binding agent.",KING S COLLEGE LONDON;;WYETH CORP,DOHERTY PATRICK;;WILLIAMS GARETH,,https://lens.org/006-172-829-123-90X,Patent Application,no,0,0,15,16,43,A61K38/10;;A61K38/12;;A61K38/10;;A61K38/12;;A61P9/10;;A61P25/00;;A61P25/16;;A61P25/28;;A61P43/00;;C07K7/06;;C07K7/06;;C07K7/08;;C07K7/08,A61K38/00;;A61K/;;A61K38/12;;C07K7/64,,0,0,,,,DISCONTINUED
98,EP,A4,EP 1663276 A4,037-594-735-930-369,2009-02-18,2009,EP 04788721 A,2004-09-10,US 2004/0029888 W;;US 50186403 P;;US 55989804 P;;US 60318704 P,2003-09-10,COMPOUNDS THAT MODULATE NEURONAL GROWTH AND THEIR USES,,WYETH CORP;;KING S COLLEGE LONDON,DOHERTY PATRICK;;WILLIAMS GARETH,KING'S COLLEGE LONDON (2010-04-21);;WYETH LLC (2010-04-21),https://lens.org/037-594-735-930-369,Search Report,no,1,0,15,16,0,A61K38/10;;C07K7/06;;C07K7/08;;A61P25/00;;A61P25/16;;A61P25/28;;A61P43/00;;A61P9/10;;A61K38/12;;C07K7/08;;C07K7/06;;A61K38/10;;A61K38/12,A61K38/00;;A61K/;;A61K38/12;;C07K7/64,,3,2,026-518-229-693-803;;072-641-164-156-549,8620518;;10.1021/bc0155566;;12009947,"PLUIJM VAN DER G ET AL: ""BONE SIALOPROTEIN PEPTIDES ARE POTENT INHIBITORS OF BREAST CANCER CELL ADHESION TO BONE"", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD.; US, vol. 56, no. 8, 1 January 1996 (1996-01-01), pages 1948 - 1955, XP008070268;;SU ZI-FEN ET AL: ""In vitro and in vivo evaluation of a technetium-99m-labeled cyclic RGD peptide as a specific marker of alphavbeta3 integrin for tumor imaging"", BIOCONJUGATE CHEMISTRY, vol. 13, no. 3, May 2002 (2002-05-01), pages 561 - 570, XP002506272, ISSN: 1043-1802;;See also references of WO 2005025514A2",DISCONTINUED
99,EP,A2,EP 2438925 A2,069-568-774-692-967,2012-04-11,2012,EP 11170573 A,2004-09-10,EP 04788721 A;;US 50186403 P;;US 55989804 P;;US 60318704 P,2003-09-10,Compounds that modulate neuronal growth and their uses,"Cyclic peptides and peptidomimetics are provided that bind to and/or modulate activities associated with Trk receptors, including processes associated with the growth and repair of the central nervous system (e.g., neuronal growth and survival, axonal growth, neurite outgrowth and synaptic plasticity). Cyclic peptides and peptidomimetics are also provided that block or reduce the effect of other factors that inhibit growth and/or repair of the central nervous system. Pharmaceutical compositions and other formulations comprising these compounds are provided. In addition, the invention provides methods for using the cyclic peptides and peptidomimetics to modulate Trk mediated activities, including processes such as neuronal growth, survival and recover, axonal growth, neurite outgrowth, and synaptic plasticity. Further, the invention provides methods for promoting central nervous system (CNS) neuron growth by administering a p75 receptor binding agent.
",WYETH LLC;;KING S COLLEGE LONDON,DOHERTY PATRICK;;WILLIAMS GARETH,,https://lens.org/069-568-774-692-967,Patent Application,yes,12,0,15,16,43,A61K38/10;;A61K38/12;;A61K38/10;;A61K38/12;;A61P9/10;;A61P25/00;;A61P25/16;;A61P25/28;;A61P43/00;;C07K7/06;;C07K7/06;;C07K7/08;;C07K7/08,A61K38/08;;A61K/;;A61K38/00;;A61K38/10;;A61K38/12;;C07K7/06;;C07K7/08;;C07K7/64,,134,107,091-343-812-351-531;;008-580-880-858-886;;093-612-516-723-383;;053-288-446-357-96X;;114-831-423-425-23X;;149-755-742-240-476;;024-272-942-406-443;;038-965-664-144-729;;006-802-095-883-662;;008-675-349-861-556;;022-546-434-060-792;;066-399-700-544-706;;012-225-417-598-187;;008-815-709-499-979;;044-599-171-606-374;;051-669-180-367-066;;055-843-007-069-31X;;008-675-349-861-556;;017-417-736-696-487;;008-360-520-436-861;;034-537-945-815-676;;066-368-253-833-386;;053-490-744-678-664;;021-928-611-338-722;;026-708-930-871-652;;009-324-146-627-26X;;035-634-067-620-429;;001-026-965-230-964;;058-386-600-099-243;;055-962-012-218-633;;051-120-944-942-14X;;068-068-602-226-014;;092-822-497-202-214;;031-621-234-931-577;;030-282-411-673-207;;042-026-345-463-828;;123-226-224-486-030;;055-150-100-518-405;;003-180-829-414-118;;076-515-315-033-107;;111-002-564-258-685;;038-648-724-595-216;;024-265-866-490-202;;052-805-777-719-415;;040-032-733-554-711;;047-443-095-282-088;;062-738-200-977-861;;095-017-480-537-402;;000-503-057-019-728;;006-901-235-936-003;;043-154-516-016-639;;029-522-233-906-972;;039-429-254-290-595;;091-040-367-867-311;;156-565-887-683-581;;016-453-733-837-59X;;099-445-964-487-33X;;028-210-680-408-263;;007-139-433-322-322;;016-453-733-837-59X;;028-607-680-603-62X;;026-708-930-871-652;;095-836-273-545-900;;021-928-611-338-722;;026-708-930-871-652;;082-366-085-178-204;;170-560-474-241-763;;008-018-414-935-436;;029-634-863-114-183;;137-488-209-080-858;;013-428-633-385-14X;;137-488-209-080-858;;112-824-723-909-078;;112-824-723-909-078;;115-315-048-904-874;;084-455-716-302-222;;052-991-854-568-959;;058-361-803-472-756;;064-187-018-698-676;;004-950-150-119-336;;023-242-174-944-359;;046-567-418-614-218;;088-822-106-739-66X;;125-470-665-664-362;;021-928-611-338-722;;026-708-930-871-652;;033-883-650-901-716;;066-624-719-841-936;;031-899-328-341-646;;059-365-953-996-816;;066-659-690-650-158;;026-708-930-871-652;;082-257-510-524-014;;008-353-136-317-82X;;043-303-151-451-107;;009-002-179-814-027;;083-850-014-746-48X;;043-945-165-587-966;;051-160-382-710-852;;135-627-650-371-271;;027-765-801-903-31X;;010-047-471-006-662;;099-445-964-487-33X;;081-974-018-672-715;;090-907-195-606-66X;;033-883-650-901-716;;082-711-356-767-751,10.1038/35039559;;11069169;;2158859;;10.1016/0092-8674(90)90801-k;;10.1152/physrev.1968.48.3.534;;4875350;;3317757;;10.1007/bfb0031026;;6159658;;10.1152/physrev.1980.60.4.1284;;2825921;;10.1073/pnas.68.10.2417;;4944623;;pmc389434;;4566923;;10.1021/bi00725a018;;4683486;;6336309;;10.1038/302538a0;;2025430;;10.1016/0896-6273(91)90180-8;;10.1038/341149a0;;2779653;;2164684;;pmc54343;;10.1073/pnas.87.14.5454;;10.1038/344339a0;;2314473;;10.1126/science.2321006;;10.1126/science.247.4949.1446;;2321006;;10.1016/0896-6273(90)90203-r;;2344409;;10.1073/pnas.87.20.8060;;2236018;;pmc54892;;10.1016/0014-5793(90)81536-w;;2365067;;2025430;;10.1016/0896-6273(91)90180-8;;1742028;;10.1016/0896-6273(91)90287-a;;1313578;;10.1073/pnas.89.7.3060;;pmc48803;;10341240;;pmc6782629;;10.1523/jneurosci.19-11-04370.1999;;10.1046/j.1460-9568.1998.00071.x;;9749723;;9391013;;pmc6573396;;10.1523/jneurosci.17-24-09583.1997;;10.1038/43705;;10490030;;010490030;;11738045;;10.2210/pdb1hcf/pdb;;10.1016/s0969-2126(01)00681-5;;8205613;;10.1016/0092-8674(94)90048-5;;10.1016/s0959-4388(00)00092-1;;10851172;;10.1006/exnr.1993.1181;;8282068;;10.1016/0197-0186(94)90044-2;;7950962;;11163887;;10.1016/s0166-2236(00)01682-9;;10.1016/s0959-4388(00)00209-9;;11399425;;10.1074/jbc.m005071200;;10896671;;10.1074/jbc.275.14.9946;;10744669;;12730196;;10.1074/jbc.m303209200;;15157416;;10.1016/j.neuron.2004.04.001;;12676795;;10.1146/annurev.biochem.72.121801.161629;;10.1016/0896-6273(94)90470-7;;7519025;;10.1126/science.1095190;;15131306;;1314703;;10.1016/0092-8674(92)90413-7;;10.1002/(sici)1097-4547(19970401)48:1<1::aid-jnr1>3.0.co;2-k;;9086177;;3360853;;pmc2115009;;10.1083/jcb.106.4.1281;;3272156;;10.1016/0896-6273(88)90212-7;;7477407;;10.1038/378498a0;;2300171;;10.1038/343269a0;;10.1016/0896-6273(94)90247-x;;7524558;;10.1016/0896-6273(94)90042-6;;7522484;;10667796;;10.1038/35000219;;10.1038/35000226;;10667797;;10.1038/35000287;;10667780;;10.1038/nature00867;;12068310;;10.1016/s0300-9084(01)01308-6;;11522397;;10.1074/jbc.m100345200;;11279053;;12060784;;pmc123081;;10.1073/pnas.072211699;;10.1016/s0896-6273(02)00770-5;;12160746;;10.1126/science.1073031;;12089450;;12692556;;10.1038/nn1045;;12151536;;20026637;;pmc6758168;;10.1523/jneurosci.22-15-06570.2002;;12598630;;pmc6742251;;10.1523/jneurosci.23-04-01416.2003;;10.1523/jneurosci.19-17-07537.1999;;10460260;;pmc6782492;;12692556;;10.1038/nn1045;;10027292;;10.1016/s0896-6273(00)80681-9;;11738045;;10.2210/pdb1hcf/pdb;;10.1016/s0969-2126(01)00681-5;;10.1007/978-1-4757-2335-9;;10.1038/43705;;10490030;;010490030;;11738045;;10.2210/pdb1hcf/pdb;;10.1016/s0969-2126(01)00681-5;;10.1021/bi00161a037;;1332764;;10.1002/bip.360320411;;1623131;;7563081;;10.1006/jmbi.1995.0527;;9247135;;10.1016/s0014-5793(97)00573-5;;7948726;;10.1002/bip.360340902;;10.1006/jmrb.1994.1027;;8137078;;7948726;;10.1002/bip.360340902;;10.1002/jcc.540040211;;10.1002/jcc.540040211;;10.1021/jp9817372;;10.1002/(sici)1097-0282(1997)43:3<191::aid-bip2>3.0.co;2-q;;7962217;;10.1021/ci00021a032;;10.1002/aja.1001970102;;8400407;;825377;;10.1002/eji.1830060713;;12654918;;10.1074/jbc.m213066200;;10.1016/s1044-7431(02)00035-0;;12691734;;pmc2199247;;11956225;;10.1083/jcb.200201098;;1993122;;10.1016/0896-6273(91)90360-c;;7917292;;10.1016/0896-6273(94)90027-2;;10.1038/43705;;10490030;;010490030;;11738045;;10.2210/pdb1hcf/pdb;;10.1016/s0969-2126(01)00681-5;;pmc2173733;;10.1083/jcb.200210164;;12578907;;10.1046/j.1471-4159.2000.0751520.x;;10987832;;10.1021/jm970367n;;9240345;;10.1006/mcne.1995.1010;;7551570;;10.1002/j.1460-2075.1995.tb07279.x;;7796806;;pmc398398;;11738045;;10.2210/pdb1hcf/pdb;;10.1016/s0969-2126(01)00681-5;;11085868;;10.1006/mcne.2000.0907;;10.1038/354411a0;;1956407;;7896793;;10.1074/jbc.270.12.6564;;10660557;;10.1074/jbc.275.6.4007;;7529173;;pmc395565;;10.1002/j.1460-2075.1994.tb06935.x;;9566117;;10.1002/(sici)1097-0282(1997)43:5<339::aid-bip2>3.0.co;2-w;;10.1002/(sici)1097-0282(1997)43:5<339::aid-bip2>3.3.co;2-9;;10.1074/jbc.m109185200;;11726665;;1312698;;7851645;;10.1006/dbio.1995.1019;;9361272;;10.1006/mcne.1997.0633;;12151536;;20026637;;pmc6758168;;10.1523/jneurosci.22-15-06570.2002;;11036610;;10.1016/s0076-6879(00)25449-9;;10.1042/bj3510095;;pmc1221339;;10.1042/0264-6021:3510095;;10998351;;pmc2173733;;10.1083/jcb.200210164;;12578907;;12930799;;pmc6740747;;10.1523/jneurosci.23-20-07602.2003,"HOMER, GAGE, NATURE, vol. 407, 2000, pages 963 - 970;;ULRICH, SCHLESSINGER, CELL, vol. 61, 1990, pages 203 - 212;;LEVI-MONTALCINI, ANGELETTI, PHYSIOL. REV., vol. 48, 1968, pages 534 - 569;;THOENEN ET AL., REV. PHYSIOL. BIOCHEM. PHARMACOL., vol. 109, 1987, pages 145 - 178;;THOENEN, BARDE, PHYSIOL. REV., vol. 60, 1980, pages 1284 - 1325;;WHITTEMORE, SEIGER, BRAIN RES., vol. 434, 1987, pages 439 - 464;;ANGELETTI, BRADSHAW, PROC. NATL. ACAD. SCI. U.S.A., vol. 68, 1971, pages 2417 - 2420;;ANGELETTI ET AL., BIOCHEMISTTY, vol. 12, 1973, pages 100 - 115;;SCOTT ET AL., NATURE, vol. 302, 1983, pages 538 - 540;;SCHWARTZ ET AL., J. NEUROCHEM., vol. 52, 1989, pages 1203 - 1209;;HALLBÖÖK ET AL., NEURON, vol. 6, 1991, pages 845 - 858;;LEIBROCK ET AL., NATURE, vol. 341, 1989, pages 149 - 152;;ERNFORS ET AL., PROC. NATL. ACAD. SCI. U.S.A., vol. 87, 1990, pages 5454 - 5458;;HÖHN ET AL., NATURE, vol. 344, 1990, pages 339;;MAISONPIERRE ET AL., SCIENCE, vol. 247, 1990, pages 1446;;ROSENTHAL ET AL., NEURON, vol. 4, 1990, pages 767;;JONES, REICHARDT, PROC. NATL. ACAD. SCI. U.S.A., vol. 87, 1990, pages 8060 - 8064;;KAISHO ET AL., FEBS LETT., vol. 266, 1990, pages 187;;HALLBOOK ET AL., NEURON, vol. 6, 1991, pages 845 - 858;;BERKMEIER ET AL., NEURON, vol. 7, 1991, pages 857 - 866;;IP ET AL., PROC. NATL. ACAD. SCI. U.S.A., vol. 89, 1992, pages 3060 - 3064;;LIU ET AL., J. NEUROSCI., vol. 19, 1999, pages 4370 - 4387;;MENEI ET AL., EUR. J NEUROSCI., vol. 10, 1998, pages 607 - 621;;KOBAYASHI ET AL., J NEUROSCI., vol. 17, 1997, pages 9583 - 9595;;WIESMANN, NATURE, vol. 401, 1999, pages 184 - 188;;BANFIELD ET AL., STRUCTURE (CAMB, vol. 9, 2001, pages 1191 - 1199;;SNIDER, CELL, vol. 77, 1994, pages 627 - 638;;KAPLAN, MILLER, CURR. OPIN. NEUROBIOL., vol. 10, 2000, pages 381 - 391;;LINDSAY ET AL., EXP. NEUROL., vol. 124, 1993, pages 103 - 118;;OLSON, NEUROCHEM. INT., vol. 25, 1994, pages 1 - 3;;BINDER ET AL., TRENDS NEUROSCI., vol. 24, 2001, pages 47 - 53;;LEE ET AL., CURR. OPIN. NEUROBIOL., vol. 11, 2001, pages 281 - 286;;LONG ET AL., J. NEUROSCI. RES., vol. 48, 1997, pages 1 - 17;;XIE ET AL., J BIOL. CHEM., vol. 275, 2000, pages 29868 - 29874;;MALIARTCHOUK ET AL., J BIOL. CHEM., vol. 275, 2000, pages 9946 - 9956;;O'LEARY ET AL., J. BIOL. CHEM., vol. 278, 2 May 2003 (2003-05-02), pages 25738 - 25744;;BARKER, NEURON, vol. 42, 2004, pages 529 - 533;;HUANG, REICHARDT, ANNU. REV. BIOCHEM., vol. 72, 2003, pages 609 - 642;;BARKER, SHOOTER, NEURON, vol. 13, 1994, pages 203 - 215;;HE, GARCIA, SCIENCE, vol. 304, 2004, pages 870 - 875;;IBANEZ ET AL., CELL, vol. 69, 1992, pages 329 - 341;;LONGO ET AL., J. NEUROSCI. RES., vol. 48, 1997, pages 1 - 17;;XIE ET AL., J. BIOL. CHEM., vol. 275, 2000, pages 29868 - 29874;;MALIARTCHOUK ET AL., J. BIOL. CHEM., vol. 275, 2000, pages 9946 - 9956;;BERRY, BIBL. ANAT., vol. 23, 1982, pages 1 - 11;;CARONI, SCHWAB, J. CELL BIOL., vol. 106, 1988, pages 1281 - 1288;;CARONI, SCHWAB, NEURON, vol. 1, 1988, pages 85 - 96;;BREGMAN ET AL., NATURE, vol. 378, 1995, pages 498 - 501;;SCHNELL, SCHWAB, NATURE, vol. 343, 1990, pages 269 - 272;;MCKERRACHER ET AL., NEURON, vol. 13, 1994, pages 805 - 811;;MUKHOPADHYAY ET AL., NEURON, vol. 13, 1994, pages 757 - 767;;CHEN ET AL., NATURE, vol. 403, 2000, pages 434 - 439;;GRANDPRE ET AL., NATURE, vol. 403, 2000, pages 439 - 444;;PRINJHA ET AL., NATURE, vol. 403, 2000, pages 383 - 384;;WANG ET AL., NATURE, vol. 417, 2002, pages 941 - 944;;VYAS, SCLMAAR, BIOCHIMIE, vol. 83, 2001, pages 677 - 682;;VINSON ET AL., J. BIOL. CHEM., vol. 276, 2001, pages 20280 - 20285;;VYAS ET AL., PROC. NATL. ACAD. SCI. U.S.A., vol. 99, 2002, pages 8412 - 8417;;DOMENICONI ET AL., NEURON, vol. 35, 2002, pages 283 - 290;;LIU ET AL., SCIENCE, vol. 297, 2002, pages 1190 - 1993;;YAMASHITA, TOHYMA, NAT. NEUROSCI., vol. 6, 2003, pages 461 - 471;;DERGHAM ET AL., J NEUROSCI., vol. 22, 2002, pages 6570 - 6577;;FOURNIER ET AL., J. NEUROSCI., vol. 23, 2003, pages 1416 - 1423;;LEHMANN ET AL., J. NEUROSCI., vol. 19, 1999, pages 7537 - 7547;;YAMASHITA, TOHYAMA, NAT. NEUROSCI., vol. 6, 2003, pages 461 - 467;;CAI ET AL., NEURON, vol. 22, 1999, pages 89 - 101;;BANFIELD, STRUCTURE (CAMB, vol. 9, 2001, pages 1191 - 1199;;WIESMAN ET AL., NATURE, vol. 401, 1999, pages 184 - 188;;""The Peptides: Analysis, Synthesis, Biology"", vol. 1-4, 1979, ACADEMIC PRESS;;BODANSKY, BODANSKY: ""The Practice of Peptide Synthesis"", 1994, SPRINGER VERLAG;;MERRIFIELD ET AL., J ANT. CHEM. SOC., vol. 85, 1963, pages 2149;;CANTOR, SCHIMMEL: ""Biophysical Chemistry"", vol. I-III, 1980, W. H. FREEMAN AND COMPANY;;""Methods Enzymol."", 1997, article ""Macroinolecular Crystallography"", pages: 276 - 277;;JAN DRENTH: ""Principles ofProtein X-Ray Crystallography"", 1994, SPRINGER-VERLAG;;WIESMANN ET AL., NATURE, vol. 401, 1999, pages 184;;BANFIELD ET AL., STURCUTRE (CAMB., vol. 9, 2001, pages 1191;;WUTHRICH: ""NMR of Proteins and Nucleic Acids"", 1986, WILEY & SONS;;WANG ET AL., TECHNIQUES IN PROTEIN CHEMISTRY IV, 1993;;NI ET AL., BIOCHEMISTRY, vol. 31, 1992, pages 11551 - 11557;;RIPOLL, NI, BIOPOLYMERS, vol. 32, 1992, pages 359 - 365;;NI, J MAGN. RESON. B, vol. 106, 1995, pages 147 - 155;;NI ET AL., J MOL. BIOL., vol. 252, 1995, pages 656 - 671;;WARDER ET AL., FEBS LETT., vol. 411, 1997, pages 19 - 26;;NING ET AL., BIOPOTYMERS, vol. 34, 1994, pages 1125 - 1137;;CANTOR, SCHIMMEL: ""Biophysical Chemistry"", 1980, W. H. FREEMAN & CO.;;NI, ZHU, J MAGN. RESON. B, vol. 102, 1994, pages 180 - 184;;NING ET AL., BIOPOLYMERS, vol. 34, 1994, pages 1125 - 1137;;NI, MAGN. RESON. B, vol. 106, 1995, pages 147 - 155;;BROOKS ET AL., J. COMPUT. CHEM., vol. 4, 1983, pages 187 - 217;;BROOKS, J. COMPUT. CHEM., vol. 4, 1983, pages 187 - 217;;JORGENSEN ET AL., J CHEM PHYS., vol. 79, 1983, pages 926 - 935;;WU, WANG, J. PHYSICAL CHEMISTRY, vol. 102, 1998, pages 7238 - 7250;;GILLESPIE, BIOPOLYMERS, vol. 43, 1997, pages 191 - 217;;MILNE ET AL., J CHEM. INF. COMPUT. SCI., vol. 34, 1994, pages 1219 - 1224;;SAMBROOK ET AL.: ""Molecular Cloning: A Laboratory Manual"", 1989, COLD SPRING HARBOR LABORATORIES, COLD SPRING HARBOR;;NEWTON ET AL., DEVELOP. DYNAMICS, vol. 197, 1993, pages 1 - 13;;HARLOW, LANE: ""Antibodies: A Laboratory Manual"", 1988, COLD SPRING HARBOR LABORATORY;;KOHLER, MILSTEIN, EUR. J IMMUNOL., vol. 6, 1976, pages 511 - 519;;HARLOW, LANE: ""Antibodies: A Laboratory Manual"", 1988, COLD SPRING HARBOR LABORATORY, pages: 309;;ELLERBROEK ET AL., J BIOL. CHEM., vol. 278, 2003, pages 19023 - 19031;;MONNIER ET AL., NEUROSCI., vol. 22, 2003, pages 319 - 330;;EICKHOLT ET AL., J CELL BIOL., vol. 157, 2002, pages 211 - 217;;""The Pharmacological Bases of Therapeutics"", 1990, PERGAMON PRESS;;DOHERTY ET AL., NEURON, vol. 6, 1991, pages 247 - 258;;WILLIAMS ET AL., NEURON, vol. 13, 1994, pages 583 - 594;;WIESMANN ET AL., NATURE, vol. 401, 1999, pages 184 - 188;;BANFIELD ET AL., STRUCTUE (CAMB, vol. 9, 2001, pages 1191 - 1199;;WILLIAMS ET AL., J CELL. BIOL., vol. 160, 2003, pages 481 - 486;;MOHAMMADI ET AL., EMBO J, vol. 17, 1998, pages 5986 - 5904;;SKAPER ET AL., J NEUROCHEM., vol. 75, 2000, pages 1520 - 1527;;HAMBY ET AL., J. MED. CHEM., vol. 40, 1997, pages 2296 - 2303;;PEREZ ET AL., MOL. CELL NEUROSCI., vol. 6, 1995, pages 97 - 105;;URFER ET AL., EMBO J., vol. 14, 1995, pages 2795 - 2805;;BANFIELD ET AL., STRUCTURE (CAMB, 2001, pages 1191 - 1199;;DOHERTY ET AL., MOL. CELL NEUROSCI, vol. 16, 2000, pages 283 - 295;;MCDONALD ET AL., NATURE, vol. 354, 1991, pages 411 - 414;;LESAUTEUR ET AL., J. BIOL. CHEM., vol. 270, 1995, pages 6564 - 6569;;WILLIAMS ET AL., J. BIOL. CHEM., vol. 275, 2000, pages 4007 - 4012;;URFER ET AL., EMBO J, vol. 13, 1994, pages 5896 - 5909;;MCINNES, SYKES, BIOPOLYMERS, vol. 43, 1997, pages 339 - 366;;WILLIAMS ET AL., J. CELL BIOL., vol. 160, 2003, pages 481 - 486;;WILLIAMS ET AL., J. BIOL. CHEM., vol. 277, 2002, pages 4361 - 4367;;TAPLEY ET AL., ONCOGENE, vol. 7, 1992, pages 371 - 381;;HUBER, CHAO, DEV. BIOL., vol. 167, 1995, pages 227 - 238;;TANG ET AL., MOL. CELL. NEUROSCI., vol. 9, 1997, pages 333 - 346;;DERGHAM ET AL., J NEUROSCI., vol. 22, 2002, pages 6570 - 6570;;FOURNIER ET AL., J NEUROSCI., vol. 23, 2003, pages 1416 - 1423;;LEHMANN ET AL., J NEUROSCI., vol. 19, 1999, pages 7537 - 7547;;NARUMIYA ET AL., METHODS ENZYMOL., vol. 325, 2000, pages 273 - 284;;DAVIES ET AL., BIOCHEM. J, vol. 351, 2000, pages 95 - 105;;VINSON ET AL., J BIOL. CHEM., vol. 276, 2001, pages 20280 - 20285;;WILLIAMS ET AL., CELL BIOL., vol. 160, 2003, pages 481 - 486;;ELLERBROEK ET AL., J. BIOL. CHEM., vol. 278, 2003, pages 19023 - 19031;;ATWAL ET AL., J NEUROSCI., vol. 23, 2003, pages 7602 - 7609",DISCONTINUED
100,CA,A1,CA 2606479 A1,115-965-877-039-528,2006-11-09,2006,CA 2606479 A,2006-04-28,US 67590205 P;;US 2006/0016217 W,2005-04-29,NOGO RECEPTOR FUNCTIONAL MOTIFS AND PEPTIDE MIMETICS RELATEDTHERETO AND METHODS OF USING THE SAME,,KING S COLLEGE LONDON;;WYETH CORP,WILLIAMS GARETH;;DOHERTY PATRICK,,https://lens.org/115-965-877-039-528,Patent Application,no,0,0,6,6,0,A61K38/00;;C07K14/705;;G01N33/6872;;G01N33/6896;;G01N2500/00;;G01N2800/28;;A61P25/00;;A61P25/16;;A61P25/28;;A61P43/00;;A61P9/10;;G01N33/6872;;A61K38/00;;C07K14/705;;G01N2800/28;;G01N2500/00;;G01N33/6896,C07K14/435;;A61K38/17;;G01N33/68,,0,0,,,,DISCONTINUED
101,US,B2,US 7196061 B2,158-324-250-021-332,2007-03-27,2007,US 93840904 A,2004-09-09,US 93840904 A;;US 50186403 P;;US 55989804 P;;US 60318704 P,2003-09-10,Compounds that modulate neuronal growth and their uses,"Cyclic peptides and peptidomimetics are provided that bind to and/or modulate activities associated with Trk receptors, including processes associated with the growth and repair of the central nervous system (e.g., neuronal growth and survival, axonal growth, neurite outgrowth and synaptic plasticity). Cyclic peptides and peptidomimetics are also provided that block or reduce the effect of other factors that inhibit growth and/or repair of the central nervous system. Pharmaceutical compositions and other formulations comprising these compounds are provided. In addition, the invention provides methods for using the cyclic peptides and peptidomimetics to modulate Trk mediated activities, including processes such as neuronal growth, survival and recover, axonal growth, neurite outgrowth, and synaptic plasticity. Further, the invention provides methods for promoting central nervous system (CNS) neuron growth by administering a p75 receptor binding agent.",KING S COLLEGE LONDON,DOHERTY PATRICK;;WILLIAMS GARETH,WYETH (2005-10-19);;KING'S COLLEGE LONDON (2005-10-19),https://lens.org/158-324-250-021-332,Granted Patent,yes,2,0,15,16,43,A61K38/10;;A61K38/12;;A61K38/10;;A61K38/12;;A61P9/10;;A61P25/00;;A61P25/16;;A61P25/28;;A61P43/00;;C07K7/06;;C07K7/06;;C07K7/08;;C07K7/08,A61K38/12;;A61K/;;A61K38/00;;C07K7/64,514/11;;530/317,31,31,072-641-164-156-549;;020-258-471-940-706;;019-486-463-730-759;;017-361-536-768-212;;006-757-312-943-554;;040-983-230-797-942;;026-708-930-871-652;;055-962-012-218-633;;028-607-680-603-62X;;091-040-367-867-311;;055-150-100-518-405;;003-180-829-414-118;;035-634-067-620-429;;053-490-744-678-664;;051-120-944-942-14X;;043-303-151-451-107;;001-026-965-230-964;;034-537-945-815-676;;076-515-315-033-107;;092-822-497-202-214;;008-353-136-317-82X;;043-945-165-587-966;;066-368-253-833-386;;023-242-174-944-359;;031-621-234-931-577;;058-386-600-099-243;;009-324-146-627-26X;;083-850-014-746-48X;;006-901-235-936-003;;021-928-611-338-722;;068-068-602-226-014,10.1021/bc0155566;;12009947;;10.1016/s0021-9258(18)50070-3;;1331077;;11877382;;pmc155354;;10.1101/gad.217902;;8846002;;10.1006/mcne.1995.1025;;10.2174/1381612023393215;;12369863;;10.1074/jbc.m411121200;;15572360;;11738045;;10.2210/pdb1hcf/pdb;;10.1016/s0969-2126(01)00681-5;;11163887;;10.1016/s0166-2236(00)01682-9;;10027292;;10.1016/s0896-6273(00)80681-9;;10.1016/s0896-6273(02)00770-5;;12160746;;10.1126/science.1095190;;15131306;;1314703;;10.1016/0092-8674(92)90413-7;;10.1016/s0959-4388(00)00092-1;;10851172;;9391013;;pmc6573396;;10.1523/jneurosci.17-24-09583.1997;;10.1016/s0959-4388(00)00209-9;;11399425;;7896793;;10.1074/jbc.270.12.6564;;10.1006/exnr.1993.1181;;8282068;;10341240;;pmc6782629;;10.1523/jneurosci.19-11-04370.1999;;10.1002/(sici)1097-4547(19970401)48:1<1::aid-jnr1>3.0.co;2-k;;9086177;;10.1074/jbc.275.14.9946;;10744669;;10.1038/354411a0;;1956407;;9566117;;10.1002/(sici)1097-0282(1997)43:5<339::aid-bip2>3.0.co;2-w;;10.1002/(sici)1097-0282(1997)43:5<339::aid-bip2>3.3.co;2-9;;10.1046/j.1460-9568.1998.00071.x;;9749723;;10.1016/s1044-7431(02)00035-0;;12691734;;12730196;;10.1074/jbc.m303209200;;10.1016/0197-0186(94)90044-2;;7950962;;8205613;;10.1016/0092-8674(94)90048-5;;7529173;;pmc395565;;10.1002/j.1460-2075.1994.tb06935.x;;10.1038/nature00867;;12068310;;10.1038/43705;;10490030;;010490030;;10.1074/jbc.m005071200;;10896671,"Su, et al., Bioconjugate Chem., 2002, 13, 561-570.;;Cardarelli, et al., The Journal of Biological Chemistry, 1992, 32, 23159-23164.;;Postigo, et al., Genes and Development, 2002, 16, 633-645.;;Memberg, et al., Molecular and Cellular Neuroscience, 1995, 6, 323-335.;;Saragovi et al., ""Small Molecule Peptidomimetic Ligands of Neurotrophin Receptors, Identifying Binding Cites, Activation Sites and Regulatory Sites,"" Current Pharmaceutical Design, 2002, vol. 8, pp. 2201-2216.;;Williams et al., ""Overcoming the Inhibitors of Myelin with a Novel Neurotrophin Strategy,"" The Journal of Biological Chemistry, Feb. 18, 2005, vol. 280, No. 7, pp. 5862-5869.;;Banfield, Mark J., et al. 2001. Specificity in Trk Receptor: Neurotrophin Interactions: The Crystal Structure of TrkB -d5 in Complex with Neurotrophin-4/5. Structure 9:1191-1199.;;Binder, Devin K., et al. 2001. BDNF and epilepsy: too much of a good thing? Trends in Neurosciences 24(1):47-53.;;Cai, Dongming, et al. 1999. Prior Exposure to Neurotrophins Blocks Inhibition of Axonal Regeneration by MAG and Myelin via a Camp-Dependent Mechanism. Neuron 22:89-101.;;Domeniconi, Marco, et al. 2002. Myelin-Associated Glycoprotein Interacts with the Nogo66 Receptor to Inhibit Neurite Outgrowth. Neuron 35:283-290.;;He, Xiao-Lin, and Garcia, K. Christopher. 2004. Structure of Nerve Growth Factor Complexed with the Shared Neurotrophin Receptor p75. Science 304:870-875.;;Ibanez, Carlos F., et al: 1992. Disruption of the Low Affinity Receptor-Binding Site in NGF Allows Neuronal Survival and Differentiation by Binding to the trk Gene Product. Cell 69:329-341.;;Kaplan, David R. and Miller, Freda D. 2000. Neurotrophin signal transduction in the nervous system. Current Opinion in Neurobiology 10:381-391.;;Kobayashi, Nao R., et al. 1994. BDNF and NT-4/5 Prevent Atrophy of Rat Rubrospinal Neurons after Cervical Axotomy, Stimulate GAP-43 and Talpha1-Tubulin mRNA Expression, and Promote Axonal Regeneration. The Journal of Neuroscience 17(24)9583-9595.;;Lee, Francis S., et al. 2001. The uniqueness of being a neurotrophin receptor. Current Opinion in Neurobiology 11:281-286.;;LeSauteur, Lynne, et al. 1995. Small Peptide Mimics of Nerve Growth Factor Bind TrkA Receptors and Affect Biological Responses. The Journal of Biological Chemistry 270(12):6564-6569.;;Lindsay, Ronald M., et al. 1993. The Therapeutic Potential of Neurotrophic Factors in the Treatment of Parkinson's Disease. Experimental Neurology 124:103-118.;;Liu, Yi, et al. 1999. Transplants of Fibroblasts Genetically Modified to Express BDNF Promote Regeneration of Adult Rat Rubrospinal Axons and Recovery of Forelimb Function. The Journal of Neuroscience 19(11)4370-4387.;;Longo, Frank M., et al. 1997. Synthetic NGF Peptide Derivatives Prevent Neuronal Death via a p75 Receptor-Dependent Mechanism. Journal of Neuroscience Research 43:1-17.;;Maliartchouk, Sergei, et al. 2000. Genuine Monovalent Ligands of TrkA Nerve Growth Factor Receptors Reveal a Novel Pharmacological Mechanism of Action. The Journal of Biological Chemistry 275(14):9946-9956.;;McDonald, Neil Q., et al. 1991. New protein fold revealed by a 2.3-Å resolution crystal structure of nerve growth factor. Nature 354(5):411-414.;;McInnes, Campbell, and Sykes, Brian D. 1998. Growth Factor Receptors: Structure, Mechanism, and Drug Discovery. Growth Factor Receptors, John Wiley & Sons, Inc.:339-366.;;Menei, Philippe, et al. 1998. Schwann cells genetically modified to secrete human BDNF promote enhanced axonal regrowth across transected adult rat spinal cord. European Journal of Neuroscience 10:607-621.;;Monnier, Philippe P., et al. 2003. The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar. Molecular and Cellular Neuroscience 22:319-330.;;O'Leary, Paul D., and Hughes, Richard A. 2003. Design of Potent Peptide Mimetics of Brain-derived Neurotrophic Factor. The Journal of Biological Chemistry 278(28):25738-25744.;;Olson, Lars. 1994. Neurotrophins in Neurodegenerative Disease: Theoretical Issues and Clinical Trials. Neurochem. Int. 25(1):1-3.;;Snider, William. D. 1994. Functions of the Neurotrophins during Nervous System Development: What the Knockouts Are Teaching Us. Cell 77:627-238.;;Urfer, Roman, et al. 1994. The binding epitopes of neurotrophin-3 to its receptors trkC and gp75 and the desisgn of a multifunctional human neurotrophin. The EMBO Journal 13(24):5896-5909.;;Wang, Kevin C., et al. 2002. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite growth. Nature 417:941-944.;;Wiesmann, Christian, et al. 1999. Crystal structure of nerve growth factor in the complex with the ligand-binding domain of the TrkA receptor. Nature 401:184-.;;Xie, Youmei, et al. 2000. Nerve Growth Factor (NGF) Loop 4 Dimeric Mimetics Activate ERK and AKT and Promote NGF-like Neurotrophic Effects. The Journal of Biological Chemistry 275(38):29868-29874.",INACTIVE
102,WO,A3,WO 2005/025514 A3,025-961-663-540-80X,2005-08-11,2005,US 2004/0029888 W,2004-09-10,US 50186403 P;;US 55989804 P;;US 60318704 P,2003-09-10,COMPOUNDS THAT MODULATE NEURONAL GROWTH AND THEIR USES,"Cyclic peptides and peptidomimetics are provided that bind to and/or modulate activities associated with Trk receptors, including processes associated with the growth and repair of the central nervous system (e.g., neuronal growth and survival, axonal growth, neurite outgrowth and synaptic plasticity). Cyclic peptides and peptidomimetics are also provided that block or reduce the effect of other factors that inhibit growth and/or repair of the central nervous system. Pharmaceutical compositions and other formulations comprising these compounds are provided. In addition, the invention provides methods for using the cyclic peptides and peptidomimetics to modulate Trk mediated activities, including processes such as neuronal growth, survival and recover, axonal growth, neurite outgrowth, and synaptic plasticity. Further, the invention provides methods for promoting central nervous system (CNS) neuron growth by administering a p75 receptor binding agent.",KING S COLLEGE LONDON;;WYETH CORP;;DOHERTY PATRICK;;WILLIAMS GARETH,DOHERTY PATRICK;;WILLIAMS GARETH,,https://lens.org/025-961-663-540-80X,Search Report,yes,2,0,15,16,0,A61K38/10;;A61K38/12;;A61K38/10;;A61K38/12;;A61P9/10;;A61P25/00;;A61P25/16;;A61P25/28;;A61P43/00;;C07K7/06;;C07K7/06;;C07K7/08;;C07K7/08,A61K/;;A61K38/00;;A61K38/12;;C07K7/64,,3,2,006-757-312-943-554;;040-983-230-797-942,10.2174/1381612023393215;;12369863;;10.1074/jbc.m411121200;;15572360,"SARAGOVI ET AL: ""Small Molecule Peptidomimetic Ligands of Neurotrophin Receptors, Identifying Binding Sites, Activation Sites and Regulatory Sites"", CURRENT PHARMACEUTICAL DESIGN, vol. 8, 2002, pages 2201 - 2216, XP008055846;;WILLIAMS ET AL: ""Overcoming the Inhibitors of Myelin with a Novel Neurotrophin Strategy"", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 280, no. 7, 18 February 2005 (2005-02-18), pages 5862 - 5869, XP002430703;;See also references of EP 1663276A4",PENDING
103,CN,A,CN 1849132 A,003-339-511-455-114,2006-10-18,2006,CN 200480026134 A,2004-09-10,US 50186403 P,2003-09-10,Compounds that modulate neuronal growth and their uses,,KING S COLLEGE LONDON,GARETH DOHERTY PATRICK WILLIAM,,https://lens.org/003-339-511-455-114,Patent Application,no,0,9,1,16,0,,A61K38/00,,0,0,,,,DISCONTINUED
104,AU,A1,AU 2004/272107 A1,012-598-698-136-959,2005-03-24,2005,AU 2004/272107 A,2004-09-10,US 50186403 P;;US 60318704 P;;US 55989804 P;;US 2004/0029888 W,2003-09-10,Compounds that modulate neuronal growth and their uses,,WYETH CORP;;KING S COLLEGE LONDON,WILLIAMS GARETH;;DOHERTY PATRICK,,https://lens.org/012-598-698-136-959,Patent Application,no,0,0,15,16,0,A61K38/10;;A61K38/12;;A61K38/10;;A61K38/12;;A61P9/10;;A61P25/00;;A61P25/16;;A61P25/28;;A61P43/00;;C07K7/06;;C07K7/06;;C07K7/08;;C07K7/08,A61K38/00;;A61K/;;A61K38/12;;C07K7/64,,0,0,,,,INACTIVE
105,EP,A2,EP 1663276 A2,056-522-925-517-141,2006-06-07,2006,EP 04788721 A,2004-09-10,US 2004/0029888 W;;US 50186403 P;;US 55989804 P;;US 60318704 P,2003-09-10,COMPOUNDS THAT MODULATE NEURONAL GROWTH AND THEIR USES,,WYETH CORP;;KING S COLLEGE LONDON,DOHERTY PATRICK;;WILLIAMS GARETH,KING'S COLLEGE LONDON (2010-04-21);;WYETH LLC (2010-04-21),https://lens.org/056-522-925-517-141,Patent Application,yes,0,0,15,16,43,A61K38/10;;A61K38/12;;A61K38/10;;A61K38/12;;A61P9/10;;A61P25/00;;A61P25/16;;A61P25/28;;A61P43/00;;C07K7/06;;C07K7/06;;C07K7/08;;C07K7/08,A61K/;;A61K38/00;;A61K38/12;;C07K7/64,,0,0,,,,DISCONTINUED
106,US,A1,US 2020/0216142 A1,095-875-429-567-965,2020-07-09,2020,US 202016738536 A,2020-01-09,US 202016738536 A;;US 201962790432 P,2019-01-09,BOTTOM BRACKET FOR BICYCLES,"A bottom bracket is connected to a spindle and a frame of a bicycle. The bottom bracket comprises a housing and an adapter. The housing is connected to the frame and comprises a substantially circular disc, one or more pins, and an actuating mechanism. The disc comprises a plurality of disc openings arranged proximate to a circumferential edge of the disc and is adapted to rotate with the spindle. The pins selectively engage with the disc openings, wherein the engagement of the pins with the disc openings prevents further rotation of the disc. The actuating mechanism selectively engages the pins with the disc openings. The adapter removably is attached to the housing and connected to the frame.",CHAN NATHAN;;DOHERTY JASAN PATRICK,CHAN NATHAN;;DOHERTY JASAN PATRICK,,https://lens.org/095-875-429-567-965,Patent Application,yes,2,0,2,2,0,B62M1/36;;B62M9/00;;B62K19/34;;B62K19/34;;B62M3/00;;B62M3/003;;B62M5/00,B62M9/00,,0,0,,,,ACTIVE
107,US,B2,US 10919603 B2,119-267-957-655-31X,2021-02-16,2021,US 202016738536 A,2020-01-09,US 202016738536 A;;US 201962790432 P,2019-01-09,Bottom bracket for bicycles,"A bottom bracket is connected to a spindle and a frame of a bicycle. The bottom bracket comprises a housing and an adapter. The housing is connected to the frame and comprises a substantially circular disc, one or more pins, and an actuating mechanism. The disc comprises a plurality of disc openings arranged proximate to a circumferential edge of the disc and is adapted to rotate with the spindle. The pins selectively engage with the disc openings, wherein the engagement of the pins with the disc openings prevents further rotation of the disc. The actuating mechanism selectively engages the pins with the disc openings. The adapter removably is attached to the housing and connected to the frame.",CHAN NATHAN;;DOHERTY JASAN PATRICK,CHAN NATHAN;;DOHERTY JASAN PATRICK,,https://lens.org/119-267-957-655-31X,Granted Patent,yes,2,0,2,2,0,B62M1/36;;B62M9/00;;B62K19/34;;B62K19/34;;B62M3/00;;B62M3/003;;B62M5/00,B62M3/00;;B62K19/34;;B62M1/36;;B62M9/00,,0,0,,,,ACTIVE
108,CA,A,CA 162044 A,013-348-961-406-165,1915-04-20,1915,CA 162044D A,1914-05-16,CA 162044T A,1914-05-16,ROCK DRILL,,HUGHES THOMAS;;DOHERTY PATRICK J,HUGHES THOMAS;;DOHERTY PATRICK J,,https://lens.org/013-348-961-406-165,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
109,GB,A,GB 2218649 A,091-435-572-665-31X,1989-11-22,1989,GB 8910518 A,1989-05-08,GB 8810851 A,1988-05-07,Game,"A game for two or more players comprises a set of cards supporting two patterns, and an arrangement such as dice for randomly generating a set of coordinates. One of the two patterns is marked to indicate the progress of the game. A first pattern defines a matrix in which each of an array of locations is identified by a respective one of the set of coordinates that can be generated, and a second pattern identifies pieces of information each identified by a respective one of the set of coordinates which can be generated. Thus a player is asked to provide the piece of information corresponding to a particular set of coordinates without reference to the second pattern and thereafter to mark his first pattern in dependence upon his ability to supply the requested information. As shown, a board 1 has a transparent dome 3 covering dice (5) and four hinged transparent panels 2 for retaining changeable cards. One side of each panel provides questions based on spelling, arithmetic, geography or translations and the other side provides peg holes for placing an array of pegs or pegs in a game corresponding to snakes-and-ladders, snooker, baseball, football, golf or grandprix. <IMAGE>",DOHERTY PATRICK J;;HARTLEY TERENCE,DOHERTY PATRICK JOHN;;HARTLEY TERENCE,,https://lens.org/091-435-572-665-31X,Patent Application,no,0,2,3,3,0,A63F9/18,A63F9/18,A6H HHT           HHT;;A6H HJB           HJB;;A6H H3C1          H3C;;A6H H82           H82,0,0,,,,DISCONTINUED
110,US,B2,US 6722721 B2,093-263-827-139-78X,2004-04-20,2004,US 16486202 A,2002-06-06,US 16486202 A,2002-06-06,Pickup truck foldable ramp tailgate,"
    A fold up ramp assists the loading and unloading of equipment and people onto and off of the bed of a pickup truck. Four individual panels are configured with a unique folding pattern that allows two of the panels to fold into two of the other panels, or nest, to form the tailgate on a pickup truck. The folded and nested panel tailgate is exactly the same size as a standard pickup truck tailgate, varying according to vehicle make and model, and utilizes the same latching mechanism. The ramp panels are fabricated of rectangular metal tubing frames having a metal meshing topside. The panels are interconnected by piano hinges fastened to the underside shared edges between the panels and running the full length of the edge to increase stability and strength. 
",SHERRER EARL W.;;DOHERTY PATRICK T.,SHERRER EARL W;;DOHERTY PATRICK T,,https://lens.org/093-263-827-139-78X,Granted Patent,yes,6,47,2,2,0,B60P1/435;;B62D33/0273;;B62D33/0273;;B60P1/435,B60P1/43;;B62D33/027,296/61;;414/557;;14/71.1,0,0,,,,EXPIRED
111,US,A1,US 2004/0032142 A1,095-442-894-461-783,2004-02-19,2004,US 16486202 A,2002-06-06,US 16486202 A,2002-06-06,PICKUP TRUCK FOLDABLE RAMP TAILGATE,"
   A fold up ramp assists the loading and unloading of equipment and people onto and off of the bed of a pickup truck. Four individual panels are configured with a unique folding pattern that allows two of the panels to fold into two of the other panels, or nest, to form the tailgate on a pickup truck. The folded and nested panel tailgate is exactly the same size as a standard pickup truck tailgate, varying according to vehicle make and model, and utilizes the same latching mechanism. The ramp panels are fabricated of rectangular metal tubing frames having a metal meshing topside. The panels are interconnected by piano hinges fastened to the underside shared edges between the panels and running the full length of the edge to increase stability and strength. 
",SHERRER EARL W.;;DOHERTY PATRICK T.,SHERRER EARL W;;DOHERTY PATRICK T,,https://lens.org/095-442-894-461-783,Patent Application,yes,0,28,2,2,0,B60P1/435;;B62D33/0273;;B62D33/0273;;B60P1/435,B60P1/43;;B62D33/027,296/61,0,0,,,,EXPIRED
112,US,A1,US 2011/0239851 A1,023-405-024-972-85X,2011-10-06,2011,US 201113075131 A,2011-03-29,US 201113075131 A;;US 31874910 P,2010-03-29,BALLISTIC STRUCTURAL INSULATED PANEL,One or more embodiments contained herein disclose a structural insulated panel having improved ballistics properties and methods for using the same.,MASON JEFF;;REDFERN PATRICK;;DOHERTY ROBERT,MASON JEFF;;REDFERN PATRICK;;DOHERTY ROBERT,L.C.O.A. COMPOSITES INC (2011-03-29),https://lens.org/023-405-024-972-85X,Patent Application,yes,0,40,2,2,0,B32B27/04;;B32B2571/00;;E04H9/10;;F41H5/0428;;F41H5/0457;;B32B5/024;;B32B5/18;;B32B7/12;;B32B9/005;;B32B9/045;;B32B9/047;;B32B13/045;;B32B13/12;;B32B13/14;;B32B15/046;;B32B15/08;;B32B15/14;;B32B15/18;;B32B15/20;;B32B21/08;;B32B21/10;;B32B27/065;;B32B27/10;;B32B27/12;;B32B27/32;;B32B27/40;;B32B29/02;;B32B2260/028;;B32B2262/0253;;B32B2262/0269;;B32B2262/101;;B32B2266/0214;;B32B2266/0228;;B32B2266/04;;B32B2307/54;;B32B2307/732;;B32B2419/04;;B32B2471/00;;B32B2571/02;;B32B2607/00;;F41H5/0428;;B32B27/04;;B32B2571/00;;E04H9/10;;F41H5/0457;;B32B2260/028;;B32B2262/0253;;B32B9/045;;B32B21/08;;B32B2307/54;;B32B13/12;;B32B9/005;;B32B2607/00;;B32B2266/0214;;B32B7/12;;B32B13/045;;B32B27/12;;B32B2307/732;;B32B29/02;;B32B5/024;;B32B15/14;;B32B27/065;;B32B2266/04;;B32B15/20;;B32B2262/0269;;B32B27/32;;B32B2419/04;;B32B2471/00;;B32B15/046;;B32B21/10;;B32B2262/101;;B32B9/047;;B32B5/18;;B32B13/14;;B32B2571/02;;B32B15/08;;B32B2266/045;;B32B27/10;;B32B27/40;;B32B2266/0228;;B32B15/18,F41H5/04,89/36.02;;89/903;;89/904;;89/917;;89/906;;89/910;;89/908,0,0,,,,DISCONTINUED
113,GB,A,GB 190407889 A,150-432-594-377-92X,1904-07-14,1904,GB 190407889D A,1904-04-05,GB 190407889T A,1904-04-05,Improvements in and relating to Machines for Affixing Labels to Bottles and other Curved Bodies.,"7889. Cassidy, P. F., and Doherty, N. F. April 5. Affixing labels.-Relates to machines, for affixing labels to bottles and other curved bodies. The paste receptacle 6 is constructed as described in Specification No. 14,521, A.D. 1901. The machine consists of a frame 1 supporting an open casing 2 having bearings 3 for two parallel guide-rods 4, upon which travels a carriage 5 carrying the paste receptacle. The carriage is moved forwards by a treadle 13, acting through a link 12, shaft 9, and links 8, 7, and is returned by a spring 14. The label hopper is carried on a frame 15, supported within the casing 2 by a spring 18 surrounding a rod 16, the lowered end of which, when the frame is in its raised position, is directly above a dog 19 extending from a hub 20 loose on the shaft 9. The dog has a side lug, normally held against a shoulder of a collar fixed on the shaft 9 by a weight 23 carried by the hub 20. When the treadle is depressed, the dog 19 is thrown forwards, and releases the lower end of the rod 16. Mounted upon the frame 15 is a plate 24 having removable vertical pins 25 which pass through holes in a plate 26 resting on the edges 27 of the casing and used to carry the packet of labels. At the front of the plate 26 is a slot 28, adjoining which is a support 29 to raise slightly that end of the pile of labels. The pins are removable and adjustable to accommodate labels of different sizes. Along each side of the frame 15 are the fixed tracks 30, to one of which a rack 31 is loosely held by screws 32 working in inclined slots 33. A pin 34 from the rack extends into a slot 35 in the casing, so that, when the frame is lowered, carrying the tracks 30 with it, the rack is forced slightly above the tracks. The axle of the paste roller carries two wheels 37, which run on the tracks 30, and one ratchet-wheel 37<a>, which gears with the rack bar 31 when the paste receptacle moves backwards. When the latter approaches the end of its backward travel, inclines 38 engage the wheels 37 and raise the receptacle from the frame 15, which then rises under the recoil of the spring 18. In the forward travel of the paste receptacle, its weight depresses the frame 15, and the pins 25 are lowered out of the way of the roller. When the frame rises, the dog 19 again takes up its position beneath the rod 16. To hold the labels while being pasted, a hook 41 is used. It is raised and lowered along with the frame 15, and is given a quarter turn, to grip or release the labels, by forming part of a rod 40, which has a sleeve 43 in which works a rod 44 operated from the shaft 9 by a lug 48, a link 47, and an arm 46. When the frame 15 is lowered, the hook grips the labels, and the paste roller on its return movement then pastes the top label, the roller having a central groove 49 to accommodate the hook. After the label has been pasted, the bottle is placed by hand in the position determined by the adjustable gauge 50 having an adjustable stop - plate 54. The bottle is then passed to an endless band 5, which is hung on crank shafts 58 carried by the stand 1, and is drawn tightly round the bottle in consequence of the weight of the latter. The shafts 58 have intermeshing gear segments 59, and are returned to their position, on the removal of the bottle, by a spring.",CASSIDY PATRICK FRANCIS;;DOHERTY NEIL FRANCIS,CASSIDY PATRICK FRANCIS;;DOHERTY NEIL FRANCIS,,https://lens.org/150-432-594-377-92X,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
114,US,A,US 756580 A,185-588-572-010-335,1904-04-05,1904,US 1903/0151830 A,1903-04-09,US 1903/0151830 A,1903-04-09,LABEL-AFFIXING MACHINE.,,BOSTON BOTTLE WIRING AND LABELING COMPANY,CASSIDY PATRICK F;;DOHERTY NEIL F,,https://lens.org/185-588-572-010-335,Granted Patent,no,0,0,1,1,0,B29C53/36;;B29C53/36;;Y10T156/1798;;Y10T156/1798,,,0,0,,,,EXPIRED
115,US,A1,US 2016/0062979 A1,142-965-753-580-16X,2016-03-03,2016,US 201414478033 A,2014-09-05,US 201414478033 A;;US 201462042671 P,2014-08-27,WORD CLASSIFICATION BASED ON PHONETIC FEATURES,"Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for obtaining a textual term; determining, by one or more computers, a vector representing a phonetic feature of the textual term; comparing the vector representing the phonetic feature of the textual term with a reference vector representing a phonetic feature of a reference textual term; and classifying the textual term based on the comparing the vector with the reference vector.",GOOGLE INC,MOTE NICOLAUS TODD;;DOHERTY RYAN PATRICK,GOOGLE LLC (2014-09-04),https://lens.org/142-965-753-580-16X,Patent Application,yes,5,16,4,4,0,G06F16/90344;;G06F40/237;;G06F16/90344;;G06F40/30;;G06F40/242;;G06F40/279;;G06F40/237,G06F40/237,,1,1,150-205-731-488-010,10.1162/coli.2010.36.1.36104,"Cook, Paul, and Suzanne Stevenson. ""Automatically identifying the source words of lexical blends in English."" Computational Linguistics 36.1 (2010): 129-149.",DISCONTINUED
116,US,A1,US 2012/0136356 A1,027-160-000-588-178,2012-05-31,2012,US 201013389130 A,2010-08-12,IE 20090623 A;;IE 20100345 A;;IE 2010000047 W,2009-08-13,INTRAMEDULLARY NAILS FOR LONG BONE FRACTURE SETTING,"An intramedullary nail has a proximal part for engagement with a proximal bone fragment and a distal part for engagement with a distal bone fragment. A motion assembly interconnects the parts and allows limited axial relative motion of the proximal and distal parts. This limited axial motion provides micromotion and in some embodiments also dynamisation. The nail may comprise a stem for fastening to one bone fragment and an insert within the stem for fastening to the other bone fragment, the insert being adapted to guide insertion of a bone screw through the stem and to prevent relative rotation of the distal and proximal bone fragments. The motion assembly may include spring bias and/or damping means between the parts, possibly including one or more Belleville washers.",DOHERTY WILLIAM;;O'CONNOR PATRICK;;HARTY JAMES;;CORK INST TECHNOLOGY,DOHERTY WILLIAM;;O'CONNOR PATRICK;;HARTY JAMES,CORK INSTITUTE OF TECHNOLOGY (2012-01-27);;ORTHOXEL DAC (2016-07-09),https://lens.org/027-160-000-588-178,Patent Application,yes,4,30,8,9,0,A61B17/7225;;A61B17/7241;;A61B17/7225;;A61B17/7241;;A61B17/725,A61B17/56,606/62,0,0,,,,ACTIVE
117,WO,A1,WO 1991/015039 A1,142-406-672-747-086,1991-10-03,1991,US 9101825 W,1991-03-19,US 49624890 A,1990-03-20,RELEASABLE CONNECTOR ASSEMBLY FOR CATHODE RAY TUBE,"A releasable cathode ray tube connector assembly exhibiting enhanced dielectric standoff for its high-voltage contacts, even at high altitudes where voltage breakdowns frequently can occur. A substantially rigid dielectric sleeve encircles a base portion of a high-voltage contact projecting from the cathode ray tube stem, and a resilient sleeve carried in a cylindrical recess of a mating plug assembly is sized to slide over this rigid sleeve and substantially fill the annular space surrounding the rigid sleeve. An enhanced voltage seal is thereby provided.",REYNOLDS IND INC,DOHERTY PATRICK D II;;MCCORMICK DAVID M,,https://lens.org/142-406-672-747-086,Patent Application,yes,4,5,3,3,0,H01R33/7621;;H01R33/7621;;H01J29/92;;H01J29/92;;H01R13/53;;H01R13/53,H01J29/92;;H01R13/53;;H01R33/76,H2E EFBX          EFBX,0,0,,,,PENDING
118,US,A1,US 2021/0398377 A1,043-661-072-386-650,2021-12-23,2021,US 202117465576 A,2021-09-02,US 202117465576 A;;US 202016925066 A;;US 202063028040 P,2020-05-21,HEALTH BASED ACCESS CONTROL,The present disclosure relates to systems and methods of control access to a controlled-access area. In one embodiment the method includes analyzing health data corresponding to a user to determine that the health data satisfies a health standard for an organization controlling the access-controlled location and the health data was captured at a sensing location offsite from the access-controlled location. In one embodiment the method includes determining that the user has authorization from the organization to enter the access-controlled location; and authorizing the user to enter the access-controlled location.,SATURDAY CAPITAL LLC,DOHERTY PATRICK;;WALL JOHN;;BIVIANO MICHAEL S,SATURDAY CAPITAL LLC (2021-05-11);;KEEE LLC (2020-07-30),https://lens.org/043-661-072-386-650,Patent Application,yes,3,0,2,3,0,G01K13/20;;H04L67/12;;H04L63/0861;;G01J5/0025;;G01J5/025;;G07C9/37;;G07C9/38;;G07C2209/02;;G07C9/257;;G01K7/02;;H04L67/12;;G07C9/253,G07C9/25;;G01K7/02,,0,0,,,,DISCONTINUED
119,IE,A1,IE 991068 A1,144-792-133-555-131,2000-10-04,2000,IE 991068 A,1999-12-20,IE 991068 A;;IE 990047 A,1999-01-21,A barrier,A barrier (1) has a base unit (2) which is secured to the ground and a top unit (3) which may be connected at any one of four different orientations. An electronic controller (6) is mounted in a door (5) of the base unit (2) so that it may be easily accessed. A drive mechanism (35) is mounted in a modular manner in the top unit (3). It is mounted by virtue of a beam drive shaft (21) which is mounted by bearings (22) at each end to opposed side walls (20) of the top unit (3). The beam is connected to the drive shaft (21) in a symmetrical manner so that the barrier may be used for either the right side or the left side of a laneway. There is excellent support and balance in the drive mechanism because it is connected between support bearings of the beam drive shaft (21). A manual override is provided to release a clutch if an electrical fault arises. The beam has a shear plate (27) which yields to minimise damage to either the drive mechanism or a beam arm (30) in the event of an accidental impact against the beam.,ELECTRO AUTOMATION RES EAR LTD,HIGGINS RORY JOHN;;DOHERTY PATRICK;;WALSH JOHN,,https://lens.org/144-792-133-555-131,Patent Application,no,0,2,4,4,0,E01F13/06,E01F13/04;;E01F13/06,,0,0,,,,DISCONTINUED
120,US,B1,US 11113913 B1,147-943-447-319-144,2021-09-07,2021,US 202016925066 A,2020-07-09,US 202016925066 A;;US 202063028040 P,2020-05-21,Temperature based access control,"The present disclosure relates to systems and methods of control access to a controlled-access area. The method includes receiving offsite sensor data, receiving offsite user identification data corresponding to the offsite sensor data, determining that the offsite sensor data satisfies an organizational standard, determining that the offsite user identification data corresponds to an approved user, and transmitting a notification to a user device. The method may also include receiving onsite user information and using the offsite sensor data and the onsite user information to determine if a user is approved for access to an access-controlled area. In some examples, the offsite sensor data may be temperature data associated with a febrile condition of a user attempting to gain access to the controlled-access area.",KEEE LLC;;SATURDAY CAPITAL LLC,DOHERTY PATRICK;;WALL JOHN;;BIVIANO MICHAEL S,SATURDAY CAPITAL LLC (2021-05-11);;KEEE LLC (2020-07-30),https://lens.org/147-943-447-319-144,Granted Patent,yes,14,6,2,3,0,G01K13/20;;H04L67/12;;H04L63/0861;;G01J5/0025;;G01J5/025;;G07C9/37;;G07C9/38;;G07C2209/02;;G07C9/257;;G01K7/02;;H04L67/12;;G07C9/253,G07C9/25;;G01K7/02;;H04L29/08,,8,0,,,"Herrera, Juan, “Authorisations based on body temperature”, nedap, May 13, 2020, 9 pages.;;Kintronics—IP Security Solutions, “IP Door Access Control—Access Control Systems Overview”, (https://kintronics.com/solutions/ip-door-access-control/ip-door-reader-comparison/), 2020, 27 pages.;;Kintronics IP Security Solutions, “Professional Biometric Door Readers—Biometric IP Door Readers for Access Control”, https://kintronics.com/solutions/ip-door-access-control/multimode-biometric-door-control-readers/professional-biometrio-door-readers/, 2020, 14 pages.;;Kintronics IP Security Solutions, “Smartphone Door Access Using Bluetooth Reader—Mobile Credentials Enabled Door Access Systems”, (https://kintronics.com/wp-content/uploads/2014/07/Mobile-Credential-concept.jpg), 2020, 9 pages.;;Mastrangelo, Teresa, “IoT and mobile apps taking on new roles in the ‘new normal’”, May 18, 2020, 5 pages.;;CMU—Queen, Scott, “CMU Changes Safeguard Student Health”, https://news.centralmethodist.edu/2020/08/changes-to-safeguard-student-health.html, Aug. 9, 2020, 3 pages.;;NYT—McNeil, Donald Jr., “Can Smart Thermometers Track the Spread of the Coronavirus?”, https://www.nytimes.com/2020/03/18/health/coronavirus-fever-thermometers.html, Mar. 18, 2020, 3 pages.;;Youtube, “Presage PreCheck—Channel”, https://www.youtube.com/channel/UCYcYvvB8f4UE55DZdtPXk9Q/videos, Sep. 2020.",ACTIVE
121,EP,A1,EP 0521072 A1,094-298-684-149-791,1993-01-07,1993,EP 91906841 A,1991-03-19,US 49624890 A,1990-03-20,RELEASABLE CONNECTOR ASSEMBLY FOR CATHODE RAY TUBE.,"Ensemble de connecteurs déconnectables pour tube cathodique présentant des caractéristiques diélectriques améliorées en ce qui concerne ces contacts de haute tension, même à des altitudes élevées où des défaillances de tension peuvent se produire fréquemment. Un manchon diélectrique rigide encercle une partie de base d'un contact de haute tension dépassant de la tige du tube cathodique, et un manchon résilient situé dans un évidement cylindrique d'un ensemble de prises mâles adaptées est dimensionné pour glisser sur ce manchon rigide et remplir l'espace annulaire entourant ledit manchon rigide. On obtient ainsi un scellement d'étanchéité de tension amélioré.",REYNOLDS IND INC,DOHERTY PATRICK D II;;MCCORMICK DAVID M,,https://lens.org/094-298-684-149-791,Patent Application,yes,0,0,3,3,0,H01R33/7621;;H01R33/7621;;H01J29/92;;H01J29/92;;H01R13/53;;H01R13/53,H01J29/92;;H01R13/53;;H01R33/76,,1,0,,,See references of WO 9115039A1,DISCONTINUED
122,US,A,US 5354221 A,104-481-055-547-603,1994-10-11,1994,US 92741692 A,1992-09-21,US 92741692 A;;US 9101825 W;;US 49624890 A,1990-03-20,Releasable connector assembly for cathode ray tube,"A releasable cathode ray tube connector assembly exhibiting enhanced dielectric standoff for its high-voltage contacts, even at high altitudes where voltage breakdowns frequently can occur. A substantially rigid dielectric sleeve encircles a base portion of a high-voltage contact projecting from the cathode ray tube stem, and a resilient sleeve carried in a cylindrical recess of a mating plug assembly is sized to slide over this rigid sleeve and substantially fill the annular space surrounding the rigid sleeve. An enhanced voltage seal is thereby provided.",REYNOLDS IND INC,DOHERTY II PATRICK D;;MCCORMICK DAVID M,REYNOLDS INDUSTRIES INC (1992-09-18);;TELEDYNE REYNOLDS INC (2004-07-02),https://lens.org/104-481-055-547-603,Granted Patent,yes,9,7,3,3,0,H01R33/7621;;H01R33/7621;;H01J29/92;;H01J29/92;;H01R13/53;;H01R13/53,H01J29/92;;H01R13/53;;H01R33/76,439/683;;439/620,0,0,,,,EXPIRED
123,US,A1,US 2017/0297739 A1,001-097-396-171-658,2017-10-19,2017,US 201715641986 A,2017-07-05,US 201715641986 A;;US 201213604787 A,2012-09-06,STABILIZED AGGREGATES AND OTHER MATERIALS AND STRUCTURES FOR ENERGY ABSORPTION,"Materials and structures for absorbing energy. The materials and structures are well suited for arresting aircraft and other vehicles, although their purposes need not be so limited. Also detailed are packaging and other solutions for maintaining system integrity, especially (but not exclusively) when foam glass or other aggregate is employed and stabilizing the location of the aggregate is desired.",ENG ARRESTING SYSTEMS CORP,VALENTINI SILVIA C;;DOHERTY SHAWN PATRICK;;LI YOUHONG,RUNWAY SAFE IPR AB (2020-02-28);;ENGINEERED ARRESTING SYSTEMS CORPORATION (2012-09-12),https://lens.org/001-097-396-171-658,Patent Application,yes,0,6,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,B64F1/02;;E01C9/00,,0,0,,,,ACTIVE
124,WO,A1,WO 2019/139980 A1,016-468-547-907-832,2019-07-18,2019,US 2019/0012890 W,2019-01-09,US 201862615242 P,2018-01-09,METHODS FOR MEASURING ANALYTE AND/OR PROTEIN IN BIOLOGICAL SAMPLES,"The disclosure directed to methods for measuring an analyte alone or in combination with total protein in biological samples. More particularly, the disclosure relates to methods for measuring an analyte and/or total protein using one or more colorimetric reagents alone or in combination with protein precipitation reagents.",IDEXX LAB INC,DOHERTY PATRICK;;KIRSPEL KEVIN;;FARACE GIOSI;;YERRAMILLI MURTHY,,https://lens.org/016-468-547-907-832,Patent Application,yes,1,1,14,14,0,G01N21/272;;G01N21/82;;G01N21/78;;G01N33/52;;G01N33/6827;;G01N31/22;;G01N21/272;;G01N21/78;;G01N21/82;;G01N33/52;;G01N31/22;;G01N33/6827;;G01N31/22;;G01N21/272;;G01N1/30;;G01N21/82;;H04N23/73;;G01N21/78;;G01N33/52;;G01N33/6827;;G06T7/0012;;G06T2207/10144;;G06T2207/30242,G01N33/52;;G01N1/28;;G01N1/30;;G01N21/27;;G01N33/68,,3,3,029-983-050-650-240;;084-757-878-185-19X;;075-502-419-943-472,10.1021/ed300567p;;pmc5220360;;28067287;;10.1038/srep40203;;10.1021/ac60289a016,"ERIC KEHOE ET AL: ""Introducing Colorimetric Analysis with Camera Phones and Digital Cameras: An Activity for High School or General Chemistry"", JOURNAL OF CHEMICAL EDUCATION, vol. 90, no. 9, 2013, pages 1191 - 1195, XP055574334;;HUISUNG KIM ET AL: ""Smartphone-based low light detection for bioluminescence application"", SCIENTIFIC REPORTS, vol. 7, no. 1, 2017, XP055574254;;LAWRENCE L STOOKEY: ""Ferrozine- A New Spectrophotometric Reagent for Iron"", ANALYTICAL CHEMISTRY, vol. 42, no. 7, 1970, pages 779 - 781, XP002565245",PENDING
125,EP,B1,EP 2892808 B1,039-745-057-173-562,2018-03-21,2018,EP 13745772 A,2013-07-29,US 201213604787 A;;US 2013/0052445 W,2012-09-06,"STABILIZED AGGREGATES AND OTHER MATERIALS AND STRUCTURES FOR PURPOSES INCLUDING, BUT NOT LIMITED TO, ENERGY ABSORPTION",,ENG ARRESTING SYS CORP,VALENTINI SYLVIA C;;LI YOUHONG;;DOHERTY SHAWN PATRICK,"RUNWAY SAFE IPR AB (2020-03-30);;RUNWAY SAFE IPR AB, SE (2020-05-25)",https://lens.org/039-745-057-173-562,Granted Patent,yes,3,0,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,B64F1/02;;E01C9/00,,1,0,,,"BARSOTTI MATTHEW A ET AL: ""Developing Improved Civil Aircraft Arresting Systems"", INTERNET CITATION, 21 January 2010 (2010-01-21), pages 1-195, XP002633947, ISBN: 978-0-309-11813-2 Retrieved from the Internet: URL:http://onlinepubs.trb.org/onlinepubs/a crp/acrp_rpt_029.pdf [retrieved on 2011-04-27]",ACTIVE
126,EP,B1,EP 3360800 B1,037-356-176-921-859,2020-09-09,2020,EP 18162492 A,2013-07-29,US 201213604787 A;;EP 13745772 A;;US 2013/0052445 W,2012-09-06,"STABILIZED AGGREGATES AND OTHER MATERIALS AND STRUCTURES FOR PURPOSES INCLUDING, BUT NOT LIMITED TO, ENERGY ABSORPTION",,RUNWAY SAFE IPR AB,VALENTINI SYLVIA C;;LI YOUHONG;;DOHERTY SHAWN PATRICK,RUNWAY SAFE IPR AB (2020-05-13),https://lens.org/037-356-176-921-859,Granted Patent,yes,4,0,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,B64F1/02;;E01C9/00,,0,0,,,,ACTIVE
127,US,A1,US 2007/0203057 A1,048-293-387-690-222,2007-08-30,2007,US 61673306 A,2006-12-27,US 61673306 A;;US 95674804 A;;US 19365302 A;;US 35104899 A;;US 11397798 A,1998-07-10,COMPOUNDS AND METHODS FOR MODULATING ADHESION MOLECULE FUNCTION,"Modulating agents and methods for enhancing or inhibiting cadherin-mediated functions are provided. The modulating agents comprise at least an HAV binding motif, an analogue or peptidomimetic thereof, or an antibody or fragment thereof that specifically binds to such a motif. Modulating agents may additionally comprise one or more cell adhesion recognition sequences recognized by cadherins and/or other adhesion molecules. Such modulating agents may, but need not, be linked to a targeting agent, drug and/or support material.",ADHEREX TECHNOLOGIES INC,DOHERTY PATRICK;;BLASCHUK OREST W;;GOUR BARBARA J,,https://lens.org/048-293-387-690-222,Patent Application,yes,18,9,13,13,95,A61K38/12;;A61K38/12;;A61P17/02;;A61P25/00;;A61P35/00;;A61P43/00;;C07K7/06;;C07K7/06;;C07K7/64;;C07K7/64;;C07K14/705;;C07K14/705,A61K38/12;;C12N15/09;;A61K38/00;;A61K39/395;;A61K47/48;;A61P17/02;;A61P25/00;;A61P35/00;;A61P43/00;;C07K7/06;;C07K7/64;;C07K14/705;;C07K16/18,514/9;;514/2,0,0,,,,DISCONTINUED
128,AU,A,AU 1999/045964 A,079-653-632-171-700,2000-02-01,2000,AU 1999/045964 A,1999-07-12,CA 9900627 W;;US 11397798 A,1998-07-10,Compounds and methods for modulating cadherin-mediated functions,,ADHEREX TECH INC,DOHERTY PATRICK;;BLASCHUK OREST W;;GOUR BARBARA J,,https://lens.org/079-653-632-171-700,Patent Application,no,0,0,13,13,0,A61K38/12;;A61K38/12;;A61P17/02;;A61P25/00;;A61P35/00;;A61P43/00;;C07K7/06;;C07K7/06;;C07K7/64;;C07K7/64;;C07K14/705;;C07K14/705,C12N15/09;;A61K38/00;;A61K39/395;;A61K47/48;;A61P17/02;;A61P25/00;;A61P35/00;;A61P43/00;;C07K7/06;;C07K7/64;;C07K14/705;;C07K16/18,,0,0,,,,EXPIRED
129,EP,A3,EP 1022392 A3,068-343-872-503-150,2002-01-30,2002,EP 99650119 A,1999-12-20,IE 990047 A,1999-01-21,A barrier,A barrier (1) has a base unit (2) which is secured to the ground and a top unit (3) which may be connected at any one of four different orientations. An electronic controller (6) is mounted in a door (5) of the base unit (2) so that is may be easily accessed. A drive mechanism (35) is mounted in a modular manner in the top unit (3). It is mounted by virtue of a beam drive shaft (21) which is mounted by bearings (22) at each end to opposed side walls (20) of the top unit (3). The beam is connected to the drive shaft (21) in a symmetrical manner so that the barrier may be used for either the right side or the left side of a laneway. There is excellent support and balance in the drive mechanism because it is connected between support bearings of the beam drive shaft (21). A manual override is provided to release a clutch if an electrical fault arises. The beam has a shear plate (27) which yields to minimise damage to either the drive mechanism or a beam arm (30) in the event of an accidental impact against the beam.,ELECTRO AUTOMATION RES EAR LTD,DOHERTY PATRICK;;WALSH JOHN ALPHONSUS;;HIGGINS RORY JOHN,,https://lens.org/068-343-872-503-150,Search Report,yes,9,0,4,4,0,E01F13/06,E01F13/04;;E01F13/06,,0,0,,,,DISCONTINUED
130,AU,B2,AU 2013/313272 B2,071-858-718-533-360,2017-05-18,2017,AU 2013/313272 A,2013-07-29,US 201213604787 A;;US 2013/0052445 W,2012-09-06,"Stabilized aggregates and other materials and structures for purposes including, but not limited to, energy absorption","Described are materials (14) and structures (10) for absorbing energy. The materials (14) and structures (10) are well suited for arresting aircraft and other vehicles, although their purposes need not be so limited. Also detailed are packaging and other solutions for maintaining system integrity, especially (but not exclusively) when foam glass or other aggregate is employed.",ENG ARRESTING SYS CORP,VALENTINI SYLVIA C;;LI YOUHONG;;DOHERTY SHAWN PATRICK,,https://lens.org/071-858-718-533-360,Granted Patent,no,4,0,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,B64F1/02;;E01C9/00,,0,0,,,,INACTIVE
131,IE,A1,IE 990144 A1,121-951-640-106-622,1999-09-08,1999,IE 990144 A,1999-02-23,IE 990144 A;;IE 980137 A,1998-02-26,A Barrier,,ELECTRO AUTOMATION RES EAR LTD,RORY JOHN DOHERTY;;WALSH PATRICK;;HIGGINS JOHN ALPHONSUS,,https://lens.org/121-951-640-106-622,Patent Application,no,0,0,6,6,0,E01F13/06;;H02P3/18;;H02P7/00;;H02P2207/073,E01F13/04;;E01F13/06;;H02P3/18;;H02P7/00,,0,0,,,,DISCONTINUED
132,US,B1,US 6300786 B1,185-990-021-895-099,2001-10-09,2001,US 42025699 A,1999-10-18,US 42025699 A;;US 7569198 A,1998-05-11,Wafer test method with probe card having on-board multiplex circuitry for expanding tester resources,"A probe card, a test method and a test system for testing semiconductor wafers are provided. The test system includes the probe card, a tester for generating test signals, and a wafer prober for placing the wafers and probe card in physical contact. The probe card includes contacts for electrically engaging die contacts on the wafer. The probe card also includes an on board multiplex circuit adapted to fan out and selectively transmit test signals from the tester to the probe card contacts. The multiplex circuit expands tester resources by allowing test signals to be written to multiple dice in parallel. Reading of the dice can be performed in groups up to the limit of the tester resources. In addition to expanding tester resources, the multiplex circuit maintains the individuality of each die, and permits defective dice to be electrically disconnected.",MICRON TECHNOLOGY INC,DOHERTY C PATRICK;;DEVARONA JORGE L;;AKRAM SALMAN,,https://lens.org/185-990-021-895-099,Granted Patent,yes,45,63,3,10,0,G01R1/07314;;G01R1/07385;;G01R31/2831;;Y10T29/49124;;Y10T29/49126;;Y10T29/49218;;Y10T29/49204;;Y10T29/49124;;Y10T29/49126;;Y10T29/49218;;Y10T29/49204;;G01R1/07385;;G01R31/2831;;G01R1/07314,G01R1/073;;G01R31/28,324/765;;324/754;;324/537;;324/158.1;;438/6;;29/830;;29/874;;29/882;;29/829,1,0,,,"U.S. application No. 09/075,691, Doherty et al.",EXPIRED
133,ZA,B,ZA 924696 B,171-227-243-843-238,1993-03-31,1993,ZA 924696 A,1992-06-25,US 72174491 A,1991-06-26,A PROCESS FOR THE GLYCOSYLATION OF AVERMECTIN COMPOUNDS,,MERCK & CO INC,ARISON BYRON H;;BYRON H ARISON;;DOHERTY PATRICK J;;PATRICK J DOHERTY;;SCHULMAN MARVIN D;;MARVIN D SCHULMAN,,https://lens.org/171-227-243-843-238,Granted Patent,no,0,0,9,9,0,A61K31/70;;A61K31/70;;A01N43/90;;A01N43/90;;A61P33/00;;A61P33/02;;C07H19/01;;C07H19/01;;C12P19/60;;C12P19/60,A01N63/00;;A01N43/90;;A61K31/70;;A61K31/7042;;A61K31/7048;;A61P33/00;;A61P33/02;;C07H17/08;;C07H19/01;;C12P19/60;;C12P19/62;;C12R1/01;;C12R1/645,,0,0,,,,EXPIRED
134,US,A1,US 2013/0020437 A1,087-808-125-281-327,2013-01-24,2013,US 201213604787 A,2012-09-06,US 201213604787 A,2012-09-06,"STABILIZED AGGREGATES AND OTHER MATERIALS AND STRUCTURES FOR PURPOSES INCLUDING, BUT NOT LIMITED TO, ENERGY ABSORPTION","Described are materials and structures for absorbing energy. The materials and structures are well suited for arresting aircraft and other vehicles, although their purposes need not be so limited. Also detailed are packaging and other solutions for maintaining system integrity, especially (but not exclusively) when foam glass or other aggregate is employed.",VALENTINI SILVIA C;;DOHERTY SHAWN PATRICK;;LI YOUHONG,VALENTINI SILVIA C;;DOHERTY SHAWN PATRICK;;LI YOUHONG,RUNWAY SAFE IPR AB (2020-02-28);;ENGINEERED ARRESTING SYSTEMS CORPORATION (2012-09-12),https://lens.org/087-808-125-281-327,Patent Application,yes,9,26,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,B64F1/02;;E01F15/00,244110 R;;404/6,0,0,,,,ACTIVE
135,KR,A,KR 20150053936 A,120-486-001-099-350,2015-05-19,2015,KR 20157008329 A,2013-07-29,US 201213604787 A;;US 2013/0052445 W,2012-09-06,"STABILIZED AGGREGATES AND OTHER MATERIALS AND STRUCTURES FOR PURPOSES INCLUDING, BUT NOT LIMITED TO, ENERGY ABSORPTION","에너지를 흡수하기 위한 물질(14) 및 구조(10)가 설명된다. 물질(14) 및 구조(10)는 그 목적이 제한되지 않으나, 항공기 및 다른 차량을 제동하기에 아주 적절하다. 특히 발포 유리 또는 다른 응집체가 채용될 때(그러나 전적으로는 아님) 시스템 무결성을 유지하기 위한 패키징 및 다른 해결책이 또한 설명된다.",ENGINEERED ARRESTING SYS CORP,VALENTINI SYLVIA C;;LI YOUHONG;;DOHERTY SHAWN PATRICK,,https://lens.org/120-486-001-099-350,Patent Application,no,0,0,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,E01C9/00,,0,0,,,,DISCONTINUED
136,JP,A,JP 2018053713 A,146-198-534-885-167,2018-04-05,2018,JP 2017221051 A,2017-11-16,US 201213604787 A,2012-09-06,"STABILIZED AGGREGATE, AND OTHER MATERIALS AND STRUCTURES INCLUDING, BUT NOT LIMITED TO, ENERGY ABSORPTION AS APPLICATION THEREOF","PROBLEM TO BE SOLVED: To provide an energy absorption member for bringing vehicles to a stop.SOLUTION: An energy absorption member for restraining aircraft travelling along a surface of a runway is provided with an aggregate 14 configured to be deformed to absorb energy, and stabilization means for stabilizing the position of the aggregate to form a bed 10. The aggregate is composed of loose particles. The stabilization means includes a net. The aggregate composed of loose particles is covered with the net. One or a plurality of anchors 22 fixedly positions the net with respect to the aggregate composed of loose particles.SELECTED DRAWING: Figure 1",ENG ARRESTING SYSTEMS CORP,SYLVIA C VALENTINI;;LI YOUHONG;;SHAWN PATRICK DOHERTY,,https://lens.org/146-198-534-885-167,Patent Application,no,11,0,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,E01C7/08;;B64F1/02;;F16F7/12,,0,0,,,,ACTIVE
137,IE,A2,IE S991069 A2,175-860-917-009-709,2000-10-04,2000,IE S991069 A,1999-12-20,IE S991069 A;;IE 990047 A,1999-01-21,A Barrier,A barrier (1) has a base unit (2) which is secured to the ground and a top unit (3) which may be connected at any one of four different orientations. An electronic controller (6) is mounted in a door (5) of the base unit (2) so that it may be easily accessed. A drive mechanism (35) is mounted in a modular manner in the top unit (3). It is mounted by virtue of a beam drive shaft (21) which is mounted by bearings (22) at each end to opposed side walls (20) of the top unit (3). The beam is connected to the drive shaft (21) in a symmetrical manner so that the barrier may be used for either the right side or the left side of a laneway. There is excellent support and balance in the drive mechanism because it is connected between support bearings of the beam drive shaft (21). A manual override is provided to release a clutch if an electrical fault arises. The beam has a shear plate (27) which yields to minimise damage to either the drive mechanism or a beam arm (30) in the event of an accidental impact against the beam.,ELECTRO AUTOMATION RES EAR LTD,DOHERTY PATRICK;;WALSH JOHN ALPHONSUS;;HIGGINS RORY JOHN,,https://lens.org/175-860-917-009-709,Patent Application,no,0,0,4,4,0,E01F13/06,E01F13/04;;E01F13/06,,0,0,,,,DISCONTINUED
138,US,B1,US 6337577 B1,195-300-382-737-004,2002-01-08,2002,US 24437399 A,1999-02-04,US 24437399 A;;US 7569198 A,1998-05-11,Interconnect and system for testing bumped semiconductor components with on-board multiplex circuitry for expanding tester resources,"
    An interconnect, a test system, and a test method for testing bumped semiconductor components, such as dice and packages, contained on substrates, such as wafers or panels, are provided. The test system includes the interconnect, a tester for generating test signals, and a wafer prober for placing the components and interconnect in physical contact. The interconnect includes interconnect contacts, such as conductive pockets, for electrically engaging bumped component contacts on the components. The interconnect also includes an on board multiplex circuit adapted to fan out and selectively transmit test signals from the tester to the interconnect contacts. The multiplex circuit expands tester resources by allowing test signals to be written to multiple components in parallel. Reading of the test signals from the components can be performed in groups up to the limit of the tester resources. In addition to expanding tester resources, the multiplex circuit maintains the individuality of each component, and permits defective components to be electrically disconnected. 
",MICRON TECHNOLOGY INC,DOHERTY C PATRICK;;DEVARONA JORGE L;;AKRAM SALMAN,MICRON TECHNOLOGY INC (1999-01-14),https://lens.org/195-300-382-737-004,Granted Patent,yes,51,65,3,10,0,G01R1/07385;;G01R1/07385;;G01R1/07314;;G01R1/07314;;G01R31/2831;;G01R31/2831,G01R1/073;;G01R31/28,324/765;;324/754;;324/755,1,0,,,"U.S. application No. 09/075,691, Doherty et al.",EXPIRED
139,CA,A1,CA 2333928 A1,003-037-553-211-632,2000-01-20,2000,CA 2333928 A,1999-07-12,CA 9900627 W;;US 11397798 A,1998-07-10,COMPOUNDS AND METHODS FOR MODULATING CADHERIN-MEDIATED FUNCTIONS,"Modulating agents and methods for enhancing or inhibiting cadherin-mediated functions are provided. The modulating agents comprise at least an HAV bindi ng motif, an analogue or peptidomimetic thereof, or an antibody or fragment thereof that specifically binds to such a motif. Modulating agents may additionally comprise one or more cell adhesion recognition sequences recognized by cadherins and/or other adhesion molecules. Such modulating agents may, but need not, be linked to a targeting agent, drug and/or suppor t material.",ADHEREX TECHNOLOGIES INC,BLASCHUK OREST W;;DOHERTY PATRICK;;GOUR BARBARA J,,https://lens.org/003-037-553-211-632,Patent Application,no,0,0,13,13,92,A61K38/12;;A61K38/12;;A61P17/02;;A61P25/00;;A61P35/00;;A61P43/00;;C07K7/06;;C07K7/06;;C07K7/64;;C07K7/64;;C07K14/705;;C07K14/705,C12N15/09;;A61K38/00;;A61K39/395;;A61K47/48;;A61P17/02;;A61P25/00;;A61P35/00;;A61P43/00;;C07K7/06;;C07K7/64;;C07K14/705;;C07K16/18,,0,0,,,,DISCONTINUED
140,EP,A1,EP 2892808 A1,076-548-927-754-627,2015-07-15,2015,EP 13745772 A,2013-07-29,US 201213604787 A;;US 2013/0052445 W,2012-09-06,"STABILIZED AGGREGATES AND OTHER MATERIALS AND STRUCTURES FOR PURPOSES INCLUDING, BUT NOT LIMITED TO, ENERGY ABSORPTION",,ENGINEERED ARRESTING SYS CORP,VALENTINI SYLVIA C;;LI YOUHONG;;DOHERTY SHAWN PATRICK,"RUNWAY SAFE IPR AB (2020-03-30);;RUNWAY SAFE IPR AB, SE (2020-05-25)",https://lens.org/076-548-927-754-627,Patent Application,yes,0,0,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,B64F1/02;;E01C9/00,,0,0,,,,ACTIVE
141,US,B1,US 6277824 B1,111-821-062-979-932,2001-08-21,2001,US 11397798 A,1998-07-10,US 11397798 A,1998-07-10,Compounds and methods for modulating adhesion molecule function,"Modulating agents and methods for enhancing or inhibiting cadherin-mediated functions are provided. The modulating agents comprise at least an HAV binding motif, an analogue or peptidomimetic thereof, or an antibody or fragment thereof that specifically binds to such a motif. Modulating agents may additionally comprise one or more cell adhesion recognition sequences recognized by cadherins and/or other adhesion molecules. Such modulating agents may, but need not, be linked to a targeting agent, drug and/or support material.",ADHEREX TECHNOLOGIES,DOHERTY PATRICK;;BLASCHUK OREST W;;GOUR BARBARA J,ADHEREX TECHNOLOGIES (1998-09-22),https://lens.org/111-821-062-979-932,Granted Patent,yes,26,33,13,13,87,A61K38/12;;A61K38/12;;A61P17/02;;A61P25/00;;A61P35/00;;A61P43/00;;C07K7/06;;C07K7/06;;C07K7/64;;C07K7/64;;C07K14/705;;C07K14/705,C12N15/09;;A61K38/00;;A61K39/395;;A61K47/48;;A61P17/02;;A61P25/00;;A61P35/00;;A61P43/00;;C07K7/06;;C07K7/64;;C07K14/705;;C07K16/18,514/13;;514/14;;514/15;;514/16;;514/17;;530/326;;530/327;;530/328;;530/329;;530/345;;530/350;;530/402,58,48,112-139-495-969-240;;077-370-171-773-772;;006-951-811-000-031;;044-315-636-518-714;;058-361-803-472-756;;073-394-708-740-681;;075-345-206-465-765;;073-062-095-884-955;;087-017-684-634-423;;042-363-908-217-67X;;132-324-582-309-662;;061-035-773-172-879;;097-164-253-011-753;;009-659-810-299-191;;034-739-229-119-712;;016-027-033-188-777;;020-258-471-940-706;;021-337-131-340-271;;090-240-069-646-318;;040-097-687-516-358;;064-919-473-284-919;;007-921-036-826-703;;078-439-331-209-812;;125-470-665-664-362;;039-261-118-830-511;;004-463-307-680-511;;142-507-339-667-106;;120-169-328-663-815;;072-444-523-887-560;;099-515-858-399-636;;009-331-313-562-906;;022-613-944-087-298;;174-629-378-329-78X;;026-663-290-717-027;;088-822-106-739-66X;;029-851-994-673-63X;;066-111-988-639-628;;024-298-917-400-264;;035-723-049-802-557;;062-427-665-260-15X;;112-862-562-340-024;;137-387-680-011-683;;134-516-505-208-947;;110-502-224-706-298;;020-462-712-767-288;;021-900-284-198-018;;009-513-816-812-599;;054-156-093-087-90X,10.3109/15419069409014199;;7982033;;10.1016/0022-2836(90)90065-t;;2313692;;10.1016/0012-1606(90)90290-y;;2328837;;8825724;;10.1080/07391102.1995.10508854;;10.1002/aja.1001970102;;8400407;;7824937;;10.1126/science.7824937;;0007824937;;10.1006/dbio.1996.0315;;8954714;;10.1016/0014-5793(95)00334-6;;7737419;;10.2210/pdb1nch/pdb;;7885471;;10.1038/374327a0;;0007885471;;8360263;;10.1002/jcp.1041560321;;8145226;;10.1021/jm00032a009;;10.1016/0012-1606(89)90283-2;;2511052;;1322849;;10.1016/0012-1606(92)90149-b;;7534489;;10.1002/bip.360370209;;1765779;;10.1002/neu.480220706;;10.1021/jm00114a022;;1920361;;10.1016/s0021-9258(18)50070-3;;1331077;;pmc39065;;8692857;;10.1073/pnas.93.13.6567;;10.1016/0959-4388(94)90031-0;;8173325;;pmc2120642;;8522583;;10.1083/jcb.131.5.1193;;8207198;;10.1006/cimm.1996.0123;;8620560;;8982873;;10.1093/oxfordjournals.jbchem.a021496;;7917292;;10.1016/0896-6273(94)90027-2;;840300;;10.1038/266068a0;;10.1073/pnas.76.1.514;;pmc382972;;284369;;8884773;;10.1016/0306-4522(96)00167-4;;371755;;10.1016/0006-8993(79)90048-9;;8112822;;10.1002/glia.440090407;;2713720;;10.1016/0361-9230(89)90133-0;;8954625;;10.1006/mcne.1996.0049;;8918827;;10.1016/s0896-6273(00)80264-0;;9052794;;10874487;;10.1016/0165-3806(91)90040-p;;1893561;;1993122;;10.1016/0896-6273(91)90360-c;;pmc2115263;;10.1083/jcb.107.4.1575;;3049625;;2182648;;10.1083/jcb.110.4.1239;;pmc2116090;;10.1073/pnas.85.19.7274;;3050992;;pmc282168;;2317870;;10.1016/0092-8674(90)90222-z;;10.1007/bf01187857;;3171610;;7583324;;10.1016/0006-8993(95)00575-b;;10.1006/dbio.1995.1255;;7556887;;10.1111/1523-1747.ep12533356;;123263;;10.1159/000401276;;752458;;7960039;;10.1002/glia.440110409;;7612967;;10.1091/mbc.6.3.327;;pmc301191;;3603044;;10.1126/science.3603044;;10.1083/jcb.85.3.890;;pmc2111442;;6248568,"Tanihara et al., ""Cloning of Five Human Cadherins Clarifies Characteristic Features of Cadherin Extracellular Domain and Provides Further Evidence for Two Structurally Different Types of Cadherin,"" Cell Adhesion and Communication 2: 15-26, 1994.;;Horn et al. Geneseq. Acc. #P91888, Jan. 1991.*;;Hodgson et al. Geneseq. Acc. #W22709, Sep. 1997.*;;Reid. PIR Acc. #A38870, Jun. 1993.*;;Liaw et al. PIR Acc. #S11693, Jun. 1993.*;;Hatta et al. PIR Acc. #A29964, Jun. 1993.*;;Ginsberg et al. PIR Acc. #A43785, Jun. 1993.*;;Blaschuk et al., ""Identification of a Conserved Region Common to Cadherins and Influenza Strain A Hemagglutinins,"" J. Mol. Biol. 211: 679-682, 1990.;;Blaschuk et al., ""Identification of a Cadherin Cell Adhesion Recognition Sequence,"" Developmental Biology 139: 227-229, 1990.;;Lutz et al., ""Secondary Structure of the HAV Peptide Which Regulates Cadherin-Cadherin Interaction,"" Journal of Biomolecular Structure & Dynamics 13(3): 447-455, 1995.;;Munro et al. Cell Adhesion and Invasion in Cancer Metastasis, R.G. Landes Company, Austin, TX, 1996, Chapter 3, ""The Structure, Function and Regulation of Cadherins,"" pp. 17-34.;;Newton et al., ""N-Cadherin Mediates Sertoli Cell-Spermatogenic Cell Adhesion,"" Developmental Dynamics 197: 1-13, 1993.;;Overduin et al., ""Solution Structure of the Epithelial Cadherin Domain Responsible for Selective Cell Adhesion,"" Science 267: 386-389, 1995.;;Redies et al . ""Cadherins in the Developing Central Nervous System: An Adhesive Code for Segmental and Functional Subdivisions,"" Developmental Biology 180: 413-423, 1996.;;Willems et al., ""Cadherin-dependent cell aggregation is affected by decapeptide derived from rat extracellular super-oxide dismutase,"" FEBS Letters 363: 289-292, 1995.;;Shapiro et al., ""Structural basis of cell-cell adhesion by cadherins,"" Nature 374: 327-337, 1995.;;Alexander et al., ""An N-Cadherin-Like Protein Contributes to Solute Barrier Maintenance in Cultured Endothelium,"" Journal of Cellular Physiology 156: 610-618, 1993.;;Ali et al., ""Conformationally Constrained Peptides and Semipeptides Derived from RGD as Potent Inhibitors of the Platelet Fibrinogen Receptor and Platelet Aggregation,"" J. Med. Chem. 37(6): 769-780, 1994.;;Blaschuk et al. ""Estradiol Stimulates Cadherin Expression in Rat Granulosa Cells,"" Developmental Biology 136: 564-567, 1989.;;Byers et al., ""Fibroblast Growth Factor Receptors Contain a Conserved HAV Region Common to Cadherins and Influenza Strain A Hemagglutinins: A Role in Protein-Protein Interactions?,"" Developmental Biology 152: 411-414, 1992.;;Craig et al., ""Concept and Progress in the Development of RGD-Containing Peptide Pharmaceuticals,"" Biopolymers (Peptide Science) 37: 157-175, 1995.;;Letourneau et al., ""Interactions of Schwann Cells with Neurites and with Other Schwann Cells Involve the Calcium-dependant Adhesion Molecule, N-cadherin,"" Journal of Neurobiology 22(7): 707-720, 1991.;;Samanen et al., ""Development of a Small RGD Peptide Fibrinogen Receptor Antagonist with Potent Antiaggregatory Activity in Vitro,"" J. Med. Chem. 34(10): 3114-3125, 1991.;;Cardarelli et al., ""The Collagen Receptor alpha2beta1, from MG-63 and HT1080 Cells, Interacts with a Cyclic RGD Peptide,"" The Journal of Biological Chemistry 267(32): 23159-23164, 1992.;;Cepek et al., ""Expression of a candidate cadherin in T lymphocytes,"" Proc. Natl. Acad. Sci. USA 93: 6567-6571, 1996.;;Doherty and Walsh, ""Signal transduction events underlying neurite outgrowth stimulated by cell adhesion molecules,"" Current Opinion in Neurobiology 4: 49-55, 1994.;;Laird et al., ""Gap Junction Turnover, Intracellular Trafficking, and Phosphorylation of Connexin43 in Brefeldin A-treated Rat Mammary Tumor Cells,"" The Journal of Cell Biology 131(5): 1193-1203, 1995.;;Lee et al., ""Expression of the Homotypic Adhesion Molecule E-Cadherin by Immature Murine Thymocytes and Thymic Epithelial Cells,"" Journal of Immunology 152: 5653-5659, 1994.;;Moran, ""The Protein Delivery Service. Advances in technologies for delivering proteins and peptides in therapeutically useful forms,"" Pharmaceutical Forum Issue 6: 4-7, 1996.;;Munro et al., ""Characterization of Cadherins Expressed by Murine Thymocytes,"" Cellular Immunology 169 309-312, 1996.;;Tsutsui et al., ""Expression of Cadherin-Catenin Complexes in Human Leukemia Cell Lines,"" J. Biochem. 120: 1034-1039, 1996.;;Wickelgren,I.""Breaking the Skin Barrier,"" PS 12: 86-88, 1996.;;Williams et al., ""Activation of the FGF Receptor Underlies Neurite Outgrowth Stimulated by L1, N-CAM, and N-Cadherin,"" Neuron 13: 583-594, 1994.;;Blakemore, ""Remyelination of CNS axons by Schwann cells transplanted from the sciatic nerve,"" Nature 266: 68-69, 1977.;;Bottenstein and Sato, ""Growth of a rat neuroblastoma cell line in serum-free supplemented medium,"" Proc.Natl. Acad. Sci. USA 76(1): 514-517, 1979.;;Brecknell et al., ""Bridge grafts of Fibroblast Growth Factor-4-Secreting Schwannoma Cells Promote Functional Axonal Regeneration in the Nigrostriatal Pathway of the Adult Rat,"" Neuroscience 74(3): 775-784, 1996.;;Brockes et al., ""Studies on Cultured Rat Schwann Cells. I. Establishment of Purified Populations from Cultures of Peripheral Nerve,"" Brain Research 165: 105-118, 1979.;;Brook et al., ""Morphology and Migration of Cultured Schwann Cells Transplanted Into the Fimbria and Hippocampus in Adult Rats,"" GLIA 9: 292-304, 1993.;;Carlstedt et al., ""Nerve Fibre Regeneration Across the PNS-CNS Interface at the Root-Spinal Cord Junction,"" Brain Research Bulletin 22: 93-102, 1989.;;Doherty and Walsh, ""CAM-FGF Receptor Interactions: A Model for Axonal Growth,"" Molecular and Cellular Neuroscience 8 99-111, 1996.;;Saffell et al., ""Expression of a Dominant Negative FGF Receptor Inhibits Axonal Growth and FGF Receptor Phosphorylation Stimulated by CAMs,"" Neuron, pp. 231-242, Feb. 1997.;;Blaschuk et al., ""E-Cadherin, estrogens and cancer: is there a connection?"" The Canadian Journal of Oncology 4(4): 291-301, 1994.;;Chuah et al., ""Differentiation and survival of rat olfactory epithelial neurons in dissociated cell culture,"" Developmental Brain Research 60: 123-132, 1991.;;Doherty et al., ""Neurite Outgrowth in Response to Transfected N-CAM and N-Cadherin Reveals Fundamental Differences in Neuronal Responsiveness to CAMS,"" Neuron 6: 247-258, 1991.;;Gumbiner et al., ""The Role of the Cell Adhesion Molecule Uvomorulin in the Formation and Maintenance of the Epithelial Junctional Complex,"" The Journal of Cell Biology 107: 1575-1587, 1988.;;Matsuzaki et al., ""cDNAs of Cell Adhesion Molecules of Different Specificity Induce Changes in Cell Shape and Border Formation in Cultured S180 Cells,"" The Journal of Cell Biology 110: 1239-1252, 1990.;;Mege et al., ""Construction of epithelioid sheets by transfection of mouse sarcoma cells with cDNAs for chicken cell adhesion molecules,"" Proc. Natl. Acad. Sci. USA 85: 7274-7278, 1988.;;Nose et al., ""Localization of Specificity Determining Sites in Cadherin Cell Adhesion Molecules,"" Cell 61: 147-155, 1990.;;Duncan et al., ""Transplantation of oligodendrocytes and Schwann cells into the spinal cord of the myelin-deficient rat,"" Journal of Neurocytology 17: 351-360, 1988.;;Fok-Seang et al., ""An analysis of astrocytic cell lines with different abilities to promote axon growth,"" Brain Research 689: 207-223, 1995.;;Fok-Seang et al., ""Migration of Oligodendrocyte Precursors on Astrocytes and Meningeal Cells,"" Developmental Biology 171: 1-15, 1995.;;Franz, ""Percutaneous Absorption. On The Relevance Of In Vitro Data,"" The Journal of Investigative Dermatology 64(3): 190-195, 1975.;;Franz, ""The Finite Dose Technique as a Valid in Vitro Model for the Study of Percutaneous Absorption in Man,"" Curr. Probl. Dermatol. 7: 58-68, 1978.;;Ghirnikar and Eng, ""Astrocyte-Schwann Cell Interactions in Culture,"" GLIA 11: 367-377, 1994.;;Iruela-Arispe et al., ""Expression of SPARC during Development of the Chicken Chorioallantoic Membrane: Evidence for Regulated Proteolysis In Vivo,"" Molecular Biology of the Cell 6: 327-343, 1995.;;Liuzzi and Lasek, ""Astrocytes Block Axonal Regeneration in Mammals by Activating the Physiological Stop Pathway,"" Science 237: 642-645, 1987.;;McCarthy and Vellis, ""Preparation of Separate Astroglial and Oligodendroglial Cell Cultures from Rat Cerebral Tissue,"" J. Cell Biology 85: 890-902, 1980.;;Orr, ""Angiogenesis Research Offers New Approaches to Treatment of Disease,"" Genetic Engineering News, pp. 15-16, 42, May 1, 1996.",EXPIRED
142,CN,A,CN 107878778 A,154-248-291-238-872,2018-04-06,2018,CN 201711160840 A,2013-07-29,US 201213604787 A;;CN 201380046313 A,2012-09-06,"Stabilized aggregates and other materials and structures for purposes including, but not limited to, energy absorption","Described are materials (14) and structures (10) for absorbing energy. The materials (14) and structures (10) are well suited for arresting aircraft and other vehicles, although their purposes need not be so limited. Also detailed are packaging and other solutions for maintaining system integrity, especially (but not exclusively) when foam glass or other aggregate is employed.",ENG ARRESTING SYS CORP,VALENTINI SYLVIA C;;LI YOUHONG;;DOHERTY SHAWN PATRICK,,https://lens.org/154-248-291-238-872,Patent Application,no,7,0,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,B64F1/02;;E01C9/00,,0,0,,,,DISCONTINUED
143,GB,A,GB 2334753 A,000-960-804-252-026,1999-09-01,1999,GB 9904299 A,1999-02-25,IE 980137 A,1998-02-26,Barrier drive,"A barrier has a beam which is moved in the vertical plane for opening and closing in applications such as car parks. Drive is provided by an AC motor (15) which has symmetrically-arranged coils for forward and reverse motions. A main controller (12) delivers full motion signals for either direction, and also low-speed signals in which parts of the main cycle are chopped. Low-speed signals are identified by a braking controller (13) which activates a braking operation in which the signals are converted to identical signals to both coils simultaneously so that they act against each other for fast braking. The braking time is reduced from approximately 1.5 seconds to 0.3 seconds.",ELECTRO AUTOMATION RESEARCH,DOHERTY PATRICK;;WALSH JOHN ALPHONSUS;;HIGGINS RORY JOHN,,https://lens.org/000-960-804-252-026,Patent Application,no,0,6,6,6,0,E01F13/06;;H02P3/18;;H02P7/00;;H02P2207/073,E01F13/04;;E01F13/06;;H02P3/18;;H02P7/00,E2M M11F1         M11Z/P;;E2M M12A          M11Z/P;;H2J JBX           JBX;;H2J JRAC          JRAC;;H2J J1N3          JBX;;H2J J1N3          JRAC;;H2J J4            JBX;;H2J J4            JRAC,0,0,,,,EXPIRED
144,PT,T,PT 2892808 T,086-332-240-837-506,2018-06-14,2018,PT 13745772 T,2013-07-29,US 201213604787 A,2012-09-06,"STABILIZED AGGREGATES AND OTHER MATERIALS AND STRUCTURES FOR PURPOSES INCLUDING, BUT NOT LIMITED TO, ENERGY ABSORPTION",,ENG ARRESTING SYS CORP,SYLVIA C VALENTINI;;YOUHONG LI;;SHAWN PATRICK DOHERTY,,https://lens.org/086-332-240-837-506,Patent Application,no,0,0,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,B64F1/02;;E01C9/00,,0,0,,,,PENDING
145,IE,A2,IE S990143 A2,139-099-011-640-980,1999-08-26,1999,IE S990143 A,1999-02-23,IE S990143 A;;IE 980136 A,1998-02-26,A barrier drive mechanism,"A barrier beam (2) is driven by a conrod (11) connected to a crank wheel (10) which is in turn driven by a drive wheel (21) by virtue of frictional engagement. The drive wheel (21) is driven by a combined motor/gearbox unit (17) having a common casing and which is secured by a flange (19) to a connector (25) which in turn pivotally connects the unit to a fixed support (6) at a pivot pin (30). The arrangement is simple, cmpact and inexpensive. <Figure 2>",ELECTRO AUTOMATION RES EAR LTD,PATRICK DOHERTY;;ALPHONSUS WALSH JOHN;;MICHAEL O'BRENNAN KEVIN,,https://lens.org/139-099-011-640-980,Patent Application,no,0,0,6,6,0,E01F13/06,E01F13/00;;E01F13/06,,0,0,,,,EXPIRED
146,US,B1,US 6246250 B1,002-609-767-296-461,2001-06-12,2001,US 7569198 A,1998-05-11,US 7569198 A,1998-05-11,Probe card having on-board multiplex circuitry for expanding tester resources,"A probe card, a test method and a test system for testing semiconductor wafers are provided. The test system includes the probe card, a tester for generating test signals, and a wafer prober for placing the wafers and probe card in physical contact. The probe card includes contacts for electrically engaging die contacts on the wafer. The probe card also includes an on board multiplex circuit adapted to fan out and selectively transmit test signals from the tester to the probe card contacts. The multiplex circuit expands tester resources by allowing test signals to be written to multiple dice in parallel. Reading of the dice can be performed in groups up to the limit of the tester resources. In addition to expanding tester resources, the multiplex circuit maintains the individuality of each die, and permits defective dice to be electrically disconnected.",MICRON TECHNOLOGY INC,DOHERTY C PATRICK;;DEVARONA JORGE L;;AKRAM SALMAN,MICRON TECHNOLOGY INC (1998-05-05),https://lens.org/002-609-767-296-461,Granted Patent,yes,34,105,3,10,0,G01R1/07314;;G01R1/07385;;G01R31/2831;;Y10T29/49124;;Y10T29/49126;;Y10T29/49218;;Y10T29/49204;;Y10T29/49124;;Y10T29/49126;;Y10T29/49218;;Y10T29/49204;;G01R1/07385;;G01R31/2831;;G01R1/07314,G01R1/073;;G01R31/28,324/765;;324/754,0,0,,,,EXPIRED
147,MX,A,MX 2015002860 A,108-001-725-723-689,2015-07-14,2015,MX 2015002860 A,2013-07-29,US 201213604787 A;;US 2013/0052445 W,2012-09-06,"STABILIZED AGGREGATES AND OTHER MATERIALS AND STRUCTURES FOR PURPOSES INCLUDING, BUT NOT LIMITED TO, ENERGY ABSORPTION.","Described are materials (14) and structures (10) for absorbing energy. The materials (14) and structures (10) are well suited for arresting aircraft and other vehicles, although their purposes need not be so limited. Also detailed are packaging and other solutions for maintaining system integrity, especially (but not exclusively) when foam glass or other aggregate is employed.",ENGINEERED ARRESTING SYS CORP,VALENTINI SYLVIA C;;LI YOUHONG;;DOHERTY SHAWN PATRICK,,https://lens.org/108-001-725-723-689,Patent Application,no,0,0,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,B64F1/02;;E01C9/00,,0,0,,,,PENDING
148,US,B2,US 10906666 B2,109-663-538-778-616,2021-02-02,2021,US 201916540805 A,2019-08-14,US 201916540805 A;;US 201715641986 A;;US 201213604787 A,2012-09-06,Stabilized aggregates and other materials and structures for energy absorption,"Materials and structures for absorbing energy. The materials and structures are well suited for arresting aircraft and other vehicles, although their purposes need not be so limited. Also detailed are packaging and other solutions for maintaining system integrity, especially (but not exclusively) when foam glass or other aggregate is employed and stabilizing the location of the aggregate is desired.",RUNWAY SAFE IPR AB,VALENTINI SILVIA C;;DOHERTY SHAWN PATRICK;;LI YOUHONG,RUNWAY SAFE IPR AB (2020-02-28);;ENGINEERED ARRESTING SYSTEMS CORPORATION (2012-09-12),https://lens.org/109-663-538-778-616,Granted Patent,yes,69,1,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,B64F1/02;;E01C9/00;;E01C11/16,,17,1,141-255-580-202-124,10.1111/j.2041-1294.2011.00071.x,"Cellular Concrete Stops Airplanes in Their Tracks, Civil Engineering, Oct. 1998, pp. 14, 16.;;Innovative Financing Backs Highway Project, Civil Engineering, Civil Engineering ASCE, New York, New York, Oct. 1, 1998, vol. 68, No. 10.;;U.S. Appl. No. 13/604,787, Corrected Notice of Allowability dated Apr. 28, 2017.;;U.S. Appl. No. 13/604,787, Corrected Notice of Allowability dated Jun. 6, 2017.;;U.S. Appl. No. 13/604,787, Final Office Action dated Jun. 16, 2016.;;U.S. Appl. No. 13/604,787, Non-Final Office Action dated Nov. 28, 2016.;;U.S. Appl. No. 13/604,787, Non-Final Office Action dated Jan. 12, 2016.;;U.S. Appl. No. 13/604,787, Notice of Allowance dated Apr. 10, 2017.;;U.S. Appl. No. 13/604,787, Restriction Requirement dated May 9, 2014.;;Barsotti et al., Developing Improved Civil Aircraft Arresting Systems, Department of Transportation Federal Aviation Administration National Academy of Science Transportation Research Board http://onlinepubs.trb.org/onlinepubs/acrp/acrp_rpt_029.pdf, Jan. 21, 2010, pp. 1-195.;;Chinese Application No. 2013800463134, Office Action (and English translation) dated Dec. 28, 2015.;;Japanese Application No. 2015-531080, Office Action (and English translation) dated Jan. 31, 2017.;;International Application No. PCT/US2013/052445, International Preliminary Report on Patentability dated Mar. 19, 2015.;;International Application No. PCT/US2013/052445, International Search Report and Written Opinion dated Dec. 2, 2013.;;Smeacetto et al., Durable Glass-Ceramic Coatings for Foam Glass, International Journal of Applied Glass Science, vol. 3, No. 1, 2012, pp. 69-74.;;European Patent Application No. 18162492.5, Extended European Search Report, dated Jun. 26, 2018.;;U.S. Appl. No. 15/641,986, Notice of Allowance, dated Jun. 20, 2019.",ACTIVE
149,WO,A2,WO 2000/002917 A2,037-661-116-307-428,2000-01-20,2000,CA 9900627 W,1999-07-12,US 11397798 A,1998-07-10,COMPOUNDS AND METHODS FOR MODULATING CADHERIN-MEDIATED FUNCTIONS,"Modulating agents and methods for enhancing or inhibiting cadherin-mediated functions are provided. The modulating agents comprise at least an HAV binding motif, an analogue or peptidomimetic thereof, or an antibody or fragment thereof that specifically binds to such a motif. Modulating agents may additionally comprise one or more cell adhesion recognition sequences recognized by cadherins and/or other adhesion molecules. Such modulating agents may, but need not, be linked to a targeting agent, drug and/or support material.",ADHEREX TECHNOLOGIES INC;;DOHERTY PATRICK;;BLASCHUK OREST W;;GOUR BARBARA J,DOHERTY PATRICK;;BLASCHUK OREST W;;GOUR BARBARA J,,https://lens.org/037-661-116-307-428,Patent Application,yes,0,22,13,13,95,A61K38/12;;A61K38/12;;A61P17/02;;A61P25/00;;A61P35/00;;A61P43/00;;C07K7/06;;C07K7/06;;C07K7/64;;C07K7/64;;C07K14/705;;C07K14/705,C12N15/09;;A61K38/00;;A61K39/395;;A61K47/48;;A61P17/02;;A61P25/00;;A61P35/00;;A61P43/00;;C07K7/06;;C07K7/64;;C07K14/705;;C07K16/18,,0,0,,,,PATENTED
150,PL,T3,PL 2892808 T3,039-701-205-715-243,2018-12-31,2018,PL 13745772 T,2013-07-29,US 201213604787 A;;EP 13745772 A;;US 2013/0052445 W,2012-09-06,"STABILIZED AGGREGATES AND OTHER MATERIALS AND STRUCTURES FOR PURPOSES INCLUDING, BUT NOT LIMITED TO, ENERGY ABSORPTION",,ENG ARRESTING SYS CORP,VALENTINI SYLVIA C;;LI YOUHONG;;DOHERTY SHAWN PATRICK,,https://lens.org/039-701-205-715-243,Patent Application,no,0,0,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,B64F1/02;;E01C9/00,,0,0,,,,PENDING
151,IE,B2,IE S81183 B2,057-580-693-308-659,2000-06-14,2000,IE S990143 A,1999-02-23,IE S990143 A;;IE 980136 A,1998-02-26,A barrier drive mechanism,,ELECTRO AUTOMATION RESEARCH EA,DOHERTY PATRICK;;WALSH JOHN ALPHONSUS;;O'BRENNAN KEVIN MICHAEL,,https://lens.org/057-580-693-308-659,Limited Patent,no,0,0,6,6,0,E01F13/06,E01F13/00;;E01F13/06,,0,0,,,,EXPIRED
152,GB,A,GB 2334752 A,082-897-917-165-944,1999-09-01,1999,GB 9904297 A,1999-02-25,IE 980136 A,1998-02-26,A barrier drive mechanism,"An upwardly pivotable barrier beam is driven by a conrod (11) connected to a crank wheel (10) which is in turn driven by a drive wheel (21) by virtue of frictional engagement. The drive wheel (21) is driven by a combined motor/gearbox unit (17) having a common casing and which is secured to a connector (25) which in turn pivotally connects the unit to a fixed support (6) at a pivot pin (30). The arrangement is simple, compact and inexpensive.",ELECTRO AUTOMATION RESEARCH,DOHERTY PATRICK;;WALSH JOHN ALPHONSUS;;O'BRENNAN KEVIN MICHAEL,,https://lens.org/082-897-917-165-944,Patent Application,no,2,0,6,6,0,E01F13/06,E01F13/00;;E01F13/06,E2M M11F1         M11Z/P;;E2M M12A          M11Z/P;;E2M M15           M11Z/P;;E2M M16           M11Z/P;;E2M M27           M11Z/P,0,0,,,,EXPIRED
153,BR,A2,BR 112015004846 A2,133-343-732-365-601,2019-10-08,2019,BR 112015004846 A,2013-07-29,US 2013/0052445 W;;US 201213604787 A,2012-09-06,material de absorção de energia e método para deter o movimento de uma aeronave,"resumo patente de invenção: ""agregados estabilizados e outros materiais e estruturas para fins que incluem, mas não se limitam à absorção de energia"". a presente invenção refere-se aos materiais (14) e às estruturas (10) para a absorção de energia. os materiais (14) e as estruturas (10) são bem adaptados para deter os aviões e outros veículos, embora os seus efeitos não precisam ser tão limitados. também são detalhados o empacotamento e outras soluções para a manutenção da integridade do sistema, especialmente (mas não de maneira exclusiva) quando o vidro de espuma ou outro agregado é utilizado.",ENG ARRESTING SYS CORP,SHAWN PATRICK DOHERTY;;SYLVIA C VALENTINI;;YOUHONG LI,RUNWAY SAFE IPR AB (SE) (2020-05-12),https://lens.org/133-343-732-365-601,Patent Application,no,0,0,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,E01C9/00;;B64F1/02,,0,0,,,,ACTIVE
154,DE,T2,DE 69223932 T2,021-795-114-864-450,1998-05-28,1998,DE 69223932 T,1992-06-25,US 72285291 A;;US 9205256 W,1991-06-28,KAPSELEXTRUSIONSSYSTEME,"Methods for producing cell capsules are disclosed in which a coagulant (22), which can include a cell suspension or other biologically active factor, and a polymeric casting solution (26) are extruded through a common extrusion port (14) having at least two concentric bores, such that the coagulant is extruded through the inner bore (16) and the polymeric casting solution is extruded through the outer bore (18). The method involves initiating extrusion of the coagulant within a temporal range of about 10 msecs to about one second from initiating delivery of the casting solution through the respective bores. Delivery of the coagulant is then shut off, and extrusion of the casting solution is terminated either immediately or after some predetermined time.",UNIV BROWN RES FOUND,AEBISCHER PATRICK;;MILLS JOHN;;WAHLBERG LARS;;DOHERTY EDWARD;;TRESCO PATRICK A,,https://lens.org/021-795-114-864-450,Granted Patent,no,0,0,19,124,0,A61J3/07;;A61K9/0024;;A61K9/5089;;B01J13/02;;B01J13/04;;C12N5/0012;;C12N5/0614;;C12N11/04;;C12N2533/30;;A61J3/00,B01J13/14;;A61J/;;A61J3/06;;A61J3/07;;A61K9/00;;A61K9/50;;B01J13/02;;B01J13/04;;C12M1/00;;C12N5/00;;C12N5/02;;C12N5/071;;C12N11/04,,0,0,,,,EXPIRED
155,AU,A1,AU 2013/313272 A1,056-498-968-681-825,2015-03-19,2015,AU 2013/313272 A,2013-07-29,US 201213604787 A;;US 2013/0052445 W,2012-09-06,"Stabilized aggregates and other materials and structures for purposes including, but not limited to, energy absorption","Described are materials (14) and structures (10) for absorbing energy. The materials (14) and structures (10) are well suited for arresting aircraft and other vehicles, although their purposes need not be so limited. Also detailed are packaging and other solutions for maintaining system integrity, especially (but not exclusively) when foam glass or other aggregate is employed.",ENGINEERED ARRESTING SYS CORP,VALENTINI SYLVIA C;;LI YOUHONG;;DOHERTY SHAWN PATRICK,,https://lens.org/056-498-968-681-825,Patent Application,no,0,0,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,B64F1/02;;E01C9/00,,0,0,,,,INACTIVE
156,CA,A1,CA 2883297 A1,134-952-824-373-756,2014-03-13,2014,CA 2883297 A,2013-07-29,US 201213604787 A;;US 2013/0052445 W,2012-09-06,"STABILIZED AGGREGATES AND OTHER MATERIALS AND STRUCTURES FOR PURPOSES INCLUDING, BUT NOT LIMITED TO, ENERGY ABSORPTION","Described are materials (14) and structures (10) for absorbing energy. The materials (14) and structures (10) are well suited for arresting aircraft and other vehicles, although their purposes need not be so limited. Also detailed are packaging and other solutions for maintaining system integrity, especially (but not exclusively) when foam glass or other aggregate is employed.",ENGINEERED ARRESTING SYS CORP,VALENTINI SYLVIA C;;LI YOUHONG;;DOHERTY SHAWN PATRICK,,https://lens.org/134-952-824-373-756,Patent Application,no,0,0,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,B64F1/02;;E01C9/00,,0,0,,,,DISCONTINUED
157,ES,T3,ES 2835474 T3,146-091-518-659-012,2021-06-22,2021,ES 18162492 T,2013-07-29,US 201213604787 A,2012-09-06,"Agregados estabilizados y otros materiales y estructuras para propósitos que incluyen, pero no se limitan a, la absorción de energía","Una pista de aterrizaje que comprende una estructura de absorción de energía para detener una aeronave que viaja a lo largo de una superficie de la pista de aterrizaje, comprendiendo la estructura de absorción de energía: i) agregado suelto (14); ii) medios (18) para estabilizar la ubicación del agregado suelto; caracterizada porque: el agregado suelto se funde en zonas (54) separadas por paredes verticales (50); a lo largo de la superficie de la pista de aterrizaje y cada zona extiende agregado suelto sobre la superficie de la pista de aterrizaje para formar un lecho (42) de una estructura monolítica que es deformable para absorber energía y, de esta manera, efectuar la detención de la aeronave.",RUNWAY SAFE IPR AB,VALENTINI SYLVIA C;;LI YOUHONG;;DOHERTY SHAWN PATRICK,,https://lens.org/146-091-518-659-012,Granted Patent,no,0,0,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,B64F1/02;;E01C9/00,,0,0,,,,ACTIVE
158,US,B1,US 6366112 B1,157-889-048-452-632,2002-04-02,2002,US 97350901 A,2001-10-09,US 97350901 A;;US 42025699 A;;US 7569198 A,1998-05-11,Probe card having on-board multiplex circuitry for expanding tester resources,"
    A probe card for testing semiconductor wafers includes probe card contacts for electrically engaging die contacts on the wafer. The probe card also includes an on board multiplex circuit adapted to fan out and selectively transmit test signals from a tester to the probe card contacts. The multiplex circuit expands tester resources by allowing test signals to be written to multiple dice in parallel. Reading of the dice can be performed in groups up to the limit of the tester resources. In addition to expanding tester resources, the multiplex circuit maintains the individuality of each die, and permits defective dice to be electrically disconnected. 
",MICRON TECHNOLOGY INC,DOHERTY C PATRICK;;DEVARONA JORGE L;;AKRAM SALMAN,,https://lens.org/157-889-048-452-632,Granted Patent,yes,46,60,3,10,0,G01R1/07314;;G01R1/07385;;G01R31/2831;;Y10T29/49124;;Y10T29/49126;;Y10T29/49218;;Y10T29/49204;;Y10T29/49124;;Y10T29/49126;;Y10T29/49218;;Y10T29/49204;;G01R1/07385;;G01R31/2831;;G01R1/07314,G01R1/073;;G01R31/28,324/765;;324/754;;324/755;;324/757;;324/758;;324/158.1,0,0,,,,EXPIRED
159,IE,A2,IE S990145 A2,110-530-536-951-231,1999-06-30,1999,IE S990145 A,1999-02-23,IE S990145 A;;IE 980137 A,1998-02-26,A barrier,,ELECTRO AUTOMATION RES EAR LTD,"DOHERTY, PATRICK;;WALSH, JOHN ALPHONSUS;;HIGGINS, RORY JOHN",,https://lens.org/110-530-536-951-231,Patent Application,no,0,0,6,6,0,E01F13/06;;H02P3/18;;H02P7/00;;H02P2207/073,E01F13/04;;E01F13/06;;H02P3/18;;H02P7/00,,0,0,,,,EXPIRED
160,EP,A2,EP 1022392 A2,113-814-230-387-280,2000-07-26,2000,EP 99650119 A,1999-12-20,IE 990047 A,1999-01-21,A barrier,A barrier (1) has a base unit (2) which is secured to the ground and a top unit (3) which may be connected at any one of four different orientations. An electronic controller (6) is mounted in a door (5) of the base unit (2) so that is may be easily accessed. A drive mechanism (35) is mounted in a modular manner in the top unit (3). It is mounted by virtue of a beam drive shaft (21) which is mounted by bearings (22) at each end to opposed side walls (20) of the top unit (3). The beam is connected to the drive shaft (21) in a symmetrical manner so that the barrier may be used for either the right side or the left side of a laneway. There is excellent support and balance in the drive mechanism because it is connected between support bearings of the beam drive shaft (21). A manual override is provided to release a clutch if an electrical fault arises. The beam has a shear plate (27) which yields to minimise damage to either the drive mechanism or a beam arm (30) in the event of an accidental impact against the beam.,ELECTRO AUTOMATION RESEARCH EA,DOHERTY PATRICK;;WALSH JOHN ALPHONSUS;;HIGGINS RORY JOHN,,https://lens.org/113-814-230-387-280,Patent Application,yes,0,9,4,4,0,E01F13/06,E01F13/04;;E01F13/06,,0,0,,,,DISCONTINUED
161,CN,A,CN 104603009 A,133-951-697-645-50X,2015-05-06,2015,CN 201380046313 A,2013-07-29,US 2013/0052445 W;;US 201213604787 A,2012-09-06,"Stabilized aggregates and other materials and structures for purposes including, but not limited to, energy absorption","Described are materials (14) and structures (10) for absorbing energy. The materials (14) and structures (10) are well suited for arresting aircraft and other vehicles, although their purposes need not be so limited. Also detailed are packaging and other solutions for maintaining system integrity, especially (but not exclusively) when foam glass or other aggregate is employed.",ENGINEERED ARRESTING SYS CORP,VALENTINI SYLVIA C;;LI YOUHONG;;DOHERTY SHAWN PATRICK,,https://lens.org/133-951-697-645-50X,Patent Application,no,6,3,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,B64F1/02;;E01C9/00,,0,0,,,,ACTIVE
162,US,A1,US 2020/0062420 A1,158-862-969-512-886,2020-02-27,2020,US 201916540805 A,2019-08-14,US 201916540805 A;;US 201715641986 A;;US 201213604787 A,2012-09-06,STABILIZED AGGREGATES AND OTHER MATERIALS AND STRUCTURES FOR ENERGY ABSORPTION,"Materials and structures for absorbing energy. The materials and structures are well suited for arresting aircraft and other vehicles, although their purposes need not be so limited. Also detailed are packaging and other solutions for maintaining system integrity, especially (but not exclusively) when foam glass or other aggregate is employed and stabilizing the location of the aggregate is desired.",ENG ARRESTING SYS CORP,VALENTINI SILVIA C;;DOHERTY SHAWN PATRICK;;LI YOUHONG,RUNWAY SAFE IPR AB (2020-02-28);;ENGINEERED ARRESTING SYSTEMS CORPORATION (2012-09-12),https://lens.org/158-862-969-512-886,Patent Application,yes,0,0,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,B64F1/02;;E01C9/00,,0,0,,,,ACTIVE
163,US,A1,US 2003/0109454 A1,189-152-303-120-884,2003-06-12,2003,US 19365302 A,2002-07-10,US 19365302 A;;US 35104899 A;;US 11397798 A,1998-07-10,Compounds and methods for modulating adhesion molecule function,"
   Modulating agents and methods for enhancing or inhibiting cadherin-mediated functions are provided. The modulating agents comprise at least an HAV binding motif, an analogue or peptidomimetic thereof, or an antibody or fragment thereof that specifically binds to such a motif. Modulating agents may additionally comprise one or more cell adhesion recognition sequences recognized by cadherins and/or other adhesion molecules. Such modulating agents may, but need not, be linked to a targeting agent, drug and/or support material. 
",ADHEREX TECHNOLOGIES INC,DOHERTY PATRICK;;BLASCHUK OREST W;;GOUR BARBARA J,,https://lens.org/189-152-303-120-884,Patent Application,yes,13,7,13,13,95,A61K38/12;;A61K38/12;;A61P17/02;;A61P25/00;;A61P35/00;;A61P43/00;;C07K7/06;;C07K7/06;;C07K7/64;;C07K7/64;;C07K14/705;;C07K14/705,C12N15/09;;A61K38/00;;A61K39/395;;A61K47/48;;A61P17/02;;A61P25/00;;A61P35/00;;A61P43/00;;C07K7/06;;C07K7/64;;C07K14/705;;C07K16/18,514/14;;514/15;;514/16;;530/326;;530/327;;530/328,0,0,,,,EXPIRED
164,ZA,B,ZA 917216 B,147-397-789-398-385,1992-04-29,1992,ZA 917216 A,1991-09-11,US 58097290 A,1990-09-12,28-HYDROXY IVERMECTIN AGLYCONE,,MERCK & CO INC,ARISON BYRON H;;BYRON H ARISON;;DOHERTY PATRICK J;;PATRICK J DOHERTY;;SCHULMAN MARVIN D;;MARVIN D SCHULMAN,,https://lens.org/147-397-789-398-385,Granted Patent,no,0,0,9,9,0,A61P33/00;;A61P33/10;;C07D493/22;;C07D493/22;;C12P17/08;;C12P17/08,A01N43/90;;A61K31/35;;A61P33/00;;A61P33/10;;C07D493/22;;C12N1/38;;C12P17/08;;C12P17/18;;C12R1/645,,0,0,,,,EXPIRED
165,JP,A,JP 2019052533 A,023-937-846-718-057,2019-04-04,2019,JP 2018216487 A,2018-11-19,US 201213604787 A,2012-09-06,"STABILIZED AGGREGATE, OTHER MATERIAL AND STRUCTURE INCLUDING, BUT NOT LIMITED TO, ENERGY ABSORPTION AS APPLICATION","To provide a vehicle restraint system which absorbs energy using aggregate, material or other structure, resulting in a halt of a vehicle.SOLUTION: In a vehicle restraint system, a restraint bed 10 configured to restrain a vehicle is at least provided with an aggregate, a roof or a cover 18 in the form of a foam glass particle as a deformable material 14, and a plurality of anchors 22. Each of the plurality of anchors has a rod extending up to the inside of a foundation for supporting the restraint bed, and a disc connected to the rod and embedded in the restraint bed.SELECTED DRAWING: Figure 1",ENG ARRESTING SYSTEMS CORP,SYLVIA C VALENTINI;;LI YOUHONG;;SHAWN PATRICK DOHERTY,,https://lens.org/023-937-846-718-057,Patent Application,no,4,0,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,E01F15/00,,0,0,,,,DISCONTINUED
166,US,B2,US 6806255 B2,049-263-035-486-710,2004-10-19,2004,US 19365302 A,2002-07-10,US 19365302 A;;US 35104899 A;;US 11397798 A,1998-07-10,Compounds and methods for modulating adhesion molecule function,"
    Modulating agents and methods for enhancing or inhibiting cadherin-mediated functions are provided. The modulating agents comprise at least an HAV binding motif, an analogue or peptidomimetic thereof, or an antibody or fragment thereof that specifically binds to such a motif. Modulating agents may additionally comprise one or more cell adhesion recognition sequences recognized by cadherins and/or other adhesion molecules. Such modulating agents may, but need not, be linked to a targeting agent, drug and/or support material. 
",ADHEREX TECHNOLOGIES INC,DOHERTY PATRICK;;BLASCHUK OREST W;;GOUR BARBARA J,,https://lens.org/049-263-035-486-710,Granted Patent,yes,29,12,13,13,95,A61K38/12;;A61K38/12;;A61P17/02;;A61P25/00;;A61P35/00;;A61P43/00;;C07K7/06;;C07K7/06;;C07K7/64;;C07K7/64;;C07K14/705;;C07K14/705,C12N15/09;;A61K38/00;;A61K39/395;;A61K47/48;;A61P17/02;;A61P25/00;;A61P35/00;;A61P43/00;;C07K7/06;;C07K7/64;;C07K14/705;;C07K16/18,514/12;;514/13;;514/14;;514/15;;514/16;;530/324;;530/325;;530/326;;530/327;;530/328;;530/329,61,51,103-932-348-507-545;;008-343-455-504-279;;042-363-908-217-67X;;132-324-582-309-662;;039-261-118-830-511;;061-035-773-172-879;;174-629-378-329-78X;;006-951-811-000-031;;077-370-171-773-772;;004-463-307-680-511;;142-507-339-667-106;;120-169-328-663-815;;072-444-523-887-560;;097-164-253-011-753;;020-258-471-940-706;;099-515-858-399-636;;021-337-131-340-271;;026-663-290-717-027;;009-659-810-299-191;;009-331-313-562-906;;090-240-069-646-318;;088-822-106-739-66X;;062-427-665-260-15X;;112-862-562-340-024;;137-387-680-011-683;;134-516-505-208-947;;110-502-224-706-298;;020-462-712-767-288;;029-851-994-673-63X;;021-900-284-198-018;;040-097-687-516-358;;064-919-473-284-919;;034-739-229-119-712;;009-513-816-812-599;;044-315-636-518-714;;066-111-988-639-628;;054-156-093-087-90X;;024-298-917-400-264;;007-921-036-826-703;;058-361-803-472-756;;035-723-049-802-557;;073-394-708-740-681;;075-345-206-465-765;;022-613-944-087-298;;016-027-033-188-777;;087-017-684-634-423;;112-139-495-969-240;;078-439-331-209-812;;078-666-093-931-091;;073-062-095-884-955;;125-470-665-664-362,10.1007/978-1-4684-6831-1_14;;7539797;;10.1074/jbc.270.23.14047;;8360263;;10.1002/jcp.1041560321;;8145226;;10.1021/jm00032a009;;840300;;10.1038/266068a0;;10.1016/0012-1606(89)90283-2;;2511052;;10874487;;10.1016/0012-1606(90)90290-y;;2328837;;10.1016/0022-2836(90)90065-t;;2313692;;10.1073/pnas.76.1.514;;pmc382972;;284369;;8884773;;10.1016/0306-4522(96)00167-4;;371755;;10.1016/0006-8993(79)90048-9;;8112822;;10.1002/glia.440090407;;1322849;;10.1016/0012-1606(92)90149-b;;10.1016/s0021-9258(18)50070-3;;1331077;;2713720;;10.1016/0361-9230(89)90133-0;;pmc39065;;8692857;;10.1073/pnas.93.13.6567;;10.1016/0165-3806(91)90040-p;;1893561;;7534489;;10.1002/bip.360370209;;8954625;;10.1006/mcne.1996.0049;;8918827;;10.1016/0959-4388(94)90031-0;;8173325;;1993122;;10.1016/0896-6273(91)90360-c;;10.1007/bf01187857;;3171610;;7583324;;10.1016/0006-8993(95)00575-b;;10.1006/dbio.1995.1255;;7556887;;10.1111/1523-1747.ep12533356;;123263;;10.1159/000401276;;752458;;7960039;;10.1002/glia.440110409;;pmc2115263;;10.1083/jcb.107.4.1575;;3049625;;7612967;;10.1091/mbc.6.3.327;;pmc301191;;pmc2120642;;8522583;;10.1083/jcb.131.5.1193;;8207198;;1765779;;10.1002/neu.480220706;;3603044;;10.1126/science.3603044;;8825724;;10.1080/07391102.1995.10508854;;2182648;;10.1083/jcb.110.4.1239;;pmc2116090;;10.1083/jcb.85.3.890;;pmc2111442;;6248568;;10.1073/pnas.85.19.7274;;3050992;;pmc282168;;10.1006/cimm.1996.0123;;8620560;;10.1002/aja.1001970102;;8400407;;2317870;;10.1016/0092-8674(90)90222-z;;7824937;;10.1126/science.7824937;;0007824937;;10.1006/dbio.1996.0315;;8954714;;10.1016/s0896-6273(00)80264-0;;9052794;;10.1021/jm00114a022;;1920361;;10.2210/pdb1nch/pdb;;7885471;;10.1038/374327a0;;0007885471;;10.3109/15419069409014199;;7982033;;8982873;;10.1093/oxfordjournals.jbchem.a021496;;10.1016/s0015-6264(66)80385-1;;10.1016/0014-5793(95)00334-6;;7737419;;7917292;;10.1016/0896-6273(94)90027-2,"Ngo J.T, Marks J., Karplus M., Computational complexity, protein structure prediction, and the Levinthal paradox in The Protein Folding Problem, ch. 14, pp. 435-508, Birkhauser, 1994.*;;Kogan et al. A single amino acid residue can determine the ligand specificity of E-selectin. J Biol Chem. 270(23):14047-55, 1995.*;;Database Swiss Prot 39. Accession No. P19022;Q14923, pp. 1 and 2, 1990.;;Alexander et al., ""An N-Cadherin-Like Protein Contributes to Solute Barrier Maintenance in Cultured Endothelium,"" Journal of Cellular Physiology 156: 610-618, 1993.;;Ali et al., ""Conformationally Constrained Peptides and Semipeptides Derived from RGD as Potent Inhibitors of the Platelet Fibrinogen Receptor and Platelet Aggregation,"" J. Med. Chem. 37(6): 769-780, 1994.;;Blakemore, ""Remyelination of CNS axons by Schwann cells transplanted from the sciatic nerve,"" Nature 266: 68-69, 1977.;;Blaschuk et al., ""Estradiol Stimulates Cadherin Expression in Rat Granulosa Cells,"" Developmental Biology 136: 564-567, 1989.;;Blaschuk et al., ""E-Cadherin, estrogens and cancer: is there a connection?"" The Canadian Journal of Oncology 4(4): 291-301, 1994.;;Blaschuk et al., ""Identification of a Cadherin Cell Adhesion Recognition Sequence,"" Developmental Biology 139: 227-229, 1990.;;Blaschuk et al., ""Identification of a Conserved Region Common to Cadherins and Influenza Strain A Hemagglutinins,"" J. Mol. Biol. 211: 679-682, 1990.;;Bottenstein and Sato, ""Growth of a rat neuroblastoma cell line in serum-free supplemented medium,"" Proc.Natl. Acad. Sci. USA 76(1): 514-517, 1979.;;Brecknell et al., ""Bridge grafts of Fibroblast Growth Factor-4-Secreting Schwannoma Cells Promote Functional Axonal Regeneration in the Nigrostriatal Pathway of the Adult Rat,"" Neuroscience 74(3): 775-784, 1996.;;Brockes et al., ""Studies on Cultured Rat Schwann Cells. I. Establishment of Purified Populations from Cultures of Peripheral Nerve,"" Brain Research 165: 105-118, 1979.;;Brook et al., ""Morphology and Migration of Cultured Schwann Cells Transplanted Into the Fimbria and Hippocampus in Adult Rats,"" GLIA 9: 292-304, 1993.;;Byers et al., ""Fibroblast Growth Factor Receptors Contain a Conserved HAV Region Common to Cadherins and Influenza Strain A Hemagglutinins: A Role in Protein-Protein Interactions?,"" Developmental Biology 152: 411-414, 1992.;;Cardarelli et al., ""The Collagen Receptor alpha2beta1, from MG-63 and HT1080 Cells, Interacts with a Cyclic RGD Peptide,"" The Journal of Biological Chemistry 267(32): 23159-23164, 1992.;;Carlstedt et al., ""Nerve Fibre Regeneration Across the PNS-CNS Interface at the Root-Spinal Cord Junction,"" Brain Research Bulletin 22: 93-102, 1989.;;Cepek et al., ""Expression of a candidate cadherin in T lymphocytes,"" Proc. Natl. Acad. Sci. USA 93: 6567-6571, 1996.;;Chuah et al., ""Differentiation and survival of rat olfactory epithelial neurons in dissociated cell culture,"" Developmental Brain Research 60: 123-132, 1991.;;Craig et al., ""Concept and Progress in the Development of RGD-Containing Peptide Pharmaceuticals,"" Biopolymers (Peptide Science)37: 157-175, 1995.;;Doherty and Walsh, ""CAM-FGF Receptor Interactions: A Model for Axonal Growth,"" Molecular and Cellular Neuroscience 8(Article No. 0049): 99-111, 1996.;;Doherty and Walsh, ""Signal transduction events underlying neurite outgrowth stimulated by cell adhesion molecules,"" Current Opinion in Neurobiology 4: 49-55, 1994.;;Doherty et al., ""Neurite Outgrowth in Response to Transfected N-CAM and N-Cadherin Reveals Fundamental Differences in Neuronal Responsiveness to CAMS,"" Neuron 6: 247-258, 1991.;;Duncan et al., ""Transplantation of oligodendrocytes and Schwann cells into the spinal cord of the myelin-deficient rat,"" Journal of Neurocytology 17: 351-360, 1988.;;Fok-Seang et al., ""An analysis of astrocytic cell lines with different abilities to promote axon growth,"" Brain Research 689: 207-223, 1995.;;Fok-Seang et al., ""Migration of Oligodendrocyte Precursors on Astrocytes and Meningeal Cells,"" Developmental Biology 171: 1-15, 1995.;;Franz, ""Percutaneous Absorption. On The Relevance Of In Vitro Data,"" The Journal of Investigative Dermatology 64(3): 190-195, 1975.;;Franz, ""The Finite Dose Technique as a Valid in Vitro Model for the Study of Percutaneous Absorption in Man,"" Curr. Probl. Dermatol. 7: 58-68, 1978.;;Ghirnikar and Eng, ""Astrocyte-Schwann Cell Interactions in Culture,"" GLIA 11: 367-377, 1994.;;Ginsberg et al., PIR Acc. No. A43785, Jun. 1993.;;Gumbiner et al., ""The Role of the Cell Adhesion Molecule Uvomorulin in the Formation and Maintenance of the Epithelial Junctional Complex,"" The Journal of Cell Biology 107: 1575-1587, 1988.;;Hatta et al., PIR Acc. No. A29964, Jun. 1993.;;Hodgson et al., Geneseq. Acc. No. W22709, Sep. 1997.;;Horn et al., Gemeseq. Acc. No. P91888, Jan. 1991.;;Iruela-Arispe et al., ""Expression of SPARC during Development of the Chicken Chorioallantoic Membrane: Evidence for Regulated Proteolysis In Vivo,"" Molecular Biology of the Cell 6: 327-343, 1995.;;Laird et al., ""Gap Junction Turnover, Intracellular Trafficking, and Phosphorylation of Connexin43 in Brefeldin A-treated Rat Mammary Tumor Cells,"" The Journal of Cell Biology 131(5): 1193-1203, 1995.;;Lee et al., ""Expression of the Homotypic Adhesion Molecule E-Cadherin by Immature Murine Thymocytes and Thymic Epithelial Cells,"" Journal of Immunology 152: 5653-5659, 1994.;;Letourneau et al., ""Interactions of Schwann Cells with Neurites and with Other Schwann Cells Involve the Calcium-dependent Adhesion Molecule, N-cadherin,"" Journal of Neurobiology 22(7): 707-720, 1991.;;Liaw et al., PIR Acc. No. S11693, Jun. 1993.;;Liuzzi and Lasek, ""Astrocytes Block Axonal Regeneration in Mammals by Activating the Physiological Stop Pathway,"" Science 237: 642-645, 1987.;;Lutz et al., ""Secondary Structure of the HAV Peptide Which Regulates Cadherin-Cadherin Interaction,"" Journal of Biomolecular Structure & Dynamics 13(3): 447-455, 1995.;;Matsuzaki et al., ""cDNAs of Cell Adhesion Molecules of Different Specificity Induce Changes in Cell Shape and Border Formation in Cultured S180 Cells,"" The Journal of Cell Biology 110: 1239-1252, 1990.;;McCarthy and Vellis, ""Preparation of Separate Astroglial and Oligodendroglial Cell Cultures from Rat Cerebral Tissue,"" J. Cell Biology 85: 890-902, 1980.;;Mege et al., ""Construction of epithelioid sheets by transfection of mouse sarcoma cells with cDNAs for chicken cell adhesion molecules,"" Proc. Natl. Acad. Sci. USA 85: 7274-7278, 1988.;;Moran, ""The Protein Delivery Service. Advances in technologies for delivering proteins and peptides in therapeutically useful forms,"" Pharmaceutical Forum Issue 6: 4-7, 1996.;;Munro et al., Cell Adhesion and Invasion in Cancer Metastasis, R.G. Landes Company, Austin, TX, 1996, Chapter 3, ""The Structure, Function and Regulation of Cadherins,"" pp. 17-34.;;Munro et al., ""Characterization of Cadherins Expressed by Murine Thymocytes,"" Cellular Immunology 169(Article No. 0123): 309-312, 1996.;;Newton et al., ""N-Cadherin Mediates Sertoli Cell-Spermatogenic Cell Adhesion,"" Developmental Dynamics 197: 1-13, 1993.;;Nose et al., ""Localization of Specificity Determining Sites in Cadherin Cell Adhesion Molecules,"" Cell 61: 147-155, 1990.;;Orr, ""Angiogenesis Research Offers New Approaches to Treatment of Disease,"" Genetic Engineering News, pp. 15-16, 42, May 1, 1996.;;Overduin et al., ""Solution Structure of the Epithelial Cadherin Domain Responsible for Selective Cell Adhesion,"" Science 267: 386-389, 1995.;;Redies and Takeichi, ""Cadherins in the Developing Central Nervous System: An Adhesive Code for Segmental and Functional Subdivisions,"" Developmental Biology 180: 413-423, 1996.;;Reid, PIR Acc. No. A38870, Jun. 1993.;;Saffell et al., ""Expression of a Dominant Negative FGF Receptor Inhibits Axonal Growth and FGF Receptor Phosphorylation Stimulated by CAMs,"" Neuron, pp. 231-242, Feb. 1997.;;Samanen et al., ""Development of a Small RGD Peptide Fibrinogen Receptor Antagonist with Potent Antiaggregatory Activity in Vitro,"" J. Med. Chem. 34(10): 3114-3125, 1991.;;Shapiro et al., ""Structural basis of cell-cell adhesion by cadherins,"" Nature 374: 327-337, 1995.;;Tanihara et al., ""Cloning of Five Human Cadherins Clarifies Characteristic Features of Cadherin Extracellular Domain and Provides Further Evidence for Two Structurally Different Types of Cadherin,"" Cell Adhesion and Communication 2: 15-26, 1994.;;Tsutsui et al., ""Expression of Cadherin-Catenin Complexes in Human Leukemia Cell Lines,"" J. Biochem. 120: 1034-1039, 1996.;;Wickelgren, ""Breaking the Skin Barrier,"" PS 12: 86-88, 1996.;;Willems et al., ""Cadherin-dependent cell aggregation is affected by decapeptide derived from rat extracellular super-oxide dismutase,"" FEBS Letters 363: 289-292, 1995.;;Williams et al., ""Activation of the FGF Receptor Underlies Neurite Outgrowth Stimulated by L1, N-CAM, and N-Cadherin,"" Neuron 13: 583-594, 1994.",EXPIRED
167,GB,B,GB 2334752 B,046-817-422-519-976,2002-04-10,2002,GB 9904297 A,1999-02-25,IE 980136 A,1998-02-26,A barrier drive mechanism,,ELECTRO AUTOMATION RES,DOHERTY PATRICK;;WALSH JOHN ALPHONSUS;;O'BRENNAN KEVIN MICHAEL,,https://lens.org/046-817-422-519-976,Granted Patent,no,2,0,6,6,0,E01F13/06,E01F13/00;;E01F13/06,E2M M11F1         M11Z/P;;E2M M12A          M11Z/P;;E2M M15           M11Z/P;;E2M M16           M11Z/P;;E2M M27           M11Z/P,0,0,,,,EXPIRED
168,US,B2,US 9802717 B2,083-242-719-597-200,2017-10-31,2017,US 201213604787 A,2012-09-06,US 201213604787 A,2012-09-06,Stabilized aggregates and other materials and structures for energy absorption,"Materials and structures for absorbing energy. The materials and structures are well suited for arresting aircraft and other vehicles, although their purposes need not be so limited. Also detailed are packaging and other solutions for maintaining system integrity, especially (but not exclusively) when foam glass or other aggregate is employed and stabilizing the location of the aggregate is desired.",VALENTINI SILVIA C;;DOHERTY SHAWN PATRICK;;LI YOUHONG;;ENG ARRESTING SYSTEMS CORP,VALENTINI SILVIA C;;DOHERTY SHAWN PATRICK;;LI YOUHONG,RUNWAY SAFE IPR AB (2020-02-28);;ENGINEERED ARRESTING SYSTEMS CORPORATION (2012-09-12),https://lens.org/083-242-719-597-200,Granted Patent,yes,60,6,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,B64F1/02;;E01C9/00,,10,1,141-255-580-202-124,10.1111/j.2041-1294.2011.00071.x,"Innovative Financing Backs Highway Project Civil Engineering, Civil Engineering ASCE New York, vol. 68(10), Oct. 1, 1998, p. 14.;;Cellular Concrete Stops Airplanes in Their Tracks Civil Engineering Oct. 1998, pp. 14, 16.;;Barsotti, et al., “Developing Improved Civil Aircraft Arresting Systems”, Department of Transportation Federal Aviation Administration National Academy of Science Transportation Research Board, Jan. 2010, pp. 1-195.;;PCT/US2013/052445, “International Search Report and Written Opinion”, Dec. 2, 2013, 12 pages.;;Barsotti et al., “Developing Improved Civil Aircraft Arresting Systems”, Internet Citation, URL:http://onlinepubs.trb.orgjonlinepubs/acrpjacrp rpt 029.pdf, Jan. 21, 2010, pp. 1-195.;;PCT/US2013/052445, International Search Report and Written Opinion, Dec. 2, 2013, 12 pages.;;International Patent Application No. PCT/US2013/052445, International Preliminary Report on Patentability dated Mar. 19, 2015.;;F. Smeacetto, et al., “Durable Glass-Ceramic Coatings for Foam Glass,” International Journal of Applied Glass Science, vol. 3, No. 1, pp. 69-74 (2012).;;China Patent Application No. 2013800463134, Office Action dated Dec. 28, 2015.;;Japan Patent Application No. 2015-531080, Office Action (and translation) dated Jan. 31, 2017.",ACTIVE
169,WO,A3,WO 2000/002917 A3,029-600-921-341-494,2000-05-04,2000,CA 9900627 W,1999-07-12,US 11397798 A,1998-07-10,COMPOUNDS AND METHODS FOR MODULATING CADHERIN-MEDIATED FUNCTIONS,"Modulating agents and methods for enhancing or inhibiting cadherin-mediated functions are provided. The modulating agents comprise at least an HAV binding motif, an analogue or peptidomimetic thereof, or an antibody or fragment thereof that specifically binds to such a motif. Modulating agents may additionally comprise one or more cell adhesion recognition sequences recognized by cadherins and/or other adhesion molecules. Such modulating agents may, but need not, be linked to a targeting agent, drug and/or support material.",ADHEREX TECHNOLOGIES INC;;DOHERTY PATRICK;;BLASCHUK OREST W;;GOUR BARBARA J,DOHERTY PATRICK;;BLASCHUK OREST W;;GOUR BARBARA J,,https://lens.org/029-600-921-341-494,Search Report,yes,7,0,13,13,0,A61K38/12;;A61K38/12;;A61P17/02;;A61P25/00;;A61P35/00;;A61P43/00;;C07K7/06;;C07K7/06;;C07K7/64;;C07K7/64;;C07K14/705;;C07K14/705,C12N15/09;;A61K38/00;;A61K39/395;;A61K47/48;;A61P17/02;;A61P25/00;;A61P35/00;;A61P43/00;;C07K7/06;;C07K7/64;;C07K14/705;;C07K16/18,,1,1,112-139-495-969-240,10.3109/15419069409014199;;7982033,"HIDENOBU TANIHARA ET AL: ""CLONING OF FIVE HUMAN CADHERINS CLARIFIES CHARACTERISTIC FEATURES OF CADHERIN EXTRACELLULAR DOMAIN AND PROVIDES FURTHER EVIDENCE FOR TWO STRUCTURALLY DIFFERENT TYPES OF CADHERIN"", CELL ADHESION AND COMMUNICATION,US,HARWOOD ACADEMIC PUBLISHERS, GMBH, YVERDON,, vol. 2, 1 January 1994 (1994-01-01), pages 15 - 26, XP000576845, ISSN: 1061-5385",PATENTED
170,US,B2,US 10427802 B2,030-631-173-338-034,2019-10-01,2019,US 201715641986 A,2017-07-05,US 201715641986 A;;US 201213604787 A,2012-09-06,Stabilized aggregates and other materials and structures for energy absorption,"Materials and structures for absorbing energy. The materials and structures are well suited for arresting aircraft and other vehicles, although their purposes need not be so limited. Also detailed are packaging and other solutions for maintaining system integrity, especially (but not exclusively) when foam glass or other aggregate is employed and stabilizing the location of the aggregate is desired.",ENG ARRESTING SYS CORP,VALENTINI SILVIA C;;DOHERTY SHAWN PATRICK;;LI YOUHONG,RUNWAY SAFE IPR AB (2020-02-28);;ENGINEERED ARRESTING SYSTEMS CORPORATION (2012-09-12),https://lens.org/030-631-173-338-034,Granted Patent,yes,62,1,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,B64F1/02;;E01C9/00,,16,1,141-255-580-202-124,10.1111/j.2041-1294.2011.00071.x,"European Patent Application No. 18162492.5, Extended European Search Report dated Jun. 26, 2018.;;Cellular Concrete Stops Airplanes in Their Tracks, Civil Engineering, Oct. 1998, pp. 14, 16.;;Innovative Financing Backs Highway Project, Civil Engineering, Civil Engineering ASCE, New York, New York, Oct. 1, 1998, vol. 68, No. 10.;;U.S. Appl. No. 13/604,787, Corrected Notice of Allowability dated Apr. 28, 2017.;;U.S. Appl. No. 13/604,787, Corrected Notice of Allowability dated Jun. 6, 2017.;;U.S. Appl. No. 13/604,787, Final Office Action dated Jun. 16, 2016.;;U.S. Appl. No. 13/604,787, Non-Final Office Action dated Nov. 28, 2016.;;U.S. Appl. No. 13/604,787, Non-Final Office Action dated Jan. 12, 2016.;;U.S. Appl. No. 13/604,787, Notice of Allowance dated Apr. 10, 2017.;;U.S. Appl. No. 13/604,787, Restriction Requirement dated May 9, 2014.;;Barsotti et al., Developing Improved Civil Aircraft Arresting Systems, Department of Transportation Federal Aviation Administration National Academy of Science Transportation Research Board http://onlinepubs.trb.org/onlinepubs/acrp/acrp_rpt_029.pdf, Jan. 21, 2010, pp. 1-195.;;Chinese Application No. 2013800463134, Office Action (and English translation) dated Dec. 28, 2015.;;Japanese Application No. 2015-531080, Office Action (and English translation) dated Jan. 31, 2017.;;International Application No. PCT/US2013/052445, International Preliminary Report on Patentability dated Mar. 19, 2015.;;International Application No. PCT/US2013/052445, International Search Report and Written Opinion dated Dec. 2, 2013.;;Smeacetto et al., Durable Glass-Ceramic Coatings for Foam Glass, International Journal of Applied Glass Science, vol. 3, No. 1, 2012, pp. 69-74.",ACTIVE
171,US,A1,US 2014/0280296 A1,052-990-332-166-595,2014-09-18,2014,US 201313826179 A,2013-03-14,US 201313826179 A,2013-03-14,PROVIDING HELP INFORMATION BASED ON EMOTION DETECTION,"A device may detect a negative emotion of a user and identify, based on detecting the negative emotion of the user, a task being performed by the user in relation to an item. The device may obtain, based on identifying the task, information to aid the user in performing the identified task in relation to the item. The information may include at least one of information, obtained from a memory associated with the device, in a help document, a user manual, or an instruction manual relating to performing the task in relation to the item; information, obtained from a network, identifying a document relating to performing the task in relation to the item; or information identifying a video relating to performing the task in relation to the item. The device may provide the obtained information to the user.",GOOGLE INC;;GOOGLE INC,JOHNSTON NICHOLAS;;DOHERTY RYAN PATRICK;;MCCLELLAN WILLARD KEVIN,GOOGLE INC (2013-03-12),https://lens.org/052-990-332-166-595,Patent Application,yes,5,43,2,2,0,G06F9/453;;G06F16/93;;G06V40/174;;G06F9/453;;G06F16/93;;G06V40/174,G06F17/30,707/769,0,0,,,,DISCONTINUED
172,GB,B,GB 2334753 B,060-260-164-938-861,2001-11-14,2001,GB 9904299 A,1999-02-25,IE 980137 A,1998-02-26,A barrier,,ELECTRO AUTOMATION RES,DOHERTY PATRICK;;WALSH JOHN ALPHONSUS;;HIGGINS RORY JOHN,,https://lens.org/060-260-164-938-861,Granted Patent,no,0,1,6,6,0,E01F13/06;;H02P3/18;;H02P7/00;;H02P2207/073,E01F13/04;;E01F13/06;;H02P3/18;;H02P7/00,E2M M11F1         M11Z/P;;E2M M12A          M11Z/P;;H2J JBX           JBX;;H2J JRAC          JRAC;;H2J J1N3          JBX;;H2J J1N3          JRAC;;H2J J4            JBX;;H2J J4            JRAC,0,0,,,,EXPIRED
173,NZ,A,NZ 705779 A,105-346-199-545-265,2017-09-29,2017,NZ 70577913 A,2013-07-29,US 2013/0052445 W;;US 201213604787 A,2012-09-06,"Stabilized aggregates and other materials and structures for purposes including, but not limited to, energy absorption","This invention relates to aggregates, materials (14) and other structures (10) and more particularly, but not necessarily exclusively to vehicle arresting systems in which aggregates, materials, or other structures are used to absorb energy to effect vehicle arrests, although their purposes need not to be so limited.. Also presented in this invention are packaging and other solutions for maintaining system integrity and structural integrity of blocks during non-emergency conditions, while being subject to tearing, breakage or other partial or complete disintegration during an arresting incident, especially (but not exclusively) when foam glass or other aggregate is employed.",ENG ARRESTING SYSTEMS CORP,VALENTINI SYLVIA C;;LI YOUHONG;;DOHERTY SHAWN PATRICK,,https://lens.org/105-346-199-545-265,Patent Application,no,0,0,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,B64F1/02;;E01C9/00,,0,0,,,,DISCONTINUED
174,EP,A2,EP 1097168 A2,155-077-340-400-948,2001-05-09,2001,EP 99928963 A,1999-07-12,CA 9900627 W;;US 11397798 A,1998-07-10,COMPOUNDS AND METHODS FOR MODULATING CADHERIN-MEDIATED FUNCTIONS,,ADHEREX TECHNOLOGIES INC,DOHERTY PATRICK;;BLASCHUK OREST W;;GOUR BARBARA J,,https://lens.org/155-077-340-400-948,Patent Application,yes,0,0,13,13,0,A61K38/12;;A61K38/12;;A61P17/02;;A61P25/00;;A61P35/00;;A61P43/00;;C07K7/06;;C07K7/06;;C07K7/64;;C07K7/64;;C07K14/705;;C07K14/705,C12N15/09;;A61K38/00;;A61K39/395;;A61K47/48;;A61P17/02;;A61P25/00;;A61P35/00;;A61P43/00;;C07K7/06;;C07K7/64;;C07K14/705;;C07K16/18,,1,0,,,See references of WO 0002917A3,DISCONTINUED
175,US,A1,US 2005/0163786 A1,043-722-100-838-703,2005-07-28,2005,US 95674804 A,2004-10-01,US 95674804 A;;US 19365302 A;;US 35104899 A;;US 11397798 A,1998-07-10,Compounds and methods for modulating adhesion molecule function,"Modulating agents and methods for enhancing or inhibiting cadherin-mediated functions are provided. The modulating agents comprise at least an HAV binding motif, an analogue or peptidomimetic thereof, or an antibody or fragment thereof that specifically binds to such a motif. Modulating agents may additionally comprise one or more cell adhesion recognition sequences recognized by cadherins and/or other adhesion molecules. Such modulating agents may, but need not, be linked to a targeting agent, drug and/or support material.",ADHEREX TECHNOLOGIES INC,DOHERTY PATRICK;;BLASCHUK OREST W;;GOUR BARBARA J,,https://lens.org/043-722-100-838-703,Patent Application,yes,17,0,13,13,95,A61K38/12;;A61K38/12;;A61P17/02;;A61P25/00;;A61P35/00;;A61P43/00;;C07K7/06;;C07K7/06;;C07K7/64;;C07K7/64;;C07K14/705;;C07K14/705,C12N15/09;;A61K38/00;;A61K39/395;;A61K47/48;;A61P17/02;;A61P25/00;;A61P35/00;;A61P43/00;;C07K7/06;;C07K7/64;;C07K14/705;;C07K16/18,424/178.1;;514/44;;514/12,0,0,,,,DISCONTINUED
176,IE,A1,IE 990142 A1,087-875-687-442-655,2000-11-01,2000,IE 990142 A,1999-02-23,IE 990142 A;;IE 980136 A,1998-02-26,A barrier drive mechanism,"A barrier beam (2) is driven by a conrod (11) connected to a crank wheel (10) which is in turn driven by a drive wheel (21) by virtue of frictional engagement. The drive wheel (21) is driven by a combined motor/gearbox unit (17) having a common casing and which is secured by a flange (19) to a connector (25) which in turn pivotally connects the unit to a fixed support (6) at a pivot pin (30). The arrangement is simple, compact and inexpensive.<Figure 2>",ELECTRO AUTOMATION RES EAR LTD,DOHERTY PATRICK;;WALSH JOHN ALPHONSUS;;O'BRENNAN KEVIN MICHAEL,,https://lens.org/087-875-687-442-655,Patent Application,no,0,0,6,6,0,E01F13/06,E01F13/00;;E01F13/06,,0,0,,,,DISCONTINUED
177,IE,B2,IE S80936 B2,094-778-289-012-130,1999-06-30,1999,IE S990145 A,1999-02-23,IE S990145 A;;IE 980137 A,1998-02-26,A barrier,,ELECTRO AUTOMATION RESEARCH EA,DOHERTY PATRICK;;WALSH JOHN ALPHONSUS;;HIGGINS RORY JOHN,,https://lens.org/094-778-289-012-130,Limited Patent,no,0,0,6,6,0,E01F13/06;;H02P3/18;;H02P7/00;;H02P2207/073,E01F13/04;;E01F13/06;;H02P3/18;;H02P7/00,,0,0,,,,EXPIRED
178,WO,A1,WO 2014/039179 A1,100-053-946-603-625,2014-03-13,2014,US 2013/0052445 W,2013-07-29,US 201213604787 A,2012-09-06,"STABILIZED AGGREGATES AND OTHER MATERIALS AND STRUCTURES FOR PURPOSES INCLUDING, BUT NOT LIMITED TO, ENERGY ABSORPTION","Described are materials (14) and structures (10) for absorbing energy. The materials (14) and structures (10) are well suited for arresting aircraft and other vehicles, although their purposes need not be so limited. Also detailed are packaging and other solutions for maintaining system integrity, especially (but not exclusively) when foam glass or other aggregate is employed.",ENGINEERED ARRESTING SYS CORP,VALENTINI SYLVIA C;;LI YOUHONG;;DOHERTY SHAWN PATRICK,,https://lens.org/100-053-946-603-625,Patent Application,yes,5,5,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,E01C9/00;;B64F1/02,,3,0,,,"BARSOTTI MATTHEW A ET AL: ""Developing Improved Civil Aircraft Arresting Systems"", INTERNET CITATION, 21 January 2010 (2010-01-21), pages 1 - 195, XP002633947, ISBN: 978-0-309-11813-2, Retrieved from the Internet <URL:http://onlinepubs.trb.org/onlinepubs/acrp/acrp_rpt_029.pdf> [retrieved on 20110427];;ALLEN PATENT, vol. 4, no. 11, pages 43 - 48;;NARMO APPLICATION, vol. 2, pages 2",PENDING
179,US,B1,US 6466047 B1,113-723-030-259-037,2002-10-15,2002,US 99950201 A,2001-12-04,US 99950201 A;;US 67507200 A;;US 24437399 A;;US 7569198 A,1998-05-11,System for testing bumped semiconductor components with on-board multiplex circuit for expanding tester resources,"
    An interconnect, a test system, and a test method for testing bumped semiconductor components, such as dice and packages, contained on substrates, such as wafers or panels, are provided. The test system includes the interconnect, a tester for generating test signals, and a wafer prober for placing the components and interconnect in physical contact. The interconnect includes interconnect contacts, such as conductive pockets, for electrically engaging bumped component contacts on the components. The interconnect also includes an on board multiplex circuit adapted to fan out and selectively transmit test signals from the tester to the interconnect contacts. The multiplex circuit expands tester resources by allowing test signals to be written to multiple components in parallel. Reading of the test signals from the components can be performed in groups up to the limit of the tester resources. In addition to expanding tester resources, the multiplex circuit maintains the individuality of each component, and permits defective components to be electrically disconnected. 
",MICRON TECHNOLOGY INC,DOHERTY C PATRICK;;DEVARONA JORGE L;;AKRAM SALMAN,,https://lens.org/113-723-030-259-037,Granted Patent,yes,58,29,3,10,0,G01R1/07385;;G01R1/07385;;G01R1/07314;;G01R1/07314;;G01R31/2831;;G01R31/2831,G01R1/073;;G01R31/28,324/765;;324/158.1,0,0,,,,EXPIRED
180,BR,B1,BR 112015004846 B1,160-349-090-514-842,2022-02-01,2022,BR 112015004846 A,2013-07-29,US 2013/0052445 W;;US 201213604787 A,2012-09-06,Material de absorção de energia para deter o movimento de uma aeronave viajando ao longo de uma superfície de uma pista e método para deter o movimento de uma aeronave,"material de absorção de energia e método para deter o movimento de uma aeronave. a presente invenção refere-se aos materiais (14) e às estruturas (10) para a absorção de energia. os materiais (14) e as estruturas (10) são bem adaptados para deter os aviões e outros veículos, embora os seus efeitos não precisam ser tão limitados. também são detalhados o empacotamento e outras soluções para a manutenção da integridade do sistema, especialmente (mas não de maneira exclusiva) quando o vidro de espuma ou outro agregado é utilizado.",ENG ARRESTING SYS CORP;;RUNWAY SAFE IPR AB,SHAWN PATRICK DOHERTY;;SILVIA C VALENTINI;;LI YOUHONG,RUNWAY SAFE IPR AB (SE) (2020-05-12),https://lens.org/160-349-090-514-842,Granted Patent,no,0,0,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,E01C9/00;;B64F1/02,,0,0,,,,ACTIVE
181,AU,B2,AU 764271 B2,080-357-195-192-499,2003-08-14,2003,AU 1999/045964 A,1999-07-12,CA 9900627 W;;US 11397798 A,1998-07-10,Compounds and methods for modulating cadherin-mediated functions,,ADHEREX TECHNOLOGIES INC,DOHERTY PATRICK;;BLASCHUK OREST W;;GOUR BARBARA J,,https://lens.org/080-357-195-192-499,Granted Patent,no,3,0,13,13,0,A61K38/12;;A61K38/12;;A61P17/02;;A61P25/00;;A61P35/00;;A61P43/00;;C07K7/06;;C07K7/06;;C07K7/64;;C07K7/64;;C07K14/705;;C07K14/705,C12N15/09;;A61K38/00;;A61K39/395;;A61K47/48;;A61P17/02;;A61P25/00;;A61P35/00;;A61P43/00;;C07K7/06;;C07K7/64;;C07K14/705;;C07K16/18,,0,0,,,,EXPIRED
182,US,B1,US 6472368 B1,095-714-556-204-799,2002-10-29,2002,US 35104899 A,1999-07-09,US 35104899 A;;US 11397798 A,1998-07-10,Compounds and methods for modulating adhesion molecule function,"
    Modulating agents and methods for enhancing or inhibiting cadherin-mediated functions are provided. The modulating agents comprise at least an HAV binding motif, an analogue or peptidomimetic thereof, or an antibody or fragment thereof that specifically binds to such a motif. Modulating agents may additionally comprise one or more cell adhesion recognition sequences recognized by cadherins and/or other adhesion molecules. Such modulating agents may, but need not, be linked to a targeting agent, drug and/or support material. 
",ADHEREX TECHNOLOGIES INC,DOHERTY PATRICK;;BLASCHUK OREST W;;GOUR BARBARA J,ADHEREX TECHNOLOGIES INC (1999-10-04),https://lens.org/095-714-556-204-799,Granted Patent,yes,27,32,13,13,95,A61K38/12;;A61K38/12;;A61P17/02;;A61P25/00;;A61P35/00;;A61P43/00;;C07K7/06;;C07K7/06;;C07K7/64;;C07K7/64;;C07K14/705;;C07K14/705,C12N15/09;;A61K38/00;;A61K39/395;;A61K47/48;;A61P17/02;;A61P25/00;;A61P35/00;;A61P43/00;;C07K7/06;;C07K7/64;;C07K14/705;;C07K16/18,514/9;;530/317,59,48,042-363-908-217-67X;;132-324-582-309-662;;039-261-118-830-511;;174-629-378-329-78X;;112-139-495-969-240;;061-035-773-172-879;;006-951-811-000-031;;077-370-171-773-772;;004-463-307-680-511;;142-507-339-667-106;;120-169-328-663-815;;072-444-523-887-560;;097-164-253-011-753;;020-258-471-940-706;;099-515-858-399-636;;021-337-131-340-271;;026-663-290-717-027;;009-659-810-299-191;;009-331-313-562-906;;090-240-069-646-318;;088-822-106-739-66X;;062-427-665-260-15X;;112-862-562-340-024;;137-387-680-011-683;;134-516-505-208-947;;110-502-224-706-298;;020-462-712-767-288;;029-851-994-673-63X;;021-900-284-198-018;;040-097-687-516-358;;064-919-473-284-919;;034-739-229-119-712;;009-513-816-812-599;;044-315-636-518-714;;066-111-988-639-628;;054-156-093-087-90X;;024-298-917-400-264;;007-921-036-826-703;;058-361-803-472-756;;035-723-049-802-557;;073-394-708-740-681;;075-345-206-465-765;;022-613-944-087-298;;016-027-033-188-777;;078-439-331-209-812;;073-062-095-884-955;;125-470-665-664-362;;087-017-684-634-423,8360263;;10.1002/jcp.1041560321;;8145226;;10.1021/jm00032a009;;840300;;10.1038/266068a0;;10874487;;10.3109/15419069409014199;;7982033;;10.1016/0012-1606(89)90283-2;;2511052;;10.1016/0012-1606(90)90290-y;;2328837;;10.1016/0022-2836(90)90065-t;;2313692;;10.1073/pnas.76.1.514;;pmc382972;;284369;;8884773;;10.1016/0306-4522(96)00167-4;;371755;;10.1016/0006-8993(79)90048-9;;8112822;;10.1002/glia.440090407;;1322849;;10.1016/0012-1606(92)90149-b;;10.1016/s0021-9258(18)50070-3;;1331077;;2713720;;10.1016/0361-9230(89)90133-0;;pmc39065;;8692857;;10.1073/pnas.93.13.6567;;10.1016/0165-3806(91)90040-p;;1893561;;7534489;;10.1002/bip.360370209;;8954625;;10.1006/mcne.1996.0049;;8918827;;10.1016/0959-4388(94)90031-0;;8173325;;1993122;;10.1016/0896-6273(91)90360-c;;10.1007/bf01187857;;3171610;;7583324;;10.1016/0006-8993(95)00575-b;;10.1006/dbio.1995.1255;;7556887;;10.1111/1523-1747.ep12533356;;123263;;10.1159/000401276;;752458;;7960039;;10.1002/glia.440110409;;pmc2115263;;10.1083/jcb.107.4.1575;;3049625;;7612967;;10.1091/mbc.6.3.327;;pmc301191;;pmc2120642;;8522583;;10.1083/jcb.131.5.1193;;8207198;;1765779;;10.1002/neu.480220706;;3603044;;10.1126/science.3603044;;8825724;;10.1080/07391102.1995.10508854;;2182648;;10.1083/jcb.110.4.1239;;pmc2116090;;10.1083/jcb.85.3.890;;pmc2111442;;6248568;;10.1073/pnas.85.19.7274;;3050992;;pmc282168;;10.1006/cimm.1996.0123;;8620560;;10.1002/aja.1001970102;;8400407;;2317870;;10.1016/0092-8674(90)90222-z;;7824937;;10.1126/science.7824937;;0007824937;;10.1006/dbio.1996.0315;;8954714;;10.1016/s0896-6273(00)80264-0;;9052794;;10.1021/jm00114a022;;1920361;;8982873;;10.1093/oxfordjournals.jbchem.a021496;;10.1016/0014-5793(95)00334-6;;7737419;;7917292;;10.1016/0896-6273(94)90027-2;;10.2210/pdb1nch/pdb;;7885471;;10.1038/374327a0;;0007885471,"Database Swiss PRot_39. Accession No. P19022;Q14923, pp. 1 and 2, 1990.*;;Alexander et al., ""An N-Cadherin-Like Protein Conributes to Solute Barrier Maintenance in Cultured Endothelium,"" Journal of Cellular Physiology 156: 610-618, 1993.;;Ali et al., ""Conformationally Constrained Peptides and Semipeptides Derived from RGD as Potent Inhibitors of the Platelet Fibrinogen Receptor and Platelet Aggregation,"" J. Med. Chem. 37: 769-780, 1994.;;Blakemore, W.F., ""Remyelination of CNS axons by Schwann cells transplanted from the sciatic nerve,"" Nature 266: 68-69, Mar. 3, 1977.;;Blaschuk et al., ""E-cadherin, estrogens and cancer: is there a connection?,"" The Canadian Journal of Oncology 4(4): 291-301, Nov. 1994.;;Tanihara et al., ""Cloning of Five Human Cadherins Clarifies Characteristic Features of Cadherin Extracellular Domain and Provides Further Evidence for Two Structurally Different Types of Cadherin,"" Cell Adhesion and Communication 2: 15-26, 1994.;;Blaschuk et al., ""Estradiol Stimulates Cadherin Expression in Rat Granulosa Cells,"" Developmental Biology 136: 564-567, 1989.;;Blaschuk et al., ""Identification of a Cadherin Cell Adhesion Recognition Sequence,"" Developmental Biology 139: 227-229, 1990.;;Blaschuk et al., ""Identification of a Conserved Region Common to Cadherins and Influenza Strain A Hemagglutinins,"" J. Mol. Biol. 211: 679-682, 1990.;;Bottenstein and Sato, ""Growth of a rat neuroblastoma cell line in serum-free supplemented medium,"" Proc.Natl. Acad. Sci. USA 76(1): 514-517, 1979.;;Brecknell et al., ""Bridge grafts of Fibroblast Growth Factor-4-Secreting Schwannoma Cells Promote Functional Axonal Regeneration in the Nigrostriatal Pathway of the Adult Rat,"" Neuroscience 74(3): 775-784, 1996.;;Brockes et al., ""Studies on Cultured Rat Schwann Cells. I. Establishment of Purified Populations from Cultures of Peripheral Nerve,"" Brain Research 165: 105-118, 1979.;;Brook et al., ""Morphology and Migration of Cultured Schwann Cells Transplanted Into the Fimbria and Hippocampus in Adult Rats,"" GLIA 9. 292-304, 1993.;;Byers et al., ""Fibroblast Growth Factor Receptors Contain a Conserved HAV Region Common to Cadherins and Influenza Strain A Hemagglutinins: A Role in Protein-Protein Interactions?,"" Developmental Biology 152: 411-414, 1992.;;Cardarelli et al., ""The Collagen Receptor alpha2beta1, from MG-63 and HT1080 Cells, Interacts with a Cyclic RGD Peptide,"" The Journal of Biological Chemistry 267(32): 23159-23164, 1992.;;Carlstedt et al., ""Nerve Fibre Regeneration Across the PNS-CNS Interface at the Root-Spinal Cord Junction,"" Brain Research Bulletin 22: 93-102, 1989.;;Cepek et al., ""Expression of a candidate cadherin in T lymphocytes,"" Proc. Natl. Acad. Sci. USA 93: 6567-6571, 1996.;;Chuah et al., ""Differentiation and survival of rat olfactory epithelial neurons in dissociated cell culture,"" Developmental Brain Research 60: 123-132, 1991.;;Craig et al., ""Concept and Progress in the Development of RGD-Containing Peptide Pharmaceuticals,"" Biopolymers (Peptide Science) 37: 157-175, 1995.;;Doherty and Walsh, ""CAM-FGF Receptor Interactions: A Model for Axonal for Growth,"" Molecular and Cellular Neuroscience 8(Article No. 0049): 99-111, 1996.;;Doherty and Walsh, ""Signal transduction events underlying neuritne outgrowth stimulated by cell adhesion molecules,"" Current Opinion in Neurobiology 4: 49-55, 1994.;;Doherty et al., ""Neurite Outgrowth in Response to Transfected N-CAM and N-Cadherin Reveals Fundamental Differences in Neuronal Responsiveness to CAMS,"" Neuron 6: 247-258, 1991.;;Duncan et al., ""Transplantation of oligodendrocytes and Schwann cell into the spinal cord of the myelin-deficient rat,"" Journal of Neurocytology 17: 351-360, 1988.;;Fok-Seang et al., ""An analysis of astrocytic cell lines with different abilities to promote axon growth,"" Brain Research 689: 207-223, 1995.;;Fok-Seang et al., ""Migration of Oligodendrocyte Precursors on Astrocytes and Meningeal Cells,"" Developmental Biology 171: 1-15, 1995.;;Franz, ""Percutaneous Absorption. On The Relevance Of In Vitro Data,"" The Journal of Investigative Dermatology 64(3): 190-195, 1975.;;Franz, ""The Finite Dose Technique as a Valid in Vitro Model for the Study of Percutaneous Absorption in Man,"" Curr. Probl. Dermatol. 7: 58-68, 1978.;;Ghirnikar and Eng, ""Astrocyte-Schwann Cell Interactions in Culture,"" GLIA 11: 367-377, 1994.;;Grinsberg et al., PIR Acc. No. A43785, Jun. 1993.;;Gumbiner et al., ""The Role of the Cell Adhesion Molecule Uvomorulin in the Formation and Maintenance of the Epithelial Junctional Complex,"" The Journal of Cell Biology 107: 1575-1587, 1988.;;Hatta et al., PIR Acc. No. A29964, Jun. 1993.;;Hodgson et al., Geneseq. Acc. No. W22709, Sep. 1997.;;Horn et al , Geneseq. Acc. No. P91888, Jan. 1991.;;Iruela-Arispe et al., ""Expression of SPARCc during Development of the Chicken Chorioallantoic Membrane: Evidence for Regulated Proteoyvsis In Vivo,"" Molecular Biology of the Cell 6: 327-343, 1995.;;Laird et al., ""Gap Junction Turnover, Intracellular Trafficking, and Phosphorylation of Connexin43 in Brefeldin A-treated Rat Mammary Tumor Cells,"" The Journal of Cell Biology 131(5): 1193-1203, 1995.;;Le et al., ""Expression of the Homotypic Adhesion Molecule E-Cadherin by Immature Murine Thymocytes and Thymic Epithelial Cells,"" Journal of Immunology 152: 5653-5659, 1994.;;Letourneau et al., ""Interactions of Schwann Cells with Neurites and with Other Schwann Cell Involve the Calcium-dependent Adhesion Molecule, N-cadherin,"" Journal of Neurobiology 22(7): 707-720, 1991.;;Liaw et al., PIR Acc. No. S11693, Jun. 1993.;;Liuzzi and Lasek, ""Astrocytes Block Axonal Regeneration in Mammals by Activating the Physiological Stop Pathway,"" Science 237: 642-645, 1987.;;Lutz et al., ""Secondary Structure of the HAV Peptide Which Regualtes Cadherin-Cadherin Interaction,"" Journal of Biomolecular Structure & Dynamics 13(3): 447-455, 1995.;;Matsuzaki et al., ""cDNAs of Cell Adhesion Molecules of Different Specificity Induce Changes in Cell Shape and Border Formation in Cultured S180 Cells,"" The Jouranl of Cell Biology 110: 1239-1252, 1990.;;McCarthy and Vellis, ""Preparation of Separate Astroglial and Oligodendroglial Cell Cultures from Rat Cerebral Tissue,"" J. Cell Biology 85: 890-902, 1980.;;Mege et al., ""Construction of epithelioid sheets by transfection of mouse sarcoma cells with cDNAs for chicken cell adhesion molecules,"" Proc. Natl. Acad. Sci. USA 85: 7274-7278, 1988.;;Moran, ""The Protein Delivery Service. Advances in technologies for delivering proteins and peptides in therapeutically useful forms,"" Pharmaceutical Forum Issue 6: 4-7, 1996.;;Munro et al., Cell Adhesion and Invasion in Cancer Metastasis, R.G. Landes Company, Austin, TX, 1996, Chapter 3, ""The Structure, Function and Regulation of Cadherins,"" pp. 17-34.;;Munro et al., ""Characterization of Cadherins Expressed by Murine Thymocytes,"" Cellular Immunology 169(Article No. 0123): 309-312, 1996.;;Newton et al., ""N-Cadherin Mediates Sertoli Cell-Spermatogenic Cell Adhesion,"" Developmental Dynamics 197: 1-13, 1993.;;Nose et al., ""Localization of Specificity Determining Sites in Cadherin Cell Adhesion Molecules,"" Cell 61: 147-155, 1990.;;Orr, ""Angiogenesis Research Offers New Approaches to Treatment of Disease,"" Genetic Engineering News, pp. 15-16, 42, May 1, 1996.;;Overduin et al., ""Solution Structure of the Epithelial Cadherin Domain Responsible for Selective Cell Adhesion,"" Science 267: 386-389, 1995.;;Redies and Takeichi, ""Cadherins in the Developing Central Nervous System: An Adhesive Code for Segmental and Functional Subdivisions,"" Developmental Biology 180: 413-423, 1996.;;Reid, PIR Acc. No. A38870, Jun. 1993.;;Saffell et al., ""Expression of a Dominant Negative FGF Receptor Inhibits Axonal Growth and FGF Receptor Phosphorylation Stimulated by CAMs, "" Neuron, pp. 231-242, Feb. 1997.;;Samanen et al., ""Development of a Small RGD Peptides Fibrinogen Receptor Antoganist with Potent Antiaggregatory Activity in Vitro,"" J. Med. Chem. 34(10): 3114-3125, 1991.;;Tsutsui et al., ""Expression of Cadherin-Catenin Complexes in Human Leukemia Cell Lines,"" J. Biochem. 120: 1034-1039, 1996.;;Wickelgren, I. ""Breaking the Skin Barrier"" , Ps 12: 86-88, 1996.;;Willems et al., ""Cadherin-dependent cell aggregation is affected by decapeptide derived from rat extracellular super-oxide dismutase,"" FEBS Letters 363: 289-292, 1995.;;Williams et al., ""Activation of the FGF Receptor Underlies Neurite Outgrowth Stimulated by L1, N-CAM, and N-Cadherin,"" Neuron 13: 583-594, 1994.;;Shapiro et al., ""Structural basis of cell-cell adhesion by cadherins,"" Nature374: 327-337, 1995.",EXPIRED
183,WO,A8,WO 2019/139980 A8,101-546-944-122-897,2020-08-20,2020,US 2019/0012890 W,2019-01-09,US 201862615242 P,2018-01-09,METHODS FOR MEASURING ANALYTE AND/OR PROTEIN IN BIOLOGICAL SAMPLES,"The disclosure directed to methods for measuring an analyte alone or in combination with total protein in biological samples. More particularly, the disclosure relates to methods for measuring an analyte and/or total protein using one or more colorimetric reagents alone or in combination with protein precipitation reagents.",IDEXX LAB INC,DOHERTY PATRICK;;KIRSPEL KEVIN;;FARACE GIOSI;;YERRAMILLI MURTHY,,https://lens.org/101-546-944-122-897,Amended Application,yes,0,0,14,14,0,G01N21/272;;G01N21/82;;G01N21/78;;G01N33/52;;G01N33/6827;;G01N31/22;;G01N21/272;;G01N21/78;;G01N21/82;;G01N33/52;;G01N31/22;;G01N33/6827;;G01N31/22;;G01N21/272;;G01N1/30;;G01N21/82;;H04N23/73;;G01N21/78;;G01N33/52;;G01N33/6827;;G06T7/0012;;G06T2207/10144;;G06T2207/30242,G01N33/52;;G01N1/28;;G01N1/30;;G01N21/27;;G01N33/68,,0,0,,,,PENDING
184,DE,D1,DE 69223932 D1,194-325-592-493-33X,1998-02-12,1998,DE 69223932 T,1992-06-25,US 72285291 A;;US 9205256 W,1991-06-28,KAPSELEXTRUSIONSSYSTEME,"Methods for producing cell capsules are disclosed in which a coagulant (22), which can include a cell suspension or other biologically active factor, and a polymeric casting solution (26) are extruded through a common extrusion port (14) having at least two concentric bores, such that the coagulant is extruded through the inner bore (16) and the polymeric casting solution is extruded through the outer bore (18). The method involves initiating extrusion of the coagulant within a temporal range of about 10 msecs to about one second from initiating delivery of the casting solution through the respective bores. Delivery of the coagulant is then shut off, and extrusion of the casting solution is terminated either immediately or after some predetermined time.",UNIV BROWN RES FOUND,AEBISCHER PATRICK;;MILLS JOHN;;WAHLBERG LARS;;DOHERTY EDWARD;;TRESCO PATRICK A,,https://lens.org/194-325-592-493-33X,Granted Patent,no,0,0,19,124,0,A61J3/07;;A61K9/0024;;A61K9/5089;;B01J13/02;;B01J13/04;;C12N5/0012;;C12N5/0614;;C12N11/04;;C12N2533/30;;A61J3/00,B01J13/14;;A61J/;;A61J3/06;;A61J3/07;;A61K9/00;;A61K9/50;;B01J13/02;;B01J13/04;;C12M1/00;;C12N5/00;;C12N5/02;;C12N5/071;;C12N11/04,,0,0,,,,EXPIRED
185,US,B1,US 6433574 B1,094-762-048-175-215,2002-08-13,2002,US 67507200 A,2000-09-28,US 67507200 A;;US 24437399 A;;US 7569198 A,1998-05-11,Interconnect and system for testing bumped semiconductor components with on-board multiplex circuitry for expanding tester resources,"
    An interconnect, a test system, and a test method for testing bumped semiconductor components, such as dice and packages, contained on substrates, such as wafers or panels, are provided. The test system includes the interconnect, a tester for generating test signals, and a wafer prober for placing the components and interconnect in physical contact. The interconnect includes interconnect contacts, such as conductive pockets, for electrically engaging bumped component contacts on the components. The interconnect also includes an on board multiplex circuit adapted to fan out and selectively transmit test signals from the tester to the interconnect contacts. The multiplex circuit expands tester resources by allowing test signals to be written to multiple components in parallel. Reading of the test signals from the components can be performed in groups up to the limit of the tester resources. In addition to expanding tester resources, the multiplex circuit maintains the individuality of each component, and permits defective components to be electrically disconnected. 
",MICRON TECHNOLOGY INC,DOHERTY C PATRICK;;DEVARONA JORGE L;;AKRAM SALMAN,,https://lens.org/094-762-048-175-215,Granted Patent,yes,62,30,3,10,0,G01R1/07385;;G01R1/07385;;G01R1/07314;;G01R1/07314;;G01R31/2831;;G01R31/2831,G01R1/073;;G01R31/28,324/765;;324/754;;324/158.1,1,0,,,"U.S. application No. 09/420,256, Doherty et al.",EXPIRED
186,EP,A1,EP 3360800 A1,164-939-446-808-899,2018-08-15,2018,EP 18162492 A,2013-07-29,US 201213604787 A;;EP 13745772 A;;US 2013/0052445 W,2012-09-06,"STABILIZED AGGREGATES AND OTHER MATERIALS AND STRUCTURES FOR PURPOSES INCLUDING, BUT NOT LIMITED TO, ENERGY ABSORPTION","Described are materials (14) and structures (10) for absorbing energy. The materials (14) and structures (10) are well suited for arresting aircraft and other vehicles, although their purposes need not be so limited. Also detailed are packaging and other solutions for maintaining system integrity, especially (but not exclusively) when foam glass or other aggregate is employed.",ENG ARRESTING SYS CORP,VALENTINI SYLVIA C;;LI YOUHONG;;DOHERTY SHAWN PATRICK,RUNWAY SAFE IPR AB (2020-05-13),https://lens.org/164-939-446-808-899,Patent Application,yes,6,0,32,32,0,B64F1/025;;E01C9/007;;E01C9/007;;B64F1/025;;E01C9/007;;E01C11/165;;B64F1/025,B64F1/02;;E01C9/00,,0,0,,,,ACTIVE
187,GB,A,GB 2281911 A,199-258-976-846-098,1995-03-22,1995,GB 9418478 A,1994-09-14,US 12318193 A,1993-09-15,Bioconversion products of 27-hydroxy avermectin,"Both isomers of 27-hydroxy avermectin aglycones represented by compound (I> <IMAGE> wherein the broken line at the 22, 23-position indicates a single or double bond, R1 is present only when the broken line is a single bond, R1 is hydrogen, and the wavy line at the 27-position represents the A and B isomers, are produced by cultivating a strain of the microorganism S. erythrea in a nutrient medium containing assimilable sources of nitrogen and carbon and an avermectin aglycone substrate under aerobic conditions until a substantial amount of compound (I) is produced and isolating the compound (I) so produced. Compound (I) may be converted to other avermectin derivatives, e.g. <IMAGE> The compounds and the intermediates used to make them are highly potent antiparasitic, insecticidal and anthelmintic avermectin agents.",MERCK & CO INC,ARISON BYRON H;;DOHERTY PATRICK J;;SCHULMAN MARVIN D,,https://lens.org/199-258-976-846-098,Patent Application,no,2,0,3,3,0,A01N43/90;;A01N43/90;;C07D493/22;;C07D493/22;;C07H19/01;;C07H19/01;;C12P17/181;;C12P17/181,A01N43/90;;C07D493/22;;C07H19/01;;C12P17/18,C2C CAA;;C2C CTU;;C2C CVA;;C2C C1485;;C2C C1671;;C2C C1672;;C2C C211;;C2C C213;;C2C C214;;C2C C215;;C2C C247;;C2C C25Y;;C2C C253;;C2C C28X;;C2C C30Y;;C2C C306;;C2C C351;;C2C C352;;C2C C36Y;;C2C C360;;C2C C361;;C2C C362;;C2C C363;;C2C C364;;C2C C388;;C2C C625;;C2C C643;;C2C C644;;C2C C652;;C2C C672;;C2C C761;;C2C C767;;C2C C80Y;;C2C C801;;U1S S1308;;U1S S1312,1,0,,,J. Antibiot. (1994) 47(3) 372-5 and Chemical Abstracts 121: 103765,DISCONTINUED
188,CN,A,CN 117178556 A,009-013-127-224-58X,2023-12-05,2023,CN 202280027593 A,2022-03-09,US 202163161767 P;;US 2022/0019554 W,2021-03-16,Method for enabling user-defined content-aware operations,"A method performed by a viewing device includes receiving a request for an operation to be performed by the viewing device. The request includes trigger criteria for performing the operation. The viewing device receives content including content-related metadata from a content provider. A condition is detected that has met the triggering criteria for the operation to be performed. Thereby, the viewing device performs the requested operation. The detection is done by the viewing device or by a service provider.",INTERDIGITAL PATENT HOLDINGS INC,SEED DALE;;DOHERTY PATRICK;;KIM SANG-HOON;;LIU LU,,https://lens.org/009-013-127-224-58X,Patent Application,no,0,0,4,4,0,H04N21/44008;;H04N21/23418;;H04N21/258;;H04N21/47208;;H04N21/44008;;H04N21/23418;;H04N21/2393;;H04N21/42204;;H04N21/8126,H04N21/234,,0,0,,,,PENDING
189,AU,A,AU 1992/018563 A,043-608-208-805-277,1993-01-07,1993,AU 1992/018563 A,1992-06-24,US 72174491 A,1991-06-26,A PROCESS FOR THE GLYCOSYLATION OF AVERMECTIN COMPOUNDS,,"MERCK & CO., INC.",BYRON H. ARISON;;PATRICK J. DOHERTY;;MARVIN D. SCHULMAN,,https://lens.org/043-608-208-805-277,Patent Application,no,0,0,9,9,0,A61K31/70;;A61K31/70;;A01N43/90;;A01N43/90;;A61P33/00;;A61P33/02;;C07H19/01;;C07H19/01;;C12P19/60;;C12P19/60,A01N63/00;;A01N43/90;;A61K31/70;;A61K31/7042;;A61K31/7048;;A61P33/00;;A61P33/02;;C07H17/08;;C07H19/01;;C12P19/60;;C12P19/62;;C12R1/01;;C12R1/645,,0,0,,,,EXPIRED
190,EP,A1,EP 3737947 A1,079-503-602-032-079,2020-11-18,2020,EP 19706049 A,2019-01-09,US 201862615242 P;;US 2019/0012890 W,2018-01-09,METHODS FOR MEASURING ANALYTE AND/OR PROTEIN IN BIOLOGICAL SAMPLES,,IDEXX LAB INC,DOHERTY PATRICK;;KIRSPEL KEVIN;;FARACE GIOSI;;YERRAMILLI MURTHY VSN,,https://lens.org/079-503-602-032-079,Patent Application,yes,0,5,14,14,0,G01N21/272;;G01N21/82;;G01N21/78;;G01N33/52;;G01N33/6827;;G01N31/22;;G01N21/272;;G01N21/78;;G01N21/82;;G01N33/52;;G01N31/22;;G01N33/6827;;G01N31/22;;G01N21/272;;G01N1/30;;G01N21/82;;H04N23/73;;G01N21/78;;G01N33/52;;G01N33/6827;;G06T7/0012;;G06T2207/10144;;G06T2207/30242,G01N33/52;;G01N1/28;;G01N1/30;;G01N21/27;;G01N33/68,,0,0,,,,PENDING
191,DE,D1,DE 69332461 D1,105-185-468-699-103,2002-12-12,2002,DE 69332461 T,1993-04-26,US 87966992 A,1992-05-06,Anrufnachrichtenaufzeichnung für Fernsprechsysteme,,AT & T CORP,DOHERTY GERARD PATRICK;;LANZILLOTTI NICHOLAS JOHN;;PAULUS CONRAD JOSEPH,,https://lens.org/105-185-468-699-103,Granted Patent,no,0,0,11,11,0,H04M15/00;;H04M15/00;;H04Q3/0016;;H04Q3/0016,H04M3/00;;H04M15/00;;H04M15/16;;H04Q3/00,,0,0,,,,EXPIRED
192,EP,A1,EP 0475518 A1,159-215-255-124-975,1992-03-18,1992,EP 91202271 A,1991-09-05,US 58097290 A,1990-09-12,28-Hydroxy ivermectin aglycone.,"Fermentation of  S .  erythraea  produces the novel avermectin, 28-hydroxy ivermectin aglycone.",MERCK & CO INC,ARISON BYRON H;;DOHERTY PATRICK J;;SCHULMAN MARVIN D,,https://lens.org/159-215-255-124-975,Patent Application,yes,1,3,9,9,0,A61P33/00;;A61P33/10;;C07D493/22;;C07D493/22;;C12P17/08;;C12P17/08,A01N43/90;;A61K31/35;;A61P33/00;;A61P33/10;;C07D493/22;;C12N1/38;;C12P17/08;;C12P17/18;;C12R1/645,,3,1,084-445-491-172-658,10.3987/com-87-4337,"CHEMICAL ABSTRACTS, vol. 109, no. 17, October 24, 1988, Columbus, Ohio, USA JUNG, M.E. et al. ""Synthetic approach to the ivermectin bottom half using internal cycloadducts of N-furfuryl acrylamides: functionality and optical activity."" page 695, column 1, abstract-no. 149 139d;;CHEMICAL ABSTRACTS, vol. 97, no. 19, November 8, 1982, Columbus, Ohio, USA MROZIK, H. et al. ""Partial syntheses of aver- mection B1a and ivermectin from avermection B2a."" page 684, column 1, abstract-no. 162 650s;;CHEMICAL ABSTRACTS, vol. 93, no. 17, October 27, 1980, Columbus, Ohio, USA CHABALA, J.C. et al. ""Ivermectin, a new broad- -spectrum antiparasitic agent."" page 22, column 1, abstract-no. 160 951j",DISCONTINUED
193,CA,A1,CA 2071574 A1,186-150-276-130-201,1992-12-27,1992,CA 2071574 A,1992-06-18,US 72174491 A,1991-06-26,PROCESS FOR THE GLYCOSYLATION OF AVERMECTIN COMPOUNDS,"102/DLR52 18437 TITLE OF THE INVENTION A PROCESS FOR THE GLYCOSYLATION OF AVERMECTIN COMPOUNDS Avermectin compounds are glycosylated the 4' and 4""-positions by adding the avermectin compounds to the fermentation medium of Saccharapolyspora erythera. The outer oleandrose sugar group of the avermectin compound is glycosylated with a glycosyl moiety, specifically a glucose group. In addition, other changes are effected in the avermectin moiety such as selective hydroxylation, epimerization at the 2-carbon and migration of the .DELTA. 3-double bond to a .DELTA. 2-position.",MERCK & CO INC,ARISON BYRON H;;DOHERTY PATRICK J;;SCHULMAN MARVIN D,,https://lens.org/186-150-276-130-201,Patent Application,no,0,0,9,9,0,A61K31/70;;A61K31/70;;A01N43/90;;A01N43/90;;A61P33/00;;A61P33/02;;C07H19/01;;C07H19/01;;C12P19/60;;C12P19/60,A01N63/00;;A01N43/90;;A61K31/70;;A61K31/7042;;A61K31/7048;;A61P33/00;;A61P33/02;;C07H17/08;;C07H19/01;;C12P19/60;;C12P19/62;;C12R1/01;;C12R1/645,,0,0,,,,DISCONTINUED
194,CA,C,CA 2092590 C,012-677-103-732-192,1996-07-09,1996,CA 2092590 A,1993-03-26,US 87966992 A,1992-05-06,CALL MESSAGE RECORDING FOR TELEPHONE SYSTEMS,"The EMI message record generated for interexchange telephone toll calls is enhanced via the addition of a primary interexchange carrier (PIC) indicator, whose value provides an indication as to whether a terminating subscriber has a particular interexchange carrier as his/her PIC. The PIC indicator may be used by the interexchange carrier when bills are rendered for its subscribers--for example, to provide different billing treatment for calls that were made over that carrier'snetwork to terminating subscribers whose PIC is, in fact, that very carrier, as opposed to calls that were made to subscribers with a different PIC.",AMERICAN TELEPHONE & TELEGRAPH,DOHERTY GERARD PATRICK;;LANZILLOTTI NICHOLAS JOHN;;PAULUS CONRAD JOSEPH,,https://lens.org/012-677-103-732-192,Granted Patent,no,0,0,11,11,0,H04M15/00;;H04M15/00;;H04Q3/0016;;H04Q3/0016,H04M3/00;;H04M15/00;;H04M15/16;;H04Q3/00,,0,0,,,,EXPIRED
195,AU,B2,AU 642295 B2,024-686-695-206-486,1993-10-14,1993,AU 1991/083833 A,1991-09-11,US 58097290 A,1990-09-12,28-hydroxy ivermectin aglycone,,MERCK & CO INC,ARISON BYRON H;;DOHERTY PATRICK J;;SCHULMAN MARVIN D,,https://lens.org/024-686-695-206-486,Granted Patent,no,2,0,9,9,0,A61P33/00;;A61P33/10;;C07D493/22;;C07D493/22;;C12P17/08;;C12P17/08,A01N43/90;;A61K31/35;;A61P33/00;;A61P33/10;;C07D493/22;;C12N1/38;;C12P17/08;;C12P17/18;;C12R1/645,,0,0,,,,EXPIRED
196,EP,A1,EP 0520557 A1,026-310-674-069-467,1992-12-30,1992,EP 92201785 A,1992-06-18,US 72174491 A,1991-06-26,A process for the glycosylation of avermectin compounds.,"Avermectin compounds are glycosylated the 4' and 4''-positions by adding the avermectin compounds to the fermentation medium of  Saccharopolyspora   erythrea . The outer oleandrose sugar group of the avermectin compound is glycosylated with a glycosyl moiety, specifically a glucose group. In addition, other changes are effected in the avermectin moiety such as selective hydroxylation, epimerization at the 2-carbon and migration of the Δ 3-double bond to a Δ 2-position.",MERCK & CO INC,ARISON BYRON H;;DOHERTY PATRICK J;;SCHULMAN MARVIN D,,https://lens.org/026-310-674-069-467,Patent Application,yes,3,2,9,9,0,A61K31/70;;A61K31/70;;A01N43/90;;A01N43/90;;A61P33/00;;A61P33/02;;C07H19/01;;C07H19/01;;C12P19/60;;C12P19/60,A01N63/00;;A01N43/90;;A61K31/70;;A61K31/7042;;A61K31/7048;;A61P33/00;;A61P33/02;;C07H17/08;;C07H19/01;;C12P19/60;;C12P19/62;;C12R1/01;;C12R1/645,,0,0,,,,DISCONTINUED
197,US,A1,US 2009/0134324 A1,142-229-407-659-478,2009-05-28,2009,US 36452709 A,2009-02-03,US 36452709 A,2009-02-03,Partitions for Forming Separate Vacuum-Chambers,A mass spectrometry system comprises a panel movable between an open and closed position relative to a housing. At least part of ion-optics is mounted to the panel. The housing surrounds ion-optics and a partition forms a gas barrier separating vacuum-chambers within the housing when the panel is in the closed position. The gas barrier formed by the partition is broken when the panel moves to the open position.,AGILENT TECHNOLOGIES INC,KING DOUGLAS J;;DOHERTY THOMAS PATRICK;;KERNAN JEFFREY THOMAS,AGILENT TECHNOLOGIES INC (2009-01-30),https://lens.org/142-229-407-659-478,Patent Application,yes,7,4,6,6,0,H01J49/06;;H01J49/24;;H01J49/06;;H01J49/24,H01J49/00;;B01D59/44,250/282;;250/281,0,0,,,,DISCONTINUED
198,AU,A,AU 1991/083833 A,021-664-397-513-916,1992-03-19,1992,AU 1991/083833 A,1991-09-11,US 58097290 A,1990-09-12,28-HYDROXY IVERMECTIN AGLYCONE,,MERCK & CO INC,ARISON BYRON H;;DOHERTY PATRICK J;;SCHULMAN MARVIN D,,https://lens.org/021-664-397-513-916,Patent Application,no,0,0,9,9,0,A61P33/00;;A61P33/10;;C07D493/22;;C07D493/22;;C12P17/08;;C12P17/08,A01N43/90;;A61K31/35;;A61P33/00;;A61P33/10;;C07D493/22;;C12N1/38;;C12P17/08;;C12P17/18;;C12R1/645,,0,0,,,,EXPIRED
199,CN,A,CN 101794701 A,087-694-919-994-545,2010-08-04,2010,CN 201010110541 A,2010-02-03,US 36452709 A,2009-02-03,Partitions for forming separate vacuum-chambers,The present invention relates to partitions for forming separate vacuum-chambers and provides a mass spectrometry system comprising a panel movable between an open position and a closed position relative to a housing. At least part of ion-optics is mounted to the panel. The housing surrounds ion-optics and a partition forms a gas barrier separating vacuum-chambers within the housing when the panel is in the closed position. The gas barrier formed by the partition is broken when the panel moves to the open position.,AGILENT TECHNOLOGIES INC,KING DOUGLAS J;;PATRICK DOHERTY THOMAS;;THOMAS KERNAN JEFFREY,,https://lens.org/087-694-919-994-545,Patent Application,no,4,1,6,6,0,H01J49/06;;H01J49/24;;H01J49/06;;H01J49/24,H01J49/26;;H01J49/02,,0,0,,,,ACTIVE
200,US,B2,US 6677776 B2,140-189-277-574-030,2004-01-13,2004,US 22382602 A,2002-08-20,US 22382602 A;;US 99950201 A;;US 67507200 A;;US 24437399 A;;US 7569198 A,1998-05-11,Method and system having switching network for testing semiconductor components on a substrate,"
    A system for testing semiconductor components contained on a substrate, such as a wafer, a panel, a leadframe or a module, includes an interconnect configured to electrically engage all of the components on the substrate at the same time. The interconnect includes a switching network configured to selectively apply test signals to selected components, to electrically isolate defective components and to transmit test signals from selected groups of components. The system also includes a test apparatus, such as a wafer prober or a carrier for handling the substrate. A method for testing includes the steps of providing the interconnect having the switching network, and controlling test signals to the components using the switching network to perform various test procedures, such as functionality tests, parametric tests and burn-in tests. 
",MICRON TECHNOLOGY INC,DOHERTY C PATRICK;;AKRAM SALMAN;;DE VARONA JORGE L,MICRON TECHNOLOGY INC (2002-08-06),https://lens.org/140-189-277-574-030,Granted Patent,yes,67,27,4,10,0,G01R1/07385;;G01R1/07385;;G01R1/07314;;G01R1/07314;;G01R31/2831;;G01R31/2831;;H01L24/97;;H01L24/97;;H01L2224/48091;;H01L2224/48091;;H01L2224/48227;;H01L2224/48227;;H01L2224/4824;;H01L2224/4824;;H01L2224/73215;;H01L2224/73215;;H01L2224/73265;;H01L2224/73265;;H01L2224/97;;H01L2224/97;;H01L2924/01005;;H01L2924/01005;;H01L2924/01006;;H01L2924/01006;;H01L2924/01013;;H01L2924/01013;;H01L2924/01029;;H01L2924/01029;;H01L2924/01033;;H01L2924/01033;;H01L2924/01039;;H01L2924/01039;;H01L2924/01042;;H01L2924/01042;;H01L2924/01046;;H01L2924/01046;;H01L2924/01047;;H01L2924/01047;;H01L2924/01073;;H01L2924/01073;;H01L2924/01074;;H01L2924/01074;;H01L2924/01077;;H01L2924/01077;;H01L2924/01078;;H01L2924/01078;;H01L2924/01079;;H01L2924/01079;;H01L2924/01087;;H01L2924/01087;;H01L2924/14;;H01L2924/14,G01R1/073;;G01R31/28,324/765;;324/158.1,0,0,,,,EXPIRED
201,US,A,US 5192671 A,012-349-764-880-528,1993-03-09,1993,US 72174491 A,1991-06-26,US 72174491 A,1991-06-26,PROCESS FOR THE GLYCOSYLATION OF AVERMECTIN COMPOUNDS,"Avermectin compounds are glycosylated the 4' and 4""-positions by adding the avermectin compounds to the fermentation medium of Saccharapolyspora erythrea. The outer oleandrose sugar group of the avermectin compound is glycosylated with a glycosyl moiety, specifically a glucose group. In addition, other changes are effected in the avermectin moiety such as selective hydroxylation, epimerization at the 2-carbon and migration of the .DELTA. 3-double bond to a .DELTA. 2-position.",MERCK & CO INC,ARISON BYRON H;;SCHULMAN MARVIN D;;DOHERTY PATRICK J,MERCK & CO. INC (1991-06-26),https://lens.org/012-349-764-880-528,Granted Patent,yes,8,8,9,9,0,A61K31/70;;A61K31/70;;A01N43/90;;A01N43/90;;A61P33/00;;A61P33/02;;C07H19/01;;C07H19/01;;C12P19/60;;C12P19/60,A01N63/00;;A01N43/90;;A61K31/70;;A61K31/7042;;A61K31/7048;;A61P33/00;;A61P33/02;;C07H17/08;;C07H19/01;;C12P19/60;;C12P19/62;;C12R1/01;;C12R1/645,435/101;;435/46;;435/100;;536/7.1,13,5,043-667-682-923-422;;052-797-150-381-88X;;069-278-131-055-897;;028-500-507-577-624;;050-964-668-074-377,10.1007/978-3-642-67724-3_7;;10.7164/antibiotics.31.63;;627524;;10.1016/0076-6879(75)43109-3;;1134368;;10.1021/ja00404a041;;10.7164/antibiotics.39.541;;3086265,"Corcoran, (1981) Antibiotics, vol. 4, pp. 132 174.;;Metzler, (1977) Biochemistry, Chapter 10, pp. 615 623.;;Mathews et al. (1990) Biochemistry, Chapter 15, pp. 532 533.;;Styren (1975) Biochemistry, 3rd Ed., pp. 339 341.;;Goldstein et al. (1978) Antibiotics, vol. 31(1), pp. 63 69.;;Metzler (1977) Biochemistry, Chapter 11 and 12, pp. 659 698.;;Corcoran et al Methods in Enzymology 43. pp. 487 498 (1975).;;Int. J. Syst. Bacteriol. 37 pp. 19 22 (1987).;;Int. J. Syst. Bacteriol. 30 p. 380 (1980).;;Arch. Microbiol. 31 p. 353 (1958).;;Wang et al. Biological Abstracts, vol. 83(2), Jan. 15, 1987, 10142.;;Springer et al., J. Am. Chem. Soc., vol. 103(14), Jul. 15, 1981, pp. 4221 4224.;;Schulman et al., J. Antibiotics, vol. 39(4), Apr. 1986, pp. 541 549.",EXPIRED
202,EP,A3,EP 0569175 A3,050-484-760-200-150,1997-10-22,1997,EP 93303228 A,1993-04-26,US 87966992 A,1992-05-06,CALL MESSAGE RECORDING FOR TELEPHONE SYSTEMS,"The EMI message record generated for interexchange telephone toll calls is enhanced via the addition of a primary interexchange carrier (PIC) indicator, whose value provides an indication as to whether a terminating subscriber has a particular interexchange carrier as his/her PIC. The PIC indicator may be used by the interexchange carrier when bills are rendered for its subscribers--for example, to provide different billing treatment for calls that were made over that carrier's network to terminating subscribers whose PIC is, in fact, that very carrier, as opposed to calls that were made to subscribers with a different PIC.",AMERICAN TELEPHONE & TELEGRAPH,DOHERTY GERARD PATRICK;;LANZILLOTTI NICHOLAS JOHN;;PAULUS CONRAD JOSEPH,AT&T CORP. (1994-06-22),https://lens.org/050-484-760-200-150,Search Report,yes,3,0,11,11,0,H04M15/00;;H04M15/00;;H04Q3/0016;;H04Q3/0016,H04M3/00;;H04M15/00;;H04M15/16;;H04Q3/00,,2,1,017-549-072-838-271,10.1109/icc.1991.162505,"B.H.HORNBACH ET AL.: ""The 5ESS International Gateway Exchange: A unique Introduction in the International Network"", ICC '91: INTERNATIONAL CONFERENCE ON COMMUNICATIONS, vol. 2/3, 23 June 1991 (1991-06-23) - 26 June 1991 (1991-06-26), DENVER USA, pages 993 - 1001, XP000269634;;R.L. AVEYARD ET AL.: ""New Billing Systems Development"", NOMS 90. IEEE 1990 NETWORK OPERATIONS & MANAGEMENT SYMPOSIUM, 11 February 1990 (1990-02-11) - 14 February 1990 (1990-02-14), SAN DIEGO, CA, USA, pages 17.2-1 - 17.2-10, XP000534180",EXPIRED
203,US,A,US 5124258 A,080-311-313-625-272,1992-06-23,1992,US 58099990 A,1990-09-12,US 58099990 A,1990-09-12,Fermentation process for the preparation of ivermectin aglycone,"Fermentation of S. erythraea produces the novel avermectin, 28-hydroxy ivermectin aglycone.",MERCK & CO INC,ARISON BYRON H;;DOHERTY PATRICK J;;SCHULMAN MARVIN D,MERCK & CO. INC. A CORP. OF NEW JERSEY (1990-09-10),https://lens.org/080-311-313-625-272,Granted Patent,yes,2,5,1,1,0,C07D493/10;;C07H19/01;;C12P17/181;;Y10S435/822;;C07D493/10;;C07H19/01;;C12P17/181;;Y10S435/822,C07D493/10;;C07H19/01;;C12P17/18,435/119;;435/75;;435/76;;435/118;;435/822,1,0,,,Biotech Abs 90 00736 (ACSRAL) Pap. Am Chem Soc (1989) 198 Meeting Abs. MBTD 134 (Abs) Paulus et al.,EXPIRED
204,AU,A1,AU 2019/207642 A1,115-499-367-167-794,2020-07-02,2020,AU 2019/207642 A,2019-01-09,US 201862615242 P;;US 2019/0012890 W,2018-01-09,Methods for measuring analyte and/or protein in biological samples,"The disclosure directed to methods for measuring an analyte alone or in combination with total protein in biological samples. More particularly, the disclosure relates to methods for measuring an analyte and/or total protein using one or more colorimetric reagents alone or in combination with protein precipitation reagents.",IDEXX LAB INC,DOHERTY PATRICK;;KIRSPEL KEVIN;;FARACE GIOSI;;YERRAMILLI MURTHY VSN,,https://lens.org/115-499-367-167-794,Patent Application,no,0,0,14,14,0,G01N21/272;;G01N21/82;;G01N21/78;;G01N33/52;;G01N33/6827;;G01N31/22;;G01N21/272;;G01N21/78;;G01N21/82;;G01N33/52;;G01N31/22;;G01N33/6827;;G01N31/22;;G01N21/272;;G01N1/30;;G01N21/82;;H04N23/73;;G01N21/78;;G01N33/52;;G01N33/6827;;G06T7/0012;;G06T2207/10144;;G06T2207/30242,G01N33/52;;G01N1/28;;G01N1/30;;G01N21/27;;G01N33/68,,0,0,,,,PENDING
205,AU,B2,AU 657546 B2,019-685-581-251-03X,1995-03-16,1995,AU 1992/018563 A,1992-06-24,US 72174491 A,1991-06-26,A process for the glycosylation of avermectin compounds,,MERCK & CO INC,ARISON BYRON H;;DOHERTY PATRICK J;;SCHULMAN MARVIN D,,https://lens.org/019-685-581-251-03X,Granted Patent,no,1,0,9,9,0,A61K31/70;;A61K31/70;;A01N43/90;;A01N43/90;;A61P33/00;;A61P33/02;;C07H19/01;;C07H19/01;;C12P19/60;;C12P19/60,A01N63/00;;A01N43/90;;A61K31/70;;A61K31/7042;;A61K31/7048;;A61P33/00;;A61P33/02;;C07H17/08;;C07H19/01;;C12P19/60;;C12P19/62;;C12R1/01;;C12R1/645,,0,0,,,,EXPIRED
206,JP,A,JP 2010182670 A,061-785-122-139-090,2010-08-19,2010,JP 2010005612 A,2010-01-14,US 36452709 A,2009-02-03,PARTITION FOR FORMING SEPARATE VACUUM CHAMBER,"<P>PROBLEM TO BE SOLVED: To provide a quick and convenient access to components of a mass spectrometer passing through a plurality of vacuum chambers. <P>SOLUTION: A mass spectrometry system 210 includes a panel 209 movable between an open position and a closed position relative to a housing 211. At least part of ion optical system 203 is mounted to the panel 209. The housing 211 surrounds the ion optical system 203 and a partition 215 forms a gas barrier separating vacuum chambers 221, 223 within the housing 211 when the panel 209 is in the closed position. The gas barrier formed by the partition 215 is broken when the panel 209 moves to the open position. <P>COPYRIGHT: (C)2010,JPO&INPIT",AGILENT TECHNOLOGIES INC,KING DOUGLAS J;;DOHERTY THOMAS PATRICK;;KERNAN JEFFREY THOMAS,,https://lens.org/061-785-122-139-090,Patent Application,no,2,0,6,6,0,H01J49/06;;H01J49/24;;H01J49/06;;H01J49/24,H01J49/42;;G01N27/62,,0,0,,,,ACTIVE
207,CA,A1,CA 2050721 A1,008-162-248-935-567,1992-03-13,1992,CA 2050721 A,1991-09-05,US 58097290 A,1990-09-12,28-HYDROXY IVERMECTIN AGLYCONE,"9588P/5921A 18087 TITLE OF THE INVENTION 28-HYDROXY IVERMECTIN AGLYCONE Fermentation of S. erythraea produces the novel avermectin, 28-hydroxy ivermectin aglycone.",MERCK & CO INC,ARISON BYRON H;;DOHERTY PATRICK J;;SCHULMAN MARVIN D,,https://lens.org/008-162-248-935-567,Patent Application,no,0,0,9,9,0,A61P33/00;;A61P33/10;;C07D493/22;;C07D493/22;;C12P17/08;;C12P17/08,A01N43/90;;A61K31/35;;A61P33/00;;A61P33/10;;C07D493/22;;C12N1/38;;C12P17/08;;C12P17/18;;C12R1/645,,0,0,,,,DISCONTINUED
208,US,A,US 5478929 A,076-789-594-305-483,1995-12-26,1995,US 24717394 A,1994-05-20,US 24717394 A;;US 12318193 A,1993-09-15,Bioconversion products of 27-hydroxy avermectin,"There are disclosed novel compounds which are derived from 22,23-dihydro avermectin B1 aglycone. The compounds are both isomers of the 27-hydroxy adduct of the substrate avermectin compound that have been glycosylated at the 4"" position to yield 4""-O-glucosyl 27-OH avermectin compounds. The compounds and the intermediates used to make them are highly potent antiparasitic, insecticidal and anthelmintic avermectin agents.",MERCK & CO INC,ARISON BYRON H;;DOHERTY PATRICK J;;SCHULMAN MARVIN D,MERCK SHARP & DOHME CORP (2012-04-26),https://lens.org/076-789-594-305-483,Granted Patent,yes,13,0,3,3,0,A01N43/90;;A01N43/90;;C07D493/22;;C07D493/22;;C07H19/01;;C07H19/01;;C12P17/181;;C12P17/181,A01N43/90;;C07D493/22;;C07H19/01;;C12P17/18,536/7.1;;536/4.1;;435/76;;435/105;;435/119,4,3,010-040-719-786-26X;;008-512-718-541-712;;028-141-328-614-467,10.1021/jm00184a014;;6893469;;10.1021/jo00342a023;;8344863;;10.7164/antibiotics.46.1016,"J. C. Chabala, et al., J. Med. Chem., 1980, 23 pp. 1134 1136.;;H. Mrozik, et al., J. Med. Chem., 1982, 47, pp. 489 492.;;B. H. Arison et al., J. Antibiotics, 46, No. 6, pp. 1016 1019 (1993).;;Chemical Abstracts, 121, AB No. 103765.",EXPIRED
209,US,A1,US 2016/0292149 A1,168-221-391-882-129,2016-10-06,2016,US 201414450233 A,2014-08-02,US 201414450233 A,2014-08-02,WORD SENSE DISAMBIGUATION USING HYPERNYMS,"Methods and apparatus related to word sense disambiguation utilizing hypernyms. In some implementations, one or more senses of a word are determined based on hypernyms for the word and an association of the word to the one or more senses is stored. In some implementations, a target word in a textual segment is identified and a word sense to assign to the target word is determined based on hypernyms that are associated with the target word.",GOOGLE INC,MOTE NICOLAUS TODD;;DOHERTY RYAN PATRICK;;EVANS COLIN HEARNE,GOOGLE LLC (2014-08-01),https://lens.org/168-221-391-882-129,Patent Application,yes,0,19,1,1,0,G06F16/3344;;G06F40/30;;G06F16/3344;;G06F40/242;;G06F40/242;;G06F40/30,G06F17/27,,0,0,,,,DISCONTINUED
210,EP,A1,EP 3017457 A1,144-298-757-199-397,2016-05-11,2016,EP 14739098 A,2014-07-03,GB 201312075 A;;EP 2014064198 W,2013-07-05,METHOD AND SYSTEM FOR MODIFYING A SUBSTRATE USING A PLASMA,,INNOVATION ULSTER LTD,BYRNE CORMAC PATRICK;;MEENAN BRIAN JOSEPH;;DOHERTY KYLE GEORGE,,https://lens.org/144-298-757-199-397,Patent Application,yes,2,0,4,4,0,H01J37/32348;;H01J37/32366;;H01J37/32449;;H01J37/32541;;H01J37/32568;;H01J37/32752;;H01J37/32825;;B05D3/141;;H01J37/32568;;H01J37/32366;;H01J37/32541;;H01J37/32752;;H01J37/32348;;H01J37/32825;;H01J37/32449;;B05D3/141;;H01J37/32715;;H01J2237/3321;;H01J2237/3341;;H01J2237/336;;H01J2237/3382,H01J37/32;;C23C16/04;;C23C16/54;;H05H1/24,,1,0,,,See also references of WO 2015001025A1,DISCONTINUED
211,EP,B1,EP 0569175 B1,182-570-481-204-201,2002-11-06,2002,EP 93303228 A,1993-04-26,US 87966992 A,1992-05-06,Call message recording for telephone systems,,AT & T CORP,DOHERTY GERARD PATRICK;;LANZILLOTTI NICHOLAS JOHN;;PAULUS CONRAD JOSEPH,AT&T CORP. (1994-06-22),https://lens.org/182-570-481-204-201,Granted Patent,yes,3,0,11,11,0,H04M15/00;;H04M15/00;;H04Q3/0016;;H04Q3/0016,H04M3/00;;H04M15/00;;H04M15/16;;H04Q3/00,,2,0,,,"ICC '91: INTERNATIONAL CONFERENCE ON COMMUNICATIONS, vol. 2/3, 23 - 26 June 1991, DENVER USA, pages 993-1001, XP000269634 B.H.HORNBACH ET AL.: ""The 5ESS International Gateway Exchange: A unique Introduction in the International Network"";;NOMS 90. IEEE 1990 NETWORK OPERATIONS & MANAGEMENT SYMPOSIUM, 11 - 14 February 1990, SAN DIEGO, CA, USA, pages 17.2-1-17.2-10, XP000534180 R.L. AVEYARD ET AL.: ""New Billing Systems Development""",EXPIRED
212,MX,A,MX 2020006728 A,016-783-598-252-602,2020-08-24,2020,MX 2020006728 A,2019-01-09,US 201862615242 P;;US 2019/0012890 W,2018-01-09,METHODS FOR MEASURING ANALYTE AND/OR PROTEIN IN BIOLOGICAL SAMPLES.,"The disclosure directed to methods for measuring an analyte alone or in combination with total protein in biological samples. More particularly, the disclosure relates to methods for measuring an analyte and/or total protein using one or more colorimetric reagents alone or in combination with protein precipitation reagents.",IDEXX LAB INC,VSN YERRAMILLI MURTHY;;FARACE GIOSI;;DOHERTY PATRICK;;KIRSPEL KEVIN,,https://lens.org/016-783-598-252-602,Patent Application,no,0,0,14,14,0,G01N21/272;;G01N21/82;;G01N21/78;;G01N33/52;;G01N33/6827;;G01N31/22;;G01N21/272;;G01N21/78;;G01N21/82;;G01N33/52;;G01N31/22;;G01N33/6827;;G01N31/22;;G01N21/272;;G01N1/30;;G01N21/82;;H04N23/73;;G01N21/78;;G01N33/52;;G01N33/6827;;G06T7/0012;;G06T2207/10144;;G06T2207/30242,G01N33/52;;G01N1/28;;G01N1/30;;G01N21/27;;G01N33/68,,0,0,,,,PENDING
213,US,A1,US 2019/0219589 A1,163-285-344-084-918,2019-07-18,2019,US 201916243882 A,2019-01-09,US 201916243882 A;;US 201862615242 P,2018-01-09,Methods for Measuring Analyte and/or Protein in Biological Samples,"The disclosure directed to methods for measuring an analyte alone or in combination with total protein in biological samples. More particularly, the disclosure relates to methods for measuring an analyte and/or total protein using one or more colorimetric reagents alone or in combination with protein precipitation reagents.",IDEXX LAB INC,DOHERTY PATRICK;;KIRSPEL KEVIN;;FARACE GIOSI;;YERRAMILLI MURTHY VSN,IDEXX LABORATORIES INC (2019-01-10),https://lens.org/163-285-344-084-918,Patent Application,yes,0,3,14,14,0,G01N21/272;;G01N21/82;;G01N21/78;;G01N33/52;;G01N33/6827;;G01N31/22;;G01N21/272;;G01N21/78;;G01N21/82;;G01N33/52;;G01N31/22;;G01N33/6827;;G01N31/22;;G01N21/272;;G01N1/30;;G01N21/82;;H04N23/73;;G01N21/78;;G01N33/52;;G01N33/6827;;G06T7/0012;;G06T2207/10144;;G06T2207/30242,G01N33/68;;G01N21/78;;G01N33/52;;G06T7/00;;H04N5/235,,0,0,,,,ACTIVE
214,US,A1,US 2016/0141152 A1,176-752-430-656-208,2016-05-19,2016,US 201414903041 A,2014-07-03,GB 201312075 A;;EP 2014064198 W,2013-07-05,METHOD AND SYSTEM FOR MODIFYING A SUBSTRATE USING A PLASMA,"A method and system of modifying a substrate using a plasma are described comprising providing a first electrode and a second electrode; arranging the substrate such that a portion of the substrate is between the electrodes; supplying a voltage to at least one of the electrodes so as to create a plasma discharge between the electrodes which contacts at least said portion of the substrate, moving either the substrate and/or said second electrode such that said substrate and said second electrode are being linearly displaced relative to each other along an axis of linear displacement during said movement; and wherein said second electrode is arranged relative to said axis of linear displacement such that said linear movement causes a first section of the portion of substrate to have a greater residence time between the electrodes during said linear displacement than a second section of said portion of the substrate. A method and system of modifying a substrate using a plasma is also described comprising providing a first electrode and a second electrode; arranging the substrate such that a portion of the substrate is between the electrodes; supplying a voltage to at least one of the electrodes so as to create a plasma discharge between the electrodes which contacts at least said portion of the substrate, moving either the substrate and/or said second electrode such that said substrate and said second electrode are being linearly displaced relative to each other along an axis of linear displacement during said movement; and further comprising the step of rotating either the substrate or said second electrode about an axis of rotation during said relative linear displacement along said axis, so that a first section of the portion of substrate has a greater residence time between the electrodes than a second section of said portion of substrate.",INNOVATION ULSTER LTD,BYRNE CORMAC PATRICK;;MEENAN BRIAN JOSEPH;;DOHERTY KYLE GEORGE,INNOVATION ULSTER LIMITED (2016-01-22),https://lens.org/176-752-430-656-208,Patent Application,yes,0,2,4,4,0,H01J37/32348;;H01J37/32366;;H01J37/32449;;H01J37/32541;;H01J37/32568;;H01J37/32752;;H01J37/32825;;B05D3/141;;H01J37/32568;;H01J37/32366;;H01J37/32541;;H01J37/32752;;H01J37/32348;;H01J37/32825;;H01J37/32449;;B05D3/141;;H01J37/32715;;H01J2237/3321;;H01J2237/3341;;H01J2237/336;;H01J2237/3382,H01J37/32,,0,0,,,,DISCONTINUED
215,US,B2,US 11531032 B2,035-768-045-088-922,2022-12-20,2022,US 201916243882 A,2019-01-09,US 201916243882 A;;US 201862615242 P,2018-01-09,Methods for measuring analyte and/or protein in biological samples,"The disclosure directed to methods for measuring an analyte alone or in combination with total protein in biological samples. More particularly, the disclosure relates to methods for measuring an analyte and/or total protein using one or more colorimetric reagents alone or in combination with protein precipitation reagents.",IDEXX LAB INC,DOHERTY PATRICK;;KIRSPEL KEVIN;;FARACE GIOSI;;YERRAMILLI MURTHY VSN,IDEXX LABORATORIES INC (2019-01-10),https://lens.org/035-768-045-088-922,Granted Patent,yes,17,0,14,14,0,G01N21/272;;G01N21/82;;G01N21/78;;G01N33/52;;G01N33/6827;;G01N31/22;;G01N21/272;;G01N21/78;;G01N21/82;;G01N33/52;;G01N31/22;;G01N33/6827;;G01N31/22;;G01N21/272;;G01N1/30;;G01N21/82;;H04N23/73;;G01N21/78;;G01N33/52;;G01N33/6827;;G06T7/0012;;G06T2207/10144;;G06T2207/30242,G01N33/52;;G01N1/30;;G01N21/27;;G01N21/78;;G01N21/82;;G01N31/22;;G01N33/68;;G06T7/00;;H04N5/235,,20,18,029-983-050-650-240;;101-866-000-026-526;;102-641-162-949-47X;;023-383-209-180-707;;080-458-058-216-91X;;038-105-459-354-938;;036-034-662-735-48X;;109-488-324-894-94X;;098-049-558-187-306;;072-024-178-930-570;;006-664-172-399-637;;063-132-677-477-629;;029-983-050-650-240;;084-757-878-185-19X;;007-284-776-902-901;;069-317-430-638-151;;048-803-295-946-54X;;075-502-419-943-472,10.1021/ed300567p;;pmc3767574;;21881677;;10.1039/c1lc20479c;;10.1039/c6ay01783e;;18371750;;10.1016/j.talanta.2007.07.037;;10.1117/12.2212351;;10.1002/1522-2683()22:5<801::aid-elps801>3.0.co;2-x;;10.1002/1522-2683()22:5<801::aid-elps801>3.3.co;2-o;;11332747;;pmc4614273;;10.1049/htl.2014.0059;;26609385;;10.1201/9781420054538.ch12;;10.1016/s0021-9258(18)74824-2;;10.1016/s0021-9258(19)51334-5;;6529809;;10.1248/cpb.32.4161;;pmc3354822;;23204582;;10.1021/ed300567p;;pmc5220360;;28067287;;10.1038/srep40203;;10.1016/s0021-9258(18)74784-4;;10.1016/0009-8981(76)90167-4;;1000844;;10.2215/cjn.06960909;;20089493;;pmc2827582;;10.1021/ac60289a016,"Kehoe, Eric, and R. Lee Penn. “Introducing colorimetric analysis with camera phones and digital cameras: an activity for high school or general chemistry.” Journal of Chemical Education 90.9 (2013): 1191-1195. (Year: 2013).;;Wang, ShuQi, et al. “Integration of cell phone imaging with microchip ELISA to detect ovarian cancer HE4 biomarker in urine at the point-of-care.” Lab on a Chip 11.20 (2011): 3411-3418. (Year: 2011).;;Morais, Camilo LM, et al. “Determination of serum protein content using cell phone image analysis.” Analytical Methods 8.34 (2016): 6458-6462. (Year: 2016).;;Alzweiri, Muhammed, et al. “Comparison of different water-miscible solvents for the preparation of plasma and urine samples in metabolic profiling studies.” Taianta 74.4 (2008): 1060-1065. (Year: 2008).;;Cmiel, Vratislav, et al. “Smartphone based point-of-care detector of urine albumin.” Optical Diagnostics and Sensing XVI: Toward Point-of-Care Diagnostics. vol. 9715. International Society for Optics and Photonics, 2016. (Year: 2016).;;Miura, Kenji. “Imaging and detection technologies for image analysis in electrophoresis.” Electrophoresis 22.5 (2001): 801-813. (Year: 2001).;;Velikova, Marina, et al. “Smartphone-based analysis of biochemical tests for health monitoring support at home.” Healthcare technology letters 1.3 (2014): 92-97. (Year: 2014).;;The Partial International Search Report for PCT/US2019/012890, 2 pages, dated Apr. 4, 2019.;;Battiato et al., “Exposure correction for imaging devices: an overview” Single-Sensor Imaging, Rastislav Lukac (Ed.) Ch 12 (2008).;;Benedict et al., “Some applications of a new color reaction for creatinine” J. Biol. Chem. 114:515-532 (1936).;;Bonsnes et al., “On the colorimetric determination of creatinine by the Jaffe reaction” J. Biol. Chem. 158:581-591 (1945).;;Fujita et al., “Determination of proteins by using the color reaction with pyrocatecol violet-molybdenum (vi) complex” Chem. Pharm. Bull. 32(10): 4161-4164 (1984).;;Harley et al., “Proteinuria in dogs and cats” Can. Vet. J. 53: 631-638 (2012).;;Kehoe et al., “Introducing colorimetric analysis with camera phones and digital cameras: an activity for high school or general chemistry,” J. Chem. Ed. 90(9):1191-1195 (2013).;;Kim et al., “Smartphone-based low light detection for bioluminescence application,” Scientific Reports 7(1): 40203 (2017).;;Langley et al., “The determination of creatinine with sodium 3,5-dinitrobenzoate” J. Biol. Chem. 115:333-341 (1936).;;Parekh, et al., “A new method for the determination of serum creatinine based on reaction with 3,5-dinitrobenzoyl chloride in an organic medium” Clin. Chim. Acta 73(2):221-31 (1976).;;Parikh et al., “Urine microscopy is associated with severity and worsening of acute kidney injury in hospitalized patients” Clin. J. Am. Nephrol 5(3): 402-408 (2010).;;Stookey, “Ferrozine- a new spectrophotometric reagent for iron,” Analytical Chemistry 42(7):779-781 (1970).;;The International Search Report for PCT/US2019/012890, 6 pages, dated Jun. 18, 2019.",ACTIVE
216,CN,A,CN 111602053 A,123-023-266-924-828,2020-08-28,2020,CN 201980007765 A,2019-01-09,US 201862615242 P;;US 2019/0012890 W,2018-01-09,METHODS FOR MEASURING ANALYTE AND/OR PROTEIN IN BIOLOGICAL SAMPLES,"The disclosure directed to methods for measuring an analyte alone or in combination with total protein in biological samples. More particularly, the disclosure relates to methods for measuring an analyte and/or total protein using one or more colorimetric reagents alone or in combination with protein precipitation reagents.",IDEXX LAB INC,DOHERTY PATRICK;;KIRSPEL KEVIN;;FARACE GIOSI;;YERRAMILLI MURTHY VSN,,https://lens.org/123-023-266-924-828,Patent Application,no,5,0,14,14,0,G01N21/272;;G01N21/82;;G01N21/78;;G01N33/52;;G01N33/6827;;G01N31/22;;G01N21/272;;G01N21/78;;G01N21/82;;G01N33/52;;G01N31/22;;G01N33/6827;;G01N31/22;;G01N21/272;;G01N1/30;;G01N21/82;;H04N23/73;;G01N21/78;;G01N33/52;;G01N33/6827;;G06T7/0012;;G06T2207/10144;;G06T2207/30242,G01N33/52;;G01N1/28;;G01N1/30;;G01N21/27;;G01N33/68,,2,0,,,"HUISUNG KIM 等: ""Smartphone-based low light detection for bioluminescence application"";;ERIC KEHOE 等: ""Introducing Colorimetric Analysis with Camera Phones and Digital Cameras: An Activity for High School or General Chemistry""",ACTIVE
217,ES,T3,ES 2184736 T3,142-134-774-461-947,2003-04-16,2003,ES 93303228 T,1993-04-26,US 87966992 A,1992-05-06,REGISTRO DE MENSAJES DE LLAMADA PARA SISTEMAS TELEFONICOS.,"EL REGISTRO DEL MENSAJE EMI GENERADOS POR LLAMADAS INTERURBANAS TELEFONICAS DE INTERCAMBIO SE MEJORA POR MEDIO DE LA ADICION DE UN INDICADOR DE LA COMPAÑIA DE SOPORTE PRIMARIA DEL INTERCAMBIO IC, CUYO VALOR SUMINISTRA UNA INDICACION DE CUANDO UN ABONADO TIENE UNA COMPAÑIA DE SOPORTE PARTICULAR PARA EL INTERCAMBIO COMO SU PIC. EL INDICADOR PIC PUEDE SER USADO POR LA COMPAÑIA DE SOPORTE DEL INTERCAMBIO CUANDO SE EMITAN LAS FACTURAS PARA SUS ABONADOS, POR EJEMPLO, PARA SUMINISTRAR UN TRATAMIENTO DE FACTURACION DIFERENTES PARA LAS LLAMADAS QUE SE HICIERON SOBRE LA RED DE LA COMPAÑIA DE SOPORTE A ABONADOS FINALES CUYO PIC ES, DE HECHO, ESA COMPAÑIA DE SOPORTE, COMO OPUESTAS A LAS LLAMADAS QUE SE HICIERON A ABONADOS CON PIC DIFERENTE.",AT & T CORP,DOHERTY GERARD PATRICK;;LANZILLOTTI NICHOLAS JOHN;;PAULUS CONRAD JOSEPH,,https://lens.org/142-134-774-461-947,Granted Patent,no,0,0,11,11,0,H04M15/00;;H04M15/00;;H04Q3/0016;;H04Q3/0016,H04M3/00;;H04M15/00;;H04M15/16;;H04Q3/00,,0,0,,,,EXPIRED
218,NZ,A,NZ 239644 A,040-424-979-325-17X,1992-11-25,1992,NZ 23964491 A,1991-09-03,US 58097290 A,1990-09-12,"28-HYDROXY IVERMECTIN AGLYCONE, PARASITICIDAL COMPOSITIONS",,MERCK & CO INC,ARISON BYRON H;;DOHERTY PATRICK J;;SCHULMAN MARVIN D,,https://lens.org/040-424-979-325-17X,Patent Application,no,0,0,9,9,0,A61P33/00;;A61P33/10;;C07D493/22;;C07D493/22;;C12P17/08;;C12P17/08,A01N43/90;;A61K31/35;;A61P33/00;;A61P33/10;;C07D493/22;;C12N1/38;;C12P17/08;;C12P17/18;;C12R1/645,,0,0,,,,PENDING
219,WO,A1,WO 2015/001025 A1,062-460-450-557-313,2015-01-08,2015,EP 2014064198 W,2014-07-03,GB 201312075 A,2013-07-05,METHOD AND SYSTEM FOR MODIFYING A SUBSTRATE USING A PLASMA,"A method and system of modifying a substrate (8) using a plasma are described comprising providing a first electrode (4) and a second electrode (6); arranging the substrate such that a portion of the substrate is between the electrodes; supplying a voltage to at least one of the electrodes so as to create a plasma discharge between the electrodes which contacts at least said portion of the substrate, moving either the substrate and/or said second electrode such that said substrate and said second electrode are being linearly displaced relative to each other along an axis (80) of linear displacement during said movement; and wherein said second electrode is arranged relative to said axis of linear displacement such that said linear movement causes a first section of the portion of substrate to have a greater residence time between the electrodes during said linear displacement than a second section of said portion of the substrate. A method and system of modifying a substrate (8) using a plasma is also described comprising providing a first electrode (4) and a second electrode (6); arranging the substrate such that a portion of the substrate is between the electrodes; supplying a voltage to at least one of the electrodes so as to create a plasma discharge between the electrodes which contacts at least said portion of the substrate, moving either the substrate and/or said second electrode such that said substrate and said second electrode are being linearly displaced relative to each other along an axis (80) of linear displacement during said movement; and further comprising the step of rotating either the substrate or said second electrode about an axis of rotation during said relative linear displacement along said axis (80), so that a first section of the portion of substrate has a greater residence time between the electrodes than a second section of said portion of substrate.",INNOVATION ULSTER LTD,BYRNE CORMAC PATRICK;;MEENAN BRIAN JOSEPH;;DOHERTY KYLE GEORGE,,https://lens.org/062-460-450-557-313,Patent Application,yes,2,1,4,4,0,H01J37/32348;;H01J37/32366;;H01J37/32449;;H01J37/32541;;H01J37/32568;;H01J37/32752;;H01J37/32825;;B05D3/141;;H01J37/32568;;H01J37/32366;;H01J37/32541;;H01J37/32752;;H01J37/32348;;H01J37/32825;;H01J37/32449;;B05D3/141;;H01J37/32715;;H01J2237/3321;;H01J2237/3341;;H01J2237/336;;H01J2237/3382,H01J37/32;;C23C16/04;;C23C16/54;;H05H1/24,,2,1,094-752-150-019-025,10.1016/j.apsusc.2005.04.016,"LIU C ET AL: ""Uniformity analysis of dielectric barrier discharge (DBD) processed polyethylene terephthalate (PET) surface"", APPLIED SURFACE SCIENCE, ELSEVIER, AMSTERDAM, NL, vol. 252, no. 6, 15 January 2006 (2006-01-15), pages 2297 - 2310, XP024892603, ISSN: 0169-4332, [retrieved on 20060115], DOI: 10.1016/J.APSUSC.2005.04.016;;See also references of EP 3017457A1",PENDING
220,CA,A1,CA 3088884 A1,117-682-101-866-414,2019-07-18,2019,CA 3088884 A,2019-01-09,US 201862615242 P;;US 2019/0012890 W,2018-01-09,METHODS FOR MEASURING ANALYTE AND/OR PROTEIN IN BIOLOGICAL SAMPLES,"The disclosure directed to methods for measuring an analyte alone or in combination with total protein in biological samples. More particularly, the disclosure relates to methods for measuring an analyte and/or total protein using one or more colorimetric reagents alone or in combination with protein precipitation reagents.",IDEXX LAB INC,DOHERTY PATRICK;;KIRSPEL KEVIN;;FARACE GIOSI;;YERRAMILLI MURTHY VSN,,https://lens.org/117-682-101-866-414,Patent Application,no,0,0,14,14,0,G01N21/272;;G01N21/82;;G01N21/78;;G01N33/52;;G01N33/6827;;G01N31/22;;G01N21/272;;G01N21/78;;G01N21/82;;G01N33/52;;G01N31/22;;G01N33/6827;;G01N31/22;;G01N21/272;;G01N1/30;;G01N21/82;;H04N23/73;;G01N21/78;;G01N33/52;;G01N33/6827;;G06T7/0012;;G06T2207/10144;;G06T2207/30242,G01N33/52;;G01N1/28;;G01N1/30;;G01N21/27;;G01N33/68,,0,0,,,,PENDING
221,US,A1,US 2004/0021480 A1,175-047-523-704-053,2004-02-05,2004,US 63318903 A,2003-08-01,US 63318903 A;;US 22382602 A;;US 67507200 A;;US 24437399 A;;US 7569198 A,1998-05-11,Method and system having switching network for testing semiconductor components on a substrate,"
   A system for testing semiconductor components contained on a substrate, such as a wafer, a panel, a leadframe or a module, includes an interconnect configured to electrically engage all of the components on the substrate at the same time. The interconnect includes a switching network configured to selectively apply test signals to selected components, to electrically isolate defective components and to transmit test signals from selected groups of components. The system also includes a test apparatus, such as a wafer prober or a carrier for handling the substrate. A method for testing includes the steps of providing the interconnect having the switching network, and controlling test signals to the components using the switching network to perform various test procedures, such as functionality tests, parametric tests and burn-in tests. 
",DOHERTY C. PATRICK;;DE VARONA JORGE L.;;AKRAM SALMAN,DOHERTY C PATRICK;;DE VARONA JORGE L;;AKRAM SALMAN,,https://lens.org/175-047-523-704-053,Patent Application,yes,67,4,4,10,0,G01R1/07385;;G01R1/07385;;G01R1/07314;;G01R1/07314;;G01R31/2831;;G01R31/2831;;H01L24/97;;H01L24/97;;H01L2224/48091;;H01L2224/48091;;H01L2224/48227;;H01L2224/48227;;H01L2224/4824;;H01L2224/4824;;H01L2224/73215;;H01L2224/73215;;H01L2224/73265;;H01L2224/73265;;H01L2224/97;;H01L2224/97;;H01L2924/01005;;H01L2924/01005;;H01L2924/01006;;H01L2924/01006;;H01L2924/01013;;H01L2924/01013;;H01L2924/01029;;H01L2924/01029;;H01L2924/01033;;H01L2924/01033;;H01L2924/01039;;H01L2924/01039;;H01L2924/01042;;H01L2924/01042;;H01L2924/01046;;H01L2924/01046;;H01L2924/01047;;H01L2924/01047;;H01L2924/01073;;H01L2924/01073;;H01L2924/01074;;H01L2924/01074;;H01L2924/01077;;H01L2924/01077;;H01L2924/01078;;H01L2924/01078;;H01L2924/01079;;H01L2924/01079;;H01L2924/01087;;H01L2924/01087;;H01L2924/14;;H01L2924/14,G01R1/073;;G01R31/28,324/765,0,0,,,,EXPIRED
222,US,B2,US 6853211 B2,074-932-258-836-337,2005-02-08,2005,US 63318903 A,2003-08-01,US 63318903 A;;US 22382602 A;;US 67507200 A;;US 24437399 A;;US 7569198 A,1998-05-11,Method and system having switching network for testing semiconductor components on a substrate,"A system for testing semiconductor components contained on a substrate, such as a wafer, a panel, a leadframe or a module, includes an interconnect configured to electrically engage all of the components on the substrate at the same time. The interconnect includes a switching network configured to selectively apply test signals to selected components, to electrically isolate defective components and to transmit test signals from selected groups of components. The system also includes a test apparatus, such as a wafer prober or a carrier for handling the substrate. A method for testing includes the steps of providing the interconnect having the switching network, and controlling test signals to the components using the switching network to perform various test procedures, such as functionality tests, parametric tests and burn-in tests.",MICRON TECHNOLOGY INC,DOHERTY C PATRICK;;DE VARONA JORGE L;;AKRAM SALMAN,,https://lens.org/074-932-258-836-337,Granted Patent,yes,68,19,4,10,0,G01R1/07385;;G01R1/07385;;G01R1/07314;;G01R1/07314;;G01R31/2831;;G01R31/2831;;H01L24/97;;H01L24/97;;H01L2224/48091;;H01L2224/48091;;H01L2224/48227;;H01L2224/48227;;H01L2224/4824;;H01L2224/4824;;H01L2224/73215;;H01L2224/73215;;H01L2224/73265;;H01L2224/73265;;H01L2224/97;;H01L2224/97;;H01L2924/01005;;H01L2924/01005;;H01L2924/01006;;H01L2924/01006;;H01L2924/01013;;H01L2924/01013;;H01L2924/01029;;H01L2924/01029;;H01L2924/01033;;H01L2924/01033;;H01L2924/01039;;H01L2924/01039;;H01L2924/01042;;H01L2924/01042;;H01L2924/01046;;H01L2924/01046;;H01L2924/01047;;H01L2924/01047;;H01L2924/01073;;H01L2924/01073;;H01L2924/01074;;H01L2924/01074;;H01L2924/01077;;H01L2924/01077;;H01L2924/01078;;H01L2924/01078;;H01L2924/01079;;H01L2924/01079;;H01L2924/01087;;H01L2924/01087;;H01L2924/14;;H01L2924/14,G01R1/073;;G01R31/28,324/765;;324/158.1,0,0,,,,EXPIRED
223,US,A,US 5140042 A,091-485-220-884-274,1992-08-18,1992,US 58097290 A,1990-09-12,US 58097290 A,1990-09-12,28-HYDROXY IVERMECTIN AGLYCONE,"Fermentation of S. erythraea produces the novel avermectin, 28-hydroxy ivermectin aglycone.",MERCK & CO INC,ARISON BYRON H;;SCHULMAN MARVIN D;;DOHERTY PATRICK J,,https://lens.org/091-485-220-884-274,Granted Patent,yes,4,4,9,9,0,A61P33/00;;A61P33/10;;C07D493/22;;C07D493/22;;C12P17/08;;C12P17/08,A01N43/90;;A61K31/35;;A61P33/00;;A61P33/10;;C07D493/22;;C12N1/38;;C12P17/08;;C12P17/18;;C12R1/645,514/450;;549/264,0,0,,,,EXPIRED
224,US,A1,US 2002/0196047 A1,110-033-976-166-715,2002-12-26,2002,US 22382602 A,2002-08-20,US 22382602 A;;US 99950201 A;;US 67507200 A;;US 24437399 A;;US 7569198 A,1998-05-11,Method and system having switching network for testing semiconductor components on a substrate,"
   A system for testing semiconductor components contained on a substrate, such as a wafer, a panel, a leadframe or a module, includes an interconnect configured to electrically engage all of the components on the substrate at the same time. The interconnect includes a switching network configured to selectively apply test signals to selected components, to electrically isolate defective components and to transmit test signals from selected groups of components. The system also includes a test apparatus, such as a wafer prober or a carrier for handling the substrate. A method for testing includes the steps of providing the interconnect having the switching network, and controlling test signals to the components using the switching network to perform various test procedures, such as functionality tests, parametric tests and burn-in tests. 
",DOHERTY C. PATRICK;;DE VARONA JORGE L.;;AKRAM SALMAN,DOHERTY C PATRICK;;DE VARONA JORGE L;;AKRAM SALMAN,MICRON TECHNOLOGY INC (2002-08-06),https://lens.org/110-033-976-166-715,Patent Application,yes,0,19,4,10,0,G01R1/07385;;G01R1/07385;;G01R1/07314;;G01R1/07314;;G01R31/2831;;G01R31/2831;;H01L24/97;;H01L24/97;;H01L2224/48091;;H01L2224/48091;;H01L2224/48227;;H01L2224/48227;;H01L2224/4824;;H01L2224/4824;;H01L2224/73215;;H01L2224/73215;;H01L2224/73265;;H01L2224/73265;;H01L2224/97;;H01L2224/97;;H01L2924/01005;;H01L2924/01005;;H01L2924/01006;;H01L2924/01006;;H01L2924/01013;;H01L2924/01013;;H01L2924/01029;;H01L2924/01029;;H01L2924/01033;;H01L2924/01033;;H01L2924/01039;;H01L2924/01039;;H01L2924/01042;;H01L2924/01042;;H01L2924/01046;;H01L2924/01046;;H01L2924/01047;;H01L2924/01047;;H01L2924/01073;;H01L2924/01073;;H01L2924/01074;;H01L2924/01074;;H01L2924/01077;;H01L2924/01077;;H01L2924/01078;;H01L2924/01078;;H01L2924/01079;;H01L2924/01079;;H01L2924/01087;;H01L2924/01087;;H01L2924/14;;H01L2924/14,G01R1/073;;G01R31/28,324/765,0,0,,,,EXPIRED
225,NZ,A,NZ 243202 A,063-805-346-874-201,1993-08-26,1993,NZ 24320292 A,1992-06-18,US 72174491 A,1991-06-26,"GLYCOSYLATED AVERMECTIN DERIVATIVES; THEIR PREPARATION BY FERMENTATION, THEIR USE AS PARASITICIDES",,MERCK & CO INC,ARISON BYRON H;;DOHERTY PATRICK J;;SCHULMAN MARVIN D,,https://lens.org/063-805-346-874-201,Patent Application,no,0,0,9,9,0,A61K31/70;;A61K31/70;;A01N43/90;;A01N43/90;;A61P33/00;;A61P33/02;;C07H19/01;;C07H19/01;;C12P19/60;;C12P19/60,A01N63/00;;A01N43/90;;A61K31/70;;A61K31/7042;;A61K31/7048;;A61P33/00;;A61P33/02;;C07H17/08;;C07H19/01;;C12P19/60;;C12P19/62;;C12R1/01;;C12R1/645,,0,0,,,,PENDING
226,EP,A2,EP 0569175 A2,047-112-865-133-817,1993-11-10,1993,EP 93303228 A,1993-04-26,US 87966992 A,1992-05-06,Call message recording for telephone systems.,"The EMI message record generated for interexchange telephone toll calls is enhanced via the addition of a primary interexchange carrier (PIC) indicator, whose value provides an indication as to whether a terminating subscriber has a particular interexchange carrier as his/her PIC. The PIC indicator may be used by the interexchange carrier when bills are rendered for its subscribers--for example, to provide different billing treatment for calls that were made over that carrier's network to terminating subscribers whose PIC is, in fact, that very carrier, as opposed to calls that were made to subscribers with a different PIC.",AMERICAN TELEPHONE & TELEGRAPH,DOHERTY GERARD PATRICK;;LANZILLOTTI NICHOLAS JOHN;;PAULUS CONRAD JOSEPH,AT&T CORP. (1994-06-22),https://lens.org/047-112-865-133-817,Patent Application,yes,0,5,11,11,0,H04M15/00;;H04M15/00;;H04Q3/0016;;H04Q3/0016,H04M3/00;;H04M15/00;;H04M15/16;;H04Q3/00,,0,0,,,,EXPIRED
227,DE,T2,DE 69332461 T2,120-799-503-432-771,2003-08-28,2003,DE 69332461 T,1993-04-26,US 87966992 A,1992-05-06,Anrufnachrichtenaufzeichnung für Fernsprechsysteme,,AT & T CORP,DOHERTY GERARD PATRICK;;LANZILLOTTI NICHOLAS JOHN;;PAULUS CONRAD JOSEPH,,https://lens.org/120-799-503-432-771,Granted Patent,no,0,0,11,11,0,H04M15/00;;H04M15/00;;H04Q3/0016;;H04Q3/0016,H04M3/00;;H04M15/00;;H04M15/16;;H04Q3/00,,0,0,,,,EXPIRED
228,KR,A,KR 20200105711 A,142-733-573-123-348,2020-09-08,2020,KR 20207022841 A,2019-01-09,US 201862615242 P;;US 2019/0012890 W,2018-01-09,생물학적 샘플에서 분석물 및/또는 단백질을 측정하기 위한 방법,"본 개시는 생물학적 샘플 중의 단독의 또는 총 단백질과 조합된 분석물을 측정하기 위한 방법에 관한 것이다. 더욱 특히, 본 개시는 하나 이상의 비색 시약을 단독으로 또는 단백질 침전 시약과 조합하여 사용하여 분석물 및/또는 총 단백질을 측정하기 위한 방법에 관한 것이다.",IDEXX LAB INC,DOHERTY PATRICK;;KIRSPEL KEVIN;;FARACE GIOSI;;YERRAMILLI MURTHY VSN,,https://lens.org/142-733-573-123-348,Patent Application,no,0,5,14,14,0,G01N21/272;;G01N21/82;;G01N21/78;;G01N33/52;;G01N33/6827;;G01N31/22;;G01N21/272;;G01N21/78;;G01N21/82;;G01N33/52;;G01N31/22;;G01N33/6827;;G01N31/22;;G01N21/272;;G01N1/30;;G01N21/82;;H04N23/73;;G01N21/78;;G01N33/52;;G01N33/6827;;G06T7/0012;;G06T2207/10144;;G06T2207/30242,G01N21/27;;G01N21/78;;G01N21/82;;G01N31/22;;G01N33/68,,0,0,,,,ACTIVE
229,NO,L,NO 930714 L,131-185-034-065-106,1993-04-19,1993,NO 930714 A,1993-02-26,US 72285291 A;;US 9205256 W,1991-06-28,EKSTRUDERINGSSYSTEMER FOR KAPSLER,"Methods for producing cell capsules are disclosed in which a coagulant (22), which can include a cell suspension or other biologically active factor, and a polymeric casting solution (26) are extruded through a common extrusion port (14) having at least two concentric bores, such that the coagulant is extruded through the inner bore (16) and the polymeric casting solution is extruded through the outer bore (18). The method involves initiating extrusion of the coagulant within a temporal range of about 10 msecs to about one second from initiating delivery of the casting solution through the respective bores. Delivery of the coagulant is then shut off, and extrusion of the casting solution is terminated either immediately or after some predetermined time.",UNIV BROWN RES FOUND,AEBISCHER PATRICK;;MILLS JOHN F;;WAHLBERG LARS;;DOHERTY EDWARD J;;TRESCO PATRICK A,,https://lens.org/131-185-034-065-106,Abstract,no,0,0,19,124,0,A61J3/07;;A61K9/0024;;A61K9/5089;;B01J13/02;;B01J13/04;;C12N5/0012;;C12N5/0614;;C12N11/04;;C12N2533/30;;A61J3/00,A61J/;;B01J13/14;;A61J3/06;;A61J3/07;;A61K9/00;;A61K9/50;;B01J13/02;;B01J13/04;;C12M1/00;;C12N5/00;;C12N5/02;;C12N5/071;;C12N11/04,,0,0,,,,PENDING
230,FI,A0,FI 930884 A0,168-502-963-290-93X,1993-02-26,1993,FI 930884 A,1993-02-26,US 72285291 A;;US 9205256 W,1991-06-28,EKSTRUDERINGSSYSTEM FOER KAPSLAR,"Methods for producing cell capsules are disclosed in which a coagulant (22), which can include a cell suspension or other biologically active factor, and a polymeric casting solution (26) are extruded through a common extrusion port (14) having at least two concentric bores, such that the coagulant is extruded through the inner bore (16) and the polymeric casting solution is extruded through the outer bore (18). The method involves initiating extrusion of the coagulant within a temporal range of about 10 msecs to about one second from initiating delivery of the casting solution through the respective bores. Delivery of the coagulant is then shut off, and extrusion of the casting solution is terminated either immediately or after some predetermined time.",UNIV BROWN RES FOUND,AEBISCHER PATRICK;;MILLS JOHN F;;WAHLBERG LARS;;DOHERTY EDWARD J;;TRESCO PATRICK A,,https://lens.org/168-502-963-290-93X,Patent Application,no,0,0,19,124,0,A61J3/07;;A61K9/0024;;A61K9/5089;;B01J13/02;;B01J13/04;;C12N5/0012;;C12N5/0614;;C12N11/04;;C12N2533/30;;A61J3/00,B01J13/14;;A61J/;;A61J3/06;;A61J3/07;;A61K9/00;;A61K9/50;;B01J13/02;;B01J13/04;;C12M1/00;;C12N5/00;;C12N5/02;;C12N5/071;;C12N11/04,,0,0,,,,PENDING
231,CA,A1,CA 2090118 A1,192-417-257-916-943,1992-12-29,1992,CA 2090118 A,1992-06-25,US 72285291 A,1991-06-28,CAPSULE EXTRUSION SYSTEMS,"2090118 9300063 PCTABS00019 Methods for producing cell capsules are disclosed in which a coagulant (22), which can include a cell suspension or other biologically active factor, and a polymeric casting solution (26) are extruded through a common extrusion port (14) having at least two concentric bores, such that the coagulant is extruded through the inner bore (16) and the polymeric casting solution is extruded through the outer bore (18). The method involves initiating extrusion of the coagulant within a temporal range of about 10 msecs to about one second from initiating delivery of the casting solution through the respective bores. Delivery of the coagulant is then shut off, and extrusion of the casting solution is terminated either immediately or after some predetermined time.",UNIV BROWN RES FOUND,AEBISCHER PATRICK;;MILLS JOHN F;;WAHLBERG LARS;;DOHERTY EDWARD J;;TRESCO PATRICK A,,https://lens.org/192-417-257-916-943,Patent Application,no,0,0,19,124,0,A61J3/07;;A61K9/0024;;A61K9/5089;;B01J13/02;;B01J13/04;;C12N5/0012;;C12N5/0614;;C12N11/04;;C12N2533/30;;A61J3/00,B01J13/14;;A61J/;;A61J3/06;;A61J3/07;;A61K9/00;;A61K9/50;;B01J13/02;;B01J13/04;;C12M1/00;;C12N5/00;;C12N5/02;;C12N5/071;;C12N11/04,,0,0,,,,DISCONTINUED
232,NO,D0,NO 930714 D0,069-754-370-188-843,1993-02-26,1993,NO 930714 A,1993-02-26,US 72285291 A;;US 9205256 W,1991-06-28,EKSTRUDERINGSSYSTEMER FOR KAPSLER,"Methods for producing cell capsules are disclosed in which a coagulant (22), which can include a cell suspension or other biologically active factor, and a polymeric casting solution (26) are extruded through a common extrusion port (14) having at least two concentric bores, such that the coagulant is extruded through the inner bore (16) and the polymeric casting solution is extruded through the outer bore (18). The method involves initiating extrusion of the coagulant within a temporal range of about 10 msecs to about one second from initiating delivery of the casting solution through the respective bores. Delivery of the coagulant is then shut off, and extrusion of the casting solution is terminated either immediately or after some predetermined time.",UNIV BROWN RES FOUND,AEBISCHER PATRICK;;MILLS JOHN F;;WAHLBERG LARS;;DOHERTY EDWARD J;;TRESCO PATRICK A,,https://lens.org/069-754-370-188-843,Patent Application,no,0,0,19,124,0,A61J3/07;;A61K9/0024;;A61K9/5089;;B01J13/02;;B01J13/04;;C12N5/0012;;C12N5/0614;;C12N11/04;;C12N2533/30;;A61J3/00,A61J/;;B01J13/14;;A61J3/06;;A61J3/07;;A61K9/00;;A61K9/50;;B01J13/02;;B01J13/04;;C12M1/00;;C12N5/00;;C12N5/02;;C12N5/071;;C12N11/04,,0,0,,,,PENDING
233,SG,A1,SG 48815 A1,026-980-220-681-101,1998-05-18,1998,SG 1996001963 A,1992-06-25,US 72285291 A,1991-06-28,Capsule extrusion systems,"Methods for producing cell capsules are disclosed in which a coagulant (22), which can include a cell suspension or other biologically active factor, and a polymeric casting solution (26) are extruded through a common extrusion port (14) having at least two concentric bores, such that the coagulant is extruded through the inner bore (16) and the polymeric casting solution is extruded through the outer bore (18). The method involves initiating extrusion of the coagulant within a temporal range of about 10 msecs to about one second from initiating delivery of the casting solution through the respective bores. Delivery of the coagulant is then shut off, and extrusion of the casting solution is terminated either immediately or after some predetermined time.",UNIV BROWN RES FOUND,AEBISCHER PATRICK;;MILLS JOHN F;;WAHLBERG LARS;;DOHERTY EDWARD J;;TRESCO PATRICK A,,https://lens.org/026-980-220-681-101,Patent Application,no,0,0,19,124,0,A61J3/07;;A61K9/0024;;A61K9/5089;;B01J13/02;;B01J13/04;;C12N5/0012;;C12N5/0614;;C12N11/04;;C12N2533/30;;A61J3/00,A61J/;;B01J13/14;;A61J3/06;;A61J3/07;;A61K9/00;;A61K9/50;;B01J13/02;;B01J13/04;;C12M1/00;;C12N5/00;;C12N5/02;;C12N5/071;;C12N11/04,,0,0,,,,PENDING
234,AU,A,AU 1992/023028 A,122-070-386-753-715,1993-01-25,1993,AU 1992/023028 A,1992-06-25,US 72285291 A;;US 9205256 W,1991-06-28,CAPSULE EXTRUSION SYSTEMS,"Methods for producing cell capsules are disclosed in which a coagulant (22), which can include a cell suspension or other biologically active factor, and a polymeric casting solution (26) are extruded through a common extrusion port (14) having at least two concentric bores, such that the coagulant is extruded through the inner bore (16) and the polymeric casting solution is extruded through the outer bore (18). The method involves initiating extrusion of the coagulant within a temporal range of about 10 msecs to about one second from initiating delivery of the casting solution through the respective bores. Delivery of the coagulant is then shut off, and extrusion of the casting solution is terminated either immediately or after some predetermined time.",BROWN UNIVERSITY RESEARCH FOUNDATION,PATRICK AEBISCHER;;JOHN F MILLS;;LARS WAHLBERG;;EDWARD J DOHERTY;;PATRICK A. TRESCO,,https://lens.org/122-070-386-753-715,Patent Application,no,0,0,19,124,0,A61J3/07;;A61K9/0024;;A61K9/5089;;B01J13/02;;B01J13/04;;C12N5/0012;;C12N5/0614;;C12N11/04;;C12N2533/30;;A61J3/00,B01J13/14;;A61J/;;A61J3/06;;A61J3/07;;A61K9/00;;A61K9/50;;B01J13/02;;B01J13/04;;C12M1/00;;C12N5/00;;C12N5/02;;C12N5/071;;C12N11/04,,0,0,,,,EXPIRED
235,IE,A1,IE 980200 A1,140-143-305-895-357,1999-09-22,1999,IE 980200 A,1998-03-19,IE 980200 A,1998-03-19,Manufacture of gate barriers,,ELECTRO AUTOMATION RES EAR LTD,"DOHERTY, RORY JOHN;;WALSH PATRICK;;PATRICK WALSH;;ALPHONSUS JOHN;;KEVIN MICHAEL O'BRENNAN HIGGINGS",,https://lens.org/140-143-305-895-357,Patent Application,no,0,0,4,4,0,E01F13/06,E01F13/06,,0,0,,,,DISCONTINUED
236,EP,A1,EP 0546158 A1,042-161-628-448-777,1993-06-16,1993,EP 92914689 A,1992-06-25,US 9205256 W;;US 72285291 A,1991-06-28,CAPSULE EXTRUSION SYSTEMS.,"Methods for producing cell capsules are disclosed in which a coagulant (22), which can include a cell suspension or other biologically active factor, and a polymeric casting solution (26) are extruded through a common extrusion port (14) having at least two concentric bores, such that the coagulant is extruded through the inner bore (16) and the polymeric casting solution is extruded through the outer bore (18). The method involves initiating extrusion of the coagulant within a temporal range of about 10 msecs to about one second from initiating delivery of the casting solution through the respective bores. Delivery of the coagulant is then shut off, and extrusion of the casting solution is terminated either immediately or after some predetermined time.",UNIV BROWN RES FOUND,AEBISCHER PATRICK;;MILLS JOHN F;;WAHLBERG LARS;;DOHERTY EDWARD J;;TRESCO PATRICK A,,https://lens.org/042-161-628-448-777,Patent Application,yes,0,0,19,124,0,A61J3/07;;A61K9/0024;;A61K9/5089;;B01J13/02;;B01J13/04;;C12N5/0012;;C12N5/0614;;C12N11/04;;C12N2533/30;;A61J3/00,B01J13/14;;A61J/;;A61J3/06;;A61J3/07;;A61K9/00;;A61K9/50;;B01J13/02;;B01J13/04;;C12M1/00;;C12N5/00;;C12N5/02;;C12N5/071;;C12N11/04,,0,0,,,,EXPIRED
237,ES,T3,ES 2111072 T3,072-943-109-144-653,1998-03-01,1998,ES 92914689 T,1992-06-25,US 72285291 A,1991-06-28,SISTEMAS DE EXTRUSION DE CAPSULAS.,"Methods for producing cell capsules are disclosed in which a coagulant (22), which can include a cell suspension or other biologically active factor, and a polymeric casting solution (26) are extruded through a common extrusion port (14) having at least two concentric bores, such that the coagulant is extruded through the inner bore (16) and the polymeric casting solution is extruded through the outer bore (18). The method involves initiating extrusion of the coagulant within a temporal range of about 10 msecs to about one second from initiating delivery of the casting solution through the respective bores. Delivery of the coagulant is then shut off, and extrusion of the casting solution is terminated either immediately or after some predetermined time.",UNIV BROWN RES FOUND,AEBISCHER PATRICK;;MILLS JOHN F;;WAHLBERG LARS;;DOHERTY EDWARD J;;TRESCO PATRICK A,,https://lens.org/072-943-109-144-653,Granted Patent,no,0,0,19,124,0,A61J3/07;;A61K9/0024;;A61K9/5089;;B01J13/02;;B01J13/04;;C12N5/0012;;C12N5/0614;;C12N11/04;;C12N2533/30;;A61J3/00,B01J13/14;;A61J/;;A61J3/06;;A61J3/07;;A61K9/00;;A61K9/50;;B01J13/02;;B01J13/04;;C12M1/00;;C12N5/00;;C12N5/02;;C12N5/071;;C12N11/04,,0,0,,,,EXPIRED
238,US,A,US 5418154 A,171-221-677-924-599,1995-05-23,1995,US 99777092 A,1992-12-24,US 99777092 A;;US 72285291 A;;US 63875991 A;;US 46199990 A;;US 12162687 A,1987-11-17,Method of preparing elongated seamless capsules containing biological material,"Elongated seamless capsules containing biological material are prepared by a method in which a coagulant, which includes a cell suspension or other biologically active factor, and a polymeric casting solution are extruded through a common extrusion port having at least two concentric bores, such that the coagulant is extruded through the inner bore and the polymeric casting solution is extruded through the outer bore. The method involves initiating extrusion of the coagulant subsequent to initiating delivery of the casting solution through the respective bores to form a capsule having a curved and smooth leading edge shape. Delivery of the coagulant is then shut off, and extrusion of the casting solution is terminated either immediately or after some predetermined time.",UNIV BROWN RES FOUND,AEBISCHER PATRICK;;MILLS JOHN F;;WAHLBERG LARS;;DOHERTY EDWARD J;;TRESCO PATRICK A,BROWN UNIVERSITY RESEARCH FOUNDATION (1994-02-28);;BROWN UNIVERSITY RESEARCH FOUND (1993-02-16);;NEUROTECH S.A (1999-12-29),https://lens.org/171-221-677-924-599,Granted Patent,yes,40,54,2,124,0,A61K9/0092;;A61K9/0092;;A61F2/022;;A61F2/022;;A61J3/07;;A61J3/07;;A61K9/0024;;A61K9/0024;;A61K9/0085;;A61K9/0085;;A61K9/4816;;A61K9/4816;;A61K9/4833;;A61K9/4833;;A61K9/5089;;A61K9/5089;;A61K35/22;;A61K35/22;;A61K35/30;;A61K35/30;;A61M31/002;;A61M31/002;;A61M2210/0687;;A61M2210/0687;;A61M2210/0693;;A61M2210/0693;;B01J13/02;;B01J13/02;;B01J13/04;;B01J13/04;;C12N5/0012;;C12N5/0012;;C12N5/0614;;C12N5/0614;;C12N5/0619;;C12N5/0619;;C12N11/04;;C12N11/04;;C12N11/082;;C12N11/082;;C12N11/087;;C12N11/087;;C12N11/098;;C12N11/098;;C12N2533/30;;C12N2533/30;;Y10S530/817;;Y10S530/817,A61F2/02;;A61J3/07;;A61K9/00;;A61K9/48;;A61K9/50;;A61K35/12;;A61K35/22;;A61K35/30;;A61M31/00;;B01J13/02;;B01J13/04;;C12N5/00;;C12N5/071;;C12N5/0793;;C12N11/04;;C12N11/08,435/182;;264/4;;264/4.7;;424/451;;X425382R;;425/382.2;;435/178;;435/179;;435/240.22;;435/240.23;;530/817,20,16,131-251-914-345-643;;002-019-774-432-601;;094-385-151-447-804;;012-580-540-994-202;;064-131-977-582-270;;087-500-626-080-637;;133-969-048-452-084;;006-997-672-497-992;;120-272-007-918-800;;086-344-509-228-673;;081-805-660-425-087;;048-506-484-646-967;;092-517-532-870-103;;037-109-446-079-14X;;128-728-979-996-17X;;014-519-924-577-221,2009346;;10.1016/0142-9612(91)90132-t;;3378159;;10.1016/0006-8993(88)91278-4;;1760745;;10.1016/0006-8993(91)91212-j;;1999230;;10.1016/0014-4886(91)90093-r;;10.1016/0014-4886(90)90049-x;;2209780;;1913150;;10.1016/0006-8993(91)90929-p;;10.1016/s0079-6123(08)62588-1;;2290954;;1004234;;10.1016/s0091-679x(08)60472-0;;18576568;;10.1002/bit.260290914;;2692662;;10.2337/diab.26.12.1136;;412720;;10.2337/diabetes.26.12.1136;;1348191;;10.1097/00002480-199201000-00006;;826831;;10.1038/264466a0;;10.1016/0014-4886(91)90022-5;;1915723;;2504616;;10.1016/0014-4886(89)90126-x;;2468675;;10.1002/jbm.820230104,"Aebisher et al. (1991) Biomaterials 12:50 56.;;Aebisher et al. (1991) Brain Research 448:364 368.;;Aebisher et al. (1991) Brain Research 560:43 49.;;Aebisher et al. (1991) Experimental Neurology 111:269 275.;;Aebisher et al. (1991) J. Biomec. Engineering 113:178 183.;;Aebisher et al. (1991) Science 242:133.;;Chang (1977) Biomedical Applications Of Immobilized Enzymes and Protein, Plenum Press, N.Y., 1:69 90.;;Hoffman et al. (1990) Experimental Neurology 110:39 44.;;Jaeger et al. (1991) Brain Research 551:163 170.;;Jaeger et al. (1990) Progress In Brain Research 82:41 46.;;Schratter (1976) Methods In Cell Biology, Academic Press N.Y. 14:95 103.;;Sefton et al. (1987) Biotechnology Bioengineering 29:1135 1143.;;Sugamori et al. (1989) Trans. Am. Soc. Artificial Internal Organs 35:791 799.;;Sun et al. (1977) Diabetes 26:1136 1139.;;Tresco et al. (1992) ASAIO Journal 38:17 23.;;Tze et al. (1976) Nature 264:466 467.;;Winn et al. (1991) Experimental Neurology 113:322 329.;;Winn et al. (1989) Experimental Neurology 105:244 250.;;Winn et al. (1989) J. Biomed. Mater. Res. 23:31 44.;;Amicon: VITAFIBER Artificial Capillary Systems for Tissue Culture Publication No. 4426.",EXPIRED
239,AU,B2,AU 661021 B2,167-551-002-805-716,1995-07-13,1995,AU 1992/023028 A,1992-06-25,US 72285291 A;;US 9205256 W,1991-06-28,Capsule extrusion systems,"Methods for producing cell capsules are disclosed in which a coagulant (22), which can include a cell suspension or other biologically active factor, and a polymeric casting solution (26) are extruded through a common extrusion port (14) having at least two concentric bores, such that the coagulant is extruded through the inner bore (16) and the polymeric casting solution is extruded through the outer bore (18). The method involves initiating extrusion of the coagulant within a temporal range of about 10 msecs to about one second from initiating delivery of the casting solution through the respective bores. Delivery of the coagulant is then shut off, and extrusion of the casting solution is terminated either immediately or after some predetermined time.",UNIV BROWN RES FOUND,AEBISCHER PATRICK;;MILLS JOHN F;;WAHLBERG LARS;;DOHERTY EDWARD J;;TRESCO PATRICK A,,https://lens.org/167-551-002-805-716,Granted Patent,no,2,0,19,124,0,A61J3/07;;A61K9/0024;;A61K9/5089;;B01J13/02;;B01J13/04;;C12N5/0012;;C12N5/0614;;C12N11/04;;C12N2533/30;;A61J3/00,B01J13/14;;A61J/;;A61J3/06;;A61J3/07;;A61K9/00;;A61K9/50;;B01J13/02;;B01J13/04;;C12M1/00;;C12N5/00;;C12N5/02;;C12N5/071;;C12N11/04,,0,0,,,,EXPIRED
240,US,A,US 5643773 A,147-162-252-630-715,1997-07-01,1997,US 43078695 A,1995-04-27,US 43078695 A;;US 99777092 A;;US 72285291 A;;US 63875991 A;;US 46199990 A;;US 12162687 A,1987-11-17,Preparation of elongated seamless capsules containing a coaxial rod and biological material,"Elongated seamless capsules containing biological material are prepared by a method in which a coagulant, which includes a cell suspension or other biological material, and a polymeric casting solution are extruded through a common extrusion port having at least two concentric bores, such that the coagulant is extruded through an inner bore and the polymeric casting solution is extruded through an outer bore. Extrusion of the coagulant is initiated subsequent to initiating delivery of the casting solution to form a capsule having a curved and smooth leading edge shape. Delivery of the coagulant is then shut off, and extrusion of the casting solution is terminated either immediately or after some predetermined time. This procedure can be modified to form in the capsule a coaxial rod that is connected to one end but not the other end of the capsule. This is accomplished by drawing casting solution into the inner bore after initiating extrusion of the casting solution through the outer bore, and then initiating delivery of the coagulant through the inner bore so as to coagulate the casting solution therein and form a rod, and ejecting the rod from the inner bore by pressure of the coagulant. Delivery of the coagulant and casting solution are then terminated as described above.",UNIV BROWN RES FOUND,AEBISCHER PATRICK;;MILLS JOHN F;;WAHLBERG LARS;;DOHERTY EDWARD J;;TRESCO PATRICK A,NEUROTECH S.A (1999-12-29),https://lens.org/147-162-252-630-715,Granted Patent,yes,42,28,2,124,0,A61K9/0092;;A61K9/0092;;A61F2/022;;A61F2/022;;A61J3/07;;A61J3/07;;A61K9/0024;;A61K9/0024;;A61K9/0085;;A61K9/0085;;A61K9/4816;;A61K9/4816;;A61K9/4833;;A61K9/4833;;A61K9/5089;;A61K9/5089;;A61K35/22;;A61K35/22;;A61K35/30;;A61K35/30;;A61M31/002;;A61M31/002;;A61M2210/0687;;A61M2210/0687;;A61M2210/0693;;A61M2210/0693;;B01J13/02;;B01J13/02;;B01J13/04;;B01J13/04;;C12N5/0012;;C12N5/0012;;C12N5/0614;;C12N5/0614;;C12N5/0619;;C12N5/0619;;C12N11/04;;C12N11/04;;C12N11/082;;C12N11/082;;C12N11/087;;C12N11/087;;C12N11/098;;C12N11/098;;C12N2533/30;;C12N2533/30;;Y10S530/817;;Y10S530/817,A61F2/02;;A61J3/07;;A61K9/00;;A61K9/48;;A61K9/50;;A61K35/12;;A61K35/22;;A61K35/30;;A61M31/00;;B01J13/02;;B01J13/04;;C12N5/00;;C12N5/071;;C12N5/0793;;C12N11/04;;C12N11/08,435/182;;264/4;;264/4.7;;424/451;;X425382 R;;425/382.2;;435/178;;435/179;;435/382;;435/325;;435/368;;530/817,20,16,131-251-914-345-643;;002-019-774-432-601;;094-385-151-447-804;;012-580-540-994-202;;064-131-977-582-270;;087-500-626-080-637;;133-969-048-452-084;;006-997-672-497-992;;120-272-007-918-800;;086-344-509-228-673;;081-805-660-425-087;;048-506-484-646-967;;092-517-532-870-103;;037-109-446-079-14X;;128-728-979-996-17X;;014-519-924-577-221,2009346;;10.1016/0142-9612(91)90132-t;;3378159;;10.1016/0006-8993(88)91278-4;;1760745;;10.1016/0006-8993(91)91212-j;;1999230;;10.1016/0014-4886(91)90093-r;;10.1016/0014-4886(90)90049-x;;2209780;;1913150;;10.1016/0006-8993(91)90929-p;;10.1016/s0079-6123(08)62588-1;;2290954;;1004234;;10.1016/s0091-679x(08)60472-0;;18576568;;10.1002/bit.260290914;;2692662;;10.2337/diab.26.12.1136;;412720;;10.2337/diabetes.26.12.1136;;1348191;;10.1097/00002480-199201000-00006;;826831;;10.1038/264466a0;;10.1016/0014-4886(91)90022-5;;1915723;;2504616;;10.1016/0014-4886(89)90126-x;;2468675;;10.1002/jbm.820230104,"Aebisher et al. (1991) Biomaterials 12:50 56.;;Aebisher et al. (1991) Brain Research 448:364 368.;;Aebisher et al. (1991) Brain Research 560:43 49.;;Aebisher et al. (1991) Experimental Neurology 111:269 275.;;Aebisher et al. (1991) J. Biomec. Engineering 113:178 183.;;Aebisher et al. (1991) Science 242:133.;;Chang (1977) Biomedical Applications of Immobilized Enzymes and Protein, Plenum Press, N.Y., 1:69 90.;;Hoffman et al. (1990) Experimental Neurology 110:39 44.;;Jaeger et al. (1991) Brain Research 551:163 170.;;Jaeger et al. (1990) Progress in Brain Research 82:41 46.;;Schratter (1976) Methods in Cell Biology, Academic Press NY 14:95 103.;;Sefton et al. (1987) Biotechnology Bioengineering 29:1135 1143.;;Sugamori et al. (1989) Trans. Am. Soc. Artificial Internal Organs 35:791 799.;;Sun et al. (1977) Diabetes 26:1136 1139.;;Tresco et al. (1992) Asaio Journal 38:17 23.;;Tze et al. (1976) Nature 264:466 487.;;Winn et al. (1991) Experimental Neurology 113:322 329.;;Winn et al. (1989) Experimental Neurology 105:244 250.;;Winn et al. (1989) J. Biomed. Meter. Res. 23:31 44.;;Amicon: Vitafiber Artificial Capillary Systems for Tissue Culture Publication No. 4426.",EXPIRED
241,GR,T3,GR 3026555 T3,155-797-469-405-235,1998-07-31,1998,GR 980400742 T,1998-04-06,US 72285291 A;;US 9205256 W,1991-06-28,CAPSULE EXTRUSION SYSTEMS,"Methods for producing cell capsules are disclosed in which a coagulant (22), which can include a cell suspension or other biologically active factor, and a polymeric casting solution (26) are extruded through a common extrusion port (14) having at least two concentric bores, such that the coagulant is extruded through the inner bore (16) and the polymeric casting solution is extruded through the outer bore (18). The method involves initiating extrusion of the coagulant within a temporal range of about 10 msecs to about one second from initiating delivery of the casting solution through the respective bores. Delivery of the coagulant is then shut off, and extrusion of the casting solution is terminated either immediately or after some predetermined time.",UNIV BROWN RES FOUND,AEBISCHER PATRICK;;MILLS JOHN F;;WAHLBERG LARS;;DOHERTY EDWARD J;;TRESCO PATRICK A,,https://lens.org/155-797-469-405-235,Granted Patent,no,0,0,19,124,0,A61J3/07;;A61K9/0024;;A61K9/5089;;B01J13/02;;B01J13/04;;C12N5/0012;;C12N5/0614;;C12N11/04;;C12N2533/30;;A61J3/00,B01J13/14;;A61J/;;A61J3/06;;A61J3/07;;A61K9/00;;A61K9/50;;B01J13/02;;B01J13/04;;C12M1/00;;C12N5/00;;C12N5/02;;C12N5/071;;C12N11/04,,0,0,,,,EXPIRED
242,FI,A,FI 930884 A,038-601-787-782-395,1993-04-21,1993,FI 930884 A,1993-02-26,US 72285291 A;;US 9205256 W,1991-06-28,EKSTRUDERINGSSYSTEM FOER KAPSLAR,"Methods for producing cell capsules are disclosed in which a coagulant (22), which can include a cell suspension or other biologically active factor, and a polymeric casting solution (26) are extruded through a common extrusion port (14) having at least two concentric bores, such that the coagulant is extruded through the inner bore (16) and the polymeric casting solution is extruded through the outer bore (18). The method involves initiating extrusion of the coagulant within a temporal range of about 10 msecs to about one second from initiating delivery of the casting solution through the respective bores. Delivery of the coagulant is then shut off, and extrusion of the casting solution is terminated either immediately or after some predetermined time.",UNIV BROWN RES FOUND,AEBISCHER PATRICK;;MILLS JOHN F;;WAHLBERG LARS;;DOHERTY EDWARD J;;TRESCO PATRICK A,,https://lens.org/038-601-787-782-395,Patent Application,no,0,0,19,124,0,A61J3/07;;A61K9/0024;;A61K9/5089;;B01J13/02;;B01J13/04;;C12N5/0012;;C12N5/0614;;C12N11/04;;C12N2533/30;;A61J3/00,B01J13/14;;A61J/;;A61J3/06;;A61J3/07;;A61K9/00;;A61K9/50;;B01J13/02;;B01J13/04;;C12M1/00;;C12N5/00;;C12N5/02;;C12N5/071;;C12N11/04,,0,0,,,,PENDING
243,DK,T3,DK 0546158 T3,062-361-661-960-707,1998-09-07,1998,DK 92914689 T,1992-06-25,US 72285291 A;;US 9205256 W,1991-06-28,Kapselekstruderingssystemer,"Methods for producing cell capsules are disclosed in which a coagulant (22), which can include a cell suspension or other biologically active factor, and a polymeric casting solution (26) are extruded through a common extrusion port (14) having at least two concentric bores, such that the coagulant is extruded through the inner bore (16) and the polymeric casting solution is extruded through the outer bore (18). The method involves initiating extrusion of the coagulant within a temporal range of about 10 msecs to about one second from initiating delivery of the casting solution through the respective bores. Delivery of the coagulant is then shut off, and extrusion of the casting solution is terminated either immediately or after some predetermined time.",UNIV BROWN RES FOUND,AEBISCHER PATRICK;;MILLS JOHN F;;WAHLBERG LARS;;DOHERTY EDWARD J;;TRESCO PATRICK A,,https://lens.org/062-361-661-960-707,Granted Patent,no,0,0,19,124,0,A61J3/07;;A61K9/0024;;A61K9/5089;;B01J13/02;;B01J13/04;;C12N5/0012;;C12N5/0614;;C12N11/04;;C12N2533/30;;A61J3/00,B01J13/14;;A61J/;;A61J3/06;;A61J3/07;;A61K9/00;;A61K9/50;;B01J13/02;;B01J13/04;;C12M1/00;;C12N5/00;;C12N5/02;;C12N5/071;;C12N11/04,,0,0,,,,EXPIRED
244,AT,T1,AT E161707 T1,045-578-662-329-571,1998-01-15,1998,AT 92914689 T,1992-06-25,US 72285291 A,1991-06-28,KAPSELEXTRUSIONSSYSTEME,"Methods for producing cell capsules are disclosed in which a coagulant (22), which can include a cell suspension or other biologically active factor, and a polymeric casting solution (26) are extruded through a common extrusion port (14) having at least two concentric bores, such that the coagulant is extruded through the inner bore (16) and the polymeric casting solution is extruded through the outer bore (18). The method involves initiating extrusion of the coagulant within a temporal range of about 10 msecs to about one second from initiating delivery of the casting solution through the respective bores. Delivery of the coagulant is then shut off, and extrusion of the casting solution is terminated either immediately or after some predetermined time.",UNIV BROWN RES FOUND,AEBISCHER PATRICK;;MILLS JOHN F;;WAHLBERG LARS;;DOHERTY EDWARD J;;TRESCO PATRICK A,,https://lens.org/045-578-662-329-571,Granted Patent,no,0,0,19,124,0,A61J3/07;;A61K9/0024;;A61K9/5089;;B01J13/02;;B01J13/04;;C12N5/0012;;C12N5/0614;;C12N11/04;;C12N2533/30;;A61J3/00,B01J13/14;;A61J/;;A61J3/06;;A61J3/07;;A61K9/00;;A61K9/50;;B01J13/02;;B01J13/04;;C12M1/00;;C12N5/00;;C12N5/02;;C12N5/071;;C12N11/04,,0,0,,,,DISCONTINUED
245,EP,B1,EP 0546158 B1,130-540-969-844-196,1998-01-07,1998,EP 92914689 A,1992-06-25,US 9205256 W;;US 72285291 A,1991-06-28,CAPSULE EXTRUSION SYSTEMS,"Methods for producing cell capsules are disclosed in which a coagulant (22), which can include a cell suspension or other biologically active factor, and a polymeric casting solution (26) are extruded through a common extrusion port (14) having at least two concentric bores, such that the coagulant is extruded through the inner bore (16) and the polymeric casting solution is extruded through the outer bore (18). The method involves initiating extrusion of the coagulant within a temporal range of about 10 msecs to about one second from initiating delivery of the casting solution through the respective bores. Delivery of the coagulant is then shut off, and extrusion of the casting solution is terminated either immediately or after some predetermined time.",UNIV BROWN RES FOUND,AEBISCHER PATRICK;;MILLS JOHN F;;WAHLBERG LARS;;DOHERTY EDWARD J;;TRESCO PATRICK A,,https://lens.org/130-540-969-844-196,Granted Patent,yes,1,0,19,124,0,A61J3/07;;A61K9/0024;;A61K9/5089;;B01J13/02;;B01J13/04;;C12N5/0012;;C12N5/0614;;C12N11/04;;C12N2533/30;;A61J3/00,B01J13/14;;A61J/;;A61J3/06;;A61J3/07;;A61K9/00;;A61K9/50;;B01J13/02;;B01J13/04;;C12M1/00;;C12N5/00;;C12N5/02;;C12N5/071;;C12N11/04,,0,0,,,,EXPIRED
246,US,A1,US 2013/0238603 A1,096-134-289-088-29X,2013-09-12,2013,US 201313867995 A,2013-04-22,US 201313867995 A;;US 76693610 A,2010-04-26,SEARCH RESULT PRESENTATION,"A data presentation system for a search engine may use classified or tagged elements in a resulting document to create a search result document that has portions redacted, modified, or changed based on the tags or classifications of elements within the document. The document may be rebuilt from the search engine database at presentation time with one or more elements changed or modified. The permission settings for a user or other factors may be used to determine which elements within the document are permitted to be accessed.",MICROSOFT CORP,SOKOLAN PATRICK;;DOHERTY DENNIS;;DUGUAY CLAUDE;;RADCLIFFE WILLIAM;;BOURASSA VIRGIL,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14),https://lens.org/096-134-289-088-29X,Patent Application,yes,0,4,4,4,0,G06F21/6227;;G06F16/248;;G06F16/972;;G06F16/248;;G06F16/972;;G06F21/6227,G06F17/30,707/722,0,0,,,,ACTIVE
247,WO,A1,WO 1993/000063 A1,089-211-848-635-097,1993-01-07,1993,US 9205256 W,1992-06-25,US 72285291 A,1991-06-28,CAPSULE EXTRUSION SYSTEMS,"Methods for producing cell capsules are disclosed in which a coagulant (22), which can include a cell suspension or other biologically active factor, and a polymeric casting solution (26) are extruded through a common extrusion port (14) having at least two concentric bores, such that the coagulant is extruded through the inner bore (16) and the polymeric casting solution is extruded through the outer bore (18). The method involves initiating extrusion of the coagulant within a temporal range of about 10 msecs to about one second from initiating delivery of the casting solution through the respective bores. Delivery of the coagulant is then shut off, and extrusion of the casting solution is terminated either immediately or after some predetermined time.",UNIV BROWN RES FOUND,AEBISCHER PATRICK;;MILLS JOHN F;;WAHLBERG LARS;;DOHERTY EDWARD J,,https://lens.org/089-211-848-635-097,Patent Application,yes,5,28,19,124,0,A61J3/07;;A61K9/0024;;A61K9/5089;;B01J13/02;;B01J13/04;;C12N5/0012;;C12N5/0614;;C12N11/04;;C12N2533/30;;A61J3/00,A61J/;;A61J3/06;;B01J13/14;;A61J3/07;;A61K9/00;;A61K9/50;;B01J13/02;;B01J13/04;;C12M1/00;;C12N5/00;;C12N5/02;;C12N5/071;;C12N11/04,,0,0,,,,PATENTED
248,US,A1,US 2011/0264628 A1,133-676-167-116-498,2011-10-27,2011,US 76693710 A,2010-04-26,US 76693710 A,2010-04-26,DATA COLLECTOR,"A data collector may monitor a data source and identify updated data, which may be processed and prepared for inclusion into a search database. The data collector may have various handlers that may interact with a data source, which may be a database, web service, file system, collaboration system, or other source, and may store a identifying signature and content signature for each document or item. The signatures may be used to identify new, changed, or deleted items, and a payload may be created containing the updates.",MICROSOFT CORP,SOKOLAN PATRICK;;DOHERTY DENNIS;;DUGUAY CLAUDE;;RADCLIFFE WILLIAM;;BOURASSA VIRGIL,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2010-04-22),https://lens.org/133-676-167-116-498,Patent Application,yes,15,14,2,2,0,G06F16/93;;G06F16/93;;G06F16/2358;;G06F16/2358,G06F17/30;;G06F7/00,707/634;;707/769;;707/754;;707/695;;X707E17008;;X707E1701;;X707E17115,0,0,,,,ACTIVE
249,US,B2,US 8973128 B2,178-938-971-415-122,2015-03-03,2015,US 201313867995 A,2013-04-22,US 201313867995 A;;US 76693610 A,2010-04-26,Search result presentation,"A data presentation system for a search engine may use classified or tagged elements in a resulting document to create a search result document that has portions redacted, modified, or changed based on the tags or classifications of elements within the document. The document may be rebuilt from the search engine database at presentation time with one or more elements changed or modified. The permission settings for a user or other factors may be used to determine which elements within the document are permitted to be accessed.",MICROSOFT CORP,SOKOLAN PATRICK;;DOHERTY DENNIS;;DUGUAY CLAUDE;;RADCLIFFE WILLIAM;;BOURASSA VIRGIL,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14),https://lens.org/178-938-971-415-122,Granted Patent,yes,13,1,4,4,0,G06F21/6227;;G06F16/248;;G06F16/972;;G06F16/248;;G06F16/972;;G06F21/6227,G06F17/00;;G06F17/30;;G06F21/62,726/19,2,0,,,"""Redaction and Removing Metadata to Control Access to Sensitive Content"", Retrieved at >, pp. 1.;;Non-Final Office Action, U.S. Appl. No. 12/766,936, mailing date May 31, 2012, pp. 7.",ACTIVE
250,WO,A1,WO 2020/168252 A1,048-003-935-895-213,2020-08-20,2020,US 2020/0018382 W,2020-02-14,US 201962806196 P,2019-02-15,SHARED PRIVACY PROTECTED DATABASES FOR PERSON OF INTEREST,"The present disclosure relates generally to a system and method for tracking persons of interest over a network, while maintaining privacy between discrete persons of interest databases. The method includes receiving a first image including a person; analyzing the first image for identifiable features corresponding to the person; comparing the identifiable features in the first image to corresponding features in one or more stored POI images in the two or more POI databases; detecting similar features in a second image of a POI that match the identifiable features in the first image within a threshold value, wherein the second image of the POI is from a first POI database of the two or more POI databases, wherein the first POI database is owned by a first user; determining the person is the POI; and extracting information related to the second image of the POI from the first POI database.",KEEE LLC,DOHERTY PATRICK;;WALL JOHN;;DAMES JOHN J;;BIVIANO MICHAEL S,,https://lens.org/048-003-935-895-213,Patent Application,yes,3,0,1,1,0,G06V40/173;;G06V20/30,G06K9/00,,0,0,,,,PENDING
251,US,B2,US 8429740 B2,086-325-863-114-755,2013-04-23,2013,US 76693610 A,2010-04-26,US 76693610 A,2010-04-26,Search result presentation,"A data presentation system for a search engine may use classified or tagged elements in a resulting document to create a search result document that has portions redacted, modified, or changed based on the tags or classifications of elements within the document. The document may be rebuilt from the search engine database at presentation time with one or more elements changed or modified. The permission settings for a user or other factors may be used to determine which elements within the document are permitted to be accessed.",SOKOLAN PATRICK;;DOHERTY DENNIS;;DUGUAY CLAUDE;;RADCLIFFE WILLIAM;;BOURASSA VIRGIL;;MICROSOFT CORP,SOKOLAN PATRICK;;DOHERTY DENNIS;;DUGUAY CLAUDE;;RADCLIFFE WILLIAM;;BOURASSA VIRGIL,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2010-04-22),https://lens.org/086-325-863-114-755,Granted Patent,yes,13,2,4,4,0,G06F21/6227;;G06F16/248;;G06F16/972;;G06F16/248;;G06F16/972;;G06F21/6227,G06F7/04;;G06F12/00,726/19,1,0,,,"""Redaction and Removing Metadata to Control Access to Sensitive Content"", Retrieved at >, pp. 1.",ACTIVE
252,US,A1,US 2011/0265177 A1,018-071-840-685-180,2011-10-27,2011,US 76693610 A,2010-04-26,US 76693610 A,2010-04-26,SEARCH RESULT PRESENTATION,"A data presentation system for a search engine may use classified or tagged elements in a resulting document to create a search result document that has portions redacted, modified, or changed based on the tags or classifications of elements within the document. The document may be rebuilt from the search engine database at presentation time with one or more elements changed or modified. The permission settings for a user or other factors may be used to determine which elements within the document are permitted to be accessed.",MICROSOFT CORP,SOKOLAN PATRICK;;DOHERTY DENNIS;;DUGUAY CLAUDE;;RADCLIFFE WILLIAM;;BOURASSA VIRGIL,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2010-04-22),https://lens.org/018-071-840-685-180,Patent Application,yes,4,39,4,4,0,G06F21/6227;;G06F16/248;;G06F16/972;;G06F16/248;;G06F16/972;;G06F21/6227,G06F17/30;;G06F21/00;;H04L9/32,726/19;;707/769;;X707E17014,0,0,,,,ACTIVE
253,US,B2,US 8949184 B2,096-027-922-576-843,2015-02-03,2015,US 76693710 A,2010-04-26,US 76693710 A,2010-04-26,Data collector,"A data collector may monitor a data source and identify updated data, which may be processed and prepared for inclusion into a search database. The data collector may have various handlers that may interact with a data source, which may be a database, web service, file system, collaboration system, or other source, and may store a identifying signature and content signature for each document or item. The signatures may be used to identify new, changed, or deleted items, and a payload may be created containing the updates.",SOKOLAN PATRICK;;DOHERTY DENNIS;;DUGUAY CLAUDE;;RADCLIFFE WILLIAM;;BOURASSA VIRGIL;;MICROSOFT TECHNOLOGY LICENSING LLC,SOKOLAN PATRICK;;DOHERTY DENNIS;;DUGUAY CLAUDE;;RADCLIFFE WILLIAM;;BOURASSA VIRGIL,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2010-04-22),https://lens.org/096-027-922-576-843,Granted Patent,yes,22,2,2,2,0,G06F16/93;;G06F16/93;;G06F16/2358;;G06F16/2358,G06F17/30,707/634,4,0,,,"""Introducing the Data Collector"", Retrieved at >, Nov. 2009, pp. 1.;;Larsen, Gregory A., ""MS SQL"", Retrieved at << http://www.databasejournal.com/features/mssql/article.php/3771871/SQL-Server-2008-Data-Collections-and-the-Management-Data-Warehouse.htm >>, Sep. 29, 2008, pp. 10.;;Lopes, et al., ""Automated Social Network Epidemic Data Collector"", Retrieved at <>, INforum-Computing Symposium, Sep. 2009, pp. 10.;;""PANGAEA®"", Retrieved at >, Retrieved Date: Feb. 22, 2010, pp. 2.",ACTIVE
254,US,B1,US 6356098 B1,054-213-064-503-634,2002-03-12,2002,US 39496099 A,1999-09-10,US 39496099 A;;US 2788098 A,1998-02-23,"Probe card, test method and test system for semiconductor wafers","
    A probe card for testing a semiconductor wafer, a test method, and a test system employing the probe card are provided. The probe card includes: a substrate; patterns of pin contacts slidably mounted to the substrate; and a force applying member for biasing the pin contacts into electrical contact with die contacts on the wafer. In an illustrative embodiment the force applying member includes spring loaded electrical connectors in physical and electrical contact with the pin contacts. Alternately, the force applying member includes a compressible pad for multiple pin contacts, or separate compressible pads for each pin contact. A penetration depth of the pin contacts into the die contacts is controlled by selecting a spring force of the force applying member, and an amount of Z-direction overdrive of the pin contacts into the die contacts. 
",MICRON TECHNOLOGY INC,AKRAM SALMAN;;DOHERTY C PATRICK;;FARNWORTH WARREN M;;HEMBREE DAVID R,,https://lens.org/054-213-064-503-634,Granted Patent,yes,36,94,2,2,0,G01R31/2886;;G01R31/2886;;G01R1/07378;;G01R1/07378,G01R1/073;;G01R31/28,324/765;;324/754;;324/755,1,0,,,"Science Over Art. Our New IC Membrane Test Probe., Packard Hughes Interconnect, technical brochure, 1993.",EXPIRED
255,US,A1,US 2007/0291145 A1,097-047-813-910-333,2007-12-20,2007,US 48656206 A,2006-07-14,US 48656206 A;;US 81462806 P,2006-06-15,"Methods, devices, and systems for selectable repair of imaging devices","An image sensor includes an array of pixels on a semiconductor device for sensing light incident on the pixel array and a plurality of anomaly registers comprising a plurality of nonvolatile elements. Each anomaly register identifies an anomalous pixel cluster and includes a location indicator with a row and column address and a size indicator with a horizontal and vertical range. In other embodiments, each anomaly register includes a first address, second address, first direction flag, and second direction flag. The first and second direction flags use a first state to indicate a row address or a second state to indicate a column address. The first and second direction flags combine to define an anomalous pixel cluster, a pair of anomalous pixel rows, or a pair of anomalous pixel columns. Some embodiments may include an anomaly type indicator and some embodiments may include a shape indicator.",DOHERTY C PATRICK;;SUKUMAR VINESH;;AMANULLAH SHAHEEN;;DATAR SACHIN;;WALTER NATHAN,DOHERTY C PATRICK;;SUKUMAR VINESH;;AMANULLAH SHAHEEN;;DATAR SACHIN;;WALTER NATHAN,APTINA IMAGING CORPORATION (2008-09-26);;MICRON TECHNOLOGY INC (2006-07-12),https://lens.org/097-047-813-910-333,Patent Application,yes,19,0,5,5,0,H04N25/67;;H04N25/67,H04N5/335,348/294,0,0,,,,DISCONTINUED
256,WO,A3,WO 2007/146991 A3,114-390-784-823-750,2008-03-13,2008,US 2007/0071094 W,2007-06-13,US 81462806 P;;US 48656206 A,2006-06-15,"METHODS, DEVICES, AND SYSTEMS FOR SELECTABLE REPAIR OF IMAGING DEVICES","An image sensor includes an array of pixels on a semiconductor device for sensing light incident on the pixel array and a plurality of anomaly registers comprising a plurality of nonvolatile elements. Each anomaly register identifies an anomalous pixel cluster and includes a location indicator with a row and column address and a size indicator with a horizontal and vertical range. In other embodiments, each anomaly register includes a first address, second address, first direction flag, and second direction flag. The first and second direction flags use a first state to indicate a row address or a second state to indicate a column address. The first and second direction flags combine to define an anomalous pixel cluster, a pair of anomalous pixel rows, or a pair of anomalous pixel columns. Some embodiments may include an anomaly type indicator and some embodiments may include a shape indicator.",MICRON TECHNOLOGY INC;;DOHERTY PATRICK C;;SUKUMAR VINESH;;AMANULLAH SHAHEEN;;DATAR SACHIN;;WALTER NATHAN,DOHERTY PATRICK C;;SUKUMAR VINESH;;AMANULLAH SHAHEEN;;DATAR SACHIN;;WALTER NATHAN,,https://lens.org/114-390-784-823-750,Search Report,yes,8,0,5,5,0,H04N25/67;;H04N25/67,H04N5/217,,0,0,,,,PENDING
257,US,B1,US 6246245 B1,126-674-364-234-642,2001-06-12,2001,US 2788098 A,1998-02-23,US 2788098 A,1998-02-23,"Probe card, test method and test system for semiconductor wafers","A probe card for testing a semiconductor wafer, a test method, and a test system employing the probe card are provided. The probe card includes: a substrate; patterns of pin contacts slidably mounted to the substrate; and a force applying member for biasing the pin contacts into electrical contact with die contacts on the wafer. In an illustrative embodiment the force applying member includes spring loaded electrical connectors in physical and electrical contact with the pin contacts. Alternately, the force applying member includes a compressible pad for multiple pin contacts, or separate compressible pads for each pin contact. A penetration depth of the pin contacts into the die contacts is controlled by selecting a spring force of the force applying member, and an amount of Z-direction overdrive of the pin contacts into the die contacts.",MICRON TECHNOLOGY INC,AKRAM SALMAN;;DOHERTY C PATRICK;;FARNWORTH WARREN M;;HEMBREE DAVID R,MICRON TECHNOLOGY INC (1998-02-18),https://lens.org/126-674-364-234-642,Granted Patent,yes,27,125,2,2,0,G01R31/2886;;G01R31/2886;;G01R1/07378;;G01R1/07378,G01R1/073;;G01R31/28,324/754;;324/761,1,0,,,"Science Over Art. Our New IC Membrane Test Probe., Packard Hughes Interconnect, technical brochure, (No Month Available), 1993.",EXPIRED
258,IE,B2,IE S80395 B2,007-486-581-782-124,1998-06-17,1998,IE S980199 A,1998-03-19,IE S980199 A,1998-03-19,Manufacture of gate barriers,,ELECTRO AUTOMATION RESEARCH EA,DOHERTY PATRICK;;WALSH JOHN ALPHONSUS;;O'BRENNAN KEVIN MICHAEL;;HIGGINS RORY JOHN,,https://lens.org/007-486-581-782-124,Limited Patent,no,0,0,2,2,0,,E01F13/08,,0,0,,,,EXPIRED
259,GB,B,GB 2335690 B,058-052-082-423-057,2002-04-03,2002,GB 9806226 A,1998-03-25,IE 980200 A,1998-03-19,Manufacture of gate barriers,,ELECTRO AUTOMATION RES,DOHERTY PATRICK;;WALSH JOHN ALPHONSUS;;O'BRENNAN KEVIN MICHAEL;;HIGGINS RORY JOHN,,https://lens.org/058-052-082-423-057,Granted Patent,no,2,0,4,4,0,E01F13/06,E01F13/06,E1G G91A          G91A,0,0,,,,EXPIRED
260,TW,A,TW 200824441 A,047-439-738-209-502,2008-06-01,2008,TW 96121949 A,2007-06-15,US 81462806 P;;US 48656206 A,2006-06-15,"Methods, devices, and systems for selectable repair of imaging devices","An image sensor includes an array of pixels on a semiconductor device for sensing light incident on the pixel array and a plurality of anomaly registers comprising a plurality of nonvolatile elements. Each anomaly register identifies an anomalous pixel cluster and includes a location indicator with a row and column address and a size indicator with a horizontal and vertical range. In other embodiments, each anomaly register includes a first address, second address, first direction flag, and second direction flag. The first and second direction flags use a first state to indicate a row address or a second state to indicate a column address. The first and second direction flags combine to define an anomalous pixel cluster, a pair of anomalous pixel rows, or a pair of anomalous pixel columns. Some embodiments may include an anomaly type indicator and some embodiments may include a shape indicator.",MICRON TECHNOLOGY INC,DOHERTY C PATRICK;;SUKUMAR VINESH;;AMANULLAH SHAHEEN;;DATAR SACHIN;;WALTER NATHAN,,https://lens.org/047-439-738-209-502,Patent of Addition,no,0,0,5,5,0,H04N25/67;;H04N25/67,H04N5/335;;H04N5/217,,0,0,,,,PENDING
261,US,B1,US 10567351 B1,059-295-459-117-168,2020-02-18,2020,US 201816033450 A,2018-07-12,US 201816033450 A;;US 201615265380 A,2016-09-14,Polymorphic one time pad matrix,"The present invention provides a simple and efficient cipher and key generation and selection capability from a predetermined, randomly changing, fixed size matrix (N) of ciphers and keys resulting in a very high-order approximation (N r,c→∞ ) of a true One Time Pad for encryption solutions such as the CipherLoc Polymorphic Key Progression Algorithmic Cipher Engine. The ciphers are randomly selected from a pool of user supplied ciphers, FIPS 140-2 or other certified ciphers and the keys are produced from various methods for generating a key that includes reading a data stream from a network or a Cryptographic Pseudo Random Number Generator (CPRNG)/Pseudo Random Number Generator (PRNG) or a Predetermined Cryptographic Key Generator (PCKG) or any combination of all. Ciphers and generated keys are randomly paired and stored in a volatile matrix for use by an encryption solution. When used with the CipherLoc Polymorphic Key Progression Algorithmic (PKPA) Cipher Engine, the OTP Matrix is a method of accomplishing the generation of the key and the selection and association of a suitable cipher with that key, for each sub-message, such that not only key space and equivalent keys (isomorphs) become important, but, the number of keys are also important, thus increasing the effective size of the key space in each sub-message.",CIPHERLOC CORP,CARLSON ALBERT HENRY;;LEBLANC ROBERT;;CARLSON ROBERT;;DOHERTY PATRICK;;GONZALES CARLOS,CIPHERLOC CORPORATION (2016-09-13),https://lens.org/059-295-459-117-168,Granted Patent,yes,3,0,2,2,0,G06F7/582;;H04L63/0428;;H04L63/0428;;H03K19/1776;;H03K19/1776;;H04L9/0625;;H04L9/0662;;H04L9/0662;;H04L9/12;;H04L9/12;;H04L63/062;;H04L63/068;;H04L63/1466,H04L29/06;;G06F7/58;;H03K19/1776;;H04L9/06;;H04L9/12,,0,0,,,,ACTIVE
262,WO,B1,WO 2007/146991 B1,176-308-222-386-003,2008-05-08,2008,US 2007/0071094 W,2007-06-13,US 81462806 P;;US 48656206 A,2006-06-15,"METHODS, DEVICES, AND SYSTEMS FOR SELECTABLE REPAIR OF IMAGING DEVICES","An image sensor includes an array of pixels on a semiconductor device for sensing light incident on the pixel array and a plurality of anomaly registers comprising a plurality of nonvolatile elements. Each anomaly register identifies an anomalous pixel cluster and includes a location indicator with a row and column address and a size indicator with a horizontal and vertical range. In other embodiments, each anomaly register includes a first address, second address, first direction flag, and second direction flag. The first and second direction flags use a first state to indicate a row address or a second state to indicate a column address. The first and second direction flags combine to define an anomalous pixel cluster, a pair of anomalous pixel rows, or a pair of anomalous pixel columns. Some embodiments may include an anomaly type indicator and some embodiments may include a shape indicator.",MICRON TECHNOLOGY INC;;DOHERTY PATRICK C;;SUKUMAR VINESH;;AMANULLAH SHAHEEN;;DATAR SACHIN;;WALTER NATHAN,DOHERTY PATRICK C;;SUKUMAR VINESH;;AMANULLAH SHAHEEN;;DATAR SACHIN;;WALTER NATHAN,,https://lens.org/176-308-222-386-003,Patent Application,no,0,0,5,5,0,H04N25/67;;H04N25/67,H04N5/217,,0,0,,,,PENDING
263,WO,A1,WO 2002/062387 A1,193-500-323-039-824,2002-08-15,2002,GB 0200542 W,2002-02-07,GB 0103031 A,2001-02-07,TREATMENT OF CONDITIONS WITH A NEED OF GSK-3 INHIBITION,"A method of treatment for the promotion of nerve regeneration, including axonal regrowth, axonal outgrowth, and prevention of growth cone collapse, in cases of acute neuronal injury, such as crush injury, acute stroke, ischaemia, neurotraumatic insult, spinal cord injury and neurotrauma in humans or non-human mammals, which method comprises the administration of an effective, non-toxic and pharmaceutically acceptable amount of a GSK-3 inhibitor or a pharmaceutically acceptable derivative thereof.",SMITHKLINE BEECHAM PLC;;DOHERTY PATRICK;;EICKHOLT BRITTA JOHANNA;;SKAPER STEPHEN DRAKE;;WALSH FRANK SINCLAIR,DOHERTY PATRICK;;EICKHOLT BRITTA JOHANNA;;SKAPER STEPHEN DRAKE;;WALSH FRANK SINCLAIR,,https://lens.org/193-500-323-039-824,Patent Application,yes,4,0,2,2,0,A61K31/00,A61K31/00,,0,0,,,,PENDING
264,IE,A2,IE S980199 A2,184-421-880-411-375,1998-06-17,1998,IE S980199 A,1998-03-19,IE S980199 A,1998-03-19,Manufacture of gate barriers,A gate barrier is produced by production of a beam in a dedicated beam production plant (20). The base is produced at a separate plant (35) alongside the beam production plant (20). A spine is mounted on a mobile platform (45) having a height-adjustable deck (48) which is mobile between the stations (40-43). There is easy connection of sub-assemblies at a workstation (41) after adjustment of the height to the desired level. A jig (80) is used for application of a locknut with correct alignment and torque. The base is moved into accurate registry using the platform (45). The platform (45) is again used to move the base into registry with a load simulator (90) for flexible application of test loads. <Fig. 5>,ELECTRO AUTOMATION RESEARCH EA,DOHERTY PATRICK;;WALSH JOHN ALPHONSUS;;O'BRENNAN KEVIN MICHAEL;;HIGGINS RORY JOHN,,https://lens.org/184-421-880-411-375,Patent Application,no,0,0,2,2,0,,E01F13/08,,0,0,,,,EXPIRED
265,WO,A2,WO 2007/146991 A2,190-831-590-729-114,2007-12-21,2007,US 2007/0071094 W,2007-06-13,US 81462806 P;;US 48656206 A,2006-06-15,"METHODS, DEVICES, AND SYSTEMS FOR SELECTABLE REPAIR OF IMAGING DEVICES","An image sensor includes an array of pixels on a semiconductor device for sensing light incident on the pixel array and a plurality of anomaly registers comprising a plurality of nonvolatile elements. Each anomaly register identifies an anomalous pixel cluster and includes a location indicator with a row and column address and a size indicator with a horizontal and vertical range. In other embodiments, each anomaly register includes a first address, second address, first direction flag, and second direction flag. The first and second direction flags use a first state to indicate a row address or a second state to indicate a column address. The first and second direction flags combine to define an anomalous pixel cluster, a pair of anomalous pixel rows, or a pair of anomalous pixel columns. Some embodiments may include an anomaly type indicator and some embodiments may include a shape indicator.",MICRON TECHNOLOGY INC;;DOHERTY PATRICK C;;SUKUMAR VINESH;;AMANULLAH SHAHEEN;;DATAR SACHIN;;WALTER NATHAN,DOHERTY PATRICK C;;SUKUMAR VINESH;;AMANULLAH SHAHEEN;;DATAR SACHIN;;WALTER NATHAN,,https://lens.org/190-831-590-729-114,Patent Application,yes,0,2,5,5,0,H04N25/67;;H04N25/67,H04N5/335,,0,0,,,,PENDING
266,US,B1,US 6910896 B1,071-660-068-360-328,2005-06-28,2005,US 1442101 A,2001-12-14,US 1442101 A;;US 25543000 P,2000-12-15,Mechanical lungs,"An apparatus is provided for simulating and monitoring a respiration pattern of a human. The apparatus generally includes a reservoir having an outlet, and actuator disposed in the reservoir for moving fluid in and out of the reservoir, and a control unit coupled to the actuator for controlling the actuator to simulate and monitor a respiration pattern of a human. Also, a method is provided for simulating and monitoring a respiration pattern of a human. The method includes steps of generating a waveform defining the respiration pattern and controlling an actuator to move fluid in and out of a reservoir based on the waveform. The apparatus and method can accurately simulate and monitor a respiration pattern of a human, especially an infant and a young child, and offer a flexibility to stimulate variety of respiration patterns.",RAM CONSULTING INC,OWENS JOHN E;;MILKOVICH SCOTT M;;STOOL DANIEL K;;DOHERTY PATRICK,RAM CONSULTING (2003-10-15),https://lens.org/071-660-068-360-328,Granted Patent,yes,6,52,1,2,0,G09B23/288;;G09B23/288,G09B23/28,434/267;;600/300,0,0,,,,EXPIRED
267,BR,A2,BR 112020012916 A2,068-485-465-848-85X,2020-12-08,2020,BR 112020012916 A,2019-01-09,US 2019/0012890 W;;US 201862615242 P,2018-01-09,métodos para medição de analito e/ou proteína em amostras biológicas,"a presente invenção refere-se a métodos para medição de um analito sozinho ou em combinação com proteína total em amostras biológicas. mais particularmente, a exposição refere-se a métodos para medição de um analito e/ou proteína total usando um ou mais reagentes colorimétricos sozinhos ou em combinação com reagentes de precipitação de proteína.",IDEXX LAB INC,GIOSI FARACE;;KEVIN KIRSPEL;;MURTHY V S N YERRAMILLI;;PATRICK DOHERTY,,https://lens.org/068-485-465-848-85X,Patent Application,no,0,0,14,14,0,G01N21/272;;G01N21/82;;G01N21/78;;G01N33/52;;G01N33/6827;;G01N31/22;;G01N21/272;;G01N21/78;;G01N21/82;;G01N33/52;;G01N31/22;;G01N33/6827;;G01N31/22;;G01N21/272;;G01N1/30;;G01N21/82;;H04N23/73;;G01N21/78;;G01N33/52;;G01N33/6827;;G06T7/0012;;G06T2207/10144;;G06T2207/30242,G01N21/27;;G01N1/28;;G01N1/30;;G01N33/52;;G01N33/68,,0,0,,,,PENDING
268,GB,A,GB 2335690 A,144-840-624-694-957,1999-09-29,1999,GB 9806226 A,1998-03-25,IE 980200 A,1998-03-19,Manufacture of gate barriers,"A gate barrier comprises a beam and a base, the base consisting a spine, mounted on a mobile platform (45) having a height-adjustable deck (48) which is movable between the stations (40-43). There is easy construction of sub-assemblies at a workstation (41) after adjustment of the height to a desired level. A jig (80, figs 7-10) is used for application of a locknut with correct alignment and torque. The base is moved into accurate registry with a load simulator (90, figs 11 and 12) for flexible application of test loads. The beam is preferably produced in a separate production plant (20, figs 2 and 3).",ELECTRO AUTOMATION RESEARCH,DOHERTY PATRICK;;WALSH JOHN ALPHONSUS;;O'BRENNAN KEVIN MICHAEL;;HIGGINS RORY JOHN,,https://lens.org/144-840-624-694-957,Patent Application,no,2,0,4,4,0,E01F13/06,E01F13/06,E1G G91A          G91A,0,0,,,,EXPIRED
269,US,B1,US 10069805 B1,141-454-460-830-849,2018-09-04,2018,US 201615265380 A,2016-09-14,US 201615265380 A,2016-09-14,Polymorphic one time pad matrix,"The present invention provides a simple and efficient cipher and key generation and selection capability from a predetermined, randomly changing, fixed size matrix (N) of ciphers and keys resulting in a very high-order approximation (N r,c→∞ ) of a true One Time Pad for encryption solutions such as the CipherLoc Polymorphic Key Progression Algorithmic Cipher Engine. The ciphers are randomly selected from a pool of user supplied ciphers, FIPS 140-2 or other certified ciphers and the keys are produced from various methods for generating a key that includes reading a data stream from a network or a Cryptographic Pseudo Random Number Generator (CPRNG)/Pseudo Random Number Generator (PRNG) or a Predetermined Cryptographic Key Generator (PCKG) or any combination of all. Ciphers and generated keys are randomly paired and stored in a volatile matrix for use by an encryption solution. When used with the CipherLoc Polymorphic Key Progression Algorithmic (PKPA) Cipher Engine, the OTP Matrix is a method of accomplishing the generation of the key and the selection and association of a suitable cipher with that key, for each sub-message, such that not only key space and equivalent keys (isomorphs) become important, but, the number of keys are also important, thus increasing the effective size of the key space in each sub-message.",CIPHERLOC CORP,CARLSON ALBERT HENRY;;LEBLANC ROBERT;;CARLSON ROBERT;;DOHERTY PATRICK;;GONZALES CARLOS,CIPHERLOC CORPORATION (2016-09-13),https://lens.org/141-454-460-830-849,Granted Patent,yes,10,8,2,2,0,G06F7/582;;H04L63/0428;;H04L63/0428;;H03K19/1776;;H03K19/1776;;H04L9/0625;;H04L9/0662;;H04L9/0662;;H04L9/12;;H04L9/12;;H04L63/062;;H04L63/068;;H04L63/1466,H04L29/06;;G06F7/58;;H03K19/177;;H04L9/06;;H04L9/12,,1,0,,,"CipherLoc, “Overcoming the Limitations of Modern Encryption Algorithms in Order to Protect the World's Data” White Paper, Retrieved From https://cipherloc.net/wp-content/uploads/2018/02/CipherLoc-White-Paper-Overcoming-the-Limitations-of-Modern-Encryption.pdf, Published Jul. 2016 (Year: 2016).",ACTIVE
270,EP,A1,EP 4329674 A1,164-870-719-870-303,2024-03-06,2024,EP 22722564 A,2022-04-25,US 202163181565 P;;IB 2022053805 W,2021-04-29,TRANSCATHETER DEVICES AND METHODS FOR TREATMENT OF A HEART,,EDWARDS LIFESCIENCES INNOVATION ISRAEL LTD,HOFFER ERAN;;BRAUON HAIM;;SHEPS TAL;;MURPHY BRIAN PATRICK;;DOHERTY THOMAS V,,https://lens.org/164-870-719-870-303,Patent Application,yes,0,0,5,5,0,A61F2/2451;;A61F2/2466;;A61F2250/001;;A61F2220/0016;;A61F2/90,A61F2/24,,0,0,,,,PENDING
271,EP,A1,EP 2464300 A1,069-744-124-951-293,2012-06-20,2012,EP 10747299 A,2010-08-12,IE 20090623 A;;IE 20100345 A;;IE 2010000047 W,2009-08-13,INTRAMEDULLARY NAILS FOR LONG BONE FRACTURE SETTING,,CORK INST TECHNOLOGY,DOHERTY WILLIAM;;O'CONNOR PATRICK;;HARTY JAMES;;DAILEY HANNAH;;DALY CHARLES;;O'DRISCOLL OLIVE,"ORTHOXEL DAC, IE (2017-08-01);;ORTHOXEL DAC (2017-04-11);;ORTHOXEL DAC, BISHOPSTOWN, IE (2017-02-16)",https://lens.org/069-744-124-951-293,Patent Application,yes,0,2,8,9,0,A61B17/7225;;A61B17/7241;;A61B17/7225;;A61B17/7241;;A61B17/725,A61B17/72,,0,0,,,,ACTIVE
272,US,A1,US 2011/0270834 A1,062-761-894-614-832,2011-11-03,2011,US 76873110 A,2010-04-28,US 76873110 A,2010-04-28,Data Classifier,"A document classifier may analyze documents for a search engine and tag the documents. A document classifier system may have several different classifiers, each with a separate algorithm for classification. Some of the data classifiers may learn or change the classification over time with a feedback loop. As those classifiers are modified, updated, replaced, or added, the documents that have already been classified by the classifier may be re-examined to update their classification. The document classifier system may maintain a database of documents with a timestamp that the document was classified that may be used to identify those documents whose classifications may be out of date.",MICROSOFT CORP,SOKOLAN PATRICK;;DOHERTY DENNIS;;DUGUAY CLAUDE;;RADCLIFFE WILLIAM;;BOURASSA VIRGIL;;SHEPPARD JOHN,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2010-04-22),https://lens.org/062-761-894-614-832,Patent Application,yes,6,182,4,4,0,G06F16/353;;G06F40/237;;G06F16/353;;G06F40/237,G06F17/30;;G06F40/237,707/737;;707/769;;707/802;;X707E17089;;X707E17014;;X707E17044,0,0,,,,ACTIVE
273,DE,T2,DE 69829986 T2,091-671-106-577-990,2006-02-23,2006,DE 69829986 T,1998-02-11,US 79771997 A;;US 9803432 W,1997-02-11,TESTKARTE ZUR WAFER-PRÜFUNG,The probe card (10) is used in the testing of a semiconductor wafer (12) which has a number of semiconductor dice each with several contact locations. The wafer is supported circuit side up for contact with the probe. The probe card comprises an interconnect substrate (16) and a membrane (18). The substrate includes patterns of contact members (20) configured to contact the contact locations of the semiconductor dice. The membrane physically and electrically attaches the interconnect substrate to a probe card fixture (22) mounted to the testing appts. A membrane mounting plate (24) secures the membrane to the fixture. A force applying mechanism (32) and spring-loaded force applying member (34) are associated with the card.,MICRON TECHNOLOGY INC,HEMBREE R;;FARNWORTH M;;AKRAM SALMAN;;WOOD G;;DOHERTY PATRICK;;KRIVY J,,https://lens.org/091-671-106-577-990,Granted Patent,no,0,3,14,17,0,G01R1/073;;G01R31/2886;;G01R1/073;;G01R31/2886,G01R1/073;;G01R31/28;;G01R31/316,,0,0,,,,EXPIRED
274,DE,D1,DE 69829986 D1,136-368-606-942-762,2005-06-02,2005,DE 69829986 T,1998-02-11,US 79771997 A;;US 9803432 W,1997-02-11,TESTKARTE ZUR WAFER-PRÜFUNG,The probe card (10) is used in the testing of a semiconductor wafer (12) which has a number of semiconductor dice each with several contact locations. The wafer is supported circuit side up for contact with the probe. The probe card comprises an interconnect substrate (16) and a membrane (18). The substrate includes patterns of contact members (20) configured to contact the contact locations of the semiconductor dice. The membrane physically and electrically attaches the interconnect substrate to a probe card fixture (22) mounted to the testing appts. A membrane mounting plate (24) secures the membrane to the fixture. A force applying mechanism (32) and spring-loaded force applying member (34) are associated with the card.,MICRON TECHNOLOGY INC,HEMBREE R;;FARNWORTH M;;AKRAM SALMAN;;WOOD G;;DOHERTY PATRICK;;KRIVY J,,https://lens.org/136-368-606-942-762,Granted Patent,no,0,0,14,17,0,G01R1/073;;G01R31/2886;;G01R1/073;;G01R31/2886,G01R1/073;;G01R31/28,,0,0,,,,EXPIRED
275,US,A1,US 2024/0065837 A1,162-526-752-220-657,2024-02-29,2024,US 202318496795 A,2023-10-27,US 202318496795 A;;IB 2022053805 W;;US 202163181565 P,2021-04-29,TRANSCATHETER DEVICES AND METHODS FOR TREATMENT OF A HEART,"A method of repairing a mitral valve of a heart of a subject comprises positioning an elongate support of an implant at the heart such that the support is aligned with a coronary sinus of the heart. A first anchor of the implant is anchored to a first location on an anterior side of the valve, such that a first tether-segment of the implant spans across the valve between the first anchor and a first end of the support. A second anchor of the implant is anchored to a second location on the anterior side of the valve, such that a second tether-segment of the implant spans across the valve between the second anchor and a second end of the support. Other embodiments are also described.",EDWARDS LIFESCIENCES INNOVATION ISRAEL LTD,HOFFER ERAN;;BRAUON HAIM;;SHEPS TAL;;MURPHY BRIAN PATRICK;;DOHERTY THOMAS V,,https://lens.org/162-526-752-220-657,Patent Application,yes,0,0,5,5,0,A61F2/2451;;A61F2/2466;;A61F2250/001;;A61F2220/0016;;A61F2/90,A61F2/24,,0,0,,,,PENDING
276,EP,A1,EP 1320254 A1,199-197-018-073-160,2003-06-18,2003,EP 01650147 A,2001-12-12,EP 01650147 A,2001-12-12,An image processing system,"Four images are acquired from overlapping fields of view, and are combined to provide a single image of higher resolution. The camera and the object are displaced relative to each other in short moves of one half a pixel.",MV RES LTD,MAHON JAMES;;DOHERTY JOHN;;HARTON ANDREW;;SMITH PATRICK;;DULLAGHAN MARK;;TOFTNESS RICHARD,,https://lens.org/199-197-018-073-160,Patent Application,yes,4,3,1,1,0,H04N23/58;;H04N25/48,H04N5/225;;H04N5/349,,0,0,,,,DISCONTINUED
277,EP,B1,EP 2464300 B1,133-504-210-243-417,2014-08-27,2014,EP 10747299 A,2010-08-12,IE 20090623 A;;IE 20100345 A;;IE 2010000047 W,2009-08-13,INTRAMEDULLARY NAILS FOR LONG BONE FRACTURE SETTING,,CORK INST TECHNOLOGY,DOHERTY WILLIAM;;O'CONNOR PATRICK;;HARTY JAMES;;DAILEY HANNAH;;DALY CHARLES;;O'DRISCOLL OLIVE,"ORTHOXEL DAC, IE (2017-08-01);;ORTHOXEL DAC (2017-04-11);;ORTHOXEL DAC, BISHOPSTOWN, IE (2017-02-16)",https://lens.org/133-504-210-243-417,Granted Patent,yes,7,0,8,9,0,A61B17/7225;;A61B17/7241;;A61B17/7225;;A61B17/7241;;A61B17/725,A61B17/72,,0,0,,,,ACTIVE
278,ES,T3,ES 2522822 T3,078-623-421-722-011,2014-11-18,2014,ES 10747299 T,2010-08-12,IE 20090623 A;;IE 20100345 A;;IE 2010000047 W,2009-08-13,Clavos intramedulares para reducción de fractura de hueso largo,"Un clavo (540) intramedular que comprende: un vástago (541) del clavo; un tornillo (115) de hueso proximal y un tornillo (115) de hueso distal; un inserto (542) dentro del vástago (541) del clavo y que tiene una rendija (543) para recibir dicho tornillo (115) de hueso proximal para el acoplamiento con un primer fragmento de hueso; teniendo el vástago del clavo una rendija (8) distal para recibir dicho tornillo (115) de hueso distal para el acoplamiento con un segundo fragmento de hueso; teniendo el vástago una rendija (546) proximal dispuesta para la alineación con la rendija (543) de tornillo de hueso de inserto, adaptándose el inserto (542) para guiar la inserción del tornillo (115) de hueso proximal a través de la rendija (546) proximal del vástago sin adoptar carga axial del tornillo de hueso proximal y estando el inserto (542) constreñido (550, 551) para moverse axialmente solo dentro del vástago (541) sin rotación relativa del inserto y el vástago; y donde, el clavo se adapta para permitir el movimiento relativo axial, limitado y repetido de menos de 1,5 mm del inserto y el vástago se determina mediante una diferencia en el tamaño en sección transversal entre el tornillo (115) de hueso proximal y la rendija (546) proximal del vástago.",CORK INST TECHNOLOGY,DOHERTY WILLIAM;;O'CONNOR PATRICK;;HARTY JAMES;;DAILEY HANNAH;;DALY CHARLES;;O'DRISCOLL OLIVE,,https://lens.org/078-623-421-722-011,Granted Patent,no,0,0,8,9,0,A61B17/7225;;A61B17/7241;;A61B17/7225;;A61B17/7241;;A61B17/725,A61B17/72,,0,0,,,,ACTIVE
279,US,A1,US 2015/0127002 A1,157-500-292-104-519,2015-05-07,2015,US 201414543983 A,2014-11-18,US 201414543983 A;;IE 20090623 A;;IE 20100345 A;;US 201213389130 A;;IE 2010000047 W,2009-08-13,INTRAMEDULLARY NAILS FOR LONG BONE FRACTURE SETTING,"An intramedullary nail has a proximal part for engagement with a proximal bone fragment and a distal part for engagement with a distal bone fragment. A motion assembly interconnects the parts and allows limited axial relative motion of the proximal and distal parts. This limited axial motion provides micromotion and in some embodiments also dynamisation. The nail may comprise a stem for fastening to one bone fragment and an insert within the stem for fastening to the other bone fragment, the insert being adapted to guide insertion of a bone screw through the stem and to prevent relative rotation of the distal and proximal bone fragments. The motion assembly may include spring bias and/or damping means between the parts, possibly including one or more Belleville washers.",CORK INST TECHNOLOGY,DOHERTY WILLIAM;;O'CONNOR PATRICK;;HARTY JAMES;;DAILEY HANNAH;;DALY CHARLES;;O'DRISCOLL OLIVE,CORK INSTITUTE OF TECHNOLOGY (2014-12-30);;ORTHOXEL DAC (2016-07-09),https://lens.org/157-500-292-104-519,Patent Application,yes,3,4,8,9,0,A61B17/7225;;A61B17/7241;;A61B17/7225;;A61B17/7241;;A61B17/725,A61B17/72,606/62,0,0,,,,ACTIVE
280,WO,A1,WO 2022/229815 A1,002-961-267-495-731,2022-11-03,2022,IB 2022053805 W,2022-04-25,US 202163181565 P,2021-04-29,TRANSCATHETER DEVICES AND METHODS FOR TREATMENT OF A HEART,"A tether (10) can be transluminally advanced into a coronary blood vessel of the heart. At a first location (14a), a first terminus (10a) of the tether is advanced through a wall of the vessel into a chamber of the heart, and is then transluminally drawn out of the chamber such that a first segment of the tether extends from the first location through the chamber. At a second location (14b), a second terminus (10b) of the tether is advanced through the wall, into the chamber, and is drawn transluminally out of the chamber such that a second segment of the tether extends from the second location through the chamber. At least one anchor (50) is slid over and along at least one of the first and second termini and anchored to tissue of the chamber. The chamber can then be reshaped by modifying tension in the tether.",EDWARDS LIFESCIENCES INNOVATION ISRAEL LTD,HOFFER ERAN;;BRAUON HAIM;;SHEPS TAL;;MURPHY BRIAN PATRICK;;DOHERTY THOMAS V,,https://lens.org/002-961-267-495-731,Patent Application,yes,15,16,5,5,0,A61F2/2451;;A61F2/2466;;A61F2250/001;;A61F2220/0016;;A61F2/90,A61F2/24,,0,0,,,,PENDING
281,WO,A1,WO 2011/018778 A1,139-478-621-456-961,2011-02-17,2011,IE 2010000047 W,2010-08-12,IE 20090623 A;;IE 20100345 A,2009-08-13,INTRAMEDULLARY NAILS FOR LONG BONE FRACTURE SETTING,"An intramedullary nail has a proximal part for engagement with a proximal bone fragment and a distal part for engagement with a distal bone fragment. A motion assembly interconnects the parts and allows limited axial relative motion of the proximal and distal parts. This limited axial motion provides micromotion and in some embodiments also dynamisation. The nail may comprise a stem (7) for fastening to one bone fragment and an insert (30) within the stem for fastening to the other bone fragment, the insert being adapted to guide insertion of a bone screw through the stem and to prevent relative rotation of the distal and proximal bone fragments. The motion assembly may include spring bias and/or damping means (33) between the parts, possibly including one or more Belleville washers.",CORK INST TECHNOLOGY;;DOHERTY WILLIAM;;O'CONNOR PATRICK;;HARTY JAMES;;DAILEY HANNAH;;DALY CHARLES;;O'DRISCOLL OLIVE,DOHERTY WILLIAM;;O'CONNOR PATRICK;;HARTY JAMES;;DAILEY HANNAH;;DALY CHARLES;;O'DRISCOLL OLIVE,,https://lens.org/139-478-621-456-961,Patent Application,yes,9,39,8,9,0,A61B17/7225;;A61B17/7241;;A61B17/7225;;A61B17/7241;;A61B17/725,A61B17/72,,0,0,,,,PENDING
282,US,A1,US 2012/0290927 A1,167-968-390-289-226,2012-11-15,2012,US 201213557054 A,2012-07-24,US 201213557054 A;;US 76873110 A,2010-04-28,Data Classifier,"A document classifier may analyze documents for a search engine and tag the documents. A document classifier system may have several different classifiers, each with a separate algorithm for classification. Some of the data classifiers may learn or change the classification over time with a feedback loop. As those classifiers are modified, updated, replaced, or added, the documents that have already been classified by the classifier may be re-examined to update their classification. The document classifier system may maintain a database of documents with a timestamp that the document was classified that may be used to identify those documents whose classifications may be out of date.",SOKOLAN PATRICK;;DOHERTY DENNIS;;DUGUAY CLAUDE;;RADCLIFFE WILLIAM;;BOURASSA VIRGIL;;SHEPPARD JOHN;;MICROSOFT CORP,SOKOLAN PATRICK;;DOHERTY DENNIS;;DUGUAY CLAUDE;;RADCLIFFE WILLIAM;;BOURASSA VIRGIL;;SHEPPARD JOHN,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2010-04-22),https://lens.org/167-968-390-289-226,Patent Application,yes,3,4,4,4,0,G06F16/353;;G06F40/237;;G06F16/353;;G06F40/237,G06F17/00;;G06F40/237,715/255,0,0,,,,ACTIVE
283,US,B2,US 9339312 B2,097-485-663-174-560,2016-05-17,2016,US 201414543983 A,2014-11-18,US 201414543983 A;;IE 20090623 A;;IE 20100345 A;;US 201213389130 A;;IE 2010000047 W,2009-08-13,Intramedullary nails for long bone fracture setting,"An intramedullary nail has a proximal part for engagement with a proximal bone fragment and a distal part for engagement with a distal bone fragment. A motion assembly interconnects the parts and allows limited axial relative motion of the proximal and distal parts. This limited axial motion provides micromotion and in some embodiments also dynamization. The nail may comprise a stem for fastening to one bone fragment and an insert within the stem for fastening to the other bone fragment, the insert being adapted to guide insertion of a bone screw through the stem and to prevent relative rotation of the distal and proximal bone fragments. The motion assembly may include spring bias and/or damping means between the parts, possibly including one or more Belleville washers.",CORK INST TECHNOLOGY,DOHERTY WILLIAM;;O'CONNOR PATRICK;;HARTY JAMES;;DAILEY HANNAH;;DALY CHARLES;;O'DRISCOLL OLIVE,CORK INSTITUTE OF TECHNOLOGY (2014-12-30);;ORTHOXEL DAC (2016-07-09),https://lens.org/097-485-663-174-560,Granted Patent,yes,12,25,8,9,0,A61B17/7225;;A61B17/7241;;A61B17/7225;;A61B17/7241;;A61B17/725,A61B17/58;;A61B17/56;;A61B17/72;;A61F2/30,,1,0,,,"International Search Report dated Jan. 18, 2011.",ACTIVE
284,US,B2,US 8612444 B2,012-145-007-922-319,2013-12-17,2013,US 201213557054 A,2012-07-24,US 201213557054 A;;US 76873110 A,2010-04-28,Data classifier,"A document classifier may analyze documents for a search engine and tag the documents. A document classifier system may have several different classifiers, each with a separate algorithm for classification. Some of the data classifiers may learn or change the classification over time with a feedback loop. As those classifiers are modified, updated, replaced, or added, the documents that have already been classified by the classifier may be re-examined to update their classification. The document classifier system may maintain a database of documents with a timestamp that the document was classified that may be used to identify those documents whose classifications may be out of date.",SOKOLAN PATRICK;;DOHERTY DENNIS;;DUGUAY CLAUDE;;RADCLIFFE WILLIAM;;BOURASSA VIRGIL;;SHEPPARD JOHN;;MICROSOFT CORP,SOKOLAN PATRICK;;DOHERTY DENNIS;;DUGUAY CLAUDE;;RADCLIFFE WILLIAM;;BOURASSA VIRGIL;;SHEPPARD JOHN,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2010-04-22),https://lens.org/012-145-007-922-319,Granted Patent,yes,14,2,4,4,0,G06F16/353;;G06F40/237;;G06F16/353;;G06F40/237,G06F7/00;;G06F40/237,707/736;;707/802,2,1,019-674-597-914-738,10.1109/itcc.2001.918768,"Goharian, et al., ""Enterprise Text Processing: A Sparse Matrix Approach"", Retrieved at << http://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arnumber=918768 Overview of the Information Retrieval Matrix Approach>>, Proceedings International Conference on Information Technology: Coding and Computing, Apr. 2001, pp. 71-75.;;Litwin, et al., ""Fast nGramBased String Search Over Data Encoded Using Algebraic Signatures"", Retrieved at >, Very Large Data Bases, Proceedings of the 33rd international conference on Very large data bases, Sep. 23-27, 2007, pp. 207-218.",ACTIVE
285,US,B2,US 8255399 B2,010-795-482-109-978,2012-08-28,2012,US 76873110 A,2010-04-28,US 76873110 A,2010-04-28,Data classifier,"A document classifier may analyze documents for a search engine and tag the documents. A document classifier system may have several different classifiers, each with a separate algorithm for classification. Some of the data classifiers may learn or change the classification over time with a feedback loop. As those classifiers are modified, updated, replaced, or added, the documents that have already been classified by the classifier may be re-examined to update their classification. The document classifier system may maintain a database of documents with a timestamp that the document was classified that may be used to identify those documents whose classifications may be out of date.",SOKOLAN PATRICK;;DOHERTY DENNIS;;DUGUAY CLAUDE;;RADCLIFFE WILLIAM;;BOURASSA VIRGIL;;SHEPPARD JOHN;;MICROSOFT CORP,SOKOLAN PATRICK;;DOHERTY DENNIS;;DUGUAY CLAUDE;;RADCLIFFE WILLIAM;;BOURASSA VIRGIL;;SHEPPARD JOHN,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2010-04-22),https://lens.org/010-795-482-109-978,Granted Patent,yes,12,7,4,4,0,G06F16/353;;G06F40/237;;G06F16/353;;G06F40/237,G06F7/00;;G06F40/237,707/736;;707/802,2,1,019-674-597-914-738,10.1109/itcc.2001.918768,"Goharian, et al., ""Enterprise Text Processing: A Sparse Matrix Approach"", Retrieved at << http://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arnumber=918768 Overview of the Information Retrieval Matrix Approach >>, Proceedings International Conference on Information Technology: Coding and Computing, Apr. 2001, pp. 71-75.;;Litwin, et al., ""Fast nGramBased String Search Over Data Encoded Using Algebraic Signatures"", Retrieved at >, Very Large Data Bases, Proceedings of the 33rd international conference on Very large data bases, Sep. 23-27, 2007, pp. 207-218.",ACTIVE
286,IE,A1,IE 20100506 A1,184-868-517-724-220,2011-03-30,2011,IE 20100506 A,2010-08-12,IE 20090623 A;;IE 20100506 A,2009-08-13,Intramedullary nails for long bone fracture setting,"An intramedullary nail has a proximal part for engagement with a proximal bone fragment and a distal part for engagement with a distal bone fragment. A motion assembly interconnects the parts and allows limited axial relative motion of the proximal and distal parts. This limited axial motion provides micromotion and in some embodiments also dynamisation. The nail may comprise a stem for fastening to one bone fragment and an insert within the stem for fastening to the other bone fragment, the insert being adapted to guide insertion of a bone screw through the stem and to prevent relative rotation of the distal and proximal bone fragments. The motion assembly may include spring bias and/or damping means between the parts, possibly including one or more Belville washers. <Figure 3>",CORK INST TECHNOLOGY,HARTY JAMES;;DOHERTY WILLIAM;;O'CONNOR PATRICK;;DAILEY HANNAH;;DALY CHARLES;;O'DRISCOLL OLIVE,,https://lens.org/184-868-517-724-220,Patent Application,no,0,1,1,9,0,,A61B17/00,,0,0,,,,DISCONTINUED
287,US,B2,US 8915917 B2,194-938-219-527-265,2014-12-23,2014,US 201013389130 A,2010-08-12,IE 20090623 A;;IE 20100345 A;;IE 2010000047 W,2009-08-13,Intramedullary nails for long bone fracture setting,"An intramedullary nail has a proximal part for engagement with a proximal bone fragment and a distal part for engagement with a distal bone fragment. A motion assembly interconnects the parts and allows limited axial relative motion of the proximal and distal parts. This limited axial motion provides micromotion and in some embodiments also dynamization. The nail may comprise a stem for fastening to one bone fragment and an insert within the stem for fastening to the other bone fragment, the insert being adapted to guide insertion of a bone screw through the stem and to prevent relative rotation of the distal and proximal bone fragments. The motion assembly may include spring bias and/or damping means between the parts, possibly including one or more Belleville washers.",DOHERTY WILLIAM;;O'CONNOR PATRICK;;HARTY JAMES;;DAILEY HANNAH;;DALY CHARLES;;O'DRISCOLL OLIVE;;CORK INST TECHNOLOGY,DOHERTY WILLIAM;;O'CONNOR PATRICK;;HARTY JAMES;;DAILEY HANNAH;;DALY CHARLES;;O'DRISCOLL OLIVE,CORK INSTITUTE OF TECHNOLOGY (2012-01-27);;ORTHOXEL DAC (2016-07-09),https://lens.org/194-938-219-527-265,Granted Patent,yes,12,75,8,9,0,A61B17/7225;;A61B17/7241;;A61B17/7225;;A61B17/7241;;A61B17/725,A61B17/56;;A61B17/58;;A61B17/72;;A61F2/30,606/62;;606/64,1,0,,,"International Search Report dated Jan. 18, 2011.",ACTIVE
288,CA,A1,CA 3216861 A1,113-239-389-879-30X,2022-11-03,2022,CA 3216861 A,2022-04-25,US 202163181565 P;;IB 2022053805 W,2021-04-29,TRANSCATHETER DEVICES AND METHODS FOR TREATMENT OF A HEART,"A tether (10) can be transluminally advanced into a coronary blood vessel of the heart. At a first location (14a), a first terminus (10a) of the tether is advanced through a wall of the vessel into a chamber of the heart, and is then transluminally drawn out of the chamber such that a first segment of the tether extends from the first location through the chamber. At a second location (14b), a second terminus (10b) of the tether is advanced through the wall, into the chamber, and is drawn transluminally out of the chamber such that a second segment of the tether extends from the second location through the chamber. At least one anchor (50) is slid over and along at least one of the first and second termini and anchored to tissue of the chamber. The chamber can then be reshaped by modifying tension in the tether.",EDWARDS LIFESCIENCES INNOVATION ISRAEL LTD,HOFFER ERAN;;BRAUON HAIM;;SHEPS TAL;;MURPHY BRIAN PATRICK;;DOHERTY THOMAS V,,https://lens.org/113-239-389-879-30X,Patent Application,no,0,0,5,5,0,A61F2/2451;;A61F2/2466;;A61F2250/001;;A61F2220/0016;;A61F2/90,A61F2/24,,0,0,,,,PENDING
289,WO,A3,WO 2008/006103 A3,014-546-169-027-421,2008-03-20,2008,US 2007/0073063 W,2007-07-09,US 81908606 P,2006-07-07,"NOGO RECEPTOR FUNCTIONAL MOTIFS, PEPTIDE MIMETICS, AND MUTATED FUNCTIONAL MOTIFS RELATED THERETO, AND METHODS OF USING THE SAME","The present invention provides novel isolated and purified polynucleotides and polypeptides related to functional motifs of the Nogo receptor 1 (NgR1) ( e.g. , the binding pocket on the side surface of NgR1, functional motifs comprising the amino acid sequence of FRG, etc.) and use of peptides mimicking these functional motifs as antagonists to NgR1 ligands, e.g. , myelin-associated glycoprotein, oligodendrocyte myelin glycoprotein, Nogo- A, Nogo-66, GTIb, an antibody to Nogo receptor, an antibody to GTIb, an antibody to p75 neurotrophin receptor, and an antibody to Lingo- 1, etc. The invention also provides antibodies to the mimetic peptide antagonists. The present invention is further directed to novel therapeutics and therapeutic targets and to methods of screening and assessing test compounds for treatments requiring axonal regeneration, i.e. , reversal of the effects of NgR1 ligand binding to the NgR1 ( i.e. , producing inhibition of axonal growth). The present invention also is directed to novel methods for treating disorders arising from inhibition of axonal growth mediated by the binding of NgRl ligands to the NgRl. Further, the invention is directed to methods of treating a subject with a neurodegenerative disorder, including, but not limited to, Parkinson's disease, Alzheimer's disease, progressive supranuclear palsy, multiple sclerosis, multiple system atrophy, corticobasal degeneration, Huntington's disease, dementia with Lewy bodies, spinocerebellar ataxia, stroke, spinal cord trauma, traumatic brain injury, multiinfarct dementia, epilepsy, and senile dementia, comprising, e.g. , antagonizing NgR1.",WYETH CORP;;KING S COLLEGE LONDON;;WOOD ANDREW;;KATZ ALAN;;GAO YING;;BATES BRIAN G;;DOHERTY PATRICK;;WILLIAMS GARETH,WOOD ANDREW;;KATZ ALAN;;GAO YING;;BATES BRIAN G;;DOHERTY PATRICK;;WILLIAMS GARETH,,https://lens.org/014-546-169-027-421,Search Report,yes,5,0,4,4,0,A61K38/00;;C07K14/705;;G01N33/6872;;G01N2500/04;;C07K14/705;;A61K38/00;;G01N33/6872;;G01N2500/04,C07K14/705;;A61K38/17;;G01N33/68,,2,2,092-101-047-476-592;;065-649-181-988-518,12839991;;10.1093/emboj/cdg325;;pmc165649;;10.2210/pdb1p8t/pdb;;12718853;;10.1016/s0896-6273(03)00232-0,"BARTON W A ET AL: ""Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins"", EMBO JOURNAL, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 22, no. 13, 1 July 2003 (2003-07-01), pages 3291 - 3302, XP002397105, ISSN: 0261-4189;;HE X L ET AL: ""Structure of the nogo receptor ectodomain: A recognition module implicated in myelin inhibition"", NEURON, CELL PRESS, vol. 38, no. 2, 24 April 2003 (2003-04-24), pages 177 - 185, XP002397106, ISSN: 0896-6273",PENDING
290,US,A1,US 2008/0027001 A1,060-675-020-731-081,2008-01-31,2008,US 77494007 A,2007-07-09,US 77494007 A;;US 81908606 P,2006-07-07,"NOGO RECEPTOR FUNCTIONAL MOTIFS, PEPTIDE MIMETICS, AND MUTATED FUNCTIONAL MOTIFS RELATED THERETO, AND METHODS OF USING THE SAME","The present invention provides novel isolated and purified polynucleotides and polypeptides related to functional motifs of the Nogo receptor 1 (NgR1) (e.g., the binding pocket on the side surface of NgR1, functional motifs comprising the amino acid sequence of FRG, etc.) and use of peptides mimicking these functional motifs as antagonists to NgR1 ligands, e.g., myelin-associated glycoprotein, oligodendrocyte myelin glycoprotein, Nogo-A, Nogo-66, GT1 b , an antibody to Nogo receptor, an antibody to GT1 b , an antibody to p75 neurotrophin receptor, and an antibody to Lingo-1, etc. The invention also provides antibodies to the mimetic peptide antagonists. The present invention is further directed to novel therapeutics and therapeutic targets and to methods of screening and assessing test compounds for treatments requiring axonal regeneration, i.e., reversal of the effects of NgR1 ligand binding to the NgR1 (i.e., producing inhibition of axonal growth). The present invention also is directed to novel methods for treating disorders arising from inhibition of axonal growth mediated by the binding of NgR1 ligands to the NgR1. Further, the invention is directed to methods of treating a subject with a neurodegenerative disorder, including, but not limited to, Parkinson's disease, Alzheimer's disease, progressive supranuclear palsy, multiple sclerosis, multiple system atrophy, corticobasal degeneration, Huntington's disease, dementia with Lewy bodies, spinocerebellar ataxia, stroke, spinal cord trauma, traumatic brain injury, multiinfarct dementia, epilepsy, and senile dementia, comprising, e.g., antagonizing NgR1.",WOOD ANDREW;;KATZ ALAN;;GAO YING;;BATES BRIAN G;;DOHERTY PATRICK;;WILLIAMS GARETH,WOOD ANDREW;;KATZ ALAN;;GAO YING;;BATES BRIAN G;;DOHERTY PATRICK;;WILLIAMS GARETH,WYETH (2007-07-19);;KING'S COLLEGE LONDON (2007-07-19),https://lens.org/060-675-020-731-081,Patent Application,yes,14,2,4,4,62,A61K38/00;;C07K14/705;;G01N33/6872;;G01N2500/04;;C07K14/705;;A61K38/00;;G01N33/6872;;G01N2500/04,C07D211/06;;A61K38/00;;C07D211/72;;C07D215/00;;C07D277/62;;C07D401/00;;C07K7/00;;C07K14/00;;C07K16/18;;C12N5/06;;C40B30/04;;G01N33/566,514/12;;435/375;;436/501;;506/9;;530/331;;530/350;;530/387.9;;544/324;;546/152;;546/201;;546/226;;546/308;;548/179,0,0,,,,DISCONTINUED
291,US,B1,US 6807362 B1,062-056-480-101-769,2004-10-19,2004,US 61864900 A,2000-07-18,US 61864900 A,2000-07-18,System and method for determining video clip boundaries for interactive custom video creation system,"
    A heuristically derived unsuitability score is computed and used as an input for metaphorical springs in which each selected video segment from recorded video of a video camera is associated with a metaphorical spring that maintains the selected segment at an optimal length while being responsive to a global system spring whose spring strength determines a final length of a final edited output video. Accordingly, user-specified changes to the final length of the final output video automatically lengthen or shorten the lengths of individual segments in such a way that high quality video segments having low unsuitability scores are emphasized over low quality video segments having high unsuitability scores. 
",FUJI XEROX CO LTD,GIRGENSOHN ANDREAS;;BORECZKY JOHN S;;DOHERTY JOHN J;;CHIU PATRICK;;WILCOX LYNN D,FUJIFILM BUSINESS INNOVATION CORP (2000-11-02),https://lens.org/062-056-480-101-769,Granted Patent,yes,7,19,2,2,0,G11B27/34;;G11B27/34;;G11B27/034;;G11B27/034,H04N5/7826;;G11B27/02;;G11B27/031;;G11B27/034;;G11B27/34;;H04N5/91,386/52;;386/46;;386/83;;360/15,18,14,022-076-506-118-436;;108-641-043-718-466;;084-275-619-572-097;;072-781-790-856-74X;;123-074-574-581-505;;003-151-043-621-702;;091-636-036-059-640;;064-179-427-608-686;;138-703-749-249-007;;071-347-296-955-701;;161-134-867-097-688;;022-023-482-368-721;;190-606-710-927-086;;035-319-071-456-158,10.1145/336296.336306;;10.1145/319463.319654;;10.1145/276627.276658;;10.1109/76.633496;;10.1007/bf01225243;;10.1145/74334.74347;;10.1109/icassp.1998.679697;;10.1145/274644.274670;;10.1109/mmcs.1999.779294;;10.1145/319463.319691;;10.1006/jvci.1996.0030;;10.1109/hicss.2000.926730;;10.21236/ada333857;;10.1109/icassp.1999.757482,"Lienhart, R., ""Dynamic Video Summarization of Home Video,"" SPIE 3972: Storage and Retrieval for Media Databases 2000, pp. 378-389, 2000.;;Smith, J.M., Stotts, D. and Kum, S.-U., ""An Orthogonal Taxanomy For Hyperlink Anchor Generation in Video Streams Using OvalTine,"" Proc. Of ACM Hypertext 2000, pp. 11-18, 2000.;;Uchihashi, S., Foote, J., Girgensohn, A. and Boreczky, J., ""Video Manga: Generating Semantically Meaningful Video Summaries,"" Proceedings of ACM Multimedia '99, pp. 383-392.;;Boissière, G., ""Automatic creation of hypervideo news libraries for the World Wide Web,"" Hypertext '98 Proceedings, ACM, Pittsburgh, PA, 1998.;;Yeung, M.M., and Yeo, B.-L., ""Video Visualization for Compact Presentation and Fast Browsing of Pictorial Content,"" IEEE Transactions on Circuits and Systems for Video Technology, vol. 7, No. 5, Oct. 1997.;;Zhang, H.J., et al., ""Automatic Parsing and Indexing of News Video,"" Multimedia Systems, 2 (6), pp. 256-266, 1995.;;Avrahami, G., Brooks, K.P., and Brown, M.H. ""A Two-View Approach to Constructing User Interfaces,"" ACM SIGGRAPH '89.;;Boreczky, J. and Wilcox L. ""A Hidden Markov Model Framework for Video Segmentation Using Audio and Image Features,"" in Proc ICASSP '98, IEEE, May 1998, Seattle.;;Boreczky, J. and Rowe, L. ""Comparison of Video Shot Boundary Detection Techniques,"" Proc. SPIE Storage and Retrieval for Image and Video Databases IV, San Jose, CA, 1996.;;Christal, M., Smith, M., Taylor, C. and Winkler, D., ""Evolving Video Skims into Useful Multimedia Abstractions,"" in Human Factors in Computing Systems, CHI 98 Conference Proceedings (Los Angeles, CA), New York: ACM, pp. 171-178, 1998.;;Girgensohn, A. and Boreczky, J. ""Time-Constrained Keyframe Selection Technique,"" in IEEE Multimedia Systems '99, IEEE Computer Society, vol. 1, pp. 756-761, 1999.;;He, L., Sanocki, E., Gupta, A., Grudin, J. ""Auto-Summarization of Audio-Video Presentation,"" ACM Multimedia, Nov. 1999.;;Knuth, D., The TE Xbook , Addison Wesley, 1984.;;Pfeiffer, S., Lienhart, R., Fischer, S. and Effelsberg, W., ""Abstracting Digital Movies Automatically,"" in Journal of Visual Communication and Image Representation 7(4), pp. 345-353, Dec. 1996.;;Russell, D. ""A Design Pattern-Based Video Summarization Technique: Moving from Low-Level Signals to High-Level Structures"" HICCS 2000.;;Smith, M. and Kanade, T., ""Video Skimming and Characterization through the Combination of Image and Language Understanding Techniques,"" in Proc. Computer Vision and Pattern Recognition, pp. 775-781, 1997.;;Uchihashi, S. and Foote, J., ""Summarizing Video Using a Shot Importance Measure and a Frame-Packing Algorithm,"" in Proc. ICASSP '99, vol. 6, pp. 3041-3044, 1999.;;Webster, B.F. The NeXT Book, Addison-Wesley, 1989.",EXPIRED
292,EP,A2,EP 2046828 A2,087-133-510-072-465,2009-04-15,2009,EP 07799406 A,2007-07-09,US 2007/0073063 W;;US 81908606 P,2006-07-07,"NOGO RECEPTOR FUNCTIONAL MOTIFS, PEPTIDE MIMETICS, AND MUTATED FUNCTIONAL MOTIFS RELATED THERETO, AND METHODS OF USING THE SAME",,WYETH CORP;;KING S COLLEGE LONDON,WOOD ANDREW;;KATZ ALAN;;GAO YING;;BATES BRIAN G;;DOHERTY PATRICK;;WILLIAMS GARETH,WYETH LLC (2010-04-21);;KING'S COLLEGE LONDON (2010-04-21),https://lens.org/087-133-510-072-465,Patent Application,yes,0,0,4,4,0,A61K38/00;;C07K14/705;;G01N33/6872;;G01N2500/04;;C07K14/705;;A61K38/00;;G01N33/6872;;G01N2500/04,C07K14/705;;A61K38/17;;G01N33/68,,0,0,,,,DISCONTINUED
293,US,A1,US 2011/0137816 A1,079-857-122-760-956,2011-06-09,2011,US 63266009 A,2009-12-07,US 63266009 A,2009-12-07,METHOD AND SYSTEM FOR PROVIDING A COLLABORATION RECOMMENDATION,"In a recruitment context, it can be difficult to determine the best third-party recruiter to help fill an open job. The disclosed system includes a recommendation engine that determines the best recruiter to help fill an open job, either for another recruiter to collaborate in a split-fee placement or for an employer having the opening. For a given candidate or job opening that becomes available and that is represented by a given user, the system analyzes disparate work information from users' transactional systems, including various criteria about their past transactions (job placements, geography, timeliness, etc.) and their current candidates to produce a recommendation. The user representing the subject candidate or job opening may then be notified of potential other users, and connected with them through an online system, in order to complete a collaborative placement.",BULLHORN INC,KORNBLUM ROBERT E;;DOHERTY PATRICK D;;GREENE GEOFFREY D;;PAPAS ARTHUR L P,BULLHORN INC (2010-02-11),https://lens.org/079-857-122-760-956,Patent Application,yes,16,20,1,1,0,G06Q10/1053;;G06Q30/02;;G06Q30/02;;G06Q10/1053,G06F17/30;;G06Q10/00,705/321;;707/602;;707/758;;X707E17005,0,0,,,,DISCONTINUED
294,WO,A2,WO 2008/006103 A2,131-068-810-159-728,2008-01-10,2008,US 2007/0073063 W,2007-07-09,US 81908606 P,2006-07-07,"NOGO RECEPTOR FUNCTIONAL MOTIFS, PEPTIDE MIMETICS, AND MUTATED FUNCTIONAL MOTIFS RELATED THERETO, AND METHODS OF USING THE SAME","The present invention provides novel isolated and purified polynucleotides and polypeptides related to functional motifs of the Nogo receptor 1 (NgR1) ( e.g. , the binding pocket on the side surface of NgR1, functional motifs comprising the amino acid sequence of FRG, etc.) and use of peptides mimicking these functional motifs as antagonists to NgR1 ligands, e.g. , myelin-associated glycoprotein, oligodendrocyte myelin glycoprotein, Nogo- A, Nogo-66, GTIb, an antibody to Nogo receptor, an antibody to GTIb, an antibody to p75 neurotrophin receptor, and an antibody to Lingo- 1, etc. The invention also provides antibodies to the mimetic peptide antagonists. The present invention is further directed to novel therapeutics and therapeutic targets and to methods of screening and assessing test compounds for treatments requiring axonal regeneration, i.e. , reversal of the effects of NgR1 ligand binding to the NgR1 ( i.e. , producing inhibition of axonal growth). The present invention also is directed to novel methods for treating disorders arising from inhibition of axonal growth mediated by the binding of NgRl ligands to the NgRl. Further, the invention is directed to methods of treating a subject with a neurodegenerative disorder, including, but not limited to, Parkinson's disease, Alzheimer's disease, progressive supranuclear palsy, multiple sclerosis, multiple system atrophy, corticobasal degeneration, Huntington's disease, dementia with Lewy bodies, spinocerebellar ataxia, stroke, spinal cord trauma, traumatic brain injury, multiinfarct dementia, epilepsy, and senile dementia, comprising, e.g. , antagonizing NgR1.",WYETH CORP;;KING S COLLEGE LONDON;;WOOD ANDREW;;KATZ ALAN;;GAO YING;;BATES BRIAN G;;DOHERTY PATRICK;;WILLIAMS GARETH,WOOD ANDREW;;KATZ ALAN;;GAO YING;;BATES BRIAN G;;DOHERTY PATRICK;;WILLIAMS GARETH,,https://lens.org/131-068-810-159-728,Patent Application,yes,0,11,4,4,62,A61K38/00;;C07K14/705;;G01N33/6872;;G01N2500/04;;C07K14/705;;A61K38/00;;G01N33/6872;;G01N2500/04,C07K14/705;;A61K38/17;;G01N33/68,,0,0,,,,PENDING
295,JP,A,JP 2002077808 A,032-862-454-698-459,2002-03-15,2002,JP 2001208688 A,2001-07-10,US 61864900 A,2000-07-18,METHOD AND SYSTEM FOR EDITING RECORDED VIDEO OF VIDEO CAMERA,"PROBLEM TO BE SOLVED: To provide a system and method for preparing and editing final output video by which the internal and external points of video required for cutting are automatically decided by automatically prolonging or shortening the lengths of individual clips in response to a user-designated change to the final length of the final output video of recorded video. SOLUTION: In a method for editing recorded video in which an inadequate score is calculated with respect to the time interval of recorded video and the recorded video is segmented into video clips having in- and out-clip boundaries, and then, individual clips correlated with a metaphorical spring having a spring strength are trimmed, the video-in and video-out points required for cutting are automatically decided while the lengths of individual clips are automatically prolonged or shortened in response to the user-designate change to the final length of the final output video.",FUJI XEROX CO LTD,ANDREAS GARGENSHORN;;JOHN S BORECKY;;JOHN J DOHERTY;;CHIU PATRICK;;WILCOX LYNN D,,https://lens.org/032-862-454-698-459,Patent Application,no,0,1,2,2,0,G11B27/34;;G11B27/34;;G11B27/034;;G11B27/034,H04N5/7826;;G11B27/02;;G11B27/031;;G11B27/034;;G11B27/34;;H04N5/91,,0,0,,,,PENDING
296,US,A1,US 2003/0137585 A1,197-381-096-870-939,2003-07-24,2003,US 31721902 A,2002-12-12,US 31721902 A;;US 33933001 P,2001-12-12,Machine vision system,"
   In a machine vision system, four images are acquired from overlapping fields of view. There is sub-pixel movement between images of either half pixel or third pixel. The images are combined to provide a single image of higher resolution. The camera and the object are displaced relative to each other by movement of the camera on a gantry system or by tilting the lens with respect to the camera. 
",MAHON JAMES;;DOHERTY JOHN;;HARTON ANDREW;;SMITH PATRICK;;DULLAGHAN MARK;;TOFTNESS RICHARD FRANK,MAHON JAMES;;DOHERTY JOHN;;HARTON ANDREW;;SMITH PATRICK;;DULLAGHAN MARK;;TOFTNESS RICHARD FRANK,MV RESEARCH LIMITED (2002-12-06),https://lens.org/197-381-096-870-939,Patent Application,yes,5,15,1,1,0,G06T3/4069;;H04N25/48;;G06T3/4069;;H04N25/48,G06T3/40;;H04N5/225;;H04N5/265,348/135;;348/142;;348/262;;382/299,0,0,,,,DISCONTINUED
297,WO,A3,WO 2002/101028 A3,049-970-593-898-771,2003-05-22,2003,GB 0202652 W,2002-06-11,GB 0114399 A,2001-06-13,BIOMATERIAL SUBSTRATES,"The present invention relates to novel substrates, to methods of making them and to uses therefor&period; The substrates of the invention comprise a base portion and a surface layer covering at least part of the base portion, with a binding layer provided therebetween&period; The surface layer provides, on at least a part of the substrate, topographical features having at least one nano scale dimension&period; These topographical features are adapted to facilitate, influence, control or inhibit cell or tissue growth thereon and&sol;or therebetween and the substrate may be used for the study, manipulation or modification of at least one cellular or tissue behaviour or response&period;",UNIV LIVERPOOL;;COUSINS BRIAN G;;GARVEY MICHAEL JOSEPH;;FINK JOHN;;WILLIAMS RACHEL LUCINDA;;DOHERTY PATRICK JOSEPH,COUSINS BRIAN G;;GARVEY MICHAEL JOSEPH;;FINK JOHN;;WILLIAMS RACHEL LUCINDA;;DOHERTY PATRICK JOSEPH,,https://lens.org/049-970-593-898-771,Search Report,yes,3,0,13,13,0,A61L15/24;;A61L15/42;;A61L27/34;;A61L27/50;;A61L2400/18;;C12N5/0068;;C12N2533/12;;C12N2533/30;;C12N2535/10;;C12N5/0068;;A61L27/34;;C12N2533/12;;C12N2535/10;;C12N2533/30;;A61L15/24;;A61L27/50;;A61L15/42;;A61L2400/18,A61L15/24;;A61L15/42;;A61L27/34;;A61L27/50;;C12N5/00;;C12N5/02,,3,3,023-684-855-207-758;;135-849-080-062-031;;070-574-322-091-358,10.1016/s0142-9612(98)00209-9;;10213360;;8718969;;10.1016/0142-9612(96)85910-2;;9260912;;10.1006/excr.1997.3625,"FLEMMING R G ET AL: ""EFFECTS OF SYNTHETIC MICRO-AND NANO-STRUCTURED SURFACES ON CELL BEHAVIOR"", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 20, March 1999 (1999-03-01), pages 573 - 588, XP002926697, ISSN: 0142-9612;;DEN BRABER E T ET AL: ""Quantitative analysis of cell proliferation and orientation on substrata with uniform parallel surface micro-grooves"", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 17, no. 11, 1996, pages 1093 - 1099, XP004032669, ISSN: 0142-9612;;OAKLEY CAROL ET AL: ""Sensitivity of fibroblasts and their cytoskeletons to substratum topographies: Topographic guidance and topographic compensation by micromachined grooves of different dimensions."", EXPERIMENTAL CELL RESEARCH, vol. 234, no. 2, 1997, pages 413 - 424, XP002229298, ISSN: 0014-4827",PENDING
298,CN,A,CN 101437483 A,070-848-208-262-286,2009-05-20,2009,CN 200780016055 A,2007-04-30,US 2007/0067765 W;;US 38104106 A,2006-05-01,Multiple chamber container with mistake proof administrationsystem,"The present disclosure provides a multiple chamber container (10) that includes a container body sealed around a peripheral edge (14) and having an outlet (16). The container also includes a first peel seal (18) having a projecting portion (42) and a second peel seal (20) that isolates the outlet (16). The second peel seal may also include a projecting portion (44). The first and second peel seals (18,20) may be configured to define a symmeterical chamber. The chamber may include an axis of symmetry extending between the first and second projecting portions (42,44). The chamber geometry of the container ensures a correct sequential opening of the first and second peel seals (18,20).",BAXTER INT,JOHN DOHERTY;;NOEL SMITH;;CHARLIE MULVIHILL;;PATRICK BALTEAU;;SILVANO SFORACCHI;;PAUL VIDREQUIN;;MARC COUSIN,,https://lens.org/070-848-208-262-286,Patent Application,no,0,5,25,25,0,A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;B29C66/91421;;B29C66/9161;;A61J1/2024;;B29C66/71;;B29C65/16;;B29C65/4895;;B29C65/04;;A61J1/2093;;B29C66/723;;A61J1/05;;A61J1/10;;B65D81/32;;B29C66/91421;;B29C66/9161;;A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;A61J1/2024;;B29C66/71;;B29C65/4895;;B29C65/16;;B29C65/04;;A61J1/2093,A61J1/00;;B65D81/32,,0,0,,,,ACTIVE
299,US,A1,US 2011/0264646 A1,005-515-759-197-748,2011-10-27,2011,US 76693210 A,2010-04-26,US 76693210 A,2010-04-26,Search Engine Data Structure,"A search engine database may a segmented structure that preserves individual document references and allows updating as well as scalability. A set of segment managers may receive new, updated, or deleted documents and update a set of term matrices from which a published search matrix may be generated. The database may have a very large term dictionary and may use a hash function to create term identifiers without having to look up terms in the dictionary. The database may be maintained by many systems operating in parallel for high scalability.",MICROSOFT CORP,SOKOLAN PATRICK;;DOHERTY DENNIS;;DUGUAY CLAUDE;;RADCLIFFE WILLIAM;;BOURASSA VIRGIL;;KING TAMMARA;;SHEPPARD JOHN,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2010-04-22),https://lens.org/005-515-759-197-748,Patent Application,yes,6,31,3,3,0,G06F16/313;;G06F16/22;;G06F16/951;;G06F16/22;;G06F16/951;;G06F16/313,G06F17/30,707/711;;707/769;;X707E17108;;X707E17002,0,0,,,,ACTIVE
300,EP,A2,EP 1395651 A2,004-552-422-807-172,2004-03-10,2004,EP 02790215 A,2002-06-11,GB 0202634 W;;GB 0114399 A,2001-06-13,BIOMATERIAL SUBSTRATES,,UNIV LIVERPOOL,COUSINS BRIAN G;;GARVEY MICHAEL JOSEPH;;FINK JOHN;;WILLIAMS RACHEL LUCINDA;;DOHERTY PATRICK JOSEPH,,https://lens.org/004-552-422-807-172,Patent Application,yes,0,0,13,13,0,A61L15/24;;A61L15/42;;A61L27/34;;A61L27/50;;A61L2400/18;;C12N5/0068;;C12N2533/12;;C12N2533/30;;C12N2535/10;;C12N5/0068;;A61L27/34;;C12N2533/12;;C12N2535/10;;C12N2533/30;;A61L15/24;;A61L27/50;;A61L15/42;;A61L2400/18,A61L15/24;;A61L15/42;;A61L27/34;;A61L27/50;;C12N5/00;;C12N5/02,,0,0,,,,DISCONTINUED
301,US,A1,US 2013/0151498 A1,080-044-298-777-230,2013-06-13,2013,US 201313764739 A,2013-02-11,US 201313764739 A;;US 76693210 A,2010-04-26,Search Engine Data Structure,"A search engine database may a segmented structure that preserves individual document references and allows updating as well as scalability. A set of segment managers may receive new, updated, or deleted documents and update a set of term matrices from which a published search matrix may be generated. The database may have a very large term dictionary and may use a hash function to create term identifiers without having to look up terms in the dictionary. The database may be maintained by many systems operating in parallel for high scalability.",MICROSOFT CORP;;MICROSOFT CORP,SOKOLAN PATRICK;;DOHERTY DENNIS;;DUGUAY CLAUDE;;RADCLIFFE WILLIAM;;BOURASSA VIRGIL;;KING TAMMY;;SHEPPARD JOHN,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14),https://lens.org/080-044-298-777-230,Patent Application,yes,1,1,3,3,0,G06F16/313;;G06F16/22;;G06F16/951;;G06F16/22;;G06F16/951;;G06F16/313,G06F17/30,707/706;;707/756,0,0,,,,DISCONTINUED
302,US,A1,US 2004/0214326 A1,195-856-753-204-332,2004-10-28,2004,US 48089704 A,2004-06-04,GB 0114399 A;;GB 0202634 W,2001-06-13,Biomaterial substrates,"
   The invention concerns the use of a biomaterial substrate to orient cell or tissue growth. The substrate comprises a base portion and a surface layer covering at least part of the base portion. The surface layer provides the substrate with topographical features having at least one nanoscale dimension of from about 1 to about 200 nm. The topographical features having the capacity to orient cell or tissue growth thereon and/or therebetween. 
",COUSINS BRIAN G;;GARVEY MICHAEL JOSEPH;;FINK JOHN;;WILLIAMS RACHEL LUCINDA;;DOHERTY PATRICK JOSEPH,COUSINS BRIAN G;;GARVEY MICHAEL JOSEPH;;FINK JOHN;;WILLIAMS RACHEL LUCINDA;;DOHERTY PATRICK JOSEPH,LIVERPOOL UNIVERSITY OF THE (2004-01-12),https://lens.org/195-856-753-204-332,Patent Application,yes,3,18,13,13,0,A61L15/24;;A61L15/42;;A61L27/34;;A61L27/50;;A61L2400/18;;C12N5/0068;;C12N2533/12;;C12N2533/30;;C12N2535/10;;C12N5/0068;;A61L27/34;;C12N2533/12;;C12N2535/10;;C12N2533/30;;A61L15/24;;A61L27/50;;A61L15/42;;A61L2400/18,A61L15/24;;A61L15/42;;A61L27/34;;A61L27/50;;C12N5/00;;C12N5/02,435/395;;435/325,0,0,,,,DISCONTINUED
303,WO,A3,WO 2003/010300 A3,150-829-458-753-690,2003-05-01,2003,GB 0202634 W,2002-06-11,GB 0114399 A,2001-06-13,USES OF BIOMATERIAL SUBSTRATES,The invention concerns the use of a biomaterial substrate to orient cell or tissue growth. The substrate comprises a base portion and a surface layer covering at least part of the base portion. The surface layer provides the substrate with topographical features having at least one nanoscale dimension of from about 1 to about 200 nm. The topographical features having the capacity to orient cell or tissue growth thereon and/or therebetween.,UNIV LIVERPOOL;;COUSINS BRIAN G;;GARVEY MICHAEL JOSEPH;;FINK JOHN;;WILLIAMS RACHEL LUCINDA;;DOHERTY PATRICK JOSEPH,COUSINS BRIAN G;;GARVEY MICHAEL JOSEPH;;FINK JOHN;;WILLIAMS RACHEL LUCINDA;;DOHERTY PATRICK JOSEPH,,https://lens.org/150-829-458-753-690,Search Report,yes,4,0,13,13,0,A61L15/24;;A61L15/42;;A61L27/34;;A61L27/50;;A61L2400/18;;C12N5/0068;;C12N2533/12;;C12N2533/30;;C12N2535/10;;C12N5/0068;;A61L27/34;;C12N2533/12;;C12N2535/10;;C12N2533/30;;A61L15/24;;A61L27/50;;A61L15/42;;A61L2400/18,A61L15/24;;A61L15/42;;A61L27/34;;A61L27/50;;C12N5/00;;C12N5/02,,3,3,023-684-855-207-758;;135-849-080-062-031;;070-574-322-091-358,10.1016/s0142-9612(98)00209-9;;10213360;;8718969;;10.1016/0142-9612(96)85910-2;;9260912;;10.1006/excr.1997.3625,"FLEMMING R G ET AL: ""EFFECTS OF SYNTHETIC MICRO-AND NANO-STRUCTURED SURFACES ON CELL BEHAVIOR"", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 20, March 1999 (1999-03-01), pages 573 - 588, XP002926697, ISSN: 0142-9612;;DEN BRABER E T ET AL: ""Quantitative analysis of cell proliferation and orientation on substrata with uniform parallel surface micro-grooves"", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 17, no. 11, 1996, pages 1093 - 1099, XP004032669, ISSN: 0142-9612;;OAKLEY CAROL ET AL: ""Sensitivity of fibroblasts and their cytoskeletons to substratum topographies: Topographic guidance and topographic compensation by micromachined grooves of different dimensions."", EXPERIMENTAL CELL RESEARCH, vol. 234, no. 2, 1997, pages 413 - 424, XP002229298, ISSN: 0014-4827",PENDING
304,WO,A2,WO 2003/010300 A2,000-927-984-060-253,2003-02-06,2003,GB 0202634 W,2002-06-11,GB 0114399 A,2001-06-13,BIOMATERIAL SUBSTRATES,The invention concerns the use of a biomaterial substrate to orient cell or tissue growth. The substrate comprises a base portion and a surface layer covering at least part of the base portion. The surface layer provides the substrate with topographical features having at least one nanoscale dimension of from about 1 to about 200 nm. The topographical features having the capacity to orient cell or tissue growth thereon and/or therebetween.,UNIV LIVERPOOL;;COUSINS BRIAN G;;GARVEY MICHAEL JOSEPH;;FINK JOHN;;WILLIAMS RACHEL LUCINDA;;DOHERTY PATRICK JOSEPH,COUSINS BRIAN G;;GARVEY MICHAEL JOSEPH;;FINK JOHN;;WILLIAMS RACHEL LUCINDA;;DOHERTY PATRICK JOSEPH,,https://lens.org/000-927-984-060-253,Patent Application,yes,0,0,13,13,0,A61L15/24;;A61L15/42;;A61L27/34;;A61L27/50;;A61L2400/18;;C12N5/0068;;C12N2533/12;;C12N2533/30;;C12N2535/10;;C12N5/0068;;A61L27/34;;C12N2533/12;;C12N2535/10;;C12N2533/30;;A61L15/24;;A61L27/50;;A61L15/42;;A61L2400/18,A61L15/24;;A61L15/42;;A61L27/34;;A61L27/50;;C12N5/00;;C12N5/02,,0,0,,,,PENDING
305,EP,A2,EP 1395650 A2,034-962-658-466-298,2004-03-10,2004,EP 02730484 A,2002-06-11,GB 0202652 W;;GB 0114399 A,2001-06-13,BIOMATERIAL SUBSTRATES,,UNIV LIVERPOOL,COUSINS BRIAN G;;GARVEY MICHAEL JOSEPH;;FINK JOHN;;WILLIAMS RACHEL LUCINDA;;DOHERTY PATRICK JOSEPH,,https://lens.org/034-962-658-466-298,Patent Application,yes,0,0,13,13,0,A61L15/24;;A61L15/42;;A61L27/34;;A61L27/50;;A61L2400/18;;C12N5/0068;;C12N2533/12;;C12N2533/30;;C12N2535/10;;C12N5/0068;;A61L27/34;;C12N2533/12;;C12N2535/10;;C12N2533/30;;A61L15/24;;A61L27/50;;A61L15/42;;A61L2400/18,A61L15/24;;A61L15/42;;A61L27/34;;A61L27/50;;C12N5/00;;C12N5/02,,3,3,023-540-334-245-414;;109-956-870-268-086;;020-012-013-517-759,10.1023/b:jmsm.0000021101.64938.b3;;15332599;;10.1016/j.biomaterials.2006.05.037;;16757021;;10.1006/jcis.1997.4886;;9241153,"COUSINS B.G. ET AL: ""The effect of silica nanoparticulate coatings on cellular response."", J MATER SCI MATER MED., vol. 15, April 2004 (2004-04-01), pages 335 - 339;;LORD M.S. ET AL: ""The effect of silica nanoparticulate coatings on serum protein adsorption and cellular response."", BIOMATERIALS, vol. 27, October 2006 (2006-10-01), pages 4856 - 4862, XP025097451, DOI: doi:10.1016/j.biomaterials.2006.05.037;;HASAN F.B.; HUANG D.D.: ""Characterization of Colloidal Silica and Its Adsorption Phenomenon with Silicon-Base Surfactants with Relation to Film Strength"", J COLLOID INTERFACE SCI., vol. 190, June 1997 (1997-06-01), pages 161 - 170",DISCONTINUED
306,AU,B2,AU 2002/302804 B2,041-890-709-723-420,2008-05-15,2008,AU 2002/302804 A,2002-06-11,GB 0114399 A;;GB 0202652 W,2001-06-13,Biomaterial substrates,,UNIV LIVERPOOL,GARVEY MICHAEL JOSEPH;;WILLIAMS RACHEL LUCINDA;;COUSINS BRIAN G;;FINK JOHN;;DOHERTY PATRICK JOSEPH,,https://lens.org/041-890-709-723-420,Granted Patent,no,3,1,13,13,0,A61L15/24;;A61L15/42;;A61L27/34;;A61L27/50;;A61L2400/18;;C12N5/0068;;C12N2533/12;;C12N2533/30;;C12N2535/10;;C12N5/0068;;A61L27/34;;C12N2533/12;;C12N2535/10;;C12N2533/30;;A61L15/24;;A61L27/50;;A61L15/42;;A61L2400/18,C12N5/00;;A61L15/24;;A61L15/42;;A61L27/34;;A61L27/50;;C12N5/02,,1,1,023-684-855-207-758,10.1016/s0142-9612(98)00209-9;;10213360,"Flemming, R.G. et al. 1993. Biomaterials. 20:573-588.",EXPIRED
307,WO,A2,WO 2002/101028 A2,026-282-461-773-535,2002-12-19,2002,GB 0202652 W,2002-06-11,GB 0114399 A,2001-06-13,SUBSTRATES,"The present invention relates to novel substrates, to methods of making them and to uses therefor&period; The substrates of the invention comprise a base portion and a surface layer covering at least part of the base portion, with a binding layer provided therebetween&period; The surface layer provides, on at least a part of the substrate, topographical features having at least one nano scale dimension&period; These topographical features are adapted to facilitate, influence, control or inhibit cell or tissue growth thereon and&sol;or therebetween and the substrate may be used for the study, manipulation or modification of at least one cellular or tissue behaviour or response&period;",UNIV LIVERPOOL;;COUSINS BRIAN G;;GARVEY MICHAEL JOSEPH;;FINK JOHN;;WILLIAMS RACHEL LUCINDA;;DOHERTY PATRICK JOSEPH,COUSINS BRIAN G;;GARVEY MICHAEL JOSEPH;;FINK JOHN;;WILLIAMS RACHEL LUCINDA;;DOHERTY PATRICK JOSEPH,,https://lens.org/026-282-461-773-535,Patent Application,yes,0,0,13,13,0,A61L15/24;;A61L15/42;;A61L27/34;;A61L27/50;;A61L2400/18;;C12N5/0068;;C12N2533/12;;C12N2533/30;;C12N2535/10;;C12N5/0068;;A61L27/34;;C12N2533/12;;C12N2535/10;;C12N2533/30;;A61L15/24;;A61L27/50;;A61L15/42;;A61L2400/18,A61L15/24;;A61L15/42;;A61L27/34;;A61L27/50;;C12N5/00;;C12N5/02,,0,0,,,,PENDING
308,US,B2,US 8375021 B2,052-491-743-646-503,2013-02-12,2013,US 76693210 A,2010-04-26,US 76693210 A,2010-04-26,Search engine data structure,"A search engine database may a segmented structure that preserves individual document references and allows updating as well as scalability. A set of segment managers may receive new, updated, or deleted documents and update a set of term matrices from which a published search matrix may be generated. The database may have a very large term dictionary and may use a hash function to create term identifiers without having to look up terms in the dictionary. The database may be maintained by many systems operating in parallel for high scalability.",MICROSOFT CORP;;SOKOLAN PATRICK;;DOHERTY DENNIS;;DUGUAY CLAUDE;;RADCLIFFE WILLIAM;;BOURASSA VIRGIL;;KING TAMMY;;SHEPPARD JOHN,SOKOLAN PATRICK;;DOHERTY DENNIS;;DUGUAY CLAUDE;;RADCLIFFE WILLIAM;;BOURASSA VIRGIL;;KING TAMMY;;SHEPPARD JOHN,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2010-04-22),https://lens.org/052-491-743-646-503,Granted Patent,yes,11,8,3,3,0,G06F16/313;;G06F16/22;;G06F16/951;;G06F16/22;;G06F16/951;;G06F16/313,G06F17/30,707/711,2,1,019-674-597-914-738,10.1109/itcc.2001.918768,"Goharian, et al., ""Enterprise Text Processing: A Sparse Matrix Approach"", Retrieved at >, Proceedings International Conference on Information Technology: Coding and Computing, Apr. 2001, pp. 71-75.;;Litwin, et al., ""Fast nGram-Based String Search over Data Encoded Using Algebraic Signatures"", Retrieved at >, Very Large Data Bases, Proceedings of the 33rd international conference on Very large data bases, Sep. 23-27, 2007, pp. 207-218.",ACTIVE
309,US,B2,US 7374903 B2,068-652-447-335-589,2008-05-20,2008,US 48078004 A,2004-06-09,GB 0114399 A;;GB 0202652 W,2001-06-13,Substrates with topographical features for the manipulation of cellular behavior and response,"The present invention relates to novel substrates, to methods of making them and to uses therefor. The substrates of the invention comprise a base portion and a surface layer covering at least part of the base portion, with a binding layer provided therebetween. The surface layer provides, on at least a part of the substrate, topographical features having at least one nano scale dimension. These topographical features are adapted to facilitate, influence, control or inhibit cell or tissue growth thereon and/or therebetween and the substrate may be used for the study, manipulation or modification of at least one cellular or tissue behavior or response.",UNIV LIVERPOOL,COUSINS BRIAN G;;GARVEY MICHAEL JOSEPH;;FINK JOHN;;WILLIAMS RACHEL LUCINDA;;DOHERTY PATRICK JOSEPH,UNIVERSITY OF LIVERPOOL THE (2004-01-12),https://lens.org/068-652-447-335-589,Granted Patent,yes,9,5,13,13,0,A61L15/24;;A61L15/42;;A61L27/34;;A61L27/50;;A61L2400/18;;C12N5/0068;;C12N2533/12;;C12N2533/30;;C12N2535/10;;C12N5/0068;;A61L27/34;;C12N2533/12;;C12N2535/10;;C12N2533/30;;A61L15/24;;A61L27/50;;A61L15/42;;A61L2400/18,C12Q1/02;;A61L15/24;;A61L15/42;;A61L27/34;;A61L27/50;;C12N5/00;;C12N5/02,435/29,6,6,023-684-855-207-758;;135-849-080-062-031;;026-474-111-536-798;;050-008-611-286-774;;070-574-322-091-358;;023-684-855-207-758,10.1016/s0142-9612(98)00209-9;;10213360;;8718969;;10.1016/0142-9612(96)85910-2;;10.1016/0142-9612(96)00016-6;;8902242;;10.1006/excr.1996.0098;;8601420;;9260912;;10.1006/excr.1997.3625;;10.1016/s0142-9612(98)00209-9;;10213360,"Flemming R. G. et al. Effects of Synthetic Micro and Nano Structured Surfaces on Cell Behavior. Biomaterials vol. 20, paes 573-588, 1999.;;E.T. den Braber et al. (1996) ""Quantitative analysis of cell proliferation and orientation on substrata with uniform parallel surface micro-grooves"" Biomaterials vol. 17 No. 11 pp. 1093-1099, Elsevier Science Limited.;;Goodman et al. (1996) ""Three-dimensional extracellular matrix textured biomaterials"" Biomaterials vol. 17, No. 21, pp. 2087-2095 (Elsevier Science Limited).;;Wojciak-Stothard et al. (1996) ""Guidance and Activation of Murine Macrophages by Nanometric Scale Topography"" Experimental Cell Research vol. 223, pp. 426-435, Article No. 0098, Academic Press, Inc.;;Oakley et al. (1997) ""Sensitivity of Fibroblasts and Their Cytoskeletons to Substratum Topographies: Topographic Guidance and Topographic Compensation by Micromachined Grooves of Different Dimensions"" Experimental Cell Research vol. 234 pp. 413-424 Article No. EX973625, Academic Press, Inc.;;Flemming et al. (1999) ""Effects of synthetic micro- and nano-structured surfaces on cell behavior"" Biomaterials vol. 20 pp. 573-588, Elsevier Science Ltd.",EXPIRED
310,AU,A1,AU 2002/355190 A1,195-478-965-975-256,2003-02-17,2003,AU 2002/355190 A,2002-06-11,GB 0114399 A;;GB 0202634 W,2001-06-13,Uses of biomaterial substrates,,UNIV LIVERPOOL,COUSINS BRIAN G;;WILLIAMS RACHEL LUCINDA;;FINK JOHN;;GARVEY MICHAEL JOSEPH;;DOHERTY PATRICK JOSEPH,,https://lens.org/195-478-965-975-256,Patent Application,no,0,0,13,13,0,A61L15/24;;A61L15/42;;A61L27/34;;A61L27/50;;A61L2400/18;;C12N5/0068;;C12N2533/12;;C12N2533/30;;C12N2535/10;;C12N5/0068;;A61L27/34;;C12N2533/12;;C12N2535/10;;C12N2533/30;;A61L15/24;;A61L27/50;;A61L15/42;;A61L2400/18,A61L15/24;;A61L15/42;;A61L27/34;;A61L27/50;;C12N5/00;;C12N5/02,,0,0,,,,DISCONTINUED
311,CA,A1,CA 2449586 A1,068-036-202-445-043,2002-12-19,2002,CA 2449586 A,2002-06-11,GB 0114399 A;;GB 0202652 W,2001-06-13,BIOMATERIAL SUBSTRATES,"The present invention relates to novel substrates, to methods of making them and to uses therefor. The substrates of the invention comprise a base portio n and a surface layer covering at least part of the base portion, with a bindi ng layer provided therebetween. The surface layer provides, on at least a part of the substrate, topographical features having at least one nano scale dimension. These topographical features are adapted to facilitate, influence , control or inhibit cell or tissue growth thereon and/or therebetween and the substrate may be used for the study, manipulation or modification of at leas t one cellular or tissue behaviour or response.",UNIV LIVERPOOL,COUSINS BRIAN G;;FINK JOHN;;GARVEY MICHAEL JOSEPH;;DOHERTY PATRICK JOSEPH;;WILLIAMS RACHEL LUCINDA,,https://lens.org/068-036-202-445-043,Patent Application,no,0,0,13,13,0,A61L15/24;;A61L15/42;;A61L27/34;;A61L27/50;;A61L2400/18;;C12N5/0068;;C12N2533/12;;C12N2533/30;;C12N2535/10;;C12N5/0068;;A61L27/34;;C12N2533/12;;C12N2535/10;;C12N2533/30;;A61L15/24;;A61L27/50;;A61L15/42;;A61L2400/18,A61L15/24;;A61L15/42;;A61L27/34;;A61L27/50;;C12N5/00;;C12N5/02,,0,0,,,,DISCONTINUED
312,US,A1,US 2007/0238174 A1,102-147-649-871-738,2007-10-11,2007,US 70866007 A,2007-02-20,US 70866007 A;;US 48078004 A;;GB 0202652 W,2002-06-11,Substrates,"The present invention relates to novel substrates, to methods of making them and to uses therefor. The substrates of the invention comprise a base portion and a surface layer covering at least part of the base portion, with a binding layer provided therebetween. The surface layer provides, on at least a part of the substrate, topographical features having at least one nano scale dimension. These topographical features are adapted to inhibit cell or tissue growth thereon and/or therebetween.",COUSINS BRIAN G;;GARVEY MICHAEL J;;FINK JOHN;;WILLIAMS RACHEL L;;DOHERTY PATRICK J,COUSINS BRIAN G;;GARVEY MICHAEL J;;FINK JOHN;;WILLIAMS RACHEL L;;DOHERTY PATRICK J,LIVERPOOL UNIVERSITY OF (2004-01-12),https://lens.org/102-147-649-871-738,Patent Application,yes,0,6,1,1,0,A61L27/50;;A61L2400/12;;A61L2400/18;;C12N5/0068;;C12N2533/12;;C12N2533/14;;C12N2533/30;;C12N5/0068;;A61L2400/18;;A61L2400/12;;C12N2533/30;;C12N2533/12;;A61L27/50;;C12N2533/14,C12N5/00;;C12N1/36;;C12N5/02;;C12N5/04;;C12N5/06,435/375;;435/245,0,0,,,,DISCONTINUED
313,US,A1,US 2004/0219670 A1,029-963-929-669-374,2004-11-04,2004,US 48078004 A,2004-06-09,GB 0114399 A;;GB 0202652 W,2001-06-13,Biomaterial substrates,"
   The present invention relates to novel substrates, to methods of making them and to uses therefor. The substrates of the invention comprise a base portion and a surface layer covering at least part of the base portion, with a binding layer provided therebetween. The surface layer provides, on at least a part of the substrate, topographical features having at least one nano scale dimension. These topographical features are adapted to facilitate, influence, control or inhibit cell or tissue growth thereon and/or therebetween and the substrate may be used for the study, manipulation or modification of at least one cellular or tissue behaviour or response. 
",COUSINS BRIAN G;;GARVEY MICHAEL JOSEPH;;FINK JOHN;;WILLIAMS RACHEL LUCINDA;;DOHERTY PATRICK JOSEPH,COUSINS BRIAN G;;GARVEY MICHAEL JOSEPH;;FINK JOHN;;WILLIAMS RACHEL LUCINDA;;DOHERTY PATRICK JOSEPH,UNIVERSITY OF LIVERPOOL THE (2004-01-12),https://lens.org/029-963-929-669-374,Patent Application,yes,1,7,13,13,0,A61L15/24;;A61L15/42;;A61L27/34;;A61L27/50;;A61L2400/18;;C12N5/0068;;C12N2533/12;;C12N2533/30;;C12N2535/10;;C12N5/0068;;A61L27/34;;C12N2533/12;;C12N2535/10;;C12N2533/30;;A61L15/24;;A61L27/50;;A61L15/42;;A61L2400/18,A61L15/24;;A61L15/42;;A61L27/34;;A61L27/50;;C12N5/00;;C12N5/02,435/375;;435/373;;435/395,0,0,,,,EXPIRED
314,WO,A3,WO 2004/114098 A3,102-904-074-079-306,2005-06-02,2005,US 2004/0019976 W,2004-06-21,US 60089103 A,2003-06-20,METHOD AND APPARATUS FOR MEASURING BENEFITS OF BUSINESS IMPROVEMENTS,A method and apparatus for measuring a benefit of business improvements. Actual performance information of a business is collected and stored in a storage device. The actual performance information is compared to estimated performance information prior to implementation of the business improvement. The benefit of the business improvement may then be measured by comparing the actual performance information to the estimated performance information.,QUALCOMM INC;;SPANGENBERG GLYNN ALAN;;DOHERTY WILLIAM PATRICK;;WYLY MONICA LYNN;;SCALES JAMES P;;SIPE DEAN JOSEPH,SPANGENBERG GLYNN ALAN;;DOHERTY WILLIAM PATRICK;;WYLY MONICA LYNN;;SCALES JAMES P;;SIPE DEAN JOSEPH,,https://lens.org/102-904-074-079-306,Search Report,yes,1,0,3,3,0,G06Q10/06;;G06Q40/00;;G06Q10/06;;G06Q40/00,G06Q10/06;;G06Q40/00,,1,0,,,"""Dictionary of Business Terms"", 2000, BARRON'S, article JACK FRIEDMAN: ""pages 349, 354, 451, 499, 594""",PENDING
315,US,A1,US 2013/0159050 A1,139-228-234-567-395,2013-06-20,2013,US 201213692614 A,2012-12-03,US 201213692614 A;;US 201161566093 P,2011-12-02,Methods and Systems for Managing Corporate Risk,"Methods and systems for facilitating transactions are disclosed. A method for identifying corporate risk, implemented on a computer system, includes obtaining corporate data on computer-readable media, the corporate data comprising at least one of internal data and external data, obtaining behavioral corporate data from the corporate data on computer-readable media, the behavioral corporate data comprising at least one event data point, obtaining data indicative of risk-creating behavior from the behavioral corporate data on computer-readable media by evaluating the corporate data against a knowledge-base of characteristic risk-creating behavior, and communicating the data indicative of risk-creating behavior to a user as threat vectors with at least one dimension, the threat vectors displayed on a graphical user interface.",TAILORED SOLUTIONS AND CONSULTING INC;;TAILORED SOLUTIONS AND CONSULTING INC,DOHERTY SEAN;;LEHR-LOPEZ NATALIE;;LOPES MARK;;PRINCI MICHAEL;;ROSSI MICHAEL;;RUTH GABE;;MURRAY PATRICK,TAILORED SOLUTIONS AND CONSULTING INC (2010-04-08),https://lens.org/139-228-234-567-395,Patent Application,yes,1,2,1,2,0,G06Q10/0635;;G06Q10/0635,G06Q10/06,705/7.28,0,0,,,,DISCONTINUED
316,US,A1,US 2004/0260585 A1,087-047-291-162-143,2004-12-23,2004,US 60089103 A,2003-06-20,US 60089103 A,2003-06-20,Method and apparatus for measuring benefits of business improvements,"
   A method and apparatus for measuring a benefit of business improvements. Actual performance information of a business is collected and stored in a storage device. The actual performance information is compared to estimated performance information prior to implementation of the business improvement. The benefit of the business improvement may then be measured by comparing the actual performance information to the estimated performance information. 
",SPANGENBERG GLYNN ALAN;;DOHERTY WILLIAM PATRICK;;WYLY MONICA LYNN;;SCALES JAMES P.;;SIPE DEAN JOSEPH,SPANGENBERG GLYNN ALAN;;DOHERTY WILLIAM PATRICK;;WYLY MONICA LYNN;;SCALES JAMES P;;SIPE DEAN JOSEPH,QUALCOMM INCORPORATED (2003-10-08),https://lens.org/087-047-291-162-143,Patent Application,yes,8,45,3,3,0,G06Q10/06;;G06Q40/00;;G06Q10/06;;G06Q40/00,G06Q10/06;;G06Q40/00,705/7,0,0,,,,DISCONTINUED
317,ES,T3,ES 2179839 T3,065-116-928-296-594,2003-02-01,2003,ES 94902302 T,1993-11-16,US 97535492 A,1992-11-16,MACROCAPSULAS MICROPOROSAS.,A method for determining the viral retentivity of an external jacket of an implantable permselective macrocapsule. Viral retentivity describes the ability of an external jacket to retard the transport of virus particles across the jacket.,UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID,,https://lens.org/065-116-928-296-594,Granted Patent,no,0,0,28,32,0,A61K9/0024;;A61K9/0024;;A61K9/50;;A61K9/0024,A61K9/00;;A61K9/50;;A61K35/12;;A61K35/30;;C12Q1/02;;A61K35/39;;A61K35/76;;C12N5/10;;C12N7/02;;C12Q1/70,,0,0,,,,EXPIRED
318,CN,A,CN 115087819 A,184-826-730-005-502,2022-09-20,2022,CN 202180013982 A,2021-01-08,US 202062958405 P;;US 2021/0012565 W,2020-01-08,PRELOADED TENSIONER DEVICE AND BELT ASSEMBLY,"A tensioner device, assembly, and methods of making the same are described herein. The tensioner device may be adapted to generate a target tension in an associated belt based on a measured length of the belt. The tensioner device may include an engagement member having a surface adapted to engage the belt and a biasing element associated with the engagement member. The biasing element has a loading configuration that causes the engagement member to exert a force on the belt to generate the target tension. In one example, the biasing element is manipulated to a loaded configuration such that the biasing element exhibits deflection and an effective spring stiffness for generating the target tension. The strap may be confined within the tensioner device with a bracket assembly surrounding one or more segments of the strap relative to the engagement member.",GATES CORP,MOLLA ASHUTOSH RAJARAM;;SERKH ALEXANDER;;LOEWEN THOMAS;;DOHERTY NEIL PATRICK;;REILAND DAVID P;;BERTRAND BENJAMIN,,https://lens.org/184-826-730-005-502,Patent Application,no,0,0,5,5,0,F16H7/22;;F16H7/20;;F16H2007/0897;;F16H2007/0893;;F16H2007/0874;;F16H2007/0865;;F16H7/0831;;F16H2007/081;;F16H7/1218;;F16H7/20;;F16H2007/081;;F16H2007/0865;;F16H2007/0874;;F16H2007/0893;;F16H2007/0897,F16H7/08;;F16H7/02;;F16H7/12;;F16H7/20;;F16H7/22,,0,0,,,,PENDING
319,WO,A2,WO 2004/114098 A2,195-630-032-439-754,2004-12-29,2004,US 2004/0019976 W,2004-06-21,US 60089103 A,2003-06-20,METHOD AND APPARATUS FOR MEASURING BENEFITS OF BUSINESS IMPROVEMENTS,A method and apparatus for measuring a benefit of business improvements. Actual performance information of a business is collected and stored in a storage device. The actual performance information is compared to estimated performance information prior to implementation of the business improvement. The benefit of the business improvement may then be measured by comparing the actual performance information to the estimated performance information.,QUALCOMM INC;;SPANGENBERG GLYNN ALAN;;DOHERTY WILLIAM PATRICK;;WYLY MONICA LYNN;;SCALES JAMES P;;SIPE DEAN JOSEPH,SPANGENBERG GLYNN ALAN;;DOHERTY WILLIAM PATRICK;;WYLY MONICA LYNN;;SCALES JAMES P;;SIPE DEAN JOSEPH,,https://lens.org/195-630-032-439-754,Patent Application,yes,0,0,3,3,0,G06Q10/06;;G06Q40/00;;G06Q10/06;;G06Q40/00,G06Q10/06;;G06Q40/00,,0,0,,,,PENDING
320,US,B1,US 6807361 B1,017-211-783-966-618,2004-10-19,2004,US 61853300 A,2000-07-18,US 61853300 A,2000-07-18,Interactive custom video creation system,"
    The present invention analyzes recorded video from a video camera to identify camera and object motion in the recorded video. Keyframes representative of clips of the recorded video are displayed on a user interface that allows a user to manipulate an order of the keyframes. Editing rules are then applied to the keyframes to intelligently splice together portions of the representative clips into a final output video. 
",FUJI XEROX CO LTD,GIRGENSOHN ANDREAS;;DOHERTY JOHN J;;WILCOX LYNN D;;BORECZKY JOHN S;;CHIU PATRICK;;FOOTE JONATHAN T,FUJIFILM BUSINESS INNOVATION CORP (2000-11-02),https://lens.org/017-211-783-966-618,Granted Patent,yes,2,171,2,2,0,G11B27/034;;G11B27/28;;G11B27/34;;G11B27/34;;G11B27/034;;G11B27/28,H04N5/91;;G11B27/034;;G11B27/28;;G11B27/34,386/52;;386/55;;386/117,9,8,091-636-036-059-640;;064-179-427-608-686;;138-703-749-249-007;;071-347-296-955-701;;161-134-867-097-688;;022-023-482-368-721;;190-606-710-927-086;;035-319-071-456-158,10.1109/icassp.1998.679697;;10.1145/274644.274670;;10.1109/mmcs.1999.779294;;10.1145/319463.319691;;10.1006/jvci.1996.0030;;10.1109/hicss.2000.926730;;10.21236/ada333857;;10.1109/icassp.1999.757482,"Boreczky, J. and Wilcox L. ""A Hidden Markov Model Framework for Video Segmentation Using Audio and Image Features,"" in Proc. ICASSP '98, IEEE, May 1998, Seattle.;;Boreczky, J. and Rowe, L. ""Comparison of Video Shot Boundary Detection Techniques,"" Proc. SPIE Storage and Retrieval for Image and Video Databases IV, San Jose, CA, 1996.;;Christal, M., Smith, M., Taylor, C and Winkler, D., ""Evolving Video Skims into Useful Multimedia Abstractions,"" in Human Factors in Computing Systems, CHI 98 Conference Proceedings (Los Angeles, CA), New York: ACM, pp. 171-178, 1998.;;Girgensohn, A. and Boreczky, J. ""Time-Constrained Keyframe Selection Technique,"" in IEEE Multimedia Systems '99, IEEE Computer Society, vol. 1, pp. 756-761, 1999.;;He, L., Sanocki, E., Gupta, A., Grudin, J. ""Auto-Summarization of Audio-Video Presentations,"" ACM Multimedia, Nov., 1999.;;Pfeiffer, S., Linehart, R., Fischer, S. and Effelsberg, W., ""Abstracting Digital Movies Automatically,"" in Journal of Visual Communication and Image Representation, 7(4), pp. 345-353., Dec. 1996.;;Russell, Daniel M, ""A Design Pattern-based Video Summarization technique: Moving from Low-level Signals to High-level Structure,"" Jan. 2000.;;Smith, M. and Kanade, T., ""Video Skimming and Characterization through the Combination of Image and Language Understanding Techniques,"" in Proc. Computer Vision and Pattern Recognition, pp. 775-781, 1997.;;Uchihashi, S. and Foote, J., ""Summarizing Video Using a Shot Importance Measure and a Frame-Packing Algorithm,"" in Proc. ICASSP '99, vol. 6, pp. 3041-3044, 1999.",EXPIRED
321,WO,A1,WO 2023/052901 A1,075-204-870-630-440,2023-04-06,2023,IB 2022058864 W,2022-09-20,US 202163250934 P,2021-09-30,PROTECTION OF CORONARY BLOOD VESSELS DURING CARDIAC PROCEDURES,"A blood vessel can be temporarily distanced from a tissue anchor (26) while the anchor is being driven into tissue of a subject. A delivery tool (110) can be used to deliver the anchor to the tissue and to drive the anchor into the tissue. A vessel-protection device (128) can be advanced transluminally into a blood vessel adjacent the tissue, and used to temporarily distance the blood vessel from the anchor while the anchor is driven into the tissue by the delivery tool. Other embodiments are also described.",EDWARDS LIFESCIENCES INNOVATION ISRAEL LTD,MURPHY BRIAN PATRICK;;FRANCIS MEENA;;KAZALBASH MURRAD MIRZA;;HALL LINDSAY MARIE;;GUERRERO MAURICIO;;DOHERTY THOMAS V,,https://lens.org/075-204-870-630-440,Patent Application,yes,6,0,1,1,0,A61B17/0401;;A61B2017/0409;;A61B2017/0464;;A61B2017/00243;;A61B2017/00876;;A61B34/20;;A61B2017/0441;;A61B2090/3966;;A61B2562/0223;;A61B2034/2051;;A61B2034/2072;;A61B2090/3925;;A61F2/958;;A61F2250/0048;;A61F2/2451;;A61F2/2445,A61F2/24;;A61B17/04;;A61B34/20,,0,0,,,,PENDING
322,JP,A,JP 2002084488 A,154-549-153-425-644,2002-03-22,2002,JP 2001208903 A,2001-07-10,US 61853300 A,2000-07-18,VIDEO GENERATING SYSTEM AND CUSTOM VIDEO GENERATING METHOD,"PROBLEM TO BE SOLVED: To provide an interactive video generating system that analyzes and synthesizes video data without the need for manual selection of start and end points by each clip. SOLUTION: The system of this invention analyzes video to decide a camera motion and a camera speed. A video clip suitably to be included in a final video is identified by using hierarchical edit rules and a key frame for each suitable clip is displayed on a story board for users. Then key frames are sequenced in a desirable sequence. By connecting selected clips, a final output video is generated.",FUJI XEROX CO LTD,ANDREAS GARGENSHORN;;JOHN J DOHERTY;;WILCOX LYNN D;;JOHN S BORECKY;;CHIU PATRICK;;JONATHAN T FOOTE,,https://lens.org/154-549-153-425-644,Patent Application,no,0,7,2,2,0,G11B27/034;;G11B27/28;;G11B27/34;;G11B27/34;;G11B27/034;;G11B27/28,H04N5/91;;G11B27/034;;G11B27/28;;G11B27/34,,0,0,,,,PENDING
323,WO,A1,WO 2023/141536 A1,174-166-026-453-893,2023-07-27,2023,US 2023/0060944 W,2023-01-20,US 202263267018 P,2022-01-21,"1,3,4,7-TETRAHYDRO-2H-PYRROLO [3',2':5,6] PYRIDO[2,3-B] [1,4] OXAZEPINE BC1-2 INHIBITORS","The present invention provides for compounds of Formula (I) wherein A, L, W, and R1 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of CLL, SLL, and/or ALL.",ABBVIE INC,DOHERTY GEORGE;;BHAT VIKRAM;;BRADY PATRICK;;DAI YUJIA;;GONG JIANCHUN;;JUDD ANDREW;;SOUERS ANDREW;;YU YIYUN,,https://lens.org/174-166-026-453-893,Patent Application,yes,2,0,3,3,3,C07D519/00;;A61P35/02;;C07D519/00,C07D519/00;;A61K31/553;;A61P35/02,,5,4,025-424-552-040-825;;024-437-144-140-823;;051-583-564-433-029;;074-633-529-904-195,26358926;;pmc4648041;;10.1002/anie.201506944;;10.1182/blood-2007-06-098012;;18056841;;pmc2234061;;10.1158/2159-8290.cd-14-0353;;24994123;;pmc4154982;;10.1016/0014-5793(95)00062-e;;7875313,"ANGEW CHEM INT ED, vol. 54, 2015, pages 13538 - 13544;;BLOOD, vol. 111, no. 4, 2008, pages 2300 - 2309;;CANCER DISCOVERY, vol. 4, no. 9, 2014, pages 1074 - 1087;;WANGFEES LETT, vol. 360, 1995, pages 111 - 114;;WANG FEES LETT, vol. 360, 1995, pages 111 - 4",PENDING
324,WO,A1,WO 1994/010950 A1,041-017-565-659-215,1994-05-26,1994,US 9311232 W,1993-11-16,US 97535492 A,1992-11-16,MICROPOROUS MACROCAPSULES,Microporous macrocapsules are disclosed which are useful as implantation devices for cell therapy. The macrocapsule comprises living cells that secrete biological substance that are therapeutically useful and that are released from the macrocapsule to the site of implantation. The capsules can have selected permeability characteristics based upon their particular usage and desired viral retentivity characteristics.,UNIV BROWN RES FOUND;;GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,,https://lens.org/041-017-565-659-215,Patent Application,yes,6,8,28,32,0,A61K9/0024;;A61K9/0024;;A61K9/50;;A61K9/0024,A61K9/00;;A61K9/50;;C12Q1/02;;A61K35/12;;A61K35/30;;A61K35/39;;A61K35/76;;C12N5/10;;C12N7/02;;C12Q1/70,,1,0,,,"""General Microbiology"", 1976, (STANIER et al.), pages 373-374, see entire document.",PATENTED
325,EP,A2,EP 1411360 A2,030-996-435-922-962,2004-04-21,2004,EP 03029861 A,1998-02-11,EP 98908647 A;;US 79771997 A,1997-02-11,Method and probe card for testing semiconductor system,"A probe card (10) for testing semiconductor wafers (12), and a method for testing wafers (12) using the probe card (10) are provided. The probe card (10) includes an interconnect substrate (16) having contact members (20) for establishing electrical communication with contact locations (15) on the wafer (12). The probe card (10) also includes a membrane (18) for physically and electrically connecting the interconnect substrate (16) to the testing apparatus (78), and a compressible member (28) for cushioning the pressure exerted on the interconnect substrate (16) by the testing apparatus (78). An indentation configured to retain bumped contacts (15B) of the wafers is formed in the substrate (16).",MICRON TECHNOLOGY INC,HEMBREE DAVID R;;FARNWORTH WARREN M;;AKRAM SALMAN;;WOOD ALAN G;;DOHERTY C PATRICK;;KRIVY ANDREW J,,https://lens.org/030-996-435-922-962,Patent Application,yes,0,1,14,17,0,G01R1/073;;G01R31/2886;;G01R1/073;;G01R31/2886,G01R1/073;;G01R31/28,,0,0,,,,DISCONTINUED
326,WO,A1,WO 2007/130904 A1,075-299-535-334-884,2007-11-15,2007,US 2007/0067765 W,2007-04-30,US 38104106 A,2006-05-01,MULTIPLE CHAMBER CONTAINER WITH MISTAKE PROOF ADMINISTRATION SYSTEM,"The present disclosure provides a multiple chamber container (10) that includes a container body sealed around a peripheral edge (14) and having an outlet (16). The container also includes a first peel seal (18) having a projecting portion (42) and a second peel seal (20) that isolates the outlet (16). The second peel seal may also include a projecting portion (44). The first and second peel seals (18,20) may be configured to define a symmeterical chamber. The chamber may include an axis of symmetry extending between the first and second projecting portions (42,44). The chamber geometry of the container ensures a correct sequential opening of the first and second peel seals (18,20).",BAXTER INT;;BAXTER HEALTHCARE SA;;BALTEAU PATRICK;;HARTMAN JEAN-PIERRE;;VIDREQUIN PAUL;;SFORACCHI SILVANO;;DOHERTY JOHN;;MULVIHILL CHARLIE;;SMITH NOEL;;COUSIN MARC,BALTEAU PATRICK;;HARTMAN JEAN-PIERRE;;VIDREQUIN PAUL;;SFORACCHI SILVANO;;DOHERTY JOHN;;MULVIHILL CHARLIE;;SMITH NOEL;;COUSIN MARC,,https://lens.org/075-299-535-334-884,Patent Application,yes,4,11,25,25,0,A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;B29C66/91421;;B29C66/9161;;A61J1/2024;;B29C66/71;;B29C65/16;;B29C65/4895;;B29C65/04;;A61J1/2093;;B29C66/723;;A61J1/05;;A61J1/10;;B65D81/32;;B29C66/91421;;B29C66/9161;;A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;A61J1/2024;;B29C66/71;;B29C65/4895;;B29C65/16;;B29C65/04;;A61J1/2093,B65D81/32;;A61J1/00,,0,0,,,,PENDING
327,CA,A1,CA 2149420 A1,105-467-978-581-514,1994-05-26,1994,CA 2149420 A,1993-11-16,US 97535492 A;;US 9311232 W,1992-11-16,MICROPOROUS MACROCAPSULES,2149420 9410950 PCTABS00032 Microporous macrocapsules are disclosed which are useful as implantation devices for cell therapy. The macrocapsule comprises living cells that secrete biological substance that are therapeutically useful and that are released from the macrocapsule to the site of implantation. The capsules can have selected permeability characteristics based upon their particular usage and desired viral retentivity characteristics.,UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,,https://lens.org/105-467-978-581-514,Patent Application,no,0,0,28,32,0,A61K9/0024;;A61K9/0024;;A61K9/50;;A61K9/0024,C12Q1/02;;A61K9/00;;A61K9/50;;A61K35/12;;A61K35/30;;A61K35/39;;A61K35/76;;C12N5/10;;C12N7/02;;C12Q1/70,,0,0,,,,EXPIRED
328,EP,A1,EP 0674497 A1,093-078-574-511-322,1995-10-04,1995,EP 94902302 A,1993-11-16,US 9311232 W;;US 97535492 A,1992-11-16,MICROPOROUS MACROCAPSULES.,A method for determining the viral retentivity of an external jacket of an implantable permselective macrocapsule. Viral retentivity describes the ability of an external jacket to retard the transport of virus particles across the jacket.,UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,BROWN UNIVERSITY RESEARCH FOUNDATION (2011-03-15),https://lens.org/093-078-574-511-322,Patent Application,yes,0,0,28,32,0,A61K9/0024;;A61K9/0024;;A61K9/50;;A61K9/0024,C12Q1/02;;A61K9/00;;A61K9/50;;A61K35/12;;A61K35/30;;A61K35/39;;A61K35/76;;C12N5/10;;C12N7/02;;C12Q1/70,,0,0,,,,EXPIRED
329,DK,T3,DK 0674497 T3,137-282-461-094-035,2002-11-18,2002,DK 94902302 T,1993-11-16,US 97535492 A;;US 9311232 W,1992-11-16,Mikroporøse makrokapsler,A method for determining the viral retentivity of an external jacket of an implantable permselective macrocapsule. Viral retentivity describes the ability of an external jacket to retard the transport of virus particles across the jacket.,UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,,https://lens.org/137-282-461-094-035,Granted Patent,no,0,0,28,32,0,A61K9/0024;;A61K9/0024;;A61K9/50;;A61K9/0024,C12Q1/02;;A61K9/00;;A61K9/50;;A61K35/12;;A61K35/30;;A61K35/39;;A61K35/76;;C12N5/10;;C12N7/02;;C12Q1/70,,0,0,,,,EXPIRED
330,EP,A4,EP 0674497 A4,048-920-148-876-011,1997-08-20,1997,EP 94902302 A,1993-11-16,US 9311232 W;;US 97535492 A,1992-11-16,MICROPOROUS MACROCAPSULES.,A method for determining the viral retentivity of an external jacket of an implantable permselective macrocapsule. Viral retentivity describes the ability of an external jacket to retard the transport of virus particles across the jacket.,UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,BROWN UNIVERSITY RESEARCH FOUNDATION (2011-03-15),https://lens.org/048-920-148-876-011,Search Report,no,1,0,28,32,0,A61K9/0024;;A61K9/0024;;A61K9/50;;A61K9/0024,C12Q1/02;;A61K9/00;;A61K9/50;;A61K35/12;;A61K35/30;;A61K35/39;;A61K35/76;;C12N5/10;;C12N7/02;;C12Q1/70,,0,0,,,,EXPIRED
331,BR,A2,BR PI0711086 A2,103-416-297-271-876,2011-08-23,2011,BR PI0711086 A,2007-04-30,US 38104106 A;;US 2007/0067765 W,2006-05-01,recipiente de múltiplas cámaras e método para abrir o mesmo,"RECIPIENTE DE MúLTIPLAS CáMARAS E MéTODO PARA ABRIR O MESMO.A presente invenção refere-se a um recipiente de múltiplas câmaras (10) que inclui um corpo de recipiente selado em torno de uma borda periférica (14) e dotada de uma saida (16). O recipiente também inclui uma primeira vedação de descascar (18) dotada de uma porção de projeção (42) e uma segunda vedação de descascar (20) que isola a saida (16). A segunda vedação de descascar (44) pode ainda incluir uma porção de projeção. As primeira e segunda vedações de descascar (18,20) podem ser configuradas para definir a câmara simétrica. A câmara pode incluir um eixo de simetria que se estende entre as primeira e segunda porções de projeção (42,44). A geometria da câmara do recipiente garante uma abertura sequencial correta das primeira e segunda vedações de descascar (18,20).",BAXTER INT;;BAXTER HEALTHCARE SA,BALTEAU PATRICK;;HARTMAN JEAN-PIERRE;;VIDREQUIN PAUL;;SFORACCHI SILVANO;;DOHERTY JOHN;;MULVIHILL CHARLIE;;SMITH NOEL;;COUSIN MARC,"NIKKISO CO., LTD. (JP) (2017-04-11);;BAXTER INTERNATIONAL INC (US) , BAXTER HEALTHCARE (2012-09-11)",https://lens.org/103-416-297-271-876,Patent Application,no,0,0,25,25,0,A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;B29C66/91421;;B29C66/9161;;A61J1/2024;;B29C66/71;;B29C65/16;;B29C65/4895;;B29C65/04;;A61J1/2093;;B29C66/723;;A61J1/05;;A61J1/10;;B65D81/32;;B29C66/91421;;B29C66/9161;;A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;A61J1/2024;;B29C66/71;;B29C65/4895;;B29C65/16;;B29C65/04;;A61J1/2093,A61J1/00;;B65D81/32,,0,0,,,,DISCONTINUED
332,TW,A,TW 200742714 A,105-766-953-148-845,2007-11-16,2007,TW 96112430 A,2007-04-10,US 38104106 A,2006-05-01,Multiple chamber container with mistake proof administration system,The present disclosure provides a multiple chamber container that includes a container body sealed around a peripheral edge and having an outlet. The container also includes a first peel seal having a projecting portion and a second peel seal that isolates the outlet. The second peel seal may also include a projecting portion. The first and second peel seals may be configured to define a symmetrical chamber. The chamber may include an axis of symmetry extending between the first and second projecting portions. The chamber geometry of the container ensures a correct sequential opening of the first and second peel seals.,BAXTER INT;;BAXTER HEALTHCARE SA,BALTEAU PATRICK;;HARTMAN JEAN-PIERRE;;VIDREQUIN PAUL;;SFORACCHI SILVANO;;DOHERTY JOHN;;MULVIHILL CHARLIE;;SMITH NOEL;;COUSIN MARC,,https://lens.org/105-766-953-148-845,Patent of Addition,no,0,0,25,25,0,A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;B29C66/91421;;B29C66/9161;;A61J1/2024;;B29C66/71;;B29C65/16;;B29C65/4895;;B29C65/04;;A61J1/2093;;B29C66/723;;A61J1/05;;A61J1/10;;B65D81/32;;B29C66/91421;;B29C66/9161;;A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;A61J1/2024;;B29C66/71;;B29C65/4895;;B29C65/16;;B29C65/04;;A61J1/2093,B65D81/32;;A61J1/05;;B65D47/36,,0,0,,,,INACTIVE
333,NO,D0,NO 951914 D0,168-793-081-257-073,1995-05-15,1995,NO 951914 A,1995-05-15,US 97535492 A;;US 9311232 W,1992-11-16,Mikroporöse makrokapsler,,UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,,https://lens.org/168-793-081-257-073,Patent Application,no,0,0,2,32,0,,A61K/;;A61K9/48;;A61K47/30,,0,0,,,,PENDING
334,PT,E,PT 674497 E,192-163-932-808-536,2002-12-31,2002,PT 94902302 T,1993-11-16,US 97535492 A,1992-11-16,MACROCAPSULAS MICROPOROSAS,A method for determining the viral retentivity of an external jacket of an implantable permselective macrocapsule. Viral retentivity describes the ability of an external jacket to retard the transport of virus particles across the jacket.,UNIV BROWN RES FOUND,GENTILE FRANK T;;DOHERTY EDWARD J;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;REIN DAVID;;HOLLAND LAURA,,https://lens.org/192-163-932-808-536,Granted Patent,no,0,0,28,32,0,A61K9/0024;;A61K9/0024;;A61K9/50;;A61K9/0024,A61K9/00;;A61K9/50;;A61K35/12;;C12Q1/02;;A61K35/30;;A61K35/39;;A61K35/76;;C12N5/10;;C12N7/02;;C12Q1/70,,0,0,,,,EXPIRED
335,EP,A3,EP 1411360 A3,000-634-492-322-65X,2004-04-28,2004,EP 03029861 A,1998-02-11,EP 98908647 A;;US 79771997 A,1997-02-11,Method and probe card for testing semiconductor system,"A probe card (10) for testing semiconductor wafers (12), and a method for testing wafers (12) using the probe card (10) are provided. The probe card (10) includes an interconnect substrate (16) having contact members (20) for establishing electrical communication with contact locations (15) on the wafer (12). The probe card (10) also includes a membrane (18) for physically and electrically connecting the interconnect substrate (16) to the testing apparatus (78), and a compressible member (28) for cushioning the pressure exerted on the interconnect substrate (16) by the testing apparatus (78). An indentation configured to retain bumped contacts (15B) of the wafers is formed in the substrate (16).",MICRON TECHNOLOGY INC,HEMBREE DAVID R;;FARNWORTH WARREN M;;AKRAM SALMAN;;WOOD ALAN G;;DOHERTY C PATRICK;;KRIVY ANDY J,,https://lens.org/000-634-492-322-65X,Search Report,yes,1,0,14,17,0,G01R1/073;;G01R31/2886;;G01R1/073;;G01R31/2886,G01R1/073;;G01R31/28,,2,0,,,"PATENT ABSTRACTS OF JAPAN vol. 1996, no. 06 28 June 1996 (1996-06-28);;PATENT ABSTRACTS OF JAPAN vol. 1995, no. 09 31 October 1995 (1995-10-31)",DISCONTINUED
336,CN,B,CN 101437483 B,011-820-561-083-786,2012-07-04,2012,CN 200780016055 A,2007-04-30,US 2007/0067765 W;;US 38104106 A,2006-05-01,Multiple chamber container with mistake proof administrationsystem,"The present disclosure provides a multiple chamber container (10) that includes a container body sealed around a peripheral edge (14) and having an outlet (16). The container also includes a first peel seal (18) having a projecting portion (42) and a second peel seal (20) that isolates the outlet (16). The second peel seal may also include a projecting portion (44). The first and second peel seals (18,20) may be configured to define a symmeterical chamber. The chamber may include an axis of symmetry extending between the first and second projecting portions (42,44). The chamber geometry of the container ensures a correct sequential opening of the first and second peel seals (18,20).",BAXTER INT;;BAXTER HEALTHCARE SA,NOEL SMITH;;JEAN-PIERRE HARTMAN;;MARC COUSIN;;CHARLIE MULVIHILL;;JOHN DOHERTY;;PATRICK BALTEAU;;SILVANO SFORACCHI;;PAUL VIDREQUIN,,https://lens.org/011-820-561-083-786,Granted Patent,no,0,0,25,25,0,A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;B29C66/91421;;B29C66/9161;;A61J1/2024;;B29C66/71;;B29C65/16;;B29C65/4895;;B29C65/04;;A61J1/2093;;B29C66/723;;A61J1/05;;A61J1/10;;B65D81/32;;B29C66/91421;;B29C66/9161;;A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;A61J1/2024;;B29C66/71;;B29C65/4895;;B29C65/16;;B29C65/04;;A61J1/2093,A61J1/00;;B65D81/32,,0,0,,,,ACTIVE
337,LV,A,LV 10906 A,016-050-246-059-691,1995-12-20,1995,LV 950168 A,1995-06-15,US 97535492 A,1992-11-16,Mikroporainas makrokapsulas,A method for determining the viral retentivity of an external jacket of an implantable permselective macrocapsule. Viral retentivity describes the ability of an external jacket to retard the transport of virus particles across the jacket.,UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,,https://lens.org/016-050-246-059-691,Patent Application,no,0,0,28,32,0,A61K9/0024;;A61K9/0024;;A61K9/50;;A61K9/0024,A61K9/00;;A61K9/50;;C12Q1/02;;A61K35/12;;A61K35/30;;A61K35/39;;A61K35/76;;C12N5/10;;C12N7/02;;C12Q1/70,,0,0,,,,EXPIRED
338,TW,B,TW I450845 B,147-377-931-920-931,2014-09-01,2014,TW 96112430 A,2007-04-10,US 38104106 A,2006-05-01,Multiple chamber container with mistake proof administration system,,BAXTER INT;;BAXTER HEALTHCARE SA,BALTEAU PATRICK;;HARTMAN JEAN-PIERRE;;VIDREQUIN PAUL;;SFORACCHI SILVANO;;DOHERTY JOHN;;MULVIHILL CHARLIE;;SMITH NOEL;;COUSIN MARC,,https://lens.org/147-377-931-920-931,Granted Patent,no,3,0,25,25,0,A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;B29C66/91421;;B29C66/9161;;A61J1/2024;;B29C66/71;;B29C65/16;;B29C65/4895;;B29C65/04;;A61J1/2093;;B29C66/723;;A61J1/05;;A61J1/10;;B65D81/32;;B29C66/91421;;B29C66/9161;;A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;A61J1/2024;;B29C66/71;;B29C65/4895;;B29C65/16;;B29C65/04;;A61J1/2093,,,0,0,,,,INACTIVE
339,AU,A,AU 1998/066629 A,196-831-395-960-415,1998-08-26,1998,AU 1998/066629 A,1998-02-11,US 79771997 A;;US 9803432 W,1997-02-11,Probe card and system for testing wafers,The probe card (10) is used in the testing of a semiconductor wafer (12) which has a number of semiconductor dice each with several contact locations. The wafer is supported circuit side up for contact with the probe. The probe card comprises an interconnect substrate (16) and a membrane (18). The substrate includes patterns of contact members (20) configured to contact the contact locations of the semiconductor dice. The membrane physically and electrically attaches the interconnect substrate to a probe card fixture (22) mounted to the testing appts. A membrane mounting plate (24) secures the membrane to the fixture. A force applying mechanism (32) and spring-loaded force applying member (34) are associated with the card.,MICRON TECHNOLOGY INC,HEMBREE DAVID R;;FARNWORTH WARREN M;;AKRAM SALMAN;;WOOD ALAN G;;DOHERTY C PATRICK;;KRIVY ANDY J,,https://lens.org/196-831-395-960-415,Patent Application,no,0,0,14,17,0,G01R1/073;;G01R31/2886;;G01R1/073;;G01R31/2886,G01R1/073;;G01R31/28,,0,0,,,,PENDING
340,US,B1,US 6359456 B1,084-988-496-218-097,2002-03-19,2002,US 92938801 A,2001-08-14,US 92938801 A;;US 30336799 A;;US 79771997 A,1997-02-11,Probe card and test system for semiconductor wafers,"
    A probe card for testing semiconductor wafers, and a method and system for testing wafers using the probe card are provided. The probe card is configured for use with a conventional testing apparatus, such as a wafer probe handler, in electrical communication with test circuitry. The probe card includes an interconnect substrate having contact members for establishing electrical communication with contact locations on the wafer. The probe card also includes a membrane for physically and electrically connecting the interconnect substrate to the testing apparatus, and a compressible member for cushioning the pressure exerted on the interconnect substrate by the testing apparatus. The interconnect substrate can be formed of silicon with raised contact members having penetrating projections. Alternately the contact members can be formed as indentations for testing bumped wafers. The membrane can be similar to multi layered TAB tape including metal foil conductors attached to a flexible, electrically-insulating, elastomeric tape. The probe card can be configured to contact all of the dice on the wafer at the same time, so that test signals can be electronically applied to selected dice as required. 
",MICRON TECHNOLOGY INC,HEMBREE DAVID R;;FARNWORTH WARREN M;;AKRAM SALMAN;;WOOD ALAN G;;DOHERTY C PATRICK;;KRIVY ANDREW J,,https://lens.org/084-988-496-218-097,Granted Patent,yes,42,71,14,17,0,G01R1/073;;G01R31/2886;;G01R1/073;;G01R31/2886,G01R1/073;;G01R31/28,324/754;;324/757;;324/765,2,0,,,"""Cobra(TM) technology makes Wentworth Labs the world's most advanced probe card manufacturer."", Wentworth Laboratories advertising brochure, (month unavailable), 1996.;;""Science Over Art. Our new IC Membrane Test Probe"", Packard Hughes Interconnect, advertising brochure, (month unavailable) 1993.",EXPIRED
341,EP,B1,EP 2012737 B1,143-572-938-575-139,2012-06-13,2012,EP 07761572 A,2007-04-30,US 2007/0067765 W;;US 38104106 A,2006-05-01,MULTIPLE CHAMBER CONTAINER WITH MISTAKE PROOF ADMINISTRATION SYSTEM,,BAXTER INT;;BAXTER HEALTHCARE SA,BALTEAU PATRICK;;HARTMAN JEAN-PIERRE;;VIDREQUIN PAUL;;SFORACCHI SILVANO;;DOHERTY JOHN;;MULVIHILL CHARLIE;;SMITH NOEL;;COUSIN MARC,"BAXTER HEALTHCARE S.A. (2010-01-06);;NIKKISO CO. LTD (2017-03-15);;BAXTER INTERNATIONAL INC. (2010-01-06);;NIKKISO CO., LTD., JP (2017-02-23);;NIKKISO CO., LTD.; JP (2017-01-19)",https://lens.org/143-572-938-575-139,Granted Patent,yes,4,0,25,25,0,A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;B29C66/91421;;B29C66/9161;;A61J1/2024;;B29C66/71;;B29C65/16;;B29C65/4895;;B29C65/04;;A61J1/2093;;B29C66/723;;A61J1/05;;A61J1/10;;B65D81/32;;B29C66/91421;;B29C66/9161;;A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;A61J1/2024;;B29C66/71;;B29C65/4895;;B29C65/16;;B29C65/04;;A61J1/2093,A61J1/00;;B65D81/32,,0,0,,,,ACTIVE
342,FI,A0,FI 952322 A0,167-190-608-130-898,1995-05-12,1995,FI 952322 A,1995-05-12,US 97535492 A;;US 9311232 W,1992-11-16,Mikrohuokoset makrokapselit,A method for determining the viral retentivity of an external jacket of an implantable permselective macrocapsule. Viral retentivity describes the ability of an external jacket to retard the transport of virus particles across the jacket.,UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,,https://lens.org/167-190-608-130-898,Patent Application,no,0,0,28,32,0,A61K9/0024;;A61K9/0024;;A61K9/50;;A61K9/0024,A61K9/00;;C12Q1/02;;A61K9/50;;A61K35/12;;A61K35/30;;A61K35/39;;A61K35/76;;C12N5/10;;C12N7/02;;C12Q1/70,,0,0,,,,PENDING
343,SK,A3,SK 62495 A3,016-624-464-218-654,1995-11-08,1995,SK 62495 A,1993-11-16,US 97535492 A;;US 9311232 W,1992-11-16,MICROPOROUS MACROCAPSULES,A method for determining the viral retentivity of an external jacket of an implantable permselective macrocapsule. Viral retentivity describes the ability of an external jacket to retard the transport of virus particles across the jacket.,UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,,https://lens.org/016-624-464-218-654,Patent Application,no,0,0,28,32,0,A61K9/0024;;A61K9/0024;;A61K9/50;;A61K9/0024,A61K9/00;;A61K9/50;;C12Q1/02;;A61K35/12;;A61K35/30;;A61K35/39;;A61K35/76;;C12N5/10;;C12N7/02;;C12Q1/70,,0,0,,,,PENDING
344,AU,A1,AU 2007/248194 A1,029-404-330-974-507,2007-11-15,2007,AU 2007/248194 A,2007-04-30,US 38104106 A;;US 2007/0067765 W,2006-05-01,Multiple chamber container with mistake proof administration system,,BAXTER INT;;BAXTER HEALTHCARE SA,HARTMAN JEAN-PIERRE;;COUSIN MARC;;VIDREQUIN PAUL;;SMITH NOEL;;MULVIHILL CHARLIE;;SFORACCHI SILVANO;;BALTEAU PATRICK;;DOHERTY JOHN,,https://lens.org/029-404-330-974-507,Patent Application,no,0,0,25,25,0,A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;B29C66/91421;;B29C66/9161;;A61J1/2024;;B29C66/71;;B29C65/16;;B29C65/4895;;B29C65/04;;A61J1/2093;;B29C66/723;;A61J1/05;;A61J1/10;;B65D81/32;;B29C66/91421;;B29C66/9161;;A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;A61J1/2024;;B29C66/71;;B29C65/4895;;B29C65/16;;B29C65/04;;A61J1/2093,A61J1/00;;B65D81/32,,0,0,,,,ACTIVE
345,AU,A,AU 1994/056713 A,163-834-531-823-834,1994-06-08,1994,AU 1994/056713 A,1993-11-16,US 97535492 A;;US 9311232 W,1992-11-16,Microporous macrocapsules,A method for determining the viral retentivity of an external jacket of an implantable permselective macrocapsule. Viral retentivity describes the ability of an external jacket to retard the transport of virus particles across the jacket.,UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,,https://lens.org/163-834-531-823-834,Patent Application,no,0,0,28,32,0,A61K9/0024;;A61K9/0024;;A61K9/50;;A61K9/0024,C12Q1/02;;A61K9/00;;A61K9/50;;A61K35/12;;A61K35/30;;A61K35/39;;A61K35/76;;C12N5/10;;C12N7/02;;C12Q1/70,,0,0,,,,EXPIRED
346,US,B2,US 9004761 B2,028-758-893-710-988,2015-04-14,2015,US 38104106 A,2006-05-01,US 38104106 A,2006-05-01,Multiple chamber container with mistake proof administration system,The present disclosure provides a multiple chamber container that includes a container body sealed around a peripheral edge and having an outlet. The container also includes a first peel seal having a projecting portion and a second peel seal that isolates the outlet. The second peel seal may also include a projecting portion. The first and second peel seals may be configured to define a symmetrical chamber. The chamber may include an axis of symmetry extending between the first and second projecting portions. The chamber geometry of the container ensures a correct sequential opening of the first and second peel seals.,BALTEAU PATRICK;;HARTMAN JEAN-PIERRE;;VIDREQUIN PAUL;;SFORACCHI SILVANO;;DOHERTY JOHN;;MULVIHILL CHARLIE;;SMITH NOEL;;COUSIN MARC;;BAXTER INT;;BAXTER HEALTHCARE SA,BALTEAU PATRICK;;HARTMAN JEAN-PIERRE;;VIDREQUIN PAUL;;SFORACCHI SILVANO;;DOHERTY JOHN;;MULVIHILL CHARLIE;;SMITH NOEL;;COUSIN MARC,BAXTER HEALTHCARE S.A (2006-07-04);;BAXTER INTERNATIONAL INC (2006-07-04),https://lens.org/028-758-893-710-988,Granted Patent,yes,133,8,25,25,0,A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;B29C66/91421;;B29C66/9161;;A61J1/2024;;B29C66/71;;B29C65/16;;B29C65/4895;;B29C65/04;;A61J1/2093;;B29C66/723;;A61J1/05;;A61J1/10;;B65D81/32;;B29C66/91421;;B29C66/9161;;A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;A61J1/2024;;B29C66/71;;B29C65/4895;;B29C65/16;;B29C65/04;;A61J1/2093,B65D30/22;;A61J1/10;;A61J1/20;;B29C65/00;;B29C65/18;;B29C65/76;;B29L31/00;;B65D81/32,383/38;;206/219;;604/410,10,0,,,"English Translation of JP 2001-097394.;;English Translation of JP 2000-390350.;;Partial English Translation of EP 1 103 487.;;Australian Patent Office Written Opinion dated Apr. 8, 2009, 5 pgs.;;Taiwan Office Action for Taiwan Application No. 096112430, dated Jul. 1, 2013.;;Korean Office Action for Korean Application No. 10-2008-7026726, dated Jun. 13, 2013.;;Japanese Office Action for Japanese Application No. 2012-217139, mailed Jan. 21, 2014.;;Japanese Notice of Final Rejection for Japanese Patent Application No. 2009-509995 dated Jul. 2, 2012.;;Japanese Office Action for Japanese Application No. 2012-217139, dated Sep. 25, 2013.;;Office Action dated Oct. 15, 2012, in related Mexican national stage application No. MX/a/2008/013939, 8 pages.",ACTIVE
347,EP,A4,EP 1018023 A4,046-717-491-016-768,2003-07-23,2003,EP 98908647 A,1998-02-11,US 9803432 W;;US 79771997 A,1997-02-11,PROBE CARD AND SYSTEM FOR TESTING WAFERS,The probe card (10) is used in the testing of a semiconductor wafer (12) which has a number of semiconductor dice each with several contact locations. The wafer is supported circuit side up for contact with the probe. The probe card comprises an interconnect substrate (16) and a membrane (18). The substrate includes patterns of contact members (20) configured to contact the contact locations of the semiconductor dice. The membrane physically and electrically attaches the interconnect substrate to a probe card fixture (22) mounted to the testing appts. A membrane mounting plate (24) secures the membrane to the fixture. A force applying mechanism (32) and spring-loaded force applying member (34) are associated with the card.,MICRON TECHNOLOGY INC,HEMBREE DAVID R;;FARNWORTH WARREN M;;AKRAM SALMAN;;WOOD ALAN G;;DOHERTY C PATRICK;;KRIVY ANDY J,,https://lens.org/046-717-491-016-768,Search Report,no,6,0,14,17,0,G01R1/073;;G01R31/2886;;G01R1/073;;G01R31/2886,G01R1/073;;G01R31/28,,3,0,,,"PATENT ABSTRACTS OF JAPAN vol. 1996, no. 06 28 June 1996 (1996-06-28);;PATENT ABSTRACTS OF JAPAN vol. 1995, no. 09 31 October 1995 (1995-10-31);;PATENT ABSTRACTS OF JAPAN vol. 1996, no. 05 31 May 1996 (1996-05-31)",EXPIRED
348,US,B2,US 7250780 B2,143-964-021-514-775,2007-07-31,2007,US 74272903 A,2003-12-19,US 74272903 A;;US 7273402 A;;US 92938801 A;;US 30336799 A;;US 79771997 A,1997-02-11,Probe card for semiconductor wafers having mounting plate and socket,"A probe card for testing semiconductor wafers, and a method and system for testing wafers using the probe card are provided. The probe card is configured for use with a conventional testing apparatus, such as a wafer probe handler, in electrical communication with test circuitry. The probe card includes an interconnect substrate having contact members for establishing electrical communication with contact locations on the wafer. The probe card also includes a membrane for physically and electrically connecting the interconnect substrate to the testing apparatus, and a compressible member for cushioning the pressure exerted on the interconnect substrate by the testing apparatus. The interconnect substrate can be formed of silicon with raised contact members having penetrating projections. Alternately the contact members can be formed as indentations for testing bumped wafers. The membrane can be similar to multi layered TAB tape including metal foil conductors attached to a flexible, electrically-insulating, elastomeric tape. The probe card can be configured to contact all of the dice on the wafer at the same time, so that test signals can be electronically applied to selected dice as required.",MICRON TECHNOLOGY INC,HEMBREE DAVID R;;FARNWORTH WARREN M;;AKRAM SALMAN;;WOOD ALAN G;;DOHERTY C PATRICK;;KRIVY ANDREW J,,https://lens.org/143-964-021-514-775,Granted Patent,yes,58,5,3,17,0,G01R31/2886;;G01R31/2886,G01R1/073;;G01R31/28,324/754;;324/757;;324/765,2,0,,,"""Cobra(TM) technology makes Wentworth Labs the world's most advanced probe card manufacturer"". Wentworth Laboratories advertising brochure, (month unavailable), 1996.;;""Science Over Art, Our new IC Membrane Test Probe"". Packard Hughes Interconnect, advertising brochure, (month unavailable), 1996.",EXPIRED
349,HU,D0,HU 9501426 D0,169-697-018-257-819,1995-06-28,1995,HU 9501426 A,1993-11-16,US 97535492 A,1992-11-16,MICROPOROUS MACROCAPSULES,A method for determining the viral retentivity of an external jacket of an implantable permselective macrocapsule. Viral retentivity describes the ability of an external jacket to retard the transport of virus particles across the jacket.,UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,,https://lens.org/169-697-018-257-819,Patent Application,no,0,0,28,32,0,A61K9/0024;;A61K9/0024;;A61K9/50;;A61K9/0024,C12Q1/02;;A61K9/00;;A61K9/50;;A61K35/12;;A61K35/30;;A61K35/39;;A61K35/76;;C12N5/10;;C12N7/02;;C12Q1/70,,0,0,,,,DISCONTINUED
350,CA,A1,CA 2647241 A1,197-469-015-659-354,2007-11-15,2007,CA 2647241 A,2007-04-30,US 38104106 A;;US 2007/0067765 W,2006-05-01,MULTIPLE CHAMBER CONTAINER WITH MISTAKE PROOF ADMINISTRATIONSYSTEM,,BAXTER INT;;BAXTER HEALTHCARE SA,DOHERTY JOHN;;SMITH NOEL;;MULVIHILL CHARLIE;;BALTEAU PATRICK;;HARTMAN JEAN-PIERRE;;SFORACCHI SILVANO;;VIDREQUIN PAUL;;COUSIN MARC,,https://lens.org/197-469-015-659-354,Patent Application,no,0,0,25,25,0,A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;B29C66/91421;;B29C66/9161;;A61J1/2024;;B29C66/71;;B29C65/16;;B29C65/4895;;B29C65/04;;A61J1/2093;;B29C66/723;;A61J1/05;;A61J1/10;;B65D81/32;;B29C66/91421;;B29C66/9161;;A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;A61J1/2024;;B29C66/71;;B29C65/4895;;B29C65/16;;B29C65/04;;A61J1/2093,A61J1/00;;B65D81/32,,0,0,,,,INACTIVE
351,KR,A,KR 20090013774 A,014-293-822-636-084,2009-02-05,2009,KR 20087026726 A,2007-04-30,US 38104106 A;;US 2007/0067765 W,2006-05-01,MULTIPLE CHAMBER CONTAINER WITH MISTAKE PROOF ADMINISTRATION SYSTEM,"The present disclosure provides a multiple chamber container (10) that includes a container body sealed around a peripheral edge (14) and having an outlet (16). The container also includes a first peel seal (18) having a projecting portion (42) and a second peel seal (20) that isolates the outlet (16). The second peel seal may also include a projecting portion (44). The first and second peel seals (18,20) may be configured to define a symmeterical chamber. The chamber may include an axis of symmetry extending between the first and second projecting portions (42,44). The chamber geometry of the container ensures a correct sequential opening of the first and second peel seals (18,20).",BAXTER INT;;BAXTER HEALTHCARE SA,BALTEAU PATRICK;;HARTMAN JEAN PIERRE;;VIDREQUIN PAUL;;SFORACCHI SILVANO;;DOHERTY JOHN;;MULVIHILL CHARLIE;;SMITH NOEL;;COUSIN MARC,,https://lens.org/014-293-822-636-084,Patent Application,no,0,2,25,25,0,A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;B29C66/91421;;B29C66/9161;;A61J1/2024;;B29C66/71;;B29C65/16;;B29C65/4895;;B29C65/04;;A61J1/2093;;B29C66/723;;A61J1/05;;A61J1/10;;B65D81/32;;B29C66/91421;;B29C66/9161;;A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;A61J1/2024;;B29C66/71;;B29C65/4895;;B29C65/16;;B29C65/04;;A61J1/2093,A61J1/05;;A61J1/10;;B65D81/32,,0,0,,,,ACTIVE
352,CA,C,CA 2647241 C,045-495-473-276-390,2013-04-16,2013,CA 2647241 A,2007-04-30,US 38104106 A;;US 2007/0067765 W,2006-05-01,MULTIPLE CHAMBER CONTAINER WITH MISTAKE PROOF ADMINISTRATION SYSTEM,"The present disclosure provides a multiple chamber container (10) that includes a container body sealed around a peripheral edge (14) and having an outlet (16). The container also includes a first peel seal (18) having a projecting portion (42) and a second peel seal (20) that isolates the outlet (16). The second peel seal may also include a projecting portion (44). The first and second peel seals (18,20) may be configured to define a symmeterical chamber. The chamber may include an axis of symmetry extending between the first and second projecting portions (42,44). The chamber geometry of the container ensures a correct sequential opening of the first and second peel seals (18,20).",BAXTER INT;;BAXTER HEALTHCARE SA,BALTEAU PATRICK;;HARTMAN JEAN-PIERRE;;VIDREQUIN PAUL;;SFORACCHI SILVANO;;DOHERTY JOHN;;MULVIHILL CHARLIE;;SMITH NOEL;;COUSIN MARC,,https://lens.org/045-495-473-276-390,Granted Patent,no,0,0,25,25,0,A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;B29C66/91421;;B29C66/9161;;A61J1/2024;;B29C66/71;;B29C65/16;;B29C65/4895;;B29C65/04;;A61J1/2093;;B29C66/723;;A61J1/05;;A61J1/10;;B65D81/32;;B29C66/91421;;B29C66/9161;;A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;A61J1/2024;;B29C66/71;;B29C65/4895;;B29C65/16;;B29C65/04;;A61J1/2093,A61J1/00;;B65D81/32,,0,0,,,,INACTIVE
353,AU,B2,AU 687371 B2,085-469-612-291-85X,1998-02-26,1998,AU 1994/056713 A,1993-11-16,US 97535492 A;;US 9311232 W,1992-11-16,Microporous macrocapsules,A method for determining the viral retentivity of an external jacket of an implantable permselective macrocapsule. Viral retentivity describes the ability of an external jacket to retard the transport of virus particles across the jacket.,UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,,https://lens.org/085-469-612-291-85X,Granted Patent,no,3,0,28,32,0,A61K9/0024;;A61K9/0024;;A61K9/50;;A61K9/0024,C12Q1/02;;A61K9/00;;A61K9/50;;A61K35/12;;A61K35/30;;A61K35/39;;A61K35/76;;C12N5/10;;C12N7/02;;C12Q1/70,,0,0,,,,EXPIRED
354,JP,A,JP 2013031680 A,139-533-943-807-831,2013-02-14,2013,JP 2012217139 A,2012-09-28,US 38104106 A,2006-05-01,MULTIPLE-CHAMBER CONTAINER WITH MISTAKE PROOF ADMINISTRATION SYSTEM,PROBLEM TO BE SOLVED: To provide a multiple-chamber container with a mistake proof administration system.SOLUTION: The multiple-chamber container (10) that includes a container body sealed around a peripheral edge (14) and having an outlet (16). The container also includes a first peel seal (18) having a projecting portion (42) and a second peel seal (20) that isolates the outlet (16). The second peel seal may also include a projecting portion (44). The first and second peel seals (18) and (20) may be configured to define a symmetric chamber. The chamber may include an axis of symmetry extending between the first and second projecting portions (42) and (44). The chamber geometry of the container ensures a correct sequential opening of the first and second peel seals (18) and (20).,BAXTER INT;;BAXTER HEALTHCARE SA,BALTEAU PATRICK;;HARTMAN JEAN-PIERRE;;VIDREQUIN PAUL;;SFORACCHI SILVANO;;DOHERTY JOHN;;MULVIHILL CHARLIE;;SMITH NOEL;;COUSIN MARC,,https://lens.org/139-533-943-807-831,Patent Application,no,9,1,25,25,0,A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;B29C66/91421;;B29C66/9161;;A61J1/2024;;B29C66/71;;B29C65/16;;B29C65/4895;;B29C65/04;;A61J1/2093;;B29C66/723;;A61J1/05;;A61J1/10;;B65D81/32;;B29C66/91421;;B29C66/9161;;A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;A61J1/2024;;B29C66/71;;B29C65/4895;;B29C65/16;;B29C65/04;;A61J1/2093,A61J1/05;;B65D30/22,,0,0,,,,ACTIVE
355,EP,A1,EP 1411359 A1,181-865-145-372-734,2004-04-21,2004,EP 03029860 A,1998-02-11,EP 98908647 A;;US 79771997 A,1997-02-11,Probe card for semiconductor wafers and system for testing wafers,"A probe card (10) for testing semiconductor wafers (12), and a method and system (82) for testing wafers (12) using the probe card (10) are provided. The probe card (10) includes an interconnect-substrate (16) having contact members (20) for establishing electrical communication with contact locations (15) on the wafer (12). The probe card (10) also includes a membrane (18) for physically and electrically connecting the interconnect-substrate (16) to the testing apparatus (78), and a compressible member (28) for cushioning the pressure exerted on the interconnect-substrate (16) by the testing apparatus (78).",MICRON TECHNOLOGY INC,HEMBREE DAVID R;;FARNWORTH WARREN M;;AKRAM SALMAN;;WOOD ALAN G;;DOHERTY C PATRICK;;KRIVY ANDREW J,,https://lens.org/181-865-145-372-734,Patent Application,yes,4,1,14,17,0,G01R1/073;;G01R31/2886;;G01R1/073;;G01R31/2886,G01R1/073;;G01R31/28,,1,0,,,"PATENT ABSTRACTS OF JAPAN vol. 1996, no. 06 28 June 1996 (1996-06-28)",DISCONTINUED
356,US,B1,US 6275052 B1,196-336-407-284-269,2001-08-14,2001,US 30336799 A,1999-04-30,US 30336799 A;;US 79771997 A,1997-02-11,Probe card and testing method for semiconductor wafers,"A probe card for testing semiconductor wafers, and a method and system for testing wafers using the probe card are provided. The probe card is configured for use with a conventional testing apparatus, such as a wafer probe handler, in electrical communication with test circuitry. The probe card includes an interconnect substrate having contact members for establishing electrical communication with contact locations on the wafer. The probe card also includes a membrane for physically and electrically connecting the interconnect substrate to the testing apparatus, and a compressible member for cushioning the pressure exerted on the interconnect substrate by the testing apparatus. The interconnect substrate can be formed of silicon with raised contact members having penetrating projections. Alternately the contact members can be formed as indentations for testing bumped wafers. The membrane can be similar to multi layered TAB tape including metal foil conductors attached to a flexible, electrically-insulating, elastomeric tape. The probe card can be configured to contact all of the dice on the wafer at the same time, so that test signals can be electronically applied to selected dice as required.",MICRON TECHNOLOGY INC,HEMBREE DAVID R;;FARNWORTH WARREN M;;AKRAM SALMAN;;WOOD ALAN G;;DOHERTY C PATRICK;;KRIVY ANDREW J,,https://lens.org/196-336-407-284-269,Granted Patent,yes,39,118,14,17,0,G01R1/073;;G01R31/2886;;G01R1/073;;G01R31/2886,G01R1/073;;G01R31/28,324/754;;324/757,2,0,,,"""Cobra(TM) technology makes Wentworth Labs the world's most advanced probe card manufacturer."", Wentworth Laboratories advertising brochure, (month available) 1996.;;""Science Overt Art. Our new IC Membrane Test Probe"", Packard Hughes Interconnect, advertising brochure, (month unavailable) 1993.",EXPIRED
357,NO,L,NO 951914 L,031-467-650-106-733,1995-05-15,1995,NO 951914 A,1995-05-15,US 97535492 A;;US 9311232 W,1992-11-16,Mikroporöse makrokapsler,Mikroporøse makrokapsler som er nyttige som implan- terlngsanordninger for celleterapl er beskrevet. Makrokapselen omfatter levende celler som utskiller biologisk forbindelse som er terapeutisk nyttig og som blir frigjort fra makrokapselen til Implanterings- stedet. Kapslene kan ha valgte permeabilitetskarakter- trekk basert på deres spesielle anvendelse og ensket virale tilbakeholdende karaktertrekk.,UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,,https://lens.org/031-467-650-106-733,Abstract,no,0,0,2,32,0,,A61K/;;A61K9/48;;A61K47/30,,0,0,,,,PENDING
358,EP,B1,EP 1018023 B1,086-046-792-503-646,2005-04-27,2005,EP 98908647 A,1998-02-11,US 9803432 W;;US 79771997 A,1997-02-11,PROBE CARD FOR TESTING WAFERS,The probe card (10) is used in the testing of a semiconductor wafer (12) which has a number of semiconductor dice each with several contact locations. The wafer is supported circuit side up for contact with the probe. The probe card comprises an interconnect substrate (16) and a membrane (18). The substrate includes patterns of contact members (20) configured to contact the contact locations of the semiconductor dice. The membrane physically and electrically attaches the interconnect substrate to a probe card fixture (22) mounted to the testing appts. A membrane mounting plate (24) secures the membrane to the fixture. A force applying mechanism (32) and spring-loaded force applying member (34) are associated with the card.,MICRON TECHNOLOGY INC,HEMBREE DAVID R;;FARNWORTH WARREN M;;AKRAM SALMAN;;WOOD ALAN G;;DOHERTY C PATRICK;;KRIVY ANDY J,,https://lens.org/086-046-792-503-646,Granted Patent,yes,8,0,14,17,0,G01R1/073;;G01R31/2886;;G01R1/073;;G01R31/2886,G01R1/073;;G01R31/28,,3,0,,,"PATENT ABSTRACTS OF JAPAN vol. 1996, no. 06, 28 June 1996 (1996-06-28) -& JP 08 050146 A (HITACHI LTD), 20 February 1996 (1996-02-20);;PATENT ABSTRACTS OF JAPAN vol. 1995, no. 09, 31 October 1995 (1995-10-31) -& JP 07 159485 A (HITACHI LTD), 23 June 1995 (1995-06-23);;PATENT ABSTRACTS OF JAPAN vol. 1996, no. 05, 31 May 1996 (1996-05-31) -& JP 08 005666 A (MATSUSHITA ELECTRIC IND CO LTD), 12 January 1996 (1996-01-12) -& US 6 005 401 A (HATADA KENZOU ET AL) 21 December 1999 (1999-12-21)",EXPIRED
359,ES,T3,ES 2389682 T3,105-478-101-160-629,2012-10-30,2012,ES 07761572 T,2007-04-30,US 38104106 A;;US 2007/0067765 W,2006-05-01,Recipiente multicámara con sistema de administración a prueba de errores,"Recipiente multicámara (10) que comprende:un cuerpo de recipiente sellado alrededor de un borde periférico (14) y con una salida (16);un primer sello despegable (18) que define cámaras en el recipiente (10); teniendo el primer sellodespegable (18) una primera parte saliente y un borde exterior, y teniendo al menos una parte del bordeexterior una parte dentada; yun segundo sello despegable (20) que aísla la salida con respecto a las cámaras, teniendo el segundosello despegable (20) una segunda parte saliente (44), sobresaliendo la primera parte saliente (42) hacia lasegunda parte saliente (44) y sobresaliendo la segunda parte saliente (44) hacia la primera parte saliente (42)de forma esencialmente simétrica con respecto a un eje de simetría esencialmente paralelo al primer sellohermético despegable (18) o al borde periférico inferior (24).",BAXTER INT;;BAXTER HEALTHCARE SA,BALTEAU PATRICK;;HARTMAN JEAN-PIERRE;;VIDREQUIN PAUL;;SFORACCHI SILVANO;;DOHERTY JOHN;;MULVIHILL CHARLIE;;SMITH NOEL;;COUSIN MARC,,https://lens.org/105-478-101-160-629,Granted Patent,no,0,0,25,25,0,A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;B29C66/91421;;B29C66/9161;;A61J1/2024;;B29C66/71;;B29C65/16;;B29C65/4895;;B29C65/04;;A61J1/2093;;B29C66/723;;A61J1/05;;A61J1/10;;B65D81/32;;B29C66/91421;;B29C66/9161;;A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;A61J1/2024;;B29C66/71;;B29C65/4895;;B29C65/16;;B29C65/04;;A61J1/2093,A61J1/00;;B65D81/32,,0,0,,,,ACTIVE
360,HU,A,HU T72986 A,108-615-799-918-514,1996-06-28,1996,HU 9501426 A,1993-11-16,US 97535492 A,1992-11-16,MICROPOROUS MACROCAPSULES,A method for determining the viral retentivity of an external jacket of an implantable permselective macrocapsule. Viral retentivity describes the ability of an external jacket to retard the transport of virus particles across the jacket.,UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,,https://lens.org/108-615-799-918-514,Unknown,no,0,0,28,32,0,A61K9/0024;;A61K9/0024;;A61K9/50;;A61K9/0024,A61K9/00;;A61K9/50;;C12Q1/02;;A61K35/12;;A61K35/30;;A61K35/39;;A61K35/76;;C12N5/10;;C12N7/02;;C12Q1/70,,0,0,,,,DISCONTINUED
361,US,A1,US 2004/0132222 A1,121-001-818-597-897,2004-07-08,2004,US 74272903 A,2003-12-19,US 74272903 A;;US 7273402 A;;US 92938801 A;;US 30336799 A;;US 79771997 A,1997-02-11,Probe card for semiconductor wafers and method and system for testing wafers,"
   A probe card for testing semiconductor wafers, and a method and system for testing wafers using the probe card are provided. The probe card is configured for use with a conventional testing apparatus, such as a wafer probe handler, in electrical communication with test circuitry. The probe card includes an interconnect substrate having contact members for establishing electrical communication with contact locations on the wafer. The probe card also includes a membrane for physically and electrically connecting the interconnect substrate to the testing apparatus, and a compressible member for cushioning the pressure exerted on the interconnect substrate by the testing apparatus. The interconnect substrate can be formed of silicon with raised contact members having penetrating projections. Alternately the contact members can be formed as indentations for testing bumped wafers. The membrane can be similar to multi layered TAB tape including metal foil conductors attached to a flexible, electrically-insulating, elastomeric tape. The probe card can be configured to contact all of the dice on the wafer at the same time, so that test signals can be electronically applied to selected dice as required. 
",HEMBREE DAVID R.;;FARNWORTH WARREN M.;;AKRAM SALMAN;;WOOD ALAN G.;;DOHERTY C. PATRICK;;KRIVY ANDREW J.,HEMBREE DAVID R;;FARNWORTH WARREN M;;AKRAM SALMAN;;WOOD ALAN G;;DOHERTY C PATRICK;;KRIVY ANDREW J,,https://lens.org/121-001-818-597-897,Patent Application,yes,53,5,3,17,0,G01R31/2886;;G01R31/2886,G01R31/28,438/11,0,0,,,,EXPIRED
362,AU,A,AU 1998/064883 A,145-545-040-015-10X,1998-07-02,1998,AU 1998/064883 A,1998-05-12,AU 1998/064883 A;;AU 1994/056713 A;;US 97535492 A,1992-11-16,Methods employing microporous macrocapsules,,BROWN UNIV RESEARCH FOUNDATION,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,,https://lens.org/145-545-040-015-10X,Patent Application,no,0,0,2,32,0,,C12Q1/70,,0,0,,,,EXPIRED
363,AT,T1,AT E294396 T1,004-486-493-060-931,2005-05-15,2005,AT 98908647 T,1998-02-11,US 79771997 A;;US 9803432 W,1997-02-11,TESTKARTE ZUR WAFER-PRÜFUNG,The probe card (10) is used in the testing of a semiconductor wafer (12) which has a number of semiconductor dice each with several contact locations. The wafer is supported circuit side up for contact with the probe. The probe card comprises an interconnect substrate (16) and a membrane (18). The substrate includes patterns of contact members (20) configured to contact the contact locations of the semiconductor dice. The membrane physically and electrically attaches the interconnect substrate to a probe card fixture (22) mounted to the testing appts. A membrane mounting plate (24) secures the membrane to the fixture. A force applying mechanism (32) and spring-loaded force applying member (34) are associated with the card.,MICRON TECHNOLOGY INC,HEMBREE DAVID R;;FARNWORTH WARREN M;;AKRAM SALMAN;;WOOD ALAN G;;DOHERTY C PATRICK;;KRIVY ANDY J,,https://lens.org/004-486-493-060-931,Granted Patent,no,0,0,14,17,0,G01R1/073;;G01R31/2886;;G01R1/073;;G01R31/2886,G01R1/073;;G01R31/28,,0,0,,,,DISCONTINUED
364,BR,A,BR 9307455 A,109-303-012-835-373,1999-06-01,1999,BR 9307455 A,1993-11-16,US 97535492 A;;US 9311232 W,1992-11-16,Macrocápsula processos de terapia celular e de determinação a retentividade viral de uma camisa externa de uma macrocápsula permeavelmente seletiva,A method for determining the viral retentivity of an external jacket of an implantable permselective macrocapsule. Viral retentivity describes the ability of an external jacket to retard the transport of virus particles across the jacket.,UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,,https://lens.org/109-303-012-835-373,Patent Application,no,0,0,28,32,0,A61K9/0024;;A61K9/0024;;A61K9/50;;A61K9/0024,C12Q1/02;;A61K9/00;;A61K9/50;;A61K35/12;;A61K35/30;;A61K35/39;;A61K35/76;;C12N5/10;;C12N7/02;;C12Q1/70,,0,0,,,,DISCONTINUED
365,EP,B1,EP 0674497 B1,141-358-994-880-277,2002-07-24,2002,EP 94902302 A,1993-11-16,US 9311232 W;;US 97535492 A,1992-11-16,MICROPOROUS MACROCAPSULES,A method for determining the viral retentivity of an external jacket of an implantable permselective macrocapsule. Viral retentivity describes the ability of an external jacket to retard the transport of virus particles across the jacket.,UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,BROWN UNIVERSITY RESEARCH FOUNDATION (2011-03-15),https://lens.org/141-358-994-880-277,Granted Patent,yes,7,0,28,32,0,A61K9/0024;;A61K9/0024;;A61K9/50;;A61K9/0024,C12Q1/02;;A61K9/00;;A61K9/50;;A61K35/12;;A61K35/30;;A61K35/39;;A61K35/76;;C12N5/10;;C12N7/02;;C12Q1/70,,1,0,,,"""General Microbiology"", 1976, (STANIER et al.), pages 373-374, see entire document.",EXPIRED
366,PL,A1,PL 309012 A1,194-434-885-354-213,1995-09-18,1995,PL 30901293 A,1993-11-16,US 9311232 W;;US 97535492 A,1992-11-16,MICROPOROUS MICROCAPSULES,A method for determining the viral retentivity of an external jacket of an implantable permselective macrocapsule. Viral retentivity describes the ability of an external jacket to retard the transport of virus particles across the jacket.,UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,,https://lens.org/194-434-885-354-213,Patent Application,no,0,0,28,32,0,A61K9/0024;;A61K9/0024;;A61K9/50;;A61K9/0024,A61K9/00;;A61K9/50;;C12Q1/02;;A61K35/12;;A61K35/30;;A61K35/39;;A61K35/76;;C12N5/10;;C12N7/02;;C12Q1/70,,0,0,,,,PENDING
367,NZ,A,NZ 258720 A,184-317-269-769-137,1997-07-27,1997,NZ 25872093 A,1993-11-16,US 97535492 A,1992-11-16,IMPLANTABLE PERMSELECTIVE MACROCAPSULES CONTAINING LIVING CELLS; METHOD FOR DETERMINING THE VIRAL RETENTIVITY OF AN EXTERNAL JACKET OF A MACROCAPSULE,A method for determining the viral retentivity of an external jacket of an implantable permselective macrocapsule. Viral retentivity describes the ability of an external jacket to retard the transport of virus particles across the jacket.,UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,,https://lens.org/184-317-269-769-137,Patent Application,no,0,0,28,32,0,A61K9/0024;;A61K9/0024;;A61K9/50;;A61K9/0024,A61K9/00;;A61K9/50;;A61K35/12;;A61K35/30;;C12Q1/02;;A61K35/39;;A61K35/76;;C12N5/10;;C12N7/02;;C12Q1/70,,0,0,,,,PENDING
368,MX,A,MX 2008013939 A,061-699-021-746-341,2009-01-26,2009,MX 2008013939 A,2007-04-30,US 38104106 A;;US 2007/0067765 W,2006-05-01,MULTIPLE CHAMBER CONTAINER WITH MISTAKE PROOF ADMINISTRATION SYSTEM.,"The present disclosure provides a multiple chamber container (10) that includes a container body sealed around a peripheral edge (14) and having an outlet (16). The container also includes a first peel seal (18) having a projecting portion (42) and a second peel seal (20) that isolates the outlet (16). The second peel seal may also include a projecting portion (44). The first and second peel seals (18,20) may be configured to define a symmeterical chamber. The chamber may include an axis of symmetry extending between the first and second projecting portions (42,44). The chamber geometry of the container ensures a correct sequential opening of the first and second peel seals (18,20).",BAXTER INT,BALTEAU PATRICK;;HARTMAN JEAN-PIERRE;;SFORACCHI SILVANO;;VIDREQUIN PAUL;;DOHERTY JOHN;;MULVIHILL CHARLIE;;COUSIN MARC;;SMITH NOEL,,https://lens.org/061-699-021-746-341,Patent Application,no,0,0,25,25,0,A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;B29C66/91421;;B29C66/9161;;A61J1/2024;;B29C66/71;;B29C65/16;;B29C65/4895;;B29C65/04;;A61J1/2093;;B29C66/723;;A61J1/05;;A61J1/10;;B65D81/32;;B29C66/91421;;B29C66/9161;;A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;A61J1/2024;;B29C66/71;;B29C65/4895;;B29C65/16;;B29C65/04;;A61J1/2093,A61J1/00;;B65D81/32,,0,0,,,,ACTIVE
369,AU,B2,AU 700766 B2,065-556-916-882-78X,1999-01-14,1999,AU 1998/064883 A,1998-05-12,AU 1998/064883 A;;AU 1994/056713 A;;US 97535492 A,1992-11-16,Methods employing microporous macrocapsules,,UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,,https://lens.org/065-556-916-882-78X,Granted Patent,no,0,0,2,32,0,,C12Q1/70,,0,0,,,,EXPIRED
370,EP,A1,EP 2012737 A1,112-041-166-236-42X,2009-01-14,2009,EP 07761572 A,2007-04-30,US 2007/0067765 W;;US 38104106 A,2006-05-01,MULTIPLE CHAMBER CONTAINER WITH MISTAKE PROOF ADMINISTRATION SYSTEM,,BAXTER INT;;BAXTER HEALTHCARE SA,BALTEAU PATRICK;;HARTMAN JEAN-PIERRE;;VIDREQUIN PAUL;;SFORACCHI SILVANO;;DOHERTY JOHN;;MULVIHILL CHARLIE;;SMITH NOEL;;COUSIN MARC,"BAXTER HEALTHCARE S.A. (2010-01-06);;NIKKISO CO. LTD (2017-03-15);;BAXTER INTERNATIONAL INC. (2010-01-06);;NIKKISO CO., LTD., JP (2017-02-23);;NIKKISO CO., LTD.; JP (2017-01-19)",https://lens.org/112-041-166-236-42X,Patent Application,yes,0,0,25,25,0,A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;B29C66/91421;;B29C66/9161;;A61J1/2024;;B29C66/71;;B29C65/16;;B29C65/4895;;B29C65/04;;A61J1/2093;;B29C66/723;;A61J1/05;;A61J1/10;;B65D81/32;;B29C66/91421;;B29C66/9161;;A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;A61J1/2024;;B29C66/71;;B29C65/4895;;B29C65/16;;B29C65/04;;A61J1/2093,A61J1/00;;B65D81/32,,0,0,,,,ACTIVE
371,EP,A1,EP 1018023 A1,102-548-253-224-38X,2000-07-12,2000,EP 98908647 A,1998-02-11,US 9803432 W;;US 79771997 A,1997-02-11,PROBE CARD FOR TESTING WAFERS,The probe card (10) is used in the testing of a semiconductor wafer (12) which has a number of semiconductor dice each with several contact locations. The wafer is supported circuit side up for contact with the probe. The probe card comprises an interconnect substrate (16) and a membrane (18). The substrate includes patterns of contact members (20) configured to contact the contact locations of the semiconductor dice. The membrane physically and electrically attaches the interconnect substrate to a probe card fixture (22) mounted to the testing appts. A membrane mounting plate (24) secures the membrane to the fixture. A force applying mechanism (32) and spring-loaded force applying member (34) are associated with the card.,MICRON TECHNOLOGY INC,HEMBREE DAVID R;;FARNWORTH WARREN M;;AKRAM SALMAN;;WOOD ALAN G;;DOHERTY C PATRICK;;KRIVY ANDY J,,https://lens.org/102-548-253-224-38X,Patent Application,yes,0,0,14,17,0,G01R1/073;;G01R31/2886;;G01R1/073;;G01R31/2886,G01R1/073;;G01R31/28,,0,0,,,,EXPIRED
372,AT,T1,AT E220883 T1,041-657-700-087-690,2002-08-15,2002,AT 94902302 T,1993-11-16,US 97535492 A;;US 9311232 W,1992-11-16,MIKROPORÖSE MAKROKAPSELN,A method for determining the viral retentivity of an external jacket of an implantable permselective macrocapsule. Viral retentivity describes the ability of an external jacket to retard the transport of virus particles across the jacket.,UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,,https://lens.org/041-657-700-087-690,Granted Patent,no,0,0,28,32,0,A61K9/0024;;A61K9/0024;;A61K9/50;;A61K9/0024,C12Q1/02;;A61K9/00;;A61K9/50;;A61K35/12;;A61K35/30;;A61K35/39;;A61K35/76;;C12N5/10;;C12N7/02;;C12Q1/70,,0,0,,,,DISCONTINUED
373,US,A1,US 2007/0261974 A1,053-756-703-837-433,2007-11-15,2007,US 38104106 A,2006-05-01,US 38104106 A,2006-05-01,MULTIPLE CHAMBER CONTAINER WITH MISTAKE PROOF ADMINSTRATION SYSTEM,The present disclosure provides a multiple chamber container that includes a container body sealed around a peripheral edge and having an outlet. The container also includes a first peel seal having a projecting portion and a second peel seal that isolates the outlet. The second peel seal may also include a projecting portion. The first and second peel seals may be configured to define a symmetrical chamber. The chamber may include an axis of symmetry extending between the first and second projecting portions. The chamber geometry of the container ensures a correct sequential opening of the first and second peel seals.,BALTEAU PATRICK;;HARTMAN JEAN-PIERRE;;VIDREQUIN PAUL;;SFORACCHI SILVANO;;DOHERTY JOHN;;MULVIHILL CHARLIE;;SMITH NOEL;;COUSIN MARC,BALTEAU PATRICK;;HARTMAN JEAN-PIERRE;;VIDREQUIN PAUL;;SFORACCHI SILVANO;;DOHERTY JOHN;;MULVIHILL CHARLIE;;SMITH NOEL;;COUSIN MARC,BAXTER HEALTHCARE S.A (2006-07-04);;BAXTER INTERNATIONAL INC (2006-07-04),https://lens.org/053-756-703-837-433,Patent Application,yes,38,26,25,25,0,A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;B29C66/91421;;B29C66/9161;;A61J1/2024;;B29C66/71;;B29C65/16;;B29C65/4895;;B29C65/04;;A61J1/2093;;B29C66/723;;A61J1/05;;A61J1/10;;B65D81/32;;B29C66/91421;;B29C66/9161;;A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;A61J1/2024;;B29C66/71;;B29C65/4895;;B29C65/16;;B29C65/04;;A61J1/2093,B65D30/22;;B65D25/08;;B65D33/00,206/219;;383/38;;383/210,0,0,,,,ACTIVE
374,AU,B2,AU 2007/248194 B2,107-823-281-468-918,2011-06-02,2011,AU 2007/248194 A,2007-04-30,US 38104106 A;;US 2007/0067765 W,2006-05-01,Multiple chamber container with mistake proof administration system,,BAXTER HEALTHCARE SA;;BAXTER INT,HARTMAN JEAN-PIERRE;;COUSIN MARC;;VIDREQUIN PAUL;;SMITH NOEL;;MULVIHILL CHARLIE;;SFORACCHI SILVANO;;BALTEAU PATRICK;;DOHERTY JOHN,,https://lens.org/107-823-281-468-918,Granted Patent,no,6,0,25,25,0,A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;B29C66/91421;;B29C66/9161;;A61J1/2024;;B29C66/71;;B29C65/16;;B29C65/4895;;B29C65/04;;A61J1/2093;;B29C66/723;;A61J1/05;;A61J1/10;;B65D81/32;;B29C66/91421;;B29C66/9161;;A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;A61J1/2024;;B29C66/71;;B29C65/4895;;B29C65/16;;B29C65/04;;A61J1/2093,A61J1/00;;B65D81/32,,0,0,,,,ACTIVE
375,LV,B,LV 10906 B,150-770-957-436-979,1996-06-20,1996,LV 950168 A,1995-06-15,US 97535492 A,1992-11-16,Microporus macrocapsules,A method for determining the viral retentivity of an external jacket of an implantable permselective macrocapsule. Viral retentivity describes the ability of an external jacket to retard the transport of virus particles across the jacket.,UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,,https://lens.org/150-770-957-436-979,Granted Patent,no,0,0,28,32,0,A61K9/0024;;A61K9/0024;;A61K9/50;;A61K9/0024,A61K9/00;;A61K9/50;;C12Q1/02;;A61K35/12;;A61K35/30;;A61K35/39;;A61K35/76;;C12N5/10;;C12N7/02;;C12Q1/70,,0,0,,,,EXPIRED
376,DK,T3,DK 2012737 T3,154-645-396-245-488,2012-09-03,2012,DK 07761572 T,2007-04-30,US 38104106 A;;US 2007/0067765 W,2006-05-01,Flerkammerbeholder med fejlsikkert administrationssystem,,BAXTER INT;;BAXTER HEALTHCARE SA,BALTEAU PATRICK;;HARTMAN JEAN-PIERRE;;VIDREQUIN PAUL;;SFORACCHI SILVANO;;DOHERTY JOHN;;SMITH NOEL;;COUSIN MARC;;MULVIHILL CHARLIE,,https://lens.org/154-645-396-245-488,Granted Patent,no,0,0,25,25,0,A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;B29C66/91421;;B29C66/9161;;A61J1/2024;;B29C66/71;;B29C65/16;;B29C65/4895;;B29C65/04;;A61J1/2093;;B29C66/723;;A61J1/05;;A61J1/10;;B65D81/32;;B29C66/91421;;B29C66/9161;;A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;A61J1/2024;;B29C66/71;;B29C65/4895;;B29C65/16;;B29C65/04;;A61J1/2093,A61J1/00;;B65D81/32,,0,0,,,,ACTIVE
377,US,B1,US 6798224 B1,068-851-160-845-17X,2004-09-28,2004,US 7273402 A,2002-02-05,US 7273402 A;;US 92938801 A;;US 30336799 A;;US 79771997 A,1997-02-11,Method for testing semiconductor wafers,"
    A probe card for testing semiconductor wafers, and a method and system for testing wafers using the probe card are provided. The probe card is configured for use with a conventional testing apparatus, such as a wafer probe handler, in electrical communication with test circuitry. The probe card includes an interconnect substrate having contact members for establishing electrical communication with contact locations on the wafer. The probe card also includes a membrane for physically and electrically connecting the interconnect substrate to the testing apparatus, and a compressible member for cushioning the pressure exerted on the interconnect substrate by the testing apparatus. The interconnect substrate can be formed of silicon with raised contact members having penetrating projections. Alternately the contact members can be formed as indentations for testing bumped wafers. The membrane can be similar to multi layered TAB tape including metal foil conductors attached to a flexible, electrically-insulating, elastomeric tape. The probe card can be configured to contact all of the dice on the wafer at the same time, so that test signals can be electronically applied to selected dice as required. 
",MICRON TECHNOLOGY INC,HEMBREE DAVID R;;FARNWORTH WARREN M;;AKRAM SALMAN;;WOOD ALAN G;;DOHERTY C PATRICK;;KRIVY ANDREW J,,https://lens.org/068-851-160-845-17X,Granted Patent,yes,53,40,3,17,0,G01R31/2886;;G01R31/2886,G01R31/28,324/754;;324/757;;324/765,2,0,,,"""COBRA(TM) technology makes Wentworth Labs the world's most advanced probe card manufacturer."" Wentworth Laboratories advertising brochure, (month unavailable), 1996.;;""Science Over Art. Our new IC Membrane Test Probe"", Packard Hughes Interconnect, advertising brochure, (month unavailable) 1993.",EXPIRED
378,JP,A,JP H08503472 A,168-283-489-043-036,1996-04-16,1996,JP 51250393 A,1993-11-16,US 9311232 W;;US 97535492 A,1992-11-16,JP H08503472 A,A method for determining the viral retentivity of an external jacket of an implantable permselective macrocapsule. Viral retentivity describes the ability of an external jacket to retard the transport of virus particles across the jacket.,UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,,https://lens.org/168-283-489-043-036,Patent Application,no,0,0,28,32,0,A61K9/0024;;A61K9/0024;;A61K9/50;;A61K9/0024,A61K9/00;;A61K9/50;;A61K35/12;;A61K35/30;;A61K35/39;;A61K35/76;;C12N5/10;;C12N7/02;;C12Q1/70;;C12Q1/02,,0,0,,,,PENDING
379,FI,A,FI 952322 A,159-146-440-284-78X,1995-07-11,1995,FI 952322 A,1995-05-12,US 97535492 A;;US 9311232 W,1992-11-16,Mikrohuokoset makrokapselit,A method for determining the viral retentivity of an external jacket of an implantable permselective macrocapsule. Viral retentivity describes the ability of an external jacket to retard the transport of virus particles across the jacket.,UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,,https://lens.org/159-146-440-284-78X,Patent Application,no,0,0,28,32,0,A61K9/0024;;A61K9/0024;;A61K9/50;;A61K9/0024,A61K9/00;;A61K9/50;;A61K35/12;;C12Q1/02;;A61K35/30;;A61K35/39;;A61K35/76;;C12N5/10;;C12N7/02;;C12Q1/70,,0,0,,,,PENDING
380,PT,E,PT 2012737 E,185-885-012-436-988,2012-08-21,2012,PT 07761572 T,2007-04-30,US 38104106 A,2006-05-01,MULTIPLE CHAMBER CONTAINER WITH MISTAKE PROOF ADMINISTRATION SYSTEM,,BAXTER HEALTHCARE SA;;BAXTER INT,BALTEAU PATRICK;;HARTMAN JEAN-PIERRE;;VIDREQUIN PAUL;;SFORACCHI SILVANO;;DOHERTY JOHN;;MULVIHILL CHARLIE;;SMITH NOEL;;COUSIN MARC,,https://lens.org/185-885-012-436-988,Granted Patent,no,0,0,25,25,0,A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;B29C66/91421;;B29C66/9161;;A61J1/2024;;B29C66/71;;B29C65/16;;B29C65/4895;;B29C65/04;;A61J1/2093;;B29C66/723;;A61J1/05;;A61J1/10;;B65D81/32;;B29C66/91421;;B29C66/9161;;A61J1/10;;B65D81/3266;;B29C65/18;;B29C65/76;;B29C66/0042;;B29C66/1122;;B29C66/223;;B29C66/244;;B29C66/2442;;B29C66/43;;B29C66/81427;;B29C66/919;;B29L2031/7148;;A61J1/2024;;B29C66/71;;B29C65/4895;;B29C65/16;;B29C65/04;;A61J1/2093,A61J1/00;;B65D81/32,,0,0,,,,ACTIVE
381,WO,A1,WO 1998/035238 A1,186-499-394-206-184,1998-08-13,1998,US 9803432 W,1998-02-11,US 79771997 A,1997-02-11,PROBE CARD AND SYSTEM FOR TESTING WAFERS,"A probe card (10) for testing semiconductor wafers (12), and a method and system (82) for testing wafers (12) using the probe card (10) are provided. The probe card (10) includes an interconnect substrate (16) having contact members (20) for establishing electrical communication with contact locations (15) on the wafer (12). The probe card (10) also includes a membrane (18) for physically and electrically connecting the interconnect substrate (16) to the testing apparatus (78), and a compressible member (28) for cushioning the pressure exerted on the interconnect substrate (16) by the testing apparatus (78).",MICRON TECHNOLOGY INC;;HEMBREE DAVID R;;FARNWORTH WARREN M;;AKRAM SALMAN;;WOOD ALAN G;;DOHERTY C PATRICK;;KRIVY ANDY J,HEMBREE DAVID R;;FARNWORTH WARREN M;;AKRAM SALMAN;;WOOD ALAN G;;DOHERTY C PATRICK;;KRIVY ANDY J,,https://lens.org/186-499-394-206-184,Patent Application,yes,4,1,14,17,0,G01R1/073;;G01R31/2886;;G01R1/073;;G01R31/2886,G01R1/073;;G01R31/28,,0,0,,,,PATENTED
382,US,A,US 6060891 A,047-054-713-324-734,2000-05-09,2000,US 79771997 A,1997-02-11,US 79771997 A,1997-02-11,Probe card for semiconductor wafers and method and system for testing wafers,"A probe card for testing semiconductor wafers, and a method and system for testing wafers using the probe card are provided. The probe card is configured for use with a conventional testing apparatus, such as a wafer probe handler, in electrical communication with test circuitry. The probe card includes an interconnect substrate having contact members for establishing electrical communication with contact locations on the wafer. The probe card also includes a membrane for physically and electrically connecting the interconnect substrate to the testing apparatus, and a compressible member for cushioning the pressure exerted on the interconnect substrate by the testing apparatus. The interconnect substrate can be formed of silicon with raised contact members having penetrating projections. Alternately the contact members can be formed as indentations for testing bumped wafers. The membrane can be similar to multi layered TAB tape including metal foil conductors attached to a flexible, electrically-insulating, elastomeric tape. The probe card can be configured to contact all of the dice on the wafer at the same time, so that test signals can be electronically applied to selected dice as required.",MICRON TECHNOLOGY INC,HEMBREE DAVID R;;FARNWORTH WARREN M;;AKRAM SALMAN;;WOOD ALAN G;;DOHERTY C PATRICK;;KRIVY ANDREW J,MICRON TECHNOLOGY INC (1997-02-04),https://lens.org/047-054-713-324-734,Granted Patent,yes,32,157,14,17,0,G01R1/073;;G01R31/2886;;G01R1/073;;G01R31/2886,G01R1/073;;G01R31/28,324/754;;324/757;;324/765,2,0,,,"Cobra technology makes Wentworth Labs the world s most advanced probe card manufacturer. , Wentworth Laboratories advertising brochure, 1996.;;Science Over Art. Our new IC Membrane Test Probe , Packard Hughes Interconnect, advertising brochure, 1993.",EXPIRED
383,CZ,A3,CZ 122795 A3,121-411-611-090-548,1996-02-14,1996,CZ 122795 A,1993-11-16,US 97535492 A,1992-11-16,IMPLANTABLE SELECTIVELY PERMEABLE MACROSCOPIC CASE AND PROCESS FOR PRODUCING THEREOF,A method for determining the viral retentivity of an external jacket of an implantable permselective macrocapsule. Viral retentivity describes the ability of an external jacket to retard the transport of virus particles across the jacket.,UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA,,https://lens.org/121-411-611-090-548,Patent Application,no,0,0,28,32,0,A61K9/0024;;A61K9/0024;;A61K9/50;;A61K9/0024,C12Q1/02;;A61K9/00;;A61K9/50;;A61K35/12;;A61K35/30;;A61K35/39;;A61K35/76;;C12N5/10;;C12N7/02;;C12Q1/70,,0,0,,,,PENDING
384,GB,A,GB 2603145 A,069-471-470-802-599,2022-08-03,2022,GB 202101111 A,2021-01-27,GB 202101111 A,2021-01-27,AN AIRCRAFT SEAT ASSEMBLY,"An aircraft seat assembly (130, figure 1a) comprising a seat (140, figure 1a) with a backrest 150, and a seat pan 160 providing a seat pan surface (161, figure 1a). The seat pan surface being moveably mounted with respect to the backrest such that it can be moved to a safety position 164 by a safety actuation mechanism which comprises a safety actuator 181b.There is an actuation controller (not shown), for controlling the safety actuator, it comprises an emergency alert signal receiver for receiving an emergency alert signal, and an actuation control signal output for sending an actuation control signal to the safety actuator. When the actuation controller receives the emergency alert signal, the at least one safety actuator is controlled to cause the seat pan surface to move to the safety position. The seat pan surface in the safety position may act to impede movement of the passenger. The safety actuator may comprise an inflatable airbag, bladder, or a gas piston. In the safety position, the seat pan is almost vertical. The safety actuator may be located within or under the seat pan.",SAFRAN SEATS;;SAFRAN SEATS GB LTD,CIARAN DOHERTY;;JOANNA HUTCHINSON;;JEAN-CHRISTOPHE GAUDEAU;;ARTHUR K GLAIN;;PATRICK JAMES SMITH;;THOMAS REES-GRALTON;;RICHARD PAYTON,,https://lens.org/069-471-470-802-599,Patent Application,no,2,0,2,2,0,B64D11/0604;;B64D11/0619;;B64D11/06205;;B64D25/04;;B64D2201/00;;B64D25/04;;B60R21/16;;B64D11/0639,B64D25/04,,0,0,,,,PENDING
385,US,B1,US 6337088 B1,025-393-431-585-811,2002-01-08,2002,US 46539295 A,1995-06-05,US 46539295 A;;US 97535492 A,1992-11-16,Microporous macrocapsules,"
    A method for determining the viral retentivity of an external jacket of an implantable permselective macrocapsule. Viral retentivity describes the ability of an external jacket to retard the transport of virus particles across the jacket. 
",UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA M,NEUROTECH S.A (1999-12-29),https://lens.org/025-393-431-585-811,Granted Patent,yes,6,7,28,32,0,A61K9/0024;;A61K9/0024;;A61K9/50;;A61K9/0024,A61K9/00;;A61K9/50;;C12Q1/02;;A61K35/12;;A61K35/30;;A61K35/39;;A61K35/76;;C12N5/10;;C12N7/02;;C12Q1/70,424/451;;424/400,3,0,,,"Freshney, Culture of Animal Cells, p. 402-3.*;;Stanier, et al., ""The Bacterial Virus"" General Microbiology 373-374 (1976).;;Freshney, ""Virus Preparation and Assay"" Culture of Animal Cells: A Manual of Basic Technique (A John Wiley & Sons, Inc.: New York) pp. 402-403.",EXPIRED
386,US,A,US 5955095 A,162-628-205-489-769,1999-09-21,1999,US 43628195 A,1995-08-14,US 43628195 A;;US 9203327 W;;US 9311232 W,1992-04-22,Microporous macrocapsules,Microporous macrocapsules are disclosed which are useful as implantation devices for cell therapy. The macrocapsule comprises living cells that secrete biological substance that are therapeutically useful and that are released from the macrocapsule to the site of implantation. The capsules can have selected permeability characteristics based upon their particular usage and desired viral retentivity characteristics.,UNIV BROWN RES FOUND,GENTILE FRANK T;;HAZLETT TYRONE;;TRESCO PATRICK A;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID;;HOLLAND LAURA M,BROWN UNIVERSITY RESEARCH FOUNDATION (1995-05-26);;NEUROTECH S.A (1999-12-29),https://lens.org/162-628-205-489-769,Granted Patent,yes,6,13,1,1,0,A61K9/4816;;A61K9/4816,A61K9/48,424/422;;424/463;;424/520,2,0,,,"Stanier, et al., The Bacterial Virus General Microbiology 373 374 (1976).;;Freshney, Virus Preparation and Assay Culture of Animal Cells: A Manual of Basic Technique (A John Wiley & Sons, Inc.: New York) pp. 402 403.",EXPIRED
387,US,S,US D0916604 S,197-719-303-716-471,2021-04-20,2021,US 202029744883 F,2020-07-31,US 202029744883 F,2020-07-31,Thermometer,,KEEE LLC,DOHERTY PATRICK;;WALL JOHN;;BIVIANO MICHAEL S;;MURRAY STEVEN W;;MURRAY JEREMY MORGAN;;FRANK BRIAN A;;TUREK JOSEPH A,SATURDAY CAPITAL LLC (2021-05-11);;KEEE LLC (2020-08-03);;M-WAVE INTERNATIONAL LLC (2020-07-31),https://lens.org/197-719-303-716-471,Design Right,no,33,4,1,1,0,,,1004;;D10/57,3,0,,,"CMU—Queen, Scott, “CMU Changes Safeguard Student Health”, https://news.centralmethodist.edu/2020/08/changes-to-safeguard-student-health.html, Aug. 9, 2020, 3 pages.;;NYT—McNeil, Donald Jr., “Can Smart Thermometers Track the Spread of the Coronavirus?”, https://www.nytimes.com/2020/03/18/health/coronavirus-fever-thermometers.html, Mar. 18, 2020, 3 pages.;;Youtube, “Presage PreCheck—Channel”, https://www.youtube.com/channel/UCYcYvvB8f4UE55DZdtPXk9Q/videos, Sep. 2020.",ACTIVE
388,US,A1,US 2023/0234971 A1,013-521-079-650-415,2023-07-27,2023,US 202318156987 A,2023-01-19,US 202318156987 A;;US 202263267018 P,2022-01-21,"1,3,4,7-Tetrahydro-2H-pyrrolo[3',2':5,6]pyrido[2,3-b][1,4]oxazepine Bcl-2 Inhibitors","The present invention provides for compounds of Formula (I) wherein A, L, W, and R 1 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of CLL, SLL, and/or ALL.",ABBVIE INC,DOHERTY GEORGE A;;BHAT VIKRAM;;BRADY PATRICK;;DAI YUJIA;;GONG JIANCHUN;;JUDD ANDREW S;;SOUERS ANDREW J;;YU YIYUN,ABBVIE INC (2024-02-16),https://lens.org/013-521-079-650-415,Patent Application,yes,0,0,3,3,0,C07D519/00;;A61P35/02;;C07D519/00,C07D519/00,,0,0,,,,PENDING
389,CA,C,CA 2149420 C,054-561-485-234-55X,2007-04-17,2007,CA 2149420 A,1993-11-16,US 97535492 A;;US 9311232 W,1992-11-16,MICROPOROUS MACROCAPSULES,Microporous macrocapsules are disclosed which are useful as implantation devices for cell therapy. The macrocapsule comprises living cells that secrete biological substance that are therapeutically useful and that are released from the macrocapsule to the site of implantation. The capsules can have selected permeability characteristics based upon their particular usage and desired viral retentivity characteristics.,UNIV BROWN RES FOUND,GENTILE FRANK T;;TRESCO PATRICK A;;HAZLETT TYRONE;;FLANAGAN THOMAS;;DOHERTY EDWARD J;;REIN DAVID H;;HOLLAND LAURA M,,https://lens.org/054-561-485-234-55X,Granted Patent,no,0,0,28,32,0,A61K9/0024;;A61K9/0024;;A61K9/50;;A61K9/0024,C12N11/00;;C12Q1/02;;A61K9/00;;A61K9/50;;A61K9/66;;A61K35/12;;A61K35/30;;A61K35/39;;A61K35/55;;A61K35/76;;A61K48/00;;A61M37/00;;C12N5/10;;C12N7/02;;C12Q1/70,,0,0,,,,EXPIRED
390,US,B1,US 11004283 B1,032-248-547-606-031,2021-05-11,2021,US 202016945472 A,2020-07-31,US 202016945472 A,2020-07-31,Temperature detection device,"Described herein is a temperature device, including systems and methods associated therewith. The temperature device may include a housing. The temperature device may further include an actuation feature associated with the housing and configured to receive a user input. The temperature device may further include a sensing feature recessed within the housing and configured to detect a temperature condition in response to a receipt of the user input. The temperature device may further include a communication module operatively connected to the sensing feature and configured to transmit and receive information associated with a detection of the temperature condition.",KEEE LLC,DOHERTY PATRICK;;WALL JOHN;;BIVIANO MICHAEL S;;MURRAY STEVEN W;;MURRAY JEREMY MORGAN;;FRANK BRIAN A;;TUREK JOSEPH A,SATURDAY CAPITAL LLC (2021-05-11);;KEEE LLC (2020-08-03);;M-WAVE INTERNATIONAL LLC (2020-07-31),https://lens.org/032-248-547-606-031,Granted Patent,yes,5,6,1,1,0,G01J5/0025;;G07C9/00563;;G01J5/0025;;G01J5/0215;;G01J5/025;;G01J5/0265;;G01J5/0275;;G01J5/028;;G01J5/04;;G01J5/10;;G01J5/10;;G07C9/00563;;G07C9/00944;;G07C9/00944;;G07C9/37;;G07C2009/00507;;G07C2009/00587;;G07C2209/63,G01K13/00;;G01J5/00;;G01J5/10;;G07C9/00;;G07C9/37,,3,0,,,"CMU—Queen, Scott, “CMU Changes Safeguard Student Health”, https://news.centralmethodist.edu/2020/08/changes-to-safeguard-student-health.html, Aug. 9, 2020, 3 pages.;;NYT—McNeil, Donald Jr., “Can Smart Thermometers Track the Spread of the Coronavirus?”, https://www.nytimes.com/2020/03/18/health/coronavirus-fever-thermometers.html, Mar. 18, 2020, 3 pages.;;Youtube, “Presage PreCheck—Channel”, https://www.youtube.com/channel/UCYcYwB8f4UE55DZdtPXk9Q/videos, Sep. 2020.",ACTIVE
391,TW,A,TW 202340210 A,181-448-996-933-635,2023-10-16,2023,TW 112102814 A,2023-01-19,US 202263267018 P,2022-01-21,"1,3,4,7-tetrahydro-2H-pyrrolo[3',2':5,6]pyrido[2,3-b][1,4]oxazepine Bcl-2 inhibitors","The present invention provides for compounds of Formula (I) wherein A, L, W, and R1 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of CLL, SLL, and/or ALL.",ABBVIE INC,DOHERTY GEORGE A;;BHAT VIKRAM;;BRADY PATRICK;;DAI YUJIA;;GONG JIANCHUN;;JUDD ANDREW S;;SOUERS ANDREW J;;YU YI-YUN,,https://lens.org/181-448-996-933-635,Patent of Addition,no,0,0,3,3,0,C07D519/00;;A61P35/02;;C07D519/00,C07D498/14;;A61K31/553;;A61K31/635;;A61P35/00;;A61P35/02,,0,0,,,,PENDING
392,US,A1,US 2022/0150878 A1,035-420-333-086-801,2022-05-12,2022,US 202217580957 A,2022-01-21,US 202217580957 A;;US 201916399874 A,2019-04-30,RESOURCE DISTRIBUTION HUB GENERATION ON A MOBILE DEVICE,"Embodiments of the present invention provide systems, apparatus, methods and/or the like for generating a resource distribution hub using for fully electronic resource distribution by using mobile device application designed to interface with an embedded Near-Field Communication (NFC) tag in a resource distribution instrument that stores instructions for processing the resource distribution authorization information. The holder (i.e., resource provider) of the resource distribution instrument can use the resource distribution instrument to communicate to a mobile communication device having an NFC reader to read the instructions and process a resource distribution according to the parameters of the mobile device application. As such, the holder (i.e., resource provider) of the resource distribution request can process the resource distribution without having to issue a credentials, aliases, pin codes, and the like conventionally used to authorizes the distribution of resources to the resource requester.",BANK OF AMERICA,MCCONNELL PATRICK THOMAS;;BURKS WILLIAM BRADLEY;;DOHERTY DANIEL JAMES;;DUPONT JUSTIN RILEY;;ELLIOTT THOMAS;;ENGLAND TONY;;MURPHY MATTHEW;;PARKER NICKOLAS PATRICK;;SELFRIDGE STEPHEN PHILIP;;TWOMBLY STEVEN MICHAEL;;WILLIAMS JAMES J,BANK OF AMERICA CORPORATION (2019-04-22),https://lens.org/035-420-333-086-801,Patent Application,yes,0,0,4,4,0,H04W4/80;;G06Q20/3278;;H04W12/068;;G06Q20/367;;H04W72/044;;H04W4/80;;G06F9/5011;;H04W12/068,H04W72/04;;G06F9/50;;H04W4/80;;H04W12/06,,0,0,,,,ACTIVE
393,US,B2,US 10998937 B2,159-029-928-153-561,2021-05-04,2021,US 201916399709 A,2019-04-30,US 201916399709 A,2019-04-30,Embedded tag for resource distribution,"Embodiments of the invention are directed facilitating an electronic resource distribution by embedding a short-range wireless tag in a resource distribution request that stores instructions for processing the resource distribution in a fully electronic processing flow. As such, the resource distribution request holder is capable of processing the request without issuing a resource distribution document to the resource requester. In additional embodiments of the invention, the short-range wireless tag further stores instructions for arranging subsequent resource distributions to the resource requester to occur without the need for the resource requester to present a resource request document.",BANK OF AMERICA,MCCONNELL PATRICK THOMAS;;BURKS WILLIAM BRADLEY;;DOHERTY DANIEL JAMES;;DUPONT JUSTIN RILEY;;ELLIOTT THOMAS;;ENGLAND TONY;;MURPHY MATTHEW;;PARKER NICKOLAS PATRICK;;SELFRIDGE STEPHEN PHILIP;;TWOMBLY STEVEN MICHAEL;;WILLIAMS JAMES J,BANK OF AMERICA CORPORATION (2019-04-22),https://lens.org/159-029-928-153-561,Granted Patent,yes,86,0,2,2,0,H04W4/80;;H04B5/77;;H04W4/80;;G06K7/10297;;G06K19/0723;;H04B5/77,H04B5/00;;G06K7/10;;G06K19/07;;H04W4/80,,0,0,,,,ACTIVE
394,US,B2,US 10979306 B2,009-153-518-431-249,2021-04-13,2021,US 201916434604 A,2019-06-07,US 201916434604 A,2019-06-07,System for backend resource management simulation and live deployment,"The invention comprises a user friendly investment strategy platform. This invention allows for a drag-and-drop platform for various sectors, strategies, vehicles, and timing in the form of blocks. This allows a user to generate any desired resource management strategy and the system may deploy the strategy as a simulated resource management action. Furthermore, the system allows for deployment of the resource action live on a resource exchange upon user authorization. The blocks include object codes that are programmed to build out any possible resource management strategy. The invention may also suggest or recommend thresholds, and other templates that allow for customization.",BANK OF AMERICA,MCCONNELL PATRICK THOMAS;;BURKS WILLIAM BRADLEY;;DOHERTY DANIEL JAMES;;DUPONT JUSTIN RILEY;;ELLIOTT THOMAS;;ENGLAND TONY;;MURPHY MATTHEW;;PARKER NICKOLAS PATRICK;;SELFRIDGE STEPHEN PHILIP;;TWOMBLY STEVEN MICHAEL;;WILLIAMS JAMES J,BANK OF AMERICA CORPORATION (2019-04-22),https://lens.org/009-153-518-431-249,Granted Patent,yes,22,0,2,2,0,H04L41/145;;H04L41/22;;H04L67/306;;H04L63/08;;H04L67/53;;H04L67/131;;H04L41/145;;H04L41/22;;H04L67/53;;H04L67/131,H04L12/24;;H04L29/06;;H04L29/08,,0,0,,,,ACTIVE
395,US,A1,US 2020/0349552 A1,119-100-208-033-906,2020-11-05,2020,US 201916399873 A,2019-04-30,US 201916399873 A,2019-04-30,SYSTEM FOR SECURE CONTACTLESS DISTRIBUTION OF DYNAMIC RESOURCES,"Embodiments of the present invention provide a system for secure contactless distribution of dynamic resources. Resource information may be written onto a near field communication (“NFC”) chip associated with a user, and a dynamic resource value element can be associated with this NFC chip. When an NFC interaction between the NFC chip associated with the user and a computing device of the user is detected, the computing device of the user extracts the resource information from the NFC chip, along with a dynamic resource value. The dynamic resource value is compared to an expected dynamic resource value and, if the values match, the extracted resource information is populated into memory fields of the computing device of the user.",BANK OF AMERICA,MCCONNELL PATRICK THOMAS;;BURKS WILLIAM BRADLEY;;DOHERTY DANIEL JAMES;;DUPONT JUSTIN RILEY;;ELLIOTT THOMAS;;ENGLAND TONY;;MURPHY MATTHEW;;PARKER NICKOLAS PATRICK;;SELFRIDGE STEPHEN PHILIP;;TWOMBLY STEVEN MICHAEL;;WILLIAMS JAMES J,BANK OF AMERICA CORPORATION (2019-04-22),https://lens.org/119-100-208-033-906,Patent Application,yes,0,0,1,1,0,G06Q20/3278;;G06Q20/3278;;G06Q20/341;;G06Q20/341;;G06Q20/352,G06Q20/32;;G06Q20/34,,0,0,,,,DISCONTINUED
396,US,B2,US 11889480 B2,083-050-201-245-124,2024-01-30,2024,US 202217580957 A,2022-01-21,US 202217580957 A;;US 201916399874 A,2019-04-30,Resource distribution hub generation on a mobile device,"Embodiments of the present invention provide systems, apparatus, methods and/or the like for generating a resource distribution hub using for fully electronic resource distribution by using mobile device application designed to interface with an embedded Near-Field Communication (NFC) tag in a resource distribution instrument that stores instructions for processing the resource distribution authorization information. The holder (i.e., resource provider) of the resource distribution instrument can use the resource distribution instrument to communicate to a mobile communication device having an NFC reader to read the instructions and process a resource distribution according to the parameters of the mobile device application. As such, the holder (i.e., resource provider) of the resource distribution request can process the resource distribution without having to issue a credentials, aliases, pin codes, and the like conventionally used to authorizes the distribution of resources to the resource requester.",BANK OF AMERICA,MCCONNELL PATRICK THOMAS;;BURKS WILLIAM BRADLEY;;DOHERTY DANIEL JAMES;;DUPONT JUSTIN RILEY;;ELLIOTT THOMAS;;ENGLAND TONY;;MURPHY MATTHEW;;PARKER NICKOLAS PATRICK;;SELFRIDGE STEPHEN PHILIP;;TWOMBLY STEVEN MICHAEL;;WILLIAMS JAMES J,BANK OF AMERICA CORPORATION (2019-04-22),https://lens.org/083-050-201-245-124,Granted Patent,yes,115,0,4,4,0,H04W4/80;;G06Q20/3278;;H04W12/068;;G06Q20/367;;H04W72/044;;H04W4/80;;G06F9/5011;;H04W12/068,H04W72/044;;G06F9/50;;H04W4/80;;H04W12/06,,1,1,151-704-872-367-055,10.1155/2018/2649598,Demystifying Authentication Concepts in Smartphones: Ways and Types to Secure Access by Gasparetti (Year: 2017).,ACTIVE
397,US,A1,US 2020/0348976 A1,125-733-940-925-89X,2020-11-05,2020,US 201916399767 A,2019-04-30,US 201916399767 A,2019-04-30,RESOURCE DISTRIBUTION INSTRUMENTS WITH EMBEDDED CODES OR COMMUNICATION DEVICES,"Embodiments of the invention are directed to facilitating electronic resource distribution by including computer-readable indicia or a short-range wireless tag on a physical resource distribution document/instrument that stores or provides access to instructions for requesting and/or processing subsequent resource distributions between the resource requester and requester provider fully electronically (i.e., absent the need for a resource distribution request document or a resource distribution document/instrument).",BANK OF AMERICA,MCCONNELL PATRICK THOMAS;;BURKS WILLIAM BRADLEY;;DOHERTY DANIEL JAMES;;DUPONT JUSTIN RILEY;;ELLIOTT THOMAS;;ENGLAND TONY;;MURPHY MATTHEW;;PARKER NICKOLAS PATRICK;;SELFRIDGE STEPHEN PHILIP;;TWOMBLY STEVEN MICHAEL;;WILLIAMS JAMES J,BANK OF AMERICA CORPORATION (2019-04-22),https://lens.org/125-733-940-925-89X,Patent Application,yes,0,0,1,1,0,G06F9/468;;G06F9/4843;;H04W4/80;;G06F9/5011;;H04W4/80;;G06F16/953;;G06F16/9035;;G06F9/468,G06F9/50;;G06F16/9035;;G06F16/953;;G06K9/00;;H04W4/80,,0,0,,,,DISCONTINUED
398,US,A1,US 2020/0389363 A1,129-501-408-362-587,2020-12-10,2020,US 201916434604 A,2019-06-07,US 201916434604 A,2019-06-07,SYSTEM FOR BACKEND RESOURCE MANAGEMENT SIMULATION AND LIVE DEPLOYMENT,"The invention comprises a user friendly investment strategy platform. This invention allows for a drag-and-drop platform for various sectors, strategies, vehicles, and timing in the form of blocks. This allows a user to generate any desired resource management strategy and the system may deploy the strategy as a simulated resource management action. Furthermore, the system allows for deployment of the resource action live on a resource exchange upon user authorization. The blocks include object codes that are programmed to build out any possible resource management strategy. The invention may also suggest or recommend risk thresholds, and other templates that allow for customization.",BANK OF AMERICA,MCCONNELL PATRICK THOMAS;;BURKS WILLIAM BRADLEY;;DOHERTY DANIEL JAMES;;DUPONT JUSTIN RILEY;;ELLIOTT THOMAS;;ENGLAND TONY;;MURPHY MATTHEW;;PARKER NICKOLAS PATRICK;;SELFRIDGE STEPHEN PHILIP;;TWOMBLY STEVEN MICHAEL;;WILLIAMS JAMES J,BANK OF AMERICA CORPORATION (2019-04-22),https://lens.org/129-501-408-362-587,Patent Application,yes,0,1,2,2,0,H04L41/145;;H04L41/22;;H04L67/306;;H04L63/08;;H04L67/53;;H04L67/131;;H04L41/145;;H04L41/22;;H04L67/53;;H04L67/131,H04L29/06;;H04L12/24;;H04L29/08,,0,0,,,,ACTIVE
399,US,B2,US 11234235 B2,129-441-481-844-089,2022-01-25,2022,US 201916399874 A,2019-04-30,US 201916399874 A,2019-04-30,Resource distribution hub generation on a mobile device,"Embodiments of the present invention provide systems, apparatus, methods and/or the like for generating a resource distribution hub using for fully electronic resource distribution by using mobile device application designed to interface with an embedded Near-Field Communication (NFC) tag in a resource distribution instrument that stores instructions for processing the resource distribution authorization information. The holder (i.e., resource provider) of the resource distribution instrument can use the resource distribution instrument to communicate to a mobile communication device having an NFC reader to read the instructions and process a resource distribution according to the parameters of the mobile device application. As such, the holder (i.e., resource provider) of the resource distribution request can process the resource distribution without having to issue a credentials, aliases, pin codes, and the like conventionally used to authorizes the distribution of resources to the resource requester.",BANK OF AMERICA,MCCONNELL PATRICK THOMAS;;BURKS WILLIAM BRADLEY;;DOHERTY DANIEL JAMES;;DUPONT JUSTIN RILEY;;ELLIOTT THOMAS;;ENGLAND TONY;;MURPHY MATTHEW;;PARKER NICKOLAS PATRICK;;SELFRIDGE STEPHEN PHILIP;;TWOMBLY STEVEN MICHAEL;;WILLIAMS JAMES J,BANK OF AMERICA CORPORATION (2019-04-22),https://lens.org/129-441-481-844-089,Granted Patent,yes,109,0,4,4,0,H04W4/80;;G06Q20/3278;;H04W12/068;;G06Q20/367;;H04W72/044;;H04W4/80;;G06F9/5011;;H04W12/068,H04W72/04;;G06F9/50;;H04W4/80;;H04W12/06,,1,1,151-704-872-367-055,10.1155/2018/2649598,Demystifying Authentication Concepts in Smartphones: Ways and Types to Secure Access by Gasparetti (Year: 2017).,ACTIVE
400,US,A1,US 2020/0351852 A1,019-314-480-385-482,2020-11-05,2020,US 201916399874 A,2019-04-30,US 201916399874 A,2019-04-30,RESOURCE DISTRIBUTION HUB GENERATION ON A MOBILE DEVICE,"Embodiments of the present invention provide systems, apparatus, methods and/or the like for generating a resource distribution hub using for fully electronic resource distribution by using mobile device application designed to interface with an embedded Near-Field Communication (NFC) tag in a resource distribution instrument that stores instructions for processing the resource distribution authorization information. The holder (i.e., resource provider) of the resource distribution instrument can use the resource distribution instrument to communicate to a mobile communication device having an NFC reader to read the instructions and process a resource distribution according to the parameters of the mobile device application. As such, the holder (i.e., resource provider) of the resource distribution request can process the resource distribution without having to issue a credentials, aliases, pin codes, and the like conventionally used to authorizes the distribution of resources to the resource requester.",BANK OF AMERICA,MCCONNELL PATRICK THOMAS;;BURKS WILLIAM BRADLEY;;DOHERTY DANIEL JAMES;;DUPONT JUSTIN RILEY;;ELLIOTT THOMAS;;ENGLAND TONY;;MURPHY MATTHEW;;PARKER NICKOLAS PATRICK;;SELFRIDGE STEPHEN PHILIP;;TWOMBLY STEVEN MICHAEL;;WILLIAMS JAMES J,BANK OF AMERICA CORPORATION (2019-04-22),https://lens.org/019-314-480-385-482,Patent Application,yes,0,2,4,4,0,H04W4/80;;G06Q20/3278;;H04W12/068;;G06Q20/367;;H04W72/044;;H04W4/80;;G06F9/5011;;H04W12/068,H04W72/04;;G06F9/50;;H04W4/80;;H04W12/06,,0,0,,,,ACTIVE
401,US,B2,US 11196737 B2,017-047-079-485-579,2021-12-07,2021,US 201916399877 A,2019-04-30,US 201916399877 A,2019-04-30,System for secondary authentication via contactless distribution of dynamic resources,"Embodiments of the present invention provide a system for secondary authentication via contactless distribution of dynamic resources. When an event request associated with a user is received, a prompt for event information is transmitted to a computing device. Based on the event information that is received, a determination is made that the event request requires a secondary authentication in the form of a near field communication (“NFC”) interaction between an NFC chip associated with the user and a secondary authentication device. The NFC chip associated with the user may additionally be associated with a dynamic resource value element. Once the NFC interaction is detected, a dynamic resource value is extracted and compared to an expected dynamic resource value. If the values match, then the user is authenticated for the requested event at the secondary authentication level.",BANK OF AMERICA,MCCONNELL PATRICK THOMAS;;BURKS WILLIAM BRADLEY;;DOHERTY DANIEL JAMES;;DUPONT JUSTIN RILEY;;ELLIOTT THOMAS;;ENGLAND TONY;;MURPHY MATTHEW;;PARKER NICKOLAS PATRICK;;SELFRIDGE STEPHEN PHILIP;;TWOMBLY STEVEN MICHAEL;;WILLIAMS JAMES J,BANK OF AMERICA CORPORATION (2019-04-22),https://lens.org/017-047-079-485-579,Granted Patent,yes,103,0,2,2,0,G06Q30/0609;;G06Q20/352;;G06Q30/0609;;H04L63/0853;;H04L63/0853;;H04L63/102;;H04L63/20;;H04W12/06;;H04W12/06;;H04W12/47,H04L29/06;;G06Q30/06;;H04W12/06,,1,0,,,"Gupta, Sandeep et al., Demystifying Authentication Concepts in Smartphones: Ways and Types to Secure Access by Gasparetti (Year: 2017), 36 pages.",ACTIVE
402,US,A1,US 2020/0350955 A1,046-863-744-611-692,2020-11-05,2020,US 201916399709 A,2019-04-30,US 201916399709 A,2019-04-30,EMBEDDED TAG FOR RESOURCE DISTRIBUTION,"Embodiments of the invention are directed facilitating an electronic resource distribution by embedding a short-range wireless tag in a resource distribution request that stores instructions for processing the resource distribution in a fully electronic processing flow. As such, the resource distribution request holder is capable of processing the request without issuing a resource distribution document to the resource requester. In additional embodiments of the invention, the short-range wireless tag further stores instructions for arranging subsequent resource distributions to the resource requester to occur without the need for the resource requester to present a resource request document.",BANK OF AMERICA,MCCONNELL PATRICK THOMAS;;BURKS WILLIAM BRADLEY;;DOHERTY DANIEL JAMES;;DUPONT JUSTIN RILEY;;ELLIOTT THOMAS;;ENGLAND TONY;;MURPHY MATTHEW;;PARKER NICKOLAS PATRICK;;SELFRIDGE STEPHEN PHILIP;;TWOMBLY STEVEN MICHAEL;;WILLIAMS JAMES J,BANK OF AMERICA CORPORATION (2019-04-22),https://lens.org/046-863-744-611-692,Patent Application,yes,0,0,2,2,0,H04W4/80;;H04B5/77;;H04W4/80;;G06K7/10297;;G06K19/0723;;H04B5/77,H04B5/00;;G06K7/10;;G06K19/07;;H04W4/80,,0,0,,,,ACTIVE
403,US,A1,US 2020/0351262 A1,149-076-998-189-737,2020-11-05,2020,US 201916399877 A,2019-04-30,US 201916399877 A,2019-04-30,SYSTEM FOR SECONDARY AUTHENTICATION VIA CONTACTLESS DISTRIBUTION OF DYNAMIC RESOURCES,"Embodiments of the present invention provide a system for secondary authentication via contactless distribution of dynamic resources. When an event request associated with a user is received, a prompt for event information is transmitted to a computing device. Based on the event information that is received, a determination is made that the event request requires a secondary authentication in the form of a near field communication (“NFC”) interaction between an NFC chip associated with the user and a secondary authentication device. The NFC chip associated with the user may additionally be associated with a dynamic resource value element. Once the NFC interaction is detected, a dynamic resource value is extracted and compared to an expected dynamic resource value. If the values match, then the user is authenticated for the requested event at the secondary authentication level.",BANK OF AMERICA,MCCONNELL PATRICK THOMAS;;BURKS WILLIAM BRADLEY;;DOHERTY DANIEL JAMES;;DUPONT JUSTIN RILEY;;ELLIOTT THOMAS;;ENGLAND TONY;;MURPHY MATTHEW;;PARKER NICKOLAS PATRICK;;SELFRIDGE STEPHEN PHILIP;;TWOMBLY STEVEN MICHAEL;;WILLIAMS JAMES J,BANK OF AMERICA CORPORATION (2019-04-22),https://lens.org/149-076-998-189-737,Patent Application,yes,0,0,2,2,0,G06Q30/0609;;G06Q20/352;;G06Q30/0609;;H04L63/0853;;H04L63/0853;;H04L63/102;;H04L63/20;;H04W12/06;;H04W12/06;;H04W12/47,H04L29/06;;G06Q30/06;;H04W12/06,,0,0,,,,ACTIVE
404,MX,A,MX 9700527 A,066-920-588-865-546,1997-04-30,1997,MX 9700527 A,1995-07-20,US 27977394 A;;US 43269895 A;;US 9509281 W,1994-07-20,GROWTH CONTROL FOR CELLS ENCAPSULATED WITHIN BIOARTIFICIAL ORGANS.,"This invention relates to methods and compositions of controlling cell distribution within a bioartificial organ by exposing the cells to a treatment that inhibits cell proliferation, promotes cell differentiation, or affects cell attachment to a growth surface within the bioartificial organ. Such treatments include (1) genetically manipulating cells, (2) exposing the cells to a proliferation-inhibiting compound or a differentiation-inducing compound or removing the cells from exposure to a proliferation-stimulating compound or a differentiation-inhibing compound; exposing the cells to irradiation, and (3) modifying a growth surface of the BAO with ECM molecules, molecules affecting cell proliferation or adhesion, or an inert scaffold, or a combination thereof. These treatments may be used in combination.",CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;MESSING ALBEE;;AEBISCHER PATRICK,,https://lens.org/066-920-588-865-546,Patent Application,no,0,0,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A61L27/00;;A61L27/18;;A01K67/027;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,PENDING
405,JP,A,JP H10506266 A,113-745-261-439-526,1998-06-23,1998,JP 50527195 A,1995-07-20,US 9509281 W;;US 27977394 A;;US 43269895 A,1994-07-20,JP H10506266 A,,CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,,https://lens.org/113-745-261-439-526,Patent Application,no,0,4,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A61L27/00;;A61L27/18;;A01K67/027;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,PENDING
406,US,A,US 5843431 A,103-015-322-123-422,1998-12-01,1998,US 43269895 A,1995-05-09,US 43269895 A;;US 27977394 A,1994-07-20,Controlling proliferation of cells before and after encapsulation in a bioartificial organ by gene transformation,"Methods and compositions are provided for controlling cell distribution within an implantable bioartificial organ by exposing the cells to a treatment that inhibits cell proliferation, promotes cell differentiation, or affects cell attachment to a growth surface within the bioartificial organ. Such treatments include (1) genetically manipulating cells, (2) exposing the cells to a proliferation-inhibiting compound or a differentiation-inducing compound or removing the cells from exposure to a proliferation-stimulating compound or a differentiation-inhibiting compound; exposing the cells to irradiation, and (3) modifying a growth surface of the bioartificial organ with extracellular matrix molecules, molecules affecting cell proliferation or adhesion, or an inert scaffold, or a combination thereof. These treatments may be used in combination. Cells can be transformed with a proliferation-promoting gene such as the oncogene, SV40, linked to a regulatable promoter such as the Mx1 promoter, the promotor is activated in vitro to express the gene to result in cell proliferation, and the promotor is inactivated before or after insertion of the cells in the bioartificial organ to inhibit expression of the gene to reduce or stop cell proliferation in vivo. The promoter can be reactivated in vivo to again express the gene to result in further cell proliferation. The gene may be a proliferation-suppressing gene such as p53 gene or RB gene, or a differentiation-inducing gene such as high mobility group chromosomal protein 14. Inhibiting gene expression in vitro causes cell proliferation, and inducing gene expression reduces or stops cell proliferation in vivo.",CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,CYTOTHERAPEUTICS INC (1995-12-15);;NEUROTECH S.A (1999-12-29);;NEUROTECH USA INC (2007-10-25),https://lens.org/103-015-322-123-422,Granted Patent,yes,37,8,5,40,4,A61L27/3839;;A61L27/3839;;A61K48/00;;A61K48/00;;A61L27/18;;A61L27/18;;A61L27/227;;A61L27/227;;A61L27/38;;C07K14/82;;C07K14/82;;C12N5/0012;;C12N5/0012;;C12N5/0068;;C12N5/0068;;C12N2510/00;;C12N2510/00;;C12N2510/04;;C12N2510/04;;C12N2533/30;;C12N2533/30;;C12N2533/54;;C12N2533/54;;C12N2533/74;;C12N2533/74,A01K67/027;;A61K48/00;;A61L27/00;;A61L27/18;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,424/93.21;;435/172.3;;435/174;;435/178;;435/377;;435/382;;435/395;;424/93.7;;424/422,99,82,048-332-719-530-735;;040-300-209-001-975;;078-401-268-829-715;;015-052-284-383-698;;051-467-747-043-981;;018-070-477-790-693;;120-596-939-734-383;;115-103-293-214-469;;004-129-864-323-871;;054-678-244-582-843;;021-321-949-597-771;;172-770-692-257-323;;060-164-752-701-836;;010-938-147-585-497;;011-276-786-730-941;;032-759-232-461-426;;108-379-915-909-34X;;028-364-375-537-319;;154-365-488-022-138;;026-016-347-959-887;;045-017-646-829-568;;066-523-881-622-501;;061-578-853-469-745;;057-767-055-501-614;;023-675-605-776-929;;104-865-628-368-26X;;173-587-013-695-171;;156-440-241-544-217;;068-141-789-713-733;;098-101-997-046-906;;034-178-376-559-657;;099-990-907-377-728;;005-358-343-205-664;;045-328-856-518-264;;004-236-732-518-638;;094-551-917-544-749;;108-168-722-195-491;;034-044-806-170-454;;038-918-079-679-253;;115-971-724-193-517;;009-792-950-241-971;;014-745-525-337-47X;;050-399-486-711-487;;059-049-072-219-166;;092-223-656-604-882;;018-117-336-909-414;;131-750-072-875-475;;003-664-236-520-709;;066-203-355-190-646;;105-834-428-184-911;;035-723-436-595-236;;034-249-775-255-429;;095-350-135-301-860;;060-291-465-466-062;;081-174-387-421-852;;052-782-286-478-646;;002-286-494-363-396;;101-732-752-675-701;;049-042-021-517-724;;164-020-307-617-474;;044-088-273-450-791;;012-333-350-448-43X;;046-111-513-250-242;;100-153-598-267-351;;028-211-379-291-005;;067-322-389-377-685;;147-346-857-684-894;;065-678-110-707-195;;076-012-254-853-704;;093-553-709-303-10X;;030-854-629-603-00X;;086-874-830-084-387;;016-063-554-957-496;;092-531-628-495-425;;055-467-864-296-721;;056-234-682-167-995;;090-908-679-116-661;;044-320-745-895-128;;001-928-366-548-586;;165-524-038-085-953;;008-119-464-657-166;;026-843-338-695-356,7918336;;8406030;;10.1016/0378-1119(93)90507-y;;2194673;;10.1016/0092-8674(90)90239-b;;10.1007/bf02623638;;2666386;;pmc386305;;10.1073/pnas.83.15.5454;;2874553;;10.1126/science.8016653;;8016653;;10.1159/000112252;;3021428;;10.1016/0168-9525(93)90012-7;;8379006;;10.1002/bip.360260018;;2437977;;pmc6577554;;10.1523/jneurosci.14-03-01030.1994;;8120611;;10.1073/pnas.82.13.4438;;pmc391116;;3892534;;10.1007/978-1-349-11358-3_15;;10.1016/0896-6273(88)90184-5;;3078410;;10.1089/hum.1993.4.4-433;;8399490;;8190271;;10.1016/0306-4522(94)90097-3;;8440318;;10.1006/excr.1993.1026;;pmc1886816;;8456938;;8476199;;2475934;;10.1016/0166-2236(89)90020-9;;8242752;;10.1016/0092-8674(93)90500-p;;10.1016/b978-0-12-483365-4.50008-6;;1504017;;10.1016/0014-4827(91)90130-m;;1901795;;10.1002/jcp.1041390208;;2715187;;10.1016/s0344-0338(11)80845-9;;8183742;;10.1007/bf02592286;;7686057;;3749886;;10.1126/science.3749886;;8352534;;10.1016/0014-4827(92)90083-k;;1383013;;10.1021/bi00396a004;;2962631;;10.1016/0092-8674(87)90707-0;;2951015;;8016642;;10.1126/science.8016642;;10.1016/0896-6273(93)90068-3;;8398146;;10.1006/ncmn.1993.1052;;10.1016/0378-1119(93)90424-2;;8359690;;8318227;;10.1016/0896-6273(93)90051-r;;10.1111/j.1749-6632.1992.tb42589.x;;1416607;;pmc363533;;10.1128/mcb.8.8.3065-3079.1988;;10.1128/mcb.8.8.3065;;2974922;;1797805;;10.1002/jbm.820251102;;10.1126/science.2961059;;2961059;;2735903;;10.1016/0006-291x(89)92622-3;;10.1002/jnr.490280407;;1870155;;10.1016/0014-4827(91)90391-7;;2070822;;6308472;;10.1038/304596a0;;8517665;;6776628;;10.1126/science.6776628;;8338876;;10.1089/hum.1993.4.3-291;;10.1016/0003-2697(90)90459-m;;2382830;;10.1097/00002480-198907000-00165;;2597562;;1612781;;10.1002/ijc.2910510511;;6241504;;10.1247/csf.9.357;;10.1523/jneurosci.14-06-03533.1994;;7515952;;pmc6576935;;482611;;10.2307/3575179;;2489072;;10.1016/0141-8130(89)90049-4;;8393300;;10.1152/ajplung.1993.265.1.l1;;10.1172/jci116723;;pmc288291;;8104197;;8514795;;10.1016/s0021-9258(19)38695-8;;3422482;;10.1073/pnas.85.4.1105;;pmc279714;;10.1016/0003-9861(92)90533-3;;1586167;;6325925;;10.1038/309030a0;;10.1523/jneurosci.12-05-01802.1992;;1578271;;pmc6575890;;8331297;;10.1111/1523-1747.ep12359508;;10.1128/mcb.13.7.4223;;10.1128/mcb.13.7.4223-4232.1993;;pmc359972;;8391634;;10.1073/pnas.90.8.3602;;pmc46349;;8475109;;1432110;;10.1523/jneurosci.12-11-04565.1992;;pmc6575989;;10.1073/pnas.89.18.8591;;pmc49966;;1528866;;8134335;;10.1073/pnas.91.6.1985;;pmc43292;;10.1126/science.2821619;;2821619;;8187171;;10.1016/0092-8674(94)90209-7;;2803948;;pmc2247318;;10.1038/bjc.1989.347;;10.1146/annurev.ne.12.030189.002423;;2648958;;8417470;;10.1128/jvi.61.8.2567-2572.1987;;pmc255700;;3037117;;pmc250578;;10.1128/jvi.62.2.619-621.1988;;3121865;;2844896;;10.1002/jcb.240380308;;3147985;;10.1016/0006-291x(86)90398-0;;3947369;;2416876;;10.1111/j.1471-4159.1986.tb12990.x;;6697250;;2248157;;10.1007/978-1-4684-5865-7_2;;10.1016/0076-6879(88)37053-9;;3131633;;2777785;;10.1016/s0021-9258(18)71604-9,"Farghali et al., The concept of Applicaiton of Immobilized and Perfused Mammalian cells (a bioreactor model) in biomedical research, Physiological Research, 43, pp. 117 120 (1994).;;Adhya, Sankar, et al., Promoter resurrection by activators a minireview, Gene, 132, pp. 1 6 (1993).;;Arnheiter, Heinz, et al., Transgenic Mice with Intracellular Immunity to Influenza Virus, Cell, 62, pp. 51 61 (1990).;;Aulthouse, Amy Lynn, et al., Expression of the Human Chondrocyte Phenotype In Vitro, In Vitro Cellular & Developmental Biology, 25, pp. 659 658 (1989).;;Baetge, E. Edward, et al., Complete Nucleotide and Deduced Amino Acid Sequence of Bovine Phenylethanolamine N methyltransferase: Partial Amino Acid Homology With Rat Tyrosine Hydroxylase, Proc. Natl. Acad. Sci. USA, 83, pp. 5454 5458 (1986).;;Barinaga, Marcia, Knockout Mice: Round Two, Science, 265, pp. 26 28 (1994).;;Baron Van Evercooren, A., et al., Schwann Cell Differentiation in vitro: Extracellular Matrix Deposition and Interaction, Dev. Neurosci., 8, pp. 182 196 (1886).;;Blau, Helen M., et al., Myoblasts in Pattern Formation and Gene Therapy, Trends in Genetics, 9, pp. 269 274 (1993).;;Bohak, Z., et al., Novel Anchorage Matrices for Suspension Culture of Mammalian Cells, Biopolymers, 26, pp. S205 S213 (1987).;;Brenner, Michael, et al., GFAP Promoter Directs Astrocyte specific Expression in Transgenic Mice, The Journal of Neuroscience, 14, pp. 1030 1037 (1994).;;Brinster et al., Factors Affecting the Efficiency of Introducing Foreign DNA into Mice by Microinjecting Eggs, Proc. Natl. Acad. Sci. USA, 82, pp. 4438 4442 (1985).;;Cabasso, Israel, Hollow Fiber Membranes, Encyclopedia of Chemical Technology (Kirk Othmer, ed.), pp. 492 517 (1980).;;Carbonetto, Salvatore, Ch. 15: Laminin Receptors: From PC12 Cells to PNS, Brain Repair (Bj o rklund, Aguayo and Ottoson, eds.), pp. 185 197 (1990).;;Celtrix Laboratories, Vitrogen 100 : Purified Collagen for Cell Culture and Biochemistry (Product Information Memorandum), Celtrix Laboratories, Palo Alto, CA (1991).;;Cepko, Connie, Retrovirus Vectors and Their Applications in Neurobiology, Neuron, 1, 345 453 (1988).;;Chang, P.L., et al., Delivery of Recombinant Gene Products with Microencapsulated Cells In Vivo, Human Gene Therapy, 4, pp. 433 440 (1993).;;Chu, C.H., and A.M. Tolkovsky, Alternative Adrenal Chromaffin Cell Fates Induced by Basic Fibroblast Growth Factor or Cyclic AMP In Vitro Depend on a Collaboration With The Growth Substrate, Neuroscience, 59, pp. 43 54 (1994).;;Collaborative Research Incorporated, CR Laminin and CR Anti Laminin (Product Information Memorandum), Collaborative Research, Inc., Bedford, MA (1987).;;Collaborative Research Incorporated, Basement Membrane Matrigel (Product Specification Sheet), Collaborative Research, Inc., Bedford, MA (1991).;;Collagen Biomedical, Collagen Test Implant Physician Package Insert, (Product Information Literature), Collagen Biomedical, Palo Alto, CA (1992).;;Collagen Biomedical, Zyderm Collagen and Zyderm Explained, (Product Information Memorandum), Collagen Biomedical, Palo Alto, CA (1992).;;Collagen Biomedical, Zyderm Collagen Implant Physician Package Insert, (Product Literature), Collagen Biomedical, Palo Alto, CA (1992).;;Collagen Biomedical, Zyplast Implant Physician Package Insert, (Product Literature), Collagen Biomedical, Palo Alto, CA (1992).;;Crouch, Gary D., et al., Ara C Treatment Leads to Differentiation and Reverses the Transformed Phenotype in a Human Rhabdomyosarcoma Cell Line, Experimental Cell Research, 204, pp. 210 216 (1993).;;Datta, Dipak B., Keeping In Touch: The Adhesion Reactions of the Cell Membrane, A Comprehensive Introduction to Membrane Biochemistry, pp. 231 256 (1987).;;de Bruine, Adriaan P., et al., Extracellular Matrix Components Induce Endocrine Differentiation in Vitro in NCI H716 Cells, American Journal of Pathology, 142, pp. 773 782 (1993).;;De Loecker, William, et al., Effects of Sodium Ascorbate (Vitamin C) and 2 Methyl 1,4 naphthoquinone (Vitamin K 3 ) Treatment on Human Tumor Cell Growth in Vitro. II. Synergism with Combined Chemotherapy Action, Anticancer Research, 13, pp. 103 106 (1993).;;Edgar, David, Neuronal aminin receptors, TINS, 12, pp. 248 251 (1989).;;El Deiry, Wafik S., et al., WAF1, a Potential Mediator of p53 Tumor Suppression, Cell, 75, pp. 817 825 (1993).;;End, Peter, and Jurgen Engel, Multidomain Proteins of the Extracellular Matrix and Cellular Growth, Receptors for Extracellular Matrix (McDonald, J. and Mecham,R., ed.), pp. 79 129 (1991).;;Epstein Baak, Ruth, et al., Inducible Transformation of Cells from Transgenic Mice Expressing SV40 under lac Operon Control, Cell Growth and Differentiation, 3, pp. 127 134 (1992).;;Fattaey, H.K., et al., Modulation of Growth Related Gene Expression and Cell Cycle Synchronization by a Sialoglycopeptide Inhibitor, Experimental Cell Research, 194, pp. 62 68 (1991).;;Fattaey, Heideh, et al., Inhibition of DNA Synthesis and Cell Division by a Cell Surface Sialoglycopeptide, Journal of Cellular Physiology, 139, pp. 269 274 (1989).;;Fujiyama, C., et al., Influence of Extracellular Matrix on the Proliferation and Differentiation of Adrenocortical Cells in Culture, Path. Res. Pract., 189, pp. 1205 1214 (1993).;;Galli, Maria C., et al., The Biology of Stem Cell Factor, a New Hematopoietic Growth Factor Involved in Stem Cell Regulation, Int. J. of Clin. Lab. Res., 23, pp. 70 77 (1993).;;Gash, D.M., et al., Amitotic Neuroblastoma Cells Used for Neural Implants in Monkeys, Science, 233, pp. 1420 1422 (1986).;;Gonos, Efstathios S., and Demetrios A. Spandidos, Oncogenes in Cellular Immortalisation and Differentiation ( Review ), Anticancer Research, 13, pp. 1117 1122 (1993).;;Grabham, Peter W., et al., Vibronectin Is the Major Serum Protein Essential for NGF Mediated Neurite Outgrowth from PC12 Cells, Experimental Cell Research, 202, pp. 337 344 (1992).;;Graf, Jeannette, et al., A Pentapeptide from the Laminin 1 Chain Mediates Cell Adhesion and Binds the 67 000 Laminin Receptor, Biochemistry, 26, pp. 6896 6900 (1987).;;Graf, Jeannette, et al., Identification of an Amino Acid Sequence in Laminin Mediating Cell Attachment, Chemotaxis, and Receptor Binding, Cell, 48, pp. 989 996 (1987).;;Gu, Hua, et al., Deletion of a DNA Polymerase Gene Segment in T Cells Using Cell Type Specific Gene Targeting, Science, 265, pp. 103 106 (1994).;;Gumbiner, Barry M., Proteins Associated with the Cytoplasmic Surface of Adhesion Molecules, Neuron, 11, pp. 551 564 (1993).;;Hammang, Joseph P., et al., Immortalized Neuronal and Neuroendocrine Cell Lines by Targeted Oncogenesis in Transgenic Mice Using the PNMT Promoter, Neuroprotocols: A Companion to Methods in Neurosciences, 3, pp. 176 183 (1993).;;Hannan, G.N., et al., An engineered PGK promoter and Lac operator repressor system for the regulation of gene expression in mammalian cells, Gene, 130, pp. 233 239 (1993).;;Hoyle, Gary W., et al., Expression of NGF in Sympathetic Neurons Leads to Excessive Axon Outgrowth from Ganglia but Decreased Terminal Innervation within Tissues, Neuron, 10, pp. 1019 1034 (1993).;;Hubbell, Jeffrey A., et al., Surface grafted Cell binding Peptides in Tissue Engineering of the Vascular Graft, Annals New York Academy of Sciences, 665, pp. 253 258 (1992).;;Hug, Hubert, et al., Organization of the Murine Mx Gene and Characterization of Its Interferon and Virus Inducible Promoter, Molecular and Cellular Biology, 8, pp. 3065 3079 (1988).;;HyClone Laboratories, CultiSpher G (Product Information Memorandum), HyClone Laboratories, Logan, UT (no date).;;HyClone Laboratories, CultiSpher GL (Product Information Memorandum), HyClone Laboratories, Logan, UT (no date).;;Ito, Yoshihiro, et al., Materials for Enhancing Cell Adhesion By Immobilization of Cell Adhesive Peptide, Journal of Biomedical Materials Research, 25, pp. 1325 1337 (1991).;;Iwamoto, Yukihide, et al., YIGSR, a Synthetic Laminin Pentapeptide, Inhibits Experimental Metastasis Formation, Science, 238, pp. 1132 1134 (1987).;;Johnson, Terry C., and Behrooz G. Sharifi, Abrogation of the Mitogenic Activity of Bombesin by a Cell Surface Sialoglycopeptide Growth Inhibitor, Biochemical and Biophysical Research Communications, 161, pp. 468 474 (1989).;;Jucker, M., et al., Fetal Rats Septal Cells Adhere to and Extend Processes on Basement Membrane, Laminin, and a Synthetic Peptide the Laminin A Chain Sequence, J. Neurosic. Res., 28, 507 517 (1991).;;Kleinman, Hynda K., et al., The Role of Laminin in Basement Membranes and in the Growth, Adhesion, and Differentiation of Cells, The Role of Extracellular Matrix in Development, pp. 123 143 (1984).;;Kleinman, Hynda K., and Benjamin S. Weeks, The Neural Cell Response to Laminin: Active Sites, Receptors, and Intracellular Signals, Comments Developmental Neurobiology, 1, pp. 251 266 (1991).;;Lakshmanarao, S.S., et al., Identification of a Cell Surface Component of Swiss 3T3 Cells Associated with an Inhibition of Cell Division, Experimental Cell Research, 195, pp. 412 415 (1991).;;Land, Hartmut, et al., Tumorigenic Conversion of Primary Embryo Fibroblasts Requires At Least Two Cooperating Oncogenes, Nature, 304, pp. 596 602 (1983).;;Leung, Ping. Y., et al., Cytotoxic Effect of Ascorbate and its Derivatives on Cultured Malignant and Nonmalignant Cell Lines, Anticancer Research, 13, pp. 475 480 (1993).;;Lim, F., et al., Microencapsulated Islets as Bioartificial Endocrine Pancreas, Science, 210, pp. 908 910 (1980).;;Liu, Hong Wen, et al., Expression of Human Factor IX by Microencapsulate Recombinant Fibroblasts, Human Gene Therapy, 4, pp. 291 301 (1993).;;Massia, Stephen P., and Jeffrey A. Hubbell, Covalent Surface Immobilization of Arg Gly Asp and Try Ile Gly Ser Arg Containing Peptides to Obtain Well Defined Cell Adhesive Substrates, Analytical Biochemistry, 187, pp. 292 301 (1990);;Matsuda, Takehisa, et al., Development of a Novel Artificial Matrix with Cell Adhesion Peptides for Cell Culture and Artificial and Hybrid Organs, Trans. Am. Soc. Artif. Intern. Organs, 35, pp. 677 679 (1989).;;Matsushima, Hiroshi, and Emil Bogenmann, Modulation of Neuroblastoma Cell Differentiation by the Extracellular Matrix, Int. J. Cancer, 51, pp. 727 732 (1992).;;Matuoka et al., Heparan Sulfate Enhances Growth of Transformed Human Cells, Cell Structure and Function, 9, p. 357 (1984).;;Messing, Albee, et al., Hypomyelinating Peripheral Neuropathies and Schwannomas in Transgeninc Mice Expressing SV40 T Antigen, The Journal of Neuroscience, 14, pp. 3533 3539 (1994).;;Mitchell, J.B., et al., Dose Rate Effects in Mammalian Cells in Culture, Radiat. Res., 79, pp. 537 551 (1979).;;Murata, Jun, et al., Inhibitory Effect of a Synthetic Polypeptide, Poly(Tyr Ile Gly Ser Arg), On the Metastatic Formation of Malignant Tumour Cells, Int. J. Biol. Macromol., 11, pp. 97 99 (1989).;;Neckers, Len, and Luke Whitesell, Antisense Technology: Biological Utility and Practical Considerations, Am. J. Physiol., 265, pp. L1 L12 (1993).;;Otonkoski, Timo, et al., Nicotinamide Is a Potent Inducer of Endocrine Differentiation in Cultured Human Fetal Pancreatic Cells, J. Clin. Invest., 92, pp. 1459 1466 (1993).;;Pash, James M., et al., Aberrant Expression of High Mobility Group Chromosomal Protein 14 Affects Cellular Differentiation, The Journal of Biological Chemistry, 268, pp. 13632 13638 (1993).;;Penttienen, Risto P., et al., Transforming Growth Factor Increases mRNA for Matrix Proteins Both in the Presence and in the Absence of Changes in mRNA Stability, Proc. Natl. Acad. Sci. USA, 85, pp. 1105 1108 (1988).;;Phillips, Charlotte L., et al., Ascorbic Acid and Transforming Growth Factor 1 Increase Collagen Biosynthesis via Different Mechanisms: Coordiante Regulation of Pro 1(I) and Pro 1(III) Collagens, Archives of Biochemistry and Biophysics, 295, pp. 397 403 (1992).;;Pierschbacher, Michael D., and Erkki Ruoslatiti, Cell Attachment Activity of Fibronectin Can Be Duplicated By Small Synthetic Fragments of the Molecule, Science, 309, pp. 30 33 (1984).;;Pleasure, Samuel, et al., Pure, Postmitotic, Polarized Human Neurons Derived from NTera 2 Cells Provide a System for Expressing Exogenous Proteins in Terminally Differentiated Neurons, The Journal of Neuroscience, 12, pp. 1802 1815 (1992).;;Prystowsky et al., Inhibition of Ornithine Decarboxylase Activity and Cell Proliferation by Ultraviolet Radiation in EGF Stimulated Cultured Human Epidermal Keratinocytes, J. Invest. Dermat., 101, pp. 54 58 (1993).;;Radvanyi, Francois, et al., Pancreatic Cells Cultured from Individual Preneoplastic Foci in a Multistage Tumorigenesis Pathway: a Potentially General Technique for Isolating Physiologically Representative Cell Lines, Molecular and Cellular Biology, 13, pp. 4223 4232 (1993).;;Ray, Jasodhara, et al., Proliferation, Differentiation, and Long Term Culture of Primary Hippocampal Neurons, Proc. Natl. Acad. Sci. USA, 90, pp. 3602 3606 (1993).;;Reemay, Inc., Reemay Spunbonded Polyester, pp. 1 20 (Product Information Literature), Reemay, Inc., Old Hickory, TN.;;Reynolds, Brent A., et al., A Multipotent EGF Responsive Striatal Embryonic Progenitor Cell Produces Neurons and Astrocytes, The Journal of Neuroscience, 12, pp. 4565 4574 (1992).;;Richards, L.J. et al., De novo Generation of Neuronal Cells From The Adult Mouse Brain, Proc. Natl. Acad. Sci. USA, 89, pp. 8591 8595 (1992).;;Ron, David, Inducible Growth Arrest: New Mechanistic Insights, Proc. Natl. Acad. Sci. USA, 91, pp. 1985 1986 (1994).;;Ruoslahti, Erkki, and Michael D. Pierschbacher, New Perspectives in Cell Adhesion: RGD and Integrins, Science, 238, pp. 491 497 (1987).;;Ruoslahti, Erkki, and John C. Reed, Anchorage Dependence, Integrins, and Apoptosis, Cell, 77, pp. 477 478 (1994).;;Saiki, I., et al., Antimetastic Effects of Synthetic Polypeptides Containing Repeated Structures of the Cell Adhesive Arg Gly Asp (RGD) and Tyr Ile Gly Ser Arg (YIGSR) Sequences, Br. J. Cancer, 60, pp. 722 728 (1989).;;Sanes, Joshua R., Extracellular Matrix Molecules That Influence Neural Development, Ann. Rev. Neurosci., 12, pp. 491 516 (1989).;;Schinstine, Malcolm, and Fred H. Gage, Factors Affecting Proviral Expression in Primary Cells Grafted into the CNS, Molecular and Cellular Approaches for the Treatment of Neurological Diseases (S.G. Waxman, ed.), pp. 311 323 (1993).;;Seliger, Barbara, et al., Murine Gamma Interferon Inhibits v mos Induced Fibroblast Transformation via Down Regulation of Retroviral Gene Expression, Journal of Virology, 61, pp. 2567 2572 (1987).;;Seliger, Barbara, et al., Gamma Interferon Regulates Long Terminal Repeat Controlled Oncogene Expression in Transformed Mouse Fibroblasts at the Level of mRNA Transcription, Journal of Virology, 62, pp. 619 621 (1988).;;Seliger, Barbara, et al., Tumor Necrosis Factor Affects LTR Controlled Oncogene Expression in Transformed Mouse Fibroblasts at the Post Transcriptional Level, The Journal of Immunology, 141, pp. 2138 2144 (1988).;;Seliger, Barbara, et al., Distinct Mechanisms of Interferon Gamma and Tumor Necrosis Factor Alpha Action in Oncogene Transformed Mouse Fibroblasts, Journal of Cellular Biochemistry, 38, pp. 205 212 (1988).;;Sharifi, Behrooz G., et al., Cell Surface Interaction is Sufficient for the Biological Activity of a Bovine Sialoglycopeptide Inhibitor, Biochemical and Biophysical Research Communications, 134, pp. 1350 1357 (1986).;;Sharifi, Behrooz G., et al., Purification and Characterization of a Bovine Cerebral Cortex Cell Surface Sialoglycopeptide that Inhibits Cell Proliferation and Metabolism, Journal of Neurochemistry, 46, pp. 461 469 (1986).;;Smalheiser, Neil R., et al., Laminin As a Substrate for Retinal Axons In Vitro, Dev. Brain Res., 12, pp. 136 140 (1984).;;SoloHill Labs, Inc., SoloHill Labs, Inc., Ann Arbor, MI.;;Stockdale, Frank E., et al., Myoblasts, Satellite Cells, and Myoblast Transfer, Myoblast Transfer Therapy (R. Griggs and G. Karpati, eds.), pp. 7 11 (1990).;;Sun, Anthony M., Microencapsulation of Pancreatic Islet Cells: A Bioartificial Endocrine Pancreas, Methods in Enzymology, 137, pp. 575 580 (1988).;;Tashiro, Ken ichiro, et al., A Synthetic Peptide Containing the IKVAV Sequence from the A Chain of Laminin Mediates Cell Attachment, Migration, and Neurite Outgrowth, The Journal of Biological Chemistry, 264, pp. 16174 16182 (1989).;;Telios Pharmaceuticals, Integrins: An Update on the Rapid Growth of Research Topics, in ECM Connections, a publication of Telios Pharmaceuticals, San Diego, CA (Jun. 1992).;;Telios Pharmaceuticals, PepTite 2000 (Product Information Memorandum), Telios Pharmaceuticals, San Diego, CA.",EXPIRED
407,US,A,US 5853717 A,006-922-062-055-461,1998-12-29,1998,US 44735695 A,1995-05-23,US 44735695 A;;US 43269895 A;;US 27977394 A,1994-07-20,Methods and compositions of growth control for cells encapsulated within bioartificial organs,"This invention relates to methods and compositions of controlling cell distribution within a bioartificial organ by exposing the cells to a treatment that inhibits cell proliferation, promotes cell differentiation, or affects cell attachment to a growth surface within the bioartificial organ. Such treatments include (1) genetically manipulating cells, (2) exposing the cells to a proliferation-inhibiting compound or a differentiation-inducing compound or removing the cells from exposure to a proliferation-stimulating compound or a differentiation-inhibiting compound; exposing the cells to irradiation, and (3) modifying a growth surface of the BAO with ECM molecules, molecules affecting cell proliferation or adhesion, or an inert scaffold, or a combination thereof. These treatments may be used in combination.",CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,NEUROTECH S.A (1999-12-29);;NEUROTECH USA INC (2007-10-25),https://lens.org/006-922-062-055-461,Granted Patent,yes,36,53,33,40,4,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A01K67/027;;A61L27/00;;A61L27/18;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,424/93.21;;435/326;;435/372.2;;435/372.3;;435/382,99,82,048-332-719-530-735;;040-300-209-001-975;;078-401-268-829-715;;015-052-284-383-698;;051-467-747-043-981;;018-070-477-790-693;;120-596-939-734-383;;115-103-293-214-469;;004-129-864-323-871;;054-678-244-582-843;;021-321-949-597-771;;172-770-692-257-323;;060-164-752-701-836;;010-938-147-585-497;;011-276-786-730-941;;032-759-232-461-426;;108-379-915-909-34X;;028-364-375-537-319;;154-365-488-022-138;;026-016-347-959-887;;045-017-646-829-568;;066-523-881-622-501;;061-578-853-469-745;;057-767-055-501-614;;023-675-605-776-929;;104-865-628-368-26X;;173-587-013-695-171;;156-440-241-544-217;;068-141-789-713-733;;098-101-997-046-906;;034-178-376-559-657;;099-990-907-377-728;;005-358-343-205-664;;045-328-856-518-264;;004-236-732-518-638;;094-551-917-544-749;;108-168-722-195-491;;034-044-806-170-454;;038-918-079-679-253;;115-971-724-193-517;;009-792-950-241-971;;014-745-525-337-47X;;050-399-486-711-487;;059-049-072-219-166;;092-223-656-604-882;;018-117-336-909-414;;131-750-072-875-475;;003-664-236-520-709;;066-203-355-190-646;;105-834-428-184-911;;035-723-436-595-236;;034-249-775-255-429;;095-350-135-301-860;;060-291-465-466-062;;081-174-387-421-852;;052-782-286-478-646;;002-286-494-363-396;;101-732-752-675-701;;049-042-021-517-724;;164-020-307-617-474;;044-088-273-450-791;;012-333-350-448-43X;;046-111-513-250-242;;100-153-598-267-351;;028-211-379-291-005;;067-322-389-377-685;;147-346-857-684-894;;065-678-110-707-195;;076-012-254-853-704;;093-553-709-303-10X;;030-854-629-603-00X;;086-874-830-084-387;;016-063-554-957-496;;092-531-628-495-425;;055-467-864-296-721;;056-234-682-167-995;;090-908-679-116-661;;044-320-745-895-128;;001-928-366-548-586;;165-524-038-085-953;;008-119-464-657-166;;026-843-338-695-356,7918336;;8406030;;10.1016/0378-1119(93)90507-y;;2194673;;10.1016/0092-8674(90)90239-b;;10.1007/bf02623638;;2666386;;pmc386305;;10.1073/pnas.83.15.5454;;2874553;;10.1126/science.8016653;;8016653;;10.1159/000112252;;3021428;;10.1016/0168-9525(93)90012-7;;8379006;;10.1002/bip.360260018;;2437977;;pmc6577554;;10.1523/jneurosci.14-03-01030.1994;;8120611;;10.1073/pnas.82.13.4438;;pmc391116;;3892534;;10.1007/978-1-349-11358-3_15;;10.1016/0896-6273(88)90184-5;;3078410;;10.1089/hum.1993.4.4-433;;8399490;;8190271;;10.1016/0306-4522(94)90097-3;;8440318;;10.1006/excr.1993.1026;;pmc1886816;;8456938;;8476199;;2475934;;10.1016/0166-2236(89)90020-9;;8242752;;10.1016/0092-8674(93)90500-p;;10.1016/b978-0-12-483365-4.50008-6;;1504017;;10.1016/0014-4827(91)90130-m;;1901795;;10.1002/jcp.1041390208;;2715187;;10.1016/s0344-0338(11)80845-9;;8183742;;10.1007/bf02592286;;7686057;;3749886;;10.1126/science.3749886;;8352534;;10.1016/0014-4827(92)90083-k;;1383013;;10.1021/bi00396a004;;2962631;;10.1016/0092-8674(87)90707-0;;2951015;;8016642;;10.1126/science.8016642;;10.1016/0896-6273(93)90068-3;;8398146;;10.1006/ncmn.1993.1052;;10.1016/0378-1119(93)90424-2;;8359690;;8318227;;10.1016/0896-6273(93)90051-r;;10.1111/j.1749-6632.1992.tb42589.x;;1416607;;pmc363533;;10.1128/mcb.8.8.3065-3079.1988;;10.1128/mcb.8.8.3065;;2974922;;1797805;;10.1002/jbm.820251102;;10.1126/science.2961059;;2961059;;2735903;;10.1016/0006-291x(89)92622-3;;10.1002/jnr.490280407;;1870155;;10.1016/0014-4827(91)90391-7;;2070822;;6308472;;10.1038/304596a0;;8517665;;6776628;;10.1126/science.6776628;;8338876;;10.1089/hum.1993.4.3-291;;10.1016/0003-2697(90)90459-m;;2382830;;10.1097/00002480-198907000-00165;;2597562;;1612781;;10.1002/ijc.2910510511;;6241504;;10.1247/csf.9.357;;10.1523/jneurosci.14-06-03533.1994;;7515952;;pmc6576935;;482611;;10.2307/3575179;;2489072;;10.1016/0141-8130(89)90049-4;;8393300;;10.1152/ajplung.1993.265.1.l1;;10.1172/jci116723;;pmc288291;;8104197;;8514795;;10.1016/s0021-9258(19)38695-8;;3422482;;10.1073/pnas.85.4.1105;;pmc279714;;10.1016/0003-9861(92)90533-3;;1586167;;6325925;;10.1038/309030a0;;10.1523/jneurosci.12-05-01802.1992;;1578271;;pmc6575890;;8331297;;10.1111/1523-1747.ep12359508;;10.1128/mcb.13.7.4223;;10.1128/mcb.13.7.4223-4232.1993;;pmc359972;;8391634;;10.1073/pnas.90.8.3602;;pmc46349;;8475109;;1432110;;10.1523/jneurosci.12-11-04565.1992;;pmc6575989;;10.1073/pnas.89.18.8591;;pmc49966;;1528866;;8134335;;10.1073/pnas.91.6.1985;;pmc43292;;10.1126/science.2821619;;2821619;;8187171;;10.1016/0092-8674(94)90209-7;;2803948;;pmc2247318;;10.1038/bjc.1989.347;;10.1146/annurev.ne.12.030189.002423;;2648958;;8417470;;10.1128/jvi.61.8.2567-2572.1987;;pmc255700;;3037117;;pmc250578;;10.1128/jvi.62.2.619-621.1988;;3121865;;2844896;;10.1002/jcb.240380308;;3147985;;10.1016/0006-291x(86)90398-0;;3947369;;2416876;;10.1111/j.1471-4159.1986.tb12990.x;;6697250;;2248157;;10.1007/978-1-4684-5865-7_2;;10.1016/0076-6879(88)37053-9;;3131633;;2777785;;10.1016/s0021-9258(18)71604-9,"Farghali et al., The concept of Application of Immobilized and Perfused Mammalian cells (a bioreactor model in biomedical research, Physiological Research , 43, pp. 117 120 (1994).;;Adhya, Sankar, et al., Promoter resurrection by activators a minireview, Gene , 132, pp. 1 6 (1993).;;Arnheiter, Heinz, et al., Transgenic Mice with Intracellular Immunity to Influenza Virus, Cell , 62, pp. 51 61 (1990).;;Aulthouse, Amy Lynn, et al., Expression of the Human Chondrocyte Phenotype in Vitro, In Virto Cellular & Developmental Biology , 25, pp. 659 668 (1989).;;Baetge, E. Edward, et al., Complete Nucleotide and Deduced Amino Acid Sequence of Bovine Phenylethanolamine N methyltransferase: Partial Amino Acid Homology With Rat Tyrosine Hydroxylase, Proc. Natl. Acad. Sci. USA , 83, pp. 5454 5458 (1986).;;Barinaga, Marcia, Knockout Mice: Round Two, Science , 265, pp. 26 28 (1994).;;Baron Van Evercooren, A., et al., Schwann Cell Differentiation in vitro: Extracellular Matrix Deposition and Interaction, Dev. Neurosci. , 8, pp. 182 296 (1986).;;Blau, Helen M., et al., Myoblasts in Pattern Formation and Gene Therapy, Trends in Genetics , 9, pp. 269 274 (1993).;;Bohak, Z., et al., Novel Anchorage Matrices for Suspension Culture of Mammalian Cells, Biopolymers , 26, pp. S205 S213 (1987).;;Brenner, Michael, et al., GFAP Promoter Directs Astrocyte specific Expression in Transgenic Mice, The Journal of Neuroscience , 14, pp. 1030 1037 (1994).;;Brinster et al., Factors Affecting the Efficiency of Introducing Foreign DNA into Mice by Microinjecting Eggs, Proc. Natl. Acad. Sci. USA , 82 pp. 4438 4442 (1985).;;Cabasso, Israel, Hollow Fiber Membranes, Encyclopedia of Chemical Technology (Kirk Othmer, ed.), pp. 492 517 (1980).;;Carbonetto, Salvatore, Ch. 15: Laminin Receptors; From PC12 Cells to PNS, Brain Repair (Bj o rklund, Aguayo and Ottoson, eds.), pp. 185 197 (1990).;;Celtrix Laboratories, Vitrogen 100 :Purified Collagen for Cell Culture and Biochemistry (Product Information Memorandum), Celtrix Laboratories, Palo Alto, CA (1991).;;Cepko, Connie, Retrovirus Vectors and Their Applications in Neurobiology, Neuron , 1, 345 53 (1988).;;Chang, P.L., et al., Delivery of Recombinant Gene Products with Microencapsulated Cells In Vivo, Human Gene Therapy , 4, pp. 433 440 (1993).;;Chu, C.H., and A.M. Tolkovsky, Alternative Adrenal Chromaffin Cell Fates Induced by Basic Fibroblast Growth Factor or Cyclic AMP in Vitro Depend on a Collaboration With The Growth Substrate, Neuroscience , 59, p. 43 54 (1994).;;Collaborative Research Incorporated, CR Laminin and CR Anti Laminin (Product Information Memorandum), Collaborative Research, Inc. Bedford, MA (1987).;;Collaborative Research Incorporated, Basement Membrane Matrigel (Product Specification Sheet), Collaborative Research, Inc., Bedford, MA (1991).;;Collagen Biomedical, Collagen Test Implant Physician Package Insert, (Product Information Literature), Collagen Biomedical, Palo Alto, CA (1992).;;Collagen Biomedical, Zyderm and Zyderm Explained, (Product Information Memorandum), Collagen Biomedical, Palo Alto, CA (1992).;;Collagen Biomedical, Zyderm Collagen Implant Physician Package Insert, (Product Literature), Collagen Biomedical, Palo Alto, CA (1992).;;Collagen Biomedical, Zyplast Implant Physician Package Insert, (Product Literature), Collagen Biomedical, Palo Alto, CA (1992).;;Crouch, Gary D., et al., Ara C Treatment Leads to Diffentiation and Reverses the Transformed Phenotype in a Human Rhabdomyosarcoma Cell Line, Experimental Cell Research , 204, pp. 210 216 (1993).;;Datta, Dipak B., Keeping In Touch: The Adhesion Reactions of the Cell Membrane, A Comprehensive Introduction to Membrane Biochemistry , pp. 231 256 (1987).;;de Bruine, Adriaan P., et al., Extracellular Matrix Components Induce Endocrine Differentiation in Vitro in NCI H716 Cells, American Journal of Pathology , 142, pp. 773 782 (1993).;;De Loecker, William, et al., Effects of Sodium Ascorbate (Vitamin C) and 2 Methyl 1,4 naphthoquinone (Vitamin K) 3 ) Treatment on Human Tumor Cell Growth in Vitro. II. Synergism with Combined Chemotherapy Action, Anticancer Research , 13, pp. 103 106 (1993).;;Edgar, David, Neuronal laminin receptors, Tins , 12, pp. 248 251 (1989).;;El Deiry, Wafik S., et al., WAF1, a Potential Mediator of p53 Tumor Suppression, Cell , 75, pp. 817 825 (1993).;;End, Peter, and Jurgen Engel, Multidomain Proteins of the Extracellular Matrix and Cellular Growth, Receptors for Extracellular Matrix (McDonald, J. and Mecham, R., ed.), pp. 79 129 (1991).;;Epstein Baak, Ruth, et al., Inducible Transformation of Cells from Transgenic Mice Expressing SV40 under lac Operon Control, Cell Growth and Differentiation , 3, pp. 127 134 (1992).;;Fattaey, H.K., et al., Modulation of Growth Related Gene Expression and Cell Cycle Synchronization by a Sialoglycopeptide Inhibitor, Experimental Cell Research , 194, pp. 62 68 (1991).;;Fattaey, Heideh, et al., Inhibition of DNA Synthesis and Cell Division by a Cell Surface Sialoglycopeptide, Journal of Cellular Physiology , 139, pp. 269 274 (1989).;;Fujiyama, C., et al., Influence of Extracellular Matrix on the Proliferation and Differntiation of Adrenocortical Cells in Culture, Path. Res. Pract. , 189, pp. 1205 1214 (1993).;;Galli, Maria C., et al., The Biology of Stem Cell Factor, a New Hematopoietic Growth Factor Involved in Stem Cell Regulation, Int. J. of Clin. Lab. Res. , 23, pp. 70 77 (1993).;;Gash, D.M., et al., Amitotic Neuroblastoma Cells Used for Neural Implants in Monkeys, Science , 233, pp. 1420 1422 (1986).;;Gonos, Efstathios S., and Demetrios A. Spandidos, Oncogenes in Cellular Immortalisation and Differentiation (Review), Anticancer Research , 13, pp. 1117 1122 (1993).;;Grabham, Peter W., et al., Vibronectin Is the Major Serum Protein Essential for NGF Mediated Neurite Outgrowth from PC12 Cells, Experimental Cell Research , 202, pp. 337 344 (1992).;;Graf, Jeannette, et al., A Pentapeptide from the Laminin 1 Chain Mediates Cell Adhesion and Binds the 67 000 Laminin Receptor, Biochemistry , 26, pp. 6896 6900 (1987).;;Graf, Jeannette, et al., Identification of an Amino Acid Sequence in Laminin Mediating Cell Attachment, Chemotaxis, and Receptor Binding, Cell , 48, pp. 989 996 (1987).;;Gu, Hua, et al., Deletion of a DNA Polymerase Gene Segment in T Cells Using Cell Type Specific Gene Targeting, Science , 265, pp. 103 106 (1994).;;Gumbiner, Barry M., Proteins Associated with the Cytoplasmic Surface of Adhesion Molecules, Neuron , 11, p. 551 564 (1993).;;Hammang, Joseph P., et al., Immortalized Neuronal and Neuroendocrine Cell Lines by Targeted Oncogenesis in Transgenic Mice Using the PNMT Promoter, Neuroprotocols; A Companion to Methods in Neurosciences , 3, pp. 176 183 (1993).;;Hannan, G.N., et al., An engineered PGK promoter and lac Operator repressor system for the regulation of gene expression in mammalian cells, Gene , 130, pp. 233 239 (1993).;;Hoyle, Gary W., et al., Expression of NGF in Sympathetic Neurons Leads to Excessive Axon Outgrowth from Ganglia but Decreased Terminal Innervation within Tissues, Neuron , 10, pp. 1019 1034 (1993).;;Hubbell, Jeffrey A., et al., Surface grafted Cell binding Peptides in Tissue Engineering of the Vascular Graft, Annals New York Academy of Sciences , 665, pp. 253 258 (1992).;;Hug, Hubert, et al., Organization of the Murine Mx Gene and Characterization of Its Interferon and Virus Inducible Promoter, Molecule and Cellular Biology , pp. 3065 3079 (1988).;;HyClone Laboratories, CultiSpher G (Product Information Memorandum), HyClone Laboratories, Logan, UT (no date).;;HyClone Laboratories, CultiSpher GL (Product Information Memorandum), HyClone Laboratories, Logan, UT (no date).;;Ito, Yoshihiro, et al., Materials for Enhancing Cell Adhesion By Immobilization of Cell Adhesive Peptide, Journal of Biomedical Materials Research , 25, pp. 1325 1337 (1991).;;Iwamoto, Yukihide, et al., YIGSR, a Synthetic Laminin Pentapeptide, Inhibits Experimental Metastasis Formation, Science , 238, pp. 1132 1134 (1987).;;Johnson, Terry C., and Behrooz G. Sharifi, Abrogation of the Mitogenic Activity of Bombesin by a Cell Surface Sialoglycopeptide Growth Inhibitor, Biochemical and Biophysical Research Communications , 161, pp. 468 474 (1989).;;Jucker, M., et al., Fetal Rats Septal Cells Adhere to and Extend Processes on Basement Membrane, Laminin, and a Synthetic Peptide the laminin A Chain Sequence, J. Neurosci. Res. , 28, 507 517 (1991).;;Kleinman, Hynda K., et al., The Role of Laminin in Basement Membranes and in the Growth, Adhesion, and Differentiation of Cells, The Role of Extracellular Matrix in Development , pp. 123 143 (1984).;;Kleinman, Hynda K., and Benjamin S. Weeks, The Neural Cell Response to Laminin: Active Sites, Receptors, and Intracellular Signals, Comments Developmental, Neurobiology , 1, pp. 251 266 (1991).;;Lakshmanarao, S.S., et al., Identification of a Cell Surface Component of Swiss 3T3 Cells Associated with an Inhibition of Cell Division, Experimental Cell Research , 195, pp. 412 415 (1991).;;Land, Hartmut, et al., Tumorigenic Conversion of Primary Embryo Fibroblasts Requires At Least Two Cooperating Oncogenes, Nature , 304, pp. 596 602 (1993).;;Leung, Ping. Y., et al., Cytotoxic Effect of Ascorbate and Its Derivatives on Cultured Malignant and Nonmalignant Cell Lines, Anticancer Research , 13, pp. 475 480 (1993).;;Lim, F., et al., Microencapsulated Islets as Bioartficial Endocrine Pancreas, Science , 210, pp. 908 910 (1980).;;Liu, Hong Wen, et al., Expression of Human Factor IX by Microencapsulated Recombinant Fibroblasts, Human Gene Therapy , 4, pp. 291 301 (1993).;;Massia, Stephen P., and Jeffrey A. Hubbell, Covalent Surface Immobilization of Arg Gly Asp and Try lle Gly Ser Arg Containing Peptides to Obtain Well Defined Cell Adhesive Substrates, Analytical Biochemistry , 187, pp. 292 301 (1990).;;Matsuda, Takehisa, et al., Development of a Novel Artificial Matrix with Cell Adhesion Peptides for Cell Culture and Artificial and Hybrid Organs, Trans. Am. Soc. Artif. Intern. Organs , 35, pp. 677 679 (1989).;;Matsushima, Hiroshi, and Emil Bogenmann, Modulation of Neuroblastoma Cell Differentiation by the Extracellular Matrix, Int. J. Cancer , 51, pp. 727 732 (1992).;;Matuoka et al., Heparan Sulfate Enhances Growth of Transformed Human Cells, Cell Structure and Function , 9, p. 357 (1984).;;Messing, Albee, et al., Hypomyelinating Peripheral Neuropathies and Schwannomas in Transgenic Mice Expressing SV40 T Antigen, The Journal of Neuroscience , 14, pp. 3533 3539 (1994).;;Mitchell, J.B., et al., Dose Rate Effects in Mammalian Cells in Culture, Radiat. Res. , 79, pp. 537 551 (1979).;;Murata,Jun, et al., Inhibitory Effect of a Synthetic Polypeptide, Poly(Tyr lle Gly Ser Arg), On the Metastatic Formation of Malignant Tumour Cells, Int. J. Biol. Macromol. , 11, pp. 97 99 (1989).;;Neckers, Len, and Luke Whitesell, Antisense Technology: Biological Utility and Practical Considerations, Am. J. Physiol. , 265, pp. L1 L12 (1993).;;Otonkoski, Timo, et al., Nicotinamide Is a Potent Inducer of Endocrine Differentiation in Cultured Human Fetal Pancreatic Cells, J. Clin. Invest. , 92, pp. 1459 1466 (1993).;;Pash, James M., et al., Aberrant Expression of High Mobility Group Chromosomal Protein 14 Affects Cellular Differentiation, The Journal of Biological Chemistry , 268, pp. 13632 13638 (1993).;;Penttinen, Risto P., et al., Transforming Growth Factor Increases mRNA for Matrix Proteins Both in the Presence and in the Absence of Changes in mRNA Stability, Proc. Natl. Acad. Sci. USA , 85, pp. 1105 1108 (1988).;;Phillips, Charlotte L., et al., Ascorbic Acid and Transforming Growth Factor 1 Increase Collagen Biosynthesis via Different Mechanisms: Coordinate Regulation of Pro 1(I) and Pro 1(III) Collagens, Archives of Biochemistry and Biophysics , 295, pp. 397 403 (1992).;;Pierschbacher, Michael D., and Erkki Ruoslatiti, Cell Attachment Activity of Fibronectin Can Be Duplicated By Small Synthetic Fragments of the Molecule, Science , 309, pp. 30 33 (1984).;;Pleasure, Samuel, et al., Pure, Postmitotic,Polarized Human Neurons Derived from NTera 2 Cells Provide a System for Expressing Exogenous Proteins in Terminally Differentiated Neurons, The Journal of Neuroscience , 12, pp. 1802 1815 (1992).;;Prystowsky et al., Inhibition of Ornithine Decarboxylase Activity and Cell Proliferation by Ultraviolet Radiation in EGF Stimulated Cultured Human Epidermal Keratinocytes, J. Invest. Dermat. , 101, pp. 54 58 (1993).;;Radvanyi, Francois, et al., Pancreatic is Cells Cultured from Individual Preneoplastic Foci in a Multistage Tumorigensis Pathway: a Potentially General Technique for Isolating Physiologically Representive Cell Lines, Molecule and Cellular Biology , 13, pp. 4223 4232 (1993).;;Ray, Jasodhara, et al., Proliferation, Differentiation, and Long Term Culture of Primary Hippocampal Neurons, Proc. Natl. Acad. Sci. USA , 90, pp. 3602 3606 (1993).;;Reemay, Inc., Reemay Spunbonded Polyester, pp. 1 20 (Product Information Literature), Reemay, Inc. Old Hickory, TN.;;Reynolds Brent A., et al., A Multipotent EGF Responsive Striatal Embryonic Progenitor Cell Produces Neurons and Astrocytes, The Journal of Neuroscience , 12, pp. 4565 4574 (1992).;;Richards, L.J. et al., De novo Generation of Neuronal Cells From The Adult Mouse Brain, Proc. Natl. Acad. Sci. USA , 89, pp. 8591 8595 (1992).;;Ron, David, Inducible Growth Arrest: New Mechanistic Insights, Proc. Natl. Acad. Sci. USA , 91, pp. 1985 1986 (1994).;;Rouslahti, Erkki,and Michael D. Pierschbacher, New Perspectives in Cell Adhesion: RGD and Integrins, Science , 238, pp. 491 497 (1987).;;Ruoslahti, Erkki, and John C. Reed, Anchorage Dependence, Integrins, and Apoptosis, Cell , 77, pp. 477 478 (1994).;;Saiki, I., et al., Antimetastatic Effects of Synthetic Polypeptides Containing Repeated Structures of the Cell Adhesives Arg Gly Asp (RGD) and Tyr lle Gly Ser Arg (YIGSR) Sequences, Br. J. Cancer , 60, pp. 722 728 (1989).;;Sanes, Joshua R., Extracellular Matrix Molecules That Influence Neural Development, Ann. Rev. Neurosci. , 12, pp. 491 516 (1989).;;Schinstine, Malcolm, and Fred H. Gage, Factors Affecting Proviral Expression in Primary Cells Grafted into the CNS, Molecular and Cellular Approaches for the Treatment of Neurological Diseases (S.G. Waxman, ed.), pp. 311 323 (1993).;;Seliger, Barbara, et al., Murine Gamma Interferon Inhibits v mos Induced Fibroblast Transformation via Down Regulation of Retroviral Gene Expression, Journal of Virology , 61, pp. 2567 2572 (1987).;;Seliger, Barbara, et al., Gamma Interferon Regulates Long Terminal Repeat Controlled Oncogene Expression in Transformed Mouse Fibroblasts at the Level of mRNA Transcription, Journal of Virology , 62, pp. 619 621 (1988).;;Seliger, Barbara, et al., Tumor Necrosis Factor Affects LTR Controlled Oncogene Expression in Transformed Mouse Fibroblasts at the Post Transcriptional Level, The Journal of Immunology , 141, pp. 2138 2144 (1988).;;Seliger, Barbara, et al., Distinct Mechanisms of Interferon Gamma and Tumour Necrosis Factor Alpha Action in Oncogene Transformed Mouse Fibroblasts, Journal of Cellular Biochemistry , 38, pp. 205 212 (1988).;;Sharifi, Behrooz G., et al., Cell Surface Interaction is Sufficient for the Biological Activity of a Bovine Sialoglycopeptide Inhibitor, Biochemical and Biophysical Research Communications , 134, pp. 1350 1357 (1986).;;Sharifi, Behrooz G., et al., Purification and Characterization of a Bovine Cerebral Cortex Cell Surface Sialoglycopeptide that Inhibits Cell Proliferation and Metabolism, Journal of Neurochemistry , 46, pp. 461 469 (1986).;;Smalheiser, Neil R., et al., Laminin As a Substrate for Retinal Axons in Vitro, Dev. Brain. Res. , 12, pp. 136 140 (1984).;;SoloHill Labs, Inc., SoloHill Labs, Inc. Ann Arbor, MI.;;Stockdale, Frank E., et al., Myoblasts, Satellite Cells, and Myoblast Transfer, Myoblast Transfer Therapy (R. Griggs and G. Karpati, eds.), pp. 7 11 (1990).;;Sun, Anthony M., Microencapsulation of Pancreatic Islet Cells: A Bioartificial Endocrine Pancreas, Methods in Enzymology , 137, pp. 575 580 (1988).;;Tashiro, Ken ichiro et al., A Synthetic Peptide Containing the IKVAV Sequence from the A Chain of Laminin Mediates Cell Attachment, Migration, and Neurite Outgrowth, The Journal of Biological Chemistry , 264, pp. 16174 16182 (1989).;;Telios Pharmaceuticals, Integrins: An Update on the Rapid Growth of Research Topics, in ECM Connections , a publication of Telios Pharmaceuticals, San Diego, CA (Jun. 1992).;;Telios Pharmaceuticals, PepTite 2000 (Product Information Memorandum), Telios Pharmaceuticals, San Diego, CA.",EXPIRED
408,US,A,US 5776747 A,066-590-958-818-466,1998-07-07,1998,US 44777895 A,1995-05-23,US 44777895 A;;US 43269895 A;;US 27977394 A,1994-07-20,Method for controlling the distribution of cells within a bioartificial organ using polycthylene oxide-poly (dimethylsiloxane) copolymer,"This invention relates to methods and compositions of controlling cell distribution within a bioartificial organ by exposing the cells to a treatment that inhibits cell proliferation, promotes cell differentiation, or affects cell attachment to a growth surface within the bioartificial organ. Such treatments include (1) genetically manipulating cells, (2) exposing the cells to a proliferation-inhibiting compound or a differentiation-inducing compound or removing the cells from exposure to a proliferation-stimulating compound or a differentiation-inhibiting compound; exposing the cells to irradiation, and (3) modifying a growth surface of the BAO with ECM molecules, molecules affecting cell proliferation or adhesion, or an inert scaffold, or a combination thereof. These treatments may be used in combination. A particular embodiment is directed to derivatizing or adsorbing polyethylene oxide-poly(dimethylsiloxane) copolymer (PEO-PDMS) onto a surface within the bioartificial organ to inhibit cellular attachment.",CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,NEUROTECH S.A (1999-12-29);;NEUROTECH USA INC (2007-10-25),https://lens.org/066-590-958-818-466,Granted Patent,yes,35,111,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A61L27/00;;A61L27/18;;A61L27/22;;A01K67/027;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,435/177;;435/180;;435/181;;435/182,99,82,048-332-719-530-735;;040-300-209-001-975;;078-401-268-829-715;;015-052-284-383-698;;051-467-747-043-981;;018-070-477-790-693;;120-596-939-734-383;;115-103-293-214-469;;004-129-864-323-871;;054-678-244-582-843;;021-321-949-597-771;;172-770-692-257-323;;060-164-752-701-836;;010-938-147-585-497;;011-276-786-730-941;;032-759-232-461-426;;108-379-915-909-34X;;028-364-375-537-319;;154-365-488-022-138;;026-016-347-959-887;;045-017-646-829-568;;066-523-881-622-501;;061-578-853-469-745;;057-767-055-501-614;;023-675-605-776-929;;104-865-628-368-26X;;173-587-013-695-171;;156-440-241-544-217;;068-141-789-713-733;;098-101-997-046-906;;034-178-376-559-657;;099-990-907-377-728;;005-358-343-205-664;;045-328-856-518-264;;004-236-732-518-638;;094-551-917-544-749;;108-168-722-195-491;;034-044-806-170-454;;038-918-079-679-253;;115-971-724-193-517;;009-792-950-241-971;;014-745-525-337-47X;;050-399-486-711-487;;059-049-072-219-166;;092-223-656-604-882;;018-117-336-909-414;;131-750-072-875-475;;003-664-236-520-709;;066-203-355-190-646;;105-834-428-184-911;;035-723-436-595-236;;034-249-775-255-429;;095-350-135-301-860;;060-291-465-466-062;;081-174-387-421-852;;052-782-286-478-646;;002-286-494-363-396;;101-732-752-675-701;;049-042-021-517-724;;164-020-307-617-474;;044-088-273-450-791;;012-333-350-448-43X;;046-111-513-250-242;;100-153-598-267-351;;028-211-379-291-005;;067-322-389-377-685;;147-346-857-684-894;;065-678-110-707-195;;076-012-254-853-704;;093-553-709-303-10X;;030-854-629-603-00X;;086-874-830-084-387;;016-063-554-957-496;;092-531-628-495-425;;055-467-864-296-721;;056-234-682-167-995;;090-908-679-116-661;;044-320-745-895-128;;001-928-366-548-586;;165-524-038-085-953;;008-119-464-657-166;;026-843-338-695-356,7918336;;8406030;;10.1016/0378-1119(93)90507-y;;2194673;;10.1016/0092-8674(90)90239-b;;10.1007/bf02623638;;2666386;;pmc386305;;10.1073/pnas.83.15.5454;;2874553;;10.1126/science.8016653;;8016653;;10.1159/000112252;;3021428;;10.1016/0168-9525(93)90012-7;;8379006;;10.1002/bip.360260018;;2437977;;pmc6577554;;10.1523/jneurosci.14-03-01030.1994;;8120611;;10.1073/pnas.82.13.4438;;pmc391116;;3892534;;10.1007/978-1-349-11358-3_15;;10.1016/0896-6273(88)90184-5;;3078410;;10.1089/hum.1993.4.4-433;;8399490;;8190271;;10.1016/0306-4522(94)90097-3;;8440318;;10.1006/excr.1993.1026;;pmc1886816;;8456938;;8476199;;2475934;;10.1016/0166-2236(89)90020-9;;8242752;;10.1016/0092-8674(93)90500-p;;10.1016/b978-0-12-483365-4.50008-6;;1504017;;10.1016/0014-4827(91)90130-m;;1901795;;10.1002/jcp.1041390208;;2715187;;10.1016/s0344-0338(11)80845-9;;8183742;;10.1007/bf02592286;;7686057;;3749886;;10.1126/science.3749886;;8352534;;10.1016/0014-4827(92)90083-k;;1383013;;10.1021/bi00396a004;;2962631;;10.1016/0092-8674(87)90707-0;;2951015;;8016642;;10.1126/science.8016642;;10.1016/0896-6273(93)90068-3;;8398146;;10.1006/ncmn.1993.1052;;10.1016/0378-1119(93)90424-2;;8359690;;8318227;;10.1016/0896-6273(93)90051-r;;10.1111/j.1749-6632.1992.tb42589.x;;1416607;;pmc363533;;10.1128/mcb.8.8.3065-3079.1988;;10.1128/mcb.8.8.3065;;2974922;;1797805;;10.1002/jbm.820251102;;10.1126/science.2961059;;2961059;;2735903;;10.1016/0006-291x(89)92622-3;;10.1002/jnr.490280407;;1870155;;10.1016/0014-4827(91)90391-7;;2070822;;6308472;;10.1038/304596a0;;8517665;;6776628;;10.1126/science.6776628;;8338876;;10.1089/hum.1993.4.3-291;;10.1016/0003-2697(90)90459-m;;2382830;;10.1097/00002480-198907000-00165;;2597562;;1612781;;10.1002/ijc.2910510511;;6241504;;10.1247/csf.9.357;;10.1523/jneurosci.14-06-03533.1994;;7515952;;pmc6576935;;482611;;10.2307/3575179;;2489072;;10.1016/0141-8130(89)90049-4;;8393300;;10.1152/ajplung.1993.265.1.l1;;10.1172/jci116723;;pmc288291;;8104197;;8514795;;10.1016/s0021-9258(19)38695-8;;3422482;;10.1073/pnas.85.4.1105;;pmc279714;;10.1016/0003-9861(92)90533-3;;1586167;;6325925;;10.1038/309030a0;;10.1523/jneurosci.12-05-01802.1992;;1578271;;pmc6575890;;8331297;;10.1111/1523-1747.ep12359508;;10.1128/mcb.13.7.4223;;10.1128/mcb.13.7.4223-4232.1993;;pmc359972;;8391634;;10.1073/pnas.90.8.3602;;pmc46349;;8475109;;1432110;;10.1523/jneurosci.12-11-04565.1992;;pmc6575989;;10.1073/pnas.89.18.8591;;pmc49966;;1528866;;8134335;;10.1073/pnas.91.6.1985;;pmc43292;;10.1126/science.2821619;;2821619;;8187171;;10.1016/0092-8674(94)90209-7;;2803948;;pmc2247318;;10.1038/bjc.1989.347;;10.1146/annurev.ne.12.030189.002423;;2648958;;8417470;;10.1128/jvi.61.8.2567-2572.1987;;pmc255700;;3037117;;pmc250578;;10.1128/jvi.62.2.619-621.1988;;3121865;;2844896;;10.1002/jcb.240380308;;3147985;;10.1016/0006-291x(86)90398-0;;3947369;;2416876;;10.1111/j.1471-4159.1986.tb12990.x;;6697250;;2248157;;10.1007/978-1-4684-5865-7_2;;10.1016/0076-6879(88)37053-9;;3131633;;2777785;;10.1016/s0021-9258(18)71604-9,"Kleinman, Hynda K., and Benjamin S. Weeks, The Neural Cell Response to Laminin: Active Sites, Receptors, and Intracellular Signals, Comments Developmental Neurobiology , pp. 251 266 (1991).;;Farghali et al., The concept of Application of Immobilized and Perfused Mammalian cells (a bioreactor model) in biomedical research, Physiological Research, 43, pp. 117 120 (1994).;;Adhya, Sankar, et al., Promoter resurrection by activators a minireview, Gene , 132, pp. 1 6 (1993).;;Arnheiter, Heinz, et al., Transgenic Mice with Intracellular Immunity to Influenza Virus, Cell , 62, pp. 51 61 (1990).;;Aulthouse, Amy Lynn, et al., Expression of the Human Chondrocyte Phenotype in Vitro, In Vitro Cellular & Developmental Biology , 25, pp. 659 668 (1989).;;Baetge, E. Edward, et al., Complete Nucleotide and Deduced Amino Acid Sequence of Bovine Phenylethanolamine N methyltransferase: Partial Amino Acid Homology with Rat Tyrosine Hydroxylase, Proc. Natl. Acad. Sci. USA , 83, pp. 5454 5458 (1986).;;Barinaga, Marcia, Knockout Mice: Round Two, Science , 265, pp. 26 28 (1994).;;Baron Van Evercooren, A., et al., Schawann Cell Differentiation in vitro: Extracellular Matrix Deposition and Interaction, Dev. Neurosci. , 8, pp. 182 196 (1986).;;Blau, Helen M., et al., Myoblasts in Pattern Formation and Gene Therapy, Trends in Genetics , 9, pp. 269 274 (1993).;;Bohak, Z. et al., Novel Anchorage Matrices for Suspension Culture of Mammalian Cells, Biopolymers , 26, pp. S205 S213 (1987).;;Brenner, Michael, et al., GFAP Promoter Directs Astrocyte specific Expression in Transgenic Mice, The Journal of Neuroscience , 14, pp. 1030 1037 (1994).;;Brinster et al., Factors Affecting the Efficiency of Introducing Foreign DNA into Mice by Microinjecting Eggs, Proc. Natl. Acad. Sci. USA , 82, pp. 4438 4442 (1985).;;Cabasso, Israel, Hollow Fiber Membranes, Encyclopedia of Chemical Technology (Kirk Othmer, ed.), pp. 492 517 (1980).;;Carbonetto, Salvatore Ch. 15: Laminin Receptors: From PC12 Cells to PNS, Brain Repair (Bj o rklund, Aguayo and Ottson, eds.), pp. 185 197 (1990).;;Celtrix Laboratories, Vitrogen 100 : Purified Collagen for Cell Culture and Biochemistry (Product Information Memorandum), Celtrix Laboratories, Palo Alto, CA (1991).;;Cepko, Connie, Retrovirus Vectors and Their Applications in Neurobiology, Neuron , 1, 345 353 (1988).;;Chang, P.L., et al., Delivery of Recombinant Gene Products with Microencapsulated Cells In Vivo, Human Gene Therapy , 4, pp. 433 440 (1993).;;Chu, C.H., and A.M. Tolkovsky, Alternative Adrenal Chromaffin Cell Fates Induced by Basic Fibroblast Growth Factor or Cyclic AMP In Vitro Depend on a Collaboration With The Growth Substrate, Neuroscience , 59, pp. 43 54 (1994).;;Collaborative Research Incorporated, CR Laminin and CR Anti Laminin (Product Information Memorandum), Collaborative Research, Inc., Bedford, MA (1987).;;Collaborative Research Incorporated, Basement Membrane Matrigel (Product Specification Sheet), Collaborative Research, Inc., Bedford, MA (1991).;;Collagen Biomedical, Collagen Test Implant Physician Package Insert, (Product Information Literature), Collagen Biomedical, Palo Alto, CA (1992).;;Collagen Biomedical Zyderm Collagen and Zyderm Explained, (Product Information Memorandum), Collagen Biomedical, Palo Alto, CA (1992).;;Collagen Biomedical, Zyderm Collagen Implant Physician Package Insert, (Product Literature), Collagen Biomedical, Palo Alto, CA (1992).;;Collagen Biomedical, Zyplast Implant Physician Package Insert, (Product Literature), Collagen Biomedical, Palo Alto, CA (1992).;;Crouch, Gary D., et al., Ara C Treatment Leads to Differentiation and Reverses the Transformed Phenotype in a Human Rhabdomyosarcoma Cell Line, Experimental Cell Research , 204, pp. 210 216 (1993).;;Datta, Dipak B., Keeping In Touch: The Adhesion Reactions of the Cell Membrane, A Comprehensive Introduction to Membrane Biochemistry , pp. 231 56 (1987).;;de Bruine, Adriaan P., et al., Extracellular Matrix Components Induce Endocrine Differentiation in Vitro in NCI H716 Cells, American Journal of Pathology , 142, pp. 773 782 (1993).;;De Loecker, William, et al., Effects of Sodium Ascorbate (Vitamin C) and 2 Methyl 1,4 naphthoquinone (Vitamin K 3 ) Treatment of Human Tumor Cell Growth in Vitro. II. Synergism with Combined Chemotherapy Action, Anticancer Research , 13, pp. 103 106 (1993).;;Edgar, David, Neuronal laminin receptors, TINS , pp. 248 251 (1989).;;El Deiry, Wafik S., et al., WAF1 , a Potential Mediator of p53 Tumor Suppression, Cell , 75, pp. 817 825 (1993).;;End, Peter, and Jurgen Engel, Multidomain Proteins of the Extracellular Matrix and Cellular Growth, Receptors for Extracellular Matrix (McDonald, J. and Mecham, R., ed.), pp. 79 129 (1991).;;Epstein Baak, Ruth, et al., Inducible Transformation of Cells from Transgenic Mice Expressing SV40 under lac Operon Control, Cell Growth and Differentiation , 3, pp. 127 134 (1992).;;Fattaey, H.K., et al., Modulation of Growth Related Gene Expression and Cell Cycle Synchronization by a Sialoglycopeptide Inhibitor, Experimental Cell Research , 194, pp. 62 68 (1991).;;Fattaey, Heideh, et al., Inhibition of DNA Synthesis and Cell Division by a Cell Surface Sialoglycopeptide, Journal of Cellular Physiology , 139, pp. 269 274 (1989).;;Fujiyama, C., et al., Influence of Extracellular Matrix on the Proliferation and Differentiation of Adrenocortical Cells in Culture, Path. Res. Pract. , 189, pp. 1205 1214 (1993).;;Galli, Maria C., et al., The Biology of Stem Cell Factor, a New Hematopoietic Growth Factor Involved in Stem Cell Regulation, Int. J. of Clin. Lab. Res. , 23, pp. 70 77 (1993).;;Gash, D.M., et al., Amitotic Neuroblastoma Cells Used for Neural Implants in Monkeys, Science , 233, pp. 1420 1422 (1986).;;Gonos, Efstathios S., and Demetrios A. Spandidos, Oncogenes in Cellular Immortalisation and Differentiation (Review), Anticancer Research , 13, pp. 1117 1122 (1993).;;Grabham, Peter W., et al., Vibronectin Is the Major Serum Protein Essential for NGF Mediated Neurite Outgrowth from PC12 Cells, Experimental Cell Research , 202, pp. 337 44 (1992).;;Graf, Jeannette, et al., A Pentapeptide form the Laminin 1 Chain Mediates Cell Adhesion and Binds the 67 000 Laminin Receptor, Biochemistry , 26, pp. 6896 6900 (1987).;;Graf, Jeannette, et al., Identification of an Amino Acid Sequence in Laminin Mediating Cell Attachment, Chemotaxis, and Receptor Binding, Cell , 48, pp. 989 996 (1987).;;Gu, Hua, et al., Deletion of a DNA Polymerase Gene Segment in T Cells Using Cell Type Specific Gene Targeting, Science , 265, pp. 103 106 (1994).;;Gumbiner, Barry M., Proteins Associated with the Cytoplasmic Surface of Adhesion Molecules, Neuron , 11, pp. 551 564 (1993).;;Hammang, Joseph P., et al., Immortalized Neuronal and Neuroendocrine Cell Lines by Targeted Oncogenesis in Transgenic Mice Using the PNMT Promoter, Neuroprotocols: A Companion Methods in Neurosciences , 3, pp. 176 183 (1993).;;Hannan, G.N., et al., An engineered PGK promoter and lac operator repressor system for the regulation of gene expression in mammalian cells, Gene , 130, pp. 233 239 (1993).;;Hoyle, Gary W., et al., Expression of NGF in Sympathetic Neurons Leads to Excessive Axon Outgrowth from Ganglia but Decreased Terminal Innervation within Tissues, Neuron , 10, pp. 1019 1034 (1993).;;Hubbell, Jeffrey A., et al., Surface grafted Cell binding Peptides in Tissue Engineering of the Vascular Graft, Annals New York Academy of Sciences , 665, pp. 253 258 (1992).;;Hug, Hubert, et al., Organization of the Murine Mx Gene and Characterization of Its Interferon and Virus Inducible Promoter, Molecular and Cellular Biology , 8, pp. 3065 3079 (1988).;;HyClone Laboratories, CultiSpher G (Product Information Memorandum), HyClone Laboratories, Logan, UT (no date).;;HyClone Laboratories, CultiSpher GL (Product Information Memorandum), HyClone Laboratories, Logan, UT (no date).;;Ito, Yoshihiro, et al., Materials for Enhancing Cell Adhesion By Immobilization of Cell Adhesive Peptide, Journal of Biomedical Materials Research , 25, pp. 1325 1337 (1991).;;Iwamoto, Yukihide, et al., YIGSR, a Synthetic Laminin Pentapeptide, Inhibits Experimental Metastasis Formation, Science , 238, pp. 1132 1134 (1987).;;Johnson, Terry C., and Behrooz G. Sharifi., Abrogation of the Mitogenic Activity of Bombesin by a Cell Surface Sialoglycopeptide Growth Inhibitor, Biochemical and Biophysical Research Communications , 161, pp. 468 474 (1989).;;Jucker, M., et al., Fetal Rats Septal Cells Adhere to and Extend Processes on Basement Membrane, Laminin, and a Synthetic Peptide the Laminin A Chain Sequence, J. Neurosci. Res. , 28, 507 517 (1991).;;Kleinman, Hynda K., et al., The Role of Laminin in Basement Membranes and in the Growth, Adhesion, and Differentiation of Cells, The Role of Extracellular Matrix in Development pp. 123 143 (1984).;;Lakshmanarao, S.S., et al., Identification of a Cell Surface Component of Swiss 3T3 Cells Associated with an Inhibition of Cell Division, Experimental Cell Research , 195, pp. 412 415 (1991).;;Land, Hartmut, et al., Tumorigenic Conversion of Primary Embryo Fibroblasts Requires At Least Two Cooperating Oncgences, Nature , 304, pp. 596 602 (1983).;;Leung, Ping. Y., et al., Cytotoxic Effect of Ascorbate and its Derivatives on Cultered Malignant and Nonmalignant Cell Lines, Anticancer Research , 13, pp. 475 480 (1993).;;Lim, F., et al., Microencapsulated Islets as Bioartificial Endocrine Pancreas, Science , 210, pp. 908 910 (1980).;;Liu, Hong Wen, et al., Expression of Human Factor IX by Microencapsulated Recombinant Fibroblasts, Human Gene Therapy , 4, pp. 291 301 (1993).;;Massia, Stephen P., and Jeffrey A. Hubbell, Covalent Surface Immobilization of Arg Gly Asp and Try lle Gly Ser Arg Containing Peptides to Obtain Well Defined Cell Adhesive Substrates, Analytical Biochemistry , 187, pp. 292 301 (1990).;;Matsuda, Takehisa, et al., Development of a Novel Artifical Matrix with Cell Adhesion Peptides for Cell Culture and Artificial and Hybrid Organs, Trans. Am. Soc. Artif. Itern. Organs , 35, pp. 677 679 (1989).;;Matsushima, Hiroshi, and Emil Bogenmann, Modulation of Neuroblastoma Cell Differentiation by the Extracellular Matrix, Int. J. Cancer , 51, pp. 727 732 (1992).;;Matuoka et al., Heparan Sulfate Enhances Growth of Transformed Human Cells, Cell Structure and Function , 9, p.357 (1984).;;Messing, Albee, et al., Hypomyelinating Peripheral Neuropathies and Schwannomas in Transgenic Mice Expressing SV40 T Antigen, The Journal of Neuroscience , 14, pp. 3533 3539 (1994).;;Mitchell, J.B., et al., Dose Rate Effects in Mammalian Cells in Culture, Radiat. Res. , 79, pp. 537 551 (1979).;;Murata, Jun, et al., Inhibitory Effect of a Synthetic Polypeptide, Poly(Tyr lle Gly Ser Arg), On the Metastatic Formation of Malignant Tumour Cells, Int. J. Biol. Macromol. , 11, pp. 97 99 (1989).;;Neckers, Len, and Lucke Whitesell, Antisense Technology: Biological Utility and Practical Considerations, Am. J. Physiol. , 265, pp. L1 L12 (1993).;;Otonkoski, Timo, et al., Nicotinamide Is a Potent Inducer of Endocrine Differentiation in Cultured Human Fetal Pancreatic Cells, J. Clin. Invest. , 92, pp. 1459 1466 (1993).;;Pash, James M., et al., Aberrant Expression of High Mobility Group Chromosomal Protein 14 Affects Cellular Differentiation, The Journal of Biological Chemistry , 268, pp. 13632 13638 (1993).;;Penttinen, Risto P., et al., Transforming Growth Factor Increases mRNA for Matrix Proteins Both in the Presence and in the Absence of Changes in mRNA Stanility, Proc. Natl. Acad. Sci. USA , 85, pp. 1105 1108 (1988).;;Phillips, Charlotte L., et al., Ascorbic Acid and Transforming Growth Factor 1 Increase Collagen Biosynthesis via Different Mechanism: Coordinate Regulation of Pro 1 (1) and Pro 1 (III) Collagens, Archives of Biochemistry and Biophysics , 295, pp. 397 403 (1992).;;Pierschbacher, Michael D., and Erkki Ruoslatiti, Cell Attachment Activity of Fibronectin Can Be Duplicated By Small Synthetic Fragments of the Molecule, Science , 309, pp. 30 33 (1984).;;Pleasure, Samuel, et al., Pure, Postmitotic, Polarized Human Neurons Derived from NTera 2 Cells Provide a System for Expressing Exogenous Proteins in Terminally Differentiated Neurons, The Journal of Neuroscience , 12, pp. 1802 1815 (1992).;;Prystowsky et al., Inhibition of Ornithine Decarboxylase Activity and Cell Proliferation b Ultraviolet Radiation in EGF Stimulated Cultured Human Epidermal Keratinocytes, J. Invest. Dermat. , 101, pp. 54 58 (1993).;;Radvanyi, Francois, et al., Pancreatic Cells Cultured from Individual Preneoplastic Foci in a Multistage Tumorigenesis Pathway: a Potentially General Technique for Isolating Physiologically Representative Cell Lines, Molecular and Cellular Biology , 13, pp. 4223 4232 (1993).;;Ray, Jasodhara, et al., Proliferation, Differentiation and Long Term Culture of Primary Hippocampal Neurons, Proc. Natl. Acad. Sci. USA , 90, pp. 3602 3606 (1993).;;Reemay, Inc., Reemay Spunbonded Polyester, pp. 1 20 (Product Information Literature), Reemay, Inc., Old Hickory, TN.;;Reynolds, Brent A., et al., A Multipotent EGF Responsive Striatal Embryonic Progenitor Cell Produces Neurons and Astrocytes, The Journal of Neuroscience , 12, pp. 4565 4574 (1992).;;Richards, L.J. et al., De novo Generation of Neuronal Cells From the Adult Mouse Brain, Proc. Natl. Acad. Sci. USA , 89, pp. 8591 8595 (1992).;;Ron, David, Inducible Growth Arrest: New Mechanistic Insights, Proc. Natl. Acad. Sci. USA , 91, p. 1985 1986 (1994).;;Ruoslahti, Erkki, and Michael D. Pierschbacher, New Perspectives in Cell Adhesion: RGD and Integrins, Science , 238, pp. 491 497 (1987).;;Ruoslahti, Erkki, and John C. Reed, Anchorage Dependence, Integrins, and Apoptosis, Cell , 77, pp. 477 478 (1994).;;Saiki, I., et al., Antimetastatic Effects of Synthetic Polypeptides Containing Repeated Structures of the Cell Adhesive Arg Gly Asp (RGD) and Try lle Gly Ser Arg (YIGSR) Sequences, Br. J. Cancer , 60, pp. 722 728 (1989).;;Sanes, Joshua R., Extracellular Matrix Molecules That Influence Neural Development, Ann. Rev. Neurosci. , 12, pp. 491 516 (1989).;;Schinstine, Malcolm, and Fred H. Gage, Factors Affecting Proviral Expression in Primary Cells Grafted into the CNS, Molecular and Cellular Approaches for the Treatment of Neurological Diseases (S.G. Waxman, ed.), pp. 311 323 (1993).;;Seliger, Barbara, et al., Murine Gamma Interferon Inhibits v mos Induced Fibroblast Transformation via Down Regulation of Retroviral Gene Expression, Journal of Virology , 61, pp. 2567 2572 (1987).;;Seliger, Barbara, et al., Gamma Interferon Regulates Long Terminal Repeat Controlled Oncogene Expression in Transformed Mouse Fibroblasts at the Level of mRNA Transcription, Journal of Virology , 62, pp. 619 621 (1988).;;Seliger, Barbara, et al., Tumor Necrosis Factor Affects LTR Controlled Oncogene Expression in Transformed Mouse Fibroblasts at the Post Transcriptional Level, The Journal of Immunology , 141, pp. 2138 2144 (1988).;;Seliger, Barbara, et al., Distinct Mechanisms of Interferon Gamma and Tumor Necrosis Factor Alpha Action in Oncogene Transformed Mouse Fibroblasts, Journal of Cellular Biochemistry , 38, pp. 205 212 (1988).;;Sharifi, Behrooz G., et al., Cell Surface Interaction is Sufficient for the Biological Activity of a Bovine Sialoglycopeptide Inhibitor, Biochemical and Biophysical Research Communications , 134, pp. 1350 1357 (1986).;;Sharifi, Behrooz G., et al., Purification and Characterization of a Bovine Cerebral Cortex Cell Surface Sialoglycopeptide that Inhibits Cell Proliferation and Metabolism, Journal of Neurochemistry , 46, pp. 461 469 (1986).;;Smalheiser, Neil R., et al., Laminin As a Substrate for Retinal Axons in Vitro, Dev. Brain Res. , 12, pp. 136 140 (1984).;;SoloHill Labs, Inc., SoloHill Labs, Inc., Ann Arbor, MI.;;Stockdale, Frank E., et al., Myoblasts, Satellite Cells and Myoblast Transfer, Myoblast Transfer Therapy (R. Griggs and G. Karpati, eds.), pp. 7 11 (1990).;;Sun, Anthony M., Microencapsulation of Pancreatic Islet Cells: A Bioartificial Endocrine Pancreas, Methods in Enzymology , 137, pp. 575 580 (1988).;;Tashiro, Ken ichiro, et al., A Synthetic Peptide Containing the IKVAV Sequence from the A Chain of Laminin Mediates Cell Attachment, Migration, and Neurite Outgrowth, The Journal of Biological Chemistry , 264, pp. 16174 16182 (1989).;;Telios Pharmaceuticals, Integrins: An Update on the Rapid Growth of Research Topics, in ECM Connections a publication of Telios Pharmaceuticals, San Diego, CA (Jun. 1992).;;Telios Pharmaceiticals, Pep Tite 2000 (Product Information Memorandum), Telios Pharmaceuticals, San Diego, CA.",EXPIRED
409,US,A,US 5840576 A,083-237-058-731-890,1998-11-24,1998,US 44519395 A,1995-05-23,US 44519395 A;;US 43269895 A;;US 27977394 A,1994-07-20,Methods and compositions of growth control for cells encapsulated within bioartificial organs,"This invention relates to methods and compositions of controlling cell distribution within a bioartificial organ by exposing the cells to a treatment that inhibits cell proliferation, promotes cell differentiation, or affects cell attachment to a growth surface within the bioartificial organ. Such treatments include (1) genetically manipulating cells, (2) exposing the cells to a proliferation-inhibiting compound or a differentiation-inducing compound or removing the cells from exposure to a proliferation-stimulating compound or a differentiation-inhibiting compound; exposing the cells to irradiation, and (3) modifying a growth surface of the BAO with ECM molecules, molecules affecting cell proliferation or adhesion, or an inert scaffold, or a combination thereof. These treatments may be used in combination.",CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,NEUROTECH S.A (1999-12-29);;NEUROTECH USA INC (2007-10-25),https://lens.org/083-237-058-731-890,Granted Patent,yes,36,47,33,40,4,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A01K67/027;;A61L27/00;;A61L27/18;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,435/325;;435/375;;435/377;;435/400,99,82,048-332-719-530-735;;040-300-209-001-975;;078-401-268-829-715;;015-052-284-383-698;;051-467-747-043-981;;018-070-477-790-693;;120-596-939-734-383;;115-103-293-214-469;;004-129-864-323-871;;054-678-244-582-843;;021-321-949-597-771;;172-770-692-257-323;;060-164-752-701-836;;010-938-147-585-497;;011-276-786-730-941;;032-759-232-461-426;;108-379-915-909-34X;;028-364-375-537-319;;154-365-488-022-138;;026-016-347-959-887;;045-017-646-829-568;;066-523-881-622-501;;061-578-853-469-745;;057-767-055-501-614;;023-675-605-776-929;;104-865-628-368-26X;;173-587-013-695-171;;156-440-241-544-217;;068-141-789-713-733;;098-101-997-046-906;;034-178-376-559-657;;099-990-907-377-728;;005-358-343-205-664;;045-328-856-518-264;;004-236-732-518-638;;094-551-917-544-749;;108-168-722-195-491;;034-044-806-170-454;;038-918-079-679-253;;115-971-724-193-517;;009-792-950-241-971;;014-745-525-337-47X;;050-399-486-711-487;;059-049-072-219-166;;092-223-656-604-882;;018-117-336-909-414;;131-750-072-875-475;;003-664-236-520-709;;066-203-355-190-646;;105-834-428-184-911;;035-723-436-595-236;;034-249-775-255-429;;095-350-135-301-860;;060-291-465-466-062;;081-174-387-421-852;;052-782-286-478-646;;002-286-494-363-396;;101-732-752-675-701;;049-042-021-517-724;;164-020-307-617-474;;044-088-273-450-791;;012-333-350-448-43X;;046-111-513-250-242;;100-153-598-267-351;;028-211-379-291-005;;067-322-389-377-685;;147-346-857-684-894;;065-678-110-707-195;;076-012-254-853-704;;093-553-709-303-10X;;030-854-629-603-00X;;086-874-830-084-387;;016-063-554-957-496;;092-531-628-495-425;;055-467-864-296-721;;056-234-682-167-995;;090-908-679-116-661;;044-320-745-895-128;;001-928-366-548-586;;165-524-038-085-953;;008-119-464-657-166;;026-843-338-695-356,7918336;;8406030;;10.1016/0378-1119(93)90507-y;;2194673;;10.1016/0092-8674(90)90239-b;;10.1007/bf02623638;;2666386;;pmc386305;;10.1073/pnas.83.15.5454;;2874553;;10.1126/science.8016653;;8016653;;10.1159/000112252;;3021428;;10.1016/0168-9525(93)90012-7;;8379006;;10.1002/bip.360260018;;2437977;;pmc6577554;;10.1523/jneurosci.14-03-01030.1994;;8120611;;10.1073/pnas.82.13.4438;;pmc391116;;3892534;;10.1007/978-1-349-11358-3_15;;10.1016/0896-6273(88)90184-5;;3078410;;10.1089/hum.1993.4.4-433;;8399490;;8190271;;10.1016/0306-4522(94)90097-3;;8440318;;10.1006/excr.1993.1026;;pmc1886816;;8456938;;8476199;;2475934;;10.1016/0166-2236(89)90020-9;;8242752;;10.1016/0092-8674(93)90500-p;;10.1016/b978-0-12-483365-4.50008-6;;1504017;;10.1016/0014-4827(91)90130-m;;1901795;;10.1002/jcp.1041390208;;2715187;;10.1016/s0344-0338(11)80845-9;;8183742;;10.1007/bf02592286;;7686057;;3749886;;10.1126/science.3749886;;8352534;;10.1016/0014-4827(92)90083-k;;1383013;;10.1021/bi00396a004;;2962631;;10.1016/0092-8674(87)90707-0;;2951015;;8016642;;10.1126/science.8016642;;10.1016/0896-6273(93)90068-3;;8398146;;10.1006/ncmn.1993.1052;;10.1016/0378-1119(93)90424-2;;8359690;;8318227;;10.1016/0896-6273(93)90051-r;;10.1111/j.1749-6632.1992.tb42589.x;;1416607;;pmc363533;;10.1128/mcb.8.8.3065-3079.1988;;10.1128/mcb.8.8.3065;;2974922;;1797805;;10.1002/jbm.820251102;;10.1126/science.2961059;;2961059;;2735903;;10.1016/0006-291x(89)92622-3;;10.1002/jnr.490280407;;1870155;;10.1016/0014-4827(91)90391-7;;2070822;;6308472;;10.1038/304596a0;;8517665;;6776628;;10.1126/science.6776628;;8338876;;10.1089/hum.1993.4.3-291;;10.1016/0003-2697(90)90459-m;;2382830;;10.1097/00002480-198907000-00165;;2597562;;1612781;;10.1002/ijc.2910510511;;6241504;;10.1247/csf.9.357;;10.1523/jneurosci.14-06-03533.1994;;7515952;;pmc6576935;;482611;;10.2307/3575179;;2489072;;10.1016/0141-8130(89)90049-4;;8393300;;10.1152/ajplung.1993.265.1.l1;;10.1172/jci116723;;pmc288291;;8104197;;8514795;;10.1016/s0021-9258(19)38695-8;;3422482;;10.1073/pnas.85.4.1105;;pmc279714;;10.1016/0003-9861(92)90533-3;;1586167;;6325925;;10.1038/309030a0;;10.1523/jneurosci.12-05-01802.1992;;1578271;;pmc6575890;;8331297;;10.1111/1523-1747.ep12359508;;10.1128/mcb.13.7.4223;;10.1128/mcb.13.7.4223-4232.1993;;pmc359972;;8391634;;10.1073/pnas.90.8.3602;;pmc46349;;8475109;;1432110;;10.1523/jneurosci.12-11-04565.1992;;pmc6575989;;10.1073/pnas.89.18.8591;;pmc49966;;1528866;;8134335;;10.1073/pnas.91.6.1985;;pmc43292;;10.1126/science.2821619;;2821619;;8187171;;10.1016/0092-8674(94)90209-7;;2803948;;pmc2247318;;10.1038/bjc.1989.347;;10.1146/annurev.ne.12.030189.002423;;2648958;;8417470;;10.1128/jvi.61.8.2567-2572.1987;;pmc255700;;3037117;;pmc250578;;10.1128/jvi.62.2.619-621.1988;;3121865;;2844896;;10.1002/jcb.240380308;;3147985;;10.1016/0006-291x(86)90398-0;;3947369;;2416876;;10.1111/j.1471-4159.1986.tb12990.x;;6697250;;2248157;;10.1007/978-1-4684-5865-7_2;;10.1016/0076-6879(88)37053-9;;3131633;;2777785;;10.1016/s0021-9258(18)71604-9,"Farghali et al., The concept of Application of Immobilized and Perfused Mammalian cells (a bioreactor model) in biomedical research, Physiological Research, 43, pp. 117 120 (1994).;;Adhya, Sankar, et al., Promoter resurrection by activators a minireview, Gene, 132, pp. 1 6 (1993).;;Arnheiter, Heinz, et al., Transgenic Mice with Intracellular Immunity to Influenza Virus, Cell, 62, pp. 51 61 (1990).;;Aulthouse, Amy Lynn, et al., Expression of the Human Chondrocyte Phenotype In Vitro, In Vitro, Cellular & Developmental Biology, 25, pp. 659 668 (1989).;;Baetge, E. Edward, et al., Complete Nucleotide and Deduced Amino Acid Sequence of Bovine Phenylethanolamine N methyltransferase: Partial Amino Acid Homology With Rat Tyrosine Hydroxylase, Proc. Natl. Acad. Sci. USA, 83, pp. 5454 5458 (1986).;;Barinaga, Marcia, Knockout Mice: Round Two, Science, 265, pp. 26 28 (1994).;;Baron Van Evercooren, A., et al., Schwann Cell Differentiation in vitro: Extracellular Matrix Deposition and Interaction, Dev. Neurosci., 8, pp. 182 196 (1986).;;Blau, Helen M., et al., Myoblasts in Pattern Formation and Gene Therapy, Trends in Genetics, 9, pp. 269 274 (1993).;;Bohak, Z., et al. Novel Anchorage Matrices for Suspension Culture of Mammalian Cells, Biopolymers, 26, pp. S205 S213 (1987).;;Brenner, Michael, et al., GFAP Promoter Directs Astrocyte specific Expression in Transgenic Mice, The Journal of Neuroscience, 14, pp. 1030 1037 (1994).;;Brinster et al., Factors Affecting the Efficiency of Introducing Foreign DNA into Mice by Microinjecting Eggs, Proc. Natl. Acad. Sci. USA, 82, pp. 4438 4442 (1985).;;Cabasso, Israel, Hollow Fiber Membranes, Encyclopedia of Chemical Technology (Kirk Othmer, ed.), pp. 492 517 (1980).;;Carbonetto, Salvatore, Ch. 15: Laminin Receptors: From PC12 Cells to PNS, Brain Repair (Bj o rklund, Aguayo and Ottoson, eds.), pp. 185 197 (1990).;;Celtrix Laboratories, Vitrogen 100 : Purified Collagen for Cell Culture and Biochemistry (Product Information Memorandum), Celtrix Laboratories, Palo Alto, CA (1991).;;Cepko, Connie, Retrovirus Vectors and Their Applications in Neurobiology, Neuron, 1, 345 53 (1988).;;Chang, P.L., et al., Delivery of Recombinant Gene Products with Microencapsulated Cells In Vivo, Human Gene Therapy, 4, pp. 433 440 (1993).;;Chu, C.H., and A.M. Tolkovsky, Alternative Adrenal Chromaffin Cell Fates Induced by Basic Fibroblast Growth Factor or Cyclic AMP In Vitro Depend on a Collaboration With The Growth Substrate, Neuroscience, 59, pp. 43 54 (1994).;;Collaborative Research Incorporated, CR LAMININ and CR ANTI LAMININ (Product Information Memorandum), Collaborative Research, Inc., Bedford, MA (1987).;;Collaborative Research Incorporated, Basement Membrane Matrigel (Product Specification Sheet), Collaborative Research, Inc., Bedford, MA (1991).;;Collagen Biomedical, Collagen Test Implant Physician Package Insert, (Product Information Literature), Collagen Biomedical, Palo Alto, CA (1992).;;Collagen Biomedical, Zyderm Collagen and Zyderm Explained, (Product Information Memorandum), Collagen Biomedical, Palo Alto, CA (1992).;;Collagen Biomedical, Zyderm Collagen Implant Physician Package Insert, (Product Literature), Collagen Biomedical, Palo Alto, CA (1992).;;Collagen Biomedical, Zyplast Implant Physician Package Insert, (Product Literature), Collagen Biomedical, Palo Alto, CA (1992).;;Crouch, Gary D., et al., Ara C Treatment Leads to Differentiation and Reverses the Transformed Phenotype in a Human Rhabdomyosarcoma Cell Line, Experimental Cell Research, 204, pp. 210 216 (1993).;;Datta, Dipak B., Keeping In Touch: The Adhesion Reactions of the Cell Membrane, A Comprehensive Introduction to Membrane Biochemistry, pp. 231 256 (1987).;;de Bruine, Adriaan P., et al., Extracellular Matrix Components Induce Endocrine Differentiation in Vitro in NCI H716 Cells, American Journal of Pathology, 142, pp. 773 782 (1993).;;De Loecker, William, et al., Effects of Sodium Ascorbate (Vitamin C) and 2 Methyl 1,4 naphthoquinone (Vitamin K 3 ) Treatment on Human Tumor Cell Growth in Vitro. II. Synergism with Combined Chemotherapy Action, Anticancer Research, 13, pp. 103 106 (1993).;;Edgar, David, Neuronal laminin receptors, TINS, 12, pp. 248 251 (1989).;;El Deiry, Wafik S., et al., WAF1, a Potential Mediator of p53 Tumor Suppression, Cell, 75, pp. 817 825 (1993).;;End, Peter, and Jurgen Engel, Multidomain Proteins of the Extracellular Matrix and Cellular Growth, Receptors for Extracellular Matrix (McDonald, J. and Mecham, R., ed.), pp. 79 129 (1991).;;Epstein Baak, Ruth, et al., Inducible Transformation of Cells from Transgenic Mice Expressing SV40 under lac Operon Control, Cell Growth and Differentiation, 3, pp. 127 134 (1992).;;Fattaey, H.K., et al., Modulation of Growth Related Gene Expression and Cell Cycle Synchronization by a Sialoglycopeptide Inhibitor, Experimental Cell Research, 194, pp. 62 68 (1991).;;Fattaey, Heideh, et al., Inhibition of DNA Synthesis and Cell Division by a Cell Surface Sialoglycopeptide, Journal of Cellular Physiology, 139, pp. 269 274 (1989).;;Fujiyama, C., et al., Influence of Extracellular Matrix on the Proliferation and Differentiation of Adrenocortical Cells in Culture, Path. Res. Pract., 189, pp. 1205 1214 (1993).;;Galli, Maria C., et al., The Biology of Stem Cell Factor, a New Hematopoietic Growth Factor Involved in Stem Cell Regulation, Int. J. of Clin. Lab. Res., 23, pp. 70 77 (1993).;;Gash, D.M., et al., Amitotic Neuroblastoma Cells Used for Neural Implants in Monkeys, Science, 233, pp. 1420 1422 (1986).;;Gonos, Efstathios S., and Demetrios A. Spandidos, Oncogenes in Cellular Immortalisation and Differentiation (Review), Anticancer Research, 13, pp. 1117 1122 (1993).;;Grabham, Peter W., et al., Vibronectin Is the Major Serum Protein Essential for NGF Mediated Neurite Outgrowth from PC12 Cells, Experimental Cell Research, 202, pp. 337 344 (1992).;;Graf, Jeannette, et al., A Pentapeptide from the Laminin 1 Chain Mediates Cell Adhesion and Binds the 67 000 Laminin Receptor, Biochemistry, 26, pp. 6896 6900 (1987).;;Graf, Jeannette, et al., Identification of an Amino Acid Sequence in Laminin Mediating Cell Attachment, Chemotaxis, and Receptor Binding, Cell, 48, pp. 989 996 (1987).;;Gu, Hua, et al., Deletion of a DNA Polymerase Gene Segment in T Cells Using Cell Type Specific Gene Targeting, Science, 265, pp. 103 106 (1994).;;Gumbiner, Barry M., Proteins Associated with the Cytoplasmic Surface of Adhesion Molecules, Neuron, 11, pp. 551 564 (1993).;;Hammang, Joseph P., et al., Immortalized Neuronal and Neuroendocrine Cell Lines by Targeted Oncogenesis in Transgenic Mice Using the PNMT Promoter, Neuroprotocols: A Companion to Methods in Neurosciences, 3, pp. 176 183 (1993).;;Hannan, G.N., et al., An engineered PGK promoter and lac operator repressor system for the regulation of gene expression in mammalian cells, Gene, 130, pp. 233 239 (1993).;;Hoyle, Gary W., et al., Expression of NGF in Sympathetic Neurons Leads to Excessive Axon Outgrowth from Ganglia but Decreased Terminal Innervation within Tissues, Neuron, 10, pp. 1019 1034 (1993).;;Hubbell, Jeffrey A., et al., Surface grafted Cell binding Peptides in Tissue Engineering of the Vascular Graft, Annals New York Academy of Sciences, 665, pp. 253 258 (1992).;;Hug, Hubert, et al., Organization of the Murine Mx Gene and Characterization of Its Interferon and Virus Inducible Promoter, Molecular and Cellular Biology, 8, pp. 3065 3079 (1988).;;HyClone Laboratories, CultiSpher G (Product Information Memorandum), HyClone Laboratories, Logan, UT (no date).;;HyClone Laboratories, CultiSpher GL (Product Information Memorandum), HyClone Laboratories, Logan, UT (no date).;;Ito, Yoshihiro, et al., Materials for Enhancing Cell Adhesion By Immobilization of Cell Adhesive Peptide, Journal of Biomedical Materials Research, 25, pp. 1325 1337 (1991).;;Iwamoto, Yukihide, et al., YIGSR, a Synthetic Laminin Pentapeptide, Inhibits Experimental Metastasis Formation, Science, 238, pp. 1132 1134 (1987).;;Johnson, Terry C., and Behrooz G. Sharifi, Abrogation of the Mitogenic Activity of Bombesin by a Cell Surface Sialoglycopeptide Growth Inhibitor, Biochemical and Biophysical Research Communications, 161, pp. 468 474 (1989).;;Jucker, M., et al., Fetal Rats Septal Cells Adhere to and Extend Processes on Basement Membrane, Laminin, and a Synthetic Peptide the Laminin A Chain Sequence, J. Neurosci. Res., 28, 507 517 (1991).;;Kleinman, Hynda K., et al., The Role of Laminin in Basement Membranes and in the Growth, Adhesion, and Differentiation of Cells, The Role of Extracellular Matrix in Development, pp. 123 143 (1984).;;Kleinman, Hynda K., and Benjamin S. Weeks, The Neural Cell Response to Laminin: Active Sites, Receptors, and Intracellular Signals, Comments Developmental Neurobiology, 1, pp. 251 266 (1991).;;Lakshmanarao, S.S., et al., Identification of a Cell Surface Component of Swiss 3T3 Cells Associated with an Inhibition of Cell Division, Experimental Cell Research, 195, pp. 412 415 (1991).;;Land, Hartmut, et al., Tumorigenic Conversion of Primary Embryo Fibroblasts Requires At Least Two Cooperating Oncogenes, Nature, 304, pp. 596 602 (1983).;;Leung, Ping. Y., et al., Cytotoxic Effect of Ascorbate and its Derivatives on Cultured Malignant and Nonmalignant Cell Lines, Anticancer Research, 13, pp. 475 480 (1993).;;Lim, F., et al., Microencapsulated Islets as Bioartificial Endocrine Pancreas, Science, 210, pp. 908 910 (1980).;;Liu, Hong Wen, et al., Expression of Human Factor IX by Microencapsulated Recombinant Fibroblasts, Human Gene Therapy, 4, pp. 291 301 (1993).;;Massia, Stephen P., and Jeffrey A. Hubbell, Covalent Surface Immobilization of Arg Gly Asp and Try lle Gly Ser Arg Containing Peptides to Obtain Well Defined Cell Adhesive Substrates, Analytical Biochemistry, 187, pp. 292 301 (1990).;;Matsuda, Takehisa, et al., Development of a Novel Artificial Matrix with Cell Adhesion Peptides for Cell Culture and Artificial and Hybrid Organs, Trans. Am. Soc. Artif. Intern. Organs, 35, pp. 677 679 (1989).;;Matsushima, Hiroshi, and Emil Bogenmann, Modulation of Neuroblastoma Cell Differentiation by the Extracellular Matrix, Int. J. Cancer, 51, pp. 727 732 (1992).;;Matuoka et al., Heparan Sulfate Enhances Growth of Transformed Human Cells, Cell Structure and Function, 9, p. 357 (1984).;;Messing, Albee, et al., Hypomyelinating Peripheral Neuropathies and Schwannomas in Transgenic Mice Expressing SV40 T Antigen, The Journal of Neuroscience, 14, pp. 3533 3539 (1994).;;Mitchell, J.B., et al. Dose Rate Effects in Mammalian Cells in Culture, Radiat, Res., 79, pp. 537 551 (1979).;;Murata, Jun, et al., Inhibitory Effect of a Synthetic Polypeptide, Poly(Tyr lle Gly Ser Arg), On the Metastatic Formation of Malignant Tumour Cells, Int, J. Biol. Macromol., 11, pp. 97 99 (1989).;;Neckers, Len, and Luke Whitesell, Antisense Technology: Biological Utility and Practical Considerations, Am. J. Physiol., 265, pp. L1 L12 (1993).;;Otonkoski, Timo, et al., Nicotinamide Is a Potent Inducer of Endocrine Differentiation in Cultured Human Fetal Pancreatic Cells, J. Clin. Invest., 92, pp. 1459 1466 (1993).;;Pash, James M., et al., Aberrant Expression of High Mobility Group Chromosomal Protein 14 Affects Cellular Differentiation, The Journal of Biological Chemistry, 268, pp. 13632 13638 (1993).;;Penttinen, Risto P., et al., Transforming Growth Factor Increases mRNA for Matrix Proteins Both in the Presence and in the Absence of Changes in mRNA Stability, Proc. Natl. Acad, Sci, USA, 85, pp. 1105 1108 (1988).;;Phillips, Charlotte L., et al., Ascorbic Acid and Transforming Growth Factor 1 Increase Collagen Biosynthesis via Different Mechanisms: Coordinate Regulation of Pro 1(1) and Pro 1 (111) Collagens, Archives of Biochemistry and Biophysics, 295, pp. 397 403 (1992).;;Pierschbacher, Michael D., and Erkki Ruoslatiti, Cell Attachment Activity of Fibronectin Can Be Duplicated By Small Synthetic Fragments of the Molecule, Science, 309, pp. 30 33 (1984).;;Pleasure, Samuel, et al., Pure, Postmitotic, Polarized Human Neurons Derived from NTera 2 Cells Provide a System for Expressing Exogenous Proteins in Terminally Differentiated Neurons, The Journal of Neuroscience, 12, pp. 1802 1815 (1992).;;Prystowsky et al., Inhibition of Ornithine Decarboxylase Activity and Cell Proliferation by Ultraviolet Radiation in EGF Stimulated Cultured Human Epidermal Keratinocytes, J. Invest. Dermat., 101, pp. 54 58 (1993).;;Radvanyi, Francois, et al., Pancreatic Cells Cultured from Individual Preneoplastic Foci in a Multistage Tumorigenesis Pathway: a Potentially General Technique for Isolating Physiologically Representative Cell Lines, Molecular and Cellular Biology, 13, pp. 4223 4232 (1993).;;Ray, Jasodhara, et al., Proliferation, Differentiation, and Long Term Culture of Primary Hippocampal Neurons, Proc. Nati. Acad. Sci. USA, 90, pp. 3602 3606 (1993).;;Reemay, Inc., Reemay Spunbonded Polyester, pp. 1 20 (Product Information Literature), Reemay, Inc., Old Hickory, TN.;;Reynolds, Brent A., et al., A Multipotent EGF Responsive Striatal Embryonic Progenitor Cell Produces Neurons and Astrocytes, The Journal of Neuroscience, 12, pp. 4565 4574 (1992).;;Richards, L.J. et al., De novo Generation of Neuronal Cells From The Adult Mouse Brain, Proc. Nati, Acad. Sci. USA, 89, pp. 8591 8595 (1992).;;Ron, David, Inducible Growth Arrest: New Mechanistic Insights, Proc. Natl. Acad. Sci. USA, 91, pp. 1985 1986 (1994).;;Ruoslahti, Erkki, and Michael D. Pierschbacher, New Perspectives in Cell Adhesion: RGD and Integrins, Science, 238, pp. 491 497 (1987).;;Ruoslahti, Erkki, and John C. Reed, Anchorage Dependence, Integrins, and Apoptosis, Cell, 77, pp. 477 478 (1994).;;Saiki, I., et al., Antimetastatic Effects of Synthetic Polypeptides Containing Repeated Structures of the Cell Adhesive Arg Gly Asp (RGD) and Tyr lle Gly Ser Arg (YIGSR) Sequences, Br. J. Cancer, 60, pp. 722 728 (1989).;;Sanes, Joshua R., Extracellular Matrix Molecules That Influence Neural Development, Ann. Rev. Neurosci., 12, pp. 491 516 (1989).;;Schinstine, Malcolm, and Fred H. Gage, Factors Affecting Proviral Expression in Primary Cells Grafted into the CNS, Molecular and Cellular Approaches for the Treatment of Neurological Diseases (S.G. Waxman, ed.), pp. 311 323 (1993).;;Seliger, Barbara, et al., Murine Gamma Interferon Inhibits v Mos Induced Fibroblast Transformation via Down Regulation of Retroviral Gene Expression, Journal of Virology, 61, pp. 2567 2572 (1987).;;Seliger, Barbara, et al., Gamma Interferon Regulates Long Terminal Repeat Controlled Oncogene Expression in Transformed Mouse Fibroblasts at the Level of mRNA Transcription, Journal of Virology, 62, pp. 619 621 (1988).;;Seliger, Barbara, et al., Tumor Necrosis Factor Affects LTR Controlled Oncogene Expression in Transformed Mouse Fibroblasts at the Post Transcriptional Level, The Journal of Immunology, 141, pp. 2138 2144 (1988).;;Seliger, Barbara, et al., Distinct Mechanisms of Interferon Gamma and Tumor Necrosis Factor Alpha Action in Oncogene Transformed Mouse Fibroblasts, Journal of Cellular Biochemistry, 38, pp. 205 212 (1988).;;Sharifi, Behrooz G., et al., Cell Surface Interaction Is Sufficient for the Biological Activity of a Bovine Sialoglycopeptide Inhibitor, Biochemical and Biophysical Research Communications, 134, pp. 1350 1357 (1986).;;Sharifi, Behrooz G., et al., Purification and Characterization of a Bovine Cerebral Cortex Cell Surface Sialoglycopeptide that Inhibits Cell Proliferation and Metabolism, Journal of Neurochemistry, 46, pp. 461 469 (1986).;;Smalheiser, Neil R., et al., Laminin As a Substrate for Retinal Axons In Vitro, Dev. Brain Res., 12, pp. 136 140 (1984).;;SoloHill Labs, Inc., SoloHill Labs, Inc., Ann Arbor, MI.;;Stockdale, Frank E., et al., Myoblasts, Satellite Cells, and Myoblast Transfer, Myoblast Transfer Therapy (R. Griggs and G. Karpati, eds.), pp. 7 11 (1990).;;Sun, Anthony M., Microencapsulation of Pancreatic Islet Cells: A Bioartificial Endocrine Pancreas, Methods in Enzymology, 137, pp. 575 580 (1988).;;Tashiro, Ken ichiro, et al., A Synthetic Peptide Containing the IKVAV Sequence from the A Chain of Laminin Mediates Cell Attachment, Migration, and Neurite Outgrowth, The Journal of Biological Chemistry, 264, pp. 16174 16182 (1989).;;Telios Pharmaceuticals, Integrins: An Update on the Rapid Growth of Research Topics, in ECM Connections, a publication of Telios Pharmaceuticals, San Diego, CA (Jun. 1992).;;Telios Pharmaceuticals, PepTite 2000 (Product Information Memorandum), Telios Pharmaceuticals, San Diego, CA.",EXPIRED
410,WO,A3,WO 1996/002646 A3,003-990-612-464-071,1996-05-17,1996,US 9509281 W,1995-07-20,US 27977394 A;;US 43269895 A,1994-07-20,GROWTH CONTROL FOR CELLS ENCAPSULATED WITHIN BIOARTIFICIAL ORGANS,"This invention relates to methods and compositions of controlling cell distribution within a bioartificial organ by exposing the cells to a treatment that inhibits cell proliferation, promotes cell differentiation, or affects cell attachment to a growth surface within the bioartificial organ. Such treatments include (1) genetically manipulating cells, (2) exposing the cells to a proliferation-inhibiting compound or a differentiation-inducing compound or removing the cells from exposure to a proliferation-stimulating compound or a differentiation-inhibing compound; exposing the cells to irradiation, and (3) modifying a growth surface of the BAO with ECM molecules, molecules affecting cell proliferation or adhesion, or an inert scaffold, or a combination thereof. These treatments may be used in combination.",CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,,https://lens.org/003-990-612-464-071,Search Report,yes,6,0,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A61L27/00;;A61L27/18;;A01K67/027;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,1,1,048-332-719-530-735,7918336,"FARGHALI, H. ET AL.: ""The concept of application of immobilized and perfused mammalian cells (a bioreactor model) in biomedical research"", PHYSIOLOGICAL RESEARCH, vol. 43, no. 2, pages 117 - 120",PENDING
411,AU,A,AU 1998/084240 A,086-538-884-383-582,1998-11-05,1998,AU 1998/084240 A,1998-09-15,AU 1998/084240 A;;AU 1995/031422 A;;US 27977394 A;;US 43269895 A,1994-07-20,Growth control for cells encapsulated within bioartificial organs,,NEUROTECH USA INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,,https://lens.org/086-538-884-383-582,Patent Application,no,0,0,2,40,0,,A01K67/00;;C12N5/10,,0,0,,,,EXPIRED
412,FI,A0,FI 970217 A0,081-331-246-471-537,1997-01-17,1997,FI 970217 A,1997-01-17,US 27977394 A;;US 43269895 A;;US 9509281 W,1994-07-20,Keinotekoisiin biologisiin välineisiin kapseloitujen solujen kasvun säätely,,CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,,https://lens.org/081-331-246-471-537,Patent Application,no,0,0,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A01K67/027;;A61L27/00;;A61L27/18;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,PENDING
413,AU,B2,AU 708186 B2,071-356-803-952-199,1999-07-29,1999,AU 1998/084240 A,1998-09-15,AU 1998/084240 A;;AU 1995/031422 A;;US 27977394 A;;US 43269895 A,1994-07-20,Growth control for cells encapsulated within bioartificial organs,,CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,,https://lens.org/071-356-803-952-199,Granted Patent,no,0,0,2,40,0,,A01K67/00;;C12N5/10,,0,0,,,,EXPIRED
414,ZA,B,ZA 955721 B,104-026-235-081-631,1996-02-21,1996,ZA 955721 A,1995-07-10,US 27977394 A,1994-07-20,Methods and compositions of growth control for cells encapsulated within bioartificial organs,,CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,,https://lens.org/104-026-235-081-631,Granted Patent,no,0,0,5,40,0,A61L27/3839;;A61L27/3839;;A61K48/00;;A61K48/00;;A61L27/18;;A61L27/18;;A61L27/227;;A61L27/227;;A61L27/38;;C07K14/82;;C07K14/82;;C12N5/0012;;C12N5/0012;;C12N5/0068;;C12N5/0068;;C12N2510/00;;C12N2510/00;;C12N2510/04;;C12N2510/04;;C12N2533/30;;C12N2533/30;;C12N2533/54;;C12N2533/54;;C12N2533/74;;C12N2533/74,A01K67/027;;A61K48/00;;A61L27/00;;A61L27/18;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,EXPIRED
415,AU,B2,AU 698624 B2,139-214-825-685-96X,1998-11-05,1998,AU 1995/031422 A,1995-07-20,US 27977394 A;;US 43269895 A;;US 9509281 W,1994-07-20,Growth control for cells encapsulated within bioartificial organs,,CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,,https://lens.org/139-214-825-685-96X,Granted Patent,no,0,0,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A01K67/027;;A61K48/00;;A61L27/00;;A61L27/18;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,EXPIRED
416,IL,A0,IL 114671 A0,179-949-695-984-264,1995-11-27,1995,IL 11467195 A,1995-07-19,US 27977394 A;;US 43269895 A,1994-07-20,Methods for controlling distribution of cells within a bioartificial organ and bioartificial organs treated thereby,,CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,,https://lens.org/179-949-695-984-264,Patent Application,no,0,0,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A01K67/027;;A61L27/00;;A61L27/18;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,PENDING
417,EP,A1,EP 0771350 A1,158-421-142-696-417,1997-05-07,1997,EP 95927373 A,1995-07-20,US 9509281 W;;US 27977394 A;;US 43269895 A,1994-07-20,GROWTH CONTROL FOR CELLS ENCAPSULATED WITHIN BIOARTIFICIAL ORGANS,,CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,NEUROTECH S.A. (2004-08-18),https://lens.org/158-421-142-696-417,Patent Application,yes,0,0,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A61L27/00;;A61L27/18;;A01K67/027;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,DISCONTINUED
418,WO,A2,WO 1996/002646 A2,011-438-690-242-563,1996-02-01,1996,US 9509281 W,1995-07-20,US 27977394 A;;US 43269895 A,1994-07-20,GROWTH CONTROL FOR CELLS ENCAPSULATED WITHIN BIOARTIFICIAL ORGANS,"This invention relates to methods and compositions of controlling cell distribution within a bioartificial organ by exposing the cells to a treatment that inhibits cell proliferation, promotes cell differentiation, or affects cell attachment to a growth surface within the bioartificial organ. Such treatments include (1) genetically manipulating cells, (2) exposing the cells to a proliferation-inhibiting compound or a differentiation-inducing compound or removing the cells from exposure to a proliferation-stimulating compound or a differentiation-inhibing compound; exposing the cells to irradiation, and (3) modifying a growth surface of the BAO with ECM molecules, molecules affecting cell proliferation or adhesion, or an inert scaffold, or a combination thereof. These treatments may be used in combination.",CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,,https://lens.org/011-438-690-242-563,Patent Application,no,0,37,33,40,4,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A61L27/00;;A61L27/18;;A01K67/027;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,PENDING
419,HU,A,HU T77875 A,062-347-855-398-942,1998-09-28,1998,HU 9700181 A,1995-07-20,US 27977394 A;;US 43269895 A,1994-07-20,METHODS AND PREPARATIONS FOR GROWTH CONTROL OF CELLS ENCAPSULATED WITHIN BIOARTIFICIAL ORGANS,,CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,,https://lens.org/062-347-855-398-942,Unknown,no,0,0,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A61L27/00;;A61L27/18;;A01K67/027;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,DISCONTINUED
420,CZ,A3,CZ 16397 A3,183-926-999-744-393,1998-03-18,1998,CZ 16397 A,1995-07-20,US 27977394 A;;US 43269895 A,1994-07-20,METHOD OF CHECKING CELL DISTRIBUTION IN BIOARTIFICIAL ORGAN,,CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,,https://lens.org/183-926-999-744-393,Patent Application,no,0,0,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A61L27/00;;A61L27/18;;A01K67/027;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,PENDING
421,AU,A,AU 1995/031422 A,181-320-884-787-685,1996-02-16,1996,AU 1995/031422 A,1995-07-20,US 27977394 A;;US 43269895 A;;US 9509281 W,1994-07-20,Growth control for cells encapsulated within bioartificial organs,,CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,,https://lens.org/181-320-884-787-685,Patent Application,no,0,0,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A01K67/027;;A61K48/00;;A61L27/00;;A61L27/18;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,EXPIRED
422,CN,A,CN 1152938 A,014-107-218-008-063,1997-06-25,1997,CN 95194187 A,1995-07-20,US 27977394 A;;US 43269895 A,1994-07-20,Growth control for cells encapsulated within bioartificial organs,,CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,,https://lens.org/014-107-218-008-063,Patent Application,no,0,2,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A61L27/00;;A61L27/18;;A01K67/027;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,DISCONTINUED
423,US,A,US 5795790 A,118-738-045-388-716,1998-08-18,1998,US 44820195 A,1995-05-23,US 44820195 A;;US 43269895 A;;US 27977394 A,1994-07-20,Method for controlling proliferation and differentiation of cells encapsulated within bioartificial organs,"Methods and compositions are provided for controlling cell distribution within a bioartificial organ by exposing the cells to a treatment that inhibits cell proliferation, promotes cell differentiation, or affects cell attachment to a growth surface within the bioartificial organ. Such treatments include (1) genetically manipulating cells, (2) exposing the cells to a proliferation-inhibiting compound or a differentiation-inducing compound or removing the cells from exposure to a proliferation-stimulating compound or a differentiation-inhibiting compound; exposing the cells to irradiation, and (3) modifying a growth surface of the bioartificial organ with extracellular matrix molecules, molecules affecting cell proliferation or adhesion, or an inert scaffold, or a combination thereof. These treatments may be used in combination. In a preferred treatment, cells are exposed to and then removed from exposure to a proliferation-stimulating and differentiation inhibiting compound prior to encapsulation of the cells in a semipermeable biocompatible jacket to form a bioartificial organ. Upon in vivo implantation of the bioartificial organ in a host, cellular proliferation is inhibited and cellular differentiation is promoted.",CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,NEUROTECH S.A (1999-12-29);;NEUROTECH USA INC (2007-10-25),https://lens.org/118-738-045-388-716,Granted Patent,yes,38,123,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A61L27/00;;A61L27/18;;A61L27/22;;A01K67/027;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,435/382;;424/93.7;;435/177;;435/178;;435/180;;435/182,99,82,048-332-719-530-735;;040-300-209-001-975;;078-401-268-829-715;;015-052-284-383-698;;051-467-747-043-981;;018-070-477-790-693;;120-596-939-734-383;;115-103-293-214-469;;004-129-864-323-871;;054-678-244-582-843;;021-321-949-597-771;;172-770-692-257-323;;060-164-752-701-836;;010-938-147-585-497;;011-276-786-730-941;;032-759-232-461-426;;108-379-915-909-34X;;028-364-375-537-319;;154-365-488-022-138;;026-016-347-959-887;;045-017-646-829-568;;066-523-881-622-501;;061-578-853-469-745;;057-767-055-501-614;;023-675-605-776-929;;104-865-628-368-26X;;173-587-013-695-171;;156-440-241-544-217;;068-141-789-713-733;;098-101-997-046-906;;034-178-376-559-657;;099-990-907-377-728;;005-358-343-205-664;;045-328-856-518-264;;004-236-732-518-638;;094-551-917-544-749;;108-168-722-195-491;;034-044-806-170-454;;038-918-079-679-253;;115-971-724-193-517;;009-792-950-241-971;;014-745-525-337-47X;;050-399-486-711-487;;059-049-072-219-166;;092-223-656-604-882;;018-117-336-909-414;;131-750-072-875-475;;003-664-236-520-709;;066-203-355-190-646;;105-834-428-184-911;;035-723-436-595-236;;034-249-775-255-429;;095-350-135-301-860;;060-291-465-466-062;;081-174-387-421-852;;052-782-286-478-646;;002-286-494-363-396;;101-732-752-675-701;;049-042-021-517-724;;164-020-307-617-474;;044-088-273-450-791;;012-333-350-448-43X;;046-111-513-250-242;;100-153-598-267-351;;028-211-379-291-005;;067-322-389-377-685;;147-346-857-684-894;;065-678-110-707-195;;076-012-254-853-704;;093-553-709-303-10X;;030-854-629-603-00X;;086-874-830-084-387;;016-063-554-957-496;;092-531-628-495-425;;055-467-864-296-721;;056-234-682-167-995;;090-908-679-116-661;;044-320-745-895-128;;001-928-366-548-586;;165-524-038-085-953;;008-119-464-657-166;;026-843-338-695-356,7918336;;8406030;;10.1016/0378-1119(93)90507-y;;2194673;;10.1016/0092-8674(90)90239-b;;10.1007/bf02623638;;2666386;;pmc386305;;10.1073/pnas.83.15.5454;;2874553;;10.1126/science.8016653;;8016653;;10.1159/000112252;;3021428;;10.1016/0168-9525(93)90012-7;;8379006;;10.1002/bip.360260018;;2437977;;pmc6577554;;10.1523/jneurosci.14-03-01030.1994;;8120611;;10.1073/pnas.82.13.4438;;pmc391116;;3892534;;10.1007/978-1-349-11358-3_15;;10.1016/0896-6273(88)90184-5;;3078410;;10.1089/hum.1993.4.4-433;;8399490;;8190271;;10.1016/0306-4522(94)90097-3;;8440318;;10.1006/excr.1993.1026;;pmc1886816;;8456938;;8476199;;2475934;;10.1016/0166-2236(89)90020-9;;8242752;;10.1016/0092-8674(93)90500-p;;10.1016/b978-0-12-483365-4.50008-6;;1504017;;10.1016/0014-4827(91)90130-m;;1901795;;10.1002/jcp.1041390208;;2715187;;10.1016/s0344-0338(11)80845-9;;8183742;;10.1007/bf02592286;;7686057;;3749886;;10.1126/science.3749886;;8352534;;10.1016/0014-4827(92)90083-k;;1383013;;10.1021/bi00396a004;;2962631;;10.1016/0092-8674(87)90707-0;;2951015;;8016642;;10.1126/science.8016642;;10.1016/0896-6273(93)90068-3;;8398146;;10.1006/ncmn.1993.1052;;10.1016/0378-1119(93)90424-2;;8359690;;8318227;;10.1016/0896-6273(93)90051-r;;10.1111/j.1749-6632.1992.tb42589.x;;1416607;;pmc363533;;10.1128/mcb.8.8.3065-3079.1988;;10.1128/mcb.8.8.3065;;2974922;;1797805;;10.1002/jbm.820251102;;10.1126/science.2961059;;2961059;;2735903;;10.1016/0006-291x(89)92622-3;;10.1002/jnr.490280407;;1870155;;10.1016/0014-4827(91)90391-7;;2070822;;6308472;;10.1038/304596a0;;8517665;;6776628;;10.1126/science.6776628;;8338876;;10.1089/hum.1993.4.3-291;;10.1016/0003-2697(90)90459-m;;2382830;;10.1097/00002480-198907000-00165;;2597562;;1612781;;10.1002/ijc.2910510511;;6241504;;10.1247/csf.9.357;;10.1523/jneurosci.14-06-03533.1994;;7515952;;pmc6576935;;482611;;10.2307/3575179;;2489072;;10.1016/0141-8130(89)90049-4;;8393300;;10.1152/ajplung.1993.265.1.l1;;10.1172/jci116723;;pmc288291;;8104197;;8514795;;10.1016/s0021-9258(19)38695-8;;3422482;;10.1073/pnas.85.4.1105;;pmc279714;;10.1016/0003-9861(92)90533-3;;1586167;;6325925;;10.1038/309030a0;;10.1523/jneurosci.12-05-01802.1992;;1578271;;pmc6575890;;8331297;;10.1111/1523-1747.ep12359508;;10.1128/mcb.13.7.4223;;10.1128/mcb.13.7.4223-4232.1993;;pmc359972;;8391634;;10.1073/pnas.90.8.3602;;pmc46349;;8475109;;1432110;;10.1523/jneurosci.12-11-04565.1992;;pmc6575989;;10.1073/pnas.89.18.8591;;pmc49966;;1528866;;8134335;;10.1073/pnas.91.6.1985;;pmc43292;;10.1126/science.2821619;;2821619;;8187171;;10.1016/0092-8674(94)90209-7;;2803948;;pmc2247318;;10.1038/bjc.1989.347;;10.1146/annurev.ne.12.030189.002423;;2648958;;8417470;;10.1128/jvi.61.8.2567-2572.1987;;pmc255700;;3037117;;pmc250578;;10.1128/jvi.62.2.619-621.1988;;3121865;;2844896;;10.1002/jcb.240380308;;3147985;;10.1016/0006-291x(86)90398-0;;3947369;;2416876;;10.1111/j.1471-4159.1986.tb12990.x;;6697250;;2248157;;10.1007/978-1-4684-5865-7_2;;10.1016/0076-6879(88)37053-9;;3131633;;2777785;;10.1016/s0021-9258(18)71604-9,"Farghali et al., The concept of Application of Immobilized and Perfused Mammalian cells (a bioreactor model) in biomedical research, Physiological Research, 43, pp. 117 120 (1994).;;Adhya, Sankar, et al., Promoter resurrection by activators a minireview, Gene, 132. pp. 1 6 (1993).;;Arnheiter, Heinz, et al., Transgenic Mice with Intracellular Immunity to Influenza Virus, Cell, 62, pp. 51 61 (1990).;;Aulthouse, Amy Lynn, et al., Expression of the Human Chondrocyte Phenotype In Vitro, In Vitro Cellular & Developmental Biology, 25, pp. 659 668 (1989).;;Baetge, E. Edward, et al., Complete Nucleotide and Deduced Amino Acid Sequence of Bovine Phenylethanolamine N methyltransferase: Partial Amino Acid Homology With Rat Tyrosine Hydroxylase, Proc. Natl. Acad. Sci. USA, 83, pp. 5454 5458 (1986).;;Barinaga, Marcia, Knockout Mice: Round Two, Science, 265, pp. 26 28 (1994).;;Baron Van Evercooren, A., et al., Schwann Cell Differentiation in vitro: Extracellular Matrix Deposition and Interaction, Dev. Neurosci., 8, pp. 182 196 (1986).;;Blau, Helen M., et al., Myoblasts in Pattern Formation and Gene Therapy, Trends in Genetics, 9, pp. 269 274 (1993).;;Bohak, Z., et al. Novel Anchorage Matrices for Suspension Culture of Mammalian Cells, Biopolymers, 26, pp. S205 S213 (1987).;;Brenner, Michael, et al., GFAP Promoter Directs Astrocyte specific Expression in Transgenic Mice, The Journal of Neuroscience, 14, pp. 1030 1037 (1994).;;Brinster et al., Factors Affecting the Efficiency of Introducing Foreign DNA into Mice by Microinjecting Eggs, Proc. Natl. Acad. Sci. USA, 82, pp. 4438 4442 (1985).;;Cabasso, Israel, Hollow Fiber Membranes, Encyclopedia of Chemical Technology (Kirk Othmer, ed.), pp. 492 517 (1980).;;Carbonetto, Salvatore, Ch. 15: Laminin Receptors: From PC12 Cells to PNS, Brain Repair (Bj o rklund, Aguayo and Ottoson, eds.), pp. 185 197 (1990).;;Celtrix Laboratories, Vitrogen 100 : Purified Collagen for Cell Culture and Biochemistry (Product Information Memorandum), Celtrix Laboratories, Palo Alto, CA (1991).;;Cepko, Connie, Retrovirus Vectors and Their Applications in Neurobiology, Neuron, 1, 345 53 (1988).;;Chang, P.L., et al., Delivery of Recombinant Gene Products with Microencapsulated Cells in Vivo, Human Gene Therapy, 4, pp. 433 440 (1993).;;Chu, C.H., and A.M. Tolkovsky, Alternative Adrenal Chromaffin Cell Fates Induced by Basic Fibroblast Growth Factor or Cyclic AMP In Vitro Depend on a Collaboration With The Growth Substrate, Neuroscience, 59, pp. 43 54 (1994).;;Collaborative Research Incorporated, CR LAMININ and CR ANTI LAMININ (Product Information Memorandum), Collaborative Research, Inc., Bedford, MA (1987).;;Collaborative Research Incorporated, Basement Membrane Matrigel (Product Specification Sheet), Collaborative Research, Inc., Bedford, MA (1991).;;Collagen Biomedical, Collagen Test Implant Physician Package Insert, (Product Information Literature), Collagen Biomedical, Palo Alto, CA (1992).;;Collagen Biomedical, Zyderm Collagen and Zyderm Explained, (Product Information Memorandum). Collagen Biomedical, Palo Alto, CA (1992).;;Collagen Biomedical, Zyderm Collagen Implant Physician Package Insert, (Product Literature), Collagen Biomedical, Palo Alto, CA (1992).;;Collagen Biomedical, Zyplast Implant Physician Package Insert, (Product Literature), Collagen Biomedical, Palo Alto, CA (1992).;;Crouch, Gary D., et al., Ara C Treatment Leads to Differentiation and Reverses the Transformed Phenotype in a Human Rhabdomyosarcoma Cell Line, Experimental Cell Research, 204, pp. 210 216 (1993).;;Datta, Dipak B., Keeping In Touch: The Adhesion Reactions of the Cell Membrane, A Comprehensive Introduction to Membrane Biochemistry, pp. 231 256 (1987).;;de Bruine, Adriaan P., et al., Extracellular Matrix Components Induce Endocrine Differentiation in Vitro in NCI H716 Cells, American Journal of Pathology, 142, pp. 773 782 (1993).;;De Loecker, William, et al., Effects of Sodium Ascorbate (Vitamin C) and 2 Methyl 1,4 naphthoquinone (Vitamin K 3 ) Treatment on Human Tumor Cell Growth in Vitro. II. Synergism with Combined Chemotherapy Action, Anticancer Research, 13, pp. 103 106 (1993).;;Edgar, David, Neuronal laminin receptors, TINS, 12, pp. 248 251 (1989).;;El Deiry, Wafik S., et al., WAF1, a Potential Mediator of p53 Tumor Suppression, Cell, 75, pp. 817 825 (1993).;;End, Peter, and Jurgen Engel, Multidomain Proteins of the Extracellular Matrix and Cellular Growth, Receptors for Extracellular Matrix (McDonald, J. and Mecham, R., ed.), pp. 79 129 (1991).;;Epstein Baak, Ruth, et al., Inducible Transformation of Cells from Transgenic Mice Expressing SV40 under lac Operon Control, Cell Growth and Differentiation, 3, pp. 127 134 (1992).;;Fattaey, H.K., et al., Modulation of Growth Related Gene Expression and Cell Cycle Synchronization by a Sialoglycopeptide Inhibitor, Experimental Cell Research, 194, pp. 62 68 (1991).;;Fattaey, Heideh. et al., Inhibition of DNA Synthesis and Cell Division by a Cell Surface Sialoglycopeptide, Journal of Cellular Physiology, 139, pp. 269 274 (1989).;;Fujiyama, C., et al., Influence of Extracellular Matrix on the Proliferation and Differentiation of Adrenocortical Cells in Culture, Path. Res. Pract., 189, pp. 1205 1214 (1993).;;Galli, Maria C., et al., The Biology of Stem Cell Factor, a New Hematopoietic Growth Factor Involved in Stem Cell Regulation, Int. J. of Clin. Lab. Res., 23, pp. 70 77 (1993).;;Gash, D.M., et al., Amitotic Neuroblastoma Cells Used for Neural Implants in Monkeys, Science, 233, pp. 1420 1422 (1986).;;Gonos, Efstathios S., and Demetrios A. Spandidos, Oncogenes in Cellular Immortalisation and Differentiation (Review), Anticancer Research, 13, pp. 1117 1122 (1993).;;Grabham, Peter W., et al., Vibronectin Is the Major Serum Protein Essential for NGF Mediated Neurite Outgrowth from PC12 Cells, Experimental Cell Research, 202, pp. 337 344 (1992).;;Graf, Jeannette. et al., A Pentapeptide from the Laminin 1 Chain Mediates Cell Adhesion and Binds the 67 000 Laminin Receptor, Biochemistry, 26, pp. 6896 6900 (1987).;;Graf, Jeannette, et al., Identification of an Amino Acid Sequence in Laminin Mediating Cell Attachment, Chemotaxis, and Receptor Binding, Cell, 48, pp. 989 996 (1987).;;Gu, Hua, et al., Deletion of a DNA Polymerase Gene Segment in T Cells Using Cell Type specific Gene Targeting, Science, 265, pp. 103 106 (1994).;;Gumbiner, Barry M., Proteins Associated with the Cytoplasmic Surface of Adhesion Molecules, Neuron, 11, pp. 551 564 (1993).;;Hammang, Joseph P., et al., Immortalized Neuronal and Neuroendocrine Cell Lines by Targeted Oncogenesis in Transgenic Mice Using the PNMT Promoter, Neuroprotocols: A Companion to Methods in Neurosciences, 3, pp. 176 183 (1993).;;Hannan, G.N., et al., An engineered PGK promoter and lac operator repressor system for the regulation of gene expression in mammalian cells, Gene, 130, pp. 233 239 (1993).;;Hoyle, Gary W., et al., Expression of NGF in Sympathetic Neurons Leads to Excessive Axon Outgrowth from Ganglia but Decreased Terminal Innervation within Tissues, Neuron, 10, pp. 1019 1034 (1993).;;Hubbell, Jeffrey A., et al., Surface grafted Cell binding Peptides in Tissue Engineering of the Vascular Graft, Annals New York Academy of Sciences, 665, pp. 253 258 (1992).;;Hug, Hubert, et al., Organization of the Murine Mx Gene and Characterization of Its Interferon and Virus inducible Promoter, Molecular and Cellular Biology, 8, pp. 3065 3079 (1988).;;HyClone Laboratories, CultiSpher G (Product Information Memorandum), HyClone Laboratories, Logan, UT (no date).;;HyClone Laboratories, CultiSpher GL (Product Information Memorandum), HyClone Laboratories, Logan, UT (no date).;;Ito, Yoshihiro, et al., Materials for Enhancing Cell Adhesion By Immobilization of Cell Adhesive Peptide, Journal of Biomedical Materials Research, 25, pp. 1325 1337 (1991).;;Iwamoto, Yukihide, et al., YIGSR, a Synthetic Laminin Pentapeptide, Inhibits Experimental Metastasis Formation, Science, 238, pp. 1132 1134 (1987).;;Johnson, Terry C., and Behrooz G. Sharifi, Abrogation of the Mitogenic Activity of Bombesin by a Cell Surface Sialoglycopeptide Growth Inhibitor, Biochemical and Biophysical Research Communications, 161, pp. 468 474 (1989).;;Jucker, M., et al., Fetal Rats Septal Cells Adhere to and Extend Processes on Basement Membrane, Laminin, and a Synthetic Peptide the Laminin A Chain Sequence, J. Neurosci. Res., 28, 507 517 (1991).;;Kleinman, Hynda K., et al., The Role of Laminin in Basement Membranes and in the Growth, Adhesion, and Differentiation of Cells, The Role of Extracellular Matrix in Development, pp. 123 143 (1984).;;Kleinman, Hynda K., and Benjamin S. Weeks, The Neural Cell Response to Laminin: Active Sites, Receptors, and Intracellular Signals, Comments Developmental Neurobiology, 1. pp. 251 266 (1991).;;Lakshmanarao, S.S., et al., Identification of a Cell Surface Component of Swiss 3T3 Cells Associated with an Inhibition of Cell Division, Experimental Cell Research, 195, pp. 412 415 (1991).;;Land, Hartmut, et al., Tumorigenic Conversion of Primary Embryo Fibroblasts Requires At Least Two Cooperating Oncogenes, Nature, 304, pp. 596 602 (1983).;;Leung, Ping. Y., et al., Cytotoxic Effect of Ascorbate and its Derivatives on Cultured Malignant and Nonmalignant Cell Lines, Anticancer Research, 13, pp. 475 480 (1993).;;Lim, F., et al., Microencapsulated Islets as Bioartificial Endocrine Pancreas, Science, 210, pp. 908 910 (1980).;;Liu, Hong Wen, et al., Expression of Human Factor IX by Microencapsulated Recombinant Fibroblasts, Human Gene Therapy, 4, pp. 291 301 (1993).;;Massia, Stephen P., and Jeffrey A. Hubbell, Covalent Surface Immobilization of Arg Gly Asp and Try lle Gly Ser Arg Containing Peptides to Obtain Well Defined Cell Adhesive Substrates, Analytical Biochemistry, 187, pp. 292 301 (1990).;;Matsuda, Takehisa, et al., Development of a Novel Artificial Matrix with Cell Adhesion Peptides for Cell Culture and Artificial and Hybrid Organs, Trans. Am. Soc. Artif. Intern. Organs, 35, pp. 677 679 (1989).;;Matsushima, Hiroshi, and Emil Bogenmann, Modulation of Neuroblastoma Cell Differentiation by the Extracellular Matrix, Int. J. Cancer, 51, pp. 727 732 (1992).;;Matuoka et al., Heparan Sulfate Enhances Growth of Transformed Human Cells, Cell Structure and Function, 9, p. 357 (1984).;;Messing, Albee, et al., Hypomyelinating Peripheral Neuropathies and Schwannomas in Transgenic Mice Expressing SV40 T Antigen, The Journal of Neuroscience, 14, pp. 3533 3539 (1994).;;Mitchell, J.B., et al. Dose Rate Effects in Mammalian Cells in Culture, Radiat. Res., 79, pp. 537 551 (1979).;;Murata, Jun, et al., Inhibitory Effect of a Synthetic Polypeptide, Poly(Tyr lle Gly Ser Arg), On the Metastatic Formation of Malignant Tumour Cells, Int. J. Biol. Macromol., 11, pp. 97 99 (1989).;;Neckers, Len, and Luke Whitesell, Antisense Technology: Biological Utility and Practical Considerations, Am. J. Physiol., 265, pp. L1 L12 (1993).;;Otonkoski, Timo, et al., Nicotinamide Is a Potent Inducer of Endocrine Differentiation in Cultured Human Fetal Pancreatic Cells, J. Clin. Invest., 92, pp. 1459 1466 (1993).;;Pash, James M., et al., Aberrant Expression of High Mobility Group Chromosomal Protein 14 Affects Cellular Differentiation, The Journal of Biological Chemistry, 268, pp. 13632 13638 (1993).;;Penttinen, Risto P., et al., Transforming Growth Factor Increases mRNA for Matrix Proteins Both in the Presence and in the Absence of Changes in mRNA Stability, Proc. Natl. Acad. Sci. USA, 85, pp. 1105 1108 (1988).;;Phillips, Charlotte L., et al., Ascorbic Acid and Transforming Growth Factor 1 Increase Collagen Biosynthesis via Different Mechanisms: Coordinate Regulation of Pro 1(1) and Pro 1 (III) Collagens, Archives of Biochemistrv and Biophysics, 295, pp. 397 403 (1992).;;Pierschbacher, Michael D., and Erkki Ruoslatiti, Cell Attachment Activity of Fibronectin Can Be Duplicated By Small Synthetic Fragments of the Molecule, Science, 309, pp. 30 33 (1984).;;Pleasure, Samuel, et al., Pure, Postmitotic, Polarized Human Neurons Derived from NTera 2 Cells Provide a System for Expressing Exogenous Proteins in Terminally Differentiated Neurons, The Journal of Neuroscience, 12, pp. 1802 1815 (1992).;;Prystowsky et al., Inhibition of Ornithine Decarboxylase Activity and Cell Proliferation by Ultraviolet Radiation in EGF Stimulated Cultured Human Epidermal Keratinocytes, J. Invest. Dermat., 101, pp. 54 58 (1993).;;Radvanyi, Francois, et al., Pancreatic Cells Cultured from Individual Preneoplastic Foci in a Multistage Tumorigenesis Pathway: a Potentially General Technique for Isolating Physiologically Representative Cell Lines, Molecular and Cellular Biology, 13, pp. 4223 4232 (1993).;;Ray, Jasodhara, et al., Proliferation, Differentiation, and Long Term Culture of Primary Hippocampal Neurons, Proc. Natl. Acad. Sci. USA, 90, pp. 3602 3606 (1993).;;Reemay, Inc., Reemay Spunbonded Polyester, pp. 1 20 (Product Information Literature), Reemay, Inc., Old Hickory, TN.;;Reynolds, Brent A., et al., A Multipotent EGF Responsive Striatal Embryonic Progenitor Cell Produces Neurons and Astrocytes, The Journal of Neuroscience, 12, pp. 4565 4574 (1992).;;Richards, L.J. et al., De novo Generation of Neuronal Cells From The Adult Mouse Brain, Proc. Natl. Acad. Sci. USA, 89, pp. 8591 8595 (1992).;;Ron, David, Inducible Growth Arrest: New Mechanistic Insights, Proc, Natl. Acad, Sci, USA, 91, pp. 1985 1986 (1994).;;Ruoslahti, Erkki, and Michael D. Pierschbacher, New Perspectives in Cell Adhesion: RGD and Integrins, Science, 238, pp. 491 497 (1987).;;Ruoslahti, Erkki, and John C. Reed, Anchorage Dependence, Integrins, and Apoptosis, Cell, 77, pp. 477 478 (1994).;;Saiki, I., et al., Antimetastatic Effects of Synthetic Polypeptides Containing Repeated Structures of the Cell Adhesive Arg Gly Asp (RGD) and Tyr lle Gly Ser Arg (YIGSR) Sequences, Br. J. Cancer, 60, pp. 722 728 (1989).;;Sanes, Joshua R., Extracellular Matrix Molecules That Influence Neural Development, Ann. Rev. Neurosci., 12, pp. 491 516 (1989).;;Schinstine, Malcolm, and Fred H. Gage, Factors Affecting Proviral Expression in Primary Cells Grafted into the CNS, Molecular and Cellular Approaches for the Treatment of Neurological Diseases (S.G. Waxman, ed.), pp. 311 323 (1993).;;Seliger, Barbara, et al., Murine Gamma Interferon Inhibits v mos lnduced Fibroblast Transformation via Down Regulation of Retroviral Gene Expression, Journal of Virology, 61, pp. 2567 2572 (1987).;;Seliger, Barbara, et al., Gamma Interferon Regulates Long Terminal Repeat Controlled Oncogene Expression in Transformed Mouse Fibroblasts at the Level of mRNA Transcription, Journal of Virology, 62, pp. 619 621 (1988).;;Seliger, Barbara, et al., Tumor Necrosis Factor Affects LTR Controlled Oncogene Expression in Transformed Mouse Fibroblasts at the Post Transcriptional Level, The Journal of Immunology, 141, pp. 2138 2144 (1988).;;Seliger, Barbara. et al., Distinct Mechanisms of Interferon Gamma and Tumor Necrosis Factor Alpha Action in Oncogene Transformed Mouse Fibroblasts, Journal of Cellular Biochemistry 38, pp. 205 212 (1988).;;Sharifi, Behrooz G., et al., Cell Surface Interaction is Sufficient for the Biological Activity of a Bovine Sialoglycopeptide Inhibitor, Biochemical and Biophysical Research Communications, 134, pp. 1350 1357 (1986).;;Sharifi, Behrooz G., et al., Purification and Characterization of a Bovine Cerebral Cortex Cell Surface Sialoglycopeptide that Inhibits Cell Proliferation and Metabolism, Journal of Neurochemistry, 46, pp. 461 469 (1986).;;Smalheiser, Neil R., et al., Laminin As a Substrate for Retinal Axons In Vitro, Dev. Brain Res., 12, pp. 136 140 (1984).;;SoloHill Labs. Inc., SoloHill Labs, Inc., Ann Arbor, MI.;;Stockdale, Frank E., et al., Myoblasts, Satellite Cells, and Myoblast Transfer, Myoblast Transfer Therapy (R. Griggs and G. Karpati, eds.), pp. 7 11 (1990).;;Sun, Anthony M., Microencapsulation of Pancreatic Islet Cells: A Bioartificial Endocrine Pancreas, Methods in Enzymology, 137, pp. 575 580 (1988).;;Tashiro, Ken ichiro, et al., A Synthetic Peptide Containing the IKVAV Sequence from the A Chain of Laminin Mediates Cell Attachment, Migration, and Neurite Outgrowth, The Journal of Biological Chemistry, 264, pp. 16174 16182 (1989).;;Telios Pharmaceuticals, Integrins: An Update on the Rapid Growth of Research Topics, in ECM Connections, a publication of Telios Pharmaceuticals, San Diego, CA (Jun. 1992).;;Telios Pharmaceuticals, PepTite 2000 (Product Information Memorandum), Telios Pharmaceuticals, San Diego, CA.",EXPIRED
424,NO,D0,NO 970156 D0,146-783-166-890-612,1997-01-14,1997,NO 970156 A,1997-01-14,US 43269895 A;;US 9509281 W;;US 27977394 A,1994-07-20,Fremgangsmåte ved inhibering av vekst av celler innkapslet i kunstige organer,,CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,,https://lens.org/146-783-166-890-612,Patent Application,no,0,0,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A01K67/027;;A61L27/00;;A61L27/18;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,DISCONTINUED
425,PL,A1,PL 318288 A1,015-112-755-312-389,1997-06-09,1997,PL 31828895 A,1995-07-20,US 27977394 A;;US 43269895 A,1994-07-20,CELL GROWTH CONTROL IN RESPECT TO CELLS ENCAPSULATED IN ARTIFICIAL BODY ORGANS,,CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,,https://lens.org/015-112-755-312-389,Patent Application,no,0,0,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A61L27/00;;A61L27/18;;A01K67/027;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,PENDING
426,US,A,US 5833979 A,020-011-315-454-808,1998-11-10,1998,US 44777195 A,1995-05-23,US 44777195 A;;US 43269895 A;;US 27977394 A,1994-07-20,Methods and compositions of growth control for cells encapsulated within bioartificial organs,"This invention relates to methods and compositions of controlling cell distribution within a bioartificial organ by exposing the cells to a treatment that inhibits cell proliferation, promotes cell differentiation, or affects cell attachment to a growth surface within the bioartificial organ. Such treatments include (1) genetically manipulating cells, (2) exposing the cells to a proliferation-inhibiting compound or a differentiation-inducing compound or removing the cells from exposure to a proliferation-stimulating compound or a differentiation-inhibiting compound; exposing the cells to irradiation, and (3) modifying a growth surface of the BAO with ECM molecules, molecules affecting cell proliferation or adhesion, or an inert scaffold, or a combination thereof. These treatments may be used in combination.",CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,NEUROTECH S.A (1999-12-29);;NEUROTECH USA INC (2007-10-25),https://lens.org/020-011-315-454-808,Granted Patent,yes,37,49,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A01K67/027;;A61L27/00;;A61L27/18;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,424/93.21;;424/553;;424/556;;435/174;;435/352,99,81,040-300-209-001-975;;078-401-268-829-715;;015-052-284-383-698;;051-467-747-043-981;;018-070-477-790-693;;120-596-939-734-383;;115-103-293-214-469;;004-129-864-323-871;;054-678-244-582-843;;021-321-949-597-771;;172-770-692-257-323;;060-164-752-701-836;;010-938-147-585-497;;011-276-786-730-941;;032-759-232-461-426;;108-379-915-909-34X;;028-364-375-537-319;;154-365-488-022-138;;026-016-347-959-887;;045-017-646-829-568;;066-523-881-622-501;;061-578-853-469-745;;057-767-055-501-614;;023-675-605-776-929;;104-865-628-368-26X;;173-587-013-695-171;;156-440-241-544-217;;068-141-789-713-733;;098-101-997-046-906;;034-178-376-559-657;;099-990-907-377-728;;005-358-343-205-664;;045-328-856-518-264;;004-236-732-518-638;;094-551-917-544-749;;108-168-722-195-491;;034-044-806-170-454;;038-918-079-679-253;;115-971-724-193-517;;009-792-950-241-971;;014-745-525-337-47X;;050-399-486-711-487;;059-049-072-219-166;;092-223-656-604-882;;018-117-336-909-414;;131-750-072-875-475;;003-664-236-520-709;;066-203-355-190-646;;105-834-428-184-911;;035-723-436-595-236;;034-249-775-255-429;;095-350-135-301-860;;060-291-465-466-062;;081-174-387-421-852;;052-782-286-478-646;;002-286-494-363-396;;101-732-752-675-701;;049-042-021-517-724;;164-020-307-617-474;;044-088-273-450-791;;012-333-350-448-43X;;046-111-513-250-242;;100-153-598-267-351;;028-211-379-291-005;;067-322-389-377-685;;147-346-857-684-894;;065-678-110-707-195;;076-012-254-853-704;;093-553-709-303-10X;;030-854-629-603-00X;;086-874-830-084-387;;016-063-554-957-496;;092-531-628-495-425;;055-467-864-296-721;;056-234-682-167-995;;090-908-679-116-661;;044-320-745-895-128;;001-928-366-548-586;;008-119-464-657-166;;026-843-338-695-356;;084-502-628-664-10X,8406030;;10.1016/0378-1119(93)90507-y;;2194673;;10.1016/0092-8674(90)90239-b;;10.1007/bf02623638;;2666386;;pmc386305;;10.1073/pnas.83.15.5454;;2874553;;10.1126/science.8016653;;8016653;;10.1159/000112252;;3021428;;10.1016/0168-9525(93)90012-7;;8379006;;10.1002/bip.360260018;;2437977;;pmc6577554;;10.1523/jneurosci.14-03-01030.1994;;8120611;;10.1073/pnas.82.13.4438;;pmc391116;;3892534;;10.1007/978-1-349-11358-3_15;;10.1016/0896-6273(88)90184-5;;3078410;;10.1089/hum.1993.4.4-433;;8399490;;8190271;;10.1016/0306-4522(94)90097-3;;8440318;;10.1006/excr.1993.1026;;pmc1886816;;8456938;;8476199;;2475934;;10.1016/0166-2236(89)90020-9;;8242752;;10.1016/0092-8674(93)90500-p;;10.1016/b978-0-12-483365-4.50008-6;;1504017;;10.1016/0014-4827(91)90130-m;;1901795;;10.1002/jcp.1041390208;;2715187;;10.1016/s0344-0338(11)80845-9;;8183742;;10.1007/bf02592286;;7686057;;3749886;;10.1126/science.3749886;;8352534;;10.1016/0014-4827(92)90083-k;;1383013;;10.1021/bi00396a004;;2962631;;10.1016/0092-8674(87)90707-0;;2951015;;8016642;;10.1126/science.8016642;;10.1016/0896-6273(93)90068-3;;8398146;;10.1006/ncmn.1993.1052;;10.1016/0378-1119(93)90424-2;;8359690;;8318227;;10.1016/0896-6273(93)90051-r;;10.1111/j.1749-6632.1992.tb42589.x;;1416607;;pmc363533;;10.1128/mcb.8.8.3065-3079.1988;;10.1128/mcb.8.8.3065;;2974922;;1797805;;10.1002/jbm.820251102;;10.1126/science.2961059;;2961059;;2735903;;10.1016/0006-291x(89)92622-3;;10.1002/jnr.490280407;;1870155;;10.1016/0014-4827(91)90391-7;;2070822;;6308472;;10.1038/304596a0;;8517665;;6776628;;10.1126/science.6776628;;8338876;;10.1089/hum.1993.4.3-291;;10.1016/0003-2697(90)90459-m;;2382830;;10.1097/00002480-198907000-00165;;2597562;;1612781;;10.1002/ijc.2910510511;;6241504;;10.1247/csf.9.357;;10.1523/jneurosci.14-06-03533.1994;;7515952;;pmc6576935;;482611;;10.2307/3575179;;2489072;;10.1016/0141-8130(89)90049-4;;8393300;;10.1152/ajplung.1993.265.1.l1;;10.1172/jci116723;;pmc288291;;8104197;;8514795;;10.1016/s0021-9258(19)38695-8;;3422482;;10.1073/pnas.85.4.1105;;pmc279714;;10.1016/0003-9861(92)90533-3;;1586167;;6325925;;10.1038/309030a0;;10.1523/jneurosci.12-05-01802.1992;;1578271;;pmc6575890;;8331297;;10.1111/1523-1747.ep12359508;;10.1128/mcb.13.7.4223;;10.1128/mcb.13.7.4223-4232.1993;;pmc359972;;8391634;;10.1073/pnas.90.8.3602;;pmc46349;;8475109;;1432110;;10.1523/jneurosci.12-11-04565.1992;;pmc6575989;;10.1073/pnas.89.18.8591;;pmc49966;;1528866;;8134335;;10.1073/pnas.91.6.1985;;pmc43292;;10.1126/science.2821619;;2821619;;8187171;;10.1016/0092-8674(94)90209-7;;2803948;;pmc2247318;;10.1038/bjc.1989.347;;10.1146/annurev.ne.12.030189.002423;;2648958;;8417470;;10.1128/jvi.61.8.2567-2572.1987;;pmc255700;;3037117;;pmc250578;;10.1128/jvi.62.2.619-621.1988;;3121865;;2844896;;10.1002/jcb.240380308;;3147985;;10.1016/0006-291x(86)90398-0;;3947369;;2416876;;10.1111/j.1471-4159.1986.tb12990.x;;6697250;;10.1016/0076-6879(88)37053-9;;3131633;;2777785;;10.1016/s0021-9258(18)71604-9;;2755510;;10.1038/340471a0,"Adhya, Sankar, et al., Promoter resurrection by activators a minireview, Gene, 132, pp. 1 6 (1993).;;Arnheiter, Heinz, et al., Transgenic Mice with Intracellular Immunity to Influenza Virus, Cell, 62, pp. 51 61 (1990).;;Aulthouse, Amy Lynn, et al., Expression of the Human Chondrocyte Phenotype In Vitro, In Vitro Cellular & Development Biology, 25, pp. 659 668 (1989).;;Baetge, E. Edward, et al., Complete Nucleotide and Deduced Amino Acid Sequence of Bovine Phenylethanolamine N methyltransferase: Partial Amino Acid Homology With Rat Tyrosine Hydroxylase, Proc. Natl. Acad. Sci. USA, 83, pp. 5454 5458 (1986).;;Barinaga, Marcia, Knockout Mice: Round Two, Science, 265, pp. 26 28 (1994).;;Baron Van Evercooren, A., et al., Schwann Cell Differentiation in vitro: Extracellular Matrix Deposition and Interaction, Dev. Neurosci., 8, pp. 182 196 (1986).;;Blau, Helen M., et al., Myoblasts in Pattern Formation and Gene Therapy, Trends in Genetics, 9, pp. 269 274 (1993).;;Bohak, Z., et al. Novel Anchorage Matrices for Suspension Culture of Mammalian Cells, Biopolymers, 26, pp. S205 S213 (1987).;;Brenner, Michael, et al., GFAP Promoter Directs Astrocyte specific Expression in Transgenic Mice, The Journal of Neuroscience, 14, pp. 1030 1037 (1994).;;Brinster et al., Factors Affecting the Efficiency of Introducing Foreign DNA into Mice by Microinjecting Eggs, Proc. Natl. Acad. Sci. USA, 82, pp. 4438 4442 (1985).;;Cabasso, Israel, Hollow Fiber Membranes, Encyclopedia of Chemical Technology (Kirk Othmer, ed.), pp. 492 517 (1980).;;Carbonetto, Salvatore, Ch. 15: Laminin Receptors: From PC12 Cells to PNS, Brain Repair (Bj o rklund, Aguayo and Ottoson, eds.), pp. 185 197 (1990).;;Celtrix Laboratories, Vitrogen 100 : Purified Collagen for Cell Culture and Biochemistry (Product Information Memorandum), Celtrix Laboratories, Palo Alto, CA (1991).;;Cepko, Connie, Retrovirus Vectors and Their Applications in Neurobiology, Neuron, 1, 345 353 (1988).;;Chang, P.L., et al., Delivery of Recombinant Gene Products with Microencapsuled Cells In Vivo, Human Gene Therapy, 4, pp. 433 440 (1993).;;Chu, C.H., and A.M. Tolkovsky, Alternative Adrenal Chromaffin Cells Fates Induced by Basic Fibroblasts Growth Factor on Cyclic AMP In Vitro Depend on a Collaboration With The Growth Substrate, Neuroscience, 59, pp. 43 54 (1994).;;Collaborative Research Incorporated, CR Laminin and CR Anti Laminin (Product Information Memorandum), Collarborative Research, Inc., Bedford, MA (1987).;;Collaborative Research Incorporated, Basement Membrane Matriegel (Product Specification Sheet), Collaborative Research, Inc., Bedford, MA (1991).;;Collagen Biomedical, Collagen Test Implant Physician Package Insert, (Product Information Literature), Collagen Biomedical, Palo Alto, CA (1992).;;Collagen Biomedical, Zyderm Collagen and Zyderm Explained, (Product Information Memorandum), Collagen Biomedical, Palo Alto, CA (1992).;;Collagen Biomedical, Zyderm Collagen Implant Physician Package Insert, (Product Literature), Collagen Biomedical, Palo Alto, CA (1992).;;Collagen Biomedical, Zyplast Implant Physician Package Insert, (Product Literature), Collagen Biomedical, Palo Alto, CA (1992).;;Crouch, Gary D., et al., Ara C Treatment Leads to Differentiation and Reverses the Transformed Phenotype in a Human Rhabdomyosarcoma Cell Line, Experimental Cell Research, 204, pp. 210 216 (1993).;;Datta, Dipak B., Keeping In Touch: The Adhesion Reactions of the Cell Membrane, A Comprehensive Introduction to Membrane Biochemistry, pp. 231 256 (1987).;;de Bruine, Adriaan P., et al., Extracellular Matrix Components Induce Endocrine Differentiation in Vitro in NCI H716 Cells, American Journal of Pathology, 142, pp. 773 782 (1993).;;De Loecker, William, et al., Effects of Sodium Ascorbate (Vitamin C) and 2 Methyl 1,4 naphthoquinone (Vitamin K 3 ) Treatment on Human Tumor Cell Growth in Vitro. II. Synergism with Combined Chemotherapy Action, Anticancer Research, 13, pp. 103 106 (1993).;;Edgar, David, Neuronal laminin receptors, TINS, 12, pp. 248 251 (1989).;;El Deiry, Wafik S., et al., WAF1, a Potential Mediator of p53 Tumor Suppression, Cell, 75, pp. 817 825 (1993).;;End, Peter, and Jurgen Engel, Multidomain Proteins of the Extracellular Matrix and Cellular Growth, Receptors for Extracellular Matrix (McDonald, J. and Mecham, R., ed.), pp. 79 129 (1991).;;Epstein Baak, Ruth, et al., Inducible Transformation of Cells from Transgenic Mice Expressing SV40 under Lac Operon Control, Cell Growth and Differentiation, 3, pp. 127 134 (1992).;;Fattaey, H.K., et al., Modulation of Growth Related Gene Expression and Cell Cycle Synchronization by a Sialoglycopeptide Inhibitor, Experimental Cell Research, 194, pp. 62 68 (1991).;;Fattaey, Heideh, et al., Inhibition of DNA Synthesis and Cell Division by a Cell Surface Sialoglycopeptide, Journal of Cellular Physiology, 139, pp. 269 274 (1989).;;Fujiyama, C., et al., Influence of Extracellular Matrix on the Proliferation and Differentiation of Adrenocortical Cells in Culture, Path. Res. Pract., 189, pp. 1205 1214 (1993).;;Galli, Maria C., et al., The Biology of Stem Cell Factor, a New Hematopoietic Growth Factor Involved in Stem Cell Regulation, Int. J. of Clin. Lab. Res., 23, pp. 70 77 (1993).;;Gash, D.M., et al., Amitotic Neuroblastoma Cells Used for Neural Implants in Monkeys, Science, 233, pp. 1420 1422 (1986).;;Gonos, Efstathios S., and Demetrios A. Spandidos, Oncogenes in Cellular Immortalisation and Differentiation (Review), Anticancer Research, 13, pp. 1117 1122 (1993).;;Grabham, Peter W., et al., Vibronectin Is the Major Serum Protein Essential for NGF Mediated Neurite Outgrowth from PC12 Cells, Experimental Cell Research, 202, pp. 337 344 (1992).;;Graf, Jeannette, et al., A Pentapeptide from the Laminin 1 Chain Mediates Cell Adhesion and Binds the 67 000 Laminin Receptor, Biochemistry, 26, p. 6896 6900 (1987).;;Graf, Jeannette, et al., Identification of an Amino Acid Sequence in Laminin Mediating Cell Attachment, Chemotaxis, and Receptor Binding, Cell, 48, pp. 989 996 (1987).;;Gu, Hua, et al., Deletion of a DNA Polymerase Gene Segment in T Cells Using Cell Type Specific Gene Targeting, Science, 265, pp. 103 106 (1994).;;Gumbiner, Barry M., Proteins Associated with the Cytoplasmic Surface of Adhesion Molecules, Neuron, 11, p. 551 564 (1993).;;Hammang, Joseph P., et al., Immortalized Neuronal and Neuroendocrine Cell Lines by Targeted Oncogenesis in Transgenic Mice Using the PNMT Promoter, Neuroprotocols: A Companion to Methods in Neurosciences, 3, pp. 176 183 (1993).;;Hannan, G.N., et al., An engineered PGK promoter and lac operator repressor system for the regulation of gene expression in mammalian cells, Gene, 103, pp. 233 239 (1993).;;Hoyle, Gary W., et al., Expression of NGF in Sympathetic Neurons Leads to Excessive Axon Outgrowth from Ganglia but Decreased Terminal Innervation within Tissues, Neuron, 10, pp. 1019 1034 (1993).;;Hubbell, Jeffrey A., et al., Surface grafted Cell binding Peptides in Tissues Engineering of the Vascular Graft, Annals New York Academy of Sciences, 665, pp. 253 258 (1992).;;Hug, Hubert, et al., Organization of the Murine Mx Gene and Characterization of Its Interferon and Virus Inducible Promoter, Molecular and Cellular Biology, 8, pp. 3065 3079 (1988).;;HyClone Laboratories, CultiSpher G (Product Information Memorandum), HyClone Laboratories, Logan, UT (no date).;;HyClone Laboratories, CultiSpher GL (Product Information Memorandum), HyClone Laboratories, Logan, UT (no date).;;Ito, Yoshihiro, et al., Materials for Enhancing Cell Adhesion By Immobilization of Cell Adhesive Peptide, Journal of Biomedical Materials Research, 25, pp. 1325 1337 (1991).;;Iwamoto, Yukihide, et al., YIGSR, a Synthetic Laminin Pentapeptide, Inhibits Experimental Metastasis Formation, Science, 238, pp. 1132 1134 (1987).;;Johnson, Terry C., and Behrooz G. Sharifi, Abrogation of the Mitogenic Activity of Bombesin by a Cell Surface Sialoglycopeptide Growth Inhibitor, Biochemical and Biophysical Research Communications, 161, pp. 468 474 (1989).;;Jucker, M., et al., Fetal Rats Septal Cells Adhere to and Extend Processes on Basement Membrane, Laminin, and a Synthetic Peptide the Laminin A Chain Sequence, J. Neurosci. Res., 28, 507 517 (1991).;;Kleinman, Hynda K., et al., The Role of Laminin in Basement Membranes and in the Growth, Adhesion, and Differentiation of Cells, The Role of Extracellular Matrix in Development, pp. 123 143 (1984).;;Kleinman, Hynda K., and Benjamin S. Weeks, The Neural Cell Response to Laminin: Active Sites, Receptors, and Intracellular Signals, Comments Development Neurobiology, 1, pp. 251 266 (1991).;;Lakshmanarao, S.S., et al., Identification of a Cell Surface Component of Swiss 3T3 Cells Associated with an Inhibition of Cell Division, Experimental Cell Research, 195, p. 412 415 (1991).;;Land, Hartmut, et al., Tumorigenic Conversion of Primary Embryo Firbroblasts Requires At Least Two Cooperating Oncogenes, Nature, 304, pp. 596 602 (1983).;;Leung, Ping Y., et al., Cytotoxic Effect of Ascorbate and its Derivatives on Cultured Malignant and Nonmalignant Cell Lines, Anticancer Research, 13, pp. 475 480 (1993).;;Lim, F., et al., Microencapsulated Islets as Bioartificial Endocrine Pancreas, Science, 201, pp. 908 910 (1980).;;Liu, Hong Wen, et al., Expression of Human Factor IX by Microencapsulated Recombinant Fibroblasts, Human Gene Therapy, 4, pp. 291 301 (1993).;;Massia, Stephen P., and Jeffrey A. Hubbell, Covalent Surface Immobilization of Arg Gly Asp and Try lle Gly Ser Arg Containing Peptides to Obtain Well Defined Cell Adhesive Substrates, Analytical Biochemistry, 187, pp. 292 301 (1990).;;Matsuda, Takehisa, et al., Development of a Novel Artificial Matrix with Cell Adhesion Peptides for Cell Culture and Artificial and Hybrid Organs, Trans. Am. Soc. Artif. Intern. Organs, 35, pp. 677 679 (1989).;;Matsushima, Hiroshi, and Emil Bogenmann, Modulation of Neuroblastoma Cell Differentiation by the Extracellular Matrix, Int. J. Cancer, 51, pp. 727 732 (1992).;;Matuoka et al., Heparan Sulfate Enhances Growth of Transformed Human Cells, Cell Structure and Function, 9, pp. 357 (1984).;;Messing, Albee, et al., Hypomyelinating Peripheral Neuropathies and Schwannomas in Transgenic Mice Expressing SV40 T Antigen, The Journal of Neuroscience, 14, pp. 3533 3539 (1994).;;Mitchell, J.B., et al. Dose Rate Effects in Mammalian Cells in Culture, Radiat. Res., 79, pp. 537 551 (1979).;;Murata, Jun, et al., Inhibitory Effect of a Synthetic Polypeptide, Poly(Tyr lle Gly Ser Arg), On the Metastatic Formation of Malginant Tumour Cells, Int. J. Biol. Macromol., 11, pp. 97 99 (1989).;;Neckers, Len, and Luke Whitesell, Antisense Technology: Biological Utility and Practical Considerations, Am. J. Physiol., 265, pp. L1 L12 (1993).;;Otonkoski, Timo, et al., Nicotinamide Is a Potent Inducer of Endocrine Differentiation in Cultured Human Fetal Pancreatic Cells, J. Clin. Invest., 92, pp. 1459 1466 (1993).;;Pash, James M., et al., Aberrant Expression of High Mobility Group Chromosomal Protein 14 Affects Cellular Differentiation, The Journal of Biological Chemistry, 268, p. 13632 13638 (1993).;;Penttinen, Risto P., et al., Transforming Growth Factor Increases mRNA for Matrix Proteins Both in the Presence and in the Absense of Changes in mRNA Stability, Proc. Natl. Acad. Sci. USA, 85, pp. 1105 1108 (1988).;;Phillips, Charlotte L., et al., Ascorbic Acid and Tranforming Growth Factor 1 Increase Collagen Biosynthesis via Different Mechanisms: Coordinate Regulation of Pro 1(I) and Pro 1(III) Collagens, Archives of Biochemistry and Biophysics, 295, pp. 397 403 (1992).;;Pierschbacher, Michael D., and Erkki Ruoslatiti, Cell Attachment Activity of Fibronectin Can Be Duplicated By Small Synthetic Fragments of the Molecule, Science, 309, pp. 30 33 (1984).;;Pleasure, Samuel, et al., Pure, Postmitotic, Polarized Human Neurons Derived from NTera 2 Cells Provide a System for Expressing Exogenous Proteins in Terminally Differentiation Neurons, The Journal of Neuroscience, 12, pp. 1802 1815 (1992).;;Prystowsky et al., Inhibition of Ornithine Decarboxylase Activity and Cell Proliferation by Ultraviolet Radiation in EGF Stimulated Cultured Human Epidermal Keratinocytes, J. Invest. Dermat., 101, pp. 54 58 (1993).;;Radvanyi, Francois, et al., Pancreatic Cells Cultured from Individual Preneoplastic Foci in a Multistage Tumorigensis Pathway: a Potentially General Technique for Isolating Physiologically Representative Cell Lines, Molecular and Cellular Biology, 13, p. 4223 4232 (1993).;;Ray, Jasodhara, et al., Proliferation, Differentiation, and Long Term Culture of Primary Hippocampal Neurons, Proc. Natl. Acad. Sci. USA, 90, pp. 3602 3606 (1993).;;Reemay, Inc., Reemay Spunbonded Polyester, pp. 1 20 (Product Information Literature), Reemay, Inc., Old Hickory, TN.;;Reynolds, Brent A., et al., A Multipotent EGF Responsive Striatal Embryonic Progenitor Cell Produces Neurons and Astroyctes, The Journal of Neuroscience, 12, pp. 4565 4574 (1992).;;Richards, L.J. et al., De novo Generation of Neuronal Cells From The Adult Mouse Brain, Proc. Natl. Acad. Sci. USA, 89, pp. 8591 8595 (1992).;;Ron, David, Inducible Growth Arrest: New Mechanistic Insights, Proc. Natl. Acad. Sci. USA, 91, pp. 1985 1986 (1994).;;Ruoslahti, Erkki, and Michael D. Pierschbacher, New Perspectives in Cell Adhesion: RGD and Integrins, Science, 238, pp. 491 497 (1987).;;Ruoslahti, Erkki, and John C. Reed, Anchorage Dependence, Integrins, and Apoptosis, Cell, 77, pp. 477 478 (1994).;;Saiki, I., et al. Antimetastatic Effects of Synthetic Polypeptides Containing Repeated Structures of the Cell Adhesion Arg Gly Asp (RGD) and Tyr lle Gly Ser Arg (YIGSR) Sequences, Br. J. Cancer, 60, pp. 722 728 (1989).;;Sanes, Joshua R., Extracellular Matrix Molecules That Influence Neural Development, Ann. Rev. Neurosci., 12, p. 491 516 (1989).;;Schinstine, Malcolm, and Fred H. Gage, Factors Affecting Proviral Expression in Primary Cells Grafted into the CNS, Molecular and Cellular Approaches for the Treatment of Neurological Diseases (S.G. Waxman, ed.), pp. 311 323 (1993).;;Seliger, Barbara, et al., Murine Gamma Interferon Inhibits v mos Induced Fibroblast Transformation via Down Regulation of Retroviral Gene Expression, Journal of Virology, 61, pp. 2567 2572 (1987).;;Seliger, Barbara, et al., Gamma Interferon Regulates Long Terminal Repeat Controlled Oncogene Expression in Transformed Mouse Fibroblasts at the Level of mRNA Transcription, Journal of Virology, 62, pp. 619 621 (1988).;;Seliger, Barbara, et al., Tumor Necrosis Factor Affects LTR Controlled Oncogene Expression in Transformed Mouse Fibroblasts at the Post Transcriptional Level, The Journal of Immunology, 141, pp. 2138 2144 (1988).;;Seliger, Barbara, et al., Distinct Mechanisms of Interferon Gamma and Tumor Necrosis Factor Alpha Action in Oncogene Transformed Mouse Fibroblasts, Journal of Cellular Biochemistry, 38, pp. 205 212 (1988).;;Sharifi, Behrooz G., et al., Cell Surface Interaction is Sufficient for the Biolgocial Activity of a Bovine Sialoglycopeptide Inhibitor, Biochemical and Biophysical Research Communications, 134, pp. 1350 1357 (1986).;;Sharifi, Behrooz G., et al., Purification and Characterization of a Bovine Cerebral Cortex Cell Surface Sialoglycopeptide that Inhibits Cell Proliferation and Metabolism, Journal of Neurochemistry, 46, pp. 461 469 (1986).;;Smalheiser, Neil R., et al., Laminin As a Substrate for Retinal Axons in Vitro, Dev. Brain Res., 12, pp. 136 140 (1984).;;SoloHill Labs, Inc., SoloHill Labs, Inc., Ann Arbor, MI.;;Stockdale, Frank E., et al., Myoblasts, Satellite Cells, and Myoblasts Transfer, Myoblasts Transfer Therapy (R. Griggs and G. Karpati, eds.), pp. 7 11 (1990).;;Sun, Anthony M., Microencapsulation of Pancreatic Islet Cells: A Bioartificial Endocrine Pancreas, Methods in Enzymology, 137, pp. 575 580 (1988).;;Tashiro, Ken ichiro, et al., A Synthetic Peptide Containing the IKVAV Sequence from the A Chain of Laminin Mediates Cell Attachment, Migration, and Neurite Outgrowth, The Journal of Biological Chemistry, 264, pp. 16174 16182 (1989).;;Telios Pharmaceuticals, Integrins: An Update on the Rapid Growth of Research Topics, in ECM Connections, a publication of Telios Pharmaceuticals, San Diego, CA (Jun. 1992).;;Telios Pharmaceuticals, PepTite 2000 (Product Information Memorandum), Telios Pharmaceuticals, San Diego, CA.;;Temple, Sally, Division and Differentiation of Isolated CNS Blast Cells in Microculture, Nature, 340, pp. 471 473 (1989).",EXPIRED
427,CA,A1,CA 2195446 A1,072-553-229-430-730,1996-02-01,1996,CA 2195446 A,1995-07-20,US 27977394 A;;US 43269895 A;;US 9509281 W,1994-07-20,GROWTH CONTROL FOR CELLS ENCAPSULATED WITHIN BIOARTIFICIAL ORGANS,"This invention relates to methods and compositions of controlling cell distribution within a bioartificial organ by exposing the cells to a treatment that inhibits cell proliferation, promotes cell differentiation, or affects cell attachment to a growth surface within the bioartificial organ. Such treatments include (1) genetically manipulating cells, (2) exposing the cells to a proliferation-inhibiting compound or a differentiation-inducing compound or removing the cells from exposure to a proliferation-stimulating compound or a differentiation-inhibing compound; exposing the cells to irradiation, and (3) modifying a growth surface of the BAO with ECM molecules, molecules affecting cell proliferation or adhesion, or an inert scaffold, or a combination thereof. These treatments may be used in combination.",CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,,https://lens.org/072-553-229-430-730,Patent Application,no,0,0,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A61L27/00;;A61L27/18;;A61L27/22;;A61L27/38;;A01K67/027;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,EXPIRED
428,FI,A,FI 970217 A,001-141-497-419-11X,1997-01-17,1997,FI 970217 A,1997-01-17,US 27977394 A;;US 43269895 A;;US 9509281 W,1994-07-20,Keinotekoisiin biologisiin välineisiin kapseloitujen solujen kasvun säätely,,CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,,https://lens.org/001-141-497-419-11X,Patent Application,no,0,0,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A01K67/027;;A61L27/00;;A61L27/18;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,PENDING
429,NO,L,NO 970156 L,015-554-503-753-602,1997-03-20,1997,NO 970156 A,1997-01-14,US 43269895 A;;US 9509281 W;;US 27977394 A,1994-07-20,Fremgangsmåte ved inhibering av vekst av celler innkapslet i kunstige organer,"Foreliggende oppfinnelse vedrører fremgangsmåter og sammensetninger for å kontrollere fordelingen av celler irme i et Icunstig organ ved å underkaste cellene en behandling som hemmer celleproliferasjonen, fremmer celledifferensiering eller påvirker cellene binding til en vekstflate irme i det kunstige organ. Slike behand- linger omfatter å (1) genetisk manipulere celler, (2) utsette cellene for en proliferasjons-hemmende forbin- delse eller en differensierings-induserende forbindelse eller å fjerne cellene fra iruivirkningen av en prolife- rasjons -stimulerende forbindelse eller en differensie- rings -hemmende forbindelse; utsette cellene for strål- ning og å (3) modifisere en vekstflate av det kunstige organ med ECM-molekyler, molekyler som påvirker celle- proliferasjonen eller klebingen, eller et inert stativ, eller en kon±)inasjon derav. Disse behandlinger kan kombineres.",CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,,https://lens.org/015-554-503-753-602,Abstract,no,0,0,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A61L27/00;;A61L27/18;;A01K67/027;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,DISCONTINUED
430,NZ,A,NZ 290629 A,017-186-828-142-312,1998-10-28,1998,NZ 29062995 A,1995-07-20,US 27977394 A;;US 43269895 A;;US 9509281 W,1994-07-20,CONTROLLING GROWTH OF CELLS WITHIN BIOARTIFICIAL ORGAN,,CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,,https://lens.org/017-186-828-142-312,Patent Application,no,0,0,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A61L27/00;;A61L27/18;;A61L27/22;;A61L27/38;;A01K67/027;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,PENDING
431,SK,A3,SK 7797 A3,126-848-044-004-714,1997-08-06,1997,SK 7797 A,1995-07-20,US 27977394 A;;US 43269895 A;;US 9509281 W,1994-07-20,A METHOD OF CONTROLLING CELL DISTRIBUTION WITHIN BIOARTIFICIAL ORGAN,,CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,,https://lens.org/126-848-044-004-714,Patent Application,no,0,0,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A61L27/00;;A61L27/18;;A01K67/027;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,PENDING
432,TR,A2,TR 199500882 A2,161-728-106-532-743,1996-06-21,1996,TR 9500882 A,1995-07-20,US 27977394 A;;US 43269895 A,1994-07-20,Biyolojik sun'i organlar icindeki kapali kalan hücrelerin büyüme kontrol yöntemleri ve icerikleri.,,CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,,https://lens.org/161-728-106-532-743,Patent Application,no,0,0,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A01K67/027;;A61L27/00;;A61L27/18;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,PENDING
433,US,A1,US 2001/0043923 A1,059-605-655-661-794,2001-11-22,2001,US 80123701 A,2001-03-07,US 80123701 A;;US 44799795 A,1995-05-23,Mx-1 conditionally immortalized cells,"
   This invention relates to methods and compositions of controlling cell distribution within a bioartificial organ by exposing the cells to a treatment that inhibits cell proliferation, promotes cell differentiation, or affects cell attachment to a growth surface within the bioartificial organ. Such treatments include (1) genetically manipulating cells, (2) exposing the cells to a proliferation-inhibiting compound or a differentiation-inducing compound or removing the cells from exposure to a proliferation-stimulating compound or a differentiation-inhibiting compound; exposing the cells to irradiation, and (3) modifying a growth surface of the BAO with ECM molecules, molecules affecting cell proliferation or adhesion, or an inert scaffold, or a combination thereof. These treatments may be used in combination. 
",SCHINSTINE MALCOLM;;SHOICHET MOLLY S.;;GENTILE FRANK T.;;HAMMANG JOSEPH P.;;HOLLAND LAURA M.;;CAIN BRIAN M.;;DOHERTY EDWARD J.;;WINN SHELLEY R.;;AEBISCHER PATRICK,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,NEUROTECH S.A (1999-12-29);;NEUROTECH USA INC (2007-10-25),https://lens.org/059-605-655-661-794,Patent Application,yes,0,2,2,2,0,A01K67/0275;;A01K2217/05;;A61K35/12;;A61L27/383;;A61L27/3834;;C12N2510/04;;A01K67/0275;;A61L27/383;;A01K2217/05;;A61L27/3834;;A61K35/12;;C12N2510/04,A01K67/027;;A61K35/12;;A61L27/38,424/93.21,0,0,,,,EXPIRED
434,US,A,US 5858747 A,080-640-106-958-768,1999-01-12,1999,US 44781095 A,1995-05-23,US 44781095 A;;US 43269895 A;;US 27977394 A,1994-07-20,Control of cell growth in a bioartificial organ with extracellular matrix coated microcarriers,"Methods and compositions are provided for controlling cell distribution within an implantable bioartificial organ by exposing the cells to a treatment that inhibits cell proliferation, promotes cell differentiation, or affects cell attachment to a growth surface within the bioartificial organ. Such treatments include (1) genetically manipulating cells, (2) exposing the cells to a proliferation-inhibiting compound or a differentiation-inducing compound or removing the cells from exposure to a proliferation-stimulating compound or a differentiation-inhibiting compound; exposing the cells to irradiation, and (3) modifying a growth surface of the bioartificial organ with extracellular matrix molecules, molecules affecting cell proliferation or adhesion, or an inert scaffold, or a combination thereof. These treatments may be used in combination. The bioartificial organ typically has a semipermeable membrane encapsulating a cell-containing core, and is preferably immunoisolatory. Cells can be grown on microcarriers and then loaded into the bioartificial organ. The microcarriers may be coated with an extracellular matrix component such as collagen to cause decreased cell proliferation or increased cell differentiation. Microcarriers containing cells can be suspended in a proliferation inhibiting hydrogel matrix prior to encapsulation.",CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,NEUROTECH S.A (1999-12-29);;NEUROTECH USA INC (2007-10-25),https://lens.org/080-640-106-958-768,Granted Patent,yes,40,156,33,40,4,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A61L27/00;;A61L27/18;;A61L27/22;;A01K67/027;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,435/182;;424/93.21;;424/93.7;;424/422;;435/176;;435/177;;435/178;;435/377;;435/382;;435/395;;435/403;;435/289.1,99,82,048-332-719-530-735;;040-300-209-001-975;;078-401-268-829-715;;015-052-284-383-698;;051-467-747-043-981;;018-070-477-790-693;;120-596-939-734-383;;115-103-293-214-469;;004-129-864-323-871;;054-678-244-582-843;;021-321-949-597-771;;172-770-692-257-323;;060-164-752-701-836;;010-938-147-585-497;;011-276-786-730-941;;032-759-232-461-426;;108-379-915-909-34X;;028-364-375-537-319;;154-365-488-022-138;;026-016-347-959-887;;045-017-646-829-568;;066-523-881-622-501;;061-578-853-469-745;;057-767-055-501-614;;023-675-605-776-929;;104-865-628-368-26X;;173-587-013-695-171;;156-440-241-544-217;;068-141-789-713-733;;098-101-997-046-906;;034-178-376-559-657;;099-990-907-377-728;;005-358-343-205-664;;045-328-856-518-264;;004-236-732-518-638;;094-551-917-544-749;;108-168-722-195-491;;034-044-806-170-454;;038-918-079-679-253;;115-971-724-193-517;;009-792-950-241-971;;014-745-525-337-47X;;050-399-486-711-487;;059-049-072-219-166;;092-223-656-604-882;;018-117-336-909-414;;131-750-072-875-475;;003-664-236-520-709;;066-203-355-190-646;;105-834-428-184-911;;035-723-436-595-236;;034-249-775-255-429;;095-350-135-301-860;;060-291-465-466-062;;081-174-387-421-852;;052-782-286-478-646;;002-286-494-363-396;;101-732-752-675-701;;049-042-021-517-724;;164-020-307-617-474;;044-088-273-450-791;;012-333-350-448-43X;;046-111-513-250-242;;100-153-598-267-351;;028-211-379-291-005;;067-322-389-377-685;;147-346-857-684-894;;065-678-110-707-195;;076-012-254-853-704;;093-553-709-303-10X;;030-854-629-603-00X;;086-874-830-084-387;;016-063-554-957-496;;092-531-628-495-425;;055-467-864-296-721;;056-234-682-167-995;;090-908-679-116-661;;044-320-745-895-128;;001-928-366-548-586;;165-524-038-085-953;;008-119-464-657-166;;026-843-338-695-356,7918336;;8406030;;10.1016/0378-1119(93)90507-y;;2194673;;10.1016/0092-8674(90)90239-b;;10.1007/bf02623638;;2666386;;pmc386305;;10.1073/pnas.83.15.5454;;2874553;;10.1126/science.8016653;;8016653;;10.1159/000112252;;3021428;;10.1016/0168-9525(93)90012-7;;8379006;;10.1002/bip.360260018;;2437977;;pmc6577554;;10.1523/jneurosci.14-03-01030.1994;;8120611;;10.1073/pnas.82.13.4438;;pmc391116;;3892534;;10.1007/978-1-349-11358-3_15;;10.1016/0896-6273(88)90184-5;;3078410;;10.1089/hum.1993.4.4-433;;8399490;;8190271;;10.1016/0306-4522(94)90097-3;;8440318;;10.1006/excr.1993.1026;;pmc1886816;;8456938;;8476199;;2475934;;10.1016/0166-2236(89)90020-9;;8242752;;10.1016/0092-8674(93)90500-p;;10.1016/b978-0-12-483365-4.50008-6;;1504017;;10.1016/0014-4827(91)90130-m;;1901795;;10.1002/jcp.1041390208;;2715187;;10.1016/s0344-0338(11)80845-9;;8183742;;10.1007/bf02592286;;7686057;;3749886;;10.1126/science.3749886;;8352534;;10.1016/0014-4827(92)90083-k;;1383013;;10.1021/bi00396a004;;2962631;;10.1016/0092-8674(87)90707-0;;2951015;;8016642;;10.1126/science.8016642;;10.1016/0896-6273(93)90068-3;;8398146;;10.1006/ncmn.1993.1052;;10.1016/0378-1119(93)90424-2;;8359690;;8318227;;10.1016/0896-6273(93)90051-r;;10.1111/j.1749-6632.1992.tb42589.x;;1416607;;pmc363533;;10.1128/mcb.8.8.3065-3079.1988;;10.1128/mcb.8.8.3065;;2974922;;1797805;;10.1002/jbm.820251102;;10.1126/science.2961059;;2961059;;2735903;;10.1016/0006-291x(89)92622-3;;10.1002/jnr.490280407;;1870155;;10.1016/0014-4827(91)90391-7;;2070822;;6308472;;10.1038/304596a0;;8517665;;6776628;;10.1126/science.6776628;;8338876;;10.1089/hum.1993.4.3-291;;10.1016/0003-2697(90)90459-m;;2382830;;10.1097/00002480-198907000-00165;;2597562;;1612781;;10.1002/ijc.2910510511;;6241504;;10.1247/csf.9.357;;10.1523/jneurosci.14-06-03533.1994;;7515952;;pmc6576935;;482611;;10.2307/3575179;;2489072;;10.1016/0141-8130(89)90049-4;;8393300;;10.1152/ajplung.1993.265.1.l1;;10.1172/jci116723;;pmc288291;;8104197;;8514795;;10.1016/s0021-9258(19)38695-8;;3422482;;10.1073/pnas.85.4.1105;;pmc279714;;10.1016/0003-9861(92)90533-3;;1586167;;6325925;;10.1038/309030a0;;10.1523/jneurosci.12-05-01802.1992;;1578271;;pmc6575890;;8331297;;10.1111/1523-1747.ep12359508;;10.1128/mcb.13.7.4223;;10.1128/mcb.13.7.4223-4232.1993;;pmc359972;;8391634;;10.1073/pnas.90.8.3602;;pmc46349;;8475109;;1432110;;10.1523/jneurosci.12-11-04565.1992;;pmc6575989;;10.1073/pnas.89.18.8591;;pmc49966;;1528866;;8134335;;10.1073/pnas.91.6.1985;;pmc43292;;10.1126/science.2821619;;2821619;;8187171;;10.1016/0092-8674(94)90209-7;;2803948;;pmc2247318;;10.1038/bjc.1989.347;;10.1146/annurev.ne.12.030189.002423;;2648958;;8417470;;10.1128/jvi.61.8.2567-2572.1987;;pmc255700;;3037117;;pmc250578;;10.1128/jvi.62.2.619-621.1988;;3121865;;2844896;;10.1002/jcb.240380308;;3147985;;10.1016/0006-291x(86)90398-0;;3947369;;2416876;;10.1111/j.1471-4159.1986.tb12990.x;;6697250;;2248157;;10.1007/978-1-4684-5865-7_2;;10.1016/0076-6879(88)37053-9;;3131633;;2777785;;10.1016/s0021-9258(18)71604-9,"Farghali et al., The concept of Application of Immobilized and Perfused Mammalian cells (a bioreactor model) in biomedical research, Physiological Research, 43, pp. 117 120 (1994).;;Adhya, Sankar, et al., Promoter resurrection by activators a minireview, Gene, 132, pp. 1 6 (1993).;;Arnheiter, Heinz, et al., Transgenic Mice with Intracellular Immunity to Influenza Virus, Cell, 62, pp. 51 61 (1990).;;Aulthouse, Amy Lynn, et al., Expression of the Human Chondrocyte Phenotype In Vitro, In Vitro Cellular & Developmental Biology, 25, pp. 659 668 (1989).;;Baetge, E. Edward, et al., Complete Nucleotide and Deduced Amino Acid Sequence of Bovine Phenylethanolamine N methyltransferase: Partial Amino Acid Homology With Rat Tyrosine Hydroxylase, Proc. Natl. Acad. Sci. USA, 83, pp. 5454 5458 (1986).;;Barinaga, Marcia, Knockout Mice: Round Two, Science, 265, pp. 26 28 (1994).;;Baron Van Evercooren, A., et al., Schwann Cell Differentiation in vitro: Extracellular Matrix Deposition and Interaction, Dev. Neurosci., 8, pp. 182 196 (1986).;;Blau, Helen M., et al., Myoblasts in Pattern Formation and Gene Therapy, Trends in Genetics, 9, pp. 269 274 (1993).;;Bohak, Z., et al. Novel Anchorage Matrices for Suspension Culture of Mammalian Cells, Biopolymers, 26, pp. S205 S213 (1987).;;Brenner, Michael, et al. , GFAP Promoter Directs Astrocyte specific Expression in Transgenic Mice, The Journal of Neuroscience, 14, pp. 1030 1037 (1994).;;Brinster et al., Factors Affecting the Efficiency of Introducing Foreign DNA into Mice by Microinjecting Eggs, Proc. Natl. Acad. Sci. USA, 82, pp. 4438 4442 (1985).;;Cabasso, Israel, Hollow Fiber Membranes, Encyclopedia of Chemical Technology (Kirk Othmer, ed.), pp. 492 517 (1980).;;Carbonetto, Salvatore, Ch. 15: Laminin Receptors: From PC12 Cells to PNS, Brain Repair (Bj o rklund, Aguayo and Ottoson, eds.), pp. 185 197 (1990).;;Celtrix Laboratories, Vitrogen 100 : Purified Collagen for Cell Culture and Biochemistry (Product Information Memorandum, Celtrix Laboratories, Palo Alto, CA (1991).;;Cepko, Connie, Retrovirus Vectors and Their Applications in Neurobiology, Neuron, 1, 345 353 (1988).;;Chang, P.L., et al., Delivery of Recombinant Gene Products with Microencapsulated Cells In Vivo. Human Gene Therapy, 4, pp. 433 440 (1993).;;Chu, C.H., and A. M. Tolkovsky, Alternative Adrenal Chromaffin Cell Fates Induced by Basic Fibroblast Growth Factor or Cyclic AMP In Vitro Depend on a Collaboration With The Growth Substrate, Neuroscience, 59, pp. 43 54 (1994).;;Collaborative Research Incorporated, CR LAMININ and CR ANTI LAMININ (Product Information Memorandum), Collaborative Research, Inc., Bedford, MA (1987).;;Collaborative Research Incorporated, Basement Membrane Matrigel (Product Specification Sheet), Collaborative Research, Inc., Bedford, MA (1991).;;Collagen Biomedical, Collagen Test Implant Physician Package Insert, (Product Information Literature), Collagen Biomedical, Palo Alto, CA (1992).;;Collagen Biomedical, Zyderm Collagen and Zyderm Explained, (Product Information Memorandum), Collagen Biomedial, Palo Alto, CA (1992).;;Collagen Biomedical, Zyderm Collagen Implant Physician Package Insert, (Product Literature), Collagen Biomedical, Palo Alto, CA (1992).;;Collagen Biomedical, Zyplast Implant Physician Package Insert, (Product Literature), Collagen Biomedical, Palo Alto, CA (1992).;;Crouch, Gary D., et al., Ara C Treatment Leads to Differentiation and Reverses the Transformed Phenotype in a Human Rhabdomyosarcoma Cell Line, Experimental Cell Research, 204, pp. 210 216 (1993).;;Datta, Dipak B., Keeping In Touch: The Adhesion Reactions of the Cell Membrane, A Comprehensive Introduction to Membrane Biochemistry, pp. 231 256 (1987).;;de Bruine, Adriaan P., et al., Extracellular Matrix Components Induce Endocrine Differentiation in Vitro in NCI H716 Cells, American Journal of Pathology, 142, pp. 773 782 (1993).;;De Loecker, William, et al., Effects of Sodium Ascorbate (Vitamin C) and 2 Methyl 1,4 naphthoquinone (Vitamin K 3 ) Treatment on Human Tumor Cell Growth in Vitro. II. Synergism with Combined Chemotherapy Action, Anticancer Research, 13, pp. 103 106 (1993).;;Edgar, David, Neuronal laminn receptors, TINS, 12, pp. 248 251 (1989).;;El Deiry, Wafik S., et al., WAF1, a Potential Mediator of p53 Tumor Suppression, Cell, 75, pp. 817 825 (1993).;;End, Peter, and Jurgen Engel, Multidomain Proteins of the Extracellular Matrix and Cellular Growth, Receptors for Extracellular Matrix (McDonald, J. and Mecham., R., ed.), pp. 79 129 (1991).;;Epstein Baak, Ruth, et al., Inducible Transformation of Cells from Transgenic Mice Expressing SV40 under Iac Operon Control, Cell Growth and Differentiation, 3, pp. 127 134 (1992).;;Fattaey, H.K., et al., Modulation of Growth Related Gene Expression and Cell Cycle Synchronization by a Sialoglycopeptide Inhibitor, Experimental Cell Research, 194, pp. 62 68 (1991).;;Fattaey, Heideh, et al., Inhibition of DNA Synthesis and Cell Division by a Cell Surface Sialoglycopeptide, Journal of Cellular Physiology, 139, pp. 269 274 (1989).;;Fujiyama, C., et al., Influence of Extracellular Matrix on the Proliferation and Differentiation of Adrenocortical Cells in Culture, Path. Res. Pract., 189, pp. 1205 1214 (1993).;;Galli, Maria C., et al., The Biology of Stem Cell Factor, a New Hematopoietic Growth Factor Involved in Stem Cell Regulation, Int. J. of Clin. Lab. Res., 23, pp. 70 77 (1993).;;Gash, D.M., et al., Amitotic Neuroblastoma Cells Used for Neural Implants in Monkeys, Science, 233, pp. 1420 1422 (1986).;;Gonos, Efstathios S., and Demetrios A. Spandidos, Oncogenes in Cellular Immortalisation and Differentiation (Review), Anticancer Research, 13, pp. 1117 1122 (1993).;;Grabham, Peter W., et al., Vibronectin Is the Major Serum Protein Essential for NGF Mediated Neurite Outgrowth from PC12 Cells, Experimental Cell Research, 202, pp. 337 344 (1992).;;Graf, Jeannette, et al., A Pentapeptide from the Laminin 1 Chain Mediates cell Adhesion and Binds the 67 000 Laminin receptor, Biochemistry, 26, pp. 6896 6900 (1987).;;Graf, Jeannette, et al., Identification of an Amino Acid Sequence in Laminin Mediating Cell Attachment, Chemotaxis, and Receptor Binding, Cell, 48, pp. 989 996 (1987).;;Gu, Hua, et al., Deletion of a DNA Polymerase Gene Segment in T Cells Using Cell Type Specific Gene Targeting, Science, 265, pp. 103 106 (1994).;;Gumbiner, Barry M., Proteins Associated with the Cytoplasmic Surface of Adhesion Molecules, Neuron, 11, pp. 551 564 (1993).;;Hammang, Joseph P., et al., Immortalized Neuronal and Neuroendocrine Cell Lines by Targeted Oncogenesis in Transgenic Mice Using the PNMT Promoter, Neuroprotocols: A Companion to Methods in Neurosciences, 3, pp. 176 183 (1993).;;Hannan, G.N., et al., An engineered PGK promoter and Lac operator repressor system for the regulation of gene expression in mammalian cells, Gene, 130, pp. 233 239 (1993).;;Hoyle, Gary W., et al., Expression of NGF in Sympathetic Neurons Leads to Excessive Axon Outgrowth from Ganglia but Decreased Terminal Innervation within Tissues, Neuron, 10, pp. 1019 1034 (1993).;;Hubbell, Jeffrey A., et al., Surface grafted Cell binding Peptides in Tissue Engineering of the Vascular Graft, Annals New York Academy of Sciences, 665, pp. 253 258 (1992).;;Hug, Hubert, et al., Organization of the Murine Mx Gene and Characterization of Its Interferon and Virus Inducible Promoter, Molecular and Cellular Biology, 8, pp. 3065 3079 (1988).;;HyClone Laboratories, CultiSpher G (Product Information Memorandum), HyClone Laboratories, Logan, UT (no date).;;HyClone Laboratories, CultiSpher GL (Product Information Memorandum), HyClone Laboratories, Logan, UT (no date).;;Ito, Yoshihiro, et al., Materials for Enhancing Cell Adhesion By Immobilization of Cell Adhesive Peptide, Journal of Biomedical Materials Research, 25, pp. 1325 1337 (1991).;;Iwamoto, Yukihide, et al., YIGSR, a Synthetic Laminin Pentapeptide, Inhibits Experimental Metastasis Formation, Science, 238, pp. 1132 1134 (1987).;;Johnson, Terry C., and Behrooz G. Sharifi, Abrogation of the Mitogenic Activity of Bombesin by a Cell Surface Sialoglycopeptide Growth Inhibitor, Biochemical and Biophysical Research Communications, 161, pp. 468 474 (1989).;;Jucker, M., et al., Fetal Rats Septal Cells Adhere to and Extend Processes on Basement Membrane, Laminin, and a Synthetic Peptide the Laminin A Chain Sequence, J. Neurosci. Res., 28, 507 517 (1991).;;Kleinman, Hynda K., et al., The Role of Laminin in Basement Membranes and in the Growth, Adhesion, and Differentiation of Cells, The Role of Extracellular Matrix in Development, pp. 123 43 (1984).;;Kleinman, Hynda K., and Benjamin S. Weeks, The Neural Cell Response to Laminin: Active Sites, Receptors, and Intracellular Signals, Comments Developmental Neurobiology, 1, pp. 251 266 (1991).;;Lakshmanarao, S.S., et al., Identification of a Cell Surface Component of Swiss 3T3 Cells Associated with an Inhibiton of Cell Division, Experimental Cell Research, 195, pp. 412 415 (1991).;;Land, Hartmut, et al., Tumorigenic Conversion of Primary Embryo Fibroblasts Requires At Least Two Cooperating Oncogenes, Nature, 304, pp. 596 602 (1983).;;Leung, Ping, Y., et al., Cytotoxic Effect of Ascorbate and its Derivatives on Cultured Malignant and Nonmalignant Cell Lines, Anticancer Research, 13, pp. 475 480 (1993).;;Lim, F., et al., Microencapsulated Islets as Bioartificial Endocrine Pancreas, Science, 210, pp. 908 910 (1980).;;Liu, Hong Wen, et al., Expression of Human Factor IX by Microencapsulated Recombinant Fibroblasts, Human Gene Therapy, 4, pp. 291 301 (1993).;;Massia, Stephen P., and Jeffrey A. Hubbell, Covalent Surface Immobilization of Arg Gly Asp and Try lle Gly Ser Arg Containing Peptides to Obtain Well Defined Cell Adhesive Substrates, Analytical Biochemistry, 187, pp. 292 301 (1990).;;Matsuda, Takehisa, et al, Development of a Novel Artificaial Matrix with Cell Adhesion Peptides for Cell Culture and Artificial and Hybrid Organs, Trans. Am. Soc. Artif. Intern. Organs, 35, pp. 677 679 (1989).;;Matsushima, Hiroshi, and Emil Bogenmann, Modulation of Neuroblastoma Cell Differentiation by the Extracellular Matrix, Int. J. Cancer, 51, pp. 727 732 (1992).;;Matuoka et al., Heparan Sulfate Enhances Growth to Transformed Human Cells, Cell Structure and Function, 9, p. 357 (1984).;;Messing, Albee, et al., Hypomyelinating Peripheral Neuropathies and Schwannomas in Transgenic Mice Expressing SV40 T Antigen, The Journal of Neuroscience, 14, pp. 3533 3539 (1994).;;Mitchell, J.B., et al., Dose Rate Effects in Mammalian Cells in Culture, Radiat. Res., 79, pp. 537 551 (1979).;;Murata, Jun, et al., Inhibitory Effect of a Synthtic Polypeptide, Poly(Tyr lle Gly Ser Arg), On the Metastatic Formation of Malignant Tumour Cells, Int. J. Biol. Macromol., 11, pp. 97 99 (1989).;;Neckers, Len, and Luke Whitesell, Antisense Technology: Biology Utility and Practical Considerations, Am. J. Physiol., 265, pp. L1 L12 (1993).;;Otonkoski, Timo, et al., Nicotinamide Is a Potent Inducer of Endocrine Differentiation in Cultured Human Fetal Pancreatic Cells, J. Clin. Invest., 92, pp. 1459 1466 (1993).;;Pash, James M., et al., Aberrant Expression of High Mobility Group Chromosomal Protein 14 Affects Cellular Differentiation, The Journal of Biological Chemistry, 268, pp. 13632 13638 (1993).;;Penttinen, Risto P., et al., Transforming Growth Factor Increases mRNA for Matrix Proteins Both in the Presence and in the Absence of Changes in mRNA Stability, Proc. Natl. Acad. Sci. USA, 85, pp. 1105 1108, (1988).;;Phillips, Charlotte L., et al., Ascorbic Acid and Transforming Growth Factor 1 Increase Collagen Biosynthesis via Different Mechanisms; Coordinate Regulation of Pro 1(I) and Pro 1(III) Collagens, Archives of Biochemistry and Biophysics, 295, pp. 397 403 (1992).;;Pierschbacher, Michael D., and Erkki Ruoslatiti, Cell Attachment Activity of Fibronectin Can Be Duplicated By Small Synthetic Fragments of the Molecule, Science, 309, pp. 30 33 (1984).;;Pleasure, Samuel, et al., Pure, Postmitotic, Polarized Human Neurons Derived from NTera 2 Cells Provide a System for Expressng Exogenous Proteins in Terminally Differentiated Neurons, The Journal of Neuroscience, 12, pp. 1802 1815 (1992).;;Prystowsky et al., Inhibition of Ornithine Decarboxylase Activity and Cell Proliferation by Ultraviolet Radiation in EGF Stimulated Cultured Human Epidermal Keratinocytes, J. Invest. Dermat., 101, pp. 54 58, (1993).;;Radvanyi, Francois, et al., Pancreatic Cells Cultured from Individual Preneoplastic Foci in a Multistage Tumorigenesis Pathway: a Potentially General Technique for Isolating Physiologically Representative Cell Lines, Molecular and Cellular Biology, 13, pp. 4223 4232 (1993).;;Ray, Jasodhara, et al., Proliferation, Differentiation, and Long Term Culture of Primary Hippocampal Neurons, Proc. Natl. Acad. Sci. USA, 90, pp. 3602 3606 (1993).;;Reemay, Inc., Reemay Spunbonded Polyester, pp. 1 20 (Product Information Literature), Reemay, Inc., Old Hickory, TN.;;Reynolds, Brent A., et al., A Multipotent EGF Responsive Striatal Embryonic Progenitor Cell Produces Neurons and Astocytes, The Journal of Neuroscience, 12, pp. 4565 4574 (1992).;;Richards, L.J. et al., De novo Generation of Neuronal Cells From The Adult Mouse Brain, Proc. Natl. Acad. Sci. USA, 89, pp. 8591 8595 (1992).;;Ron, David, Inducible Growth Arrest: New Mechanistic Insights, Proc. Natl. Acad. Sci. USA, 91, pp. 1985 1986 (1994).;;Ruoslahti, Erkki, and Michael D. Pierschbacher, New Perspectives in Cell Adhesion: RGD and Integrins, Science, 238, pp. 491 497 (1987).;;Ruoslahti, Erkki, and John C. Reed, Anchorage Dependence, Integrins, and Apoptosis, Cell, 77, pp. 477 478 (1994).;;Saiki, I., et al., Antimetastatic Effects of Synthetic Polypeptides Containing Repeated Structures of the Cell Adhesive Arg Gly Asp (RGD) and Tyr lle Gly Ser Arg (YIGSR) Sequences, Br. J. Cancer, 60, pp. 722 728 (1989).;;Sanes, Joshua R., Extracellular Matrix Molecules That Influence Neural Development, Ann. Rev. Neurosci., 12, pp. 491 516 (1989).;;Schinstine, Malcolm, and Fred H. Gage, Factors Affecting Proviral Expression in Primary Cells Grafted into the CNS, Molecular and Cellular Approaches for the Treatment of Neurological Diseases (S.G. Waxman, ed.), pp. 311 323 (1993).;;Seliger, Barbara, et al., Murine Gamma Interferon Inhibits v mos Induced Fibroblast Transformation via Down Regulation of Retroviral Gene Expression, Journal of Virology, 61, pp. 2567 2572 (1987).;;Seliger, Barbara, et al., Gamma Interferon Regulates Long Terminal Repeat Controlled Oncogene Expression in Transformed Mouse Fibroblasts at the Level of mRNA Transcription, Journal of Virology, 62, pp. 619 621 (1988).;;Seliger, Barbara, et al., Tumor Necrosis Factor Affects LTR Controlled Oncogene Expression in Transformed Mouse Fibroblasts at the Post Transcriptional Level, The Journal of Innumology, 141, pp. 2138 2144 (1988).;;Seliger, Barbara, et al., Distinct Mechanisms of Interferon Gamma and Tumor Necrosis Factor Alpha Action in Oncogene Transformed Mouse Fibroblasts, Journal of Cellular Biochemistry, 38, pp. 205 212 (1988).;;Sharifi, Behrooz G., et al., Cell Surface Interaction is Sufficient for the Biological Activity of a Bovine Sialoglycopeptide Inhibitor, Biochemical and Biophysical Research Communications, 134, pp. 1350 1357 (1986).;;Sharifi, Behrooz G., et al., Purification and Characterization of a Bovine Cerebral Cortex Cell Surface Sialoglycopeptide that Inhibits Cell Proliferation and Metabolism, Journal of Neurochemistry, 46, pp. 461 469 (1986).;;Smalheiser, Neil R., et al., Laminin As a Substrate for Retinal Axons In Vitro, Dev. Brain Res., 12, pp. 136 140 (1984).;;SoloHill Labs, Inc., SoloHill Labs, Inc., Ann Arbor, MI.;;Stockdale, Frank E., et al., Myoblasts, Satellite Cells, and Myoblast Transfer, Myoblast Transfer Therapy (R. Griggs and G. Karpati, eds.), pp. 7 11 (1990).;;Sun, Anthony M., Microencapsulation of Pancreatic Islet Cells: A Bioartificial Endocrine Pancreas, Methods in Enzymology, 137, pp. 575 580 (1988).;;Tashiro, Ken ichiro, et al., A Synthetic Peptide Containing the IKVAV Sequence from the A Chain of Laminin Mediates Cell Attachment, Migration, and Neurite Outgrowth, The Journal of Biological Chemistry, 264, pp. 16174 16182 (1989).;;Telios Pharmaceuticals, Integrins: An Update on the Rapid Growth of Research Topics, ECM Connections, a publication of Telios Pharmaceuticals, San Diego, CA (Jun. 1992).;;Telios Pharmaceuticals, PepTite 2000 (Product Information Memorandum), Telios Pharmaceuticals, San Diego, CA.",EXPIRED
435,US,A,US 5935849 A,097-485-738-794-458,1999-08-10,1999,US 27977394 A,1994-07-20,US 27977394 A,1994-07-20,Methods and compositions of growth control for cells encapsulated within bioartificial organs,"This invention relates to methods and compositions of controlling cell distribution within a bioartificial organ by exposing the cells to a treatment that inhibits cell proliferation, promotes cell differentiation, or affects cell attachment to a growth surface within the bioartificial organ. Such treatments include (1) genetically manipulating cells, (2) exposing the cells to a proliferation-inhibiting compound or a differentiation-inducing compound or removing the cells from exposure to a proliferation-stimulating compound or a differentiation-inhibiting compound; exposing the cells to irradiation, and (3) modifying a growth surface of the BAO with ECM molecules, molecules affecting cell proliferation or adhesion, or an inert scaffold, or a combination thereof. These treatments may be used in combination.",CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,CYTOTHERAPEUTICS INC (1994-11-05);;NEUROTECH S.A (1999-12-29);;NEUROTECH USA INC (2007-10-25),https://lens.org/097-485-738-794-458,Granted Patent,yes,36,90,5,40,4,A61L27/3839;;A61L27/3839;;A61K48/00;;A61K48/00;;A61L27/18;;A61L27/18;;A61L27/227;;A61L27/227;;A61L27/38;;C07K14/82;;C07K14/82;;C12N5/0012;;C12N5/0012;;C12N5/0068;;C12N5/0068;;C12N2510/00;;C12N2510/00;;C12N2510/04;;C12N2510/04;;C12N2533/30;;C12N2533/30;;C12N2533/54;;C12N2533/54;;C12N2533/74;;C12N2533/74,A01K67/027;;A61K48/00;;A61L27/00;;A61L27/18;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,435/325;;435/375;;435/377;;435/400,99,82,040-300-209-001-975;;078-401-268-829-715;;015-052-284-383-698;;051-467-747-043-981;;018-070-477-790-693;;120-596-939-734-383;;115-103-293-214-469;;004-129-864-323-871;;054-678-244-582-843;;021-321-949-597-771;;172-770-692-257-323;;060-164-752-701-836;;010-938-147-585-497;;011-276-786-730-941;;032-759-232-461-426;;108-379-915-909-34X;;028-364-375-537-319;;154-365-488-022-138;;026-016-347-959-887;;045-017-646-829-568;;066-523-881-622-501;;061-578-853-469-745;;057-767-055-501-614;;023-675-605-776-929;;104-865-628-368-26X;;173-587-013-695-171;;156-440-241-544-217;;068-141-789-713-733;;098-101-997-046-906;;034-178-376-559-657;;099-990-907-377-728;;005-358-343-205-664;;045-328-856-518-264;;004-236-732-518-638;;094-551-917-544-749;;108-168-722-195-491;;034-044-806-170-454;;038-918-079-679-253;;115-971-724-193-517;;009-792-950-241-971;;014-745-525-337-47X;;050-399-486-711-487;;059-049-072-219-166;;092-223-656-604-882;;018-117-336-909-414;;131-750-072-875-475;;003-664-236-520-709;;066-203-355-190-646;;105-834-428-184-911;;035-723-436-595-236;;034-249-775-255-429;;095-350-135-301-860;;060-291-465-466-062;;081-174-387-421-852;;052-782-286-478-646;;002-286-494-363-396;;101-732-752-675-701;;049-042-021-517-724;;164-020-307-617-474;;044-088-273-450-791;;012-333-350-448-43X;;046-111-513-250-242;;100-153-598-267-351;;028-211-379-291-005;;067-322-389-377-685;;147-346-857-684-894;;065-678-110-707-195;;076-012-254-853-704;;093-553-709-303-10X;;030-854-629-603-00X;;086-874-830-084-387;;016-063-554-957-496;;092-531-628-495-425;;055-467-864-296-721;;056-234-682-167-995;;090-908-679-116-661;;044-320-745-895-128;;001-928-366-548-586;;165-524-038-085-953;;008-119-464-657-166;;026-843-338-695-356;;084-502-628-664-10X,8406030;;10.1016/0378-1119(93)90507-y;;2194673;;10.1016/0092-8674(90)90239-b;;10.1007/bf02623638;;2666386;;pmc386305;;10.1073/pnas.83.15.5454;;2874553;;10.1126/science.8016653;;8016653;;10.1159/000112252;;3021428;;10.1016/0168-9525(93)90012-7;;8379006;;10.1002/bip.360260018;;2437977;;pmc6577554;;10.1523/jneurosci.14-03-01030.1994;;8120611;;10.1073/pnas.82.13.4438;;pmc391116;;3892534;;10.1007/978-1-349-11358-3_15;;10.1016/0896-6273(88)90184-5;;3078410;;10.1089/hum.1993.4.4-433;;8399490;;8190271;;10.1016/0306-4522(94)90097-3;;8440318;;10.1006/excr.1993.1026;;pmc1886816;;8456938;;8476199;;2475934;;10.1016/0166-2236(89)90020-9;;8242752;;10.1016/0092-8674(93)90500-p;;10.1016/b978-0-12-483365-4.50008-6;;1504017;;10.1016/0014-4827(91)90130-m;;1901795;;10.1002/jcp.1041390208;;2715187;;10.1016/s0344-0338(11)80845-9;;8183742;;10.1007/bf02592286;;7686057;;3749886;;10.1126/science.3749886;;8352534;;10.1016/0014-4827(92)90083-k;;1383013;;10.1021/bi00396a004;;2962631;;10.1016/0092-8674(87)90707-0;;2951015;;8016642;;10.1126/science.8016642;;10.1016/0896-6273(93)90068-3;;8398146;;10.1006/ncmn.1993.1052;;10.1016/0378-1119(93)90424-2;;8359690;;8318227;;10.1016/0896-6273(93)90051-r;;10.1111/j.1749-6632.1992.tb42589.x;;1416607;;pmc363533;;10.1128/mcb.8.8.3065-3079.1988;;10.1128/mcb.8.8.3065;;2974922;;1797805;;10.1002/jbm.820251102;;10.1126/science.2961059;;2961059;;2735903;;10.1016/0006-291x(89)92622-3;;10.1002/jnr.490280407;;1870155;;10.1016/0014-4827(91)90391-7;;2070822;;6308472;;10.1038/304596a0;;8517665;;6776628;;10.1126/science.6776628;;8338876;;10.1089/hum.1993.4.3-291;;10.1016/0003-2697(90)90459-m;;2382830;;10.1097/00002480-198907000-00165;;2597562;;1612781;;10.1002/ijc.2910510511;;6241504;;10.1247/csf.9.357;;10.1523/jneurosci.14-06-03533.1994;;7515952;;pmc6576935;;482611;;10.2307/3575179;;2489072;;10.1016/0141-8130(89)90049-4;;8393300;;10.1152/ajplung.1993.265.1.l1;;10.1172/jci116723;;pmc288291;;8104197;;8514795;;10.1016/s0021-9258(19)38695-8;;3422482;;10.1073/pnas.85.4.1105;;pmc279714;;10.1016/0003-9861(92)90533-3;;1586167;;6325925;;10.1038/309030a0;;10.1523/jneurosci.12-05-01802.1992;;1578271;;pmc6575890;;8331297;;10.1111/1523-1747.ep12359508;;10.1128/mcb.13.7.4223;;10.1128/mcb.13.7.4223-4232.1993;;pmc359972;;8391634;;10.1073/pnas.90.8.3602;;pmc46349;;8475109;;1432110;;10.1523/jneurosci.12-11-04565.1992;;pmc6575989;;10.1073/pnas.89.18.8591;;pmc49966;;1528866;;8134335;;10.1073/pnas.91.6.1985;;pmc43292;;10.1126/science.2821619;;2821619;;8187171;;10.1016/0092-8674(94)90209-7;;2803948;;pmc2247318;;10.1038/bjc.1989.347;;10.1146/annurev.ne.12.030189.002423;;2648958;;8417470;;10.1128/jvi.61.8.2567-2572.1987;;pmc255700;;3037117;;pmc250578;;10.1128/jvi.62.2.619-621.1988;;3121865;;2844896;;10.1002/jcb.240380308;;3147985;;10.1016/0006-291x(86)90398-0;;3947369;;2416876;;10.1111/j.1471-4159.1986.tb12990.x;;6697250;;2248157;;10.1007/978-1-4684-5865-7_2;;10.1016/0076-6879(88)37053-9;;3131633;;2777785;;10.1016/s0021-9258(18)71604-9;;2755510;;10.1038/340471a0,"Adhya, Sankar, et al., Promoter resurrection by activators a minireview, Gene , 132, pp. 1 6 (1993).;;Arnheiter, Heinz, et al., Transgenic Mice with Intracellular Immunity to Influena Virus, Cell , 62, pp. 51 61 (1990).;;Aulthouse, Amy Lynn, et al., Expression of the Human Chondrocyte Phenotype In Vitro, In Vitro Cellular & Developmental Biology , 25, pp. 659 668 (1989).;;Baetge, E. Edward, et al., Complete Nucleotide and Deduced Amino Acid Sequence of Bovine Phenylethanolamine N methyltransferase: Partial Amino Acid Homology With Rat Tyrosine Hydroxylase, Proc. Natl. Acad. Sci. USA , 83, pp. 5454 5458 (1986).;;Barinaga, Marcia, Knockout Mice: Round Two, Science , 265, pp. 26 28 (1994).;;Baron Van Evercooren, A., et al., Schwann Cell Differentiation in vitro: Extracellular Matrix Deposition and Interaction, Dev. Neurosci. , 8, pp. 182 196 (1986).;;Blau, Helen M., et al., Myoblasts in Pattern Formation and Gene Therapy, Trends in Genetics , 9, pp. 269 274 (1993).;;Bohak Z, ., et al. Novel Anchorage Matrices for Suspension Culture of Mammalian Cells, Biopolymers , 26, pp. S205 S213 (1987).;;Brenner, Michael, et al., GFAP Promoter Directs Astrocyte specific Expression in Transgenic Mice, The Journal of Neuroscience , 14, pp. 1030 1037 (1994).;;Brinster et al., Factors Affecting the Efficiency of Introducing Foreign DNA into Mice by Microinjecting Eggs, Proc. Natl. Acad. Sci. USA , 82, pp. 4438 4442 (1985).;;Cabasso, Israel, Hollow Fiber Membranes, Encyclopedia of Chemical Technology (Kirk Othmer, ed.), pp. 492 517 (1980).;;Carbonetto, Salvatore, Ch. 15: Laminin Receptors: From PC12 Cells to PNS, Brain Repair (Bj o rklund, Aguayo and Ottoson, eds.), pp. 185 197 (1990).;;Celtrix Laboratories, Vitrogen 100 : Purified Collagen for Cell Culture and Biochemistry (Product Information Memorandum), Celtrix Laboratories, Palo Alto, CA (1991).;;Cepko, Connie, Retrovirus Vectors and Their Applications in Neurobiology, Neuron , 1, 345 53 (1988).;;Chang, P.L., et al., Deleivery of Recombinant Gene Products with Microencapsulated Cells In Vivo, Human Gene Therapy , 4, pp. 433 440 (1993).;;Chu, C.H., and A.M. Tolkovsky, Alternative Adrenal Chromaffin Cell Fates Induced by Basic Fibroblast Growth Factor or Cyclic AMP In Vitro Depend on a Collaboration With The Growth Substrate, Neuroscience , 59, pp. 43 54 (1994).;;Collaborative Research Incorporated, CR LAMININ an CR ANTI LAMININ (Product Information Memorandum), Collaborative Research, Inc., Bedford, MA (1987).;;Collaborative Research Incorporated, Basement Membrane Matrigel (Product Specification Sheet), Collaborative Research, Inc., Bedford, MA (1991).;;Collagen Biomedical, Collagen Test Implant Physician Package Insert, (Product Information Literature), Collagen Biomedical, Palo Alto, CA (1992).;;Collagen Biomedical, Zyderm Collagen and Zyderm Explained, (Product Information Memorandum), Collagen Biomedical, Palo Alto, CA (1992).;;Collagen Biomedical, Zyderm Collagen Implant Physician Package Insert, (Product Literature), Collagen Biomedical, Palo Alto, CA (1992).;;Collagen Biomedical, Zyplast Implant Physician Package Insert, (Product Literature), Collagen Biomedical, Palo Alto, CA (1992).;;Crouch, Gary D., et al., Ara C Treatment Leads to Differentiation and Reverses the Transformed Phenotype in a Human Rhabdomyosarcoma Cell Line, Experimental Cell Research , 204, pp. 210 216 (1993).;;Datta, Dipak B., Keeping In Touch: The Adhesion Reactions of the Cell Membrane, A Comprehensive Introduction to Membrane Biochemistry , pp. 231 256 (1987).;;de Bruine, Adriaan P., et al., Extracellular Matrix Components Induce Endocrine Differentiation in Vitro in NCI H716 Cells, American Journal of Pathology , 142, pp. 773 782 (1993).;;De Loecker, William, et al., Effects of Sodium Ascorbate (Vitamin C) and 2 Methyl 1,4 naphthoquinone (Vitamin K 3 ) Treatment on Human Tumor Cell Growth in Vitro. II. Synergism with Combined Chemotherapy Action, Anticancer Research , 13, pp. 103 106 (1993).;;Edgar, David, Neuronal laminin receptors, TINS , 12, pp. 248 251 (1989).;;El Deiry, Wafik S., et al., WAF1 , a Potential Mediator of p53 Tumor Suppression, Cell , 75, pp. 817 825 (1993).;;End, Peter, and Jurgen Engel, Multidomain Proteins of the Extracellular Matrix and Cellular Growth, Receptors for Extracellular Matrix (McDonald, J. and Mecham, R., ed.), pp. 79 129 (1991).;;Epstein Baak, Ruth, et al., Inducible Transformation of Cells from transgenic Mice Expressing SV40 under lac Operon Control, Cell Growth and Differentiation , 3, pp. 127 134 (1992).;;Fattaey, H.K., et al., Modulation of Growth Related Gene Expression and Cell Cycle Synchronization by a Sialoglycopeptide Inhibitor, Experimental Cell Research , 194, pp. 62 68 (1991).;;Fattaey, Heideh, et al., Inhibition of DNA Synthesis and Cell Division by a Cell Surface Sialoglycopeptide, Journal of Cellular Physiology , 139, pp. 269 274 (1989).;;Fujiyama, C., et al., Influence of Extracellular Matrix on the Proliferation and Differentiation of Adrenocortical Cells in Culture, Path. Res. Pract. , 189, pp. 1205 1214 (1993).;;Gali, Maria C., et al., The Biology of Stem Cell Factor, a New Hematopoietic Growth Factor Involved in Stem Cell Regulation, Int. J. of Clin. Lab. Res. , 23, pp. 70 77 (1993).;;Gash, D.M., et al., Amitotic Neuroblastoma Cells Used for Neural Implants in Monkeys, Science , 233, p. 1420 1422 (1986).;;Gonos, Efstathios S., and Demetrios A. Spandidos, Oncogenes in Cellular Immortalisation and Differentiation (Review), Anticancer Research , 13, pp. 1117 1122 (1993).;;Grabham, Peter W., et al. Vibronectin Is the Major Serum Protein Essential for NGF Mediated Neurite Outgrowth from PC12 Cells, Experimental Cell Research , 202, pp. 337 344 (1992).;;Graf, Jeannette, et al., A Pentapeptide from the Laminin 1 Chain Mediates Cell Adhesion and Binds the 67 000 Laminin Receptor, Biochemistry , 26, pp. 6896 6900 (1987).;;Graf, Jeannette, et al., Identification of an Amino Acid Sequence in Laminin Mediating Cell Attachment, Chemotaxi, and Receptor Binding, Cell , 48, pp. 989 996 (1987).;;Gu, Hua, et al., Deletion of a DNA Polymerase Gene Segment in T Cells Using Cell Type Specific Gene Targeting, Science , 265, pp. 103 106 (1994).;;Gumbiner, Barry M., Proteins Associated with the Cytoplasmic Surface of Adhesion Molecules, Neuron , 11, pp. 551 564 (1993).;;Hammang, Joseph P., Immortalized Neuronal and Neuroendocrine Cell Lines by Targeted Oncogenesis in Transgenic Mice Using the PNMT Promoter, Neuroprotocols: A Companion to Methods in Neurosciences , 3, pp. 176 183 (1993).;;Hannan, G.N., et al., An engineered PGK promoter and lac operator repressor system for the regulation of gene expression in mammalian cells, Gene , 130, pp. 233 239 (1993).;;Hoyle, Gary W., et al., Expression of NGF in Sympathetic Neurons Leads to Excessive Axon Outgrowth from Ganglia but Decreased Terminal Innervation within Tissues, Neuron , 10, pp. 1019 1034 (1993).;;Hubbell, Jeffrey A., et al., Surface grafted Cell binding Peptides in Tissue Engineering of the Vascular Graft, Annals New York Academy of Sciences , 665, pp. 253 258 (1992).;;Hug, Hubert, et al., Organization of the Murine Mx Gene and Characterization of its Interferon and Virus Inducible Promoter, Molecular and Cellular Biology , 8, pp. 3065 3079 (1988).;;HyClone Laboratories, CultiSpher G (Product Information Memorandum), HyClone Laboratories, Logan, UT (no dates).;;HyClone Laboratories, CultiSpher GL (Product Information Memorandum), HyClone Laboratories, Logan, UT (no date).;;Ito, Yoshihiro, et al., Materials for Enhancing Cell Adhesion by Immobilization of Cell Adhesive Peptide, Journal of Biomedical Materials Research , 25, pp. 1325 1337 (1991).;;Iwamoto, Yukihide, et al., YIGSR, a Synthetic Laminin Pentapeptide, Inhibits Experimental Metastasis Formation, Science , 238, pp. 1132 1134 (1987).;;Johnson, Terry C., and Behrooz G. Sharifi, Abrogation of the Mitogenic Activity of Bombesin by a Cell Surface Sialoglycopeptide Growth Inhibitor, Biochemical and Biophysical Research Communications , 161, pp. 468 474 (1989).;;Jucker, M., et al. Fetal Rats Septal Cells Adhere to and Extend Processes on Basement Membrane, Laminin, and a Synthetic Peptide the Laminin A Chain Sequence, J. Neurosci. Res. , 28, 507 517 (1991).;;Kleinman, Hynda K., et al., The Role of Laminin in Basement Membranes and in the Growth, Adhesion, and Differentiation of Cells, The Role of Extracellular Matrix in Development , pp. 123 143 (1984).;;Kleinman, Hynda K., and Benjamin S. Weeks, The Neural Cell Response to Laminin: Active Sites, Receptors, and Intracellular Signals, Comments Developmental Neurobilogy , 1, pp. 251 266 (1991).;;Lakshmanarao, S.S., et al., Identification of Cell Surface Component of Swiss 3T3 Cells Associated with a Inhibition of Cell Division, Experimental Cell Research , 195, pp. 412 415 (1991).;;Land, Hartmut, et al., Tumorigenic Conversion of Primary Embryo Fibroblasts Requires At Least Two Cooperating Oncogenes, Nature , 304, pp. 596 602 (1983).;;Leung, Ping. Y., et al., Cytotoxic Effect of Ascorbate and its Derivatives on Cultured Malignant and Nonmalignant Cell Lines, Anticancer Research , 13, pp. 475 480 (1993).;;Lim, F., et al., Microencapsulated Islets as Bioartificial Endocrine Pancreas, Science , 210, pp. 908 910 (1980).;;Liu, Hong Wen, et al., Expression of Human Factor IX by Microencapsulated Recombinant Fibroblasts, Human Gene Therapy , 4, pp. 291 301 (1993).;;Massia, Stephen P., and Jeffrey A. Hubbell, Covalent Surface Immobilization of Arg Gly Asp and Try lle Gly Ser Arg Containing Peptides to Obtain Well Defined Cell Adhesive Substrates, Analytical Biochemistry , 187, pp. 292 301 (1990).;;Matsuda, Takehisa, et al., Development of a Novel Artificial Matrix with Cell Adhesion Peptides for Cell Culture and Artificial and Hybrid Organs, Trans. Am. Soc. Artif. Intern. Organs , 35, pp. 677 679 (1989).;;Matsushima, Hiroshi, and Emil Bogenmann, Modulation of Neuroblastoma Cell Differentiation by the Extracellular Matrix, Int. J. Cancer , 51, pp. 727 732 (1992).;;Matuoka et al., Heparan Sulfate Enhances Growth of Transformed Human Cells, Cell Structure and Function , 9, p. 357 (1984).;;Messing, Albee, et al., Hypomyelinating Peripheral Neuropathies and Schwannomas in Transgenic Mice Expressing SV40 T Antigen, The Journal of Neuroscience , 14, pp. 3533 3539 (1994).;;Mitchell, J.B., et al. Dose Rate Effects in Mammalian Cells in Culture, Radiat. Res. , 79, pp. 537 551 (1979).;;Murata, Jun, et al., Inhibitory Effect of a Synthetic Polypeptide, Poly(Tyr lle Gly Ser Arg), On the Metastatic Formation of Malignant Tumour Cells, Int. J. Biol. Macromol. , 11, pp. 97 99 (1989).;;Neckers, Len, and Luke Whitesell, Antisense Technology: Biological Untility and Practical Considerations, Am. J. Physiol , 265, pp. L1 L12 (1993).;;Otonkoski, Timo, et al., Nicotinamide Is a Potent Inducer of Endocrine Diferentiation in Cultured Human Fetal Pancreatic Cells, J. Clin. Invest. , 92, pp. 1459 1466 (1993).;;Pash, James M., et al., Aberrant Expression of High Mobility Group Chromosomal Protein 14 Affects Cellular Differentiation, The Journal of Biological Chemistry , 268, pp. 13632 13638 (1993).;;Penttinen, Risto P., et al., Transforming Growth Factor Increases mRNA for Matrix Proteins Both in the Presence and in the Absence of Changes in mRNA Stability, Proc. Natl. Acad. Sci. USA , 85, pp. 1105 1108 (1988).;;Phillips, Charlotte L., et al., Ascorbic Acid and Transforming Growth Factor 1 Increase Collagen Biosynthesis via Different mechanisms: Coordinate Regulation of Pro 1(I) and Pro 1(III) Collagens, Archives of Biochemistry and Biophysics , 295, pp. 397 403 (1992).;;Pierschbacher, Michael D., and Erkki Ruoslatti, Cell Attachment Activity of Fibronectin Can Be Duplicated By Small Synthetic Fragments of the Molecule, Science , 309, pp. 30 33 (1984).;;Pleasure, Samuel, et al., Postmitotic, Polarized Human Neurons Derived from NTera 2 Cells Provide a System for Expressing Exogenous Proteins in Terminally Differentiated Neurons, The Journal of Neuroscience , 12, pp. 1802 1815 (1992).;;Prystowsky et al., Inhibition of Ornithine Decarboxylase Activity and Cell Proliferation by Ulraviolet Radiation in EGF Stimulated Cultured Human epidermal Keratinocytes, J. Invest. Dermat. , 101, pp. 54 58 (1993).;;Radvanyi, Francois, et al., Pancreatic Cells Cultured from Individual Preneoplastic Foci in a Multistage Tumorigenesis Pathway: a Potentially General Technique for Isolating Physiologically Representative Cell Lines, Molecular and Cellular Biology , 13, pp. 4223 4232 (1993).;;Ray, Jasodhara, et al., Differentiation, and Long Term Culture of Primary Hippocampal Neurons, Proc. Natl. Acad. Sci. USA , 90, pp. 3602 3606 (1993).;;Reemay, Inc., Reemay Spundonded Polyester, pp. 1 20 (Product Information Literature), Reemay, Inc., Old Hickory, TN. (no date).;;Reynolds, Brent A., et al., A Multipotent EGF Responsive Striatal Embryonic Progenitor Cell Produces Neurons and Astrocytes, The Journal of Neuroscience , 12, pp. 4565 4574 (1992).;;Richards, L.J. et al., De novo Generation of Neuronal Cells From The Adult Mouse Brain, Proc. Natl. Acad. Sci. USA , 89, pp. 8591 8595 (1992).;;Ron, David, Inducible Growth Arrest: New Mechanistic Insights, Proc. Natl. Acad. Sci. USA , 91, pp. 1985 1986 (1994).;;Ruoslahti, Erkki, and Michael D. Pierschbacher, New Perspectives in Cell Adhesion: RGD and Integrins, Science , 238, pp. 491 497 (1987).;;Ruoslahti, Erkki, and John C. Reed, Anchorage Dependence, Integrins, and Apoptosis, Cell , 77, pp. 477 478 (1994).;;Saiki, I., et al., Antimetastatic Effects of Synthetic Polypeptides Containing Repeated Structures of the Cell Adhesive Arg Gly Asp (RGD) and Tyr lle Gly Ser Arg (YIGSR) Sequences, Br. J. Cancer , 60, pp. 722 728 (1989).;;Sanes, Joshua R., Extracellular Matrix Molecules That Influence Neural Development, Ann. Rev. Neurosci. , 12, pp. 491 519 (1989).;;Schinstine, Malcolm, and Fred H. Gage, Factors Affecting Proviral Expression in Primary Cells Grafted into the CNS, Molecular and Cellular Approaches for the Treatment of Neurological Diseases (S.G. Waxman, ed.), pp. 311 323 (1993).;;Seliger, Barbara, et al., Murine Gamma Interferon Inhibits v mos induced Fibroblast Transformation via Down Regulation of Retroviral Gene Expression, Journal of Virology , 61, pp. 2567 72 (1987).;;Seliger, Barbara, et al., Gamma Interferon Regulates Long Terminal Repeat Controlled Oncogene Expression in Transformed Mouse Fibroblasts at the Level of mRNA Transcription, Journal of Virology , 62, pp. 619 621 (1988).;;Seliger, Barbara, et al., Tumor Necrosis Factor Affects LTR Controlled Oncogene Expression in Transformed Mouse Fibroblasts at the Post Transcriptional Level, The Journal of Immunology , 141, pp. 2138 2144 (1988).;;Seliger, Barbara, et al., Distinct Mechanisms of Interferon Gamma and Tumor Necrosis Factor Alpha Action in Oncogene Transformed Mouse Fibroblasts, Journal of Cellular Biochemistry , 38, pp. 205 212 (1988).;;Sharifi, Behrooz G., et al., Cell Surface Interaction is Sufficient for the Biological Activity of a Bovine Sialoglycopeptide Inhibitor, Biochemical and Biophysical Research Communications , 134, pp. 1350 1357 (1986).;;Sharifi, Behrooz G., et al., Purification and Characterization of a Bovine Cerebral Cortex Cell Surface Sialoglycopeptide that Inhibits Cell Proliferation and Metabolism, Journal of Neurochemisty , 46, pp. 461 469 (1986).;;Smalheiser, Neil R., et al., Laminin As a Substrate for Retinal Axons In Vitro, Dev. Brain Res. , 12, pp. 136 140 (1984).;;SoloHill Labs, Inc., SoloHill Labs, Inc., Ann Arbor, MI. (no date).;;Stockdale, Frank E., et al., Myoblasts, Satellite Cells, and Myoblast Transfer, Myoblast Transfer Therapy (R. Griggs and G. Karpati, eds.), pp. 7 11 (1990).;;Sun, Anthony M., Microencapsulation of Pancreatic Islet Cells: A Bioartificial Endocrine Pancreas, Methods in Enzymology , 137, pp. 575 580 (1988).;;Tashiro, Ken ichiro, et al., A Synthetic Peptide Containing the IKVAV Sequence from the A Chain of Laminin Mediates Cell Attachment, Migration, and Neurite Outgrowth, The Journal of Biological Chemistry , 264, pp. 16174 16182 (1989).;;Telios Pharmaceuticals, Integrins: An Update on the Rapid Growth of Research Topics, in ECM Connections , a publication of Telios Pharmaceuticals, San Diego, CA (Jun. 1992).;;Telios Pharmaceuticals, PepTite 2000 (Product Information Memorandum), Telios Pharmaceuticals, San Diego, CA. (no date).;;Temple, Sally, Division and Differentiation of Isolated CNS Blast Cells in Microculture, Nature , 340, pp. 471 473 (1989).",EXPIRED
436,BR,A,BR 9508312 A,124-505-836-440-269,1999-06-01,1999,BR 9508312 A,1995-07-20,US 27977394 A;;US 43269895 A;;US 9509281 W,1994-07-20,Controle de crescimento para células encapsuladas dentro de órgãos bioartificiais,,CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK,,https://lens.org/124-505-836-440-269,Patent Application,no,0,0,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A61L27/00;;A61L27/18;;A01K67/027;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,PENDING
437,US,A1,US 2014/0240423 A1,153-672-790-860-662,2014-08-28,2014,US 201313922776 A,2013-06-20,US 201313922776 A;;US 201361769026 P,2013-02-25,PRINTER WITH VACUUM BELT ASSEMBLY HAVING INDEPENDENTLY LATERALLY MOVABLE BELTS,"A printer includes a vacuum belt assembly for moving print media in a media feed direction along a media path. The vacuum belt assembly includes: a plurality of endless belts tensioned between first and second pulleys, the first and second pulleys having respective first and second axes of rotation perpendicular with the media feed direction; and a vacuum chamber for drawing print media onto an upper surface of the belts. Each belt is independently laterally slidable along one of the first and second axes.",ZAMTEC LTD,CRESSMAN BILL STONE;;REGAS KENNETH ANDREW;;LUCAS JONATHAN DAY;;BURNEY DAVID COLLINS;;KIRK PATRICK;;INDERIEDEN STEVE;;DOHERTY NEIL;;POH LAI SAY;;KOH JOO BENG;;MAGSAKAY GILBERT,MEMJET TECHNOLOGY LIMITED (2013-04-29),https://lens.org/153-672-790-860-662,Patent Application,yes,4,6,8,8,0,B41J11/0085;;B41J11/0085;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007,B41J11/00,347/104,0,0,,,,ACTIVE
438,US,A1,US 2015/0029281 A1,138-885-530-777-526,2015-01-29,2015,US 201414515221 A,2014-10-15,US 201414515221 A;;US 201313922926 A;;US 201361769026 P,2013-02-25,PRINTER WITH VACUUM BELT ASSEMBLY HAVING CONTROLLED SUCTION,"A printer includes a vacuum belt assembly for moving print media in a media feed direction along a media path. The vacuum belt assembly includes: a plurality of spaced apart endless belts tensioned between first and second pulleys; a vacuum chamber for drawing print media onto an upper surface of the belts; and a plurality of vacuum antechambers communicating with the vacuum chamber, each vacuum antechamber having a perimeter opening for suction engagement with print media, a length dimension of each perimeter opening extending longitudinally in the media feed direction. A first perimeter opening of a first vacuum antechamber positioned towards an upstream side of the vacuum belt assembly is shorter than a second perimeter opening of a second vacuum antechamber positioned towards a downstream side of the vacuum belt assembly. The upstream and downstream sides are defined with respect to the media feed direction.",MEMJET TECHNOLOGY LTD,CRESSMAN WILLIAM STONE;;REGAS KENNETH ANDREW;;LUCAS JONATHAN DAY;;BURNEY DAVID COLLINS;;KIRK PATRICK;;INDERIEDEN STEVE;;DOHERTY NEIL;;POH LAI SAY;;KOH JOO BENG;;MAGSAKAY GILBERT,MEMJET TECHNOLOGY LIMITED (2013-04-29),https://lens.org/138-885-530-777-526,Patent Application,yes,2,4,8,8,0,B41J11/0085;;B41J11/0085;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007,B41J11/00,347/104,3,0,,,copending Application No. 13/922776;;copending Application No. 13/922942;;copending Application No. 13/922926,ACTIVE
439,US,B2,US 8926086 B2,011-340-755-297-544,2015-01-06,2015,US 201313922926 A,2013-06-20,US 201313922926 A;;US 201361769026 P,2013-02-25,Printer with vacuum belt assembly having controlled suction,"A printer includes a vacuum belt assembly for moving print media in a media feed direction along a media path. The vacuum belt assembly includes: a plurality of spaced apart endless belts tensioned between first and second pulleys; a vacuum chamber for drawing print media onto an upper surface of the belts; and a plurality of vacuum antechambers communicating with the vacuum chamber, each vacuum antechamber having a perimeter opening for suction engagement with print media, a length dimension of each perimeter opening extending longitudinally in the media feed direction. A first perimeter opening of a first vacuum antechamber positioned towards an upstream side of the vacuum belt assembly is shorter than a second perimeter opening of a second vacuum antechamber positioned towards a downstream side of the vacuum belt assembly. The upstream and downstream sides are defined with respect to the media feed direction.",ZAMTEC LTD;;MEMJET TECHNOLOGY LTD,CRESSMAN BILL STONE;;REGAS KENNETH ANDREW;;LUCAS JONATHAN DAY;;BURNEY DAVID COLLINS;;KIRK PATRICK;;INDERIEDEN STEVE;;DOHERTY NEIL;;POH LAI SAY;;KOH JOO BENG;;MAGSAKAY GILBERT,MEMJET TECHNOLOGY LIMITED (2013-04-29),https://lens.org/011-340-755-297-544,Granted Patent,yes,8,3,8,8,0,B41J11/0085;;B41J11/0085;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007,B41J2/01;;B41J11/00,347/104,2,0,,,"Copending U.S. Appl. No. 13/922,776.;;Copending U.S. Appl. No. 13/922,942.",ACTIVE
440,US,B2,US 8939574 B2,158-858-846-991-344,2015-01-27,2015,US 201313922942 A,2013-06-20,US 201313922942 A;;US 201361769026 P,2013-02-25,Printer with vacuum belt assembly having non-apertured belts,"A printer includes a vacuum belt assembly for moving print media in a media feed direction along a media path. The vacuum belt assembly includes a plurality of moving belt modules, each moving belt module including: a body having an internal chamber defining at least part of a vacuum chamber; a first pulley positioned at a first end of the body; a second pulley positioned at a second end of the body; and a set of spaced apart endless belts tensioned between the first and second pulleys. The belts are non-apertured and the vacuum chamber communicates with an interstitial gap defined between each adjacent pair of belts in the set so as to draw print media onto an upper surface of the moving belt module.",ZAMTEC LTD;;MEMJET TECHNOLOGY LTD,CRESSMAN WILLIAM STONE;;REGAS KENNETH ANDREW;;LUCAS JONATHAN DAY;;BURNEY DAVID COLLINS;;KIRK PATRICK;;INDERIEDEN STEVE;;DOHERTY NEIL;;POH LAI SAY;;KOH JOO BENG;;MAGSAKAY GILBERT,MEMJET TECHNOLOGY LIMITED (2013-04-29),https://lens.org/158-858-846-991-344,Granted Patent,yes,9,3,8,8,0,B41J11/0085;;B41J11/0085;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007,B41J2/01;;B41J11/00,347/104,2,0,,,"Copending U.S. Appl. No. 13/922,776.;;Copending U.S. Appl. No. 13/922,926.",ACTIVE
441,US,B2,US 9409419 B2,064-668-754-676-974,2016-08-09,2016,US 201313922776 A,2013-06-20,US 201313922776 A;;US 201361769026 P,2013-02-25,Printer with vacuum belt assembly having independently laterally movable belts,"A printer includes a vacuum belt assembly for moving print media in a media feed direction along a media path. The vacuum belt assembly includes: a plurality of endless belts tensioned between first and second pulleys, the first and second pulleys having respective first and second axes of rotation perpendicular with the media feed direction; and a vacuum chamber for drawing print media onto an upper surface of the belts. Each belt is independently laterally slidable along one of the first and second axes.",ZAMTEC LTD;;MEMJET TECHNOLOGY LTD,CRESSMAN BILL STONE;;REGAS KENNETH ANDREW;;LUCAS JONATHAN DAY;;BURNEY DAVID COLLINS;;KIRK PATRICK;;INDERIEDEN STEVE;;DOHERTY NEIL;;POH LAI SAY;;KOH JOO BENG;;MAGSAKAY GILBERT,MEMJET TECHNOLOGY LIMITED (2013-04-29),https://lens.org/064-668-754-676-974,Granted Patent,yes,16,0,8,8,0,B41J11/0085;;B41J11/0085;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007,B41J11/00,,2,0,,,"Copending U.S. Appl. No. 13/922,926.;;Copending U.S. Appl. No. 13/922,942.",ACTIVE
442,US,B2,US 9302507 B2,077-386-196-305-939,2016-04-05,2016,US 201414515221 A,2014-10-15,US 201414515221 A;;US 201313922926 A;;US 201361769026 P,2013-02-25,Method of transporting print medium in a printer,"A method of transporting a print medium in a printer. The includes suctioning the print medium onto an upper surface of a plurality of moving belts. The print medium experiences greater suction at an upstream side of the belts relative to a downstream side of the belts, the upstream and downstream sides being defined relative to a media feed direction.",MEMJET TECHNOLOGY LTD,CRESSMAN WILLIAM STONE;;REGAS KENNETH ANDREW;;LUCAS JONATHAN DAY;;BURNEY DAVID COLLINS;;KIRK PATRICK;;INDERIEDEN STEVE;;DOHERTY NEIL;;POH LAI SAY;;KOH JOO BENG;;MAGSAKAY GILBERT,MEMJET TECHNOLOGY LIMITED (2013-04-29),https://lens.org/077-386-196-305-939,Granted Patent,yes,11,0,8,8,0,B41J11/0085;;B41J11/0085;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007,B41J11/00,,3,0,,,"Copending U.S. Appl. No. 13/922,776.;;Copending U.S. Appl. No. 13/922,942.;;Copending U.S. Appl. No. 13/922,926.",ACTIVE
443,US,A1,US 2014/0240425 A1,169-218-325-670-848,2014-08-28,2014,US 201313922942 A,2013-06-20,US 201313922942 A;;US 201361769026 P,2013-02-25,PRINTER WITH VACUUM BELT ASSEMBLY HAVING NON-APERTURED BELTS,"A printer includes a vacuum belt assembly for moving print media in a media feed direction along a media path. The vacuum belt assembly includes a plurality of moving belt modules, each moving belt module including: a body having an internal chamber defining at least part of a vacuum chamber; a first pulley positioned at a first end of the body; a second pulley positioned at a second end of the body; and a set of spaced apart endless belts tensioned between the first and second pulleys. The belts are non-apertured and the vacuum chamber communicates with an interstitial gap defined between each adjacent pair of belts in the set so as to draw print media onto an upper surface of the moving belt module.",ZAMTEC LTD,CRESSMAN BILL STONE;;REGAS KENNETH ANDREW;;LUCAS JONATHAN DAY;;BURNEY DAVID COLLINS;;KIRK PATRICK;;INDERIEDEN STEVE;;DOHERTY NEIL;;POH LAI SAY;;KOH JOO BENG;;MAGSAKAY GILBERT,MEMJET TECHNOLOGY LIMITED (2013-04-29),https://lens.org/169-218-325-670-848,Patent Application,yes,0,1,8,8,0,B41J11/0085;;B41J11/0085;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007,B41J11/00,347/104,0,0,,,,ACTIVE
444,US,A1,US 2014/0240424 A1,149-730-320-936-405,2014-08-28,2014,US 201313922926 A,2013-06-20,US 201313922926 A;;US 201361769026 P,2013-02-25,PRINTER WITH VACUUM BELT ASSEMBLY HAVING CONTROLLED SUCTION,"A printer includes a vacuum belt assembly for moving print media in a media feed direction along a media path. The vacuum belt assembly includes: a plurality of spaced apart endless belts tensioned between first and second pulleys; a vacuum chamber for drawing print media onto an upper surface of the belts; and a plurality of vacuum antechambers communicating with the vacuum chamber, each vacuum antechamber having a perimeter opening for suction engagement with print media, a length dimension of each perimeter opening extending longitudinally in the media feed direction. A first perimeter opening of a first vacuum antechamber positioned towards an upstream side of the vacuum belt assembly is shorter than a second perimeter opening of a second vacuum antechamber positioned towards a downstream side of the vacuum belt assembly. The upstream and downstream sides are defined with respect to the media feed direction.",ZAMTEC LTD,CRESSMAN BILL STONE;;REGAS KENNETH ANDREW;;LUCAS JONATHAN DAY;;BURNEY DAVID COLLINS;;KIRK PATRICK;;INDERIEDEN STEVE;;DOHERTY NEIL;;POH LAI SAY;;KOH JOO BENG;;MAGSAKAY GILBERT,MEMJET TECHNOLOGY LIMITED (2013-04-29),https://lens.org/149-730-320-936-405,Patent Application,yes,0,0,8,8,0,B41J11/0085;;B41J11/0085;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007,B41J11/00,347/104,0,0,,,,ACTIVE
445,EE,A,EE 9700018 A,195-096-417-695-268,1997-06-16,1997,EE 9700018 A,1995-07-20,US 27977394 A;;US 43269895 A;;US 9509281 W,1994-07-20,Bioloogilistesse tehiselunditesse kapseldatud rakkude kasvu kontrollimine,,CYTOTHERAPEUTICS INC,MOLLY S SHOICHET;;FRANK T GENTILE;;JOSEPH P HAMMANG;;BRIAN M CAIN;;EDWARD J DOHERTY;;SHELLEY R WINN;;MALCOLM SCHINSTINE;;LAURA M HOLLAND;;PATRICK AEBISCHER;;ALBEE MESSING,,https://lens.org/195-096-417-695-268,Patent Application,no,0,0,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A61L27/00;;A61L27/18;;A01K67/027;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,PENDING
446,EP,A2,EP 1983053 A2,185-548-940-796-751,2008-10-22,2008,EP 08003594 A,1995-07-20,EP 95927373 A;;US 27977394 A;;US 43269895 A,1994-07-20,Cell distribution control for cells within bioartifical organs,"This invention relates to methods and compositions of controlling cell distribution within a bioartificial organ by exposing the cells to a treatment that inhibits cell proliferation, promotes cell differentiation, or affects cell attachment to a growth surface within the bioartificial organ. Such treatments include (1) genetically manipulating cells, (2) exposing the cells to a proliferation-inhibiting compound or a differentiation-inducing compound or removing the cells from exposure to a proliferation-stimulating compound or a differentiation-inhibiting compound; exposing the cells to irradiation, and (3) modifying a growth surface of the BAO with ECM molecules, molecules affecting cell proliferation or adhesion, or an inert scaffold, or a combination thereof. These treatments may be used in combination.",NEUROTECH USA INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK;;MESSING ALBEE,,https://lens.org/185-548-940-796-751,Patent Application,yes,24,0,5,40,4,A61L27/3839;;A61L27/3839;;A61K48/00;;A61K48/00;;A61L27/18;;A61L27/18;;A61L27/227;;A61L27/227;;A61L27/38;;C07K14/82;;C07K14/82;;C12N5/0012;;C12N5/0012;;C12N5/0068;;C12N5/0068;;C12N2510/00;;C12N2510/00;;C12N2510/04;;C12N2510/04;;C12N2533/30;;C12N2533/30;;C12N2533/54;;C12N2533/54;;C12N2533/74;;C12N2533/74,A01K67/027;;C12N15/12;;A61K35/12;;A61K48/00;;A61L27/00;;A61L27/18;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09,,59,50,018-117-336-909-414;;035-954-015-159-020;;156-440-241-544-217;;067-322-389-377-685;;100-153-598-267-351;;115-103-293-214-469;;059-049-072-219-166;;060-164-752-701-836;;045-328-856-518-264;;034-044-806-170-454;;078-401-268-829-715;;078-401-268-829-715;;016-063-554-957-496;;092-531-628-495-425;;012-864-134-556-076;;026-016-347-959-887;;004-236-732-518-638;;081-174-387-421-852;;104-865-628-368-26X;;049-042-021-517-724;;069-595-759-212-13X;;046-111-513-250-242;;173-587-013-695-171;;032-759-232-461-426;;052-782-286-478-646;;120-596-939-734-383;;061-578-853-469-745;;057-767-055-501-614;;021-277-502-985-182;;095-350-135-301-860;;012-333-350-448-43X;;021-277-502-985-182;;023-675-605-776-929;;108-379-915-909-34X;;035-723-436-595-236;;108-379-915-909-34X;;011-276-786-730-941;;164-020-307-617-474;;098-101-997-046-906;;014-745-525-337-47X;;015-052-284-383-698;;045-017-646-829-568;;021-321-949-597-771;;028-211-379-291-005;;100-194-559-825-69X;;034-249-775-255-429;;094-551-917-544-749;;051-467-747-043-981;;075-223-191-737-442;;051-467-747-043-981,6776628;;10.1126/science.6776628;;10.1016/0076-6879(90)92072-l;;2074790;;8352534;;10.1073/pnas.89.18.8591;;pmc49966;;1528866;;10.1073/pnas.90.8.3602;;pmc46349;;8475109;;10.1016/0168-9525(93)90012-7;;8379006;;6308472;;10.1038/304596a0;;10.1016/0896-6273(88)90184-5;;3078410;;10.1006/ncmn.1993.1052;;pmc363533;;10.1128/mcb.8.8.3065-3079.1988;;10.1128/mcb.8.8.3065;;2974922;;2194673;;10.1016/0092-8674(90)90239-b;;2194673;;10.1016/0092-8674(90)90239-b;;10.1128/jvi.61.8.2567-2572.1987;;pmc255700;;3037117;;pmc250578;;10.1128/jvi.62.2.619-621.1988;;3121865;;8352939;;10.1016/0896-6273(93)90177-s;;8242752;;10.1016/0092-8674(93)90500-p;;10.1016/0378-1119(93)90424-2;;8359690;;8393300;;10.1152/ajplung.1993.265.1.l1;;10.1007/bf02592286;;7686057;;10.1016/0003-9861(92)90533-3;;1586167;;8323753;;10.3109/02841869309083900;;10.1128/mcb.13.7.4223;;10.1128/mcb.13.7.4223-4232.1993;;pmc359972;;8391634;;3749886;;10.1126/science.3749886;;8440318;;10.1006/excr.1993.1026;;10.1172/jci116723;;pmc288291;;8104197;;10.1159/000112252;;3021428;;10.1016/0014-4827(91)90130-m;;1901795;;10.1002/jcp.1041390208;;2715187;;10.2307/3578352;;8438056;;482611;;10.2307/3575179;;8331297;;10.1111/1523-1747.ep12359508;;10.2307/3578352;;8438056;;10.1016/s0344-0338(11)80845-9;;8183742;;pmc1886816;;8456938;;6241504;;10.1247/csf.9.357;;pmc1886816;;8456938;;8190271;;10.1016/0306-4522(94)90097-3;;6325925;;10.1038/309030a0;;10.1021/bi00396a004;;2962631;;10.1002/jnr.490280407;;1870155;;10.1007/bf02623638;;2666386;;10.1016/b978-0-12-483365-4.50008-6;;10.1073/pnas.82.13.4438;;pmc391116;;3892534;;1432110;;10.1523/jneurosci.12-11-04565.1992;;pmc6575989;;10.1002/0471238961.0815121213150308.a01;;10.1523/jneurosci.14-06-03533.1994;;7515952;;pmc6576935;;8318227;;10.1016/0896-6273(93)90051-r;;pmc386305;;10.1073/pnas.83.15.5454;;2874553;;10.1523/jneurosci.14-05-02455.1994;;pmc6577454;;8182421;;pmc386305;;10.1073/pnas.83.15.5454;;2874553,"LIM ET AL., SCIENCE, vol. 210, 1980, pages 908 - 910;;SUN, A.M., METHODS IN ENZYMOLOAY, vol. 137, 1988, pages 575 - 579;;WOLLHEIM: ""Establishment and Culture of Insulin- Secreting B Cell Lines"", METHODS IN ENZVMOLOAV, vol. 192, 1990, pages 223 - 235;;GONOS: ""Oncogenes in Cellular Immortalisation and Differentiation"", ANTICANCER RESEARCH, vol. 13, 1993, pages 1117;;PLEASURE ET AL., JOURN. NEUROSCIENCE, vol. 12, 1992, pages 1802 - 15;;RICHARDS ET AL., PNAS, vol. 89, 1992, pages 8591 - 8595;;RAY ET AL., PNAS, vol. 90, 1993, pages 3602 - 3606;;BLAU ET AL., TIG, vol. 9, 1993, pages 269 - 74;;LAND ET AL., NATURE, vol. 304, 1983, pages 596 - 602;;CEPKO, NEURON, vol. 1, 1988, pages 345 - 53;;HAMMANG ET AL., NEUROPROTOCOLS, vol. 3, 1993, pages 176 - 83;;HUG ET AL., MOL. CELL. BIOL., vol. 8, 1988, pages 3065 - 79;;ARNHEITER ET AL., CELL, vol. 52, 1990, pages 51 - 61;;ARNHEITER ET AL., CELL, vol. 5, no. 2, 1990, pages 51 - 61;;SCHINSTINE; GAGE, MOLECULAR AND CELLULAR APPROACHES TO THE TREATMENT OF NEUROLOGICAL DISEASE, vol. 71, 1993;;SELIGER ET AL., J. IMMUNOL., vol. 14, no. 1, 1988, pages 2138 - 44;;SELIGER ET AL., J. VIROLOAY, vol. 61, 1987, pages 2567 - 72;;SELIGER ET AL., VIROLOGY., vol. 62, 1988, pages 619 - 21;;WEINBERG, NEURON, vol. 11, 1993, pages 191 - 96;;EL-DEIRY ET AL.: ""WAF1, a Potential Mediator of p53 Tumor Suppression"", CELL, vol. 75, 1993, pages 817 - 825;;RON, PROC. NATL. ACAD. SCI. USA, vol. 91, 1994, pages 1985 - 86;;HANNAN ET AL., GENE, vol. 130, 1993, pages 233 - 39;;NECKERS ET AL.: ""Antisense Technology: Biological Utility And Practical Considerations"", AM. J. PHVSIOL., vol. 265;;LUNA, CELL. MOL. PHVSIOL., vol. 9, 1993, pages L1 - L12;;GALLI ET AL.: ""The Biology of Stem Cell Factor, a New Hematopoietic Growth Factor Involved in Stem Cell Regulation"", INT. J. CLIN. LAB. RES., vol. 23, 1993, pages 70 - 77;;PHILLIPS ET AL.: ""Ascorbic Acid and Transforming Growth Factor-Bl Increase Collagen Biosynthesis via Different Mechanisms: Coordinate Regulation of Proal(I) and Proal(III) Collagens"", ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, vol. 295, 1992, pages 397 - 403;;TOWNSEND JR. ET AL.: ""Studies of Growth Regulation in a Neuroendocrine Cell Line"", ACTA ONCOLOQICA, vol. 32, 1993, pages 125 - 130;;RADVANYI ET AL., MOL. CELL. BIOL., vol. 13, 1993, pages 4223 - 27;;GASH ET AL.: ""Amitotic Neuroblastoma Cells Used for Neural Implants in Monkeys"", SCIENCE, vol. 233, 1986, pages 1420 - 22;;CROUCH ET AL.: ""Ara-C Treatment Leads to Differentiation and Reverses the Transformed Phenotype in a Human Rhabdomyosarcoma Cell Line"", EXPERIMENTAL CELL RESEARCH, vol. 204, 1993, pages 210 - 16;;OTONKOSKI ET AL.: ""Nicotinamide Is a Potent Inducer of Endocrine Differentiation in Cultured Human Fetal Pancreatic Cells"", J. CLIN. INVEST., vol. 92, 1993, pages 1459 - 66;;BARON-VAN EVERCOOREN ET AL.: ""Schwann Cell Differentiation in vitro: Extracellular Matrix Deposition and Interaction"", DEV. NEUROSCI., vol. 8, 1986, pages 182 - 96;;TOOLE-SIMMS ET AL., JOUR. CELL. PHYSIOL., vol. 147, 1991, pages 292 - 97;;FATTAEY ET AL., EXP. CELL. RES., vol. 194, 1991, pages 62 - 68;;FATTAEY ET AL., JOUR. CELL. PHVSIOL., vol. 139, 1989, pages 269 - 74;;STANLEY, RADIAT. RES., vol. 133, 1993, pages 163 - 9;;MITCHELL ET AL., RADIAT. RES., vol. 79, 1979, pages 537 - 51;;PRYSTOWSKY ET AL., J. INVEST. DERMATOL., vol. 101, 1993, pages 54 - 58;;YI ET AL., RADIATION RESEARCH, vol. 133, 1993, pages 163 - 69;;FUJIYAMA ET AL.: ""Influence of Extracellular Matrix on the Proliferation and Differentiation of Adrenocortical Cells in Culture"", PATH. RES. PRACT., vol. 189, 1993, pages 12051 - 14;;BRUINE ET AL.: ""Extracellular Matrix Components Induce Endocrine Differentiation In Vitro in NCI-H716 Cells"", AMERICAN JOURNAL OF PATHOLOQV, vol. 142, 1993, pages 773 - 782;;MATUOKA ET AL., CELL STRUCTURE 41 AND FUNCTION, vol. 9, 1984, pages 357;;BRUINE ET AL.: ""Extracellular Matrix Components Induce Endocrine Differentiation In Vitro in NCI-H716 Cells"", AMERICAN JOURNAL OF PATHOLOAV, vol. 142, 1993, pages 773 - 782;;CHU ET AL., NEUROSCIENCE, vol. 95, 1994, pages 43 - 54;;PIERSCHBACHER ET AL., SCIENCE, vol. 309, 1984, pages 30 - 33;;GRAF ET AL., BIOCHEMISTRY, vol. 26, 1987, pages 6896 - 900;;SMALLHEISER ET AL., DEV. BRAIN RES., vol. 12, 1984, pages 136 - 40;;JUCKER ET AL., J. NEUROSCI. RES., vol. 28, 1991, pages 507 - 17;;AULTHOUSE: ""Expression of the Human Chondrocyte Phenotype In Vitro"", IN VITRO CELLULAR & DEVELOPMENTAL BIOLOQY, vol. 25, 1989, pages 659 - 668;;END; ENGEL: ""Receptors For Extracellular Matrix"", 1991, ACADEMIC PREE, article ""Multidomain Proteins Of The Extracellular Matrix And Cellular Growth"", pages: 79 - 129;;""Methods In Enzvmology"", 1993, ACADEMIC PRESS;;BRINSTER ET AL., PROC. NATL. ACAD. SCI. USA, vol. 82, 1985, pages 4438 - 4442;;REYNOLDS; WEISS, J. NEUROSCIENCE, vol. 12, 1992, pages 4565 - 74;;CABASSO: ""Kirk-Othmer EnCyclopedia of Chemical Technology"", vol. 12, 1980, WILEY, article ""Hollow Fiber Membranes"", pages: 492 - 517;;MESSING ET AL., J. NEUROSCIENCE, vol. 14, 1994, pages 3533 - 39;;HOYLE ET AL., NEURON, vol. 10, 1993, pages 1019 - 34;;BAETGE ET AL., PROC. NATL. ACAD. SCI., vol. 83, 1986, pages 5454 - 58;;HOYLE ET AL., J. NEUROSCI., vol. 14, 1994, pages 2455 - 63;;BAETGE ET AL., PROC. NATL. ACAD. SCI. USA, vol. 83, 1986, pages 5454 - 58",DISCONTINUED
447,WO,A3,WO 1996/002646 A3,113-618-686-581-497,1996-02-01,1996,US US9509281,1995-07-20,"US 8/279,773;;US 8/432,698",1994-07-20,GROWTH CONTROL FOR CELLS ENCAPSULATED WITHIN BIOARTIFICIAL ORGANS,"This invention relates to methods and compositions of controlling cell distribution within a bioartificial organ by exposing the cells to a treatment that inhibits cell proliferation, promotes cell differentiation, or affects cell attachment to a growth surface within the bioartificial organ. Such treatments include (1) genetically manipulating cells, (2) exposing the cells to a proliferation-inhibiting compound or a differentiation-inducing compound or removing the cells from exposure to a proliferation-stimulating compound or a differentiation-inhibing compound; exposing the cells to irradiation, and (3) modifying a growth surface of the BAO with ECM molecules, molecules affecting cell proliferation or adhesion, or an inert scaffold, or a combination thereof. These treatments may be used in combination.","CYTOTHERAPEUTICS, INC.","SCHINSTINE, Malcolm;;SHOICHET, Molly, S.;;GENTILE, Frank, T.;;HAMMANG, Joseph, P.;;HOLLAND, Laura, M.;;CAIN, Brian, M.;;DOHERTY, Edward, J.;;WINN, Shelley, R.;;AEBISCHER, Patrick;;MESSING, Albee",,https://lens.org/113-618-686-581-497,Search Report,yes,0,0,1,1,0,,A61K48/00;;A61L27/18;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00,,0,0,,,,UNKNOWN
448,CA,A1,CA 2694296 A1,081-952-519-548-838,1996-02-01,1996,CA 2694296 A,1995-07-20,US 27977394 A;;US 43269895 A;;CA 2195446 A,1994-07-20,GROWTH CONTROL FOR CELLS ENCAPSULATED WITHIN BIOARTIFICIAL ORGANS,,NEUROTECH USA INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK;;MESSING ALBEE,,https://lens.org/081-952-519-548-838,Patent Application,no,0,0,5,40,4,A61L27/3839;;A61L27/3839;;A61K48/00;;A61K48/00;;A61L27/18;;A61L27/18;;A61L27/227;;A61L27/227;;A61L27/38;;C07K14/82;;C07K14/82;;C12N5/0012;;C12N5/0012;;C12N5/0068;;C12N5/0068;;C12N2510/00;;C12N2510/00;;C12N2510/04;;C12N2510/04;;C12N2533/30;;C12N2533/30;;C12N2533/54;;C12N2533/54;;C12N2533/74;;C12N2533/74,A01K67/027;;C12N5/071;;A61K35/12;;A61K48/00;;A61L27/00;;A61L27/18;;A61L27/22;;A61L27/38;;C07K14/82;;C12M3/00;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,DISCONTINUED
449,JP,A,JP 2005224614 A,105-732-714-144-26X,2005-08-25,2005,JP 2005035315 A,2005-02-10,US 27977394 A;;US 43269895 A,1994-07-20,PROLIFERATION CONTROL OF CELL ENCAPSULATED IN ARTIFICIAL ORGAN IN LIVING BODY,"<P>PROBLEM TO BE SOLVED: To provide a method and a composition for controlling the proliferation of an encapsulated cell which combines various advantages of a proliferating cell and a differentiated nondividing cell. <P>SOLUTION: In the method and composition, the distribution of a cell (namely, the number of cells in a BAO or the present position of cells, or both of them) is controlled, when a cell is encapsulated in BAO. (1) The method and composition modify the cells encapsulated in the BAO and (2) the composition modifies proliferation surface in the BAO. <P>COPYRIGHT: (C)2005,JPO&NCIPI",CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK;;ALBEE MESSING,,https://lens.org/105-732-714-144-26X,Patent Application,no,0,0,33,40,4,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A61L27/00;;A61L27/18;;A01K67/027;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,PENDING
450,CA,C,CA 2195446 C,150-658-680-160-323,2010-05-25,2010,CA 2195446 A,1995-07-20,US 27977394 A;;US 43269895 A;;US 9509281 W,1994-07-20,GROWTH CONTROL FOR CELLS ENCAPSULATED WITHIN BIOARTIFICIAL ORGANS,"This invention relates to methods and compositions of controlling cell distribution within a bioartificial organ by exposing the cells to a treatment that inhibits cell proliferation, promotes cell differentiation, or affects cell attachment to a growth surface within the bioartificial organ. Such treatments include (1) genetically manipulating cells, (2) exposing the cells to a proliferation-inhibiting compound or a differentiation-inducing compound or removing the cells from exposure to a proliferation-stimulating compound or a differentiation-inhibing compound; exposing the cells to irradiation, and (3) modifying a growth surface of the BAO with ECM molecules, molecules affecting cell proliferation or adhesion, or an inert scaffold, or a combination thereof. These treatments may be used in combination.",CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK;;MESSING ALBEE,,https://lens.org/150-658-680-160-323,Granted Patent,no,0,0,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A01K67/027;;A61K35/12;;C12N5/071;;A61K48/00;;A61L27/00;;A61L27/18;;A61L27/22;;A61L27/38;;C07K14/82;;C12M3/00;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12;;C12N15/85,,0,0,,,,EXPIRED
451,JP,A,JP 2006198414 A,026-579-982-800-313,2006-08-03,2006,JP 2006031612 A,2006-02-08,US 27977394 A;;US 43269895 A,1994-07-20,PROLIFERATION CONTROL OF CELL ENCAPSULATED IN ARTIFICIAL ORGAN IN LIVING BODY,"<P>PROBLEM TO BE SOLVED: To provide a method and a composition for controlling the proliferation of an encapsulated cell which combines various advantages of a proliferating cell and a differentiated nondividing cell. <P>SOLUTION: In the method and composition, the distribution of a cell (namely, the number of cells in a BAO or the present position of cells, or both of them) is controlled, when a cell is encapsulated in BAO. (1) The method and composition is for modifying the cells encapsulated in the BAO and (2) the composition is for modifying proliferation surface in the BAO. <P>COPYRIGHT: (C)2006,JPO&NCIPI",NEUROTECH SA,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK;;ALBEE MESSING,,https://lens.org/026-579-982-800-313,Patent Application,no,0,0,33,40,4,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A01K67/027;;A61K35/12;;A61L27/00;;A61K48/00;;A61L27/18;;A61L27/22;;A61L27/38;;A61P43/00;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,PENDING
452,IS,A,IS 4417 A,063-585-232-625-571,1997-01-17,1997,IS 4417 A,1997-01-17,US 9509281 W;;US 27977394 A;;US 43269895 A,1994-07-20,Vaxtarstýring frumna innan lifandi gervilíffæra,,CYTOTHERAPEUTICS INC,SCHINSTINE MALCOLM;;SHOICHET MOLLY S;;GENTILE FRANK T;;HAMMANG JOSEPH P;;HOLLAND LAURA M;;CAIN BRIAN M;;DOHERTY EDWARD J;;WINN SHELLEY R;;AEBISCHER PATRICK;;MESSING ALBEE,,https://lens.org/063-585-232-625-571,Patent Application,no,0,0,33,40,0,A61K48/00;;A61L27/18;;A61L27/227;;A61L27/383;;A61L27/3834;;A61L27/3839;;A61L27/3895;;C07K14/82;;C12N5/0068;;C12N2510/00;;C12N2510/04;;C12N2533/30;;C12N2533/54;;C12N2533/74;;A61P43/00;;C12N5/0068;;A61L27/18;;A61L27/3834;;C12N2533/74;;C12N2533/54;;A61K48/00;;A61L27/383;;C07K14/82;;C12N2510/04;;C12N2533/30;;A61L27/3839;;A61L27/227;;A61L27/3895;;C12N2510/00,A61K48/00;;A61L27/00;;A61L27/18;;A01K67/027;;A61L27/22;;A61L27/38;;C07K14/82;;C12N5/00;;C12N5/10;;C12N15/09;;C12N15/12,,0,0,,,,PENDING
453,US,A1,US 2023/0289034 A1,182-388-039-845-152,2023-09-14,2023,US 202318199574 A,2023-05-19,US 202318199574 A;;US 202117505916 A;;US 202017030804 A;;US 202063032970 P;;US 202063022869 P;;US 202063008586 P,2020-04-10,USER INTERFACES FOR ENABLING AN ACTIVITY,"The present disclosure generally relates to user interfaces for enabling an activity using a computer system. In some embodiments, exemplary user interfaces for invoking an activity associated with an application are described. In some embodiments, exemplary user interfaces for customizing displayed content based on circumstances under which the content was invoked are described. In some embodiments, exemplary user interfaces for managing applications that were used to enable activities are described. In some embodiments, exemplary user interfaces for managing settings for applications used to enable activities are described.",APPLE INC,ZHANG YONGJUN;;ABBASIAN REZA;;ADLER DARIN;;COFFMAN PATRICK L;;DOHERTY NICHOLAS STEPHEN;;FALKENBURG STEVEN;;FEDERIGHI CRAIG M;;FERRY KENNETH ARTHUR ABRAHAM;;FOSS CHRISTOPHER PATRICK;;GOLDBERG BRIAN ERIK;;KO HEENA;;PAUL GRANT;;RITCHIE GRANT C;;STACK CAELAN G;;YING CHARLES H;;ZHANG XIAOYUE,,https://lens.org/182-388-039-845-152,Patent Application,yes,0,0,10,37,0,G06F3/048;;G06F21/00;;H04M1/00;;H04W4/00;;H04L67/34;;G06F3/0488;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F9/451;;G06F3/04817;;G06F8/38;;G06F3/04842;;G06F3/0488;;G06F9/44568;;G06F9/54;;H04L67/34;;H04L67/5651,G06F3/04817;;G06F3/04842;;G06F3/0488;;G06F8/38;;G06F9/445;;G06F9/54;;H04L67/00;;H04L67/5651,,0,0,,,,PENDING
454,US,A1,US 2011/0025748 A1,163-922-528-400-590,2011-02-03,2011,US 84575210 A,2010-07-29,US 84575210 A;;US 23011009 P,2009-07-31,WIDE FORMAT PRINTER WITH FIXED PRINTHEADS AND MOVABLE VACUUM PLATEN,"A wide format printer that has a printhead assembly, a drive roller for feeding media along a media path and a vacuum platen assembly configured for movement relative to the fixed printhead assembly. The media path is more than 432 mm (17 inches) wide.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/163-922-528-400-590,Patent Application,yes,6,5,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J29/38;;B41J2/01;;G06F15/00,347/16;;358/1.5;;347/104,0,0,,,,ACTIVE
455,US,A1,US 2011/0026048 A1,024-994-734-396-222,2011-02-03,2011,US 84573610 A,2010-07-29,US 84573610 A;;US 23011009 P,2009-07-31,PRINTING SYSTEM WITH AEROSOL COLLECTION FROM BOTH SIDES OF MEDIA PATH,"A printing system that has an inkjet printhead assembly for printing media fed along a media path, and an aerosol collection system for collecting ink aerosol generated by the printhead assembly. The printhead assembly is positioned on a first side of the media path and the aerosol collection system has a first aerosol collection opening positioned on the first side of the media path and a second aerosol collection opening positioned on a second side of the media path.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;ZAMTEC LIMITED (2012-05-03),https://lens.org/024-994-734-396-222,Patent Application,yes,4,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,G06K15/10,358/1.8,0,0,,,,DISCONTINUED
456,AU,B2,AU 2010/278669 B2,101-311-044-765-68X,2014-11-13,2014,AU 2010/278669 A,2010-07-29,US 23011009 P;;AU 2010/000954 W,2009-07-31,Printing system with fixed printheads and movable vacuum platen,"A printing system that has a printhead assembly, a drive roller for feeding media along a media path and a vacuum platen assembly configured for movement relative to the fixed printhead assembly.",MEMJET TECHNOLOGY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,ZAMTEC LIMITED (2013-04-04),https://lens.org/101-311-044-765-68X,Granted Patent,no,2,0,100,100,0,B41J2/175;;B41J2/1752;;B41J29/02;;B41J3/543;;B41J11/001;;B41J15/04;;B41J2/16547;;B41J2/16585;;B41J11/0085;;B41J11/007;;B41J11/02;;B41J13/08;;B41J29/10;;B41J29/377;;B41J2/175;;B41J2/1752;;B41J29/02;;B41J3/543;;B41J11/001;;B41J15/04;;B41J2/16547;;B41J2/16585;;B41J2/18;;B41J11/007;;B41J2/165;;B41J11/0085,B41J11/02;;B41J13/08;;B41J29/10;;B41J29/377,,0,0,,,,ACTIVE
457,US,A1,US 2011/0025767 A1,023-286-817-418-77X,2011-02-03,2011,US 84575410 A,2010-07-29,US 84575410 A;;US 23011009 P,2009-07-31,WIDE FORMAT PRINTER WITH INK ACCUMMULATORS FOR HYDROSTATIC PRESSURE REGULATION,"A wide format printer that has a printhead assembly with nozzles for ejecting ink onto media fed along a media path more than 432 mm (17 inches) wide, a plurality of ink containers, a plurality accumulator reservoirs, each having an inlet for connection to one of the ink containers, an outlet for connection to the printhead assembly and a fluid level regulator for maintaining fluid levels in the reservoir within a controlled fluid level range. During use, the plurality of ink accumulator reservoirs are mounted at a fixed elevation relative to the nozzles such that hydrostatic fluid pressure at the nozzles is maintained within a predetermined range.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;ZAMTEC LIMITED (2012-05-03),https://lens.org/023-286-817-418-77X,Patent Application,yes,11,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165;;B41J2/175,347/34;;347/85,0,0,,,,DISCONTINUED
458,US,B2,US 8641168 B2,066-637-467-372-485,2014-02-04,2014,US 84573710 A,2010-07-29,US 84573710 A;;US 23011009 P,2009-07-31,Printing system with adjustable aerosol collection,"A printing system that has a drive roller for feeding different sizes of media along a media path, an inkjet printhead assembly for printing the media and an ink aerosol collection system for removing ink aerosol from areas adjacent the media path. The ink aerosol collection system is configured to remove aerosol at a greater rate in response to an increase in the media size.",ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON;;ZAMTEC LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/066-637-467-372-485,Granted Patent,yes,65,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165,347/34,0,0,,,,ACTIVE
459,US,A1,US 2011/0025775 A1,106-059-689-822-397,2011-02-03,2011,US 84577010 A,2010-07-29,US 84577010 A;;US 23011009 P,2009-07-31,WIDE FORMAT PRINTER WITH AEROSOL COLLECTION FROM BOTH SIDES OF MEDIA PATH,"A wide format printer that has an inkjet printhead assembly for printing media fed along a media path that is more than 432 mm (17 inches) wide, and an aerosol collection system for collecting ink aerosol generated by the printhead assembly. The printhead assembly is positioned on a first side of the media path and the aerosol collection system has a first aerosol collection opening positioned on the first side of the media path and a second aerosol collection opening positioned on a second side of the media path.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/106-059-689-822-397,Patent Application,yes,65,2,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165,347/34,0,0,,,,ACTIVE
460,US,A1,US 2011/0025771 A1,159-662-887-999-280,2011-02-03,2011,US 84576510 A,2010-07-29,US 84576510 A;;US 23011009 P,2009-07-31,WIDE FORMAT PRINTER WITH PUMP TO PRIME PRINTHEADS,"A wide format printer that has an ink supply, a feed line coupled to the ink supply, a return line coupled to the ink supply, a plurality of printheads collectively spanning a paper path more than 432 mm (17 inches) wide, each of the printheads being coupled to the feed line and the return line and, a pumping system configured to generate fluid flow from the feed line to the return line via the printheads to prime the printheads.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;ZAMTEC LIMITED (2012-05-03),https://lens.org/159-662-887-999-280,Patent Application,yes,4,2,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165;;B41J2/175,347/34;;347/85,0,0,,,,DISCONTINUED
461,US,A1,US 2011/0025776 A1,163-045-775-586-01X,2011-02-03,2011,US 84577110 A,2010-07-29,US 84577110 A;;US 23011009 P,2009-07-31,WIDE FORMAT PRINTER WITH DATUM FEATURES ON PRINTHEAD CARRIAGE,"A wide format printer that has a print zone, a media path extending through the print zone along a paper axis, the media path being more than 432 mm (17 inches) wide, a printhead carriage for mounting a plurality of printhead modules adjacent the print zone such that the printhead modules collectively span the media path and are staggered with respect to the paper axis. The printhead modules each have nozzles arranged in parallel rows and a plurality of datum features for holding the printhead carriage such that the parallel rows extend normal to the paper feed axis.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;ZECH LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/163-045-775-586-01X,Patent Application,yes,5,3,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165;;B41J2/14;;B41J2/175,347/34;;347/49;;347/85,0,0,,,,ACTIVE
462,US,A1,US 2019/0322110 A1,181-253-468-323-630,2019-10-24,2019,US 201916460891 A,2019-07-02,US 201916460891 A;;US 201815976707 A;;US 201514877454 A;;US 201514636054 A;;US 201414272259 A;;US 201313779024 A;;US 84575210 A;;US 23011009 P,2009-07-31,PRINTING SYSTEM HAVING MULTIPLE PRINTHEADS AND BYPASS LINES,A printing system includes: an ink supply; a feed line coupled to the ink supply; a return line coupled to the ink supply; and a plurality of printhead modules each having an inlet port fluidically coupled to the feed line and an outlet port fluidically coupled to the return line. Each print module has a bypass line fluidically coupling the feed line to the return line. The bypass line is open for both priming and printing operations.,MEMJET TECHNOLOGY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,,https://lens.org/181-253-468-323-630,Patent Application,yes,0,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J11/00;;B41J2/165;;B41J2/175;;B41J3/54;;B41J29/02,,0,0,,,,ACTIVE
463,US,A1,US 2011/0025781 A1,004-787-341-265-558,2011-02-03,2011,US 84574910 A,2010-07-29,US 84574910 A;;US 23011009 P,2009-07-31,INKJET PRINTER WITH PRINTHEAD MODULES HAVING INDIVIDUAL INK INTERFACES,"An inkjet printer that has a print zone, a media path extending through the print zone along a paper axis, a printhead carriage with a plurality of printhead mounting sites for mounting a plurality of printhead modules adjacent the print zone such that the printhead modules collectively span the media path and a plurality of interfaces for supplying ink to, and receiving ink from each of the printhead modules respectively.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/004-787-341-265-558,Patent Application,yes,19,1,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/14,347/49,0,0,,,,ACTIVE
464,US,A1,US 2011/0025770 A1,041-603-352-162-899,2011-02-03,2011,US 84576410 A,2010-07-29,US 84576410 A;;US 23011009 P,2009-07-31,WIDE FORMAT PRINTER WITH MULTIPLE INK ACCUMULATORS,"A wide format printer that has an ink supply, an accumulator reservoir, a valve coupling the accumulator reservoir to the ink supply, the valve being configured to open when the ink level in the accumulator reservoir reaches a lower limit of a predetermined ink level range, and close when the ink level in the accumulator reservoir reaches an upper limit of the ink level range and, a plurality of printheads collectively spanning a paper path more than 432 mm (17 inches) wide, each of the printheads being in fluid communication with the accumulator reservoir and each of the printheads having nozzles for ejecting ink onto media. During printing, the accumulator reservoir is fixed relative to the printheads such that hydrostatic ink pressure at the nozzles is generated by the elevation of the ink level in the accumulator reservoir relative to the elevation of the of the nozzles.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/041-603-352-162-899,Patent Application,yes,18,3,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165;;B41J2/175,347/34;;347/85,0,0,,,,ACTIVE
465,US,B2,US 8646864 B2,057-806-538-312-112,2014-02-11,2014,US 84576010 A,2010-07-29,US 84576010 A;;US 23011009 P,2009-07-31,Wide format printer with input roller and movable media engagement output for simultaneously engaging media,A wide format printer that has a drive roller configured to engage and push media into a print zone and a movable media engagement assembly configured to engage one side of the media and pull the media while the drive roller remains engaged with the media wherein the print zone is more than 432 mm (17 inches) wide.,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON;;ZAMTEC LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/057-806-538-312-112,Granted Patent,yes,64,2,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J29/38;;B41J2/01,347/16;;347/101;;347/104,3,0,,,"Office Action dated Oct. 24, 2012 in U.S. Appl. No. 12/845,728.;;Office Action dated Oct. 23, 2012 in U.S. Appl. No. 12/845,729.;;Office Action dated Sep. 13, 2012 in U.S. Appl. No. 12/845,759.",ACTIVE
466,US,B2,US 8454125 B2,094-566-560-296-034,2013-06-04,2013,US 84577110 A,2010-07-29,US 84577110 A;;US 23011009 P,2009-07-31,Wide format printer with datum features on printhead carriage,"A wide format printer that has a print zone, a media path extending through the print zone along a paper axis, the media path being more than 432 mm (17 inches) wide, a printhead carriage for mounting a plurality of printhead modules adjacent the print zone such that the printhead modules collectively span the media path and are staggered with respect to the paper axis. The printhead modules each have nozzles arranged in parallel rows and a plurality of datum features for holding the printhead carriage such that the parallel rows extend normal to the paper feed axis.",ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON;;ZAMTEC LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/094-566-560-296-034,Granted Patent,yes,5,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165,347/41,0,0,,,,ACTIVE
467,CN,A,CN 102470678 A,113-314-873-825-773,2012-05-23,2012,CN 201080028037 A,2010-07-29,AU 2010/000954 W;;US 23011009 P,2009-07-31,Printing system with fixed printheads and movable vacuum platen,"A printing system that has a printhead assembly, a drive roller for feeding media along a media path and a vacuum platen assembly configured for movement relative to the fixed printhead assembly.",SILVERBROOK RES PTY LTD,ROBERT ROSATI;;DAVID PETCH;;DAVID BURNEY;;JIM SYKORA;;REGAS KENNETH A;;ANDY BOUND;;NEIL DOHERTY;;SCOTT DENNIS;;BEN JONES;;OKSANA BUYDA;;LOCSON TONTHAT;;ANDREW BUYDA;;PATRICK KIRK;;LOREN HUNT;;JASON DEWEY;;JIM TRINCHERA;;BILL CRESSMAN;;RON ZECH,"MAGTE TECHNOLOGY CO., LTD. (2015-03-11);;ZAMTEC LTD. (2013-04-09)",https://lens.org/113-314-873-825-773,Patent Application,no,10,3,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J11/02;;B41J13/08;;B41J29/10;;B41J29/377,,0,0,,,,ACTIVE
468,US,B2,US 8356889 B2,147-286-063-742-886,2013-01-22,2013,US 84575110 A,2010-07-29,US 84575110 A;;US 23011009 P,2009-07-31,Print engine with ink supply conduits extending from a long side of elongate printhead carriage,"A print engine for an inkjet printer which has a media path extending past a printhead assembly along a paper axis, has an elongate printhead carriage extending transverse to the paper axis, a series of interfaces for supplying ink to respective printhead modules spaced along the printhead carriage such that during use, the printhead modules span the media path and ink conduits connected to the interfaces for feeding ink to the printhead modules. The printhead carriage has a series formations to position the ink conduits such that they all extend away from the interfaces in a direction transverse to the long axis to a common side of the printhead carriage.",ZAMTEC LTD;;ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/147-286-063-742-886,Granted Patent,yes,5,3,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/17,347/84;;347/85;;347/66;;347/40;;347/42,0,0,,,,ACTIVE
469,US,B2,US 8567899 B2,156-385-829-623-70X,2013-10-29,2013,US 84573010 A,2010-07-29,US 84573010 A;;US 23011009 P,2009-07-31,Printing system with independently operable printhead service modules,A printing system that has a printhead assembly for printing media fed along a media path and a plurality of service modules for the printhead assembly. Each of the service modules is configured to operate in a plurality of different modes and each of the service modules are independently operable.,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON;;ZAMTEC LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/156-385-829-623-70X,Granted Patent,yes,63,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165;;G01D15/20,347/29;;346/134,1,0,,,"Cited in NonFinal Office Action, U.S. Appl. No. 12/845,762 dated Aug. 21, 2012.",ACTIVE
470,US,B2,US 8439493 B2,011-095-947-273-372,2013-05-14,2013,US 84576110 A,2010-07-29,US 84576110 A;;US 23011009 P,2009-07-31,Wide format printer with printheads supplied by multiple ink conduits connected by a bypass line,"A wide format printer that has an ink supply, a feed line coupled to the ink supply, a return line coupled to the ink supply, a plurality of printheads collectively spanning a paper path more than 432 mm (17 inches) wide, each of the printheads being fluidically coupled to the first and second conduits and, a bypass line coupling the feed line to the return line.",ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON;;ZAMTEC LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/011-095-947-273-372,Granted Patent,yes,13,3,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/18;;B41J2/175,347/89;;347/85,0,0,,,,ACTIVE
471,US,A1,US 2011/0025804 A1,067-225-725-003-54X,2011-02-03,2011,US 84575810 A,2010-07-29,US 84575810 A;;US 23011009 P,2009-07-31,WIDE FORMAT PRINTER WITH MEDIA ENCODER IN THE PLATEN,"A wide format printer that has a vacuum platen assembly, a printhead assembly spaced from the vacuum platen assembly, a media path extending between the vacuum platen assembly and the printhead assembly and a media encoder embedded within the vacuum platen assembly wherein, the media path is greater than 432 mm (17 inches) wide.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/067-225-725-003-54X,Patent Application,yes,8,11,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/01,347/104,1,0,,,"Outdoor Photography, High-Tech B&W Printers; October 7, 2008; pages 1-2.",ACTIVE
472,AU,A1,AU 2010/278669 A1,098-043-892-999-193,2013-03-21,2013,AU 2010/278669 A,2010-07-29,US 23011009 P;;AU 2010/000954 W,2009-07-31,Printing system with fixed printheads and movable vacuum platen,"A printing system that has a printhead assembly, a drive roller for feeding media along a media path and a vacuum platen assembly configured for movement relative to the fixed printhead assembly.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,ZAMTEC LIMITED (2013-04-04),https://lens.org/098-043-892-999-193,Patent Application,no,0,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J11/02;;B41J13/08;;B41J29/10;;B41J29/377,,0,0,,,,ACTIVE
473,US,A1,US 2011/0025761 A1,117-136-610-785-614,2011-02-03,2011,US 84574310 A,2010-07-29,US 84574310 A;;US 23011009 P,2009-07-31,PRINTING SYSTEM WITH MULTIPLE INK ACCUMULATORS,"A printing system that has an ink supply, an accumulator reservoir, a valve coupling the accumulator reservoir to the ink supply, the valve being configured to open when the ink level in the accumulator reservoir reaches a lower limit of a predetermined ink level range, and close when the ink level in the accumulator reservoir reaches an upper limit of the ink level range, and a plurality of printheads in fluid communication with the accumulator reservoir. Each of the printheads has nozzles for ejecting ink onto media. During printing, the accumulator reservoir is fixed relative to the printheads such that hydrostatic ink pressure at the nozzles is generated by the elevation of the ink level in the accumulator reservoir relative to the elevation of the of the nozzles.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;ZAMTEC LIMITED (2012-05-03),https://lens.org/117-136-610-785-614,Patent Application,yes,8,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165;;B41J2/175,347/34;;347/85,0,0,,,,DISCONTINUED
474,SG,A1,SG 175928 A1,116-638-850-112-21X,2011-12-29,2011,SG 2011081940 A,2010-07-29,US 23011009 P;;AU 2010/000954 W,2009-07-31,PRINTING SYSTEM WITH FIXED PRINTHEADS AND MOVABLE VACUUM PLATEN,"A printing system that has a printhead assembly, a drive roller for feeding media along a media path and a vacuum platen assembly configured for movement relative to the fixed printhead assembly.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,,https://lens.org/116-638-850-112-21X,Patent Application,no,0,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,,,0,0,,,,PENDING
475,US,B2,US 8388093 B2,106-482-277-461-511,2013-03-05,2013,US 84575210 A,2010-07-29,US 84575210 A;;US 23011009 P,2009-07-31,Wide format printer with fixed printheads and movable vacuum platen,"A wide format printer that has a printhead assembly, a drive roller for feeding media along a media path and a vacuum platen assembly configured for movement relative to the fixed printhead assembly. The media path is more than 432 mm (17 inches) wide.",ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON;;ZAMTEC LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/106-482-277-461-511,Granted Patent,yes,6,6,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J29/38,347/16;;347/104,0,0,,,,ACTIVE
476,US,A1,US 2014/0240396 A1,167-595-773-000-769,2014-08-28,2014,US 201414272259 A,2014-05-07,US 201414272259 A;;US 201313779024 A;;US 84575210 A;;US 23011009 P,2009-07-31,PRINTER HAVING ROTATABLE SERVICE MODULES EMBEDDED IN FIXED VACUUM PLATEN,"A printing system includes: a fixed printhead assembly having an array of printheads and vacuum platen assembly. The vacuum platen assembly includes a fixed vacuum platen and a plurality of rotatable service modules embedded in the fixed vacuum platen. Each service module is positioned opposite a respective printhead, and each service module comprises a respective vacuum platen module.",ZAMTEC LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-08-02);;MEMJET TECHNOLOGY LIMITED (2013-02-01),https://lens.org/167-595-773-000-769,Patent Application,yes,2,2,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165,347/29;;347/104,0,0,,,,ACTIVE
477,US,A1,US 2011/0025750 A1,178-657-967-445-58X,2011-02-03,2011,US 84576010 A,2010-07-29,US 84576010 A;;US 23011009 P,2009-07-31,WIDE FORMAT PRINTER WITH INPUT ROLLER AND MOVABLE MEDIA ENGAGEMENT OUTPUT FOR SIMULTANEOUSLY ENGAGING MEDIA,A wide format printer that has a drive roller configured to engage and push media into a print zone and a movable media engagement assembly configured to engage one side of the media and pull the media while the drive roller remains engaged with the media wherein the print zone is more than 432 mm (17 inches) wide.,SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/178-657-967-445-58X,Patent Application,yes,16,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J29/38;;B41J2/01,347/16;;358/1.5;;347/104,0,0,,,,ACTIVE
478,US,A1,US 2011/0025802 A1,168-370-905-890-038,2011-02-03,2011,US 84573310 A,2010-07-29,US 84573310 A;;US 23011009 P,2009-07-31,PRINTING SYSTEM WITH INDEPENDENTLY MOVABLE PRINTHEAD SERVICE MODULES,"A printing system that has a media transport system configured to transport media along a media path, a printhead assembly fixed relative to the media path and a plurality of service modules for the printhead assembly. Each of the service modules is independently movable relative to the media path.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/168-370-905-890-038,Patent Application,yes,62,5,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/01,347/104,0,0,,,,ACTIVE
479,US,A1,US 2011/0026047 A1,092-015-209-410-617,2011-02-03,2011,US 84572610 A,2010-07-29,US 84572610 A;;US 23011009 P,2009-07-31,INKJET PRINTING SYSTEM WITH MEDIA ENCODER IN THE PLATEN,"An inkjet printing system that has a vacuum platen assembly, a printhead assembly spaced from the vacuum platen assembly and a media encoder embedded within the vacuum platen assembly.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;ZAMTEC LIMITED (2012-05-03),https://lens.org/092-015-209-410-617,Patent Application,yes,4,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,G06K15/10,358/1.8,0,0,,,,DISCONTINUED
480,US,A1,US 2011/0025747 A1,097-251-627-708-05X,2011-02-03,2011,US 84573410 A,2010-07-29,US 84573410 A;;US 23011009 P,2009-07-31,PRINTING SYSTEM FOR MEDIA OF DIFFERENT SIZES,"A printing system that has a media transport system configured to transport media of differing dimensions along a media path, a printhead assembly for printing media transported along the media path, the media path having differing widths depending on the dimensions of the media and, a plurality of service modules for the printhead assembly. Each of the service modules is configured to operate in a plurality of different modes. During use, the media path extends between the printhead assembly and at least some of the service modules configured to operate in one of the modes while any of the service modules beyond the media path operate in another of the modes.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/097-251-627-708-05X,Patent Application,yes,62,1,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J29/38;;B41J2/01,347/16;;347/104,0,0,,,,ACTIVE
481,US,A1,US 2011/0025805 A1,103-805-737-943-306,2011-02-03,2011,US 84576310 A,2010-07-29,US 84576310 A;;US 23011009 P,2009-07-31,Wide format printer with independently movable printed service modules,"A wide format printer that has a media transport system configured to transport media along a media path that is more than 432 mm (17 inches) wide, a printhead assembly fixed relative to the media path and a plurality of service modules for the printhead assembly. Each of the service modules is independently movable relative to the media path.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/103-805-737-943-306,Patent Application,yes,11,2,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/01,347/104,2,0,,,"Outdoor Photography; High-Tech B&W Printers; October 7, 2008, pages 1-2.;;Outdoor Photography; High-Tech B&W Printers; October 7, 2008; pages 1-2.",ACTIVE
482,US,B2,US 8485656 B2,128-966-958-283-502,2013-07-16,2013,US 84576310 A,2010-07-29,US 84576310 A;;US 23011009 P,2009-07-31,Wide format printer with independently movable printed service modules,"A wide format printer that has a media transport system configured to transport media along a media path that is more than 432 mm (17 inches) wide, a printhead assembly fixed relative to the media path and a plurality of service modules for the printhead assembly. Each of the service modules is independently movable relative to the media path.",ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON;;ZAMTEC LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/128-966-958-283-502,Granted Patent,yes,11,5,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/01;;B41J2/165,347/104;;347/30,1,0,,,"Outdoor Photography; High-Tech B&W Printers; Oct. 7, 2008; pp. 1-2.",ACTIVE
483,US,A1,US 2011/0025769 A1,165-861-076-814-405,2011-02-03,2011,US 84576110 A,2010-07-29,US 84576110 A;;US 23011009 P,2009-07-31,WIDE FORMAT PRINTER WITH PRINTHEADS SUPPLIED BY MULTIPLE INK CONDUITS CONNECTED BY A BYPASS LINE,"A wide format printer that has an ink supply, a feed line coupled to the ink supply, a return line coupled to the ink supply, a plurality of printheads collectively spanning a paper path more than 432 mm (17 inches) wide, each of the printheads being fluidically coupled to the first and second conduits and, a bypass line coupling the feed line to the return line.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/165-861-076-814-405,Patent Application,yes,13,2,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165;;B41J2/175,347/34;;347/85,0,0,,,,ACTIVE
484,EP,A1,EP 2496421 A1,045-075-018-348-259,2012-09-12,2012,EP 10803733 A,2010-07-29,US 23011009 P;;AU 2010/000954 W,2009-07-31,PRINTING SYSTEM WITH FIXED PRINTHEADS AND MOVABLE VACUUM PLATEN,,SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,ZAMTEC LIMITED (2014-02-12);;MEMJET TECHNOLOGY LIMITED (2014-09-24);;MEMJET TECHNOLOLGY LIMITED (2014-08-13),https://lens.org/045-075-018-348-259,Patent Application,yes,0,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J11/02;;B41J2/165;;B41J2/175;;B41J3/54;;B41J11/00;;B41J13/08;;B41J15/04;;B41J29/02;;B41J29/10;;B41J29/377,,0,0,,,,ACTIVE
485,US,B2,US 8449073 B2,053-272-278-469-746,2013-05-28,2013,US 84577210 A,2010-07-29,US 84577210 A;;US 23011009 P,2009-07-31,Wide format printer with printhead carriage connected to ink supply from a single side,"A wide format printer that has a print zone, a media path more than 432 mm (17 inches) wide and extending through the print zone along a paper axis, a printhead carriage with a plurality of printhead mounting sites for mounting a plurality of printhead modules adjacent the print zone such that the printhead modules collectively span the media path, the printhead carriage having a long side extending transverse to the paper axis, the long side having access formations for ink conduits and a plurality of interfaces for connection to the ink conduits to supply ink to each of the printhead modules respectively. All ink for the plurality of printhead modules is supplied by ink conduits extending through the access formations on the long side of the printhead carriage.",ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON;;ZAMTEC LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/053-272-278-469-746,Granted Patent,yes,11,1,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/155;;B41J2/14;;B41J2/175,347/42;;347/49;;347/85,0,0,,,,ACTIVE
486,US,A1,US 2011/0025755 A1,062-730-104-618-811,2011-02-03,2011,US 84576210 A,2010-07-29,US 84576210 A;;US 23011009 P,2009-07-31,WIDE FORMAT PRINTER WITH INDEPENDENTLY OPERABLE PRINTHEAD SERVICE MODULES,"A wide format printer that has a printhead assembly for printing media fed along a media path, the media path being more than 432 mm (17 inches) wide, and a plurality of service modules for the printhead assembly. Each of the service modules is configured to operate in a plurality of different modes and each of the service modules are independently operable.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;ZAMTEC LIMITED (2012-05-03),https://lens.org/062-730-104-618-811,Patent Application,yes,13,8,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165,347/29,0,0,,,,DISCONTINUED
487,US,A1,US 2011/0025803 A1,107-434-123-019-00X,2011-02-03,2011,US 84575510 A,2010-07-29,US 84575510 A;;US 23011009 P,2009-07-31,WIDE FORMAT PRINTER WITH INPUT MEDIA ROLLER AND OUTPUT VACUUM BELTS,"A wide format printer that has a print zone, a drive roller positioned upstream of the print zone, a vacuum platen assembly positioned under the print zone, a printhead assembly overlaying and spanning the print zone and a vacuum belt assembly configured to receive media from the print zone. The print zone is more than 432 mm (17 inches) wide.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;ZAMTEC LIMITED (2012-05-03),https://lens.org/107-434-123-019-00X,Patent Application,yes,12,4,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/01,347/104,1,0,,,"Outdoor Photography; High-Tech B&W Printers; October 7, 2008; pages 1-2.",DISCONTINUED
488,ES,T3,ES 2546511 T3,139-041-847-514-675,2015-09-24,2015,ES 10803733 T,2010-07-29,US 23011009 P;;AU 2010/000954 W,2009-07-31,Sistema de impresión con cabezas de impresión fijas y plato de vacío movible,"Un sistema de impresión que comprende: un ensamblaje de cabeza de impresión (42, 44, 46, 48, 50) que define una zona de impresión (14), el ensamblaje de cabeza de impresión incluye una gama escalonada de cabezas de impresión que se superponen entre sí para abarcar conjuntamente un recorrido de medios sin espacios entre sí, un rodillo de accionamiento (16) posicionado corriente arriba de la zona de impresión para alimentar los medios a lo largo del recorrido de medios; y un ensamblaje de plato de vacío posicionado opuesto al ensamblaje de cabeza de impresión, comprendiendo el ensamblaje de plato de vacío un plato de vacío fijo (26) y una pluralidad de carruseles de servicio (22) incrustados en el plato de vacío fijo, en el que: cada carrusel de vacío (22) comprende un plato de vacío configurado para la alineación con una de las cabezas de impresión correspondiente; y cada carrusel de servicio (22) se configura para cruzar el recorrido de medios para acoplarse a su cabeza de impresión correspondiente durante una operación de tapado o limpieza.",MEMJET TECHNOLOGY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,,https://lens.org/139-041-847-514-675,Granted Patent,no,0,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J11/02;;B41J2/165;;B41J2/175;;B41J3/54;;B41J11/00;;B41J13/08;;B41J15/04;;B41J29/02;;B41J29/10;;B41J29/377,,0,0,,,,ACTIVE
489,US,A1,US 2018/0257402 A1,147-064-285-034-806,2018-09-13,2018,US 201815976707 A,2018-05-10,US 201815976707 A;;US 201514877454 A;;US 201514636054 A;;US 201414272259 A;;US 201313779024 A;;US 84575210 A;;US 23011009 P,2009-07-31,PRINTER HAVING TRANSPORT ASSEMBLY SUITABLE FOR WIDE PRINT MEDIA,"A printer comprising: a fixed printhead assembly defining a print zone; an input transport assembly for feeding print media along a media path and into the print zone, the input transport assembly being positioned upstream of the print zone; and an exit transport assembly positioned downstream of the print zone for receiving the print media from the print zone. The input transport assembly exerts a higher gripping force on the print media than the exit transport assembly and the exit transport assembly is configured to provide a higher transport speed than the input transport assembly, such that the print media has a degree of slippage relative to the exit transport assembly.",MEMJET TECHNOLOGY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,,https://lens.org/147-064-285-034-806,Patent Application,yes,4,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J11/00;;B41J2/175;;B41J3/54;;B41J29/02,,0,0,,,,DISCONTINUED
490,EP,A4,EP 2496421 A4,165-477-064-025-795,2014-08-20,2014,EP 10803733 A,2010-07-29,US 23011009 P;;AU 2010/000954 W,2009-07-31,PRINTING SYSTEM WITH FIXED PRINTHEADS AND MOVABLE VACUUM PLATEN,,MEMJET TECHNOLOLGY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,ZAMTEC LIMITED (2014-02-12);;MEMJET TECHNOLOGY LIMITED (2014-09-24);;MEMJET TECHNOLOLGY LIMITED (2014-08-13),https://lens.org/165-477-064-025-795,Search Report,no,3,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J11/02;;B41J2/165;;B41J2/175;;B41J3/54;;B41J11/00;;B41J13/08;;B41J15/04;;B41J29/02;;B41J29/10;;B41J29/377,,1,0,,,See also references of WO 2011011824A1,ACTIVE
491,AU,B2,AU 2014/259492 B2,167-652-293-962-174,2015-10-29,2015,AU 2014/259492 A,2014-11-04,AU 2010/278669 A;;AU 2014/259492 A,2010-07-29,PRINTING SYSTEM WITH FIXED PRINTHEADS AND MOVABLE VACUUM PLATEN,"A printing system that has a printhead assembly having a staggered array of printheads that overlap each other to collectively span a media path, a drive roller for feeding media along a media path and a vacuum platen assembly comprising a fixed vacuum platen and a plurality of movable modules embedded in the fixed vacuum platen, each module having a vacuum platen configured for alignment with a corresponding one of the array of printheads, wherein the fixed vacuum platen is positioned adjacent a section of the media path defining a print zone.",MEMJET TECHNOLOGY LTD,BOUND ANDY;;ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,,https://lens.org/167-652-293-962-174,Granted Patent,no,2,0,2,2,0,,B41J11/02;;B41J13/08;;B41J29/10;;B41J29/377,,0,0,,,,ACTIVE
492,US,B2,US 8579430 B2,172-558-059-281-004,2013-11-12,2013,US 84577010 A,2010-07-29,US 84577010 A;;US 23011009 P,2009-07-31,Wide format printer with aerosol collection from both sides of media path,"A wide format printer that has an inkjet printhead assembly for printing media fed along a media path that is more than 432 mm (17 inches) wide, and an aerosol collection system for collecting ink aerosol generated by the printhead assembly. The printhead assembly is positioned on a first side of the media path and the aerosol collection system has a first aerosol collection opening positioned on the first side of the media path and a second aerosol collection opening positioned on a second side of the media path.",ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON;;ZAMTEC LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/172-558-059-281-004,Granted Patent,yes,66,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165;;B41J2/01,347/104;;347/29,0,0,,,,ACTIVE
493,US,B2,US 8602526 B2,037-557-125-251-243,2013-12-10,2013,US 84574910 A,2010-07-29,US 84574910 A;;US 23011009 P,2009-07-31,Inkjet printer with printhead modules having individual ink interfaces,"An inkjet printer that has a print zone, a media path extending through the print zone along a paper axis, a printhead carriage with a plurality of printhead mounting sites for mounting a plurality of printhead modules adjacent the print zone such that the printhead modules collectively span the media path and a plurality of interfaces for supplying ink to, and receiving ink from each of the printhead modules respectively.",ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON;;ZAMTEC LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/037-557-125-251-243,Granted Patent,yes,19,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/155,347/42;;347/49;;347/50;;347/86,0,0,,,,ACTIVE
494,US,B2,US 9981488 B2,066-284-580-087-861,2018-05-29,2018,US 201514877454 A,2015-10-07,US 201514877454 A;;US 201514636054 A;;US 201414272259 A;;US 201313779024 A;;US 84575210 A;;US 23011009 P,2009-07-31,Modular vacuum belt assembly with interconnecting moving belt modules,A printer includes a modular vacuum belt assembly for moving print media in a media feed direction along a media path. The modular vacuum belt assembly includes a plurality of moving belt modules interconnected along a width of the media path. Neighboring moving belt modules are interconnected via a connecting fixed vacuum plenum.,MEMJET TECHNOLOGY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-08-02);;MEMJET TECHNOLOGY LIMITED (2013-02-01),https://lens.org/066-284-580-087-861,Granted Patent,yes,57,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165;;B41J2/175;;B41J3/54;;B41J11/00;;B41J15/04;;B41J29/02,,3,0,,,"International Search Report for PCT/AU2010/000954 dated Jan. 13, 2011, 3 pages.;;Written Opinion for PCT/AU2010/000954 dated Jan. 13, 2011, 3 pages.;;EP1083733.4 Search Report dated Jul. 17, 2014, 10 pages.",ACTIVE
495,US,A1,US 2011/0025766 A1,156-808-288-365-032,2011-02-03,2011,US 84575310 A,2010-07-29,US 84575310 A;;US 23011009 P,2009-07-31,WIDE FORMAT PRINTER WITH ADJUSTABLE AEROSOL COLLECTION,"A wide format printer that has a drive roller for feeding different sizes of media along a media path at least 432 mm (17 inches) wide, an inkjet printhead assembly for printing the media and an ink aerosol collection system for removing ink aerosol from areas adjacent the media path. The ink aerosol collection system is configured to remove aerosol at a greater rate in response to an increase in the media size.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;ZAMTEC LIMITED (2012-05-03),https://lens.org/156-808-288-365-032,Patent Application,yes,12,17,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165,347/34,0,0,,,,DISCONTINUED
496,US,A1,US 2011/0025800 A1,184-626-417-023-708,2011-02-03,2011,US 84572810 A,2010-07-29,US 84572810 A;;US 23011009 P,2009-07-31,METHOD OF PRINTING USING INPUT ROLLER AND MOVABLE MEDIA ENGAGEMENT OUTPUT,A method of printing by translating media across a print zone at a first speed based upon the angular velocity of a drive roller and subsequently translating the media at a second speed determined by a movable media engagement assembly configured to engage one side of the media.,SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;ZAMTEC LIMITED (2012-05-03),https://lens.org/184-626-417-023-708,Patent Application,yes,8,1,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/01,347/104,0,0,,,,DISCONTINUED
497,WO,A1,WO 2011/011824 A1,174-734-337-400-521,2011-02-03,2011,AU 2010/000954 W,2010-07-29,US 23011009 P,2009-07-31,PRINTING SYSTEM WITH FIXED PRINTHEADS AND MOVABLE VACUUM PLATEN,"A printing system that has a printhead assembly, a drive roller for feeding media along a media path and a vacuum platen assembly configured for movement relative to the fixed printhead assembly.",SILVERBROOK RES PTY LTD;;ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,,https://lens.org/174-734-337-400-521,Patent Application,yes,11,5,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J11/02;;B41J13/08;;B41J29/10;;B41J29/377,,1,0,,,See also references of EP 2496421A4,PENDING
498,US,A1,US 2011/0025772 A1,181-804-631-292-01X,2011-02-03,2011,US 84576710 A,2010-07-29,US 84576710 A;;US 23011009 P,2009-07-31,WIDE FORMAT PRINTER WITH PUMP TO CREATE PRESSURE DIFFERENCE ACROSS PRINTHEADS,"A wide format printer that has an ink supply, a feed line coupled to the ink supply, a return line coupled to the ink supply, a plurality of printheads collectively spanning a paper path more than 432 mm (17 inches) wide, the printheads each coupled to the feed line and the return line and, a pumping system to generate a pressure difference between the feed line and the return line during a printhead replacement operation.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;ZAMTEC LIMITED (2012-05-03),https://lens.org/181-804-631-292-01X,Patent Application,yes,13,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165;;B41J2/175,347/34;;347/85,1,0,,,"Machine generated English translation of specification of JP2004-167839 to Ogawa et al., ""INK CIRCULATION SYSTEM,"" generated 1/8/2013 via http://www4.ipdl.inpit.go.jp/Tokujitu/PAJdetail.ipdl?N0000=60&N0120=01&N2001=2&N3001=2004-167839; 10pp",DISCONTINUED
499,JP,A,JP 2014080036 A,032-935-929-608-117,2014-05-08,2014,JP 2014010007 A,2014-01-23,US 23011009 P,2009-07-31,PRINTING SYSTEM WITH FIXED PRINTHEADS AND MOVABLE VACUUM PLATEN,PROBLEM TO BE SOLVED: To provide an excellent printing system with fixed printheads and movable vacuum platen.SOLUTION: A printing system has: a printhead assembly; a drive roller for feeding media along a media path; and a vacuum platen assembly configured for movement relative to the fixed printhead assembly.,ZAMTEC LTD,ROBERT ROSATI;;DAVID PETCH;;DAVID BURNEY;;JIM SYKORA;;KENNETH A REGAS;;ANDY BOUND;;NEIL DOHERTY;;SCOTT DENNIS;;BEN JONES;;OKSANA BUYDA;;LOCSON TONTHAT;;ANDREW BUYDA;;PATRICK KIRK;;LOREN HUNT;;JASON DEWEY;;JIM TRINCHERA;;BILL CRESSMAN;;RON ZECH,,https://lens.org/032-935-929-608-117,Patent Application,no,6,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J11/08;;B41J2/01;;B41J2/165;;B41J2/18;;B41J2/185;;B65H5/22,,0,0,,,,ACTIVE
500,US,A1,US 2013/0169726 A1,090-768-859-738-722,2013-07-04,2013,US 201313779024 A,2013-02-27,US 201313779024 A;;US 84575210 A;;US 23011009 P,2009-07-31,PRINTER HAVING FIXED VACUUM PLATEN AND MOVING BELT ASSEMBLY,"A printer includes: a fixed printhead assembly defining a print zone; a drive roller for feeding media along a media path and into the print zone, the drive roller being positioned upstream of the print zone; a fixed vacuum platen for receiving the media from the drive roller, the fixed vacuum platen being positioned in the print zone opposite the fixed printhead assembly; and a moving belt assembly positioned downstream of the print zone for receiving the media from the fixed vacuum platen.",ZAMTEC LTD;;ZAMTEC LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/090-768-859-738-722,Patent Application,yes,2,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J11/00,347/104,0,0,,,,ACTIVE
501,US,B2,US 9180692 B2,142-484-858-605-32X,2015-11-10,2015,US 201514636054 A,2015-03-02,US 201514636054 A;;US 201414272259 A;;US 201313779024 A;;US 84575210 A;;US 23011009 P,2009-07-31,Printer having modular vacuum belt assembly,"A printing system includes: a fixed printhead assembly having an array of printheads and vacuum platen assembly. The vacuum platen assembly includes a fixed vacuum platen and a plurality of rotatable service modules embedded in the fixed vacuum platen. Each service module is positioned opposite a respective printhead, and each service module comprises a respective vacuum platen module.",MEMJET TECHNOLOGY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-08-02);;MEMJET TECHNOLOGY LIMITED (2013-02-01),https://lens.org/142-484-858-605-32X,Granted Patent,yes,54,2,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J29/38;;B41J2/165;;B41J2/175;;B41J3/54;;B41J11/00;;B41J15/04;;B41J29/02,,3,0,,,"International Search Report for PCT/AU2010/000954 issued Jan. 13, 2011, 3 pages.;;Written Opinion for PCT/AU2010/000954 issued Jan. 13, 2011, 3 pages.;;EP1083733.4 Search Report issued Jul. 17, 2014, 10 pages.",ACTIVE
502,US,B2,US 8382242 B2,190-155-048-139-906,2013-02-26,2013,US 84573510 A,2010-07-29,US 84573510 A;;US 23011009 P,2009-07-31,Printing system with spittoon and aerosol collection,"A printing system that has a media feed assembly for feeding different sizes of media along a media path, the media path having a width corresponding to a maximum width of media that can be printed by the printing system. The system also having a printhead assembly positioned on a first side of the media path and spanning the width of the media path, an aerosol collection duct with an opening on the first side of the media path and a spittoon system positioned on a second side of the media path opposing the first side. The printhead assembly is configured to eject non-printing ink drops from any section not required to print media that is less than the maximum width, and the spittoon system is configured to collect the non-printing ink drops.",ZAMTEC LTD;;ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/190-155-048-139-906,Granted Patent,yes,4,4,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165,347/36;;347/34,0,0,,,,ACTIVE
503,US,B2,US 9056473 B2,007-194-505-038-817,2015-06-16,2015,US 201414272259 A,2014-05-07,US 201414272259 A;;US 201313779024 A;;US 84575210 A;;US 23011009 P,2009-07-31,Printer having rotatable service modules embedded in fixed vacuum platen,"A printing system includes: a fixed printhead assembly having an array of printheads and vacuum platen assembly. The vacuum platen assembly includes a fixed vacuum platen and a plurality of rotatable service modules embedded in the fixed vacuum platen. Each service module is positioned opposite a respective printhead, and each service module comprises a respective vacuum platen module.",ZAMTEC LTD;;MERNJET TECHNOLOGY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-08-02);;MEMJET TECHNOLOGY LIMITED (2013-02-01),https://lens.org/007-194-505-038-817,Granted Patent,yes,54,2,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J29/38;;B41J2/165;;B41J2/175;;B41J3/54;;B41J11/00;;B41J15/04;;B41J29/02,,3,0,,,"International Search Report for PCT/AU2010/000954 issued Jan. 13, 2011, 3 pages.;;Written Opinion for PCT/AU2010/000954 issued Jan. 13, 2011, 3 pages.;;EP1083733.4 Search Report issued Jul. 17, 2014, 10 pages.",ACTIVE
504,US,A1,US 2011/0026046 A1,052-315-518-019-885,2011-02-03,2011,US 84575610 A,2010-07-29,US 84575610 A;;US 23011009 P,2009-07-31,WIDE FORMAT PRINTER WITH SCANNER TO ALIGN PRINTHEAD ASSEMBLY,"A wide format printer that has a printhead assembly, a vacuum platen assembly opposite the printhead assembly, a media path between the printhead assembly and the vacuum platen, a drive roller for moving media along the media path, a vacuum belt assembly to move the media away from the vacuum platen assembly and a scanner adjacent the vacuum belt to capture information from the media for feedback control of the printhead assembly. The media path is more than 432 mm (17 inches wide).",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;ZAMTEC LIMITED (2012-05-03),https://lens.org/052-315-518-019-885,Patent Application,yes,6,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,G06F15/00;;G06K1/00,358/1.5;;358/1.9,0,0,,,,DISCONTINUED
505,KR,A,KR 20120049879 A,076-054-988-806-830,2012-05-17,2012,KR 20127003431 A,2010-07-29,US 23011009 P;;AU 2010/000954 W,2009-07-31,PRINTING SYSTEM WITH FIXED PRINTHEADS AND MOVABLE VACUUM PLATEN,,SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,,https://lens.org/076-054-988-806-830,Patent Application,no,0,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J13/08;;B41J29/10;;B41J29/377,,0,0,,,,ACTIVE
506,US,A1,US 2011/0025739 A1,148-666-368-392-961,2011-02-03,2011,US 84577210 A,2010-07-29,US 84577210 A;;US 23011009 P,2009-07-31,WIDE FORMAT PRINTER WITH PRINTHEAD CARRIAGE CONNECTED TO INK SUPPLY FROM A SINGLE SIDE,"A wide format printer that has a print zone, a media path more than 432 mm (17 inches) wide and extending through the print zone along a paper axis, a printhead carriage with a plurality of printhead mounting sites for mounting a plurality of printhead modules adjacent the print zone such that the printhead modules collectively span the media path, the printhead carriage having a long side extending transverse to the paper axis, the long side having access formations for ink conduits and a plurality of interfaces for connection to the ink conduits to supply ink to each of the printhead modules respectively. All ink for the plurality of printhead modules is supplied by ink conduits extending through the access formations on the long side of the printhead carriage.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/148-666-368-392-961,Patent Application,yes,11,7,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J29/38;;B41J2/14,347/9;;347/49,0,0,,,,ACTIVE
507,US,B2,US 8876267 B2,062-013-283-871-14X,2014-11-04,2014,US 84574110 A,2010-07-29,US 84574110 A;;US 23011009 P,2009-07-31,Printing system with multiple printheads each supplied by multiple conduits,"A printing system that has an ink supply, a feed line coupled to the ink supply, a return line coupled to the ink supply, a plurality of printheads each fluidically coupled to the feed and the return lines via separate couplings. Each of the printheads receives ink from both the feed and the return lines.",ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON;;MEMJET TECHNOLOGY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/062-013-283-871-14X,Granted Patent,yes,102,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/175,347/85;;347/86,0,0,,,,ACTIVE
508,US,A1,US 2011/0025798 A1,068-127-675-217-116,2011-02-03,2011,US 84572410 A,2010-07-29,US 84572410 A;;US 23011009 P,2009-07-31,PRINTING SYSTEM WITH INPUT MEDIA ROLLER AND OUTPUT VACUUM BELTS,"A printing system that has a print zone, a drive roller positioned at an input side of the print zone, a vacuum platen assembly positioned under the print zone, a printhead assembly overlaying and spanning the print zone and a vacuum belt assembly configured to receive media from the print zone.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/068-127-675-217-116,Patent Application,yes,62,1,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/01,347/104,0,0,,,,ACTIVE
509,US,A1,US 2011/0025773 A1,096-442-921-310-865,2011-02-03,2011,US 84576810 A,2010-07-29,US 84576810 A;;US 23011009 P,2009-07-31,WIDE FORMAT PRINTER WITH SPITTOON AND AEROSOL COLLECTION,"A wide format printer that has a media feed assembly for feeding different sizes of media along a media path having a width from 914 mm (36 inches) to 1372 mm (54 inches), a printhead assembly positioned on a first side of the media path and spanning the width of the media path, an aerosol collection duct with an opening on the first side of the media path and a spittoon system positioned on a second side of the media path opposing the first side. The printhead assembly is configured to eject non-printing ink drops from any section not required to print media that is less than the maximum width, and the spittoon system is configured to collect the non-printing ink drops.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;ZAMTEC LIMITED (2012-05-03),https://lens.org/096-442-921-310-865,Patent Application,yes,14,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165,347/34,0,0,,,,DISCONTINUED
510,CN,B,CN 102470678 B,127-503-876-733-138,2014-12-31,2014,CN 201080028037 A,2010-07-29,AU 2010/000954 W;;US 23011009 P,2009-07-31,Printing system with fixed printheads and movable vacuum platen,,ZAMTEC LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,"MAGTE TECHNOLOGY CO., LTD. (2015-03-11);;ZAMTEC LTD. (2013-04-09)",https://lens.org/127-503-876-733-138,Granted Patent,no,0,1,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J11/02;;B41J13/08;;B41J29/10;;B41J29/377,,0,0,,,,ACTIVE
511,CN,A,CN 104401128 A,005-428-895-164-638,2015-03-11,2015,CN 201410718688 A,2010-07-29,US 23011009 P;;CN 201080028037 A,2009-07-31,Printing system with fixed printheads and movable vacuum platen,"A printing system that has a printhead assembly, a drive roller for feeding media along a media path and a vacuum platen assembly configured for movement relative to the fixed printhead assembly.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,,https://lens.org/005-428-895-164-638,Patent Application,no,9,6,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/01,,0,0,,,,ACTIVE
512,US,A1,US 2011/0025774 A1,004-266-714-174-111,2011-02-03,2011,US 84576910 A,2010-07-29,US 84576910 A;;US 23011009 P,2009-07-31,WIDE FORMAT PRINTER WITH PUMP TO PRIME MULTIPLE PRINTHEADS,"A wide format printer that has an ink supply, a feed line coupled to the ink supply, a return line coupled to the ink supply, a plurality of printheads collectively spanning a paper path more than 432 mm (17 inches) wide, the printheads each fluidically coupled to the feed and the return lines, a bypass line coupling the first conduit to the return line and, a pumping system configured to initially prime ink through the feed line, the return line, and the bypass line before priming each of the printheads.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;ZAMTEC LIMITED (2012-05-03),https://lens.org/004-266-714-174-111,Patent Application,yes,10,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165;;B41J2/175,347/34;;347/85,0,0,,,,DISCONTINUED
513,US,B2,US 8567939 B2,005-203-673-067-069,2013-10-29,2013,US 84573310 A,2010-07-29,US 84573310 A;;US 23011009 P,2009-07-31,Printing system with independently movable printhead service modules,"A printing system that has a media transport system configured to transport media along a media path, a printhead assembly fixed relative to the media path and a plurality of service modules for the printhead assembly. Each of the service modules is independently movable relative to the media path.",ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON;;ZAMTEC LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/005-203-673-067-069,Granted Patent,yes,62,3,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/01;;B41J3/00,347/104;;347/2;;347/29,1,0,,,"NonFinal Office Action, U.S. Appl. No. 12/845,762 dated Aug. 21, 2012.",ACTIVE
514,US,A1,US 2015/0165790 A1,060-579-645-668-203,2015-06-18,2015,US 201514636054 A,2015-03-02,US 201514636054 A;;US 201414272259 A;;US 201313779024 A;;US 84575210 A;;US 23011009 P,2009-07-31,PRINTER HAVING MODULAR VACUUM BELT ASSEMBLY,"A printing system includes: a fixed printhead assembly having an array of printheads and vacuum platen assembly. The vacuum platen assembly includes a fixed vacuum platen and a plurality of rotatable service modules embedded in the fixed vacuum platen. Each service module is positioned opposite a respective printhead, and each service module comprises a respective vacuum platen module.",MEMJET TECHNOLOGY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-08-02);;MEMJET TECHNOLOGY LIMITED (2013-02-01),https://lens.org/060-579-645-668-203,Patent Application,yes,1,4,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J11/00,,0,0,,,,ACTIVE
515,US,A1,US 2011/0025762 A1,070-901-397-939-611,2011-02-03,2011,US 84574410 A,2010-07-29,US 84574410 A;;US 23011009 P,2009-07-31,PRINTING SYSTEM WITH PUMP TO PRIME PRINTHEADS,"A printing system that has an ink supply, a feed line coupled to the ink supply, a return line coupled to the ink supply, a plurality of printheads each coupled to the feed line and the return line and a pumping system configured to generate fluid flow from the feed line to the return line via the printheads to prime the printheads.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;ZAMTEC LIMITED (2012-05-03),https://lens.org/070-901-397-939-611,Patent Application,yes,8,5,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165;;B41J2/175,347/34;;347/85,0,0,,,,DISCONTINUED
516,US,A1,US 2011/0025759 A1,094-473-641-657-767,2011-02-03,2011,US 84574110 A,2010-07-29,US 84574110 A;;US 23011009 P,2009-07-31,PRINTING SYSTEM WITH MULTIPLE PRINTHEADS EACH SUPPLIED BY MULTIPLE CONDUITS,"A printing system that has an ink supply, a feed line coupled to the ink supply, a return line coupled to the ink supply, a plurality of printheads each fluidically coupled to the feed and the return lines via separate couplings. Each of the printheads receives ink from both the feed and the return lines.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/094-473-641-657-767,Patent Application,yes,52,2,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165;;B41J2/175,347/34;;347/85,0,0,,,,ACTIVE
517,EP,A1,EP 2939840 A1,155-145-181-367-432,2015-11-04,2015,EP 15169931 A,2010-07-29,US 23011009 P;;EP 10803733 A;;AU 2010/000954 W,2009-07-31,PRINTING SYSTEM WITH DRIVE ROLLER AND VACUUM BELT ASSEMBLY,"A printing system comprises: a print zone (14); a drive roller (16) positioned upstream of the print zone; a fixed vacuum platen (26) positioned under the print zone; a printhead assembly (42, 44, 46, 48, 50) overlaying and spanning the print zone; and a vacuum belt assembly (20) positioned downstream of the print zone, the vacuum belt assembly being configured to receive media from the print zone. The vacuum belt assembly comprises a plurality of individual moving belts and the moving belts are configured to transport the media at a faster speed than the drive roller. During use, the media simultaneously engages both the drive roller and the moving belts, such that the media slips relative to the moving belts.
",MEMJET TECHNOLOGY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,,https://lens.org/155-145-181-367-432,Patent Application,yes,12,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J11/02;;B41J2/165;;B41J2/175;;B41J3/54;;B41J11/00;;B41J13/08;;B41J15/04;;B41J29/02;;B41J29/10;;B41J29/377,,0,0,,,,ACTIVE
518,US,A1,US 2020/0331279 A1,186-075-552-244-241,2020-10-22,2020,US 202016919010 A,2020-07-01,US 202016919010 A;;US 201916460891 A;;US 201815976707 A;;US 201514877454 A;;US 201514636054 A;;US 201414272259 A;;US 201313779024 A;;US 84575210 A;;US 23011009 P,2009-07-31,PRINTING SYSTEM HAVING MULTIPLE PRINTHEADS AND BYPASS LINES,A printing system includes: an ink supply; a feed line coupled to the ink supply; a return line coupled to the ink supply; and a plurality of printhead modules each having an inlet port fluidically coupled to the feed line and an outlet port fluidically coupled to the return line; and bypass lines fluidically coupling the feed line to the return line. A bypass line is open for both priming and printing operations.,MEMJET TECHNOLOGY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,,https://lens.org/186-075-552-244-241,Patent Application,yes,0,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J11/00;;B41J2/165;;B41J2/175;;B41J2/18;;B41J3/54;;B41J29/02,,0,0,,,,ACTIVE
519,US,A1,US 2011/0025763 A1,187-644-888-217-662,2011-02-03,2011,US 84574610 A,2010-07-29,US 84574610 A;;US 23011009 P,2009-07-31,PRINTING SYSTEM WITH PUMP TO CREATE PRESSURE DIFFERENCE ACROSS PRINTHEADS,"A printing system that has an ink supply, a first conduit coupled to the ink supply, a second conduit coupled to the ink supply, a plurality of printheads each coupled to the first conduit and the second conduit and a pumping system to generate a pressure difference between the first conduit and the second conduit during a printhead replacement operation.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;ZAMTEC LIMITED (2012-05-03),https://lens.org/187-644-888-217-662,Patent Application,yes,14,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165;;B41J2/175,347/34;;347/85,1,0,,,"Machine generated English translation of JP2004-167839A to Ogawa et al., ""INK CIRCULATION SYSTEM,"" generated via http://www19.ipdl.inpit.go.jp/PA1/cgi-bin/PA1DETAIL on 11/16/2012; 10pp",DISCONTINUED
520,US,A1,US 2011/0025799 A1,001-032-665-714-562,2011-02-03,2011,US 84572510 A,2010-07-29,US 84572510 A;;US 23011009 P,2009-07-31,PRINTING SYSTEM WITH SCANNER TO ALIGN PRINTHEAD ASSEMBLY,"A printing system that has a printhead assembly, a vacuum platen assembly opposite the printhead assembly, a media path between the printhead assembly and the vacuum platen, a drive roller for moving media along the media path, a vacuum belt assembly to move the media away from the vacuum platen assembly and a scanner adjacent the vacuum belt to capture information from the media for feedback control of the printhead assembly.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/001-032-665-714-562,Patent Application,yes,62,3,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/01,347/104,0,0,,,,ACTIVE
521,US,B2,US 8540361 B2,002-987-888-198-604,2013-09-24,2013,US 84572410 A,2010-07-29,US 84572410 A;;US 23011009 P,2009-07-31,Printing system with input media roller and output vacuum belts,"A printing system that has a print zone, a drive roller positioned at an input side of the print zone, a vacuum platen assembly positioned under the print zone, a printhead assembly overlaying and spanning the print zone and a vacuum belt assembly configured to receive media from the print zone.",ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON;;ZAMTEC LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/002-987-888-198-604,Granted Patent,yes,63,4,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/01;;B41J2/165;;B41J29/38;;G01D15/10,347/104;;347/16;;347/35;;347/212,0,0,,,,ACTIVE
522,EP,B1,EP 2496421 B1,022-084-131-443-83X,2015-06-24,2015,EP 10803733 A,2010-07-29,US 23011009 P;;AU 2010/000954 W,2009-07-31,PRINTING SYSTEM WITH FIXED PRINTHEADS AND MOVABLE VACUUM PLATEN,,MEMJET TECHNOLOGY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,ZAMTEC LIMITED (2014-02-12);;MEMJET TECHNOLOGY LIMITED (2014-09-24);;MEMJET TECHNOLOLGY LIMITED (2014-08-13),https://lens.org/022-084-131-443-83X,Granted Patent,yes,2,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J11/02;;B41J2/165;;B41J2/175;;B41J3/54;;B41J11/00;;B41J13/08;;B41J15/04;;B41J29/02;;B41J29/10;;B41J29/377,,0,0,,,,ACTIVE
523,US,B2,US 8556368 B2,083-888-245-753-269,2013-10-15,2013,US 84573410 A,2010-07-29,US 84573410 A;;US 23011009 P,2009-07-31,Printing system for media of different sizes,"A printing system that has a media transport system configured to transport media of differing dimensions along a media path, a printhead assembly for printing media transported along the media path, the media path having differing widths depending on the dimensions of the media and, a plurality of service modules for the printhead assembly. Each of the service modules is configured to operate in a plurality of different modes. During use, the media path extends between the printhead assembly and at least some of the service modules configured to operate in one of the modes while any of the service modules beyond the media path operate in another of the modes.",ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON;;ZAMTEC LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/083-888-245-753-269,Granted Patent,yes,62,3,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J29/38;;B41J2/165,347/16;;347/14;;347/23,1,0,,,"U.S. Appl. No. 12/845,766, Office Action mailed May 17, 2012.",ACTIVE
524,US,A1,US 2011/0025768 A1,082-378-931-622-019,2011-02-03,2011,US 84575710 A,2010-07-29,US 84575710 A;;US 23011009 P,2009-07-31,WIDE FORMAT PRINTER WITH MULTIPLE PRINTHEADS EACH SUPPLIED BY MULTIPLE CONDUITS,"A wide format printer that has an ink supply, a feed line to the ink supply, a return line coupled to the ink supply, and a plurality of printheads collectively spanning a paper path more than 432 mm (17 inches) wide. Each printhead is fluidically coupled to the feed and the return via separate couplings. During printing, the printheads receives ink from both the feed and return lines.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIKR PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/082-378-931-622-019,Patent Application,yes,11,3,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165;;B41J2/14,347/34;;347/49,0,0,,,,ACTIVE
525,US,A1,US 2011/0025760 A1,156-020-157-354-313,2011-02-03,2011,US 84574210 A,2010-07-29,US 84574210 A;;US 23011009 P,2009-07-31,PRINTING SYSTEM WITH PRINTHEADS SUPPLIED BY MULTIPLE INK CONDUITS CONNECTED BY A BYPASS LINE,"A printing system with an ink supply, a feed line coupled to the ink supply, a return line coupled to the ink supply, a plurality of printheads each fluidically coupled to the first and return lines and a bypass line coupling the feed line to the return line.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;ZAMTEC LIMITED (2012-05-03),https://lens.org/156-020-157-354-313,Patent Application,yes,7,3,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165;;B41J2/175,347/34;;347/85,0,0,,,,DISCONTINUED
526,US,A1,US 2011/0025754 A1,166-818-720-015-747,2011-02-03,2011,US 84573010 A,2010-07-29,US 84573010 A;;US 23011009 P,2009-07-31,PRINTING SYSTEM WITH INDEPENDENTLY OPERABLE PRINTHEAD SERVICE MODULES,A printing system that has a printhead assembly for printing media fed along a media path and a plurality of service modules for the printhead assembly. Each of the service modules is configured to operate in a plurality of different modes and each of the service modules are independently operable.,SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/166-818-720-015-747,Patent Application,yes,43,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165,347/29;;347/35;;347/104,0,0,,,,ACTIVE
527,AU,A1,AU 2014/259492 A1,009-583-533-675-903,2014-11-27,2014,AU 2014/259492 A,2014-11-04,AU 2010/278669 A;;AU 2014/259492 A,2010-07-29,PRINTING SYSTEM WITH FIXED PRINTHEADS AND MOVABLE VACUUM PLATEN,"A printing system that has a printhead assembly having a staggered array of printheads that overlap each other to collectively span a media path, a drive roller for feeding media along a media path and a vacuum platen assembly comprising a fixed vacuum platen and a plurality of movable modules embedded in the fixed vacuum platen, each module having a vacuum platen configured for alignment with a corresponding one of the array of printheads, wherein the fixed vacuum platen is positioned adjacent a section of the media path defining a print zone.",MEMJET TECHNOLOGY LTD,BOUND ANDY;;ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,,https://lens.org/009-583-533-675-903,Patent Application,no,0,2,2,2,0,,B41J11/02;;B41J13/08;;B41J29/10;;B41J29/377,,0,0,,,,ACTIVE
528,US,A1,US 2016/0023484 A1,019-391-259-319-338,2016-01-28,2016,US 201514877454 A,2015-10-07,US 201514877454 A;;US 201514636054 A;;US 201414272259 A;;US 201313779024 A;;US 84575210 A;;US 23011009 P,2009-07-31,MODULAR VACUUM BELT ASSEMBLY WITH INTERCONNECTING MOVING BELT MODULES,A printer includes a modular vacuum belt assembly for moving print media in a media feed direction along a media path. The modular vacuum belt assembly includes a plurality of moving belt modules interconnected along a width of the media path. Neighboring moving belt modules are interconnected via a connecting fixed vacuum plenum.,MEMJET TECHNOLOGY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-08-02);;MEMJET TECHNOLOGY LIMITED (2013-02-01),https://lens.org/019-391-259-319-338,Patent Application,yes,4,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J11/00,,0,0,,,,ACTIVE
529,US,A1,US 2011/0025765 A1,041-534-437-544-734,2011-02-03,2011,US 84574810 A,2010-07-29,US 84574810 A;;US 23011009 P,2009-07-31,PRINTING SYSTEM WITH DATUM FEATURES ON PRINTHEAD CARRIAGE,"A printing system that has a print zone, a media path extending through the print zone along a paper axis, a printhead carriage for mounting a plurality of printhead modules adjacent the print zone such that the printhead modules collectively span the media path and are staggered with respect to the paper axis, the printhead modules each having nozzles arranged in parallel rows and a plurality of datum features for holding the printhead carriage such that the parallel rows extend normal to the paper feed axis.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;ZAMTEC LIMITED (2012-05-03),https://lens.org/041-534-437-544-734,Patent Application,yes,15,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165;;B41J2/14;;B41J2/19,347/34;;347/37;;347/92,0,0,,,,DISCONTINUED
530,EP,B1,EP 2939840 B1,079-732-703-554-211,2019-05-15,2019,EP 15169931 A,2010-07-29,US 23011009 P;;EP 10803733 A;;AU 2010/000954 W,2009-07-31,PRINTING SYSTEM WITH DRIVE ROLLER AND VACUUM BELT ASSEMBLY,,MEMJET TECHNOLOGY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,,https://lens.org/079-732-703-554-211,Granted Patent,yes,1,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J11/02;;B41J2/165;;B41J2/175;;B41J3/54;;B41J11/00;;B41J13/08;;B41J15/04;;B41J29/02;;B41J29/10;;B41J29/377,,0,0,,,,ACTIVE
531,US,A1,US 2011/0026057 A1,137-901-420-949-527,2011-02-03,2011,US 84572710 A,2010-07-29,US 84572710 A;;US 23011009 P,2009-07-31,PRINTING SYSTEM WITH INPUT ROLLER AND MOVABLE MEDIA ENGAGEMENT OUTPUT,"A printing system with a print zone where droplets of ink print onto media, a drive roller configured to translate the media into the print zone and a movable media engagement assembly for vacuum engagement of one side of the media to draw the media away from the print zone.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/137-901-420-949-527,Patent Application,yes,62,1,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,H04N1/60,358/1.9,0,0,,,,ACTIVE
532,US,B2,US 11077681 B2,158-226-927-300-685,2021-08-03,2021,US 202016919010 A,2020-07-01,US 202016919010 A;;US 201916460891 A;;US 201815976707 A;;US 201514877454 A;;US 201514636054 A;;US 201414272259 A;;US 201313779024 A;;US 84575210 A;;US 23011009 P,2009-07-31,Printing system having multiple printheads and bypass lines,A printing system includes: an ink supply; a feed line coupled to the ink supply; a return line coupled to the ink supply; and a plurality of printhead modules each having an inlet port fluidically coupled to the feed line and an outlet port fluidically coupled to the return line; and bypass lines fluidically coupling the feed line to the return line. A bypass line is open for both priming and printing operations.,MEMJET TECHNOLOGY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,,https://lens.org/158-226-927-300-685,Granted Patent,yes,4,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J11/00;;B41J2/165;;B41J2/175;;B41J2/18;;B41J3/54;;B41J15/04;;B41J29/02,,0,0,,,,ACTIVE
533,US,B2,US 10737512 B2,159-484-284-882-228,2020-08-11,2020,US 201916460891 A,2019-07-02,US 201916460891 A;;US 201815976707 A;;US 201514877454 A;;US 201514636054 A;;US 201414272259 A;;US 201313779024 A;;US 84575210 A;;US 23011009 P,2009-07-31,Printing system having multiple printheads and bypass lines,A printing system includes: an ink supply; a feed line coupled to the ink supply; a return line coupled to the ink supply; and a plurality of printhead modules each having an inlet port fluidically coupled to the feed line and an outlet port fluidically coupled to the return line. Each print module has a bypass line fluidically coupling the feed line to the return line. The bypass line is open for both priming and printing operations.,MEMJET TECHNOLOGY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,,https://lens.org/159-484-284-882-228,Granted Patent,yes,4,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J11/00;;B41J2/165;;B41J2/175;;B41J2/18;;B41J3/54;;B41J15/04;;B41J29/02,,0,0,,,,ACTIVE
534,US,B2,US 8388094 B2,193-782-271-351-661,2013-03-05,2013,US 84575910 A,2010-07-29,US 84575910 A;;US 23011009 P,2009-07-31,Wide format printer with input roller and movable media engagement output,"A wide format printer that has a print zone where droplets of ink print onto media, a drive roller configured to translate the media into the print zone and a movable media engagement assembly for vacuum engagement of one side of the media to draw the media away from the print zone wherein, the print zone is more than 432 mm (17 inches) wide.",ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON;;ZAMTEC LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/193-782-271-351-661,Granted Patent,yes,6,2,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J29/38,347/16;;347/104;;347/101,0,0,,,,ACTIVE
535,US,B2,US 8746832 B2,005-621-828-064-252,2014-06-10,2014,US 201313779024 A,2013-02-27,US 201313779024 A;;US 84575210 A;;US 23011009 P,2009-07-31,Printer having fixed vacuum platen and moving belt assembly,"A printer includes: a fixed printhead assembly defining a print zone; a drive roller for feeding media along a media path and into the print zone, the drive roller being positioned upstream of the print zone; a fixed vacuum platen for receiving the media from the drive roller, the fixed vacuum platen being positioned in the print zone opposite the fixed printhead assembly; and a moving belt assembly positioned downstream of the print zone for receiving the media from the fixed vacuum platen.",ZAMTEC LTD;;ZAMTEC LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/005-621-828-064-252,Granted Patent,yes,71,1,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J29/38,347/16;;347/104,2,0,,,"International Search Report for PCT/AU2010/000954 issued Jan. 13, 2011, 3 pages.;;Written Opinion for PCT/AU2010/000954 issued Jan. 13, 2011, 3 pages.",ACTIVE
536,US,B2,US 8480221 B2,009-117-828-885-264,2013-07-09,2013,US 84575710 A,2010-07-29,US 84575710 A;;US 23011009 P,2009-07-31,Wide format printer with multiple printheads each supplied by multiple conduits,"A wide format printer that has an ink supply, a feed line to the ink supply, a return line coupled to the ink supply, and a plurality of printheads collectively spanning a paper path more than 432 mm (17 inches) wide. Each printhead is fluidically coupled to the feed and the return via separate couplings. During printing, the printheads receives ink from both the feed and return lines.",ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON;;ZAMTEC LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/009-117-828-885-264,Granted Patent,yes,15,3,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/18;;B41J2/175;;B41J2/19,347/89;;347/85;;347/92,0,0,,,,ACTIVE
537,US,A1,US 2011/0026058 A1,033-495-108-276-485,2011-02-03,2011,US 84573710 A,2010-07-29,US 84573710 A;;US 23011009 P,2009-07-31,PRINTING SYSTEM WITH ADJUSTABLE AEROSOL COLLECTION,"A printing system that has a drive roller for feeding different sizes of media along a media path, an inkjet printhead assembly for printing the media and an ink aerosol collection system for removing ink aerosol from areas adjacent the media path. The ink aerosol collection system is configured to remove aerosol at a greater rate in response to an increase in the media size.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/033-495-108-276-485,Patent Application,yes,64,8,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,H04N1/60,358/1.9,0,0,,,,ACTIVE
538,US,A1,US 2011/0025806 A1,075-728-704-099-866,2011-02-03,2011,US 84576610 A,2010-07-29,US 84576610 A;;US 23011009 P,2009-07-31,WIDE FORMAT PRINTER FOR MEDIA OF DIFFERENT SIZES,"A wide format printer that has a media transport system configured to transport media of differing dimensions along a media path, and a printhead assembly for printing media transported along the media path, the media path having variable widths depending on the dimensions of the media but a minimum width of 432 mm (17 inches). The printer also has a plurality of service modules for the printhead assembly, each being configured to operate in a plurality of different modes. The media path extends between the printhead assembly and at least some of the service modules configured to operate in one of the modes while any of the service modules beyond the media path operate in another of the modes.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;ZAMTEC LIMITED (2012-05-03),https://lens.org/075-728-704-099-866,Patent Application,yes,11,1,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/01,347/104,1,0,,,"Outdoor Photography; High-Tech B&W Printers; October 7, 2008; pages 1-2.",DISCONTINUED
539,US,A1,US 2011/0025742 A1,095-511-665-177-486,2011-02-03,2011,US 84575110 A,2010-07-29,US 84575110 A;;US 23011009 P,2009-07-31,PRINT ENGINE WITH INK SUPPLY CONDUITS EXTENDING FROM A LONG SIDE OF ELONGATE PRINTHEAD CARRIAGE,"A print engine for an inkjet printer which has a media path extending past a printhead assembly along a paper axis, has an elongate printhead carriage extending transverse to the paper axis, a series of interfaces for supplying ink to respective printhead modules spaced along the printhead carriage such that during use, the printhead modules span the media path and ink conduits connected to the interfaces for feeding ink to the printhead modules. The printhead carriage has a series formations to position the ink conduits such that they all extend away from the interfaces in a direction transverse to the long axis to a common side of the printhead carriage.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/095-511-665-177-486,Patent Application,yes,5,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J29/38;;B41J2/175,347/12;;347/85,0,0,,,,ACTIVE
540,US,A1,US 2011/0025749 A1,155-489-525-584-860,2011-02-03,2011,US 84575910 A,2010-07-29,US 84575910 A;;US 23011009 P,2009-07-31,WIDE FORMAT PRINTER WITH INPUT ROLLER AND MOVABLE MEDIA ENGAGEMENT OUTPUT,"A wide format printer that has a print zone where droplets of ink print onto media, a drive roller configured to translate the media into the print zone and a movable media engagement assembly for vacuum engagement of one side of the media to draw the media away from the print zone wherein, the print zone is more than 432 mm (17 inches) wide.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/155-489-525-584-860,Patent Application,yes,6,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J29/38;;B41J2/01;;G06F15/00,347/16;;358/1.5;;347/104,0,0,,,,ACTIVE
541,US,A1,US 2011/0026049 A1,172-216-064-096-153,2011-02-03,2011,US 84574010 A,2010-07-29,US 84574010 A;;US 23011009 P,2009-07-31,PRINTING SYSTEM WITH INK ACCUMULATORS FOR HYDROSTATIC PRESSURE REGULATION,"A printing system with a printhead assembly with nozzles for ejecting ink, a plurality of ink containers, a accumulator reservoirs each having an inlet for connection to one of the ink containers, an outlet for connection to the printhead assembly and a fluid level regulator for maintaining fluid levels in the reservoir within a controlled fluid level range. The ink accumulator reservoirs are mounted at a fixed elevation relative to the nozzles such that hydrostatic fluid pressure at the nozzles is maintained within a predetermined range.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;ZAMTEC LIMITED (2012-05-03),https://lens.org/172-216-064-096-153,Patent Application,yes,26,4,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,G06K15/10,358/1.8,0,0,,,,DISCONTINUED
542,US,B2,US 8480211 B2,178-724-802-239-953,2013-07-09,2013,US 84576410 A,2010-07-29,US 84576410 A;;US 23011009 P,2009-07-31,Wide format printer with multiple ink accumulators,"A wide format printer that has an ink supply, an accumulator reservoir, a valve coupling the accumulator reservoir to the ink supply, the valve being configured to open when the ink level in the accumulator reservoir reaches a lower limit of a predetermined ink level range, and close when the ink level in the accumulator reservoir reaches an upper limit of the ink level range and, a plurality of printheads collectively spanning a paper path more than 432 mm (17 inches) wide, each of the printheads being in fluid communication with the accumulator reservoir and each of the printheads having nozzles for ejecting ink onto media. During printing, the accumulator reservoir is fixed relative to the printheads such that hydrostatic ink pressure at the nozzles is generated by the elevation of the ink level in the accumulator reservoir relative to the elevation of the of the nozzles.",ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON;;ZAMTEC LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/178-724-802-239-953,Granted Patent,yes,18,3,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/175;;B41J2/155;;B41J2/18,347/85;;347/42;;347/89,0,0,,,,ACTIVE
543,US,A1,US 2011/0025738 A1,199-836-602-267-86X,2011-02-03,2011,US 84575010 A,2010-07-29,US 84575010 A;;US 23011009 P,2009-07-31,PRINTER SYSTEM WITH PRINTHEAD CARRIAGE CONNECTED TO INK SUPPLY FROM A SINGLE SIDE,"A printing system that has a print zone, a media path extending through the print zone along a paper axis, a printhead carriage with a plurality of printhead mounting sites for mounting a plurality of printhead modules adjacent the print zone such that the printhead modules collectively span the media path, the printhead carriage having a long side extending transverse to the paper axis, the long side having access formations for ink conduits and a plurality of interfaces for connection to the ink conduits to supply ink to each of the printhead modules respectively. All ink for the plurality of printhead modules is supplied by ink conduits extending through the access formations on said long side of the printhead carriage.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;ZAMTEC LIMITED (2012-05-03),https://lens.org/199-836-602-267-86X,Patent Application,yes,5,18,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J29/38;;B41J2/14;;B41J2/175,347/9;;347/85;;347/50,0,0,,,,DISCONTINUED
544,US,B2,US 8550617 B2,031-886-570-000-96X,2013-10-08,2013,US 84572510 A,2010-07-29,US 84572510 A;;US 23011009 P,2009-07-31,Printing system with scanner to align printhead assembly,"A printing system that has a printhead assembly, a vacuum platen assembly opposite the printhead assembly, a media path between the printhead assembly and the vacuum platen, a drive roller for moving media along the media path, a vacuum belt assembly to move the media away from the vacuum platen assembly and a scanner adjacent the vacuum belt to capture information from the media for feedback control of the printhead assembly.",ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON;;ZAMTEC LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/031-886-570-000-96X,Granted Patent,yes,63,2,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/01;;B41J2/145;;B41J3/36;;B41J29/38;;B41J29/393,347/104,0,0,,,,ACTIVE
545,US,A1,US 2011/0025764 A1,009-142-300-338-275,2011-02-03,2011,US 84574710 A,2010-07-29,US 84574710 A;;US 23011009 P,2009-07-31,PRINTING SYSTEM WITH PUMP TO PRIME MULTIPLE PRINTHEADS,"A printing system that has an ink supply, a feed line coupled to the ink supply, a return line coupled to the ink supply, a plurality of printheads each fluidically coupled to the feed and the return lines, a bypass line coupling the feed line to the return line and a pumping system configured to initially prime ink through the feed line, the return line, and the bypass line before priming each of the printheads.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;ZAMTEC LIMITED (2012-05-03),https://lens.org/009-142-300-338-275,Patent Application,yes,7,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165;;B41J2/175,347/34;;347/85,0,0,,,,DISCONTINUED
546,US,B2,US 8567898 B2,066-168-566-015-847,2013-10-29,2013,US 84572710 A,2010-07-29,US 84572710 A;;US 23011009 P,2009-07-31,Printing system with input roller and movable media engagement output,"A printing system with a print zone where droplets of ink print onto media, a drive roller configured to translate the media into the print zone and a movable media engagement assembly for vacuum engagement of one side of the media to draw the media away from the print zone.",ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON;;ZAMTEC LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/066-168-566-015-847,Granted Patent,yes,63,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165;;B41J2/01,347/22;;347/104,0,0,,,,ACTIVE
547,US,A1,US 2011/0025801 A1,088-183-161-751-217,2011-02-03,2011,US 84572910 A,2010-07-29,US 84572910 A;;US 23011009 P,2009-07-31,PRINTING SYSTEM WITH MEDIA SIMULTANEOUSLY ENGAGING INPUT ROLLER AND MOVABLE MEDIA ENGAGEMENT OUTPUT,A printing system with a drive roller configured to engage and push media into a print zone and a movable media engagement assembly configured to engage one side of the media and pull the media while the drive roller remains engaged with the media.,SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;ZAMTEC LIMITED (2012-05-03),https://lens.org/088-183-161-751-217,Patent Application,yes,8,0,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/01,347/104,0,0,,,,DISCONTINUED
548,US,A1,US 2011/0025797 A1,115-529-749-811-877,2011-02-03,2011,US 84572310 A,2010-07-29,US 84572310 A;;US 23011009 P,2009-07-31,PRINTING SYSTEM WITH FIXED PRINTHEADS AND MOVABLE VACUUM PLATEN,"A printing system that has a printhead assembly, a drive roller for feeding media along a media path and a vacuum platen assembly configured for movement relative to the fixed printhead assembly.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;ZAMTEC LIMITED (2012-05-03),https://lens.org/115-529-749-811-877,Patent Application,yes,10,7,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/01,347/104,0,0,,,,DISCONTINUED
549,US,A1,US 2011/0025758 A1,142-363-606-614-835,2011-02-03,2011,US 84573510 A,2010-07-29,US 84573510 A;;US 23011009 P,2009-07-31,PRINTING SYSTEM WITH SPITTOON AND AEROSOL COLLECTION,"A printing system that has a media feed assembly for feeding different sizes of media along a media path, the media path having a width corresponding to a maximum width of media that can be printed by the printing system. The system also having a printhead assembly positioned on a first side of the media path and spanning the width of the media path, an aerosol collection duct with an opening on the first side of the media path and a spittoon system positioned on a second side of the media path opposing the first side. The printhead assembly is configured to eject non-printing ink drops from any section not required to print media that is less than the maximum width, and the spittoon system is configured to collect the non-printing ink drops.",SILVERBROOK RES PTY LTD,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/142-363-606-614-835,Patent Application,yes,4,3,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/165,347/34,0,0,,,,ACTIVE
550,US,B2,US 8353592 B2,161-336-915-192-037,2013-01-15,2013,US 84575810 A,2010-07-29,US 84575810 A;;US 23011009 P,2009-07-31,Wide format printer with media encoder in the platen,"A wide format printer that has a vacuum platen assembly, a printhead assembly spaced from the vacuum platen assembly, a media path extending between the vacuum platen assembly and the printhead assembly and a media encoder embedded within the vacuum platen assembly wherein, the media path is greater than 432 mm (17 inches) wide.",ZAMTEC LTD;;ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,ROSATI ROBERT;;PETCH DAVID;;BURNEY DAVID;;SYKORA JIM;;REGAS KENNETH A;;BOUND ANDY;;DOHERTY NEIL;;DENNIS SCOTT;;JONES BEN;;BUYDA OKSANA;;TONTHAT LOCSON;;BUYDA ANDREW;;KIRK PATRICK;;HUNT LOREN;;DEWEY JASON;;TRINCHERA JIM;;CRESSMAN BILL;;ZECH RON,SILVERBROOK RESEARCH PTY LTD (2010-07-19);;MEMJET TECHNOLOGY LIMITED (2012-05-03),https://lens.org/161-336-915-192-037,Granted Patent,yes,8,3,100,100,0,B41J11/0085;;B41J11/0085;;B41J11/02;;B41J2/165;;B41J2/16547;;B41J2/16547;;B41J2/16585;;B41J2/16585;;B41J2/175;;B41J2/175;;B41J2/1752;;B41J2/1752;;B41J2/18;;B41J3/543;;B41J3/543;;B41J11/001;;B41J11/001;;B41J11/007;;B41J11/007;;B41J13/08;;B41J15/04;;B41J15/04;;B41J29/02;;B41J29/02;;B41J29/10;;B41J29/377,B41J2/01;;B41J2/015;;B41J2/165;;B41J29/38,347/104;;347/9;;347/21;;347/34,1,0,,,"Outdoor Photography, High-Tech B&W Printers; Oct. 7, 2008; pp. 1-2.",ACTIVE
551,CN,A,CN 111818916 A,011-810-177-649-352,2020-10-23,2020,CN 201880066930 A,2018-08-15,US 201762545872 P;;US 201762555477 P;;US 201862692667 P;;US 2018/0000196 W,2017-08-15,Macrocyclic MCL-1 inhibitors and methods of use,"The present disclosure provides for compounds of Formula (I), wherein A2, A3, A4, A6, A7, A8, A15, RA, R5, R9, R10A, R10B, R11, R12, R13, R14, R16, W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).",ABBVIE INC;;ABBVIE DEUTSCHLAND,BRAJE WILFRIED;;DOHERTY GEORGE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI-FU;;LAI CHUNQUI;;KLING ANDREAS;;POHLKI FRAUKE;;TESKE JESSC;;WENDT MICHAEL;;BRADY PATRICK;;WANG XILU;;PENNING THOMAS;;MICHAELIDES MICHAEL,,https://lens.org/011-810-177-649-352,Patent Application,no,5,1,13,14,0,C07D495/16;;C07D519/00;;A61P35/00;;A61K45/06;;A61K31/519;;A61P35/00;;C07D495/16;;C07D519/00,A61K31/395;;A61P35/00;;C07D515/22,,1,1,002-864-807-651-770,27760111;;10.1038/nature19830,"ANDRÁS KOTSCHY ET AL.: ""The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models"", 《NATURE》",DISCONTINUED
552,EP,A4,EP 3668502 A4,152-035-323-918-767,2021-01-13,2021,EP 18845598 A,2018-08-15,US 201762545872 P;;US 201762555477 P;;US 201862692667 P;;US 2018/0000196 W,2017-08-15,MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE,,ABBVIE INC;;ABBVIE DEUTSCHLAND,BRAJE WILFRIED;;DOHERTY GEORGE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI-FU;;LAI CHUNQUI;;KLING ANDREAS;;POHLKI FRAUKE;;TESKE JESSC;;WENDT MICHAEL;;BRADY PATRICK;;WANG XILU;;PENNING THOMAS;;MICHAELIDES MICHAEL,ABBVIE DEUTSCHLAND GMBH & CO. KG (2020-07-15);;ABBVIE INC. (2020-07-15),https://lens.org/152-035-323-918-767,Search Report,no,4,0,13,14,0,C07D495/16;;C07D519/00;;A61P35/00;;A61K45/06;;A61K31/519;;A61P35/00;;C07D495/16;;C07D519/00,C07D515/22;;A61K31/395;;A61P35/00,,1,0,,,See also references of WO 2019035927A1,DISCONTINUED
553,CA,A1,CA 3073114 A1,058-252-227-723-111,2019-02-21,2019,CA 3073114 A,2018-08-15,US 201762545872 P;;US 201762555477 P;;US 201862692667 P;;US 2018/0000196 W,2017-08-15,MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE,"The present disclosure provides for compounds of Formula (I) wherein A2, A3, A4, A6, A7, A8, A15, RA, R5, R9, R10A, R10B, R11, R12, R13, R14, R16, W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).",ABBVIE INC;;ABBVIE DEUTSCHLAND,BRAJE WILFRIED;;DOHERTY GEORGE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI-FU;;LAI CHUNQUI;;KLING ANDREAS;;POHLKI FRAUKE;;TESKE JESSC;;WENDT MICHAEL;;BRADY PATRICK;;WANG XILU;;PENNING THOMAS;;MICHAELIDES MICHAEL,,https://lens.org/058-252-227-723-111,Patent Application,no,0,0,13,14,0,C07D495/16;;C07D519/00;;A61P35/00;;A61K45/06;;A61K31/519;;A61P35/00;;C07D495/16;;C07D519/00,A61K31/395;;A61P35/00;;C07D515/22,,0,0,,,,PENDING
554,BR,A2,BR 112020003200 A2,074-497-175-329-846,2020-10-06,2020,BR 112020003200 A,2018-08-15,US 2018/0000196 W;;US 201762555477 P;;US 201762545872 P;;US 201862692667 P,2017-08-15,inibidores macrocíclicos de mcl-1 e métodos de uso,"a presente divulgação fornece compostos de fórmula (i) (i), em que a2, a3, a4, a6, a7, a8, a15, ra, r5, r9, r10a, r10b, r11, r12, r13, r14, r16, w, x, e y têm qualquer um dos valores definidos no relatório descritivo e seus sais farmaceuticamente aceitáveis, que são úteis como agentes no tratamento de doenças e condições, incluindo câncer. também são fornecidas composições farmacêuticas que compreendem compostos de fórmula (i).",ABBVIE DEUTSCHLAND;;ABBVIE INC,AARON KUNZER;;ANDREAS KLING;;ANDREW JUDD;;ANDREW SOUERS;;ANTHONY MASTRACCHIO;;CHENG JI;;CHUNQIU LAI;;FRAUKE POHLKI;;GEORGE DOHERTY;;GERARD SULLIVAN;;JESSE TESKE;;KATJA JANTOS;;MICHAEL MICHAELIDES;;MICHAEL WENDT;;PATRICK BRADY;;THOMAS PENNING;;WILFRIED BRAJE;;XIAOHONG SONG;;XILU WANG;;ZHI-FU TAO,,https://lens.org/074-497-175-329-846,Patent Application,no,0,0,13,14,0,C07D495/16;;C07D519/00;;A61P35/00;;A61K45/06;;A61K31/519;;A61P35/00;;C07D495/16;;C07D519/00,A61K31/395;;A61P35/00;;C07D515/22,,0,0,,,,DISCONTINUED
555,EP,A1,EP 3668502 A1,168-650-954-513-630,2020-06-24,2020,EP 18845598 A,2018-08-15,US 201762545872 P;;US 201762555477 P;;US 201862692667 P;;US 2018/0000196 W,2017-08-15,MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE,,ABBVIE INC;;ABBVIE DEUTSCHLAND;;BRAJE WILFRIED;;DOHERTY GEORGE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI FU;;LAI CHUNQIU;;KLING ANDREAS;;POHLKI FRAUKE;;TESKE JESSE;;WENDT MICHAEL;;BRADY PATRICK;;WANG XILU;;PENNING THOMAS;;MICHAELIDES MICHAEL,BRAJE WILFRIED;;DOHERTY GEORGE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI-FU;;LAI CHUNQUI;;KLING ANDREAS;;POHLKI FRAUKE;;TESKE JESSC;;WENDT MICHAEL;;BRADY PATRICK;;WANG XILU;;PENNING THOMAS;;MICHAELIDES MICHAEL,ABBVIE DEUTSCHLAND GMBH & CO. KG (2020-07-15);;ABBVIE INC. (2020-07-15),https://lens.org/168-650-954-513-630,Patent Application,yes,0,0,13,14,0,C07D495/16;;C07D519/00;;A61P35/00;;A61K45/06;;A61K31/519;;A61P35/00;;C07D495/16;;C07D519/00,A61K31/395;;A61P35/00;;C07D515/22,,0,0,,,,DISCONTINUED
556,US,A1,US 2023/0399340 A1,077-046-572-351-904,2023-12-14,2023,US 202218046011 A,2022-10-12,US 202218046011 A;;US 202016639555 A;;US 2018/0000196 W;;US 201862692667 P;;US 201762555477 P;;US 201762545872 P,2017-08-15,MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE,"The present disclosure provides for compounds of Formula (I) wherein A 2 , A 3 , A 4 , A 6 , A 7 , A 8 , A 15 , R A , R 5 , R 9 , R 10A , R 10B , R 11 , R 12 , R 13 , R 14 , R 16 , W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).",ABBVIE INC;;ABBVIE DEUTSCHLAND,BRAJE WILFRIED;;DOHERTY GEORGE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI-FU;;LAI CHUNQIU;;KLING ANDREAS;;POHLKI FRAUKE;;TESKE JESSE;;WENDT MICHAEL;;BRADY PATRICK;;WANG XILU;;PENNING THOMAS;;MICHAELIDES MICHAEL,,https://lens.org/077-046-572-351-904,Patent Application,yes,0,0,13,14,0,C07D495/16;;C07D519/00;;A61P35/00;;A61K45/06;;A61K31/519;;A61P35/00;;C07D495/16;;C07D519/00,C07D495/16;;A61P35/00;;C07D519/00,,0,0,,,,PENDING
557,US,A1,US 2020/0239494 A1,013-955-403-667-103,2020-07-30,2020,US 201816639555 A,2018-08-15,US 201816639555 A;;US 201862692667 P;;US 201762555477 P;;US 201762545872 P;;US 2018/0000196 W,2017-08-15,MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE,"The present disclosure provides for compounds of Formula (I) wherein A 2 , A 3 , A 4 , A 6 , A 7 , A 8 , A 15 , R A , R 5 , R 9 , R 10A , R 10B , R 11 , R 12 , R 13 , R 14 , R 16 , W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).",ABBVIE INC;;ABBVIE DEUTSCHLAND,BRAJE WILFRIED;;DOHERTY GEORGE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI-FU;;LAI CHUNQIU;;KLING ANDREAS;;POHLKI FRAUKE;;TESKE JESSE;;WENDT MICHAEL;;BRADY PATRICK;;WANG XILU;;PENNING THOMAS;;MICHAELIDES MICHAEL,,https://lens.org/013-955-403-667-103,Patent Application,yes,0,0,13,14,0,C07D495/16;;C07D519/00;;A61P35/00;;A61K45/06;;A61K31/519;;A61P35/00;;C07D495/16;;C07D519/00,C07D495/16;;A61P35/00;;C07D519/00,,0,0,,,,DISCONTINUED
558,WO,A1,WO 2019/035927 A1,138-422-360-321-356,2019-02-21,2019,US 2018/0000196 W,2018-08-15,US 201762555477 P;;US 201762545872 P;;US 201862692667 P,2017-08-15,MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE,"The present disclosure provides for compounds of Formula (I) wherein A 2 , A 3 , A 4 , A 6 , A 7 , A 8 , A 15 , R A , R 5 , R 9 , R 10A , R 10B , R 11 , R 12 , R 13 , R 14 , R 16 , W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).",ABBVIE INC;;ABBVIE DEUTSCHLAND;;BRAJE WILFRIED;;DOHERTY GEORGE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI FU;;LAI CHUNQUI;;KLING ANDREAS;;POHLKI FRAUKE;;TESKE JESSC;;WENDT MICHAEL;;BRADY PATRICK;;WANG XILU;;PENNING THOMAS;;MICHAELIDES MICHAEL,BRAJE WILFRIED;;DOHERTY GEORGE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI-FU;;LAI CHUNQUI;;KLING ANDREAS;;POHLKI FRAUKE;;TESKE JESSC;;WENDT MICHAEL;;BRADY PATRICK;;WANG XILU;;PENNING THOMAS;;MICHAELIDES MICHAEL,,https://lens.org/138-422-360-321-356,Patent Application,yes,3,12,13,14,0,C07D495/16;;C07D519/00;;A61P35/00;;A61K45/06;;A61K31/519;;A61P35/00;;C07D495/16;;C07D519/00,A61K31/395;;A61P35/00;;C07D515/22,,2,1,002-864-807-651-770,27760111;;10.1038/nature19830,"KOTSCHY ET AL.: ""The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models"", NATURE, vol. 538, 27 October 2016 (2016-10-27), pages 477 - 482, XP055571783, DOI: doi:10.1038/nature19830;;See also references of EP 3668502A4",PENDING
559,MX,A,MX 2020001719 A,046-828-547-862-86X,2020-11-06,2020,MX 2020001719 A,2018-08-15,US 201762545872 P;;US 201762555477 P;;US 201862692667 P;;US 2018/0000196 W,2017-08-15,MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE.,"The present disclosure provides for compounds of Formula (I) wherein A<sup>2</sup>, A<sup>3</sup>, A<sup>4</sup>, A<sup>6</sup>, A<sup>7</sup>, A<sup>8</sup>, A<sup>15</sup>, R<sup>A</sup>, R<sup>5</sup>, R<sup>9</sup>, R<sup>10A</sup>, R<sup>10B</sup>, R<sup>11</sup>, R<sup>12</sup>, R<sup>13</sup>, R<sup>14</sup>, R<sup>16</sup>, W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).",ABBVIE INC,POHLKI FRAUKE;;JANTOS KATJA;;KLING ANDREAS;;DOHERTY GEORGE;;WANG XILU;;TAO ZHI-FU;;JUDD ANDREW;;SOUERS ANDREW;;MASTRACCHIO ANTHONY;;LAI CHUNQIU;;SONG XIAOHONG;;PENNING THOMAS;;BRAJE WILFRIED;;KUNZER AARON;;SULLIVAN GERARD;;MICHAELIDES MICHAEL;;WENDT MICHAEL;;BRADY PATRICK;;JI CHENG;;TESKE JESSC,,https://lens.org/046-828-547-862-86X,Patent Application,no,0,0,13,14,0,C07D495/16;;C07D519/00;;A61P35/00;;A61K45/06;;A61K31/519;;A61P35/00;;C07D495/16;;C07D519/00,A61K31/395;;A61P35/00;;C07D515/22,,0,0,,,,PENDING
560,AU,A1,AU 2018/318692 A1,100-895-216-847-784,2020-03-12,2020,AU 2018/318692 A,2018-08-15,US 201862692667 P;;US 201762545872 P;;US 201762555477 P;;US 2018/0000196 W,2017-08-15,Macrocyclic MCL-1 inhibitors and methods of use,The present disclosure provides for compounds of Formula (I) wherein A,ABBVIE DEUTSCHLAND;;ABBVIE INC,BRAJE WILFRIED;;DOHERTY GEORGE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI-FU;;LAI CHUNQIU;;KLING ANDREAS;;POHLKI FRAUKE;;TESKE JESSC;;WENDT MICHAEL;;BRADY PATRICK;;WANG XILU;;PENNING THOMAS;;MICHAELIDES MICHAEL,,https://lens.org/100-895-216-847-784,Patent Application,no,0,0,13,14,0,C07D495/16;;C07D519/00;;A61P35/00;;A61K45/06;;A61K31/519;;A61P35/00;;C07D495/16;;C07D519/00,C07D515/22;;A61K31/395;;A61P35/00,,0,0,,,,DISCONTINUED
561,TW,A,TW 201920193 A,124-283-858-544-973,2019-06-01,2019,TW 107128511 A,2018-08-15,US 201762545872 P;;US 201762555477 P;;US 201862692667 P,2017-08-15,Macrocyclic MCL-1 inhibitors and methods of use,"The present disclosure provides for compounds of Formula (I) wherein A2, A3, A4, A6, A7, A8, A15, RA, R5, R9, R10A, R10B, R11, R12, R13, R14, R16, W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).",ABBVIE INC;;ABBVIE DEUTSCHLAND,BRAJE WILFRIED;;DOHERTY GEORGE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;SONG XIAO-HONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI-FU;;LAI CHUN-QIU;;KLING ANDREAS;;POHLKI FRAUKE;;TESKE JESSE;;WENDT MICHAEL;;BRADY PATRICK;;WANG XILU;;PENNING THOMAS;;MICHAELIDES MICHAEL,,https://lens.org/124-283-858-544-973,Patent of Addition,no,0,0,13,14,0,C07D495/16;;C07D519/00;;A61P35/00;;A61K45/06;;A61K31/519;;A61P35/00;;C07D495/16;;C07D519/00,C07D495/04;;A61K31/519;;A61K31/5365;;A61K31/537;;A61K31/5377;;A61K31/541;;A61K31/553;;A61K31/675;;A61K31/7064;;A61P35/00;;C07D495/16;;C07D519/00;;C07F9/576,,0,0,,,,PENDING
562,CN,A,CN 112533598 A,079-579-564-005-109,2021-03-19,2021,CN 201880066954 A,2018-08-15,US 201762545836 P;;US 201762555470 P;;US 2018/0000167 W,2017-08-15,MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE,"The present disclosure provides for compounds of Formula (I) wherein A2, A3, A4, A6, A7, A8, A15, RA, R5, R9, R10A, R10B, R11, R12, R13, R14, R16, W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).",ABBVIE INC;;ABBVIE DEUTSCHLAND,BRADY PATRICK;;BRAJE WILFRIED;;DAI YUJIA;;DOHERTY GEORGE;;GONG JANE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;RISI ROBERTO;;SONG XUCHEN;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI-FU;;TESKE JESSE;;WANG XIAOMING;;WENDT MICHAEL;;YU YIYUN;;ZHU GUIDONG;;PENNING THOMAS;;LAI CHUNQIU,,https://lens.org/079-579-564-005-109,Patent Application,no,7,0,24,25,0,C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;A61K31/519;;C07D491/16;;C07D498/16,A61K31/395;;A61P35/00;;C07D515/22,,1,0,,,ANDRÁS KOTSCHY.ET AL,DISCONTINUED
563,CN,A,CN 111758030 A,190-639-895-584-489,2020-10-09,2020,CN 201980014993 A,2019-02-21,US 201862633126 P;;US 201862687126 P;;US 2019/0018860 W,2018-02-21,SYSTEMS AND METHODS FOR ALLERGEN DETECTION,The present invention is drawn to devices and systems for allergen detection in food samples. The allergen detection system includes a disposable analysis cartridge and a detection device with an optimized optical system.,DOTS TECH CORP,GILBOA-GEFFEN ADI;;WEEKS ALAN LLOYD;;VILLAREAL VALERIE;;MURPHY PATRICK;;ROBERTSON ERIC ANTHONY;;CARPENTER DAVID;;DAY DEIRDRE ELLEN;;DEAN MATTHEW BERNARD;;CAMPBELL TODD GLENDON;;KINTZ GREGORY J;;KOH PAUL;;DOSTAL DAVID JENNINGS;;DOHERTY KEVIN;;JENSEN JOEL F;;LAW WILLIAM;;MEAD JR;;ALCORTA J EFRAIN,,https://lens.org/190-639-895-584-489,Patent Application,no,11,2,8,8,0,G01N33/02;;G01N33/54366;;G01N33/5308;;C12Q1/6816;;G01N33/48707;;C12Q1/6816;;G01N33/02;;G01N33/5308;;G01N33/54366,G01N33/02;;G01N33/53;;G01N33/543,,0,0,,,,ACTIVE
564,CA,A1,CA 3091669 A1,194-703-236-079-242,2019-08-29,2019,CA 3091669 A,2019-02-21,US 201862633126 P;;US 201862687126 P;;US 2019/0018860 W,2018-02-21,SYSTEMS AND METHODS FOR ALLERGEN DETECTION,[0260] The present invention is drawn to devices and systems for allergen detection in food samples. The allergen detection system includes a disposable analysis cartridge and a detection device with an optimized optical system.,DOTS TECH CORP,GILBOA-GEFFEN ADI;;WEEKS ALAN LLOYD;;VILLAREAL VALERIE;;MURPHY PATRICK;;ROBERTSON ERIC ANTHONY;;CARPENTER DAVID;;DAY DEIRDRE ELLEN;;DEAN MATTHEW BERNARD;;CAMPBELL TODD GLENDON;;KINTZ GREGORY J;;KOH PAUL;;DOSTAL DAVID JENNINGS;;DOHERTY KEVIN;;JENSEN JOEL F;;LAW WILLIAM;;MEAD JR;;ALCORTA J EFRAIN,,https://lens.org/194-703-236-079-242,Patent Application,no,0,0,8,8,0,G01N33/02;;G01N33/54366;;G01N33/5308;;C12Q1/6816;;G01N33/48707;;C12Q1/6816;;G01N33/02;;G01N33/5308;;G01N33/54366,G01N33/02;;G01N33/53;;G01N33/543,,0,0,,,,PENDING
565,EP,A1,EP 3668503 A1,181-426-736-255-834,2020-06-24,2020,EP 18845893 A,2018-08-15,US 201762545836 P;;US 201762555470 P;;US 2018/0000167 W,2017-08-15,MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE,,ABBVIE INC;;ABBVIE DEUTSCHLAND,BRADY PATRICK;;BRAJE WILFRIED;;DAI YUJIA;;DOHERTY GEORGE;;GONG JANE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;RISI ROBERTO;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI-FU;;TESKE JESSE;;WANG XILU;;WENDT MICHAEL;;YU YIYUN;;ZHU GUIDONG;;PENNING THOMAS;;LAI CHUNQIU,,https://lens.org/181-426-736-255-834,Patent Application,yes,0,0,24,25,0,C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;A61K31/519;;C07D491/16;;C07D498/16,A61K31/395;;A61P35/00;;C07D515/22,,0,0,,,,DISCONTINUED
566,BR,A2,BR 112020003163 A2,042-198-091-090-152,2020-09-15,2020,BR 112020003163 A,2018-08-15,US 2018/0000167 W;;US 201762545836 P;;US 201762555470 P,2017-08-15,inibidores macrocíclicos de mcl-1 e métodos de uso,"a presente divulgação fornece compostos de fórmula (i), em que a2, a3, a4, a6, a7, a8, a15, ra, r5, r9, r10a, r10b, r11, r12, r13, r14, r16, w, x e y têm qualquer um dos valores definidos no relatório descritivo, e sais farmaceuticamente aceitáveis dos mesmos, que são úteis como agentes para o tratamento de doenças e afecções, incluindo câncer. também são fornecidas composições farmacêuticas que compreendem compostos de fórmula (i).",ABBVIE DEUTSCHLAND;;ABBVIE INC,AARON KUNZER;;ANDREW JUDD;;ANDREW SOUERS;;ANTHONY MASTRACCHIO;;CHENG JI;;CHUNQIU LAI;;GEORGE DOHERTY;;GERARD SULLIVAN;;GUIDONG ZHU;;JANE GONG;;JESSE TESKE;;KATJA JANTOS;;MICHAEL WENDT;;PATRICK BRADY;;ROBERTO RISI;;THOMAS PENNING;;WILFRIED BRAJE;;XIAOHONG SONG;;XILU WANG;;YIYUN YU;;YUJIA DAI;;ZHI-FU TAO,,https://lens.org/042-198-091-090-152,Patent Application,no,0,0,24,25,0,C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;A61K31/519;;C07D491/16;;C07D498/16,A61K31/395;;A61P35/00;;C07D515/22,,0,0,,,,DISCONTINUED
567,US,A1,US 2021/0292339 A1,136-640-903-450-596,2021-09-23,2021,US 202017079141 A,2020-10-23,US 202017079141 A;;US 201916575114 A;;US 201815998688 A;;US 201762555470 P;;US 201762545836 P,2017-08-15,MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE,"The present disclosure provides for compounds of Formula (I) wherein A 2 , A 3 , A 4 , A 6 , A 7 , A 8 , A 15 , R A , R 5 , R 9 , R 10A , R 10B , R 11 , R 12 , R 13 , R 14 , R 16 , W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).",ABBVIE INC;;ABBVIE DEUTSCHLAND,BRAJE WILFRIED;;DOHERTY GEORGE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI-FU;;LAI CHUNQIU;;TESKE JESSE;;WENDT MICHAEL;;BRADY PATRICK;;WANG XILU;;PENNING THOMAS;;DAI YUJIA;;GONG JANE;;RISI ROBERTO;;YU YIYUN;;ZHU GUIDONG,,https://lens.org/136-640-903-450-596,Patent Application,yes,0,0,24,25,0,C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;A61K31/519;;C07D491/16;;C07D498/16,C07D498/18;;A61K31/519;;A61P35/00;;C07D491/16;;C07D495/16;;C07D495/18;;C07D498/16;;C07D519/00,,0,0,,,,DISCONTINUED
568,WO,A1,WO 2019/035899 A1,189-077-906-213-978,2019-02-21,2019,US 2018/0000167 W,2018-08-15,US 201762545836 P;;US 201762555470 P,2017-08-15,MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE,"The present disclosure provides for compounds of Formula (I) wherein A 2 , A 3 , A 4 , A 6 , A 7 , A 8 , A 15 , R A , R 5 , R 9 , R 10A , R 10B , R 11 , R 12 , R 13 , R 14 , R 16 , W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).",ABBVIE INC;;ABBVIE DEUTSCHLAND;;BRADY PATRICK;;BRAJE WILFRIED;;DAI YUJIA;;DOHERTY GEORGE;;GONG JANE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;RISI ROBERTO;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI FU;;TESKE JESSE;;WANG XILU;;WENDT MICHAEL;;YU YIYUN;;ZHU GUIDONG;;PENNING THOMAS;;LAI CHUNQIU,BRADY PATRICK;;BRAJE WILFRIED;;DAI YUJIA;;DOHERTY GEORGE;;GONG JANE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;RISI ROBERTO;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI-FU;;TESKE JESSE;;WANG XILU;;WENDT MICHAEL;;YU YIYUN;;ZHU GUIDONG;;PENNING THOMAS;;LAI CHUNQIU,,https://lens.org/189-077-906-213-978,Patent Application,yes,4,9,24,25,0,C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;A61K31/519;;C07D491/16;;C07D498/16,A61K31/395;;A61P35/00;;C07D515/22,,2,1,002-864-807-651-770,27760111;;10.1038/nature19830,"KOTSCHY ET AL.: ""The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models"", NATURE, vol. 538, 27 October 2016 (2016-10-27), pages 477 - 482, XP055571783, DOI: doi:10.1038/nature19830;;See also references of EP 3668503A4",PENDING
569,WO,A1,WO 2019/165014 A1,083-072-736-993-88X,2019-08-29,2019,US 2019/0018860 W,2019-02-21,US 201862633126 P;;US 201862687126 P,2018-02-21,SYSTEMS AND METHODS FOR ALLERGEN DETECTION,[0260] The present invention is drawn to devices and systems for allergen detection in food samples. The allergen detection system includes a disposable analysis cartridge and a detection device with an optimized optical system.,DOTS TECH CORP,GILBOA-GEFFEN ADI;;WEEKS ALAN LLOYD;;VILLAREAL VALERIE;;MURPHY PATRICK;;ROBERTSON ERIC ANTHONY;;CARPENTER DAVID;;DAY DEIRDRE ELLEN;;DEAN MATTHEW BERNARD;;CAMPBELL TODD GLENDON;;KINTZ GREGORY J;;KOH PAUL;;DOSTAL DAVID JENNINGS;;DOHERTY KEVIN;;JENSEN JOEL F;;LAW WILLIAM;;MEAD JR;;ALCORTA J EFRAÍN,,https://lens.org/083-072-736-993-88X,Patent Application,yes,22,3,8,8,0,G01N33/02;;G01N33/54366;;G01N33/5308;;C12Q1/6816;;G01N33/48707;;C12Q1/6816;;G01N33/02;;G01N33/5308;;G01N33/54366,G01N33/02;;G01N33/53;;G01N33/543,,1,0,,,See also references of EP 3756006A4,PENDING
570,TW,A,TW 201942574 A,197-572-611-627-16X,2019-11-01,2019,TW 108105809 A,2019-02-21,US 201862633126 P;;US 201862687126 P,2018-02-21,Systems and methods for allergen detection,The present invention is drawn to devices and systems for allergen detection in food samples. The allergen detection system includes a disposable analysis cartridge and a detection device with an optimized optical system.,DOTS TECH CORP,GILBOA-GEFFEN ADI;;WEEKS ALAN LLOYD;;VILLAREAL VALERIE;;MURPHY PATRICK;;ROBERTSON ERIC ANTHONY;;CARPENTER DAVID;;DAY DEIRDRE ELLEN;;DEAN MATTHEW BERNARD;;CAMPBELL TODD GLENDON;;KINTZ GREGORY J;;KOH PAUL;;DOSTAL DAVID JENNINGS;;DOHERTY KEVIN;;JENSEN JOEL F;;LAW WILLIAM;;MEAD JR;;ALCORTA J EFRAIN,,https://lens.org/197-572-611-627-16X,Patent of Addition,no,0,1,8,8,0,G01N33/02;;G01N33/54366;;G01N33/5308;;C12Q1/6816;;G01N33/48707;;C12Q1/6816;;G01N33/02;;G01N33/5308;;G01N33/54366,G01N33/02;;C12M1/34;;C12Q1/68;;G01N1/02;;G01N1/28;;G01N33/68,,0,0,,,,PENDING
571,EP,A4,EP 3668503 A4,140-896-556-072-191,2021-04-07,2021,EP 18845893 A,2018-08-15,US 201762545836 P;;US 201762555470 P;;US 2018/0000167 W,2017-08-15,MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE,,ABBVIE INC;;ABBVIE DEUTSCHLAND,BRADY PATRICK;;BRAJE WILFRIED;;DAI YUJIA;;DOHERTY GEORGE;;GONG JANE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;RISI ROBERTO;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI-FU;;TESKE JESSE;;WANG XILU;;WENDT MICHAEL;;YU YIYUN;;ZHU GUIDONG;;PENNING THOMAS;;LAI CHUNQIU,,https://lens.org/140-896-556-072-191,Search Report,no,0,0,24,25,0,C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;A61K31/519;;C07D491/16;;C07D498/16,C07D515/22;;A61K31/395;;A61P35/00,,1,1,002-415-168-852-686,pmc5304306;;10.1021/acsmedchemlett.6b00464;;28197319,"JEFFREY W. JOHANNES ET AL: ""Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl-1 Inhibitors"", ACS MEDICINAL CHEMISTRY LETTERS, vol. 8, no. 2, 27 December 2016 (2016-12-27), US, pages 239 - 244, XP055723792, ISSN: 1948-5875, DOI: 10.1021/acsmedchemlett.6b00464",DISCONTINUED
572,CA,A1,CA 3073108 A1,062-623-328-443-551,2019-02-21,2019,CA 3073108 A,2018-08-15,US 201762545836 P;;US 201762555470 P;;US 2018/0000167 W,2017-08-15,MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE,"The present disclosure provides for compounds of Formula (I) wherein A2, A3, A4, A6, A7, A8, A15, RA, R5, R9, R10A, R10B, R11, R12, R13, R14, R16, W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).",ABBVIE INC;;ABBVIE DEUTSCHLAND,BRADY PATRICK;;BRAJE WILFRIED;;DAI YUJIA;;DOHERTY GEORGE;;GONG JANE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;RISI ROBERTO;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI-FU;;TESKE JESSE;;WANG XILU;;WENDT MICHAEL;;YU YIYUN;;ZHU GUIDONG;;PENNING THOMAS;;LAI CHUNQIU,,https://lens.org/062-623-328-443-551,Patent Application,no,0,0,24,25,0,C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;A61K31/519;;C07D491/16;;C07D498/16,A61K31/395;;A61P35/00;;C07D515/22,,0,0,,,,PENDING
573,US,A1,US 2022/0259226 A1,179-550-461-596-395,2022-08-18,2022,US 202217660355 A,2022-04-22,US 202217660355 A;;US 202017079141 A;;US 201916575114 A;;US 201815998688 A;;US 201762555470 P;;US 201762545836 P,2017-08-15,MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE,"The present disclosure provides for compounds of Formula (I) wherein A 2 , A 3 , A 4 , A 6 , A 7 , A 8 , A 15 , R A , R 5 , R 9 , R 10A , R 10B , R 11 , R 12 , R 13 , R 14 , R 16 , W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).",ABBVIE INC;;ABBVIE DEUTSCHLAND,BRAJE WILFRIED;;DOHERTY GEORGE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI-FU;;LAI CHUNQIU;;TESKE JESSE;;WENDT MICHAEL;;BRADY PATRICK;;WANG XILU;;PENNING THOMAS;;DAI YUJIA;;GONG JANE;;RISI ROBERTO;;YU YIYUN;;ZHU GUIDONG,,https://lens.org/179-550-461-596-395,Patent Application,yes,0,0,24,25,0,C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;A61K31/519;;C07D491/16;;C07D498/16,C07D498/18;;A61K31/519;;A61P35/00;;C07D491/16;;C07D495/16;;C07D495/18;;C07D498/16;;C07D519/00,,0,0,,,,DISCONTINUED
574,AU,A1,AU 2018/317828 A1,103-625-073-425-224,2020-04-02,2020,AU 2018/317828 A,2018-08-15,US 201762555470 P;;US 201762545836 P;;US 2018/0000167 W,2017-08-15,Macrocyclic MCL-1 inhibitors and methods of use,The present disclosure provides for compounds of Formula (I) wherein A,ABBVIE DEUTSCHLAND;;ABBVIE INC,BRADY PATRICK;;BRAJE WILFRIED;;DAI YUJIA;;DOHERTY GEORGE;;GONG JANE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;RISI ROBERTO;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI-FU;;TESKE JESSE;;WANG XILU;;WENDT MICHAEL;;YU YIYUN;;ZHU GUIDONG;;PENNING THOMAS;;LAI CHUNQIU,,https://lens.org/103-625-073-425-224,Patent Application,no,0,0,24,25,0,C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;A61K31/519;;C07D491/16;;C07D498/16,C07D515/22;;A61K31/395;;A61P35/00,,0,0,,,,DISCONTINUED
575,EP,A4,EP 3756006 A4,078-753-672-712-331,2021-11-24,2021,EP 19757911 A,2019-02-21,US 201862633126 P;;US 201862687126 P;;US 2019/0018860 W,2018-02-21,SYSTEMS AND METHODS FOR ALLERGEN DETECTION,,DOTS TECH CORP,GILBOA-GEFFEN ADI;;WEEKS ALAN LLOYD;;VILLAREAL VALERIE;;MURPHY PATRICK;;ROBERTSON ERIC ANTHONY;;CARPENTER DAVID;;DAY DEIRDRE ELLEN;;DEAN MATTHEW BERNARD;;CAMPBELL TODD GLENDON;;KINTZ GREGORY J;;KOH PAUL;;DOSTAL DAVID JENNINGS;;DOHERTY KEVIN;;JENSEN JOEL F;;LAW WILLIAM;;MEAD JR RUSSELL C;;ALCORTA J EFRAÍN,,https://lens.org/078-753-672-712-331,Search Report,no,6,0,8,8,0,G01N33/02;;G01N33/54366;;G01N33/5308;;C12Q1/6816;;G01N33/48707;;C12Q1/6816;;G01N33/02;;G01N33/5308;;G01N33/54366,G01N33/02;;C12Q1/6816;;G01N33/53;;G01N33/543,,1,0,,,See also references of WO 2019165014A1,DISCONTINUED
576,EP,A1,EP 3756006 A1,121-689-658-322-971,2020-12-30,2020,EP 19757911 A,2019-02-21,US 201862633126 P;;US 201862687126 P;;US 2019/0018860 W,2018-02-21,SYSTEMS AND METHODS FOR ALLERGEN DETECTION,,DOTS TECH CORP,GILBOA-GEFFEN ADI;;WEEKS ALAN LLOYD;;VILLAREAL VALERIE;;MURPHY PATRICK;;ROBERTSON ERIC ANTHONY;;CARPENTER DAVID;;DAY DEIRDRE ELLEN;;DEAN MATTHEW BERNARD;;CAMPBELL TODD GLENDON;;KINTZ GREGORY J;;KOH PAUL;;DOSTAL DAVID JENNINGS;;DOHERTY KEVIN;;JENSEN JOEL F;;LAW WILLIAM;;MEAD JR RUSSELL C;;ALCORTA J EFRAÍN,,https://lens.org/121-689-658-322-971,Patent Application,yes,0,0,8,8,0,G01N33/02;;G01N33/54366;;G01N33/5308;;C12Q1/6816;;G01N33/48707;;C12Q1/6816;;G01N33/02;;G01N33/5308;;G01N33/54366,G01N33/02;;G01N33/53;;G01N33/543,,0,0,,,,DISCONTINUED
577,US,A1,US 2021/0311032 A1,089-463-557-883-358,2021-10-07,2021,US 201916971701 A,2019-02-21,US 201916971701 A;;US 201862633126 P;;US 201862687126 P;;US 2019/0018860 W,2018-02-21,SYSTEMS AND METHODS FOR ALLERGEN DETECTION,The present invention is drawn to devices and systems for allergen detection in food samples. The allergen detection system includes a disposable analysis cartridge and a detection device with an optimized optical system.,DOTS TECH CORP,GILBOA-GEFFEN ADI;;WEEKS ALAN LLOYD;;VILLAREAL VALERIE;;MURPHY PATRICK;;ROBERTSON ERIC ANTHONY;;CARPENTER DAVID;;DAY DEIRDRE ELLEN;;DEAN MATTHEW BERNARD;;CAMPBELL TODD GLENDON;;KINTZ GREGORY J;;KOH PAUL;;DOSTAL DAVID JENNINGS;;DOHERTY KEVIN;;JENSEN JOEL F;;LAW WILLIAM;;MEAD JR RUSSELL C;;ALCORTA J EFRAÍN,DOTS TECHNOLOGY CORP (2018-08-24);;MOUNT MITCHELL OPTICS (2018-08-29);;FUNCTION ENGINEERING INC (2018-09-06),https://lens.org/089-463-557-883-358,Patent Application,yes,1,1,8,8,0,G01N33/02;;G01N33/54366;;G01N33/5308;;C12Q1/6816;;G01N33/48707;;C12Q1/6816;;G01N33/02;;G01N33/5308;;G01N33/54366,G01N33/53;;C12Q1/6816;;G01N33/02;;G01N33/543,,0,0,,,,PENDING
578,US,B2,US 11175929 B2,106-414-047-662-647,2021-11-16,2021,US 202017030804 A,2020-09-24,US 202017030804 A;;US 202063032970 P;;US 202063022869 P;;US 202063008586 P,2020-04-10,User interfaces for enabling an activity,"The present disclosure generally relates to user interfaces for enabling an activity using a computer system. In some embodiments, exemplary user interfaces for invoking an activity associated with an application are described. In some embodiments, exemplary user interfaces for customizing displayed content based on circumstances under which the content was invoked are described. In some embodiments, exemplary user interfaces for managing applications that were used to enable activities are described. In some embodiments, exemplary user interfaces for managing settings for applications used to enable activities are described.",APPLE INC,ZHANG YONGJUN;;ABBASIAN REZA;;ADLER DARIN;;CHAN ADA;;DUBOIS DANA J;;FALKENBURG STEVEN;;FEDERIGHI CRAIG M;;FERRY KENNETH ARTHUR ABRAHAM;;FOSS CHRISTOPHER PATRICK;;GHARABALLY SAM H;;GOLDBERG BRIAN ERIK;;DOHERTY NICHOLAS STEPHEN;;KO HEENA;;KOWALCZYKOWSKI KEITH P;;PAUL GRANT;;ROBBIN JEFFREY L;;SAVAGE JAMES S;;SIBSON MATTHEW;;SINGH GURSHAMNJOT;;STACK CAELAN G;;YIN LUMING;;YING CHARLES H;;XUE MARK M;;ZHANG HENGLIANG;;ZHANG XIAOYUE;;COFFMAN PATRICK L,APPLE INC (2021-09-06),https://lens.org/106-414-047-662-647,Granted Patent,yes,52,0,10,37,0,G06F3/048;;G06F21/00;;H04M1/00;;H04W4/00;;H04L67/34;;G06F3/0488;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F9/451;;G06F3/04817;;G06F8/38;;G06F3/04842;;G06F3/0488;;G06F9/44568;;G06F9/54;;H04L67/34;;H04L67/5651,G06F9/54;;G06F3/0488;;G06F9/445;;H04L29/08,,19,0,,,"Applicant-Initiated Interview Summary received for U.S. Appl. No. 17/031,687, dated Mar. 5, 2021, 4 pages.;;Final Office Action received for U.S. Appl. No. 17/031,687, dated Mar. 24, 2021, 32 pages.;;Applicant-Initiated Interview Summary received for U.S. Appl. No. 14/960,279, dated Nov. 17, 2020, 4 pages.;;Search Report and Opinion received for Danish Patent Application No. PA202070634, dated Jan. 6, 2021, 9 pages.;;Non-Final Office Action received for U.S. Appl. No. 17/031,687, dated Dec. 21, 2020, 28 pages.;;Search Report and Opinion received for Danish Patent Application No. PA202070633, dated Dec. 21, 2020, 10 pages.;;Storehub, “QR Table Ordering and Cashback—Beep Order & Cashback”, Available online on: < https://www.youtube.com/watch?v=TCukF45kOU8&ab_channel=StoreHub>, Jul. 25, 2019, 3 pages.;;Final Office Action received for U.S. Appl. No. 14/960,279, dated Feb. 9, 2021, 26 pages.;;Advisory Action received for U.S. Appl. No. 14/960,279, dated Apr. 13, 2021, 3 pages.;;Applicant-Initiated Interview Summary received for U.S. Appl. No. 17/031,687, dated May 28, 2021, 4 pages.;;Office Action received for Australian Patent Application No. 2020239759, dated Jun. 3, 2021, 6 pages.;;Office Action received for Danish Patent Application No. PA202070634, dated Jun. 4, 2021, 3 pages.;;Android Developers, “Android App Bundle”, Online available at: http://web.archive.org/web/20200303021924/https:/developer.android.com/platform/technology/app-bundle, Mar. 3, 2020, 5 pages.;;Android Developers, “Deliver features on-demand with dynamic features”, Online available at: https://www.youtube.com/watch?v=httqEshsBk, May 23, 2018, 3 pages.;;Howtoinstall, “How to Download and Install Winamp 5.6 on Windows 2017”, Online available at: https://www.youtube.com/watch?v=-6YDT9UkuEg, Oct. 17, 2017, 3 pages.;;Office Action received for Danish Patent Application No. PA202070633, dated May 6, 2021, 6 pages.;;Invitation to Pay Additional Fees received for PCT Patent Application No. PCT/US2021/025051, dated Jul. 28, 2021, 17 pages.;;Office Action received for Australian Patent Application No. 2020239747, dated Jul. 29, 2021, 9 pages.;;International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2021/025051, dated Sep. 23, 2021, 21 pages.",ACTIVE
579,UY,A,UY 37844 A,123-251-657-565-660,2019-03-29,2019,UY 37844 A,2018-08-15,US 201762545872 P;;US 201762555477 P;;US 201862692667 P,2017-08-15,INHIBIDORES DE MCL-1 MACROCÍCLICOS Y MÉTODOS DE USO,"La presente divulgación proporciona compuestos de Fórmula (I), en onde A2, A3, A4, A6, A7, A8, A15, RA, R5, R9, R10A, R10B, R11, R12, R13, R14, R16, W, X, e Y tienen cualquiera de los valores definidos en la memoria descriptiva, y sales farmacéuticamente aceptables de los mismos, que sean útiles como agentes en el tratamiento de enfermedades y afecciones, incluido el cáncer. También se proporcionan composiciones farmacéuticas que comprenden compuestos de Fórmula (I).",ABBVIE INC;;ABBVIE DEUTSCHLAND,AARON R KUNZER;;ANDREW S JUDD;;ANDREW J SOUERS;;MASTRACCHIO ANTHONY;;JI CHENG;;LAI CHUNQIU;;GERARD M SULLIVAN;;JESSE A TESKE;;MICHAEL D WENDT;;BRADY PATRICK;;BRAJE WILFRIED;;SONG XIAOHONG;;ZHI-FU TAO;;DOHERTY GEORGE;;POHLKI FRAUKE;;MICHAELIDES MICHAEL;;THOMAS D PENNING;;KLING ANDREAS;;JANTOS KATJA;;WANG XILU,,https://lens.org/123-251-657-565-660,Patent Application,no,0,0,13,14,0,C07D495/16;;C07D519/00;;A61P35/00;;A61K45/06;;A61K31/519;;A61P35/00;;C07D495/16;;C07D519/00,A61P35/00;;A61K31/357;;A61K31/496;;A61K31/506;;A61K31/519;;A61K31/5377;;A61K31/541;;C07D403/14;;C07D407/14;;C07D413/14;;C07D417/14;;C07D471/04;;C07D471/10;;C07D491/048;;C07D493/04;;C07D495/04;;C07D515/18;;C07H7/06,,0,0,,,,DISCONTINUED
580,AR,A1,AR 112692 A1,028-755-240-916-096,2019-11-27,2019,AR P180102348 A,2018-08-15,US 201762545872 P,2017-08-15,INHIBIDORES DE MCL-1 MACROCÍCLICOS Y MÉTODOS DE USO,"Compuestos que son útiles como agentes en el tratamiento de enfermedades y afecciones, incluido el cáncer. También se proporcionan composiciones farmacéuticas que comprenden a estos compuestos. Reivindicación 1: Un compuesto de fórmula (1) o una sal farmacéuticamente aceptable del mismo, donde A² es CR², A³ es N, A⁴ es CR⁴ᵃ, y A⁶ es C; o A² es CR², A³ es N, A⁴ es O ó S, y A⁶ es C; o A² es N, A³ es C, A⁴ es O ó S y A⁶ es C; o A² es N, A³ es C, A⁴ es CR⁴ᵃ, y A⁶ es N; RA es hidrógeno, CH₃, halógeno, CN, CH₂F, CHF₂, o CF₃; X es O, o N(Rˣ²); en la que Rˣ² es hidrógeno, alquilo C₁₋₃, o ciclopropilo sin sustituir; Y es (CH₂)ₘ, -CH=CH-(CH₂)ₙ-, (CH₂)ₚ-CH=CH-, o -(CH₂)q-CH=CH-(CH₂)ʳ-; en donde 0, 1, 2, ó 3 grupos CH₂ se reemplazan cada uno independientemente por O, N(Rʸᵃ), C(Rʸᵃ)(Rʸᵇ), C(O), NC(O)Rʸᵃ, o S(O)₂; m es 2, 3, 4 ó 5; n es 1, 2, ó 3; p es 1, 2, ó 3; q es 1 ó 2; y r es 1 ó 2; en donde la suma de q y r es 2 ó 3; Rʸᵃ, en cada caso, es independientemente hidrógeno, alquenilo C₂₋₆, alquinilo C₂₋₆, G¹, alquilo C₁₋₆, o haloalquilo C₁₋₆; en donde el alquenilo C₂₋₆, alquinilo C₂₋₆, alquilo C₁₋₆, y haloalquilo C₁₋₆ están opcionalmente sustituidos con 1 ó 2 sustituyentes seleccionados independientemente del grupo que consiste en oxo, -N(Rʸᵈ)(Rʸᵉ), G¹, -ORʸᶠ, -SRʸᵍ, -S(O)₂N(Rʸᵈ)(Rʸᵉ), y -S(O)₂-G¹; y Rʸᵇ es alquenilo C₂₋₆, alquinilo C₂₋₆, G¹, alquilo C₁₋₆, o haloalquilo C₁₋₆; en donde el alquenilo C₂₋₆, alquinilo C₂₋₆, alquilo C₁₋₆, y haloalquilo C₁₋₆ están opcionalmente sustituidos con 1 ó 2 sustituyentes seleccionados independientemente del grupo que consiste en oxo, -N(Rʸᵈ)(Rʸᵉ), G¹, -ORʸᶠ, -SRʸᵍ, -S(O)₂N(Rʸᵈ)(Rʸᵉ), y -S(O)₂-G¹; o Rʸᵃ y Rʸᵇ, junto con el átomo de carbono al que están unidos, forman un cicloalquilo C₃₋₇ monocíclico, cicloalquenilo C₄₋₇ monocíclico, o un heterociclo monocíclico de 4 - 7 miembros; en donde el cicloalquilo C₃₋₇ monocíclico, cicloalquenilo C₄₋₇ monocíclico, y el heterociclo monocíclico de 4 - 7 miembros están cada uno opcionalmente sustituidos con 1, 2 ó 3 grupos Rˢ seleccionados independientemente; Rʸᵈ, Rʸᵉ, Rʸᶠ y Rʸᵍ, en cada caso, son cada uno independientemente hidrógeno, G¹, alquilo C₁₋₆, o haloalquilo C₁₋₆; en donde el alquilo C₁₋₆ y el haloalquilo C₁₋₆ están opcionalmente sustituidos con un sustituyente seleccionado del grupo que consiste en G¹, -ORʸʰ, -SRʸʰ, -SO₂Rʸʰ, y -N(Rʸⁱ)(Rʸᵏ); G¹, en cada caso, es un heterociclo de 4 - 11 miembros; en donde cada G¹ está opcionalmente sustituido con 1, 2 ó 3 sustituyentes seleccionados independientemente entre el grupo que consiste en G², -(alquilenilo C₁₋₆)-G², -L¹A-(alquilenilo C₁₋₆)ₛ-Rˣ¹, y Rˢ; G², en cada caso, es un cicloalquilo C₃₋₇ monocíclico, cicloalquenilo C₄₋₇ monocíclico o un heterociclo de 4 - 11 miembros; en donde cada G² está opcionalmente sustituido con 1 grupo Rᵗ seleccionados independientemente; L¹A es un enlace, O, N(H), N(alquilo C₁₋₆), N[(alquil C₁₋₆)-Rˣ¹], S, S(O) o S(O)₂, C(O)NH, C(O)N(alquilo C₁₋₆) o C(O)N[(alquil C₁₋₆)-Rˣ¹]; R² es independientemente hidrógeno, halógeno, CH₃, o CN; R⁴ᵃ, en cada caso, es independientemente hidrógeno, halógeno, CN, alquenilo C₂₋₄, alquinilo C₂₋₄, alquilo C₁₋₄, haloalquilo C₁₋₄, GA, alquil C₁₋₄-GA, o alquil C₁₋₄-O-GA; en donde cada GA es independientemente arilo C₆₋₁₀, cicloalquilo C₃₋₇ monocíclico, cicloalquenilo C₄₋₇ monocíclico, o heterociclo de 4 - 7 miembros; en donde cada GA está sustituido opcionalmente con 1, 2, ó 3 grupos Rᵘ; R⁵ es independientemente hidrógeno, halógeno, G³, alquilo C₁₋₆, alquenilo C₂₋₆, o alquinilo C₂₋₆; en donde el alquilo C₁₋₆, alquenilo C₂₋₆, y alquinilo C₂₋₆ están cada uno opcionalmente sustituidos con un G³; G³, en cada caso, es independientemente arilo C₆₋₁₀, heteroarilo de 5 - 11 miembros, cicloalquilo C₃₋₁₁, cicloalquenilo C₄₋₁₁ o heterociclo de 4 - 7 miembros; en donde cada G³ está sustituido opcionalmente con 1, 2 ó 3 grupos Rᵛ; A⁷ es N o CR⁷; A⁸ es N o CR⁸; A¹⁵ es N o CR¹⁵; R⁷, R¹² y R¹⁶ son cada uno independientemente hidrógeno, halógeno, alquilo C₁₋₄, haloalquilo C₁₋₄, -CN, -OR⁷ᵃ, -SR⁷ᵃ, o -N(R⁷ᵇ)(R⁷ᶜ); R⁸, R¹³, R¹⁴ y R¹⁵, son cada uno independientemente hidrógeno, halógeno, alquilo C₁₋₄, haloalquilo C₁₋₄, -CN, -OR⁸ᵃ,-SR⁸ᵃ, -N(R⁸ᵃ)(R⁸ᶜ), o cicloalquilo C₃₋₄ monocíclico; en donde el cicloalquilo C₃₋₄ monocíclico está opcionalmente sustituido con uno o dos sustituyentes seleccionados independientemente del grupo que consiste en halógeno, alquilo C₁₋₃, y haloalquilo C₁₋₃; o R⁸ y R¹³ son cada uno independientemente hidrógeno, halógeno, alquilo C₁₋₄, haloalquilo C₁₋₄, -CN, -OR⁸ᵃ, -SR⁸ᵃ, -N(R⁸ᵇ)(R⁸ᶜ), o cicloalquilo C₃₋₄ monocíclico; en donde el cicloalquilo C₃₋₄ monocíclico está opcionalmente sustituido con uno o dos sustituyentes seleccionados independientemente del grupo que consiste en halógeno, alquilo C₁₋₃, y haloalquilo C₁₋₃; y R¹⁴ y R¹⁵, junto con los átomos de carbono a los que están unidos, forman un anillo monocíclico seleccionado del grupo que consiste en benceno, ciclobutano, ciclopentano, y piridina; en donde el anillo monocíclico está opcionalmente sustituido con 1, 2, ó 3 sustituyentes seleccionados independientemente del grupo que consiste en halógeno, alquilo C₁₋₄, haloalquilo C₁₋₄, -CN, -OR⁸ᵃ, -SR⁸ᵃ, y -N(R⁸ᵇ)(R⁸ᶜ); R⁹ es -OH, -O-alquilo C₁₋₄, -O-CH₂-OC(O)(alquilo C₁₋₆), -NHOH, un resto de la fórmula (2); o -N(H)S(O)₂-(alquilo C₁₋₆); R¹⁰A y R¹⁰B, son cada uno independientemente hidrógeno, alquilo C₁₋₃, o haloalquilo C₁₋₃ o R¹⁰A y R¹⁰B, junto con el átomo de carbono al que están unidos, forman un ciclopropilo; en donde el ciclopropilo está opcionalmente sustituido con uno o dos sustituyentes seleccionados independientemente del grupo que consiste en halógeno, alquilo C₁₋₃ y haloalquilo C₁₋₃; W es -CH=CH-, alquilo C₁₋₄, -L¹-CHF-, -L¹-CH₂- o -CH₂-L¹-; en donde L¹ en cada caso, es independientemente O, S, S(O), S(O)₂, S(O)₂N(H), N(H) o N(alquilo C₁₋₃); R¹¹ es un arilo C₆₋₁₀ o un heteroarilo de 5 - 11 miembros; en donde cada R¹¹ está opcionalmente sustituido con 1, 2, ó 3 grupos Rʷ seleccionados independientemente; Rʷ, en cada caso, es independientemente alquilo C₁₋₆, alquenilo C₂₋₆, alquinilo C₂₋₆, halógeno, haloalquilo C₁₋₆, -CN, NO₂, -OR¹¹ᵃ, -SR¹¹ᵇ, -S(O)₂R¹¹ᵇ, -S(O)₂N(R¹¹ᶜ)₂, -C(O)R¹¹ᵃ, -C(O)N(R¹¹ᶜ)₂, -N(R¹¹ᶜ)₂, -N(R¹¹ᶜ)C(O)R¹¹ᵇ)₂, -N(R¹¹ᶜ)S(O)₂R¹¹ᵇ, -N(R¹¹ᶜ)C(O)O(R¹¹ᵇ), -N(R¹¹ᶜ)C(O)N(R¹¹ᶜ)₂, G⁴, -(alquilenil C₁₋₆)-OR¹¹ᵃ, -(alquilenil C₁₋₆)-OC(O)N(R¹¹ᶜ)₂, -(alquilenil C₁₋₆)-SR¹¹ᵃ, -(alquilenil C₁₋₆)-S(O)₂R¹¹ᵇ, -(alquilenil C₁₋₆)-S(O)₂N(R¹¹ᶜ)₂, -(alquilenil C₁₋₆)-C(O)R¹¹ᵃ, -(alquilenil C₁₋₆)-C(O)N(R¹¹ᶜ)₂, -(alquilenil C₁₋₆)-N(R¹¹ᶜ)₂, -(alquilenil C₁₋₆)-N(R¹¹ᶜ)C(O)R¹¹ᵇ, -(alquilenil C₁₋₆)-N(R¹¹ᶜ)S(O)₂R¹¹ᵇ, -(alquilenil C₁₋₆)-N(R¹¹ᶜ)C(O)O(R¹¹ᵇ), -(alquilenil C₁₋₆)-N(R¹¹ᶜ)C(O)N(R¹¹ᶜ)₂, -(alquilenil C₁₋₆)-CN, -N(alquilenil C₁₋₆)₂-G⁴ o -(alquilenil C₁₋₆)-G⁴; R¹¹ᵃ y R¹¹ᶜ, en cada caso, son cada uno independientemente hidrógeno, alquilo C₁₋₆, alquenilo C₂₋₆, haloalquilo C₁₋₆, G⁴, -(alquilenil C₂₋₆)-OR¹¹ᵈ, -(alquilenil C₂₋₆)-N(R¹¹ᵉ)₂, o -(alquilenil C₂₋₆)-G⁴; R¹¹ᵇ, en cada caso, es independientemente alquilo C₁₋₆, alquenilo C₂₋₆, haloalquilo C₁₋₆, G⁴, -(alquilenil C₂₋₆)-OR¹¹ᵈ, -(alquilenil C₂₋₆)-N(R¹¹ᵉ)₂, o -(alquilenil C₂₋₆)-G⁴; G⁴, en cada caso, es independientemente Rˣ¹, fenilo, heteroarilo monocíclico, cicloalquilo C₃₋₁₁, cicloalquenilo C₄₋₁₁ o heterociclo de 4 - 11 miembros; en donde cada fenilo, heteroarilo monocíclico, cicloalquilo C₃₋₁₁, cicloalquenilo C₄₋₁₁ y heterociclo de 4 - 11 miembros está opcionalmente sustituido con 1, 2, 3 ó 4 sustituyentes seleccionados independientemente entre el grupo que consiste en G⁵, Rʸ, -(alquilenil C₁₋₆)-G⁵, -L³-(alquilenil C₁₋₆)ₛ-Rˣ¹, -(alquilenil C₁₋₆)ₛ-L³-(alquilenil C₁₋₆)ₛ-Rˣ¹, -L³-(cicloalquil C₃₋₇)-Rˣ¹, -L³-(cicloalquenil C₄₋₇)-Rˣ¹, -L³-(heterociclo de 4 - 7 miembros)-Rˣ¹ y -L²-(alquilenil C₁₋₆)ₛ-G⁵; L² es O, C(O), N(H), N(alquilo C₁₋₆), NHC(O), C(O)O, S, S(O), OS(O)₂; L³ es un enlace, O, C(O), N(H), N(alquilo C₁₋₆), NHC(O), N(alquil C₁₋₆)C(O), N[(alquil C₁₋₆)ₛ-Rˣ¹], N[(alquil C₁₋₆)ₛ-Rˣ¹]C(O), S, S(O) o S(O)₂, C(O)NH, C(O)N(alquil C₁₋₆) o C(O)N[(alquil C₁₋₆)ₛ-Rˣ¹]; s, en cada caso, es independientemente 0 ó 1; G⁵, en cada caso, es independientemente fenilo, heteroarilo monocíclico, cicloalquilo C₃₋₇ monocíclico, cicloalquenilo C₄₋₇ monocíclico o heterociclo de 4 - 12 miembros; en donde cada G⁵ está opcionalmente sustituido con 1 grupo Rᶻ seleccionado independientemente; Rˢ, Rᵗ, Rᵘ, Rᵛ, Rʸ, y Rᶻ, en cada caso, son cada uno independientemente alquilo C₁₋₆, alquenilo C₂₋₆, alquinilo C₂₋₆, halógeno, haloalquilo C₁₋₆, -CN, oxo, NO₂, P(O)(Rᵏ)₂, -ORᵐ, -OC(O)Rᵏ, -OC(O)N(Rʲ)₂, -SRʲ, -S(O)₂Rᵏ, -S(O)₂N(Rʲ)₂, -C(O)Rʲ, -C(O)N(Rʲ)₂, -N(Rʲ)₂, -N(Rʲ)C(O)Rᵏ, -N(Rʲ)S(O)₂Rᵏ, -N(Rʲ)C(O)O(Rᵏ), -N(Rʲ)C(O)N(Rʲ)₂, -(alquilenil C₁₋₆)-ORʲ, -(alquilenil C₁₋₆)-OC(O)N(Rʲ)₂, -(alquilenil C₁₋₆)-SRʲ, -(alquilenil C₁₋₆)-S(O)₂Rᵏ, -(alquilenil C₁₋₆)-S(O)₂N(Rʲ)₂, -(alquilenil C₁₋₆)-C(O)Rʲ, -(alquilenil C₁₋₆)-C(O)N(Rʲ)₂, -(alquilenil C₁₋₆)-C(O)N(Rʲ)S(O)₂Rᵏ, -(alquilenil C₁₋₆)-N(Rʲ)₂, (alquilenil C₁₋₆)-N(Rʲ)C(O)Rᵏ, -(alquilenil C₁₋₆)-N(Rʲ)S(O)₂Rᵏ, -(alquilenil C₁₋₆)-N(Rʲ)C(O)O(Rᵏ), -(alquilenil C₁₋₆)-N(Rʲ)C(O)N(Rʲ)₂ o -(alquilenil C₁₋₆)-CN; Rᵐ es hidrógeno, alquilo C₁₋₆, haloalquilo C₁₋₆, -(alquilenil C₂₋₆)-ORʲ, o -(alquilenil C₂₋₆)-N(Rʲ)₂; Rʸʰ, Rʸⁱ, Rʸᵏ, R⁷ᵃ, R⁷ᵇ, R⁷ᶜ, R⁸ᵃ, R⁸ᵇ, R⁸ᶜ, R¹¹ᵈ, R¹¹ᵉ, Rʲ, en cada caso, son cada uno independientemente hidrógeno, alquilo C₁₋₆ o haloalquilo C₁₋₆; Rˣ¹, en cada caso, se selecciona independientemente entre el grupo que consiste en un polietilenglicol, un poliol, un poliéter, CH₂P(O)(Rᵏ)₂, C(O)OH, S(O)(=NH)(alquilo C₁₋₃), un isóstero de ácido carboxílico, cicloalquilo C₃₋₁₁, cicloalquenilo C₄₋₁₁ o heterociclo de 4 - 11 miembros, en donde el cicloalquilo C₃₋₁₁, el cicloalquenilo C₄₋₁₁ y el heterociclo de 4 - 11 miembros están sustituidos con dos o más grupos ORⁿ y opcionalmente sustituidos con 1 grupo Rᶻ seleccionado independientemente, o un compuesto seleccionado del grupo de fórmulas (3); Rᵏ, en cada caso, es independientemente alquilo C₁₋₆ o haloalquilo C₁₋₆; Rⁿ, en cada caso, es independientemente hidrógeno o alquilo C₁₋₆; Rᵖ es alquilo C₁₋₃ o ciclopropilo; Rq, en cada caso, es independientemente C(O)OH, halógeno, -O-alquilo C₁₋₆ o alquilo C₁₋₆; t es 0, 1 ó 2; y z, en cada caso, es independientemente 1, 2, 3 ó 4; en donde está presente al menos un Rˣ¹.",ABBVIE INC;;ABBVIE DEUTSCHLAND,MICHAELIDES MICHAEL;;PENNIG THOMAS D;;POHLKI FRAUKE;;DOHERTY GEORGE;;KLING ANDREAS;;TAO ZHI;;FU - WANG XILU;;SONG XIAOHONG;;BRAJE WILFRIED;;BRADY PATRICK;;WENDT MICHAEL D;;JANTOS KATJA;;TESKE JESSE A;;SULLIVAN GERARD M;;LAI CHUNQIU;;JI CHENG;;MASTRACCHIO ANTHONY;;SOUERS ANDREW J;;JUDD ANDREW S;;KUNZER AARON R,,https://lens.org/028-755-240-916-096,Patent Application,no,0,0,1,14,0,,C07D495/14;;A61K31/357;;A61K31/4365;;A61P35/00;;A61P35/02,,0,0,,,,PENDING
581,EP,A4,EP 3860760 A4,026-254-735-851-871,2022-09-28,2022,EP 19869384 A,2019-10-04,US 201862741756 P;;US 201962862174 P;;US 2019/0054599 W,2018-10-05,SYSTEMS AND METHODS FOR ALLERGEN DETECTION,,DOTS TECH CORP,MURPHY PATRICK;;ROBERTSON ERIC ANTHONY;;DAY DEIRDRE ELLEN;;DEAN MATTHEW BERNARD;;CAMPBELL TODD GLENDON;;BURKE BRIAN CHRISTOPHER;;SMITH TYLER S;;HARTNER THOMAS CHRISTOPHER;;THOMPSON STANLEY OWEN;;TRINH NHAT NAM;;CARPENTER DAVID;;KINTZ GREGORY J;;KOH PAUL;;DOSTAL DAVID JENNINGS;;DOHERTY KEVIN;;LAW WILLIAM;;MEAD RUSSELL C JR;;ALCORTA J EFRAÍN,,https://lens.org/026-254-735-851-871,Search Report,no,5,0,7,7,0,G01N21/6428;;G01N2021/6439;;G01N21/6456;;G01N2201/0221;;B01L3/502;;B01L2400/0644;;B01L2400/0487;;B01L2400/049;;B01L2300/0809;;B01L2200/10;;B01L2300/0867;;B01L2300/0681;;B01L2300/0654;;C12Q1/6837;;B01L3/502;;B01L2200/025;;B01L2200/026;;B01L2200/04;;B01L2200/0689;;B01L2200/10;;B01L2200/16;;B01L2300/025;;B01L2300/04;;B01L2300/0609;;B01L2300/0663;;B01L2300/0681;;B01L2300/087;;B01L2300/1822;;B01L2300/1827;;B01L2400/0622;;B01L2400/0644;;G01N21/6428;;G01N21/6456;;G01N2021/6439,B01L3/00;;C12N15/10;;G01N21/29;;G01N30/96;;G01N33/53;;G02B6/42;;G06T1/00,,2,0,,,"BOGDANOV V L ET AL: ""FLUORESCENT IMAGING AND QUANTITATION OF SOLID SUPPORT BOUND NUCLEIC ACIDS"", PROCEEDINGS OF SPIE, IEEE, US, vol. 2985, 1 January 1997 (1997-01-01), pages 129 - 137, XP000890164, ISBN: 978-1-62841-730-2, DOI: 10.1117/12.274346;;See also references of WO 2020072843A1",DISCONTINUED
582,EP,A1,EP 3860760 A1,061-285-131-873-907,2021-08-11,2021,EP 19869384 A,2019-10-04,US 201862741756 P;;US 201962862174 P;;US 2019/0054599 W,2018-10-05,SYSTEMS AND METHODS FOR ALLERGEN DETECTION,,DOTS TECH CORP,MURPHY PATRICK;;ROBERTSON ERIC ANTHONY;;DAY DEIRDRE ELLEN;;DEAN MATTHEW BERNARD;;CAMPBELL TODD GLENDON;;BURKE BRIAN CHRISTOPHER;;SMITH TYLER S;;HARTNER THOMAS CHRISTOPHER;;THOMPSON STANLEY OWEN;;TRINH NHAT NAM;;CARPENTER DAVID;;KINTZ GREGORY J;;KOH PAUL;;DOSTAL DAVID JENNINGS;;DOHERTY KEVIN;;LAW WILLIAM;;MEAD RUSSELL C JR;;ALCORTA J EFRAÍN,,https://lens.org/061-285-131-873-907,Patent Application,yes,0,0,7,7,0,G01N21/6428;;G01N2021/6439;;G01N21/6456;;G01N2201/0221;;B01L3/502;;B01L2400/0644;;B01L2400/0487;;B01L2400/049;;B01L2300/0809;;B01L2200/10;;B01L2300/0867;;B01L2300/0681;;B01L2300/0654;;C12Q1/6837;;B01L3/502;;B01L2200/025;;B01L2200/026;;B01L2200/04;;B01L2200/0689;;B01L2200/10;;B01L2200/16;;B01L2300/025;;B01L2300/04;;B01L2300/0609;;B01L2300/0663;;B01L2300/0681;;B01L2300/087;;B01L2300/1822;;B01L2300/1827;;B01L2400/0622;;B01L2400/0644;;G01N21/6428;;G01N21/6456;;G01N2021/6439,B01L3/00;;C12N15/10;;G01N21/29;;G01N30/96;;G01N33/53;;G02B6/42;;G06T1/00,,0,0,,,,DISCONTINUED
583,CA,A1,CA 3073113 A1,057-252-998-996-672,2019-02-21,2019,CA 3073113 A,2018-08-15,US 201762545836 P;;US 201762555470 P;;US 2018/0000183 W,2017-08-15,MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE,"The present disclosure provides for compounds of Formula (I) wherein A2, A3, A4, A6, A7, A8, A15, RA, R5, R9, R10A, R10B, R11, R12, R13, R14, R16, W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).",ABBVIE INC;;ABBVIE DEUTSCHLAND,BRADY PATRICK;;BRAJE WILFRIED;;DAI YUJIA;;DOHERTY GEORGE;;GONG JANE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;RISI ROBERTO;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI-FU;;TESKE JESSE;;WANG XILU;;WENDT MICHAEL;;YU YIYUN;;ZHU GUIDONG;;PENNING THOMAS;;LAI CHUNQIU;;KLING ANDREAS;;POHLKI FRAUKE;;POTIN DOMINIQUE;;GUILLIER FABRICE,,https://lens.org/057-252-998-996-672,Patent Application,no,0,0,24,25,0,C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;A61K31/519;;C07D491/16;;C07D498/16,A61K31/395;;A61P35/00;;C07D515/22,,0,0,,,,PENDING
584,CN,A,CN 112739343 A,112-492-558-725-890,2021-04-30,2021,CN 201880067012 A,2018-08-15,US 201762545836 P;;US 201762555470 P;;US 2018/0000183 W,2017-08-15,MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE,"The present disclosure provides for compounds of Formula (I) wherein A2, A3, A4, A6, A7, A8, A15, RA, R5, R9, R10A, R10B, R11, R12, R13, R14, R16, W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).",ABBVIE INC;;ABBVIE DEUTSCHLAND,BRADY PATRICK;;BRAJE WILFRIED;;DAI YUJIA;;DOHERTY GEORGE;;GONG JANE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;RISI ROBERTO;;SONG XUCHEN;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI-FU;;TESKE JESSE;;WANG XIAOMING;;WENDT MICHAEL;;YU YIYUN;;ZHU GUIDONG;;PENNING THOMAS;;LAI CHUNQIU;;KLING ANDREAS;;POHLKI FRAUKE;;POTIN DOMINIQUE;;GUILLIER FABRICE,,https://lens.org/112-492-558-725-890,Patent Application,no,3,0,24,25,0,C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;A61K31/519;;C07D491/16;;C07D498/16,A61K31/395;;A61P35/00;;C07D515/22,,2,0,,,"ANDRÁS KOTSCHY 等: ""The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models"";;JEFFREY W. JOHANNES 等: ""Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl‑1 Inhibitors""",DISCONTINUED
585,AU,A1,AU 2018/317836 A1,108-844-331-633-993,2020-03-19,2020,AU 2018/317836 A,2018-08-15,US 201762555470 P;;US 201762545836 P;;US 2018/0000183 W,2017-08-15,Macrocyclic MCL-1 inhibitors and methods of use,The present disclosure provides for compounds of Formula (I) wherein A,ABBVIE DEUTSCHLAND;;ABBVIE INC,BRADY PATRICK;;BRAJE WILFRIED;;DAI YUJIA;;DOHERTY GEORGE;;GONG JANE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;RISI ROBERTO;;TAO ZHI-FU;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TESKE JESSE;;WANG XILU;;WENDT MICHAEL;;YU YIYUN;;ZHU GUIDONG;;PENNING THOMAS;;LAI CHUNQIU;;KLING ANDREAS;;POHLKI FRAUKE;;POTIN DOMINIQUE;;GUILLIER FABRICE,,https://lens.org/108-844-331-633-993,Patent Application,no,0,0,24,25,0,C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;A61K31/519;;C07D491/16;;C07D498/16,C07D515/22;;A61K31/395;;A61P35/00,,0,0,,,,DISCONTINUED
586,US,A1,US 2020/0255451 A1,109-239-998-521-608,2020-08-13,2020,US 201816639560 A,2018-08-15,US 201816639560 A;;US 201762545836 P;;US 201762555470 P;;US 2018/0000183 W,2017-08-15,MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE,"The present disclosure provides for compounds of Formula (I) wherein A 2 , A 3 , A 4 , A 6 , A 7 , A 8 , A 15 , R A , R 5 , R 9 , R 10A , R 10B , R 11 , R 12 , R 13 , R 14 , R 16 , W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).",ABBVIE INC;;ABBVIE DEUTSCHLAND,BRAJE WILFRIED;;DOHERTY GEORGE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI-FU;;LAI CHUNQIU;;KLING ANDREAS;;POHLKI FRAUKE;;TESKE JESSE;;WENDT MICHAEL;;BRADY PATRICK;;WANG XILU;;PENNING THOMAS;;DAI YUJIA;;GONG JANE;;RISI ROBERTO;;YU YIYUN;;ZHU GUIDONG;;POTIN DOMINIQUE;;GUILLIER FABRICE,,https://lens.org/109-239-998-521-608,Patent Application,yes,0,2,24,25,0,C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;A61K31/519;;C07D491/16;;C07D498/16,C07D498/16;;A61P35/00;;C07D491/16;;C07D495/16;;C07D519/00,,0,0,,,,DISCONTINUED
587,WO,A1,WO 2019/035914 A1,124-605-956-404-471,2019-02-21,2019,US 2018/0000183 W,2018-08-15,US 201762555470 P;;US 201762545836 P,2017-08-15,MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE,"The present disclosure provides for compounds of Formula (I) wherein A 2 , A 3 , A 4 , A 6 , A 7 , A 8 , A 15 , R A , R 5 , R 9 , R 10A , R 10B , R 11 , R 12 , R 13 , R 14 , R 16 , W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).",ABBVIE INC;;ABBVIE DEUTSCHLAND;;BRADY PATRICK;;BRAJE WILFRIED;;DAI YUJIA;;DOHERTY GEORGE;;GONG JANE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;RISI ROBERTO;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI FU;;TESKE JESSE;;WANG XILU;;WENDT MICHAEL;;YU YIYUN;;ZHU GUIDONG;;PENNING THOMAS;;LAI CHUNQUI;;KLING ANDREAS;;POHLKI FRAUKE;;POTIN DOMINIQUE;;GUILLIER FABRICE,BRADY PATRICK;;BRAJE WILFRIED;;DAI YUJIA;;DOHERTY GEORGE;;GONG JANE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;RISI ROBERTO;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI-FU;;TESKE JESSE;;WANG XILU;;WENDT MICHAEL;;YU YIYUN;;ZHU GUIDONG;;PENNING THOMAS;;LAI CHUNQUI;;KLING ANDREAS;;POHLKI FRAUKE;;POTIN DOMINIQUE;;GUILLIER FABRICE,,https://lens.org/124-605-956-404-471,Patent Application,yes,3,12,24,25,0,C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;A61K31/519;;C07D491/16;;C07D498/16,A61K31/395;;A61P35/00;;C07D515/22,,2,1,002-864-807-651-770,27760111;;10.1038/nature19830,"KOTSCHY ET AL.: ""The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models"", NATURE, vol. 538, no. 7626, 27 October 2016 (2016-10-27), pages 477 - 482, XP055571783, Retrieved from the Internet <URL:https://www.nature.com/articles/nature19830.pdf>;;See also references of EP 3668504A4",PENDING
588,EP,A1,EP 3668504 A1,005-267-681-833-926,2020-06-24,2020,EP 18846740 A,2018-08-15,US 201762545836 P;;US 201762555470 P;;US 2018/0000183 W,2017-08-15,MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE,,ABBVIE INC;;ABBVIE DEUTSCHLAND,BRADY PATRICK;;BRAJE WILFRIED;;DAI YUJIA;;DOHERTY GEORGE;;GONG JANE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;RISI ROBERTO;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI-FU;;TESKE JESSE;;WANG XILU;;WENDT MICHAEL;;YU YIYUN;;ZHU GUIDONG;;PENNING THOMAS;;LAI CHUNQIU;;KLING ANDREAS;;POHLKI FRAUKE;;POTIN DOMINIQUE;;GUILLIER FABRICE,,https://lens.org/005-267-681-833-926,Patent Application,yes,0,0,24,25,0,C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;A61K31/519;;C07D491/16;;C07D498/16,A61K31/395;;A61P35/00;;C07D515/22,,0,0,,,,DISCONTINUED
589,WO,A8,WO 2019/035914 A8,107-829-237-905-428,2019-09-19,2019,US 2018/0000183 W,2018-08-15,US 201762555470 P;;US 201762545836 P,2017-08-15,MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE,"The present disclosure provides for compounds of Formula (I) wherein A 2 , A 3 , A 4 , A 6 , A 7 , A 8 , A 15 , R A , R 5 , R 9 , R 10A , R 10B , R 11 , R 12 , R 13 , R 14 , R 16 , W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).",ABBVIE INC;;ABBVIE DEUTSCHLAND;;BRADY PATRICK;;BRAJE WILFRIED;;DAI YUJIA;;DOHERTY GEORGE;;GONG JANE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;RISI ROBERTO;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI FU;;TESKE JESSE;;WANG XILU;;WENDT MICHAEL;;YU YIYUN;;ZHU GUIDONG;;PENNING THOMAS;;LAI CHUNQUI;;KLING ANDREAS;;POHLKI FRAUKE;;POTIN DOMINIQUE;;GUILLIER FABRICE,BRADY PATRICK;;BRAJE WILFRIED;;DAI YUJIA;;DOHERTY GEORGE;;GONG JANE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;RISI ROBERTO;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI-FU;;TESKE JESSE;;WANG XILU;;WENDT MICHAEL;;YU YIYUN;;ZHU GUIDONG;;PENNING THOMAS;;LAI CHUNQUI;;KLING ANDREAS;;POHLKI FRAUKE;;POTIN DOMINIQUE;;GUILLIER FABRICE,,https://lens.org/107-829-237-905-428,Amended Application,yes,0,0,24,25,0,C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;A61K31/519;;C07D491/16;;C07D498/16,A61K31/395;;A61P35/00;;C07D515/22,,0,0,,,,PENDING
590,BR,A2,BR 112020003130 A2,000-505-846-274-704,2020-10-13,2020,BR 112020003130 A,2018-08-15,US 2018/0000183 W;;US 201762545836 P;;US 201762555470 P,2017-08-15,inibidores macrocíclicos de mcl-1 e métodos de uso,"a presente divulgação fornece compostos de fórmula (i) (i), em que a2, a3, a4, a6, a7, a8, a15, ra, r5, r9, r10a, r10b, r11, r12, r13, r14, r16, w, x e y têm qualquer um dos valores definidos no relatório descritivo e sais farmaceuticamente aceitáveis dos mesmos, que são úteis como agentes para o tra-tamento de doenças e afecções, incluindo câncer. também são fornecidas compo-sições farmacêuticas que compreendem compostos de fórmula (i).",ABBVIE DEUTSCHLAND;;ABBVIE INC,AARON KUNZER;;ANDREAS KLING;;ANDREW JUDD;;ANDREW SOUERS;;ANTHONY MASTRACCHIO;;CHENG JI;;CHUNQIU LAI;;DOMINIQUE POTIN;;FABRICE GUILLIER;;FRAUKE POHLKI;;GEORGE DOHERTY;;GERARD SULLIVAN;;GUIDONG ZHU;;JANE GONG;;JESSE TESKE;;KATJA JANTOS;;MICHAEL WENDT;;PATRICK BRADY;;ROBERTO RISI;;THOMAS PENNING;;WILFRIED BRAJE;;XIAOHONG SONG;;XILU WANG;;YIYUN YU;;YUJIA DAI;;ZHI-FU TAO,,https://lens.org/000-505-846-274-704,Patent Application,no,0,0,24,25,0,C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;A61K31/519;;C07D491/16;;C07D498/16,A61K31/395;;A61P35/00;;C07D515/22,,0,0,,,,DISCONTINUED
591,EP,A4,EP 3668504 A4,101-145-332-340-001,2021-05-05,2021,EP 18846740 A,2018-08-15,US 201762545836 P;;US 201762555470 P;;US 2018/0000183 W,2017-08-15,MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE,,ABBVIE INC;;ABBVIE DEUTSCHLAND,BRADY PATRICK;;BRAJE WILFRIED;;DAI YUJIA;;DOHERTY GEORGE;;GONG JANE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW;;KUNZER AARON;;MASTRACCHIO ANTHONY;;RISI ROBERTO;;SONG XIAOHONG;;SOUERS ANDREW;;SULLIVAN GERARD;;TAO ZHI-FU;;TESKE JESSE;;WANG XILU;;WENDT MICHAEL;;YU YIYUN;;ZHU GUIDONG;;PENNING THOMAS;;LAI CHUNQIU;;KLING ANDREAS;;POHLKI FRAUKE;;POTIN DOMINIQUE;;GUILLIER FABRICE,,https://lens.org/101-145-332-340-001,Search Report,no,0,0,24,25,0,C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;A61K31/519;;C07D491/16;;C07D498/16,C07D515/22;;A61K31/395;;A61P35/00,,1,1,002-415-168-852-686,pmc5304306;;10.1021/acsmedchemlett.6b00464;;28197319,"JEFFREY W. JOHANNES ET AL: ""Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl-1 Inhibitors"", ACS MEDICINAL CHEMISTRY LETTERS, vol. 8, no. 2, 27 December 2016 (2016-12-27), US, pages 239 - 244, XP055723792, ISSN: 1948-5875, DOI: 10.1021/acsmedchemlett.6b00464",DISCONTINUED
592,US,A1,US 2019/0055264 A1,084-912-003-861-754,2019-02-21,2019,US 201815998688 A,2018-08-15,US 201815998688 A;;US 201762545836 P;;US 201762555470 P,2017-08-15,Macrocyclic MCL-1 inhibitors and methods of use,"The present disclosure provides for compounds of Formula (I) wherein A 2 , A 3 , A 4 , A 6 , A 7 , A 8 , A 15 , R A , R 5 , R 9 , R 10A , R 10B , R 11 , R 12 , R 13 , R 14 , R 16 , W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).",ABBVIE INC;;ABBVIE DEUTSCHLAND,BRADY PATRICK B;;BRAJE WILFRIED;;DAI YUJIA;;DOHERTY GEORGE A;;GONG JANE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW S;;KUNZER AARON R;;LAI CHUNQIU;;MASTRACCHIO ANTHONY;;RISI ROBERTO M;;SONG XIAOHONG;;SOUERS ANDREW J;;SULLIVAN GERARD M;;TAO ZHI-FU;;TESKE JESSE A;;WANG XILU;;WENDT MICHAEL D;;YU YIYUN;;ZHU GUIDONG;;PENNING THOMAS D,ABBVIE DEUTSCHLAND GMBH & CO. KG (2020-02-07);;ABBVIE INC (2020-02-07),https://lens.org/084-912-003-861-754,Patent Application,yes,0,6,24,25,0,C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;A61K31/519;;C07D491/16;;C07D498/16,C07D498/18;;A61P35/00;;C07D495/18;;C07D519/00,,0,0,,,,DISCONTINUED
593,US,A1,US 2020/0010480 A1,095-192-870-805-28X,2020-01-09,2020,US 201916575114 A,2019-09-18,US 201916575114 A;;US 201815998688 A;;US 201762545836 P;;US 201762555470 P,2017-08-15,Macrocyclic MCL-1 Inhibitors and Methods of Use,"The present disclosure provides for compounds of Formula (I) wherein A 2 , A 3 , A 4 , A 6 , A 7 , A 8 , A 15 , R A , R 5 , R 9 , R 10A , R 10B , R 11 , R 12 , R 13 , R 14 , R 16 , W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).",ABBVIE INC;;ABBVIE DEUTSCHLAND,BRADY PATRICK B;;BRAJE WILFRIED;;DAI YUJIA;;DOHERTY GEORGE A;;GONG JANE;;JANTOS KATJA;;JI CHENG;;JUDD ANDREW S;;KUNZER AARON R;;LAI CHUNQIU;;MASTRACCHIO ANTHONY;;RISI ROBERTO M;;SONG XIAOHONG;;SOUERS ANDREW J;;SULLIVAN GERARD M;;TAO ZHI-FU;;TESKE JESSE A;;WANG XILU;;WENDT MICHAEL D;;YU YIYUN;;ZHU GUIDONG;;PENNING THOMAS D,ABBVIE DEUTSCHLAND GMBH & CO. KG (2020-02-07);;ABBVIE INC (2020-02-07),https://lens.org/095-192-870-805-28X,Patent Application,yes,0,0,24,25,0,C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;A61K31/519;;C07D491/16;;C07D498/16,C07D498/18;;A61P35/00;;C07D495/16;;C07D495/18;;C07D519/00,,0,0,,,,DISCONTINUED
594,EP,A1,EP 4028869 A1,176-608-306-696-185,2022-07-20,2022,EP 21724821 A,2021-03-31,US 2021/0025051 W;;US 202063008586 P;;US 202063022869 P;;US 202063032970 P;;DK PA202070633 A;;DK PA202070634 A,2020-04-10,USER INTERFACES FOR ENABLING AN ACTIVITY,,APPLE INC,ZHANG YONGJUN;;ABBASIAN REZA;;ADLER DARIN;;CHAN ADA;;COFFMAN PATRICK L;;DOHERTY NICHOLAS STEPHEN;;DUBOIS DANA J;;ETZEL CHARLES B;;FALKENBURG STEVEN;;FEDERIGHI CRAIG M;;FERRY KENNETH ARTHUR ABRAHAM;;FOSS CHRISTOPHER PATRICK;;GHARABALLY SAM H;;GOLDBERG BRIAN ERIK;;KHAN NAHIR A;;KO HEENA;;KOWALCZYKOWSKI KEITH P;;MEHRA RISHAB;;PAUL GRANT;;RAMASWAMY PALLAVIKA;;RITCHIE GRANT;;ROBBIN JEFFREY L;;SAVAGE JAMES S;;SIBSON MATTHEW;;SINGH GURSHAMNJOT;;STACK CAELAN G;;XUE MARK M;;YIN LUMING;;YING CHARLES H;;ZHANG HENGLIANG;;ZHANG XIAOYUE,APPLE INC. (2023-07-12),https://lens.org/176-608-306-696-185,Patent Application,yes,0,0,27,37,0,G06F3/04817;;G06F3/0488;;G06F8/61;;G06F9/445;;H04M1/72472;;G06F9/451;;G06F8/61;;G06F9/44568;;G06F9/52;;G06F9/54;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F8/38;;H04L67/34;;H04L67/5651,G06F3/0481;;G06F3/0488;;G06F8/61;;G06F9/445,,0,0,,,,ACTIVE
595,AU,A1,AU 2022/202261 A1,017-134-750-408-517,2022-04-21,2022,AU 2022/202261 A,2022-04-05,AU 2022/202261 A;;AU 2020/239759 A;;DK PA202070634 A;;US 202063008586 P;;US 202063022869 P;;DK PA202070633 A;;US 202063032970 P,2020-04-10,User interfaces for enabling an activity,"The present disclosure generally relates to user interfaces for enabling an activity using a computer system. In some embodiments, exemplary user interfaces for invoking an activity associated with an application are described. In some embodiments, exemplary user interfaces for customizing displayed content based on circumstances under which the content was invoked are described. In some embodiments, exemplary user interfaces for managing applications that were used to enable activities are described. In some embodiments, exemplary user interfaces for managing settings for applications used to enable activities are described.",APPLE INC,ZHANG YONGJUN;;ABBASIAN REZA;;ADLER DARIN;;CHAN ADA;;COFFMAN PATRICK L;;DOHERTY NICHOLAS STEPHEN;;DUBOIS DANA J;;ETZEL CHARLES B;;FALKENBURG STEVEN;;FEDERIGHI CRAIG M;;FERRY KENNETH ARTHUR ABRAHAM;;FOSS CHRISTOPHER PATRICK;;GHARABALLY SAM H;;GOLDBERG BRIAN ERIK;;KHAN NAHIR A;;KO HEENA;;KOWALCZYKOWSKI KEITH P;;MEHRA RISHAB;;PAUL GRANT;;RAMASWAMY PALLAVIKA;;RITCHIE GRANT;;ROBBIN JEFFREY L;;SAVAGE JAMES S;;SIBSON MATTHEW;;SINGH SHAMAN;;STACK CAELAN G;;XUE MARK M;;YIN LUMING;;YING CHARLES H;;ZHANG HENGLIANG;;ZHANG XIAOYUE,,https://lens.org/017-134-750-408-517,Patent Application,no,0,0,27,37,0,G06F3/04817;;G06F3/0488;;G06F8/61;;G06F9/445;;H04M1/72472;;G06F9/451;;G06F8/61;;G06F9/44568;;G06F9/52;;G06F9/54;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F8/38;;H04L67/34;;H04L67/5651,G06F3/048;;G06F9/451,,0,0,,,,ACTIVE
596,DK,B1,DK 180985 B1,130-430-494-825-997,2022-09-02,2022,DK PA202070634 A,2020-09-23,US 202063008586 P;;US 202063022869 P;;US 202063032970 P,2020-04-10,Brugergrænseflader for muliggørelse af en aktivitet,"The present disclosure generally relates to user interfaces for enabling an activity using a computer system. In some embodiments, exemplary user interfaces for invoking an activity associated with an application are described. In some embodiments, exemplary user interfaces for customizing displayed content based on circumstances under which the content was invoked are described. In some embodiments, exemplary user interfaces for managing applications that were used to enable activities are described. In some embodiments, exemplary user interfaces for managing settings for applications used to enable activities are described.",APPLE INC,PATRICK L COFFMAN;;YONGJUN ZHANG;;REZA ABBASIAN;;DARIN ADLER;;ADA CHAN;;DANA J DUBOIS;;CHARLES B ETZEL;;KENNETH ARTHUR ABRAHAM FERRY;;STEVEN FALKENBURG;;CRAIG M FEDERIGHI;;CHRISTOPHER PATRICK FOSS;;SAM H GHARABALLY;;BRIAN ERIK GOLDBERG;;HEENA KO;;RISHAB MEHRA;;GRANT PAUL;;JEFFREY L ROBBIN;;JAMES S SAVAGE;;MATTHEW SIBSON;;GURSHAMNJOT SINGH;;CAELAN G STACK;;LUMING YIN;;CHARLES H YING;;MARK M XUE;;HENGLIANG ZHANG;;NICHOLAS STEPHEN DOHERTY;;NAHIR A KHAN;;KEITH P KOWALCZYKOWSKI;;PALLAVIKA RAMASWAMY;;XIAOYUE ZHANG;;GRANT RITCHIE,,https://lens.org/130-430-494-825-997,Granted Patent,no,0,0,10,37,0,G06F3/048;;G06F21/00;;H04M1/00;;H04W4/00;;H04L67/34;;G06F3/0488;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F9/451;;G06F3/04817;;G06F8/38;;G06F3/04842;;G06F3/0488;;G06F9/44568;;G06F9/54;;H04L67/34;;H04L67/5651,H04W4/00;;G06F3/048;;G06F21/00;;H04M1/00,,0,0,,,,ACTIVE
597,AU,B9,AU 2020/239759 B9,160-796-982-823-645,2022-09-22,2022,AU 2020/239759 A,2020-09-24,DK PA202070634 A;;US 202063008586 P;;US 202063022869 P;;DK PA202070633 A;;US 202063032970 P,2020-04-10,User interfaces for enabling an activity,"The present disclosure generally relates to user interfaces for enabling an activity using a computer system. In some embodiments, exemplary user interfaces for invoking an activity associated with an application are described. In some embodiments, exemplary user interfaces for customizing displayed content based on circumstances under which the content was invoked are described. In some embodiments, exemplary user interfaces for managing applications that were used to enable activities are described. In some embodiments, exemplary user interfaces for managing settings for applications used to enable activities are described. N -y 7cr - -42 - ~ C 3* o A~ 0 -G",APPLE INC,ZHANG YONGJUN;;ABBASIAN REZA;;ADLER DARIN;;CHAN ADA;;DUBOIS DANA J;;ETZEL CHARLES B;;FERRY KENNETH ARTHUR ABRAHAM;;FALKENBURG STEVEN;;FEDERIGHI CRAIG M;;FOSS CHRISTOPHER PATRICK;;GHARABALLY SAM H;;GOLDBERG BRIAN ERIK;;DOHERTY NICHOLAS STEPHEN;;KHAN NAHIR A;;KO HEENA;;KOWALCZYKOWSKI KEITH P;;MEHRA RISHAB;;PAUL GRANT;;RAMASWAMY PALLAVIKA;;ROBBIN JEFFREY L;;SAVAGE JAMES S;;SIBSON MATTHEW;;SINGH GURSHAMNJOT;;STACK CAELAN G;;YIN LUMING;;YING CHARLES H;;XUE MARK M;;ZHANG HENGLIANG;;ZHANG XIAOYUE;;COFFMAN PATRICK L,,https://lens.org/160-796-982-823-645,Amended Patent,no,2,0,27,37,0,G06F3/04817;;G06F3/0488;;G06F8/61;;G06F9/445;;H04M1/72472;;G06F9/451;;G06F8/61;;G06F9/44568;;G06F9/52;;G06F9/54;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F8/38;;H04L67/34;;H04L67/5651,G06F3/048;;G06F9/451,,0,0,,,,ACTIVE
598,TW,A,TW 202028742 A,140-630-601-114-285,2020-08-01,2020,TW 108136034 A,2019-10-04,US 201862741756 P;;US 201962862174 P,2018-10-05,Systems and methods for allergen detection,"The present disclosure is drawn to devices and systems for target detection in samples, particularly allergen detection in food samples. The allergen detection system includes a sampler, a disposable analysis cartridge and a detection device with an optimized optical system. The allergen detection utilizes nucleic acid molecules as detection agents and detection probes.",DOTS TECH CORP,GILBOA-GEFFEN ADI;;WEEKS ALAN LLOYD;;VILLAREAL VALERIE;;MURPHY PATRICK;;ROBERTSON ERIC ANTHONY;;DAY DEIRDRE ELLEN;;DEAN MATTHEW BERNARD;;CAMPBELL TODD GLENDON;;BURKE BRAIN CHRISTOPHER;;SMITH TYLER S;;HARTNER THOMAS CHRISTOPHER;;THOMPSON STANLEY OWEN;;TRINH NHAT NAM;;CARPENTER DAVID;;KINTZ GREGORY J;;KOH PAUL;;DOSTAL DAVID JENNINGS;;DOHERTY KEVIN;;JENSEN JOEL F;;LAW WILLIAM;;MEAD JR;;ALCORTA J EFRAIN,,https://lens.org/140-630-601-114-285,Patent of Addition,no,0,0,7,7,0,G01N21/6428;;G01N2021/6439;;G01N21/6456;;G01N2201/0221;;B01L3/502;;B01L2400/0644;;B01L2400/0487;;B01L2400/049;;B01L2300/0809;;B01L2200/10;;B01L2300/0867;;B01L2300/0681;;B01L2300/0654;;C12Q1/6837;;B01L3/502;;B01L2200/025;;B01L2200/026;;B01L2200/04;;B01L2200/0689;;B01L2200/10;;B01L2200/16;;B01L2300/025;;B01L2300/04;;B01L2300/0609;;B01L2300/0663;;B01L2300/0681;;B01L2300/087;;B01L2300/1822;;B01L2300/1827;;B01L2400/0622;;B01L2400/0644;;G01N21/6428;;G01N21/6456;;G01N2021/6439,G01N33/53;;B01L3/00;;C12N15/10;;G01N21/29;;G06T1/00,,0,0,,,,PENDING
599,TW,A,TW 201920204 A,109-629-120-524-142,2019-06-01,2019,TW 107128525 A,2018-08-15,US 201762545836 P;;US 201762555470 P,2017-08-15,Macrocyclic MCL-1 inhibitors and methods of use,"The present disclosure provides for compounds of Formula (I) wherein A2, A3, A4, A6, A7, A8, A15, RA, R5, R9, R<SP>10A<SP>, R<SP>10B<SP>, R11, R12, R13, R14, R16, W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).",ABBVIE INC;;ABBVIE DEUTSCHLAND,KUNZER AARON;;JUDD ANDREW;;SOUERS ANDREW;;MASTRACCHIO ANTHONY;;JI CHENG;;LAI CHUN-QIU;;SULLIVAN GERARD;;ZHU GUI-DONG;;GONG JANE;;TESKE JESSE;;JANTOS KATJA;;WENDT MICHAEL;;BRADY PATRICK;;RISI ROBERTO;;BRAJE WILFRIED;;SONG XIAO-HONG;;WANG XILU;;DAI YUJIA;;TAO ZHI-FU;;DOHERTY GEORGE;;KLING ANDREAS;;POTIN DOMINIQUE;;GUILLIER FABRICE;;POHLKI FRAUKE;;PENNING THOMAS;;YU YI-YUN,,https://lens.org/109-629-120-524-142,Patent of Addition,no,0,0,24,25,0,C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;A61K31/519;;C07D491/16;;C07D498/16,C07D515/16;;A61K31/519;;A61P35/00,,0,0,,,,PENDING
600,AU,B2,AU 2022/202261 B2,066-776-999-893-871,2023-04-13,2023,AU 2022/202261 A,2022-04-05,AU 2022/202261 A;;AU 2020/239759 A;;DK PA202070634 A;;US 202063008586 P;;US 202063022869 P;;DK PA202070633 A;;US 202063032970 P,2020-04-10,User interfaces for enabling an activity,"The present disclosure generally relates to user interfaces for enabling an activity using a computer system. In some embodiments, exemplary user interfaces for invoking an activity associated with an application are described. In some embodiments, exemplary user interfaces for customizing displayed content based on circumstances under which the content was invoked are described. In some embodiments, exemplary user interfaces for managing applications that were used to enable activities are described. In some embodiments, exemplary user interfaces for managing settings for applications used to enable activities are described.",APPLE INC,ZHANG YONGJUN;;ABBASIAN REZA;;ADLER DARIN;;CHAN ADA;;COFFMAN PATRICK L;;DOHERTY NICHOLAS STEPHEN;;DUBOIS DANA J;;ETZEL CHARLES B;;FALKENBURG STEVEN;;FEDERIGHI CRAIG M;;FERRY KENNETH ARTHUR ABRAHAM;;FOSS CHRISTOPHER PATRICK;;GHARABALLY SAM H;;GOLDBERG BRIAN ERIK;;KHAN NAHIR A;;KO HEENA;;KOWALCZYKOWSKI KEITH P;;MEHRA RISHAB;;PAUL GRANT;;RAMASWAMY PALLAVIKA;;RITCHIE GRANT;;ROBBIN JEFFREY L;;SAVAGE JAMES S;;SIBSON MATTHEW;;SINGH GURSHAMNJOT;;STACK CAELAN G;;XUE MARK M;;YIN LUMING;;YING CHARLES H;;ZHANG HENGLIANG;;ZHANG XIAOYUE;;DYE ALAN C,,https://lens.org/066-776-999-893-871,Granted Patent,no,5,0,27,37,0,G06F3/04817;;G06F3/0488;;G06F8/61;;G06F9/445;;H04M1/72472;;G06F9/451;;G06F8/61;;G06F9/44568;;G06F9/52;;G06F9/54;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F8/38;;H04L67/34;;H04L67/5651,G06F3/048;;G06F9/451,,0,0,,,,ACTIVE
601,EP,B1,EP 4028869 B1,040-155-157-623-984,2024-02-21,2024,EP 21724821 A,2021-03-31,US 2021/0025051 W;;US 202063008586 P;;US 202063022869 P;;US 202063032970 P;;DK PA202070633 A;;DK PA202070634 A,2020-04-10,USER INTERFACES FOR ENABLING AN ACTIVITY,,APPLE INC,ZHANG YONGJUN;;ABBASIAN REZA;;ADLER DARIN;;CHAN ADA;;COFFMAN PATRICK L;;DOHERTY NICHOLAS STEPHEN;;DUBOIS DANA J;;ETZEL CHARLES B;;FALKENBURG STEVEN;;FEDERIGHI CRAIG M;;FERRY KENNETH ARTHUR ABRAHAM;;FOSS CHRISTOPHER PATRICK;;GHARABALLY SAM H;;GOLDBERG BRIAN ERIK;;KHAN NAHIR A;;KO HEENA;;KOWALCZYKOWSKI KEITH P;;MEHRA RISHAB;;PAUL GRANT;;RAMASWAMY PALLAVIKA;;RITCHIE GRANT;;ROBBIN JEFFREY L;;SAVAGE JAMES S;;SIBSON MATTHEW;;SINGH GURSHAMNJOT;;STACK CAELAN G;;XUE MARK M;;YIN LUMING;;YING CHARLES H;;ZHANG HENGLIANG;;ZHANG XIAOYUE;;DYE ALAN C,APPLE INC. (2023-07-12),https://lens.org/040-155-157-623-984,Granted Patent,yes,8,0,27,37,0,G06F3/04817;;G06F3/0488;;G06F8/61;;G06F9/445;;H04M1/72472;;G06F9/451;;G06F8/61;;G06F9/44568;;G06F9/52;;G06F9/54;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F8/38;;H04L67/34;;H04L67/5651,G06F3/0481;;G06F3/0488;;G06F8/61;;G06F9/445;;H04M1/72472,,0,0,,,,ACTIVE
602,WO,A9,WO 2021/206976 A9,187-069-044-419-012,2022-11-10,2022,US 2021/0025051 W,2021-03-31,US 202063008586 P;;US 202063022869 P;;US 202063032970 P;;DK PA202070633 A;;DK PA202070634 A,2020-04-10,USER INTERFACES FOR ENABLING AN ACTIVITY,"The present disclosure generally relates to user interfaces for enabling an activity using a computer system. In some embodiments, exemplary user interfaces for invoking an activity associated with an application are described. In some embodiments, exemplary user interfaces for customizing displayed content based on circumstances under which the content was invoked are described. In some embodiments, exemplary user interfaces for managing applications that were used to enable activities are described. In some embodiments, exemplary user interfaces for managing settings for applications used to enable activities are described.",APPLE INC,ZHANG YONGJUN;;ABBASIAN REZA;;ADLER DARIN;;CHAN ADA;;COFFMAN PATRICK L;;DOHERTY NICHOLAS STEPHEN;;DUBOIS DANA J;;ETZEL CHARLES B;;FALKENBURG STEVEN;;FEDERIGHI CRAIG M;;FERRY KENNETH ARTHUR ABRAHAM;;FOSS CHRISTOPHER PATRICK;;GHARABALLY SAM H;;GOLDBERG BRIAN ERIK;;KHAN NAHIR A;;KO HEENA;;KOWALCZYKOWSKI KEITH P;;MEHRA RISHAB;;PAUL GRANT;;RAMASWAMY PALLAVIKA;;RITCHIE GRANT;;ROBBIN JEFFREY L;;SAVAGE JAMES S;;SIBSON MATTHEW;;SINGH GURSHAMNJOT;;STACK CAELAN G;;XUE MARK M;;YIN LUMING;;YING CHARLES H;;ZHANG HENGLIANG;;ZHANG XIAOYUE;;DYE ALAN C,,https://lens.org/187-069-044-419-012,Search Report,yes,0,0,27,37,0,G06F3/04817;;G06F3/0488;;G06F8/61;;G06F9/445;;H04M1/72472;;G06F9/451;;G06F8/61;;G06F9/44568;;G06F9/52;;G06F9/54;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F8/38;;H04L67/34;;H04L67/5651,G06F3/0481;;G06F3/0488;;G06F8/61;;G06F9/445,,0,0,,,,PENDING
603,AU,A1,AU 2023/203678 A1,169-118-303-656-131,2023-07-06,2023,AU 2023/203678 A,2023-06-13,AU 2023/203678 A;;AU 2022/202261 A;;AU 2020/239759 A;;DK PA202070634 A;;US 202063008586 P;;US 202063022869 P;;DK PA202070633 A;;US 202063032970 P,2020-04-10,User interfaces for enabling an activity,"The present disclosure generally relates to user interfaces for enabling an activity using a computer system. In some embodiments, exemplary user interfaces for invoking an activity associated with an application are described. In some embodiments, exemplary user interfaces for customizing displayed content based on circumstances under which the content was invoked are described. In some embodiments, exemplary user interfaces for managing applications that were used to enable activities are described. In some embodiments, exemplary user interfaces for managing settings for applications used to enable activities are described.",APPLE INC,ZHANG YONGJUN;;ABBASIAN REZA;;ADLER DARIN;;CHAN ADA;;COFFMAN PATRICK L;;DOHERTY NICHOLAS STEPHEN;;DUBOIS DANA J;;ETZEL CHARLES B;;FALKENBURG STEVEN;;FEDERIGHI CRAIG M;;FERRY KENNETH ARTHUR ABRAHAM;;FOSS CHRISTOPHER PATRICK;;GHARABALLY SAM H;;GOLDBERG BRIAN ERIK;;KHAN NAHIR A;;KO HEENA;;KOWALCZYKOWSKI KEITH P;;MEHRA RISHAB;;PAUL GRANT;;RAMASWAMY PALLAVIKA;;RITCHIE GRANT;;ROBBIN JEFFREY L;;SAVAGE JAMES S;;SIBSON MATTHEW;;SINGH GURSHAMNJOT;;STACK CAELAN G;;XUE MARK M;;YIN LUMING;;YING CHARLES H;;ZHANG HENGLIANG;;ZHANG XIAOYUE;;DYE ALAN C,,https://lens.org/169-118-303-656-131,Patent Application,no,0,0,27,37,0,G06F3/04817;;G06F3/0488;;G06F8/61;;G06F9/445;;H04M1/72472;;G06F9/451;;G06F8/61;;G06F9/44568;;G06F9/52;;G06F9/54;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F8/38;;H04L67/34;;H04L67/5651,G06F3/048;;G06F9/451,,0,0,,,,PENDING
604,EP,A2,EP 4277252 A2,083-807-923-040-050,2023-11-15,2023,EP 23199956 A,2021-03-31,US 202063032970 P;;DK PA202070633 A;;US 202063008586 P;;US 202063022869 P;;DK PA202070634 A;;EP 21724821 A;;US 2021/0025051 W,2020-04-10,USER INTERFACES FOR ENABLING AN ACTIVITY,"The present disclosure generally relates to user interfaces for enabling an activity using a computer system. In some embodiments, exemplary user interfaces for invoking an activity associated with an application are described. In some embodiments, exemplary user interfaces for customizing displayed content based on circumstances under which the content was invoked are described. In some embodiments, exemplary user interfaces for managing applications that were used to enable activities are described. In some embodiments, exemplary user interfaces for managing settings for applications used to enable activities are described.
",APPLE INC,ZHANG YONGJUN;;ABBASIAN REZA;;ADLER DARIN;;CHAN ADA;;COFFMAN PATRICK L;;DOHERTY NICHOLAS STEPHEN;;DUBOIS DANA J;;ETZEL CHARLES B;;FALKENBURG STEVEN;;FEDERIGHI CRAIG M;;FERRY KENNETH ARTHUR ABRAHAM;;FOSS CHRISTOPHER PATRICK;;GHARABALLY SAM H;;GOLDBERG BRIAN ERIK;;KHAN NAHIR A;;KO HEENA;;KOWALCZYKOWSKI KEITH P;;MEHRA RISHAB;;PAUL GRANT;;RAMASWAMY PALLAVIKA;;RITCHIE GRANT;;ROBBIN JEFFREY L;;SAVAGE JAMES S;;SIBSON MATTHEW;;SINGH GURSHAMNJOT;;STACK CAELAN G;;XUE MARK M;;YIN LUMING;;YING CHARLES H;;ZHANG HENGLIANG;;ZHANG XIAOYUE;;DYE ALAN C,,https://lens.org/083-807-923-040-050,Patent Application,yes,28,0,27,37,0,G06F3/04817;;G06F3/0488;;G06F8/61;;G06F9/445;;H04M1/72472;;G06F9/451;;G06F8/61;;G06F9/44568;;G06F9/52;;G06F9/54;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F8/38;;H04L67/34;;H04L67/5651,H04M1/72472,,0,0,,,,PENDING
605,EP,A3,EP 4277252 A3,159-976-532-192-447,2024-01-10,2024,EP 23199956 A,2021-03-31,US 202063032970 P;;DK PA202070633 A;;US 202063008586 P;;US 202063022869 P;;DK PA202070634 A;;EP 21724821 A;;US 2021/0025051 W,2020-04-10,USER INTERFACES FOR ENABLING AN ACTIVITY,"The present disclosure generally relates to user interfaces for enabling an activity using a computer system. In some embodiments, exemplary user interfaces for invoking an activity associated with an application are described. In some embodiments, exemplary user interfaces for customizing displayed content based on circumstances under which the content was invoked are described. In some embodiments, exemplary user interfaces for managing applications that were used to enable activities are described. In some embodiments, exemplary user interfaces for managing settings for applications used to enable activities are described.
",APPLE INC,ZHANG YONGJUN;;ABBASIAN REZA;;ADLER DARIN;;CHAN ADA;;COFFMAN PATRICK L;;DOHERTY NICHOLAS STEPHEN;;DUBOIS DANA J;;ETZEL CHARLES B;;FALKENBURG STEVEN;;FEDERIGHI CRAIG M;;FERRY KENNETH ARTHUR ABRAHAM;;FOSS CHRISTOPHER PATRICK;;GHARABALLY SAM H;;GOLDBERG BRIAN ERIK;;KHAN NAHIR A;;KO HEENA;;KOWALCZYKOWSKI KEITH P;;MEHRA RISHAB;;PAUL GRANT;;RAMASWAMY PALLAVIKA;;RITCHIE GRANT;;ROBBIN JEFFREY L;;SAVAGE JAMES S;;SIBSON MATTHEW;;SINGH GURSHAMNJOT;;STACK CAELAN G;;XUE MARK M;;YIN LUMING;;YING CHARLES H;;ZHANG HENGLIANG;;ZHANG XIAOYUE;;DYE ALAN C,,https://lens.org/159-976-532-192-447,Search Report,yes,3,0,27,37,0,G06F3/04817;;G06F3/0488;;G06F8/61;;G06F9/445;;H04M1/72472;;G06F9/451;;G06F8/61;;G06F9/44568;;G06F9/52;;G06F9/54;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F8/38;;H04L67/34;;H04L67/5651,G06F3/0481;;G06F3/0488;;G06F8/61;;G06F9/445,,0,0,,,,PENDING
606,CN,A,CN 116027943 A,174-725-016-239-402,2023-04-28,2023,CN 202310042931 A,2021-03-31,DK PA202070633 A;;DK PA202070634 A;;US 202063008586 P;;US 202063022869 P;;US 202063032970 P;;CN 202180040304 A;;US 2021/0025051 W,2020-04-10,User interface for enabling activities,"The present disclosure generally relates to user interfaces for enabling activities. In some embodiments, an exemplary user interface for invoking activities associated with an application is described. In some embodiments, an exemplary user interface is described for customizing display content based on a situation in which the content is invoked. In some embodiments, an exemplary user interface for managing an application for enabling an activity is described. In some embodiments, an exemplary user interface is described for managing settings for an activity-enabled application.",APPLE INC,ZHANG YU;;ABBASIAN REZA;;ADLER DORON;;CHEN ALVIN;;COFFMAN PATRICK L;;DOHERTY NIRANJAN S;;DUBOIS DANIEL J;;ETZEL CHRISTOPHER B;;FALKENBURG STEVEN;;FEDERIGHI CRAIG M;;FERRY KAREN A A;;FOSS CHRISTOPHER PATRICK;;GARABALLI SAM H;;GOLDBERG BRIAN E;;KHAN NAWAZ A;;KO HEENA;;KOWALCZYKOWSKI KEVIN P;;MEHRA RAJDEEP;;PAUL GRANT;;RAMASWAMY PRASANNA;;RICCI GIOVANNI;;ROBBIN JEFFREY L;;SAVAGE JOHN S;;SIBSON MICHAEL;;SINGH GURPREET;;STACK CAELAN G;;XUE MINGZHE M;;YIN LUMING;;YING CHANGHAN HOBIE;;ZHANG HENGLIANG;;ZHANG XIAOYUE;;A C DAY,,https://lens.org/174-725-016-239-402,Patent Application,no,0,0,27,37,0,G06F3/04817;;G06F3/0488;;G06F8/61;;G06F9/445;;H04M1/72472;;G06F9/451;;G06F8/61;;G06F9/44568;;G06F9/52;;G06F9/54;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F8/38;;H04L67/34;;H04L67/5651,G06F3/04817;;G06F3/0482;;G06F3/0488,,0,0,,,,PENDING
607,KR,A,KR 20230019187 A,112-803-802-204-313,2023-02-07,2023,KR 20230010187 A,2023-01-26,US 202063008586 P;;US 202063022869 P;;US 202063032970 P;;DK PA202070633 A;;DK PA202070634 A;;KR 20200123866 A,2020-04-10,USER INTERFACES FOR ENABLING AN ACTIVITY,"The present disclosure generally relates to user interfaces for enabling an activity using a computer system. In some embodiments, exemplary user interfaces for invoking an activity associated with an application are described. In some embodiments, exemplary user interfaces for customizing displayed content based on circumstances under which the content was invoked are described. In some embodiments, exemplary user interfaces for managing applications that were used to enable activities are described. In some embodiments, exemplary user interfaces for managing settings for applications used to enable activities are described.",APPLE INC,ZHANG YONGJUN;;ABBASIAN REZA;;ADLER DARIN;;CHAN ADA;;DUBOIS DANA J;;ETZEL CHARLES B;;FERRY KENNETH ARTHUR ABRAHAM;;FALKENBURG STEVEN;;FEDERIGHI CRAIG M;;FOSS CHRISTOPHER PATRICK;;GHARABALLY SAM H;;GOLDBERG BRIAN ERIK;;DOHERTY NICHOLAS STEPHEN;;KHAN NAHIR A;;KO HEENA;;KOWALCZYKOWSKI KEITH P;;MEHRA RISHAB;;PAUL GRANT;;RAMASWAMY PALLAVIKA;;ROBBIN JEFFREY L;;SAVAGE JAMES S;;SIBSON MATTHEW;;SINGH GURSHAMNJOT;;STACK CAELAN G;;YIN LUMING;;YING CHARLES H;;XUE MARK M;;ZHANG HENGLIANG;;ZHANG XIAOYUE;;COFFMAN PATRICK L;;RITCHIE GRANT;;DYE ALAN C,,https://lens.org/112-803-802-204-313,Patent Application,no,0,0,27,37,0,G06F3/04817;;G06F3/0488;;G06F8/61;;G06F9/445;;H04M1/72472;;G06F9/451;;G06F8/61;;G06F9/44568;;G06F9/52;;G06F9/54;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F8/38;;H04L67/34;;H04L67/5651,G06F9/451;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F8/38;;G06F8/61;;G06F9/445;;G06F9/52;;G06F9/54;;H04L67/00;;H04L67/5651,,0,0,,,,DISCONTINUED
608,CN,A,CN 115943359 A,003-912-882-819-30X,2023-04-07,2023,CN 202180040304 A,2021-03-31,DK PA202070633 A;;DK PA202070634 A;;US 202063008586 P;;US 202063022869 P;;US 202063032970 P;;US 2021/0025051 W,2020-04-10,User interface for enabling activities,"The present disclosure generally relates to a user interface for enabling activities using a computer system. In some embodiments, an exemplary user interface for invoking activities associated with an application is described. In some embodiments, an exemplary user interface is described for customizing display content based on a situation in which the content is invoked. In some embodiments, an exemplary user interface for managing an application for enabling an activity is described. In some embodiments, an exemplary user interface is described for managing settings for an activity-enabled application.",APPLE INC,ZHANG YU;;ABBASIAN REZA;;ADLER DORON;;CHEN ALVIN;;COFFMAN PATRICK L;;DOHERTY NIRANJAN S;;DUBOIS DANIEL J;;ETZEL CHRISTOPHER B;;FALKENBURG STEVEN;;FEDERIGHI CRAIG M;;FERRY KAREN A A;;FOSS CHRISTOPHER PATRICK;;GARABALLI SAM H;;GOLDBERG BRIAN E;;KHAN NAWAZ A;;KO HEENA;;KOWALCZYKOWSKI KEVIN P;;MEHRA RAJDEEP;;PAUL GRANT;;RAMASWAMY PRASANNA;;RICCI GIOVANNI;;ROBBIN JEFFREY L;;SAVAGE JOHN S;;SIBSON MICHAEL;;SINGH GURPREET;;STACK CAELAN G;;XUE MINGZHE M;;YIN LUMING;;YING CHANGHAN HOBIE;;ZHANG HENGLIANG;;ZHANG XIAOYUE;;A C DAY,,https://lens.org/003-912-882-819-30X,Patent Application,no,0,0,27,37,0,G06F3/04817;;G06F3/0488;;G06F8/61;;G06F9/445;;H04M1/72472;;G06F9/451;;G06F8/61;;G06F9/44568;;G06F9/52;;G06F9/54;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F8/38;;H04L67/34;;H04L67/5651,G06F3/0481;;G06F3/0488;;G06F8/61;;G06F9/445,,0,0,,,,PENDING
609,AR,A1,AR 112415 A1,139-029-460-400-276,2019-10-23,2019,AR P180102345 A,2018-08-15,US 201762545836 P,2017-08-15,INHIBIDORES DE MCL-1 MACROCÍCLICOS Y MÉTODOS DE USO,"Agentes para el tratamiento de enfermedades y afecciones, incluido el cáncer. También se proporcionan composiciones farmacéuticas que comprenden compuestos de fórmula (1). Reivindicación 1: Un compuesto de fórmula (1) o una sal farmacéuticamente aceptable del mismo, en donde A² es CR², A³ es N, A⁴ es CR⁴ᵃ, y A⁶ es C; o A² es CR², A³ es N, A⁴ es O ó S, y A⁶ es C; o A² es CR², A³ es C, A⁴ es O ó S y A⁶ es C; o A² es N, A³ es C, A⁴ es O ó S y A⁶ es C; o A² es N, A³ es C, A⁴ es CR⁴ᵃ, y A⁶ es N; RA es hidrógeno, CH₃, halógeno, CN, CH₂F, CHF₂, o CF₃; X es O, o N(Rˣ²); en la que Rˣ² es hidrógeno, alquilo C₁₋₃, o ciclopropilo sin sustituir; Y es (CH₂)ₘ, -CH=CH-(CH₂)ₙ-, -(CH₂)ₚ-CH=CH-, o -(CH₂)q-CH=CH-(CH₂)ʳ-; en donde 0, 1, 2, ó 3 grupos CH₂ se reemplazan cada uno independientemente por O, N(Rʸᵃ), C(Rʸᵃ)(Rʸᵇ), C(O), NC(O)Rʸᵃ, o S(O)₂; m es 2, 3, 4 ó 5; n es 1, 2, ó 3; p es 1, 2, ó 3; q es 1 ó 2; y r es 1 ó 2; en donde la suma de q y r es 2 ó 3; Rʸᵃ, en cada caso, es independientemente hidrógeno, alquenilo C₂₋₆, alquinilo C₂₋₆, G¹, alquilo C₁₋₆, o haloalquilo C₁₋₆; en donde el alquenilo C₂₋₆, alquinilo C₂₋₆, alquilo C₁₋₆, y haloalquilo C₁₋₆ están opcionalmente sustituidos con 1 ó 2 sustituyentes seleccionados independientemente del grupo que consiste en oxo, -N(Rʸᵈ)(Rʸᵉ), G¹, -ORʸᶠ, -SRʸᵍ, -S(O)₂N(Rʸᵈ)(Rʸᵉ), y -S(O)₂-G¹; y Rʸᵇ es alquenilo C₂₋₆, alquinilo C₂₋₆, G¹, alquilo C₁₋₆, o haloalquilo C₁₋₆; en donde el alquenilo C₂₋₆, alquinilo C₂₋₆, alquilo C₁₋₆, y haloalquilo C₁₋₆ están opcionalmente sustituidos con 1 ó 2 sustituyentes seleccionados independientemente del grupo que consiste en oxo, -N(Rʸᵈ)(Rʸᵉ), G¹, -ORʸᶠ, -SRʸᵍ, -S(O)₂N(Rʸᵈ)(Rʸᵉ), y -S(O)₂-G¹; o Rʸᵃ y Rʸᵇ, junto con el átomo de carbono al que están unidos, forman un cicloalquilo C₃₋₇ monocíclico, cicloalquenilo C₄₋₇ monocíclico, o un heterociclo monocíclico de 4 - 7 miembros; en donde el cicloalquilo C₃₋₇ monocíclico, cicloalquenilo C₄₋₇ monocíclico, y el heterociclo monocíclico de 4 - 7 miembros están cada uno opcionalmente sustituidos con 1 -ORᵐ y 0, 1, 2, ó 3 grupos Rˢ seleccionados independientemente; Rʸᵈ, Rʸᵉ, Rʸᶠ, y Rʸᵍ, en cada caso, son cada uno independientemente hidrógeno, G¹, alquilo C₁₋₆, o haloalquilo C₁₋₆; en donde el alquilo C₁₋₆ y el haloalquilo C₁₋₆ están opcionalmente sustituidos con un sustituyente seleccionado del grupo que consiste en G¹, -ORʸʰ, -SRʸʰ, -SO₂Rʸʰ, y -N(Rʸⁱ)(Rʸᵏ); G¹, en cada caso, es piperazinilo, piperidinilo, pirrolidinilo, tiomorfolinilo, tetrahidropiranilo, morfolinilo, u oxetanilo; en donde cada G¹ está opcionalmente sustituido con 1 -ORᵐ y 0, 1, 2, ó 3 sustituyentes seleccionados independientemente del grupo que consiste en G², -(alquilenil C₁₋₂)-G², y Rˢ; G², en cada caso, es un cicloalquilo C₃₋₇ monocíclico, cicloalquenilo C₄₋₇ monocíclico, oxetanilo, o morfolinilo; en donde cada G² está opcionalmente sustituido con 1 grupos Rᵗ seleccionados independientemente; R² es independientemente hidrógeno, halógeno, CH₃, o CN; R⁴ᵃ, en cada caso, es independientemente hidrógeno, halógeno, CN, alquenilo C₂₋₄, alquinilo C₂₋₄, alquilo C₁₋₄, haloalquilo C₁₋₄, GA, alquil C₁₋₄-GA, o alquil C₁₋₄-O-GA; en donde cada GA es independientemente arilo C₆₋₁₀, cicloalquilo C₃₋₇ monocíclico, cicloalquenilo C₄₋₇ monocíclico, o heterociclo de 4 - 7 miembros; en donde cada GA está sustituido opcionalmente con 1, 2, ó 3 grupos Rᵘ; R⁵ es independientemente hidrógeno, halógeno, G³, alquilo C₁₋₆, alquenilo C₂₋₆, o alquinilo C₂₋₆; en donde el alquilo C₁₋₆, alquenilo C₂₋₆, y alquinilo C₂₋₆ están cada uno opcionalmente sustituidos con un -ORᵐ o G³; G³, en cada caso, es independientemente arilo C₆₋₁₁ heteroarilo de 5 - 11 miembros, cicloalquilo C₃₋₁₁, cicloalquenilo C₄₋₁₁, oxetanilo, o 2-oxaespiro[3.3]heptanilo; en donde cada G³ está sustituido opcionalmente con 1, 2, ó 3 grupos Rᵛ; A⁷ es N o CR⁷; A⁸ es N O CR⁸; A¹⁵ es N o CR¹⁵; R⁷, R¹²; R¹⁶ son cada uno independientemente hidrógeno, halógeno, alquilo C₁₋₄, haloalquilo C₁₋₄, -CN, -OR⁷ᵃ, -SR⁷ᵃ, o -N(R⁷ᵇ)(R⁷ᶜ); R⁸, R¹³, R¹⁴, y R¹⁵ son cada uno independientemente hidrógeno, halógeno, alquilo C₁₋₄, haloalquilo C₁₋₄, -CN, -OR⁸ᵃ, -SR⁸ᵃ, -N(R⁸ᵇ)(R⁸ᶜ), o cicloalquilo C₃₋₄ monocíclico; en donde el cicloalquilo C₃₋₄ monocíclico está opcionalmente sustituido con uno o dos sustituyentes seleccionados independientemente del grupo que consiste en halógeno, alquilo C₁₋₃, y haloalquilo C₁₋₃; o R⁸ y R¹³ son cada uno independientemente hidrógeno, halógeno, alquilo C₁₋₄, haloalquilo C₁₋₄, -CN, OR⁸ᵃ, -SR⁸ᵃ, -N(R⁸ᵇ)(R⁸ᶜ), o cicloalquilo C₃₋₄ monocíclico; en donde el cicloalquilo C₃₋₄ monocíclico está opcionalmente sustituido con uno o dos sustituyentes seleccionados independientemente del grupo que consiste en halógeno, alquilo C₁₋₃, y haloalquilo C₁₋₃; y R¹⁴ y R¹⁵, junto con los átomos de carbono a los que están unidos, forman un anillo monocíclico seleccionado del grupo que consiste en benceno, ciclobutano, ciclopentano, y piridina; en donde el anillo monocíclico está opcionalmente sustituido con 1, 2, ó 3 sustituyentes seleccionados independientemente del grupo que consiste en halógeno, alquilo C₁₋₄, haloalquilo C₁₋₄, -CN, -OR⁸ᵃ, -SR⁸ᵃ, y -N(R⁸ᵇ)(R⁸ᶜ); R⁹ es -OH, -O-alquilo C₁₋₄, -O-CH₂-OC(O)(alquilo C₁₋₆), -NHOH, un resto de la fórmula (2); o -N(H)S(O)₂-(alquilo C₁₋₆); R¹⁰A y R¹⁰B, son cada uno independientemente hidrógeno, alquilo C₁₋₃, o haloalquilo C₁₋₃; o R¹⁰A y R¹⁰B, junto con el átomo de carbono al que están unidos, forman un ciclopropilo; en donde el ciclopropilo está opcionalmente sustituido con uno o dos sustituyentes seleccionados independientemente del grupo que consiste en halógeno y CH₃; W es -CH=CH-, alquilo C₁₋₄, -O-CHF-, -L¹-CH₂-, o -CH₂-L¹-; en donde L¹ en cada caso, es independientemente O, S, S(O), S(O)₂, S(O)₂N(H), N(H), O N(alquilo C₁₋₃); R¹¹ es un arilo C₆₋₁₀ o un heteroarilo de 5 - 11 miembros; en donde cada R¹¹ está opcionalmente sustituido con 1, 2, ó 3 grupos Rʷ seleccionados independientemente; Rʷ, en cada caso, es independientemente alquilo C₁₋₆, alquenilo C₂₋₆, alquinilo C₂₋₆, halógeno, haloalquilo C₁₋₆, -CN, NO₂, -OR¹¹ᵃ, -SR¹¹ᵇ, -S(O)₂R¹¹ᵇ, -S(O)₂N(R¹¹ᶜ)₂, -C(O)R¹¹ᵃ, -C(O)N(R¹¹ᶜ)₂, -N(R¹¹ᶜ)₂, -N(R¹¹ᶜ)C(O)R¹¹ᵇ, -N(R¹¹ᶜ)S(O)₂R¹¹ᵇ, -N(R¹¹ᶜ)C(O)O(R¹¹ᵇ), -N(R¹¹ᶜ)C(O)N(R¹¹ᶜ)₂, G⁴, -(alquilenil C₁₋₆)-OR¹¹ᵃ, -(alquilenil C₁₋₆)-OC(O)N(R¹¹ᶜ)₂, -(alquilenil C₁₋₆)-SR¹¹ᵃ, -(alquilenil C₁₋₆)-S(O)₂R¹¹ᵇ, -(alquilenil C₁₋₆)-S(O)₂N(R¹¹ᶜ)₂, -(alquilenil C₁₋₆)-C(O)R¹¹ᵃ, -(alquilenil C₁₋₆)-C(O)N(R¹¹ᶜ)₂, -(alquilenil C₁₋₆)-N(R¹¹ᶜ)₂, -(alquilenil C₁₋₆)-N(R¹¹ᶜ)C(O)R¹¹ᵇ, -(alquilenil C₁₋₆)-N(R¹¹ᶜ)S(O)₂R¹¹ᵇ, -(alquilenil C₁₋₆)-N(R¹¹ᶜ)C(O)O(R¹¹ᵇ), -(alquilenil C₁₋₆)-N(R¹¹ᶜ)C(O)N(R¹¹ᶜ)₂, -(alquilenil C₁₋₆)-CN, o -(alquilenil C₁₋₆)-G⁴; R¹¹ᵃ y R¹¹ᶜ, en cada caso, son cada uno independientemente hidrógeno, alquilo C₁₋₆, alquenilo C₂₋₆, haloalquilo C₁₋₆, G⁴, -(alquilenil C₁₋₆)-OR¹¹ᵈ, -(alquilenil C₂₋₆)-N(R¹¹ᵉ)₂, O-(alquilenil C₂₋₆)-G⁴; R¹¹ᵇ, en cada caso, es independientemente alquilo C₁₋₆, alquenilo C₂₋₆ haloalquilo C₁₋₆, G⁴, -(alquilenil C₂₋₆)-OR¹¹ᵈ, -(alquilenil C₂₋₆)-N(R¹¹ᵉ)₂, O-(alquilenil C₂₋₆)-G⁴; G⁴, en cada caso, es independientemente fenilo, heteroarilo monocíclico, cicloalquilo C₃₋₁₁, cicloalquenilo C₄₋₁₁, oxetanilo, tetrahidrofuranilo, tetrahidropiranilo, morfolinilo, 2,6-dioxa-9-azaespiro[4.5]decanilo, 2-oxa-5-azabiciclo[2.2.1]heptanilo, 3-oxa-8-azabiciclo[3.2.1]octanilo, piperazinilo, piperidinilo, azetidinilo, dihidropiranilo, tetrahidropiridinilo, dihidropirrolilo, o pirrolidinilo; en donde cada G⁴ está opcionalmente sustituido con 1 -ORᵐ y 0, 1, 2, 3, ó 4 sustituyentes seleccionados independientemente del grupo que consiste en G⁵, Rʸ, -(alquilenil C₁₋₆)-G⁵, y -L²-(alquilenil C₁₋₆)ₛ-G⁵; L² es O, C(O), N(H), N(alquilo C₁₋₆), NHC(O), C(O)O, S, S(O), o S(O)₂; s es 0 ó 1; G⁵, en cada caso, es independientemente fenilo, heteroarilo monocíclico, cicloalquilo C₃₋₇ monocíclico, cicloalquenilo C₄₋₇ monocíclico, o piperazina; en donde cada G⁵ está opcionalmente sustituido con 1 grupo -ORᵐ o Rᶻ seleccionado independientemente; Rˢ, Rᵗ, Rᵘ, Rᵛ, Rʸ y Rᶻ, en cada caso, son cada uno independientemente alquilo C₁₋₆, alquenilo C₂₋₆, alquinilo C₂₋₆, halógeno, haloalquilo C₁₋₆, -CN, oxo, NO₂, P(O)(Rᵏ)₂, -OC(O)Rᵏ, -OC(O)N(Rʲ)₂, -SRʲ, -S(O)₂Rᵏ, -S(O)₂N(Rʲ)₂, -C(O)Rʲ, -C(O)N(Rʲ)₂, -N(Rʲ)₂, -N(Rʲ)C(O)Rᵏ, -N(Rʲ)S(O)₂Rᵏ, -N(Rʲ)C(O)ₒ(Rᵏ), -N(Rʲ)C(O)N(Rʲ)₂, -(alquilenil C₁₋₆)-ORʲ, -(alquilenil C₁₋₆)-OC(O)N(Rʲ)₂, -(alquilenil C₁₋₆)-SRʲ, -(alquilenil C₁₋₆)-S(O)₂Rᵏ, -(alquilenil C₁₋₆)-S(O)₂N(Rʲ)₂, -(alquilenil C₁₋₆)-C(O)Rʲ, -(alquilenil C₁₋₆)-C(O)N(Rʲ)₂, -(alquilenil C₁₋₆)-N(Rʲ)₂, -(alquilenil C₁₋₆)-N(Rʲ)C(O)Rᵏ, -(alquilenil C₁₋₆)-N(Rʲ)S(O)₂Rᵏ, -(alquilenil C₁₋₆)-N(Rʲ)C(O)O(Rᵏ), -(alquilenil C₁₋₆)-N(Rʲ)C(O)N(Rʲ)₂, o -(alquilenil C₁₋₆)-CN; Rᵐ es hidrógeno, alquilo C₁₋₆, haloalquilo C₁₋₆, -(alquilenil C₂₋₆)-ORʲ, o -(alquilenil C₂₋₆)-N(Rʲ)₂; Rʸʰ, Rʸⁱ, Rʸᵏ, R⁷ᵃ, R⁷ᵇ, R⁷ᶜ, R⁸ᵃ, R⁸ᵇ, R⁸ᶜ, R¹¹ᵈ, R¹¹ᵉ, y Rʲ, en cada caso, son cada uno independientemente hidrógeno, alquilo C₁₋₆, -(alquilenil C₁₋₆)-ORᵏ, o haloalquilo C₁₋₆; y Rᵏ, en cada caso, es independientemente alquilo C₁₋₆ o haloalquilo C₁₋₆.",ABBVIE INC;;ABBVIE DEUTSCHLAND,YU YIYUN;;PENNIG THOMAS D;;POHLKI FRAUKE;;GUILLIER FABRICE;;POTIN DOMINIQUE;;KLING ANDREAS;;DOHERTY GEORGE;;TAO ZHI;;FU - DAI YUJIA;;WANG XILU;;SONG XIAOHONG;;BRAJE WILFRIED;;RISI ROBERTO;;BRADY PATRICK;;WENDT MICHAEL D;;JANTOS KATJA;;TESKE JESSE A;;GONG JANE;;ZHU GUI;;DONG - SULLIVAN GERARD M;;LAI CHUNQIU;;JI CHENG;;MASTRACCHIO ANTHONY;;SOUERS ANDREW J;;JUDD ANDREW S;;KUNZER AARON R,,https://lens.org/139-029-460-400-276,Patent Application,no,0,0,1,25,0,,C07D515/22;;A61K31/395;;A61P35/00,,0,0,,,,PENDING
610,CA,A1,CA 3114778 A1,015-614-051-615-509,2020-04-09,2020,CA 3114778 A,2019-10-04,US 201862741756 P;;US 201962862174 P;;US 2019/0054599 W,2018-10-05,SYSTEMS AND METHODS FOR ALLERGEN DETECTION,"The present disclosure is drawn to devices and systems for target detection in samples, particularly allergen detection in food samples. The allergen detection system includes a sampler, a disposable analysis cartridge and a detection device with an optimized optical system. The allergen detection utilizes nucleic acid molecules as detection agents and detection probes.",DOTS TECH CORP,GILBOA-GEFFEN ADI;;WEEKS ALAN LLOYD;;VILLAREAL VALERIE;;MURPHY PATRICK;;ROBERTSON ERIC ANTHONY;;DAY DEIRDRE ELLEN;;DEAN MATTHEW BERNARD;;CAMPBELL TODD GLENDON;;BURKE BRIAN CHRISTOPHER;;SMITH TYLER S;;HARTNER THOMAS CHRISTOPHER;;THOMPSON STANLEY OWEN;;TRINH NHAT NAM;;CARPENTER DAVID;;KINTZ GREGORY J;;KOH PAUL;;DOSTAL DAVID JENNINGS;;DOHERTY KEVIN;;JENSEN JOEL F;;LAW WILLIAM;;MEAD RUSSELL C;;ALCORTA J EFRAIN,,https://lens.org/015-614-051-615-509,Patent Application,no,0,0,7,7,0,G01N21/6428;;G01N2021/6439;;G01N21/6456;;G01N2201/0221;;B01L3/502;;B01L2400/0644;;B01L2400/0487;;B01L2400/049;;B01L2300/0809;;B01L2200/10;;B01L2300/0867;;B01L2300/0681;;B01L2300/0654;;C12Q1/6837;;B01L3/502;;B01L2200/025;;B01L2200/026;;B01L2200/04;;B01L2200/0689;;B01L2200/10;;B01L2200/16;;B01L2300/025;;B01L2300/04;;B01L2300/0609;;B01L2300/0663;;B01L2300/0681;;B01L2300/087;;B01L2300/1822;;B01L2300/1827;;B01L2400/0622;;B01L2400/0644;;G01N21/6428;;G01N21/6456;;G01N2021/6439,B01L3/00;;C12N15/10;;G01N21/29;;G01N30/96;;G01N33/53;;G02B6/42;;G06T1/00,,0,0,,,,PENDING
611,UY,A,UY 37842 A,006-960-642-501-445,2019-03-29,2019,UY 37842 A,2018-08-15,US 201762545836 P;;US 201762555470 P,2017-08-15,INHIBIDORES DE MCL-1 MACROCÍCLICOS Y MÉTODOS DE USO,"La presente divulgación proporciona compuestos de Fórmula (I) ,en donde A2, A3, A4, A6, A7, A8, A15, RA, R5, R9, R10A, R10B, R11, R12, R13, R14, R16, W, X, e Y tienen cualquiera de los valores definidos en la memoria descriptiva, y sales farmacéuticamente aceptables de los mismos, que sean útiles como agentes para el tratamiento de enfermedades y afecciones, incluido el cáncer. También se proporcionan composiciones farmacéuticas que comprenden compuestos de Fórmula (I).",ABBVIE INC;;ABBVIE DEUTSCHLAND,POTIN DOMINIQUE;;AARON R KUNZER;;ANDREW S JUDD;;ANDREW J SOUERS;;MASTRACCHIO ANTHONY;;JI CHENG;;LAI CHUNQIU;;GERARD M SULLIVAN;;GUI-DONG ZHU;;GONG JANE;;JESSE A TESKE;;MICHAEL D WENDT;;BRADY PATRICK;;RISI ROBERTO;;BRAJE WILFRIED;;SONG XIAOHONG;;ZHI-FU TAO;;DOHERTY GEORGE;;GUILLIER FABRICE;;POHLKI FRAUKE;;THOMAS D PENNIG;;YU YIYUN;;KLING ANDREAS;;JANTOS KATJA;;DAI YUJIA;;WANG XILU,,https://lens.org/006-960-642-501-445,Patent Application,no,0,0,24,25,0,C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;C07D498/18;;A61P35/00;;C07D519/00;;C07D495/18;;C07D495/16;;A61K31/519;;C07D491/16;;C07D498/16,A61P35/00;;A61K31/337;;A61K31/496;;A61K31/506;;A61K31/519;;A61K31/5377;;C07D401/14;;C07D403/14;;C07D407/14;;C07D413/14;;C07D471/04;;C07D491/16;;C07D495/04;;C07D498/10;;C07D515/18,,0,0,,,,DISCONTINUED
612,WO,A1,WO 2020/072843 A1,007-010-422-008-410,2020-04-09,2020,US 2019/0054599 W,2019-10-04,US 201862741756 P;;US 201962862174 P,2018-10-05,SYSTEMS AND METHODS FOR ALLERGEN DETECTION,"The present disclosure is drawn to devices and systems for target detection in samples, particularly allergen detection in food samples. The allergen detection system includes a sampler, a disposable analysis cartridge and a detection device with an optimized optical system. The allergen detection utilizes nucleic acid molecules as detection agents and detection probes.",DOTS TECH CORP,GILBOA-GEFFEN ADI;;WEEKS ALAN LLOYD;;VILLAREAL VALERIE;;MURPHY PATRICK;;ROBERTSON ERIC ANTHONY;;DAY DEIRDRE ELLEN;;DEAN MATTHEW BERNARD;;CAMPBELL TODD GLENDON;;BURKE BRIAN CHRISTOPHER;;SMITH TYLER S;;HARTNER THOMAS CHRISTOPHER;;THOMPSON STANLEY OWEN;;TRINH NHAT NAM;;CARPENTER DAVID;;KINTZ GREGORY J;;KOH PAUL;;DOSTAL DAVID JENNINGS;;DOHERTY KEVIN;;JENSEN JOEL F;;LAW WILLIAM;;MEAD RUSSELL C;;ALCORTA J EFRAÍN,,https://lens.org/007-010-422-008-410,Patent Application,yes,7,1,7,7,0,G01N21/6428;;G01N2021/6439;;G01N21/6456;;G01N2201/0221;;B01L3/502;;B01L2400/0644;;B01L2400/0487;;B01L2400/049;;B01L2300/0809;;B01L2200/10;;B01L2300/0867;;B01L2300/0681;;B01L2300/0654;;C12Q1/6837;;B01L3/502;;B01L2200/025;;B01L2200/026;;B01L2200/04;;B01L2200/0689;;B01L2200/10;;B01L2200/16;;B01L2300/025;;B01L2300/04;;B01L2300/0609;;B01L2300/0663;;B01L2300/0681;;B01L2300/087;;B01L2300/1822;;B01L2300/1827;;B01L2400/0622;;B01L2400/0644;;G01N21/6428;;G01N21/6456;;G01N2021/6439,B01L3/00;;C12N15/10;;G01N21/29;;G01N30/96;;G01N33/53;;G02B6/42;;G06T1/00,,1,0,,,See also references of EP 3860760A4,PENDING
613,US,A1,US 2021/0389245 A1,050-036-620-319-134,2021-12-16,2021,US 201917282807 A,2019-10-04,US 201917282807 A;;US 201962862174 P;;US 201862741756 P;;US 2019/0054599 W,2018-10-05,SYSTEMS AND METHODS FOR ALLERGEN DETECTION,"The present disclosure is drawn to devices and systems for target detection in samples, particularly allergen detection in food samples. The allergen detection system includes a sampler, a disposable analysis cartridge and a detection device with an optimized optical system. The allergen detection utilizes nucleic acid molecules as detection agents and detection probes.",DOTS TECH CORP,GILBOA-GEFFEN ADI;;WEEKS ALAN LLOYD;;VILLAREAL VALERIE;;MURPHY PATRICK;;ROBERTSON ERIC ANTHONY;;DAY DEIRDRE ELLEN;;DEAN MATTHEW BERNARD;;CAMPBELL TODD GLENDON;;BURKE BRIAN CHRISTOPHER;;SMITH TYLER S;;HARTNER THOMAS CHRISTOPHER;;THOMPSON STANLEY OWEN;;TRINH NHAT NAM;;CARPENTER DAVID;;KINTZ GREGORY J;;KOH PAUL;;DOSTAL DAVID JENNINGS;;DOHERTY KEVIN;;JENSEN JOEL F;;LAW WILLIAM;;MEAD JR RUSSELL C;;ALCORTA J EFRAÍN,DOTS TECHNOLOGY CORP (2020-01-31);;MOUNT MITCHELL OPTICS (2020-01-31);;FUNCTION ENGINEERING INC (2020-01-31),https://lens.org/050-036-620-319-134,Patent Application,yes,1,1,7,7,0,G01N21/6428;;G01N2021/6439;;G01N21/6456;;G01N2201/0221;;B01L3/502;;B01L2400/0644;;B01L2400/0487;;B01L2400/049;;B01L2300/0809;;B01L2200/10;;B01L2300/0867;;B01L2300/0681;;B01L2300/0654;;C12Q1/6837;;B01L3/502;;B01L2200/025;;B01L2200/026;;B01L2200/04;;B01L2200/0689;;B01L2200/10;;B01L2200/16;;B01L2300/025;;B01L2300/04;;B01L2300/0609;;B01L2300/0663;;B01L2300/0681;;B01L2300/087;;B01L2300/1822;;B01L2300/1827;;B01L2400/0622;;B01L2400/0644;;G01N21/6428;;G01N21/6456;;G01N2021/6439,G01N21/64;;B01L3/00,,0,0,,,,PENDING
614,US,A1,US 2021/0318893 A1,167-783-429-684-59X,2021-10-14,2021,US 202017030804 A,2020-09-24,US 202017030804 A;;US 202063032970 P;;US 202063022869 P;;US 202063008586 P,2020-04-10,USER INTERFACES FOR ENABLING AN ACTIVITY,"The present disclosure generally relates to user interfaces for enabling an activity using a computer system. In some embodiments, exemplary user interfaces for invoking an activity associated with an application are described. In some embodiments, exemplary user interfaces for customizing displayed content based on circumstances under which the content was invoked are described. In some embodiments, exemplary user interfaces for managing applications that were used to enable activities are described. In some embodiments, exemplary user interfaces for managing settings for applications used to enable activities are described.",APPLE INC,ZHANG YONGJUN;;ABBASIAN REZA;;ADLER DARIN;;CHAN ADA;;DUBOIS DANA J;;FALKENBURG STEVEN;;FEDERIGHI CRAIG M;;FERRY KENNETH ARTHUR ABRAHAM;;FOSS CHRISTOPHER PATRICK;;GHARABALLY SAM H;;GOLDBERG BRIAN ERIK;;DOHERTY NICHOLAS;;KO HEENA;;KOWALCYKOWSKI KEITH;;PAUL GRANT;;ROBBIN JEFFREY L;;SAVAGE JAMES S;;SIBSON MATTHEW;;SINGH GURSHAMNJOT;;STACK CAELAN G;;YIN LUMING;;YING CHARLES H;;XUE MARK M;;ZHANG HENGLIANG;;ZHANG SELINA,APPLE INC (2021-09-06),https://lens.org/167-783-429-684-59X,Patent Application,yes,0,8,10,37,0,G06F3/048;;G06F21/00;;H04M1/00;;H04W4/00;;H04L67/34;;G06F3/0488;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F9/451;;G06F3/04817;;G06F8/38;;G06F3/04842;;G06F3/0488;;G06F9/44568;;G06F9/54;;H04L67/34;;H04L67/5651,G06F9/445;;G06F3/0488;;G06F9/54;;H04L29/08,,0,0,,,,ACTIVE
615,DK,A1,DK 202070634 A1,056-544-296-276-96X,2021-11-12,2021,DK PA202070634 A,2020-09-23,US 202063008586 P;;US 202063022869 P;;US 202063032970 P,2020-04-10,USER INTERFACES FOR ENABLING AN ACTIVITY,"The present disclosure generally relates to user interfaces for enabling an activity using a computer system. In some embodiments, exemplary user interfaces for invoking an activity associated with an application are described. In some embodiments, exemplary user interfaces for customizing displayed content based on circumstances under which the content was invoked are described. In some embodiments, exemplary user interfaces for managing applications that were used to enable activities are described. In some embodiments, exemplary user interfaces for managing settings for applications used to enable activities are described.",APPLE INC,YONGJUN ZHANG;;REZA ABBASIAN;;DARIN ADLER;;ADA CHAN;;DANA J DUBOIS;;CHARLES B ETZEL;;KENNETH ARTHUR ABRAHAM FERRY;;STEVEN FALKENBURG;;CRAIG M FEDERIGHI;;CHRISTOPHER PATRICK FOSS;;SAM H GHARABALLY;;BRIAN ERIK GOLDBERG;;HEENA KO;;RISHAB MEHRA;;GRANT PAUL;;JEFFREY L ROBBIN;;JAMES S SAVAGE;;MATTHEW SIBSON;;SHAMAN SINGH;;CAELAN G STACK;;LUMING YIN;;CHARLES H YING;;MARK M XUE;;HENGLIANG ZHANG;;NICHOLAS STEPHEN DOHERTY;;NAHIR A KHAN;;KEITH P KOWALCZYKOWSKI;;PALLAVIKA RAMASWAMY;;XIAOYUE ZHANG,,https://lens.org/056-544-296-276-96X,Unknown,no,0,0,10,37,0,G06F3/048;;G06F21/00;;H04M1/00;;H04W4/00;;H04L67/34;;G06F3/0488;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F9/451;;G06F3/04817;;G06F8/38;;G06F3/04842;;G06F3/0488;;G06F9/44568;;G06F9/54;;H04L67/34;;H04L67/5651,H04W4/00;;G06F3/048;;G06F21/00;;H04M1/00,,0,0,,,,ACTIVE
616,AU,B2,AU 2020/239759 B2,094-073-737-764-02X,2022-01-27,2022,AU 2020/239759 A,2020-09-24,DK PA202070634 A;;US 202063008586 P;;US 202063022869 P;;DK PA202070633 A;;US 202063032970 P,2020-04-10,User interfaces for enabling an activity,"The present disclosure generally relates to user interfaces for enabling an activity using a computer system. In some embodiments, exemplary user interfaces for invoking an activity associated with an application are described. In some embodiments, exemplary user interfaces for customizing displayed content based on circumstances under which the content was invoked are described. In some embodiments, exemplary user interfaces for managing applications that were used to enable activities are described. In some embodiments, exemplary user interfaces for managing settings for applications used to enable activities are described. N -y 7cr - -42 - ~ C 3* o A~ 0 -G",APPLE INC,ZHANG YONGJUN;;ABBASIAN REZA;;ADLER DARIN;;CHAN ADA;;DUBOIS DANA J;;ETZEL CHARLES B;;FERRY KENNETH ARTHUR ABRAHAM;;FALKENBURG STEVEN;;FEDERIGHI CRAIG M;;FOSS CHRISTOPHER PATRICK;;GHARABALLY SAM H;;GOLDBERG BRIAN ERIK;;DOHERTY NICHOLAS STEPHEN;;KHAN NAHIR A;;KO HEENA;;KOWALCZYKOWSKI KEITH P;;MEHRA RISHAB;;PAUL GRANT;;RAMASWAMY PALLAVIKA;;ROBBIN JEFFREY L;;SAVAGE JAMES S;;SIBSON MATTHEW;;SINGH SHAMAN;;STACK CAELAN G;;YIN LUMING;;YING CHARLES H;;XUE MARK M;;ZHANG HENGLIANG;;ZHANG XIAOYUE,,https://lens.org/094-073-737-764-02X,Granted Patent,no,2,0,27,37,0,G06F3/04817;;G06F3/0488;;G06F8/61;;G06F9/445;;H04M1/72472;;G06F9/451;;G06F8/61;;G06F9/44568;;G06F9/52;;G06F9/54;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F8/38;;H04L67/34;;H04L67/5651,G06F3/048;;G06F9/451,,0,0,,,,ACTIVE
617,AU,A1,AU 2020/239747 A1,144-513-324-520-287,2021-10-28,2021,AU 2020/239747 A,2020-09-24,DK PA202070633 A;;DK PA202070634 A;;US 202063008586 P;;US 202063022869 P;;US 202063032970 P,2020-04-10,User interfaces for enabling an activity,"The present disclosure generally relates to user interfaces for enabling an activity using a computer system. In some embodiments, exemplary user interfaces for invoking an activity associated with an application are described. In some embodiments, exemplary user interfaces for customizing displayed content based on circumstances under which the content was invoked are described. In some embodiments, exemplary user interfaces for managing applications that were used to enable activities are described. In some embodiments, exemplary user interfaces for managing settings for applications used to enable activities are described. /r r B>4 oo",APPLE INC,ZHANG YONGJUN;;ABBASIAN REZA;;ADLER DARIN;;CHAN ADA;;DUBOIS DANA J;;ETZEL CHARLES B;;FERRY KENNETH ARTHUR ABRAHAM;;FALKENBURG STEVEN;;FEDERIGHI CRAIG M;;FOSS CHRISTOPHER PATRICK;;GHARABALLY SAM H;;GOLDBERG BRIAN ERIK;;DOHERTY NICHOLAS STEPHEN;;KHAN NAHIR A;;KO HEENA;;KOWALCZYKOWSKI KEITH P;;MEHRA RISHAB;;PAUL GRANT;;RAMASWAMY PALLAVIKA;;ROBBIN JEFFREY L;;SAVAGE JAMES S;;SIBSON MATTHEW;;SINGH SHAMAN;;STACK CAELAN G;;YIN LUMING;;YING CHARLES H;;XUE MARK M;;ZHANG HENGLIANG;;ZHANG XIAOYUE,,https://lens.org/144-513-324-520-287,Patent Application,no,0,0,27,37,0,G06F3/04817;;G06F3/0488;;G06F8/61;;G06F9/445;;H04M1/72472;;G06F9/451;;G06F8/61;;G06F9/44568;;G06F9/52;;G06F9/54;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F8/38;;H04L67/34;;H04L67/5651,G06F3/048;;G06F9/06,,0,0,,,,ACTIVE
618,JP,A,JP 2021168103 A,104-710-327-417-711,2021-10-21,2021,JP 2020159956 A,2020-09-24,US 202063008586 P;;US 202063022869 P;;US 202063032970 P;;DK PA202070633 A;;DK PA202070634 A,2020-04-10,USER INTERFACE FOR ENABLING ACTIVITY,"To provide faster and more efficient methods and interfaces for enabling an activity.SOLUTION: User interfaces invoke an activity associated with an application. In some embodiments, the user interfaces customize displayed content based on circumstances under which the content was invoked, manage applications that were used to enable activities, and manage settings for applications used to enable activities.SELECTED DRAWING: Figure 7C",APPLE INC,ZHANG YONGJUN;;REZA ABBASIAN;;DARIN ADLER;;CHAN ADA;;DANA J DUBOIS;;CHARLES B ETZEL;;KENNETH ARTHUR ABRAHAM FERRY;;STEVEN FALKENBURG;;CRAIG M FEDERIGHI;;CHRISTOPHER PATRICK FOSS;;SAM H GHARABALLY;;BRIAN ERIK GOLDBERG;;NICHOLAS STEPHEN DOHERTY;;NAHIR A KHAN;;KO HEENA;;KEITH P KOWALCZYKOWSKI;;RISHAB MEHRA;;GRANT PAUL;;PALLAVIKA RAMASWAMY;;JEFFREY L ROBBIN;;JAMES S SAVAGE;;MATTHEW SIBSON;;SINGH SHAMAN;;CAELAN G STACK;;YIN LUMING;;CHARLES H YING;;MARK M XUE;;ZHANG HENGLIANG;;ZHANG XIAOYUE,,https://lens.org/104-710-327-417-711,Patent Application,no,7,0,27,37,0,G06F3/04817;;G06F3/0488;;G06F8/61;;G06F9/445;;H04M1/72472;;G06F9/451;;G06F8/61;;G06F9/44568;;G06F9/52;;G06F9/54;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F8/38;;H04L67/34;;H04L67/5651,G06F3/0481;;G06F3/0484,,0,0,,,,ACTIVE
619,AU,A1,AU 2020/239759 A1,187-032-254-129-217,2021-10-28,2021,AU 2020/239759 A,2020-09-24,DK PA202070634 A;;US 202063008586 P;;US 202063022869 P;;DK PA202070633 A;;US 202063032970 P,2020-04-10,User interfaces for enabling an activity,"The present disclosure generally relates to user interfaces for enabling an activity using a computer system. In some embodiments, exemplary user interfaces for invoking an activity associated with an application are described. In some embodiments, exemplary user interfaces for customizing displayed content based on circumstances under which the content was invoked are described. In some embodiments, exemplary user interfaces for managing applications that were used to enable activities are described. In some embodiments, exemplary user interfaces for managing settings for applications used to enable activities are described. N -y 7cr - -42 - ~ C 3* o A~ 0 -G",APPLE INC,ZHANG YONGJUN;;ABBASIAN REZA;;ADLER DARIN;;CHAN ADA;;DUBOIS DANA J;;ETZEL CHARLES B;;FERRY KENNETH ARTHUR ABRAHAM;;FALKENBURG STEVEN;;FEDERIGHI CRAIG M;;FOSS CHRISTOPHER PATRICK;;GHARABALLY SAM H;;GOLDBERG BRIAN ERIK;;DOHERTY NICHOLAS STEPHEN;;KHAN NAHIR A;;KO HEENA;;KOWALCZYKOWSKI KEITH P;;MEHRA RISHAB;;PAUL GRANT;;RAMASWAMY PALLAVIKA;;ROBBIN JEFFREY L;;SAVAGE JAMES S;;SIBSON MATTHEW;;SINGH SHAMAN;;STACK CAELAN G;;YIN LUMING;;YING CHARLES H;;XUE MARK M;;ZHANG HENGLIANG;;ZHANG XIAOYUE,,https://lens.org/187-032-254-129-217,Patent Application,no,0,0,27,37,0,G06F3/04817;;G06F3/0488;;G06F8/61;;G06F9/445;;H04M1/72472;;G06F9/451;;G06F8/61;;G06F9/44568;;G06F9/52;;G06F9/54;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F8/38;;H04L67/34;;H04L67/5651,G06F3/048;;G06F9/451,,0,0,,,,ACTIVE
620,KR,A,KR 20210126476 A,009-082-525-938-536,2021-10-20,2021,KR 20200123889 A,2020-09-24,US 202063008586 P;;US 202063022869 P;;US 202063032970 P;;DK PA202070633 A;;DK PA202070634 A,2020-04-10,USER INTERFACES FOR ENABLING AN ACTIVITY,"The present disclosure generally relates to user interfaces for enabling an activity using a computer system. In some embodiments, exemplary user interfaces for invoking an activity associated with an application are described. In some embodiments, exemplary user interfaces for customizing displayed content based on circumstances under which the content was invoked are described. In some embodiments, exemplary user interfaces for managing applications which were used to enable activities are described. In some embodiments, exemplary user interfaces for managing settings for applications used to enable activities are described.",APPLE INC,ZHANG YONGJUN;;ABBASIAN REZA;;ADLER DARIN;;CHAN ADA;;DUBOIS DANA J;;ETZEL CHARLES B;;FERRY KENNETH ARTHUR ABRAHAM;;FALKENBURG STEVEN;;FEDERIGHI CRAIG M;;FOSS CHRISTOPHER PATRICK;;GHARABALLY SAM H;;GOLDBERG BRIAN ERIK;;DOHERTY NICHOLAS STEPHEN;;KHAN NAHIR A;;KO HEENA;;KOWALCZYKOWSKI KEITH P;;MEHRA RISHAB;;PAUL GRANT;;RAMASWAMY PALLAVIKA;;ROBBIN JEFFREY L;;SAVAGE JAMES S;;SIBSON MATTHEW;;SINGH SHAMAN;;STACK CAELAN G;;YIN LUMING;;YING CHARLES H;;XUE MARK M;;ZHANG HENGLIANG;;ZHANG XIAOYUE,,https://lens.org/009-082-525-938-536,Patent Application,no,4,0,27,37,0,G06F3/04817;;G06F3/0488;;G06F8/61;;G06F9/445;;H04M1/72472;;G06F9/451;;G06F8/61;;G06F9/44568;;G06F9/52;;G06F9/54;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F8/38;;H04L67/34;;H04L67/5651,G06F9/451;;G06F3/041;;G06F3/048;;G06F3/14;;G06F8/61;;G06F9/445,,0,0,,,,ACTIVE
621,AU,B2,AU 2020/239747 B2,163-192-893-166-307,2021-11-04,2021,AU 2020/239747 A,2020-09-24,DK PA202070633 A;;DK PA202070634 A;;US 202063008586 P;;US 202063022869 P;;US 202063032970 P,2020-04-10,User interfaces for enabling an activity,"The present disclosure generally relates to user interfaces for enabling an activity using a computer system. In some embodiments, exemplary user interfaces for invoking an activity associated with an application are described. In some embodiments, exemplary user interfaces for customizing displayed content based on circumstances under which the content was invoked are described. In some embodiments, exemplary user interfaces for managing applications that were used to enable activities are described. In some embodiments, exemplary user interfaces for managing settings for applications used to enable activities are described. /r r B>4 oo",APPLE INC,ZHANG YONGJUN;;ABBASIAN REZA;;ADLER DARIN;;CHAN ADA;;DUBOIS DANA J;;ETZEL CHARLES B;;FERRY KENNETH ARTHUR ABRAHAM;;FALKENBURG STEVEN;;FEDERIGHI CRAIG M;;FOSS CHRISTOPHER PATRICK;;GHARABALLY SAM H;;GOLDBERG BRIAN ERIK;;DOHERTY NICHOLAS STEPHEN;;KHAN NAHIR A;;KO HEENA;;KOWALCZYKOWSKI KEITH P;;MEHRA RISHAB;;PAUL GRANT;;RAMASWAMY PALLAVIKA;;ROBBIN JEFFREY L;;SAVAGE JAMES S;;SIBSON MATTHEW;;SINGH SHAMAN;;STACK CAELAN G;;YIN LUMING;;YING CHARLES H;;XUE MARK M;;ZHANG HENGLIANG;;ZHANG XIAOYUE,,https://lens.org/163-192-893-166-307,Granted Patent,no,2,0,27,37,0,G06F3/04817;;G06F3/0488;;G06F8/61;;G06F9/445;;H04M1/72472;;G06F9/451;;G06F8/61;;G06F9/44568;;G06F9/52;;G06F9/54;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F8/38;;H04L67/34;;H04L67/5651,G06F3/048;;G06F9/06,,0,0,,,,ACTIVE
622,JP,A,JP 2021168104 A,120-656-493-603-97X,2021-10-21,2021,JP 2020159957 A,2020-09-24,US 202063008586 P;;US 202063022869 P;;US 202063032970 P;;DK PA202070633 A;;DK PA202070634 A,2020-04-10,USER INTERFACE FOR ENABLING ACTIVITY,"To provide faster and more efficient methods and interfaces for enabling an activity.SOLUTION: User interfaces invoke an activity associated with an application, customize displayed content based on circumstances under which the content was invoked, manage applications that were used to enable activities, and manage settings for applications used to enable activities.SELECTED DRAWING: Figure 11M",APPLE INC,ZHANG YONGJUN;;REZA ABBASIAN;;DARIN ADLER;;CHAN ADA;;DANA J DUBOIS;;CHARLES B ETZEL;;KENNETH ARTHUR ABRAHAM FERRY;;STEVEN FALKENBURG;;CRAIG M FEDERIGHI;;CHRISTOPHER PATRICK FOSS;;SAM H GHARABALLY;;BRIAN ERIK GOLDBERG;;NICHOLAS STEPHEN DOHERTY;;NAHIR A KHAN;;KO HEENA;;KEITH P KOWALCZYKOWSKI;;RISHAB MEHRA;;GRANT PAUL;;PALLAVIKA RAMASWAMY;;JEFFREY L ROBBIN;;JAMES S SAVAGE;;MATTHEW SIBSON;;SINGH SHAMAN;;CAELAN G STACK;;YIN LUMING;;CHARLES H YING;;MARK M XUE;;ZHANG HENGLIANG;;ZHANG XIAOYUE,,https://lens.org/120-656-493-603-97X,Patent Application,no,6,0,27,37,0,G06F3/04817;;G06F3/0488;;G06F8/61;;G06F9/445;;H04M1/72472;;G06F9/451;;G06F8/61;;G06F9/44568;;G06F9/52;;G06F9/54;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F8/38;;H04L67/34;;H04L67/5651,G06F3/0484;;G06F3/0481,,0,0,,,,ACTIVE
623,DK,A1,DK 202070633 A1,150-425-774-124-596,2021-11-12,2021,DK PA202070633 A,2020-09-23,US 202063008586 P;;US 202063022869 P;;US 202063032970 P,2020-04-10,USER INTERFACES FOR ENABLING AN ACTIVITY,"The present disclosure generally relates to user interfaces for enabling an activity using a computer system. In some embodiments, exemplary user interfaces for invoking an activity associated with an application are described. In some embodiments, exemplary user interfaces for customizing displayed content based on circumstances under which the content was invoked are described. In some embodiments, exemplary user interfaces for managing applications that were used to enable activities are described. In some embodiments, exemplary user interfaces for managing settings for applications used to enable activities are described.",APPLE INC,YONGJUN ZHANG;;REZA ABBASIAN;;DARIN ADLER;;ADA CHAN;;DANA J DUBOIS;;CHARLES B ETZEL;;KENNETH ARTHUR ABRAHAM FERRY;;STEVEN FALKENBURG;;CRAIG M FEDERIGHI;;CHRISTOPHER PATRICK FOSS;;SAM H GHARABALLY;;BRIAN ERIK GOLDBERG;;HEENA KO;;RISHAB MEHRA;;GRANT PAUL;;JEFFREY L ROBBIN;;JAMES S SAVAGE;;MATTHEW SIBSON;;SHAMAN SINGH;;CAELAN G STACK;;LUMING YIN;;CHARLES H YING;;MARK M XUE;;HENGLIANG ZHANG;;NICHOLAS STEPHEN DOHERTY;;NAHIR A KHAN;;KEITH P KOWALCZYKOWSKI;;PALLAVIKA RAMASWAMY;;XIAOYUE ZHANG,,https://lens.org/150-425-774-124-596,Unknown,no,0,0,10,37,0,G06F3/048;;G06F21/00;;H04M1/00;;H04W4/00;;H04L67/34;;G06F3/0488;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F9/451;;G06F3/04817;;G06F8/38;;G06F3/04842;;G06F3/0488;;G06F9/44568;;G06F9/54;;H04L67/34;;H04L67/5651,G06Q50/12;;G06Q30/06;;H04W4/021,,0,0,,,,DISCONTINUED
624,KR,A,KR 20210126475 A,033-245-385-309-802,2021-10-20,2021,KR 20200123866 A,2020-09-24,US 202063008586 P;;US 202063022869 P;;US 202063032970 P;;DK PA202070633 A;;DK PA202070634 A,2020-04-10,USER INTERFACES FOR ENABLING AN ACTIVITY,"This disclosure relates to generally to a user interface for enabling activity using a computer system. In some embodiments, exemplary user interfaces for invoking activity associated with application are described. In some embodiments, exemplary user interfaces are described for customizing displayed contents based on circumstances in which the contents were invoked. In some embodiments, exemplary user interfaces for managing the applications which were used to enable the activities are described. In some embodiments, exemplary user interfaces for managing settings for the application used to enable the activities are described.",APPLE INC,ZHANG YONGJUN;;ABBASIAN REZA;;ADLER DARIN;;CHAN ADA;;DUBOIS DANA J;;ETZEL CHARLES B;;FERRY KENNETH ARTHUR ABRAHAM;;FALKENBURG STEVEN;;FEDERIGHI CRAIG M;;FOSS CHRISTOPHER PATRICK;;GHARABALLY SAM H;;GOLDBERG BRIAN ERIK;;DOHERTY NICHOLAS STEPHEN;;KHAN NAHIR A;;KO HEENA;;KOWALCZYKOWSKI KEITH P;;MEHRA RISHAB;;PAUL GRANT;;RAMASWAMY PALLAVIKA;;ROBBIN JEFFREY L;;SAVAGE JAMES S;;SIBSON MATTHEW;;SINGH SHAMAN;;STACK CAELAN G;;YIN LUMING;;YING CHARLES H;;XUE MARK M;;ZHANG HENGLIANG;;ZHANG XIAOYUE,,https://lens.org/033-245-385-309-802,Patent Application,no,4,0,27,37,0,G06F3/04817;;G06F3/0488;;G06F8/61;;G06F9/445;;H04M1/72472;;G06F9/451;;G06F8/61;;G06F9/44568;;G06F9/52;;G06F9/54;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F8/38;;H04L67/34;;H04L67/5651,G06F9/451;;G06F3/041;;G06F3/048;;G06F3/14;;G06F8/61;;G06F9/445,,0,0,,,,ACTIVE
625,WO,A4,WO 2021/206976 A4,162-219-308-057-11X,2022-01-06,2022,US 2021/0025051 W,2021-03-31,US 202063008586 P;;US 202063022869 P;;US 202063032970 P;;DK PA202070633 A;;DK PA202070634 A,2020-04-10,USER INTERFACES FOR ENABLING AN ACTIVITY,"The present disclosure generally relates to user interfaces for enabling an activity using a computer system. In some embodiments, exemplary user interfaces for invoking an activity associated with an application are described. In some embodiments, exemplary user interfaces for customizing displayed content based on circumstances under which the content was invoked are described. In some embodiments, exemplary user interfaces for managing applications that were used to enable activities are described. In some embodiments, exemplary user interfaces for managing settings for applications used to enable activities are described.",APPLE INC,ZHANG YONGJUN;;ABBASIAN REZA;;ADLER DARIN;;CHAN ADA;;DOHERTY NICHOLAS STEPHEN;;DUBOIS DANA J;;ETZEL CHARLES B;;FALKENBURG STEVEN;;FEDERIGHI CRAIG M;;FERRY KENNETH ARTHUR ABRAHAM;;FOSS CHRISTOPHER PATRICK;;GHARABALLY SAM H;;GOLDBERG BRIAN ERIK;;KHAN NAHIR A;;KO HEENA;;KOWALCZYKOWSKI KEITH P;;MEHRA RISHAB;;PAUL GRANT;;RAMASWAMY PALLAVIKA;;RITCHIE GRANT;;ROBBIN JEFFREY L;;SAVAGE JAMES S;;SIBSON MATTHEW;;SINGH GURSHAMNJOT;;STACK CAELAN G;;XUE MARK M;;YIN LUMING;;YING CHARLES H;;ZHANG HENGLIANG;;ZHANG XIAOYUE,,https://lens.org/162-219-308-057-11X,Patent Application,yes,0,0,27,37,0,G06F3/04817;;G06F3/0488;;G06F8/61;;G06F9/445;;H04M1/72472;;G06F9/451;;G06F8/61;;G06F9/44568;;G06F9/52;;G06F9/54;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F8/38;;H04L67/34;;H04L67/5651,G06F3/0481;;G06F3/0488;;G06F8/61;;G06F9/445,,0,0,,,,PENDING
626,WO,A1,WO 2021/206976 A1,129-832-370-218-26X,2021-10-14,2021,US 2021/0025051 W,2021-03-31,US 202063008586 P;;US 202063022869 P;;US 202063032970 P;;DK PA202070633 A;;DK PA202070634 A,2020-04-10,USER INTERFACES FOR ENABLING AN ACTIVITY,"The present disclosure generally relates to user interfaces for enabling an activity using a computer system. In some embodiments, exemplary user interfaces for invoking an activity associated with an application are described. In some embodiments, exemplary user interfaces for customizing displayed content based on circumstances under which the content was invoked are described. In some embodiments, exemplary user interfaces for managing applications that were used to enable activities are described. In some embodiments, exemplary user interfaces for managing settings for applications used to enable activities are described.",APPLE INC,ZHANG YONGJUN;;ABBASIAN REZA;;ADLER DARIN;;CHAN ADA;;DOHERTY NICHOLAS STEPHEN;;DUBOIS DANA J;;ETZEL CHARLES B;;FALKENBURG STEVEN;;FEDERIGHI CRAIG M;;FERRY KENNETH ARTHUR ABRAHAM;;FOSS CHRISTOPHER PATRICK;;GHARABALLY SAM H;;GOLDBERG BRIAN ERIK;;KHAN NAHIR A;;KO HEENA;;KOWALCZYKOWSKI KEITH P;;MEHRA RISHAB;;PAUL GRANT;;RAMASWAMY PALLAVIKA;;RITCHIE GRANT;;ROBBIN JEFFREY L;;SAVAGE JAMES S;;SIBSON MATTHEW;;SINGH GURSHAMNJOT;;STACK CAELAN G;;XUE MARK M;;YIN LUMING;;YING CHARLES H;;ZHANG HENGLIANG;;ZHANG XIAOYUE,,https://lens.org/129-832-370-218-26X,Patent Application,yes,31,0,27,37,0,G06F3/04817;;G06F3/0488;;G06F8/61;;G06F9/445;;H04M1/72472;;G06F9/451;;G06F8/61;;G06F9/44568;;G06F9/52;;G06F9/54;;G06F3/04842;;G06F3/04883;;G06F3/04886;;G06F8/38;;H04L67/34;;H04L67/5651,G06F3/0481;;G06F3/0488;;G06F8/61;;G06F9/445,,0,0,,,,PENDING
